{"config": {"terminology": {"item": "Researcher", "items": "Researchers", "link": "Publication", "links": "Publications", "link_strength": "Publication collaborations", "total_link_strength": "Total collaborations"}, "templates": {}, "styles": {"description_heading": "color: #757575; font-weight: 600;"}}, "network": {"items": [{"id": "cytokine storm", "label": "cytokine storm"}, {"id": "humoral immune response", "label": "humoral immune response"}, {"id": "viral replication", "label": "viral replication"}, {"id": "high-income countries", "label": "high-income countries"}, {"id": "interviews", "label": "interviews"}, {"id": "epithelial cells", "label": "epithelial cells"}, {"id": "clinical symptoms", "label": "clinical symptoms"}, {"id": "Web of Science", "label": "Web of Science"}, {"id": "care providers", "label": "care providers"}, {"id": "innate immune response", "label": "innate immune response"}, {"id": "complications", "label": "complications"}, {"id": "conservation", "label": "conservation"}, {"id": "justice", "label": "justice"}, {"id": "blood pressure", "label": "blood pressure"}, {"id": "health care workers", "label": "health care workers"}, {"id": "COVID-19 mRNA vaccines", "label": "COVID-19 mRNA vaccines"}, {"id": "acute respiratory distress syndrome", "label": "acute respiratory distress syndrome"}, {"id": "policy", "label": "policy"}, {"id": "educators", "label": "educators"}, {"id": "kidney disease", "label": "kidney disease"}, {"id": "clinical manifestations", "label": "clinical manifestations"}, {"id": "SARS-CoV-2", "label": "SARS-CoV-2"}, {"id": "vaccination status", "label": "vaccination status"}, {"id": "semi-structured interviews", "label": "semi-structured interviews"}, {"id": "thematic analysis", "label": "thematic analysis"}, {"id": "observational cohort study", "label": "observational cohort study"}, {"id": "mRNA vaccines", "label": "mRNA vaccines"}, {"id": "young adults", "label": "young adults"}, {"id": "COVID-19 patients", "label": "COVID-19 patients"}, {"id": "mental health", "label": "mental health"}, {"id": "prospective study", "label": "prospective study"}, {"id": "first dose", "label": "first dose"}, {"id": "severe illness", "label": "severe illness"}, {"id": "prospective cohort study", "label": "prospective cohort study"}, {"id": "blood samples", "label": "blood samples"}, {"id": "ischemic stroke", "label": "ischemic stroke"}, {"id": "unvaccinated individuals", "label": "unvaccinated individuals"}, {"id": "study protocol", "label": "study protocol"}, {"id": "hospital stay", "label": "hospital stay"}, {"id": "spike protein", "label": "spike protein"}, {"id": "therapy", "label": "therapy"}, {"id": "intensive care unit admission", "label": "intensive care unit admission"}, {"id": "motivation", "label": "motivation"}, {"id": "primary outcome", "label": "primary outcome"}, {"id": "intensive care", "label": "intensive care"}, {"id": "pediatric patients", "label": "pediatric patients"}, {"id": "severe acute respiratory syndrome coronavirus 2", "label": "severe acute respiratory syndrome coronavirus 2"}, {"id": "cross-sectional study", "label": "cross-sectional study"}, {"id": "treatment strategies", "label": "treatment strategies"}, {"id": "study participants", "label": "study participants"}, {"id": "case report", "label": "case report"}, {"id": "women", "label": "women"}, {"id": "mortality rate", "label": "mortality rate"}, {"id": "diabetes mellitus", "label": "diabetes mellitus"}, {"id": "COVID-19 pandemic", "label": "COVID-19 pandemic"}, {"id": "cohort study", "label": "cohort study"}, {"id": "SARS-CoV-2 infection", "label": "SARS-CoV-2 infection"}, {"id": "learning model", "label": "learning model"}, {"id": "SARS-CoV2", "label": "SARS-CoV2"}, {"id": "long COVID", "label": "long COVID"}, {"id": "immune response", "label": "immune response"}, {"id": "health records", "label": "health records"}, {"id": "COVID-19 infection", "label": "COVID-19 infection"}, {"id": "healthcare professionals", "label": "healthcare professionals"}, {"id": "prevalence", "label": "prevalence"}, {"id": "electronic health records", "label": "electronic health records"}, {"id": "B cells", "label": "B cells"}, {"id": "animal models", "label": "animal models"}, {"id": "actors", "label": "actors"}, {"id": "clinical care", "label": "clinical care"}, {"id": "pulmonary disease", "label": "pulmonary disease"}, {"id": "variants of concern", "label": "variants of concern"}, {"id": "coronavirus disease", "label": "coronavirus disease"}, {"id": "cohort", "label": "cohort"}, {"id": "healthcare workers", "label": "healthcare workers"}, {"id": "greater risk", "label": "greater risk"}, {"id": "antibody levels", "label": "antibody levels"}, {"id": "side effects", "label": "side effects"}, {"id": "symptoms", "label": "symptoms"}, {"id": "inflammatory diseases", "label": "inflammatory diseases"}, {"id": "governance", "label": "governance"}, {"id": "ecosystems", "label": "ecosystems"}, {"id": "patient care", "label": "patient care"}, {"id": "social media", "label": "social media"}, {"id": "pandemic", "label": "pandemic"}, {"id": "physical activity", "label": "physical activity"}, {"id": "qualitative study", "label": "qualitative study"}, {"id": "adverse effects", "label": "adverse effects"}, {"id": "medical records", "label": "medical records"}, {"id": "patient outcomes", "label": "patient outcomes"}, {"id": "pregnancy", "label": "pregnancy"}, {"id": "hospital admission", "label": "hospital admission"}, {"id": "social determinants", "label": "social determinants"}, {"id": "care workers", "label": "care workers"}, {"id": "Health Organization", "label": "Health Organization"}, {"id": "protective effect", "label": "protective effect"}, {"id": "general population", "label": "general population"}, {"id": "SARS-CoV-2 Omicron variant", "label": "SARS-CoV-2 Omicron variant"}, {"id": "COVID-19", "label": "COVID-19"}, {"id": "nasopharyngeal swabs", "label": "nasopharyngeal swabs"}, {"id": "use disorders", "label": "use disorders"}, {"id": "intensive care unit", "label": "intensive care unit"}, {"id": "training", "label": "training"}, {"id": "acute respiratory syndrome coronavirus 2 infection", "label": "acute respiratory syndrome coronavirus 2 infection"}, {"id": "context", "label": "context"}, {"id": "antiviral therapy", "label": "antiviral therapy"}, {"id": "clinical studies", "label": "clinical studies"}, {"id": "C-reactive protein", "label": "C-reactive protein"}, {"id": "community", "label": "community"}, {"id": "countries", "label": "countries"}, {"id": "clinical trials", "label": "clinical trials"}, {"id": "COVID-19 severity", "label": "COVID-19 severity"}, {"id": "vaccination program", "label": "vaccination program"}, {"id": "care professionals", "label": "care professionals"}, {"id": "infection", "label": "infection"}, {"id": "health policy", "label": "health policy"}, {"id": "SARS-CoV-2 spike protein", "label": "SARS-CoV-2 spike protein"}, {"id": "unit admission", "label": "unit admission"}, {"id": "primary care", "label": "primary care"}, {"id": "ICU admission", "label": "ICU admission"}, {"id": "vaccine hesitancy", "label": "vaccine hesitancy"}, {"id": "dose", "label": "dose"}, {"id": "D-dimer", "label": "D-dimer"}, {"id": "people", "label": "people"}, {"id": "future research", "label": "future research"}, {"id": "cells", "label": "cells"}, {"id": "SARS-CoV-2 antibodies", "label": "SARS-CoV-2 antibodies"}, {"id": "median time", "label": "median time"}, {"id": "second dose", "label": "second dose"}, {"id": "society", "label": "society"}, {"id": "syndrome", "label": "syndrome"}, {"id": "health issues", "label": "health issues"}, {"id": "admission", "label": "admission"}, {"id": "middle-income countries", "label": "middle-income countries"}, {"id": "Secondary outcomes", "label": "Secondary outcomes"}, {"id": "care unit", "label": "care unit"}, {"id": "market", "label": "market"}, {"id": "body mass index", "label": "body mass index"}, {"id": "virus infection", "label": "virus infection"}, {"id": "care services", "label": "care services"}, {"id": "high mortality", "label": "high mortality"}, {"id": "respiratory syndrome coronavirus 2", "label": "respiratory syndrome coronavirus 2"}, {"id": "perspective", "label": "perspective"}, {"id": "institutions", "label": "institutions"}, {"id": "species", "label": "species"}, {"id": "algorithm", "label": "algorithm"}, {"id": "inflammatory response", "label": "inflammatory response"}, {"id": "third dose", "label": "third dose"}, {"id": "mRNA vaccination", "label": "mRNA vaccination"}, {"id": "health problems", "label": "health problems"}, {"id": "employees", "label": "employees"}, {"id": "SARS-CoV-2 vaccination", "label": "SARS-CoV-2 vaccination"}, {"id": "viral load", "label": "viral load"}, {"id": "observational study", "label": "observational study"}, {"id": "vaccination rates", "label": "vaccination rates"}, {"id": "Omicron infection", "label": "Omicron infection"}, {"id": "disease progression", "label": "disease progression"}, {"id": "respiratory failure", "label": "respiratory failure"}, {"id": "respiratory tract", "label": "respiratory tract"}, {"id": "study period", "label": "study period"}, {"id": "cancer", "label": "cancer"}, {"id": "climate change", "label": "climate change"}, {"id": "respiratory disease", "label": "respiratory disease"}, {"id": "disease", "label": "disease"}, {"id": "syndrome coronavirus 2", "label": "syndrome coronavirus 2"}, {"id": "high prevalence", "label": "high prevalence"}, {"id": "health concern", "label": "health concern"}, {"id": "United States", "label": "United States"}, {"id": "disease control", "label": "disease control"}, {"id": "T cell responses", "label": "T cell responses"}, {"id": "cancer patients", "label": "cancer patients"}, {"id": "health outcomes", "label": "health outcomes"}, {"id": "antibody response", "label": "antibody response"}, {"id": "inclusion criteria", "label": "inclusion criteria"}, {"id": "higher odds", "label": "higher odds"}, {"id": "diagnosis", "label": "diagnosis"}, {"id": "infection rate", "label": "infection rate"}, {"id": "antiviral activity", "label": "antiviral activity"}, {"id": "clinical presentation", "label": "clinical presentation"}, {"id": "engagement", "label": "engagement"}, {"id": "symptom onset", "label": "symptom onset"}, {"id": "experience", "label": "experience"}, {"id": "case-control study", "label": "case-control study"}, {"id": "learners", "label": "learners"}, {"id": "respiratory symptoms", "label": "respiratory symptoms"}, {"id": "skills", "label": "skills"}, {"id": "teachers", "label": "teachers"}, {"id": "young people", "label": "young people"}, {"id": "violence", "label": "violence"}, {"id": "disease severity", "label": "disease severity"}, {"id": "narratives", "label": "narratives"}, {"id": "respiratory distress syndrome", "label": "respiratory distress syndrome"}, {"id": "government", "label": "government"}, {"id": "health measures", "label": "health measures"}, {"id": "MAIN OUTCOME", "label": "MAIN OUTCOME"}, {"id": "myocardial infarction", "label": "myocardial infarction"}, {"id": "odds ratio", "label": "odds ratio"}, {"id": "mortality", "label": "mortality"}, {"id": "antibody titers", "label": "antibody titers"}, {"id": "inflammatory syndrome", "label": "inflammatory syndrome"}, {"id": "incidence", "label": "incidence"}, {"id": "lower risk", "label": "lower risk"}, {"id": "book", "label": "book"}, {"id": "ill patients", "label": "ill patients"}, {"id": "primary endpoint", "label": "primary endpoint"}, {"id": "length of stay", "label": "length of stay"}, {"id": "artificial intelligence", "label": "artificial intelligence"}, {"id": "study population", "label": "study population"}, {"id": "acute phase", "label": "acute phase"}, {"id": "students", "label": "students"}, {"id": "RT-PCR", "label": "RT-PCR"}, {"id": "learning", "label": "learning"}, {"id": "study design", "label": "study design"}, {"id": "most patients", "label": "most patients"}, {"id": "COVID-19 symptoms", "label": "COVID-19 symptoms"}, {"id": "acute respiratory syndrome coronavirus 2", "label": "acute respiratory syndrome coronavirus 2"}, {"id": "case series", "label": "case series"}, {"id": "systematic review", "label": "systematic review"}, {"id": "independent predictors", "label": "independent predictors"}, {"id": "mean age", "label": "mean age"}, {"id": "SARS-CoV-2 RNA", "label": "SARS-CoV-2 RNA"}, {"id": "adverse outcomes", "label": "adverse outcomes"}, {"id": "serious adverse events", "label": "serious adverse events"}, {"id": "education", "label": "education"}, {"id": "rights", "label": "rights"}, {"id": "electronic medical records", "label": "electronic medical records"}, {"id": "public health measures", "label": "public health measures"}, {"id": "research", "label": "research"}, {"id": "health interventions", "label": "health interventions"}, {"id": "multiple sclerosis", "label": "multiple sclerosis"}, {"id": "mechanical ventilation", "label": "mechanical ventilation"}, {"id": "median age", "label": "median age"}, {"id": "psychological distress", "label": "psychological distress"}, {"id": "monoclonal antibodies", "label": "monoclonal antibodies"}, {"id": "cardiovascular disease", "label": "cardiovascular disease"}, {"id": "Medical Center", "label": "Medical Center"}, {"id": "depressive symptoms", "label": "depressive symptoms"}, {"id": "central nervous system", "label": "central nervous system"}, {"id": "mass index", "label": "mass index"}, {"id": "clinical characteristics", "label": "clinical characteristics"}, {"id": "health professionals", "label": "health professionals"}, {"id": "COVID-19 diagnosis", "label": "COVID-19 diagnosis"}, {"id": "IL-6", "label": "IL-6"}, {"id": "hospital mortality", "label": "hospital mortality"}, {"id": "age groups", "label": "age groups"}, {"id": "oxidative stress", "label": "oxidative stress"}, {"id": "lung disease", "label": "lung disease"}, {"id": "severe cases", "label": "severe cases"}, {"id": "autoimmune diseases", "label": "autoimmune diseases"}, {"id": "SARS-CoV-2 pandemic", "label": "SARS-CoV-2 pandemic"}, {"id": "clinical practice", "label": "clinical practice"}, {"id": "care system", "label": "care system"}, {"id": "vaccine dose", "label": "vaccine dose"}, {"id": "disease 2019", "label": "disease 2019"}, {"id": "health disparities", "label": "health disparities"}, {"id": "receptor-binding domain", "label": "receptor-binding domain"}, {"id": "program", "label": "program"}, {"id": "treatment options", "label": "treatment options"}, {"id": "pilot study", "label": "pilot study"}, {"id": "persistent symptoms", "label": "persistent symptoms"}, {"id": "heart failure", "label": "heart failure"}, {"id": "cell responses", "label": "cell responses"}, {"id": "health care professionals", "label": "health care professionals"}, {"id": "therapeutic strategies", "label": "therapeutic strategies"}, {"id": "curriculum", "label": "curriculum"}, {"id": "pain", "label": "pain"}, {"id": "safety profile", "label": "safety profile"}, {"id": "distress syndrome", "label": "distress syndrome"}, {"id": "quality of life", "label": "quality of life"}, {"id": "booster doses", "label": "booster doses"}, {"id": "hospital discharge", "label": "hospital discharge"}, {"id": "immune system", "label": "immune system"}, {"id": "organization", "label": "organization"}, {"id": "emergency department", "label": "emergency department"}, {"id": "COVID-19 outcomes", "label": "COVID-19 outcomes"}, {"id": "disease burden", "label": "disease burden"}, {"id": "mouse model", "label": "mouse model"}, {"id": "health services", "label": "health services"}, {"id": "SARS-CoV-2 variants", "label": "SARS-CoV-2 variants"}, {"id": "healthy controls", "label": "healthy controls"}, {"id": "infectious diseases", "label": "infectious diseases"}, {"id": "cross-sectional survey", "label": "cross-sectional survey"}, {"id": "hazard ratio", "label": "hazard ratio"}, {"id": "neural network", "label": "neural network"}, {"id": "weight loss", "label": "weight loss"}, {"id": "control group", "label": "control group"}, {"id": "booster dose", "label": "booster dose"}, {"id": "breast cancer", "label": "breast cancer"}, {"id": "multivariable logistic regression", "label": "multivariable logistic regression"}, {"id": "anxiety", "label": "anxiety"}, {"id": "case study", "label": "case study"}, {"id": "Alzheimer's disease", "label": "Alzheimer's disease"}, {"id": "type 2 diabetes", "label": "type 2 diabetes"}, {"id": "pregnant women", "label": "pregnant women"}, {"id": "vaccine", "label": "vaccine"}, {"id": "hospitalized patients", "label": "hospitalized patients"}, {"id": "mental health outcomes", "label": "mental health outcomes"}, {"id": "flow cytometry", "label": "flow cytometry"}, {"id": "adult patients", "label": "adult patients"}, {"id": "high risk", "label": "high risk"}, {"id": "logistic regression models", "label": "logistic regression models"}, {"id": "teaching", "label": "teaching"}, {"id": "World Health Organization", "label": "World Health Organization"}, {"id": "mental health problems", "label": "mental health problems"}, {"id": "breakthrough infections", "label": "breakthrough infections"}, {"id": "hospitalization", "label": "hospitalization"}, {"id": "COVID-19 pneumonia", "label": "COVID-19 pneumonia"}, {"id": "transplant recipients", "label": "transplant recipients"}, {"id": "SARS-CoV-2 replication", "label": "SARS-CoV-2 replication"}, {"id": "care settings", "label": "care settings"}, {"id": "trials", "label": "trials"}, {"id": "Delta variant", "label": "Delta variant"}, {"id": "booster vaccination", "label": "booster vaccination"}, {"id": "economy", "label": "economy"}, {"id": "protein", "label": "protein"}, {"id": "vaccination coverage", "label": "vaccination coverage"}, {"id": "pneumonia", "label": "pneumonia"}, {"id": "race/ethnicity", "label": "race/ethnicity"}, {"id": "COVID-19 vaccine", "label": "COVID-19 vaccine"}, {"id": "COVID-19 cases", "label": "COVID-19 cases"}, {"id": "BNT162b2 vaccine", "label": "BNT162b2 vaccine"}, {"id": "coronavirus 2", "label": "coronavirus 2"}, {"id": "incidence rate", "label": "incidence rate"}, {"id": "patient characteristics", "label": "patient characteristics"}, {"id": "perception", "label": "perception"}, {"id": "clinical data", "label": "clinical data"}, {"id": "medical students", "label": "medical students"}, {"id": "SARS-CoV-2 vaccines", "label": "SARS-CoV-2 vaccines"}, {"id": "vaccine effectiveness", "label": "vaccine effectiveness"}, {"id": "higher education", "label": "higher education"}, {"id": "practice", "label": "practice"}, {"id": "high incidence", "label": "high incidence"}, {"id": "course", "label": "course"}, {"id": "disease 2019 pandemic", "label": "disease 2019 pandemic"}, {"id": "participants", "label": "participants"}, {"id": "sociodemographic characteristics", "label": "sociodemographic characteristics"}, {"id": "chronic kidney disease", "label": "chronic kidney disease"}, {"id": "beneficial effects", "label": "beneficial effects"}, {"id": "T cells", "label": "T cells"}, {"id": "gene expression", "label": "gene expression"}, {"id": "Omicron variant", "label": "Omicron variant"}, {"id": "children", "label": "children"}, {"id": "years of age", "label": "years of age"}, {"id": "cell types", "label": "cell types"}, {"id": "clinical outcomes", "label": "clinical outcomes"}, {"id": "adverse events", "label": "adverse events"}, {"id": "predictive value", "label": "predictive value"}, {"id": "immune cells", "label": "immune cells"}, {"id": "mice", "label": "mice"}, {"id": "clinical setting", "label": "clinical setting"}, {"id": "care", "label": "care"}, {"id": "sector", "label": "sector"}, {"id": "health conditions", "label": "health conditions"}, {"id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "label": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection"}, {"id": "retrospective cohort study", "label": "retrospective cohort study"}, {"id": "syndrome coronavirus 2 infection", "label": "syndrome coronavirus 2 infection"}, {"id": "coronavirus 2 infection", "label": "coronavirus 2 infection"}, {"id": "outcome measures", "label": "outcome measures"}, {"id": "injury", "label": "injury"}, {"id": "chronic diseases", "label": "chronic diseases"}, {"id": "therapeutic target", "label": "therapeutic target"}, {"id": "SARS-CoV-2 transmission", "label": "SARS-CoV-2 transmission"}, {"id": "health system", "label": "health system"}, {"id": "COVID-19 vaccination", "label": "COVID-19 vaccination"}, {"id": "cause mortality", "label": "cause mortality"}, {"id": "severe COVID-19", "label": "severe COVID-19"}, {"id": "patients", "label": "patients"}, {"id": "severe disease", "label": "severe disease"}, {"id": "coronavirus disease 2019 (COVID-19) pandemic", "label": "coronavirus disease 2019 (COVID-19) pandemic"}, {"id": "care facilities", "label": "care facilities"}, {"id": "hospital", "label": "hospital"}, {"id": "viral infection", "label": "viral infection"}, {"id": "nervous system", "label": "nervous system"}, {"id": "vaccination", "label": "vaccination"}, {"id": "care unit admission", "label": "care unit admission"}, {"id": "inflammation", "label": "inflammation"}, {"id": "humoral response", "label": "humoral response"}, {"id": "politics", "label": "politics"}, {"id": "health care", "label": "health care"}, {"id": "Meta-Analysis", "label": "Meta-Analysis"}, {"id": "SARS-CoV-2 virus", "label": "SARS-CoV-2 virus"}, {"id": "time points", "label": "time points"}, {"id": "vaccine doses", "label": "vaccine doses"}, {"id": "article", "label": "article"}, {"id": "technology", "label": "technology"}, {"id": "health status", "label": "health status"}, {"id": "intervention group", "label": "intervention group"}, {"id": "COVID-19 disease", "label": "COVID-19 disease"}, {"id": "crisis", "label": "crisis"}, {"id": "logistic regression analysis", "label": "logistic regression analysis"}, {"id": "surgery", "label": "surgery"}, {"id": "social support", "label": "social support"}, {"id": "University", "label": "University"}, {"id": "University Hospital", "label": "University Hospital"}, {"id": "genes", "label": "genes"}, {"id": "illness", "label": "illness"}, {"id": "coronavirus disease 2019", "label": "coronavirus disease 2019"}, {"id": "schools", "label": "schools"}, {"id": "older age", "label": "older age"}, {"id": "discourse", "label": "discourse"}, {"id": "vaccination campaign", "label": "vaccination campaign"}, {"id": "patient population", "label": "patient population"}, {"id": "acute infection", "label": "acute infection"}, {"id": "older adults", "label": "older adults"}, {"id": "risk factors", "label": "risk factors"}, {"id": "need", "label": "need"}, {"id": "logistic regression", "label": "logistic regression"}, {"id": "vaccine uptake", "label": "vaccine uptake"}, {"id": "retrospective study", "label": "retrospective study"}], "links": [{"source_id": "COVID-19 pandemic", "target_id": "cohort study", "strength": 24}, {"source_id": "cohort study", "target_id": "COVID-19 pandemic", "strength": 24}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 infection", "strength": 174}, {"source_id": "intensive care unit", "target_id": "care unit", "strength": 78}, {"source_id": "severe disease", "target_id": "patients", "strength": 26}, {"source_id": "COVID-19", "target_id": "patients", "strength": 234}, {"source_id": "respiratory distress syndrome", "target_id": "acute respiratory distress syndrome", "strength": 45}, {"source_id": "distress syndrome", "target_id": "patients", "strength": 26}, {"source_id": "high risk", "target_id": "patients", "strength": 48}, {"source_id": "patients", "target_id": "intensive care unit", "strength": 44}, {"source_id": "patients", "target_id": "COVID-19", "strength": 234}, {"source_id": "patients", "target_id": "high risk", "strength": 48}, {"source_id": "observational study", "target_id": "patients", "strength": 47}, {"source_id": "primary outcome", "target_id": "SARS-CoV-2", "strength": 19}, {"source_id": "patients", "target_id": "primary outcome", "strength": 68}, {"source_id": "respiratory failure", "target_id": "patients", "strength": 26}, {"source_id": "patients", "target_id": "hospital mortality", "strength": 32}, {"source_id": "patients", "target_id": "disease 2019", "strength": 46}, {"source_id": "severe COVID-19", "target_id": "COVID-19", "strength": 66}, {"source_id": "hospital stay", "target_id": "patients", "strength": 20}, {"source_id": "mechanical ventilation", "target_id": "patients", "strength": 53}, {"source_id": "adverse events", "target_id": "patients", "strength": 48}, {"source_id": "patients", "target_id": "mechanical ventilation", "strength": 53}, {"source_id": "COVID-19 infection", "target_id": "patients", "strength": 81}, {"source_id": "patients", "target_id": "antibody response", "strength": 21}, {"source_id": "vaccine", "target_id": "mRNA vaccines", "strength": 64}, {"source_id": "vaccine", "target_id": "antibody response", "strength": 24}, {"source_id": "vaccination", "target_id": "patients", "strength": 52}, {"source_id": "COVID-19", "target_id": "infection", "strength": 66}, {"source_id": "infection", "target_id": "COVID-19", "strength": 66}, {"source_id": "clinical trials", "target_id": "patients", "strength": 51}, {"source_id": "mass index", "target_id": "body mass index", "strength": 34}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 vaccination", "strength": 19}, {"source_id": "SARS-CoV-2 infection", "target_id": "infection", "strength": 164}, {"source_id": "COVID-19 vaccination", "target_id": "SARS-CoV-2 infection", "strength": 19}, {"source_id": "COVID-19 infection", "target_id": "SARS-CoV-2 infection", "strength": 31}, {"source_id": "intensive care unit admission", "target_id": "unit admission", "strength": 27}, {"source_id": "COVID-19 vaccine", "target_id": "COVID-19 vaccination", "strength": 60}, {"source_id": "vaccination", "target_id": "COVID-19 vaccination", "strength": 67}, {"source_id": "patients", "target_id": "COVID-19 vaccination", "strength": 26}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "syndrome coronavirus 2", "strength": 129}, {"source_id": "COVID-19", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 20}, {"source_id": "COVID-19", "target_id": "coronavirus 2", "strength": 39}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 129}, {"source_id": "syndrome coronavirus 2", "target_id": "respiratory syndrome coronavirus 2", "strength": 130}, {"source_id": "coronavirus 2", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 127}, {"source_id": "coronavirus 2", "target_id": "syndrome coronavirus 2", "strength": 128}, {"source_id": "mental health", "target_id": "COVID-19 pandemic", "strength": 56}, {"source_id": "COVID-19", "target_id": "disease", "strength": 23}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "disease 2019", "strength": 36}, {"source_id": "syndrome coronavirus 2", "target_id": "disease 2019", "strength": 36}, {"source_id": "coronavirus disease 2019", "target_id": "coronavirus 2", "strength": 37}, {"source_id": "disease 2019", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 36}, {"source_id": "disease 2019", "target_id": "respiratory syndrome coronavirus 2", "strength": 36}, {"source_id": "SARS-CoV-2 infection", "target_id": "cohort study", "strength": 46}, {"source_id": "SARS-CoV-2", "target_id": "cohort study", "strength": 42}, {"source_id": "cohort study", "target_id": "SARS-CoV-2", "strength": 42}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 patients", "strength": 30}, {"source_id": "disease 2019", "target_id": "COVID-19 patients", "strength": 27}, {"source_id": "students", "target_id": "COVID-19 pandemic", "strength": 45}, {"source_id": "students", "target_id": "education", "strength": 75}, {"source_id": "students", "target_id": "COVID-19", "strength": 28}, {"source_id": "education", "target_id": "COVID-19", "strength": 22}, {"source_id": "immune response", "target_id": "COVID-19 vaccine", "strength": 24}, {"source_id": "immune response", "target_id": "mRNA vaccines", "strength": 21}, {"source_id": "immune response", "target_id": "vaccine", "strength": 48}, {"source_id": "systematic review", "target_id": "Meta-Analysis", "strength": 21}, {"source_id": "vaccination", "target_id": "immune response", "strength": 26}, {"source_id": "Meta-Analysis", "target_id": "systematic review", "strength": 21}, {"source_id": "health records", "target_id": "electronic health records", "strength": 29}, {"source_id": "risk factors", "target_id": "SARS-CoV-2 infection", "strength": 35}, {"source_id": "risk factors", "target_id": "infection", "strength": 37}, {"source_id": "viral load", "target_id": "SARS-CoV-2", "strength": 19}, {"source_id": "clinical characteristics", "target_id": "patients", "strength": 24}, {"source_id": "vaccine", "target_id": "adverse events", "strength": 30}, {"source_id": "cross-sectional study", "target_id": "patients", "strength": 25}, {"source_id": "SARS-CoV-2 infection", "target_id": "syndrome coronavirus 2", "strength": 30}, {"source_id": "central nervous system", "target_id": "nervous system", "strength": 37}, {"source_id": "infection", "target_id": "Omicron variant", "strength": 29}, {"source_id": "booster dose", "target_id": "vaccine", "strength": 20}, {"source_id": "COVID-19 pandemic", "target_id": "teaching", "strength": 21}, {"source_id": "experience", "target_id": "education", "strength": 21}, {"source_id": "teaching", "target_id": "education", "strength": 38}, {"source_id": "teaching", "target_id": "learning", "strength": 28}, {"source_id": "learning", "target_id": "education", "strength": 46}, {"source_id": "students", "target_id": "skills", "strength": 33}, {"source_id": "learning", "target_id": "students", "strength": 59}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "Omicron variant", "strength": 31}, {"source_id": "breakthrough infections", "target_id": "infection", "strength": 29}, {"source_id": "antibody titers", "target_id": "SARS-CoV-2", "strength": 22}, {"source_id": "infection", "target_id": "breakthrough infections", "strength": 29}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 patients", "strength": 63}, {"source_id": "crisis", "target_id": "policy", "strength": 19}, {"source_id": "policy", "target_id": "crisis", "strength": 19}, {"source_id": "education", "target_id": "higher education", "strength": 28}, {"source_id": "education", "target_id": "teachers", "strength": 40}, {"source_id": "curriculum", "target_id": "education", "strength": 23}, {"source_id": "cohort study", "target_id": "study period", "strength": 25}, {"source_id": "immune response", "target_id": "infection", "strength": 70}, {"source_id": "risk factors", "target_id": "COVID-19 infection", "strength": 27}, {"source_id": "cohort study", "target_id": "retrospective cohort study", "strength": 66}, {"source_id": "COVID-19", "target_id": "mean age", "strength": 19}, {"source_id": "symptoms", "target_id": "patients", "strength": 43}, {"source_id": "severe COVID-19", "target_id": "SARS-CoV-2", "strength": 26}, {"source_id": "COVID-19", "target_id": "observational study", "strength": 31}, {"source_id": "COVID-19 patients", "target_id": "disease severity", "strength": 27}, {"source_id": "vaccination", "target_id": "mRNA vaccination", "strength": 19}, {"source_id": "risk factors", "target_id": "SARS-CoV-2", "strength": 32}, {"source_id": "T cells", "target_id": "T cell responses", "strength": 28}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 variants", "strength": 31}, {"source_id": "patients", "target_id": "cancer", "strength": 26}, {"source_id": "COVID-19 vaccine", "target_id": "second dose", "strength": 33}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 patients", "strength": 55}, {"source_id": "SARS-CoV-2 infection", "target_id": "symptoms", "strength": 22}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "syndrome coronavirus 2 infection", "strength": 36}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 36}, {"source_id": "COVID-19 patients", "target_id": "SARS-CoV-2 infection", "strength": 55}, {"source_id": "symptoms", "target_id": "SARS-CoV-2", "strength": 22}, {"source_id": "COVID-19", "target_id": "retrospective cohort study", "strength": 22}, {"source_id": "retrospective cohort study", "target_id": "patients", "strength": 37}, {"source_id": "cohort study", "target_id": "patients", "strength": 94}, {"source_id": "logistic regression", "target_id": "COVID-19", "strength": 23}, {"source_id": "COVID-19", "target_id": "COVID-19 vaccine", "strength": 31}, {"source_id": "COVID-19 vaccine", "target_id": "COVID-19", "strength": 31}, {"source_id": "SARS-CoV-2 infection", "target_id": "vaccine effectiveness", "strength": 27}, {"source_id": "public health measures", "target_id": "health measures", "strength": 19}, {"source_id": "health measures", "target_id": "public health measures", "strength": 19}, {"source_id": "cohort study", "target_id": "high risk", "strength": 29}, {"source_id": "COVID-19", "target_id": "COVID-19 cases", "strength": 21}, {"source_id": "mortality", "target_id": "risk factors", "strength": 23}, {"source_id": "COVID-19 vaccination", "target_id": "second dose", "strength": 20}, {"source_id": "cohort study", "target_id": "observational cohort study", "strength": 27}, {"source_id": "COVID-19", "target_id": "cross-sectional study", "strength": 20}, {"source_id": "COVID-19 pandemic", "target_id": "cross-sectional study", "strength": 22}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "patients", "strength": 25}, {"source_id": "COVID-19 pandemic", "target_id": "teachers", "strength": 26}, {"source_id": "curriculum", "target_id": "students", "strength": 20}, {"source_id": "control group", "target_id": "patients", "strength": 29}, {"source_id": "COVID-19", "target_id": "disease severity", "strength": 35}, {"source_id": "disease", "target_id": "infection", "strength": 19}, {"source_id": "COVID-19", "target_id": "coronavirus disease", "strength": 19}, {"source_id": "coronavirus disease", "target_id": "COVID-19", "strength": 19}, {"source_id": "disease severity", "target_id": "infection", "strength": 23}, {"source_id": "severe disease", "target_id": "infection", "strength": 23}, {"source_id": "Delta variant", "target_id": "Omicron variant", "strength": 21}, {"source_id": "Delta variant", "target_id": "SARS-CoV-2", "strength": 26}, {"source_id": "health problems", "target_id": "mental health problems", "strength": 19}, {"source_id": "chronic kidney disease", "target_id": "kidney disease", "strength": 23}, {"source_id": "patients", "target_id": "COVID-19 severity", "strength": 19}, {"source_id": "spike protein", "target_id": "SARS-CoV-2 infection", "strength": 19}, {"source_id": "SARS-CoV-2 infection", "target_id": "spike protein", "strength": 19}, {"source_id": "viral infection", "target_id": "SARS-CoV-2", "strength": 30}, {"source_id": "intensive care unit", "target_id": "COVID-19", "strength": 24}, {"source_id": "acute respiratory distress syndrome", "target_id": "patients", "strength": 25}, {"source_id": "COVID-19", "target_id": "intensive care unit", "strength": 24}, {"source_id": "COVID-19", "target_id": "high risk", "strength": 50}, {"source_id": "Health Organization", "target_id": "World Health Organization", "strength": 38}, {"source_id": "patients", "target_id": "hospital admission", "strength": 28}, {"source_id": "primary outcome", "target_id": "patients", "strength": 68}, {"source_id": "patients", "target_id": "most patients", "strength": 21}, {"source_id": "coronavirus disease 2019", "target_id": "SARS-CoV-2 infection", "strength": 23}, {"source_id": "coronavirus disease 2019", "target_id": "patients", "strength": 44}, {"source_id": "hospital mortality", "target_id": "patients", "strength": 32}, {"source_id": "healthy controls", "target_id": "patients", "strength": 35}, {"source_id": "systematic review", "target_id": "clinical trials", "strength": 19}, {"source_id": "retrospective study", "target_id": "patients", "strength": 30}, {"source_id": "patients", "target_id": "COVID-19 pneumonia", "strength": 20}, {"source_id": "patients", "target_id": "hospital discharge", "strength": 20}, {"source_id": "patients", "target_id": "adverse events", "strength": 48}, {"source_id": "adult patients", "target_id": "patients", "strength": 59}, {"source_id": "patients", "target_id": "COVID-19 infection", "strength": 81}, {"source_id": "patients", "target_id": "adult patients", "strength": 59}, {"source_id": "mRNA vaccines", "target_id": "second dose", "strength": 23}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "vaccine", "strength": 36}, {"source_id": "clinical practice", "target_id": "patients", "strength": 19}, {"source_id": "vaccine", "target_id": "patients", "strength": 35}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "vaccination", "strength": 20}, {"source_id": "emergency department", "target_id": "patients", "strength": 22}, {"source_id": "patients", "target_id": "cancer patients", "strength": 29}, {"source_id": "patients", "target_id": "clinical trials", "strength": 51}, {"source_id": "SARS-CoV-2 infection", "target_id": "vaccine", "strength": 30}, {"source_id": "mRNA vaccines", "target_id": "COVID-19 vaccine", "strength": 31}, {"source_id": "COVID-19 vaccine", "target_id": "SARS-CoV-2 infection", "strength": 24}, {"source_id": "COVID-19 vaccine", "target_id": "SARS-CoV-2", "strength": 32}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 infection", "strength": 31}, {"source_id": "COVID-19 vaccine", "target_id": "infection", "strength": 21}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 vaccination", "strength": 20}, {"source_id": "SARS-CoV-2", "target_id": "vaccination", "strength": 44}, {"source_id": "unit admission", "target_id": "intensive care unit admission", "strength": 27}, {"source_id": "vaccination", "target_id": "antibody response", "strength": 19}, {"source_id": "vaccination", "target_id": "infection", "strength": 33}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "syndrome coronavirus 2", "strength": 128}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "coronavirus 2", "strength": 126}, {"source_id": "COVID-19", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 39}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 128}, {"source_id": "health outcomes", "target_id": "mental health outcomes", "strength": 24}, {"source_id": "COVID-19 outcomes", "target_id": "COVID-19", "strength": 19}, {"source_id": "coronavirus disease 2019", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 37}, {"source_id": "coronavirus disease 2019", "target_id": "syndrome coronavirus 2", "strength": 37}, {"source_id": "coronavirus 2", "target_id": "coronavirus disease 2019", "strength": 37}, {"source_id": "mortality", "target_id": "COVID-19", "strength": 36}, {"source_id": "COVID-19 patients", "target_id": "coronavirus disease 2019", "strength": 27}, {"source_id": "education", "target_id": "students", "strength": 75}, {"source_id": "COVID-19", "target_id": "education", "strength": 22}, {"source_id": "mRNA vaccines", "target_id": "immune response", "strength": 21}, {"source_id": "vaccination", "target_id": "vaccine", "strength": 51}, {"source_id": "electronic health records", "target_id": "health records", "strength": 29}, {"source_id": "infection", "target_id": "risk factors", "strength": 37}, {"source_id": "COVID-19 patients", "target_id": "clinical outcomes", "strength": 20}, {"source_id": "COVID-19", "target_id": "adverse events", "strength": 22}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19", "strength": 105}, {"source_id": "SARS-CoV-2 infection", "target_id": "viral infection", "strength": 24}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 infection", "strength": 105}, {"source_id": "viral infection", "target_id": "SARS-CoV-2 infection", "strength": 24}, {"source_id": "systematic review", "target_id": "patients", "strength": 44}, {"source_id": "COVID-19 patients", "target_id": "mechanical ventilation", "strength": 26}, {"source_id": "patients", "target_id": "clinical characteristics", "strength": 24}, {"source_id": "adverse events", "target_id": "serious adverse events", "strength": 30}, {"source_id": "SARS-CoV-2 infection", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 30}, {"source_id": "experience", "target_id": "COVID-19 pandemic", "strength": 24}, {"source_id": "teaching", "target_id": "COVID-19 pandemic", "strength": 21}, {"source_id": "education", "target_id": "experience", "strength": 21}, {"source_id": "learning", "target_id": "COVID-19 pandemic", "strength": 27}, {"source_id": "learning", "target_id": "teaching", "strength": 28}, {"source_id": "health services", "target_id": "COVID-19 pandemic", "strength": 22}, {"source_id": "education", "target_id": "pandemic", "strength": 22}, {"source_id": "pandemic", "target_id": "education", "strength": 22}, {"source_id": "Omicron variant", "target_id": "SARS-CoV-2 Omicron variant", "strength": 31}, {"source_id": "infection", "target_id": "cohort study", "strength": 41}, {"source_id": "crisis", "target_id": "pandemic", "strength": 19}, {"source_id": "pandemic", "target_id": "crisis", "strength": 19}, {"source_id": "education", "target_id": "curriculum", "strength": 23}, {"source_id": "teachers", "target_id": "schools", "strength": 21}, {"source_id": "infection", "target_id": "immune response", "strength": 70}, {"source_id": "ill patients", "target_id": "patients", "strength": 30}, {"source_id": "patients", "target_id": "ill patients", "strength": 30}, {"source_id": "COVID-19 infection", "target_id": "risk factors", "strength": 27}, {"source_id": "cohort study", "target_id": "primary outcome", "strength": 21}, {"source_id": "MAIN OUTCOME", "target_id": "cohort study", "strength": 23}, {"source_id": "patients", "target_id": "symptoms", "strength": 43}, {"source_id": "mortality", "target_id": "patients", "strength": 57}, {"source_id": "severe COVID-19", "target_id": "SARS-CoV-2 infection", "strength": 22}, {"source_id": "severe COVID-19", "target_id": "patients", "strength": 34}, {"source_id": "clinical trials", "target_id": "trials", "strength": 24}, {"source_id": "SARS-CoV-2", "target_id": "risk factors", "strength": 32}, {"source_id": "immune response", "target_id": "SARS-CoV-2", "strength": 73}, {"source_id": "immune response", "target_id": "humoral immune response", "strength": 23}, {"source_id": "immune response", "target_id": "T cells", "strength": 35}, {"source_id": "T cell responses", "target_id": "immune response", "strength": 24}, {"source_id": "T cells", "target_id": "SARS-CoV-2", "strength": 35}, {"source_id": "T cells", "target_id": "cell responses", "strength": 20}, {"source_id": "disease severity", "target_id": "SARS-CoV-2 infection", "strength": 33}, {"source_id": "patients", "target_id": "cohort", "strength": 19}, {"source_id": "coronavirus 2 infection", "target_id": "syndrome coronavirus 2 infection", "strength": 37}, {"source_id": "mechanical ventilation", "target_id": "COVID-19", "strength": 29}, {"source_id": "cohort study", "target_id": "COVID-19", "strength": 55}, {"source_id": "vaccine", "target_id": "COVID-19", "strength": 23}, {"source_id": "logistic regression analysis", "target_id": "patients", "strength": 19}, {"source_id": "primary outcome", "target_id": "COVID-19", "strength": 28}, {"source_id": "COVID-19", "target_id": "risk factors", "strength": 62}, {"source_id": "COVID-19 vaccination", "target_id": "COVID-19", "strength": 22}, {"source_id": "COVID-19", "target_id": "COVID-19 vaccination", "strength": 22}, {"source_id": "cohort study", "target_id": "risk factors", "strength": 34}, {"source_id": "risk factors", "target_id": "high risk", "strength": 21}, {"source_id": "risk factors", "target_id": "mortality", "strength": 23}, {"source_id": "symptoms", "target_id": "persistent symptoms", "strength": 19}, {"source_id": "high risk", "target_id": "SARS-CoV-2 infection", "strength": 24}, {"source_id": "observational cohort study", "target_id": "cohort study", "strength": 27}, {"source_id": "healthcare workers", "target_id": "COVID-19", "strength": 21}, {"source_id": "COVID-19", "target_id": "healthcare workers", "strength": 21}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "patients", "strength": 25}, {"source_id": "patients", "target_id": "coronavirus 2", "strength": 25}, {"source_id": "teachers", "target_id": "students", "strength": 37}, {"source_id": "teachers", "target_id": "teaching", "strength": 25}, {"source_id": "teaching", "target_id": "teachers", "strength": 25}, {"source_id": "learning", "target_id": "teachers", "strength": 26}, {"source_id": "education", "target_id": "University", "strength": 21}, {"source_id": "patients", "target_id": "coronavirus disease", "strength": 20}, {"source_id": "infection", "target_id": "high risk", "strength": 22}, {"source_id": "health care professionals", "target_id": "care professionals", "strength": 23}, {"source_id": "SARS-CoV-2 infection", "target_id": "severe disease", "strength": 22}, {"source_id": "Delta variant", "target_id": "SARS-CoV-2 variants", "strength": 19}, {"source_id": "T cells", "target_id": "patients", "strength": 19}, {"source_id": "COVID-19", "target_id": "adult patients", "strength": 20}, {"source_id": "hospital admission", "target_id": "COVID-19", "strength": 21}, {"source_id": "SARS-CoV-2", "target_id": "T cell responses", "strength": 23}, {"source_id": "antibody response", "target_id": "SARS-CoV-2", "strength": 23}, {"source_id": "spike protein", "target_id": "SARS-CoV-2", "strength": 53}, {"source_id": "cell responses", "target_id": "T cell responses", "strength": 31}, {"source_id": "acute respiratory distress syndrome", "target_id": "respiratory distress syndrome", "strength": 45}, {"source_id": "acute respiratory distress syndrome", "target_id": "distress syndrome", "strength": 45}, {"source_id": "World Health Organization", "target_id": "Health Organization", "strength": 38}, {"source_id": "severe disease", "target_id": "COVID-19", "strength": 31}, {"source_id": "COVID-19", "target_id": "severe disease", "strength": 31}, {"source_id": "COVID-19", "target_id": "distress syndrome", "strength": 20}, {"source_id": "COVID-19", "target_id": "care unit", "strength": 25}, {"source_id": "respiratory distress syndrome", "target_id": "patients", "strength": 26}, {"source_id": "distress syndrome", "target_id": "respiratory distress syndrome", "strength": 48}, {"source_id": "care unit", "target_id": "patients", "strength": 49}, {"source_id": "patients", "target_id": "respiratory distress syndrome", "strength": 26}, {"source_id": "SARS-CoV-2", "target_id": "primary outcome", "strength": 19}, {"source_id": "SARS-CoV-2", "target_id": "patients", "strength": 109}, {"source_id": "therapy", "target_id": "patients", "strength": 40}, {"source_id": "SARS-CoV-2 infection", "target_id": "patients", "strength": 103}, {"source_id": "patients", "target_id": "coronavirus disease 2019", "strength": 44}, {"source_id": "patients", "target_id": "healthy controls", "strength": 35}, {"source_id": "COVID-19", "target_id": "clinical trials", "strength": 41}, {"source_id": "clinical trials", "target_id": "COVID-19", "strength": 41}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 infection", "strength": 21}, {"source_id": "adverse events", "target_id": "primary outcome", "strength": 20}, {"source_id": "disease 2019", "target_id": "COVID-19 infection", "strength": 23}, {"source_id": "second dose", "target_id": "vaccine", "strength": 34}, {"source_id": "antibody response", "target_id": "vaccine", "strength": 24}, {"source_id": "SARS-CoV-2", "target_id": "severe disease", "strength": 33}, {"source_id": "median age", "target_id": "patients", "strength": 27}, {"source_id": "patients", "target_id": "median age", "strength": 27}, {"source_id": "patients", "target_id": "emergency department", "strength": 22}, {"source_id": "patients", "target_id": "MAIN OUTCOME", "strength": 28}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 vaccine", "strength": 24}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 vaccine", "strength": 32}, {"source_id": "vaccine", "target_id": "SARS-CoV-2 infection", "strength": 30}, {"source_id": "COVID-19 vaccination", "target_id": "SARS-CoV-2", "strength": 20}, {"source_id": "COVID-19 infection", "target_id": "infection", "strength": 70}, {"source_id": "intensive care unit admission", "target_id": "care unit admission", "strength": 27}, {"source_id": "care unit admission", "target_id": "unit admission", "strength": 30}, {"source_id": "patients", "target_id": "COVID-19 vaccine", "strength": 34}, {"source_id": "patients", "target_id": "mean age", "strength": 37}, {"source_id": "patients", "target_id": "admission", "strength": 23}, {"source_id": "infection", "target_id": "SARS-CoV-2 infection", "strength": 164}, {"source_id": "SARS-CoV-2", "target_id": "coronavirus 2", "strength": 66}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2", "strength": 62}, {"source_id": "COVID-19", "target_id": "disease 2019 pandemic", "strength": 20}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "syndrome coronavirus 2", "strength": 130}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "coronavirus 2", "strength": 128}, {"source_id": "syndrome coronavirus 2", "target_id": "SARS-CoV-2", "strength": 64}, {"source_id": "syndrome coronavirus 2", "target_id": "coronavirus 2", "strength": 128}, {"source_id": "coronavirus 2", "target_id": "SARS-CoV-2", "strength": 66}, {"source_id": "mental health outcomes", "target_id": "health outcomes", "strength": 24}, {"source_id": "health outcomes", "target_id": "COVID-19 pandemic", "strength": 20}, {"source_id": "COVID-19 pandemic", "target_id": "mental health", "strength": 56}, {"source_id": "COVID-19", "target_id": "coronavirus disease 2019", "strength": 76}, {"source_id": "COVID-19", "target_id": "mortality", "strength": 36}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "disease 2019", "strength": 36}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "coronavirus disease 2019", "strength": 37}, {"source_id": "coronavirus 2", "target_id": "disease 2019", "strength": 36}, {"source_id": "disease 2019", "target_id": "coronavirus 2", "strength": 36}, {"source_id": "patients", "target_id": "COVID-19 patients", "strength": 171}, {"source_id": "patients", "target_id": "care", "strength": 22}, {"source_id": "education", "target_id": "COVID-19 pandemic", "strength": 40}, {"source_id": "immune response", "target_id": "vaccination", "strength": 26}, {"source_id": "vaccine", "target_id": "immune response", "strength": 48}, {"source_id": "SARS-CoV-2", "target_id": "viral load", "strength": 19}, {"source_id": "SARS-CoV-2 infection", "target_id": "Omicron variant", "strength": 25}, {"source_id": "COVID-19 patients", "target_id": "COVID-19", "strength": 117}, {"source_id": "clinical outcomes", "target_id": "COVID-19", "strength": 32}, {"source_id": "adverse events", "target_id": "COVID-19", "strength": 22}, {"source_id": "patients", "target_id": "mortality rate", "strength": 35}, {"source_id": "serious adverse events", "target_id": "adverse events", "strength": 30}, {"source_id": "patients", "target_id": "quality of life", "strength": 29}, {"source_id": "SARS-CoV-2 infection", "target_id": "respiratory syndrome coronavirus 2", "strength": 30}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 infection", "strength": 30}, {"source_id": "coronavirus 2", "target_id": "SARS-CoV-2 infection", "strength": 30}, {"source_id": "nervous system", "target_id": "central nervous system", "strength": 37}, {"source_id": "immune response", "target_id": "disease 2019", "strength": 24}, {"source_id": "education", "target_id": "institutions", "strength": 22}, {"source_id": "skills", "target_id": "education", "strength": 22}, {"source_id": "education", "target_id": "skills", "strength": 22}, {"source_id": "Omicron variant", "target_id": "SARS-CoV-2 variants", "strength": 39}, {"source_id": "SARS-CoV-2", "target_id": "antibody titers", "strength": 22}, {"source_id": "COVID-19 pandemic", "target_id": "crisis", "strength": 27}, {"source_id": "teaching", "target_id": "students", "strength": 34}, {"source_id": "teachers", "target_id": "education", "strength": 40}, {"source_id": "patients", "target_id": "disease", "strength": 33}, {"source_id": "symptoms", "target_id": "COVID-19", "strength": 48}, {"source_id": "disease", "target_id": "patients", "strength": 33}, {"source_id": "immune response", "target_id": "COVID-19", "strength": 35}, {"source_id": "clinical trials", "target_id": "adverse events", "strength": 22}, {"source_id": "observational study", "target_id": "COVID-19", "strength": 31}, {"source_id": "SARS-CoV-2 infection", "target_id": "severe COVID-19", "strength": 22}, {"source_id": "mRNA vaccination", "target_id": "vaccination", "strength": 19}, {"source_id": "SARS-CoV-2", "target_id": "T cells", "strength": 35}, {"source_id": "cell responses", "target_id": "T cells", "strength": 20}, {"source_id": "multivariable logistic regression", "target_id": "logistic regression", "strength": 21}, {"source_id": "logistic regression", "target_id": "multivariable logistic regression", "strength": 21}, {"source_id": "logistic regression", "target_id": "patients", "strength": 26}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 36}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "infection", "strength": 21}, {"source_id": "hospital mortality", "target_id": "COVID-19", "strength": 20}, {"source_id": "COVID-19 patients", "target_id": "cohort study", "strength": 21}, {"source_id": "mortality", "target_id": "cohort study", "strength": 22}, {"source_id": "vaccine", "target_id": "vaccine effectiveness", "strength": 22}, {"source_id": "COVID-19", "target_id": "vaccination", "strength": 27}, {"source_id": "persistent symptoms", "target_id": "symptoms", "strength": 19}, {"source_id": "COVID-19 patients", "target_id": "severe COVID-19", "strength": 20}, {"source_id": "severe COVID-19", "target_id": "COVID-19 patients", "strength": 20}, {"source_id": "cross-sectional study", "target_id": "COVID-19", "strength": 20}, {"source_id": "COVID-19 patients", "target_id": "immune response", "strength": 23}, {"source_id": "immune response", "target_id": "COVID-19 patients", "strength": 23}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "patients", "strength": 25}, {"source_id": "coronavirus 2", "target_id": "patients", "strength": 25}, {"source_id": "patients", "target_id": "syndrome coronavirus 2", "strength": 25}, {"source_id": "patients", "target_id": "control group", "strength": 29}, {"source_id": "COVID-19 pandemic", "target_id": "patients", "strength": 28}, {"source_id": "high risk", "target_id": "infection", "strength": 22}, {"source_id": "countries", "target_id": "policy", "strength": 20}, {"source_id": "coronavirus 2", "target_id": "immune response", "strength": 19}, {"source_id": "infection", "target_id": "severe disease", "strength": 23}, {"source_id": "clinical trials", "target_id": "vaccine", "strength": 22}, {"source_id": "SARS-CoV-2 variants", "target_id": "Delta variant", "strength": 19}, {"source_id": "Omicron variant", "target_id": "Delta variant", "strength": 21}, {"source_id": "mental health", "target_id": "depressive symptoms", "strength": 19}, {"source_id": "patients", "target_id": "older age", "strength": 20}, {"source_id": "COVID-19", "target_id": "hospital admission", "strength": 21}, {"source_id": "SARS-CoV-2", "target_id": "antibody response", "strength": 23}, {"source_id": "T cell responses", "target_id": "cell responses", "strength": 31}, {"source_id": "SARS-CoV-2", "target_id": "infection", "strength": 118}, {"source_id": "viral infection", "target_id": "infection", "strength": 38}, {"source_id": "intensive care unit", "target_id": "patients", "strength": 44}, {"source_id": "acute respiratory distress syndrome", "target_id": "COVID-19", "strength": 19}, {"source_id": "COVID-19", "target_id": "respiratory distress syndrome", "strength": 20}, {"source_id": "COVID-19", "target_id": "general population", "strength": 24}, {"source_id": "respiratory distress syndrome", "target_id": "COVID-19", "strength": 20}, {"source_id": "hospital admission", "target_id": "patients", "strength": 28}, {"source_id": "general population", "target_id": "COVID-19", "strength": 24}, {"source_id": "patients", "target_id": "acute respiratory distress syndrome", "strength": 25}, {"source_id": "patients", "target_id": "severe disease", "strength": 26}, {"source_id": "patients", "target_id": "distress syndrome", "strength": 26}, {"source_id": "coronavirus disease 2019", "target_id": "disease 2019", "strength": 149}, {"source_id": "hospital discharge", "target_id": "patients", "strength": 20}, {"source_id": "electronic medical records", "target_id": "medical records", "strength": 20}, {"source_id": "COVID-19 infection", "target_id": "coronavirus disease 2019", "strength": 21}, {"source_id": "primary outcome", "target_id": "adverse events", "strength": 20}, {"source_id": "vaccination", "target_id": "SARS-CoV-2 infection", "strength": 34}, {"source_id": "severe disease", "target_id": "SARS-CoV-2", "strength": 33}, {"source_id": "infection", "target_id": "patients", "strength": 84}, {"source_id": "SARS-CoV-2", "target_id": "mRNA vaccines", "strength": 29}, {"source_id": "SARS-CoV-2", "target_id": "vaccine", "strength": 56}, {"source_id": "mRNA vaccines", "target_id": "COVID-19 mRNA vaccines", "strength": 21}, {"source_id": "mRNA vaccines", "target_id": "SARS-CoV-2 infection", "strength": 22}, {"source_id": "COVID-19 vaccine", "target_id": "mRNA vaccines", "strength": 31}, {"source_id": "vaccine", "target_id": "SARS-CoV-2", "strength": 56}, {"source_id": "COVID-19 vaccination", "target_id": "patients", "strength": 26}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 infection", "strength": 30}, {"source_id": "adverse events", "target_id": "COVID-19 vaccine", "strength": 25}, {"source_id": "clinical outcomes", "target_id": "patients", "strength": 49}, {"source_id": "antibody response", "target_id": "COVID-19 vaccine", "strength": 19}, {"source_id": "vaccination", "target_id": "COVID-19 vaccine", "strength": 50}, {"source_id": "patients", "target_id": "ICU admission", "strength": 26}, {"source_id": "SARS-CoV-2", "target_id": "syndrome coronavirus 2", "strength": 64}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2", "strength": 63}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2", "strength": 129}, {"source_id": "COVID-19", "target_id": "respiratory syndrome coronavirus 2", "strength": 39}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "COVID-19", "strength": 20}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "disease 2019 pandemic", "strength": 65}, {"source_id": "coronavirus 2", "target_id": "COVID-19", "strength": 39}, {"source_id": "coronavirus 2", "target_id": "respiratory syndrome coronavirus 2", "strength": 128}, {"source_id": "health care workers", "target_id": "care workers", "strength": 26}, {"source_id": "COVID-19 pandemic", "target_id": "COVID-19", "strength": 94}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "coronavirus disease 2019", "strength": 37}, {"source_id": "syndrome coronavirus 2", "target_id": "coronavirus disease 2019", "strength": 37}, {"source_id": "coronavirus disease 2019", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 37}, {"source_id": "disease 2019", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 36}, {"source_id": "disease 2019", "target_id": "syndrome coronavirus 2", "strength": 36}, {"source_id": "care", "target_id": "patients", "strength": 22}, {"source_id": "schools", "target_id": "students", "strength": 28}, {"source_id": "COVID-19", "target_id": "students", "strength": 28}, {"source_id": "COVID-19 vaccine", "target_id": "immune response", "strength": 24}, {"source_id": "SARS-CoV-2 infection", "target_id": "risk factors", "strength": 35}, {"source_id": "primary outcome", "target_id": "Secondary outcomes", "strength": 66}, {"source_id": "COVID-19 infection", "target_id": "COVID-19", "strength": 90}, {"source_id": "COVID-19", "target_id": "COVID-19 patients", "strength": 117}, {"source_id": "patients", "target_id": "kidney disease", "strength": 20}, {"source_id": "mechanical ventilation", "target_id": "COVID-19 patients", "strength": 26}, {"source_id": "cohort study", "target_id": "vaccination", "strength": 24}, {"source_id": "quality of life", "target_id": "patients", "strength": 29}, {"source_id": "SARS-CoV-2 infection", "target_id": "coronavirus 2", "strength": 30}, {"source_id": "disease 2019", "target_id": "immune response", "strength": 24}, {"source_id": "immune response", "target_id": "coronavirus disease 2019", "strength": 23}, {"source_id": "education", "target_id": "teaching", "strength": 38}, {"source_id": "education", "target_id": "learning", "strength": 46}, {"source_id": "pandemic", "target_id": "COVID-19 pandemic", "strength": 80}, {"source_id": "learning", "target_id": "skills", "strength": 22}, {"source_id": "SARS-CoV-2", "target_id": "coronavirus disease 2019", "strength": 40}, {"source_id": "COVID-19 patients", "target_id": "SARS-CoV-2", "strength": 63}, {"source_id": "variants of concern", "target_id": "SARS-CoV-2", "strength": 25}, {"source_id": "crisis", "target_id": "COVID-19 pandemic", "strength": 27}, {"source_id": "experience", "target_id": "students", "strength": 26}, {"source_id": "COVID-19", "target_id": "pandemic", "strength": 40}, {"source_id": "patients", "target_id": "primary endpoint", "strength": 21}, {"source_id": "COVID-19 patients", "target_id": "risk factors", "strength": 26}, {"source_id": "cohort study", "target_id": "MAIN OUTCOME", "strength": 23}, {"source_id": "COVID-19", "target_id": "COVID-19 disease", "strength": 21}, {"source_id": "COVID-19", "target_id": "symptoms", "strength": 48}, {"source_id": "patients", "target_id": "mortality", "strength": 57}, {"source_id": "COVID-19", "target_id": "immune response", "strength": 35}, {"source_id": "trials", "target_id": "clinical trials", "strength": 24}, {"source_id": "disease severity", "target_id": "patients", "strength": 47}, {"source_id": "patients", "target_id": "disease severity", "strength": 47}, {"source_id": "SARS-CoV-2", "target_id": "immune response", "strength": 73}, {"source_id": "immune response", "target_id": "T cell responses", "strength": 24}, {"source_id": "T cell responses", "target_id": "T cells", "strength": 28}, {"source_id": "T cells", "target_id": "immune response", "strength": 35}, {"source_id": "SARS-CoV-2 variants", "target_id": "SARS-CoV-2 infection", "strength": 31}, {"source_id": "cohort", "target_id": "patients", "strength": 19}, {"source_id": "second dose", "target_id": "COVID-19 vaccine", "strength": 33}, {"source_id": "vaccination", "target_id": "second dose", "strength": 21}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "infection", "strength": 20}, {"source_id": "systematic review", "target_id": "Web of Science", "strength": 19}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 36}, {"source_id": "coronavirus 2 infection", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 37}, {"source_id": "coronavirus 2 infection", "target_id": "infection", "strength": 21}, {"source_id": "SARS-CoV-2", "target_id": "symptoms", "strength": 22}, {"source_id": "COVID-19", "target_id": "cohort study", "strength": 55}, {"source_id": "cohort study", "target_id": "COVID-19 patients", "strength": 21}, {"source_id": "COVID-19 patients", "target_id": "mortality", "strength": 19}, {"source_id": "study period", "target_id": "patients", "strength": 24}, {"source_id": "infection", "target_id": "vaccine", "strength": 25}, {"source_id": "COVID-19", "target_id": "primary outcome", "strength": 28}, {"source_id": "COVID-19 cases", "target_id": "COVID-19", "strength": 21}, {"source_id": "high risk", "target_id": "risk factors", "strength": 21}, {"source_id": "SARS-CoV-2 infection", "target_id": "immune response", "strength": 55}, {"source_id": "immune response", "target_id": "SARS-CoV-2 infection", "strength": 55}, {"source_id": "syndrome coronavirus 2", "target_id": "patients", "strength": 25}, {"source_id": "patients", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 25}, {"source_id": "students", "target_id": "teachers", "strength": 37}, {"source_id": "University", "target_id": "students", "strength": 24}, {"source_id": "teachers", "target_id": "learning", "strength": 26}, {"source_id": "University", "target_id": "education", "strength": 21}, {"source_id": "disease severity", "target_id": "COVID-19", "strength": 35}, {"source_id": "policy", "target_id": "countries", "strength": 20}, {"source_id": "infection", "target_id": "SARS-CoV-2 variants", "strength": 30}, {"source_id": "care professionals", "target_id": "health care professionals", "strength": 23}, {"source_id": "immune response", "target_id": "coronavirus 2", "strength": 19}, {"source_id": "SARS-CoV-2", "target_id": "Delta variant", "strength": 26}, {"source_id": "COVID-19", "target_id": "mortality rate", "strength": 27}, {"source_id": "older age", "target_id": "patients", "strength": 20}, {"source_id": "prospective cohort study", "target_id": "cohort study", "strength": 53}, {"source_id": "SARS-CoV-2", "target_id": "spike protein", "strength": 53}, {"source_id": "T cell responses", "target_id": "SARS-CoV-2", "strength": 23}, {"source_id": "SARS-CoV-2", "target_id": "viral infection", "strength": 30}, {"source_id": "infection", "target_id": "viral infection", "strength": 38}, {"source_id": "COVID-19", "target_id": "acute respiratory distress syndrome", "strength": 19}, {"source_id": "respiratory distress syndrome", "target_id": "distress syndrome", "strength": 48}, {"source_id": "distress syndrome", "target_id": "acute respiratory distress syndrome", "strength": 45}, {"source_id": "patients", "target_id": "observational study", "strength": 47}, {"source_id": "patients", "target_id": "SARS-CoV-2", "strength": 109}, {"source_id": "SARS-CoV-2 infection", "target_id": "disease 2019", "strength": 23}, {"source_id": "disease 2019", "target_id": "coronavirus disease 2019", "strength": 149}, {"source_id": "disease 2019", "target_id": "patients", "strength": 46}, {"source_id": "patients", "target_id": "SARS-CoV-2 infection", "strength": 103}, {"source_id": "patients", "target_id": "respiratory failure", "strength": 26}, {"source_id": "systematic review", "target_id": "COVID-19", "strength": 30}, {"source_id": "patients", "target_id": "hospital stay", "strength": 20}, {"source_id": "COVID-19 infection", "target_id": "disease 2019", "strength": 23}, {"source_id": "medical records", "target_id": "electronic medical records", "strength": 20}, {"source_id": "second dose", "target_id": "mRNA vaccines", "strength": 23}, {"source_id": "antibody response", "target_id": "patients", "strength": 21}, {"source_id": "patients", "target_id": "vaccine", "strength": 35}, {"source_id": "clinical data", "target_id": "patients", "strength": 22}, {"source_id": "patients", "target_id": "clinical data", "strength": 22}, {"source_id": "vaccination", "target_id": "SARS-CoV-2 vaccination", "strength": 20}, {"source_id": "disease severity", "target_id": "SARS-CoV-2", "strength": 28}, {"source_id": "cancer patients", "target_id": "patients", "strength": 29}, {"source_id": "SARS-CoV-2 infection", "target_id": "mRNA vaccines", "strength": 22}, {"source_id": "mRNA vaccines", "target_id": "SARS-CoV-2", "strength": 29}, {"source_id": "COVID-19 vaccine", "target_id": "vaccine", "strength": 113}, {"source_id": "COVID-19 vaccination", "target_id": "COVID-19 vaccine", "strength": 60}, {"source_id": "COVID-19 vaccination", "target_id": "vaccination", "strength": 67}, {"source_id": "ICU admission", "target_id": "patients", "strength": 26}, {"source_id": "care unit admission", "target_id": "intensive care unit admission", "strength": 27}, {"source_id": "COVID-19 vaccine", "target_id": "adverse events", "strength": 25}, {"source_id": "COVID-19 vaccine", "target_id": "vaccination", "strength": 50}, {"source_id": "COVID-19 vaccine", "target_id": "patients", "strength": 34}, {"source_id": "vaccination", "target_id": "SARS-CoV-2", "strength": 44}, {"source_id": "patients", "target_id": "clinical outcomes", "strength": 49}, {"source_id": "infection", "target_id": "COVID-19 infection", "strength": 70}, {"source_id": "infection", "target_id": "COVID-19 vaccine", "strength": 21}, {"source_id": "SARS-CoV-2", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 63}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19", "strength": 129}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "COVID-19", "strength": 39}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "respiratory syndrome coronavirus 2", "strength": 129}, {"source_id": "COVID-19", "target_id": "syndrome coronavirus 2", "strength": 39}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2", "strength": 64}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "COVID-19", "strength": 39}, {"source_id": "syndrome coronavirus 2", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 128}, {"source_id": "disease 2019 pandemic", "target_id": "COVID-19", "strength": 20}, {"source_id": "COVID-19 pandemic", "target_id": "health outcomes", "strength": 20}, {"source_id": "care workers", "target_id": "health care workers", "strength": 26}, {"source_id": "COVID-19", "target_id": "COVID-19 pandemic", "strength": 94}, {"source_id": "COVID-19", "target_id": "mental health", "strength": 24}, {"source_id": "COVID-19", "target_id": "COVID-19 outcomes", "strength": 19}, {"source_id": "coronavirus disease 2019", "target_id": "respiratory syndrome coronavirus 2", "strength": 37}, {"source_id": "disease", "target_id": "COVID-19", "strength": 23}, {"source_id": "students", "target_id": "schools", "strength": 28}, {"source_id": "COVID-19 pandemic", "target_id": "students", "strength": 45}, {"source_id": "policy", "target_id": "COVID-19 pandemic", "strength": 29}, {"source_id": "education", "target_id": "schools", "strength": 23}, {"source_id": "mRNA vaccines", "target_id": "vaccination", "strength": 29}, {"source_id": "vaccine", "target_id": "vaccination", "strength": 51}, {"source_id": "Secondary outcomes", "target_id": "primary outcome", "strength": 66}, {"source_id": "Omicron variant", "target_id": "SARS-CoV-2", "strength": 50}, {"source_id": "Omicron variant", "target_id": "SARS-CoV-2 infection", "strength": 25}, {"source_id": "clinical outcomes", "target_id": "COVID-19 patients", "strength": 20}, {"source_id": "COVID-19", "target_id": "COVID-19 infection", "strength": 90}, {"source_id": "kidney disease", "target_id": "patients", "strength": 20}, {"source_id": "COVID-19 vaccination", "target_id": "vaccine", "strength": 41}, {"source_id": "vaccine", "target_id": "COVID-19 vaccination", "strength": 41}, {"source_id": "adverse events", "target_id": "vaccine", "strength": 30}, {"source_id": "risk factors", "target_id": "patients", "strength": 84}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 infection", "strength": 29}, {"source_id": "spike protein", "target_id": "SARS-CoV-2 spike protein", "strength": 24}, {"source_id": "coronavirus disease 2019", "target_id": "immune response", "strength": 23}, {"source_id": "immune response", "target_id": "antibody response", "strength": 24}, {"source_id": "Omicron variant", "target_id": "infection", "strength": 29}, {"source_id": "educators", "target_id": "education", "strength": 24}, {"source_id": "students", "target_id": "pandemic", "strength": 26}, {"source_id": "students", "target_id": "learning", "strength": 59}, {"source_id": "skills", "target_id": "students", "strength": 33}, {"source_id": "SARS-CoV-2 variants", "target_id": "spike protein", "strength": 25}, {"source_id": "cohort study", "target_id": "infection", "strength": 41}, {"source_id": "SARS-CoV-2", "target_id": "disease 2019", "strength": 39}, {"source_id": "SARS-CoV-2", "target_id": "variants of concern", "strength": 25}, {"source_id": "students", "target_id": "higher education", "strength": 24}, {"source_id": "schools", "target_id": "teachers", "strength": 21}, {"source_id": "study period", "target_id": "cohort study", "strength": 25}, {"source_id": "Secondary outcomes", "target_id": "patients", "strength": 42}, {"source_id": "care unit", "target_id": "COVID-19 patients", "strength": 19}, {"source_id": "patients", "target_id": "Secondary outcomes", "strength": 42}, {"source_id": "COVID-19 patients", "target_id": "infection", "strength": 34}, {"source_id": "infection", "target_id": "COVID-19 patients", "strength": 34}, {"source_id": "COVID-19 infection", "target_id": "cohort study", "strength": 23}, {"source_id": "cohort study", "target_id": "COVID-19 infection", "strength": 23}, {"source_id": "retrospective cohort study", "target_id": "cohort study", "strength": 66}, {"source_id": "COVID-19 disease", "target_id": "COVID-19", "strength": 21}, {"source_id": "mean age", "target_id": "COVID-19", "strength": 19}, {"source_id": "immune response", "target_id": "patients", "strength": 44}, {"source_id": "SARS-CoV-2", "target_id": "severe COVID-19", "strength": 26}, {"source_id": "patients", "target_id": "severe COVID-19", "strength": 34}, {"source_id": "disease severity", "target_id": "COVID-19 patients", "strength": 27}, {"source_id": "humoral immune response", "target_id": "immune response", "strength": 23}, {"source_id": "SARS-CoV-2 infection", "target_id": "T cells", "strength": 20}, {"source_id": "T cells", "target_id": "SARS-CoV-2 infection", "strength": 20}, {"source_id": "patients", "target_id": "logistic regression", "strength": 26}, {"source_id": "second dose", "target_id": "vaccination", "strength": 21}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "syndrome coronavirus 2 infection", "strength": 37}, {"source_id": "COVID-19", "target_id": "mechanical ventilation", "strength": 29}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "coronavirus 2 infection", "strength": 37}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "infection", "strength": 21}, {"source_id": "Web of Science", "target_id": "systematic review", "strength": 19}, {"source_id": "symptoms", "target_id": "SARS-CoV-2 infection", "strength": 22}, {"source_id": "infection", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 21}, {"source_id": "infection", "target_id": "coronavirus 2 infection", "strength": 21}, {"source_id": "COVID-19", "target_id": "logistic regression", "strength": 23}, {"source_id": "patients", "target_id": "retrospective cohort study", "strength": 37}, {"source_id": "patients", "target_id": "cohort study", "strength": 94}, {"source_id": "COVID-19", "target_id": "vaccine", "strength": 23}, {"source_id": "COVID-19", "target_id": "hospital mortality", "strength": 20}, {"source_id": "patients", "target_id": "logistic regression analysis", "strength": 19}, {"source_id": "patients", "target_id": "study period", "strength": 24}, {"source_id": "vaccine effectiveness", "target_id": "SARS-CoV-2 infection", "strength": 27}, {"source_id": "risk factors", "target_id": "COVID-19", "strength": 62}, {"source_id": "vaccination", "target_id": "COVID-19", "strength": 27}, {"source_id": "SARS-CoV-2 infection", "target_id": "high risk", "strength": 24}, {"source_id": "cross-sectional study", "target_id": "COVID-19 pandemic", "strength": 22}, {"source_id": "patients", "target_id": "respiratory syndrome coronavirus 2", "strength": 25}, {"source_id": "students", "target_id": "University", "strength": 24}, {"source_id": "teachers", "target_id": "COVID-19 pandemic", "strength": 26}, {"source_id": "COVID-19", "target_id": "COVID-19 severity", "strength": 30}, {"source_id": "coronavirus disease", "target_id": "patients", "strength": 20}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 variants", "strength": 67}, {"source_id": "SARS-CoV-2 variants", "target_id": "SARS-CoV-2", "strength": 67}, {"source_id": "infection", "target_id": "disease", "strength": 19}, {"source_id": "immune response", "target_id": "innate immune response", "strength": 19}, {"source_id": "disease", "target_id": "SARS-CoV-2", "strength": 19}, {"source_id": "pediatric patients", "target_id": "patients", "strength": 19}, {"source_id": "depressive symptoms", "target_id": "mental health", "strength": 19}, {"source_id": "mortality rate", "target_id": "COVID-19", "strength": 27}, {"source_id": "kidney disease", "target_id": "chronic kidney disease", "strength": 23}, {"source_id": "adult patients", "target_id": "COVID-19", "strength": 20}, {"source_id": "cohort study", "target_id": "prospective cohort study", "strength": 53}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2", "strength": 174}, {"source_id": "infection", "target_id": "SARS-CoV-2", "strength": 118}, {"source_id": "distress syndrome", "target_id": "COVID-19", "strength": 20}, {"source_id": "care unit", "target_id": "intensive care unit", "strength": 78}, {"source_id": "care unit", "target_id": "COVID-19", "strength": 25}, {"source_id": "high risk", "target_id": "COVID-19", "strength": 50}, {"source_id": "patients", "target_id": "care unit", "strength": 49}, {"source_id": "patients", "target_id": "therapy", "strength": 40}, {"source_id": "SARS-CoV-2 infection", "target_id": "coronavirus disease 2019", "strength": 23}, {"source_id": "disease 2019", "target_id": "SARS-CoV-2 infection", "strength": 23}, {"source_id": "COVID-19", "target_id": "severe COVID-19", "strength": 66}, {"source_id": "COVID-19", "target_id": "systematic review", "strength": 30}, {"source_id": "clinical trials", "target_id": "systematic review", "strength": 19}, {"source_id": "COVID-19 pneumonia", "target_id": "patients", "strength": 20}, {"source_id": "patients", "target_id": "retrospective study", "strength": 30}, {"source_id": "mRNA vaccines", "target_id": "vaccine", "strength": 64}, {"source_id": "patients", "target_id": "clinical practice", "strength": 19}, {"source_id": "vaccine", "target_id": "SARS-CoV-2 vaccines", "strength": 36}, {"source_id": "vaccine", "target_id": "second dose", "strength": 34}, {"source_id": "SARS-CoV-2 infection", "target_id": "vaccination", "strength": 34}, {"source_id": "patients", "target_id": "vaccination", "strength": 52}, {"source_id": "SARS-CoV-2", "target_id": "disease severity", "strength": 28}, {"source_id": "MAIN OUTCOME", "target_id": "patients", "strength": 28}, {"source_id": "patients", "target_id": "infection", "strength": 84}, {"source_id": "pregnant women", "target_id": "women", "strength": 27}, {"source_id": "women", "target_id": "pregnant women", "strength": 27}, {"source_id": "body mass index", "target_id": "mass index", "strength": 34}, {"source_id": "vaccine", "target_id": "COVID-19 vaccine", "strength": 113}, {"source_id": "COVID-19 infection", "target_id": "SARS-CoV-2", "strength": 30}, {"source_id": "COVID-19 vaccine", "target_id": "antibody response", "strength": 19}, {"source_id": "unit admission", "target_id": "care unit admission", "strength": 30}, {"source_id": "mean age", "target_id": "patients", "strength": 37}, {"source_id": "antibody response", "target_id": "vaccination", "strength": 19}, {"source_id": "infection", "target_id": "vaccination", "strength": 33}, {"source_id": "admission", "target_id": "patients", "strength": 23}, {"source_id": "SARS-CoV-2", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 62}, {"source_id": "SARS-CoV-2", "target_id": "respiratory syndrome coronavirus 2", "strength": 64}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 128}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "COVID-19", "strength": 39}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "respiratory syndrome coronavirus 2", "strength": 128}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 128}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "coronavirus 2", "strength": 127}, {"source_id": "COVID-19", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 39}, {"source_id": "syndrome coronavirus 2", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 129}, {"source_id": "syndrome coronavirus 2", "target_id": "COVID-19", "strength": 39}, {"source_id": "disease 2019 pandemic", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 65}, {"source_id": "coronavirus 2", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 126}, {"source_id": "mental health", "target_id": "COVID-19", "strength": 24}, {"source_id": "COVID-19", "target_id": "disease 2019", "strength": 78}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "coronavirus disease 2019", "strength": 37}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "disease 2019", "strength": 36}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19", "strength": 76}, {"source_id": "disease 2019", "target_id": "COVID-19", "strength": 78}, {"source_id": "cohort study", "target_id": "SARS-CoV-2 infection", "strength": 46}, {"source_id": "COVID-19 patients", "target_id": "COVID-19 infection", "strength": 30}, {"source_id": "COVID-19 patients", "target_id": "disease 2019", "strength": 27}, {"source_id": "COVID-19 patients", "target_id": "patients", "strength": 171}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 patients", "strength": 27}, {"source_id": "schools", "target_id": "education", "strength": 23}, {"source_id": "COVID-19 pandemic", "target_id": "policy", "strength": 29}, {"source_id": "COVID-19 pandemic", "target_id": "education", "strength": 40}, {"source_id": "vaccination", "target_id": "mRNA vaccines", "strength": 29}, {"source_id": "SARS-CoV-2", "target_id": "Omicron variant", "strength": 50}, {"source_id": "COVID-19", "target_id": "clinical outcomes", "strength": 32}, {"source_id": "mortality rate", "target_id": "patients", "strength": 35}, {"source_id": "patients", "target_id": "systematic review", "strength": 44}, {"source_id": "vaccination", "target_id": "cohort study", "strength": 24}, {"source_id": "patients", "target_id": "risk factors", "strength": 84}, {"source_id": "patients", "target_id": "cross-sectional study", "strength": 25}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 infection", "strength": 30}, {"source_id": "SARS-CoV-2 infection", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 29}, {"source_id": "syndrome coronavirus 2", "target_id": "SARS-CoV-2 infection", "strength": 30}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "spike protein", "strength": 24}, {"source_id": "antibody response", "target_id": "immune response", "strength": 24}, {"source_id": "vaccine", "target_id": "booster dose", "strength": 20}, {"source_id": "COVID-19 pandemic", "target_id": "experience", "strength": 24}, {"source_id": "COVID-19 pandemic", "target_id": "learning", "strength": 27}, {"source_id": "institutions", "target_id": "education", "strength": 22}, {"source_id": "education", "target_id": "educators", "strength": 24}, {"source_id": "COVID-19 pandemic", "target_id": "health services", "strength": 22}, {"source_id": "COVID-19 pandemic", "target_id": "pandemic", "strength": 80}, {"source_id": "skills", "target_id": "learning", "strength": 22}, {"source_id": "pandemic", "target_id": "students", "strength": 26}, {"source_id": "SARS-CoV-2 variants", "target_id": "Omicron variant", "strength": 39}, {"source_id": "spike protein", "target_id": "SARS-CoV-2 variants", "strength": 25}, {"source_id": "coronavirus disease 2019", "target_id": "SARS-CoV-2", "strength": 40}, {"source_id": "disease 2019", "target_id": "SARS-CoV-2", "strength": 39}, {"source_id": "SARS-CoV-2", "target_id": "clinical trials", "strength": 23}, {"source_id": "clinical trials", "target_id": "SARS-CoV-2", "strength": 23}, {"source_id": "students", "target_id": "experience", "strength": 26}, {"source_id": "students", "target_id": "teaching", "strength": 34}, {"source_id": "pandemic", "target_id": "COVID-19", "strength": 40}, {"source_id": "higher education", "target_id": "students", "strength": 24}, {"source_id": "higher education", "target_id": "education", "strength": 28}, {"source_id": "COVID-19 patients", "target_id": "care unit", "strength": 19}, {"source_id": "primary endpoint", "target_id": "patients", "strength": 21}, {"source_id": "risk factors", "target_id": "COVID-19 patients", "strength": 26}, {"source_id": "primary outcome", "target_id": "cohort study", "strength": 21}, {"source_id": "patients", "target_id": "immune response", "strength": 44}, {"source_id": "adverse events", "target_id": "clinical trials", "strength": 22}, {"source_id": "SARS-CoV-2 infection", "target_id": "disease severity", "strength": 33}, {"source_id": "cancer", "target_id": "patients", "strength": 26}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "coronavirus 2 infection", "strength": 36}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "coronavirus 2 infection", "strength": 37}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 37}, {"source_id": "coronavirus 2 infection", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 36}, {"source_id": "infection", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 20}, {"source_id": "infection", "target_id": "syndrome coronavirus 2 infection", "strength": 21}, {"source_id": "retrospective cohort study", "target_id": "COVID-19", "strength": 22}, {"source_id": "cohort study", "target_id": "mortality", "strength": 22}, {"source_id": "mortality", "target_id": "COVID-19 patients", "strength": 19}, {"source_id": "vaccine effectiveness", "target_id": "vaccine", "strength": 22}, {"source_id": "vaccine", "target_id": "infection", "strength": 25}, {"source_id": "high risk", "target_id": "cohort study", "strength": 29}, {"source_id": "risk factors", "target_id": "cohort study", "strength": 34}, {"source_id": "second dose", "target_id": "COVID-19 vaccination", "strength": 20}, {"source_id": "immune response", "target_id": "viral infection", "strength": 29}, {"source_id": "viral infection", "target_id": "immune response", "strength": 29}, {"source_id": "patients", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 25}, {"source_id": "students", "target_id": "curriculum", "strength": 20}, {"source_id": "COVID-19 severity", "target_id": "COVID-19", "strength": 30}, {"source_id": "patients", "target_id": "COVID-19 pandemic", "strength": 28}, {"source_id": "SARS-CoV-2 variants", "target_id": "infection", "strength": 30}, {"source_id": "severe disease", "target_id": "SARS-CoV-2 infection", "strength": 22}, {"source_id": "infection", "target_id": "disease severity", "strength": 23}, {"source_id": "vaccine", "target_id": "clinical trials", "strength": 22}, {"source_id": "SARS-CoV-2", "target_id": "disease", "strength": 19}, {"source_id": "patients", "target_id": "pediatric patients", "strength": 19}, {"source_id": "patients", "target_id": "T cells", "strength": 19}, {"source_id": "COVID-19 severity", "target_id": "patients", "strength": 19}, {"source_id": "inflammatory response", "target_id": "distress syndrome", "strength": 3}, {"source_id": "severe disease", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "severe disease", "strength": 3}, {"source_id": "hospital admission", "target_id": "general population", "strength": 3}, {"source_id": "general population", "target_id": "hospital admission", "strength": 3}, {"source_id": "booster dose", "target_id": "primary outcome", "strength": 3}, {"source_id": "third dose", "target_id": "observational study", "strength": 3}, {"source_id": "first dose", "target_id": "primary outcome", "strength": 3}, {"source_id": "primary outcome", "target_id": "antibody levels", "strength": 3}, {"source_id": "electronic medical records", "target_id": "observational study", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "electronic medical records", "strength": 3}, {"source_id": "symptom onset", "target_id": "disease 2019", "strength": 3}, {"source_id": "medical records", "target_id": "adverse events", "strength": 3}, {"source_id": "BNT162b2 vaccine", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "clinical practice", "strength": 3}, {"source_id": "antibody response", "target_id": "side effects", "strength": 3}, {"source_id": "clinical practice", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "clinical data", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "cause mortality", "target_id": "hospital admission", "strength": 3}, {"source_id": "inflammatory syndrome", "target_id": "vaccine", "strength": 3}, {"source_id": "vaccine", "target_id": "inflammatory syndrome", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "adverse events", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "hospitalization", "strength": 3}, {"source_id": "case-control study", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "unit admission", "target_id": "adverse events", "strength": 3}, {"source_id": "adverse events", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "adverse events", "target_id": "care unit admission", "strength": 3}, {"source_id": "mean age", "target_id": "unit admission", "strength": 3}, {"source_id": "admission", "target_id": "lower risk", "strength": 3}, {"source_id": "observational study", "target_id": "mental health outcomes", "strength": 3}, {"source_id": "general population", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "care workers", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "mental health", "strength": 3}, {"source_id": "social determinants", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "mortality", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "disease", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "COVID-19 symptoms", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "care", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "systematic review", "target_id": "booster vaccination", "strength": 3}, {"source_id": "safety profile", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "retrospective study", "strength": 3}, {"source_id": "side effects", "target_id": "case series", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "adverse events", "strength": 3}, {"source_id": "beneficial effects", "target_id": "adverse events", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "B cells", "strength": 3}, {"source_id": "booster vaccination", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "ICU admission", "target_id": "distress syndrome", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "intensive care", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "adverse events", "strength": 3}, {"source_id": "cohort study", "target_id": "respiratory disease", "strength": 3}, {"source_id": "depressive symptoms", "target_id": "patients", "strength": 3}, {"source_id": "central nervous system", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "disease 2019", "target_id": "nervous system", "strength": 3}, {"source_id": "nervous system", "target_id": "disease 2019", "strength": 3}, {"source_id": "disease 2019", "target_id": "antibody levels", "strength": 3}, {"source_id": "central nervous system", "target_id": "immune system", "strength": 3}, {"source_id": "immune system", "target_id": "central nervous system", "strength": 3}, {"source_id": "clinical care", "target_id": "health system", "strength": 3}, {"source_id": "cross-sectional survey", "target_id": "vaccine", "strength": 3}, {"source_id": "healthcare workers", "target_id": "logistic regression", "strength": 3}, {"source_id": "health status", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "vaccination rates", "target_id": "Omicron variant", "strength": 3}, {"source_id": "vaccination rates", "target_id": "infection", "strength": 3}, {"source_id": "infection", "target_id": "vaccination rates", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "variants of concern", "strength": 3}, {"source_id": "narratives", "target_id": "community", "strength": 3}, {"source_id": "politics", "target_id": "justice", "strength": 3}, {"source_id": "thematic analysis", "target_id": "article", "strength": 3}, {"source_id": "people", "target_id": "article", "strength": 3}, {"source_id": "teaching", "target_id": "future research", "strength": 3}, {"source_id": "health issues", "target_id": "infection", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "pneumonia", "strength": 3}, {"source_id": "C-reactive protein", "target_id": "risk factors", "strength": 3}, {"source_id": "viral load", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "years of age", "strength": 3}, {"source_id": "adverse events", "target_id": "antibody titers", "strength": 3}, {"source_id": "hazard ratio", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "risk factors", "target_id": "emergency department", "strength": 3}, {"source_id": "observational study", "target_id": "emergency department", "strength": 3}, {"source_id": "healthcare workers", "target_id": "cell responses", "strength": 3}, {"source_id": "T cell responses", "target_id": "risk factors", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "T cells", "strength": 3}, {"source_id": "cancer", "target_id": "multivariable logistic regression", "strength": 3}, {"source_id": "cancer", "target_id": "cohort", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "pain", "strength": 3}, {"source_id": "clinical presentation", "target_id": "infection", "strength": 3}, {"source_id": "disease 2019", "target_id": "respiratory symptoms", "strength": 3}, {"source_id": "symptoms", "target_id": "Web of Science", "strength": 3}, {"source_id": "infection", "target_id": "clinical presentation", "strength": 3}, {"source_id": "serious adverse events", "target_id": "safety profile", "strength": 3}, {"source_id": "first dose", "target_id": "safety profile", "strength": 3}, {"source_id": "age groups", "target_id": "higher odds", "strength": 3}, {"source_id": "nasopharyngeal swabs", "target_id": "age groups", "strength": 3}, {"source_id": "nasopharyngeal swabs", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "logistic regression", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "logistic regression", "target_id": "older adults", "strength": 3}, {"source_id": "symptoms", "target_id": "higher odds", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "disease control", "strength": 3}, {"source_id": "disease control", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "World Health Organization", "strength": 3}, {"source_id": "hospital mortality", "target_id": "study period", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "study period", "strength": 3}, {"source_id": "disease 2019", "target_id": "study period", "strength": 3}, {"source_id": "study period", "target_id": "hospital mortality", "strength": 3}, {"source_id": "study period", "target_id": "high mortality", "strength": 3}, {"source_id": "cohort", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "health measures", "strength": 3}, {"source_id": "public health measures", "target_id": "disease 2019", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "clinical setting", "target_id": "high risk", "strength": 3}, {"source_id": "women", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "higher odds", "strength": 3}, {"source_id": "COVID-19 diagnosis", "target_id": "diagnosis", "strength": 3}, {"source_id": "mean age", "target_id": "body mass index", "strength": 3}, {"source_id": "infection rate", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "disease 2019", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "study period", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "pain", "target_id": "risk factors", "strength": 3}, {"source_id": "booster vaccination", "target_id": "humoral immune response", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "severe disease", "strength": 3}, {"source_id": "care providers", "target_id": "cohort study", "strength": 3}, {"source_id": "care providers", "target_id": "mean age", "strength": 3}, {"source_id": "study period", "target_id": "observational cohort study", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "high prevalence", "target_id": "cohort study", "strength": 3}, {"source_id": "practice", "target_id": "training", "strength": 3}, {"source_id": "course", "target_id": "training", "strength": 3}, {"source_id": "disease 2019", "target_id": "SARS-CoV-2 replication", "strength": 3}, {"source_id": "disease 2019", "target_id": "treatment strategies", "strength": 3}, {"source_id": "SARS-CoV-2 replication", "target_id": "T cells", "strength": 3}, {"source_id": "viral load", "target_id": "T cells", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "SARS-CoV-2 replication", "strength": 3}, {"source_id": "viral infection", "target_id": "healthy controls", "strength": 3}, {"source_id": "infection", "target_id": "SARS-CoV-2 replication", "strength": 3}, {"source_id": "cancer patients", "target_id": "patient care", "strength": 3}, {"source_id": "myocardial infarction", "target_id": "patient characteristics", "strength": 3}, {"source_id": "health interventions", "target_id": "middle-income countries", "strength": 3}, {"source_id": "outcome measures", "target_id": "vaccine", "strength": 3}, {"source_id": "Omicron infection", "target_id": "antibody response", "strength": 3}, {"source_id": "B cells", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "animal models", "strength": 3}, {"source_id": "spike protein", "target_id": "flow cytometry", "strength": 3}, {"source_id": "therapeutic target", "target_id": "central nervous system", "strength": 3}, {"source_id": "neural network", "target_id": "learning", "strength": 3}, {"source_id": "learning", "target_id": "learning model", "strength": 3}, {"source_id": "climate change", "target_id": "actors", "strength": 3}, {"source_id": "actors", "target_id": "climate change", "strength": 3}, {"source_id": "medical students", "target_id": "pandemic", "strength": 3}, {"source_id": "engagement", "target_id": "people", "strength": 3}, {"source_id": "skills", "target_id": "case study", "strength": 3}, {"source_id": "society", "target_id": "students", "strength": 3}, {"source_id": "practice", "target_id": "curriculum", "strength": 3}, {"source_id": "engagement", "target_id": "training", "strength": 3}, {"source_id": "training", "target_id": "engagement", "strength": 3}, {"source_id": "teachers", "target_id": "participants", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "hospitalization", "strength": 3}, {"source_id": "prospective study", "target_id": "primary outcome", "strength": 3}, {"source_id": "respiratory disease", "target_id": "primary outcome", "strength": 3}, {"source_id": "lower risk", "target_id": "mass index", "strength": 3}, {"source_id": "pulmonary disease", "target_id": "infection", "strength": 3}, {"source_id": "hospital stay", "target_id": "ICU admission", "strength": 3}, {"source_id": "ICU admission", "target_id": "hospital stay", "strength": 3}, {"source_id": "therapy", "target_id": "hospital admission", "strength": 3}, {"source_id": "observational study", "target_id": "prospective study", "strength": 3}, {"source_id": "viral replication", "target_id": "epithelial cells", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "booster doses", "target_id": "variants of concern", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "pregnancy", "strength": 3}, {"source_id": "viral infection", "target_id": "disease", "strength": 3}, {"source_id": "Medical Center", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "government", "target_id": "society", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "health services", "strength": 3}, {"source_id": "governance", "target_id": "politics", "strength": 3}, {"source_id": "case study", "target_id": "climate change", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "T cell responses", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "healthcare workers", "strength": 3}, {"source_id": "first dose", "target_id": "side effects", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "T cell responses", "strength": 3}, {"source_id": "mental health", "target_id": "schools", "strength": 3}, {"source_id": "care", "target_id": "care professionals", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "healthcare workers", "strength": 3}, {"source_id": "systematic review", "target_id": "health conditions", "strength": 3}, {"source_id": "health services", "target_id": "health records", "strength": 3}, {"source_id": "health disparities", "target_id": "United States", "strength": 3}, {"source_id": "COVID-19 pneumonia", "target_id": "ill patients", "strength": 3}, {"source_id": "risk factors", "target_id": "hospital stay", "strength": 3}, {"source_id": "ill patients", "target_id": "mortality rate", "strength": 3}, {"source_id": "admission", "target_id": "respiratory failure", "strength": 3}, {"source_id": "disease severity", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "clinical trials", "target_id": "clinical presentation", "strength": 3}, {"source_id": "treatment options", "target_id": "patient outcomes", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "C-reactive protein", "target_id": "IL-6", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "admission", "strength": 3}, {"source_id": "distress syndrome", "target_id": "clinical trials", "strength": 3}, {"source_id": "clinical trials", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "severe disease", "target_id": "years of age", "strength": 3}, {"source_id": "humoral response", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "time points", "target_id": "antibody levels", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "cytokine storm", "strength": 3}, {"source_id": "disease 2019", "target_id": "cytokine storm", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "study protocol", "target_id": "infection", "strength": 3}, {"source_id": "infection", "target_id": "study protocol", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "infection rate", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "infection", "strength": 3}, {"source_id": "women", "target_id": "care unit", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "electronic health records", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "health records", "strength": 3}, {"source_id": "clinical data", "target_id": "infection", "strength": 3}, {"source_id": "infection", "target_id": "clinical data", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "age groups", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "multivariable logistic regression", "target_id": "observational study", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "health disparities", "strength": 3}, {"source_id": "immune system", "target_id": "oxidative stress", "strength": 3}, {"source_id": "cohort study", "target_id": "heart failure", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "Delta variant", "strength": 3}, {"source_id": "treatment options", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "Omicron variant", "target_id": "antibody levels", "strength": 3}, {"source_id": "care professionals", "target_id": "health professionals", "strength": 3}, {"source_id": "World Health Organization", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "hospital admission", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "medical records", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "hospital admission", "strength": 3}, {"source_id": "hospital admission", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "hospital admission", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "clinical practice", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "COVID-19 severity", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "COVID-19 severity", "strength": 3}, {"source_id": "adverse events", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "complications", "target_id": "heart failure", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "observational study", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "observational study", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "serious adverse events", "strength": 3}, {"source_id": "vaccine dose", "target_id": "adverse events", "strength": 3}, {"source_id": "trials", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "second dose", "target_id": "time points", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "dose", "target_id": "time points", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "therapy", "target_id": "pneumonia", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "disease severity", "strength": 3}, {"source_id": "women", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "vaccine uptake", "target_id": "health system", "strength": 3}, {"source_id": "young adults", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "cancer patients", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "severe illness", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "severe illness", "strength": 3}, {"source_id": "cytokine storm", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "severe illness", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "mental health", "target_id": "healthcare workers", "strength": 3}, {"source_id": "pregnant women", "target_id": "mental health problems", "strength": 3}, {"source_id": "pregnant women", "target_id": "care providers", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "mental health", "strength": 3}, {"source_id": "middle-income countries", "target_id": "health services", "strength": 3}, {"source_id": "genes", "target_id": "cell types", "strength": 3}, {"source_id": "medical records", "target_id": "hospital mortality", "strength": 3}, {"source_id": "symptom onset", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "symptom onset", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "trials", "target_id": "mortality", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "antibody levels", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "blood samples", "strength": 3}, {"source_id": "cause mortality", "target_id": "clinical trials", "strength": 3}, {"source_id": "vaccination", "target_id": "variants of concern", "strength": 3}, {"source_id": "cancer patients", "target_id": "side effects", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "Meta-Analysis", "strength": 3}, {"source_id": "Web of Science", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "side effects", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "Meta-Analysis", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "vaccination", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "high risk", "target_id": "cohort", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "patient characteristics", "strength": 3}, {"source_id": "ill patients", "target_id": "therapy", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "observational cohort study", "strength": 3}, {"source_id": "observational cohort study", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "therapy", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "vaccine dose", "target_id": "high risk", "strength": 3}, {"source_id": "primary outcome", "target_id": "health care workers", "strength": 3}, {"source_id": "high risk", "target_id": "unvaccinated individuals", "strength": 3}, {"source_id": "care workers", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "health problems", "target_id": "risk factors", "strength": 3}, {"source_id": "risk factors", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "electronic health records", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "booster dose", "strength": 3}, {"source_id": "viral load", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "treatment options", "target_id": "mouse model", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "healthy controls", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "healthy controls", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "healthy controls", "strength": 3}, {"source_id": "healthy controls", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "chronic kidney disease", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "observational study", "strength": 3}, {"source_id": "primary outcome", "target_id": "surgery", "strength": 3}, {"source_id": "Medical Center", "target_id": "vaccine", "strength": 3}, {"source_id": "vaccine", "target_id": "Medical Center", "strength": 3}, {"source_id": "infection", "target_id": "Medical Center", "strength": 3}, {"source_id": "COVID-19 diagnosis", "target_id": "risk factors", "strength": 3}, {"source_id": "diagnosis", "target_id": "risk factors", "strength": 3}, {"source_id": "risk factors", "target_id": "care system", "strength": 3}, {"source_id": "primary care", "target_id": "observational study", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "multiple sclerosis", "strength": 3}, {"source_id": "case report", "target_id": "nervous system", "strength": 3}, {"source_id": "disease severity", "target_id": "body mass index", "strength": 3}, {"source_id": "age groups", "target_id": "health system", "strength": 3}, {"source_id": "infectious diseases", "target_id": "vaccination", "strength": 3}, {"source_id": "vaccination", "target_id": "infectious diseases", "strength": 3}, {"source_id": "narratives", "target_id": "violence", "strength": 3}, {"source_id": "health policy", "target_id": "COVID-19", "strength": 3}, {"source_id": "research", "target_id": "curriculum", "strength": 3}, {"source_id": "motivation", "target_id": "course", "strength": 3}, {"source_id": "COVID-19", "target_id": "program", "strength": 3}, {"source_id": "training", "target_id": "program", "strength": 3}, {"source_id": "United States", "target_id": "discourse", "strength": 3}, {"source_id": "heart failure", "target_id": "primary outcome", "strength": 3}, {"source_id": "COVID-19", "target_id": "surgery", "strength": 3}, {"source_id": "mean age", "target_id": "medical records", "strength": 3}, {"source_id": "medical records", "target_id": "most patients", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "kidney disease", "strength": 3}, {"source_id": "risk factors", "target_id": "clinical symptoms", "strength": 3}, {"source_id": "Health Organization", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "cohort study", "target_id": "chronic kidney disease", "strength": 3}, {"source_id": "cohort study", "target_id": "disease progression", "strength": 3}, {"source_id": "median age", "target_id": "kidney disease", "strength": 3}, {"source_id": "antibody titers", "target_id": "disease 2019", "strength": 3}, {"source_id": "case report", "target_id": "inflammatory diseases", "strength": 3}, {"source_id": "risk factors", "target_id": "autoimmune diseases", "strength": 3}, {"source_id": "infection rate", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "lower risk", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "clinical setting", "target_id": "infection", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "high-income countries", "strength": 3}, {"source_id": "high-income countries", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "myocardial infarction", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "health problems", "strength": 3}, {"source_id": "high prevalence", "target_id": "health problems", "strength": 3}, {"source_id": "observational cohort study", "target_id": "therapy", "strength": 3}, {"source_id": "cohort study", "target_id": "severe cases", "strength": 3}, {"source_id": "severe cases", "target_id": "cohort study", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "study participants", "strength": 3}, {"source_id": "odds ratio", "target_id": "study participants", "strength": 3}, {"source_id": "COVID-19 diagnosis", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "study participants", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "logistic regression models", "target_id": "vaccine uptake", "strength": 3}, {"source_id": "vaccination program", "target_id": "vaccine uptake", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "electronic health records", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "control group", "strength": 3}, {"source_id": "study participants", "target_id": "cohort study", "strength": 3}, {"source_id": "vaccine", "target_id": "control group", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "government", "target_id": "institutions", "strength": 3}, {"source_id": "body mass index", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "antiviral activity", "target_id": "clinical studies", "strength": 3}, {"source_id": "Omicron infection", "target_id": "vaccine dose", "strength": 3}, {"source_id": "high risk", "target_id": "pregnancy", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "Medical Center", "strength": 3}, {"source_id": "Medical Center", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "hospital stay", "strength": 3}, {"source_id": "vaccine dose", "target_id": "booster doses", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "case report", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "immune response", "target_id": "SARS-CoV-2 RNA", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "mouse model", "target_id": "Alzheimer's disease", "strength": 3}, {"source_id": "United States", "target_id": "practice", "strength": 3}, {"source_id": "community", "target_id": "context", "strength": 3}, {"source_id": "high risk", "target_id": "pulmonary disease", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "booster dose", "strength": 3}, {"source_id": "booster dose", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "booster dose", "strength": 3}, {"source_id": "adverse events", "target_id": "care unit", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "admission", "strength": 3}, {"source_id": "transplant recipients", "target_id": "mortality", "strength": 3}, {"source_id": "COVID-19", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "antibody titers", "strength": 3}, {"source_id": "disease severity", "target_id": "infectious diseases", "strength": 3}, {"source_id": "blood samples", "target_id": "disease severity", "strength": 3}, {"source_id": "blood samples", "target_id": "immune system", "strength": 3}, {"source_id": "infectious diseases", "target_id": "flow cytometry", "strength": 3}, {"source_id": "independent predictors", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "dose", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "dose", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "patient characteristics", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "health policy", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "vaccination", "strength": 3}, {"source_id": "hospitalization", "target_id": "care unit", "strength": 3}, {"source_id": "infectious diseases", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "older age", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "years of age", "target_id": "study period", "strength": 3}, {"source_id": "immune response", "target_id": "control group", "strength": 3}, {"source_id": "age groups", "target_id": "adverse events", "strength": 3}, {"source_id": "care", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "care", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "case study", "target_id": "social media", "strength": 3}, {"source_id": "COVID-19", "target_id": "case study", "strength": 3}, {"source_id": "case study", "target_id": "article", "strength": 3}, {"source_id": "institutions", "target_id": "need", "strength": 3}, {"source_id": "need", "target_id": "institutions", "strength": 3}, {"source_id": "program", "target_id": "pandemic", "strength": 3}, {"source_id": "practice", "target_id": "community", "strength": 3}, {"source_id": "community", "target_id": "book", "strength": 3}, {"source_id": "research", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "motivation", "target_id": "engagement", "strength": 3}, {"source_id": "engagement", "target_id": "motivation", "strength": 3}, {"source_id": "ill patients", "target_id": "care unit admission", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "ill patients", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "adult patients", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "study period", "strength": 3}, {"source_id": "observational study", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "study period", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "B cells", "strength": 3}, {"source_id": "B cells", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "Omicron variant", "target_id": "vaccination campaign", "strength": 3}, {"source_id": "vaccine dose", "target_id": "vaccination campaign", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "booster dose", "strength": 3}, {"source_id": "booster dose", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "intensive care unit", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "respiratory disease", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "respiratory disease", "strength": 3}, {"source_id": "respiratory disease", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "sector", "target_id": "interviews", "strength": 3}, {"source_id": "rights", "target_id": "politics", "strength": 3}, {"source_id": "older age", "target_id": "older adults", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "social support", "strength": 3}, {"source_id": "participants", "target_id": "perception", "strength": 3}, {"source_id": "heart failure", "target_id": "high risk", "strength": 3}, {"source_id": "older adults", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "booster dose", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "Omicron variant", "strength": 3}, {"source_id": "vaccination status", "target_id": "side effects", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "cohort", "strength": 3}, {"source_id": "adult patients", "target_id": "severe disease", "strength": 3}, {"source_id": "prospective study", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "length of stay", "target_id": "emergency department", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "study period", "strength": 3}, {"source_id": "disease", "target_id": "treatment options", "strength": 3}, {"source_id": "symptoms", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "hospital", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "medical records", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "median time", "strength": 3}, {"source_id": "mortality", "target_id": "health records", "strength": 3}, {"source_id": "course", "target_id": "institutions", "strength": 3}, {"source_id": "blood samples", "target_id": "observational study", "strength": 3}, {"source_id": "observational study", "target_id": "blood samples", "strength": 3}, {"source_id": "observational study", "target_id": "high risk", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "therapy", "strength": 3}, {"source_id": "primary outcome", "target_id": "University Hospital", "strength": 3}, {"source_id": "healthy controls", "target_id": "therapy", "strength": 3}, {"source_id": "adverse events", "target_id": "spike protein", "strength": 3}, {"source_id": "third dose", "target_id": "inflammatory diseases", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "University Hospital", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "care unit admission", "strength": 3}, {"source_id": "COVID-19", "target_id": "high-income countries", "strength": 3}, {"source_id": "risk factors", "target_id": "middle-income countries", "strength": 3}, {"source_id": "clinical trials", "target_id": "inflammatory response", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "gene expression", "strength": 3}, {"source_id": "severe illness", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "middle-income countries", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "observational study", "target_id": "middle-income countries", "strength": 3}, {"source_id": "disease 2019", "target_id": "middle-income countries", "strength": 3}, {"source_id": "Omicron infection", "target_id": "vaccination status", "strength": 3}, {"source_id": "adverse events", "target_id": "inflammatory syndrome", "strength": 3}, {"source_id": "inflammatory syndrome", "target_id": "adverse events", "strength": 3}, {"source_id": "study period", "target_id": "second dose", "strength": 3}, {"source_id": "mental health outcomes", "target_id": "psychological distress", "strength": 3}, {"source_id": "psychological distress", "target_id": "mental health outcomes", "strength": 3}, {"source_id": "vaccine", "target_id": "older adults", "strength": 3}, {"source_id": "independent predictors", "target_id": "older adults", "strength": 3}, {"source_id": "adult patients", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "study period", "target_id": "symptoms", "strength": 3}, {"source_id": "University Hospital", "target_id": "healthcare workers", "strength": 3}, {"source_id": "health system", "target_id": "hospital", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "vaccine", "strength": 3}, {"source_id": "time points", "target_id": "symptoms", "strength": 3}, {"source_id": "employees", "target_id": "anxiety", "strength": 3}, {"source_id": "anxiety", "target_id": "employees", "strength": 3}, {"source_id": "psychological distress", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "mean age", "target_id": "University Hospital", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "vaccine", "target_id": "animal models", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "epithelial cells", "strength": 3}, {"source_id": "Delta variant", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "primary outcome", "target_id": "mortality rate", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "kidney disease", "strength": 3}, {"source_id": "age groups", "target_id": "incidence", "strength": 3}, {"source_id": "age groups", "target_id": "vaccination status", "strength": 3}, {"source_id": "vaccination status", "target_id": "age groups", "strength": 3}, {"source_id": "high risk", "target_id": "primary endpoint", "strength": 3}, {"source_id": "thematic analysis", "target_id": "young people", "strength": 3}, {"source_id": "care professionals", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "care professionals", "strength": 3}, {"source_id": "booster dose", "target_id": "electronic health records", "strength": 3}, {"source_id": "booster dose", "target_id": "health records", "strength": 3}, {"source_id": "electronic health records", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "antiviral therapy", "target_id": "viral replication", "strength": 3}, {"source_id": "countries", "target_id": "people", "strength": 3}, {"source_id": "engagement", "target_id": "program", "strength": 3}, {"source_id": "educators", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "motivation", "target_id": "schools", "strength": 3}, {"source_id": "risk factors", "target_id": "health professionals", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "emergency department", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "mortality", "target_id": "C-reactive protein", "strength": 3}, {"source_id": "second dose", "target_id": "health care workers", "strength": 3}, {"source_id": "care workers", "target_id": "second dose", "strength": 3}, {"source_id": "primary outcome", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "T cells", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "T cells", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "disease severity", "target_id": "adverse events", "strength": 3}, {"source_id": "older age", "target_id": "mortality rate", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "electronic medical records", "strength": 3}, {"source_id": "disease burden", "target_id": "trials", "strength": 3}, {"source_id": "cause mortality", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "long COVID", "target_id": "inflammation", "strength": 3}, {"source_id": "antibody levels", "target_id": "care workers", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "median age", "strength": 3}, {"source_id": "vaccine dose", "target_id": "median age", "strength": 3}, {"source_id": "care workers", "target_id": "antibody levels", "strength": 3}, {"source_id": "observational study", "target_id": "incidence", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "COVID-19", "strength": 3}, {"source_id": "viral load", "target_id": "viral replication", "strength": 3}, {"source_id": "viral replication", "target_id": "viral load", "strength": 3}, {"source_id": "skills", "target_id": "thematic analysis", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "T cell responses", "strength": 3}, {"source_id": "immune response", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "immune response", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "study population", "target_id": "cohort study", "strength": 3}, {"source_id": "case series", "target_id": "symptoms", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "case series", "strength": 3}, {"source_id": "Omicron variant", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "Omicron variant", "strength": 3}, {"source_id": "adverse effects", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "disease 2019", "target_id": "healthcare workers", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "receptor-binding domain", "strength": 3}, {"source_id": "future research", "target_id": "teachers", "strength": 3}, {"source_id": "emergency department", "target_id": "vaccine", "strength": 3}, {"source_id": "adult patients", "target_id": "serious adverse events", "strength": 3}, {"source_id": "patients", "target_id": "virus infection", "strength": 3}, {"source_id": "transplant recipients", "target_id": "high risk", "strength": 3}, {"source_id": "high risk", "target_id": "vaccination status", "strength": 3}, {"source_id": "high risk", "target_id": "vaccine doses", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "incidence", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "respiratory disease", "strength": 3}, {"source_id": "adult patients", "target_id": "patient population", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "respiratory disease", "strength": 3}, {"source_id": "mortality rate", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "blood samples", "target_id": "primary outcome", "strength": 3}, {"source_id": "clinical trials", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "primary outcome", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "type 2 diabetes", "target_id": "clinical trials", "strength": 3}, {"source_id": "need", "target_id": "community", "strength": 3}, {"source_id": "research", "target_id": "educators", "strength": 3}, {"source_id": "healthy controls", "target_id": "inflammatory response", "strength": 3}, {"source_id": "hospital discharge", "target_id": "admission", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "mortality rate", "strength": 3}, {"source_id": "T cell responses", "target_id": "vaccine doses", "strength": 3}, {"source_id": "transplant recipients", "target_id": "T cell responses", "strength": 3}, {"source_id": "vaccine doses", "target_id": "antibody levels", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "virus infection", "strength": 3}, {"source_id": "transplant recipients", "target_id": "disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "infectious diseases", "target_id": "transplant recipients", "strength": 3}, {"source_id": "disease", "target_id": "treatment strategies", "strength": 3}, {"source_id": "mean age", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "severe cases", "target_id": "vaccine", "strength": 3}, {"source_id": "disease severity", "target_id": "care unit admission", "strength": 3}, {"source_id": "cause mortality", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "cause mortality", "target_id": "body mass index", "strength": 3}, {"source_id": "race/ethnicity", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "disease 2019", "target_id": "cause mortality", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "incidence rate", "strength": 3}, {"source_id": "immune response", "target_id": "Alzheimer's disease", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "middle-income countries", "strength": 3}, {"source_id": "symptoms", "target_id": "case-control study", "strength": 3}, {"source_id": "primary outcome", "target_id": "complications", "strength": 3}, {"source_id": "cytokine storm", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "nasopharyngeal swabs", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "lower risk", "target_id": "disease 2019", "strength": 3}, {"source_id": "medical records", "target_id": "unit admission", "strength": 3}, {"source_id": "symptoms", "target_id": "pain", "strength": 3}, {"source_id": "participants", "target_id": "learning", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "case report", "strength": 3}, {"source_id": "clinical presentation", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "study period", "strength": 3}, {"source_id": "study period", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "care system", "strength": 3}, {"source_id": "median age", "target_id": "hospital stay", "strength": 3}, {"source_id": "systematic review", "target_id": "complications", "strength": 3}, {"source_id": "hospital admission", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "electronic health records", "target_id": "logistic regression models", "strength": 3}, {"source_id": "odds ratio", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "health care", "target_id": "health professionals", "strength": 3}, {"source_id": "spike protein", "target_id": "BNT162b2 vaccine", "strength": 3}, {"source_id": "vaccine", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "young adults", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "young adults", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "adverse events", "strength": 3}, {"source_id": "therapy", "target_id": "mean age", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "Delta variant", "target_id": "clinical data", "strength": 3}, {"source_id": "inflammatory response", "target_id": "inflammation", "strength": 3}, {"source_id": "clinical presentation", "target_id": "persistent symptoms", "strength": 3}, {"source_id": "high risk", "target_id": "greater risk", "strength": 3}, {"source_id": "pregnant women", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "adverse effects", "target_id": "immune response", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "cell types", "strength": 3}, {"source_id": "viral infection", "target_id": "ill patients", "strength": 3}, {"source_id": "antibody levels", "target_id": "cell responses", "strength": 3}, {"source_id": "cell responses", "target_id": "healthy controls", "strength": 3}, {"source_id": "greater risk", "target_id": "severe disease", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "severe cases", "strength": 3}, {"source_id": "vaccine dose", "target_id": "hospitalization", "strength": 3}, {"source_id": "clinical practice", "target_id": "time points", "strength": 3}, {"source_id": "clinical practice", "target_id": "cohort study", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "weight loss", "strength": 3}, {"source_id": "mental health", "target_id": "middle-income countries", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "severe disease", "strength": 3}, {"source_id": "lower risk", "target_id": "severe disease", "strength": 3}, {"source_id": "Delta variant", "target_id": "health care workers", "strength": 3}, {"source_id": "adult patients", "target_id": "electronic health records", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "odds ratio", "strength": 3}, {"source_id": "odds ratio", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "training", "target_id": "perception", "strength": 3}, {"source_id": "perception", "target_id": "training", "strength": 3}, {"source_id": "institutions", "target_id": "technology", "strength": 3}, {"source_id": "immune cells", "target_id": "innate immune response", "strength": 3}, {"source_id": "systematic review", "target_id": "length of stay", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "chronic kidney disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "kidney disease", "strength": 3}, {"source_id": "ICU admission", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "electronic health records", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "vaccination status", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "vaccine doses", "strength": 3}, {"source_id": "care facilities", "target_id": "control group", "strength": 3}, {"source_id": "control group", "target_id": "systematic review", "strength": 3}, {"source_id": "immune response", "target_id": "study participants", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "coronavirus 2 infection", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "emergency department", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "emergency department", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "emergency department", "strength": 3}, {"source_id": "hospital mortality", "target_id": "median age", "strength": 3}, {"source_id": "age groups", "target_id": "older age", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "primary outcome", "strength": 3}, {"source_id": "dose", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "high risk", "target_id": "health issues", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "central nervous system", "strength": 3}, {"source_id": "COVID-19", "target_id": "autoimmune diseases", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "symptom onset", "strength": 3}, {"source_id": "intervention group", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "cell responses", "target_id": "disease 2019", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "Meta-Analysis", "strength": 3}, {"source_id": "severe disease", "target_id": "Meta-Analysis", "strength": 3}, {"source_id": "injury", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "injury", "target_id": "distress syndrome", "strength": 3}, {"source_id": "disease", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "disease", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "vaccine", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "disease severity", "strength": 3}, {"source_id": "systematic review", "target_id": "severe disease", "strength": 3}, {"source_id": "cohort study", "target_id": "myocardial infarction", "strength": 3}, {"source_id": "retrospective study", "target_id": "infection", "strength": 3}, {"source_id": "severe illness", "target_id": "protective effect", "strength": 3}, {"source_id": "risk factors", "target_id": "severe illness", "strength": 3}, {"source_id": "protective effect", "target_id": "severe illness", "strength": 3}, {"source_id": "infection", "target_id": "retrospective study", "strength": 3}, {"source_id": "vaccine", "target_id": "blood samples", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "distress syndrome", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "antibody response", "target_id": "flow cytometry", "strength": 3}, {"source_id": "practice", "target_id": "perception", "strength": 3}, {"source_id": "skills", "target_id": "perception", "strength": 3}, {"source_id": "motivation", "target_id": "COVID-19", "strength": 3}, {"source_id": "curriculum", "target_id": "context", "strength": 3}, {"source_id": "disease severity", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "central nervous system", "target_id": "immune response", "strength": 3}, {"source_id": "receptor-binding domain", "target_id": "variants of concern", "strength": 3}, {"source_id": "United States", "target_id": "qualitative study", "strength": 3}, {"source_id": "older age", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "pulmonary disease", "target_id": "clinical trials", "strength": 3}, {"source_id": "pregnant women", "target_id": "primary outcome", "strength": 3}, {"source_id": "hospitalized patients", "target_id": "ill patients", "strength": 3}, {"source_id": "care workers", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "quality of life", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "World Health Organization", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "World Health Organization", "strength": 3}, {"source_id": "Health Organization", "target_id": "disease severity", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "symptom onset", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "antibody levels", "strength": 3}, {"source_id": "side effects", "target_id": "primary outcome", "strength": 3}, {"source_id": "incidence rate", "target_id": "second dose", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "clinical trials", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "inflammatory syndrome", "strength": 3}, {"source_id": "viral infection", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "inflammatory response", "strength": 3}, {"source_id": "inflammatory response", "target_id": "severe cases", "strength": 3}, {"source_id": "severe disease", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "general population", "strength": 3}, {"source_id": "severe cases", "target_id": "inflammatory response", "strength": 3}, {"source_id": "antibody levels", "target_id": "primary outcome", "strength": 3}, {"source_id": "observational study", "target_id": "third dose", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "most patients", "strength": 3}, {"source_id": "retrospective study", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "COVID-19 pneumonia", "target_id": "primary outcome", "strength": 3}, {"source_id": "symptom onset", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "symptom onset", "target_id": "primary outcome", "strength": 3}, {"source_id": "healthcare workers", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "clinical practice", "target_id": "vaccine", "strength": 3}, {"source_id": "emergency department", "target_id": "predictive value", "strength": 3}, {"source_id": "type 2 diabetes", "target_id": "body mass index", "strength": 3}, {"source_id": "type 2 diabetes", "target_id": "mass index", "strength": 3}, {"source_id": "blood pressure", "target_id": "mass index", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "greater risk", "strength": 3}, {"source_id": "transplant recipients", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "primary outcome", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "lower risk", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "vaccination", "target_id": "admission", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "social determinants", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "disease", "strength": 3}, {"source_id": "electronic medical records", "target_id": "logistic regression models", "strength": 3}, {"source_id": "logistic regression models", "target_id": "adult patients", "strength": 3}, {"source_id": "disease 2019", "target_id": "COVID-19 symptoms", "strength": 3}, {"source_id": "vaccine", "target_id": "study protocol", "strength": 3}, {"source_id": "study participants", "target_id": "COVID-19 diagnosis", "strength": 3}, {"source_id": "women", "target_id": "trials", "strength": 3}, {"source_id": "trials", "target_id": "women", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "case series", "strength": 3}, {"source_id": "control group", "target_id": "retrospective study", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "Web of Science", "strength": 3}, {"source_id": "Web of Science", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "therapy", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "clinical data", "target_id": "observational study", "strength": 3}, {"source_id": "immune cells", "target_id": "vaccine", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "B cells", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "B cells", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "distress syndrome", "target_id": "intensive care", "strength": 3}, {"source_id": "ICU admission", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "adverse events", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "vaccination", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "cohort study", "strength": 3}, {"source_id": "vaccination", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "central nervous system", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "central nervous system", "strength": 3}, {"source_id": "disease 2019", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "nervous system", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "case series", "strength": 3}, {"source_id": "antibody levels", "target_id": "disease 2019", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "vaccine", "target_id": "infection rate", "strength": 3}, {"source_id": "dose", "target_id": "infection rate", "strength": 3}, {"source_id": "clinical practice", "target_id": "health outcomes", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "hospital", "strength": 3}, {"source_id": "hospital", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "skills", "target_id": "interviews", "strength": 3}, {"source_id": "variants of concern", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "government", "target_id": "article", "strength": 3}, {"source_id": "experience", "target_id": "case study", "strength": 3}, {"source_id": "learning", "target_id": "future research", "strength": 3}, {"source_id": "pandemic", "target_id": "future research", "strength": 3}, {"source_id": "clinical practice", "target_id": "therapy", "strength": 3}, {"source_id": "primary outcome", "target_id": "primary endpoint", "strength": 3}, {"source_id": "mean age", "target_id": "illness", "strength": 3}, {"source_id": "mean age", "target_id": "age groups", "strength": 3}, {"source_id": "symptoms", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "hospital discharge", "target_id": "median time", "strength": 3}, {"source_id": "immune response", "target_id": "COVID-19 pneumonia", "strength": 3}, {"source_id": "clinical trials", "target_id": "years of age", "strength": 3}, {"source_id": "hazard ratio", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "years of age", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "years of age", "target_id": "clinical trials", "strength": 3}, {"source_id": "therapy", "target_id": "clinical studies", "strength": 3}, {"source_id": "antibody titers", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "risk factors", "target_id": "humoral immune response", "strength": 3}, {"source_id": "T cells", "target_id": "healthcare workers", "strength": 3}, {"source_id": "cohort", "target_id": "cancer", "strength": 3}, {"source_id": "respiratory symptoms", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "immune system", "target_id": "vaccine", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "higher odds", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "logistic regression", "strength": 3}, {"source_id": "older adults", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "clinical presentation", "strength": 3}, {"source_id": "cohort study", "target_id": "clinical presentation", "strength": 3}, {"source_id": "clinical presentation", "target_id": "cohort study", "strength": 3}, {"source_id": "symptoms", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "disease progression", "target_id": "clinical trials", "strength": 3}, {"source_id": "systematic review", "target_id": "trials", "strength": 3}, {"source_id": "adverse events", "target_id": "World Health Organization", "strength": 3}, {"source_id": "vaccine", "target_id": "adverse outcomes", "strength": 3}, {"source_id": "booster vaccination", "target_id": "incidence rate", "strength": 3}, {"source_id": "vaccine dose", "target_id": "BNT162b2 vaccine", "strength": 3}, {"source_id": "cohort", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "disease 2019", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "primary outcome", "target_id": "higher odds", "strength": 3}, {"source_id": "logistic regression models", "target_id": "hospital admission", "strength": 3}, {"source_id": "body mass index", "target_id": "mean age", "strength": 3}, {"source_id": "incidence", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "high incidence", "strength": 3}, {"source_id": "risk factors", "target_id": "pain", "strength": 3}, {"source_id": "antibody response", "target_id": "humoral immune response", "strength": 3}, {"source_id": "vaccine doses", "target_id": "healthcare workers", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "long COVID", "strength": 3}, {"source_id": "observational cohort study", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "cohort study", "target_id": "care providers", "strength": 3}, {"source_id": "healthcare workers", "target_id": "prospective study", "strength": 3}, {"source_id": "prospective study", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "high prevalence", "target_id": "healthcare workers", "strength": 3}, {"source_id": "training", "target_id": "practice", "strength": 3}, {"source_id": "training", "target_id": "course", "strength": 3}, {"source_id": "SARS-CoV-2 replication", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "SARS-CoV-2 replication", "strength": 3}, {"source_id": "SARS-CoV-2 replication", "target_id": "infection", "strength": 3}, {"source_id": "T cells", "target_id": "viral load", "strength": 3}, {"source_id": "care providers", "target_id": "care services", "strength": 3}, {"source_id": "care services", "target_id": "care providers", "strength": 3}, {"source_id": "quality of life", "target_id": "patient care", "strength": 3}, {"source_id": "health interventions", "target_id": "health conditions", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "middle-income countries", "strength": 3}, {"source_id": "antibody response", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "spike protein", "strength": 3}, {"source_id": "mouse model", "target_id": "flow cytometry", "strength": 3}, {"source_id": "inflammatory response", "target_id": "T cells", "strength": 3}, {"source_id": "therapeutic target", "target_id": "IL-6", "strength": 3}, {"source_id": "learning", "target_id": "neural network", "strength": 3}, {"source_id": "economy", "target_id": "discourse", "strength": 3}, {"source_id": "politics", "target_id": "economy", "strength": 3}, {"source_id": "society", "target_id": "University", "strength": 3}, {"source_id": "program", "target_id": "need", "strength": 3}, {"source_id": "participants", "target_id": "teachers", "strength": 3}, {"source_id": "need", "target_id": "participants", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "lower risk", "strength": 3}, {"source_id": "primary outcome", "target_id": "respiratory disease", "strength": 3}, {"source_id": "lower risk", "target_id": "body mass index", "strength": 3}, {"source_id": "infection", "target_id": "pulmonary disease", "strength": 3}, {"source_id": "ICU admission", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "age groups", "target_id": "infection rate", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "B cells", "strength": 3}, {"source_id": "immune response", "target_id": "prospective study", "strength": 3}, {"source_id": "epithelial cells", "target_id": "viral replication", "strength": 3}, {"source_id": "vaccine", "target_id": "mice", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "severe disease", "target_id": "booster doses", "strength": 3}, {"source_id": "vaccination", "target_id": "unvaccinated individuals", "strength": 3}, {"source_id": "pregnant women", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "pregnancy", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "Medical Center", "strength": 3}, {"source_id": "healthcare workers", "target_id": "first dose", "strength": 3}, {"source_id": "clinical trials", "target_id": "health system", "strength": 3}, {"source_id": "primary outcome", "target_id": "health services", "strength": 3}, {"source_id": "health services", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "politics", "target_id": "governance", "strength": 3}, {"source_id": "clinical data", "target_id": "retrospective study", "strength": 3}, {"source_id": "T cell responses", "target_id": "cohort study", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "lower risk", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "systematic review", "strength": 3}, {"source_id": "emergency department", "target_id": "primary care", "strength": 3}, {"source_id": "side effects", "target_id": "first dose", "strength": 3}, {"source_id": "vaccine", "target_id": "symptoms", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "risk factors", "target_id": "care settings", "strength": 3}, {"source_id": "care settings", "target_id": "risk factors", "strength": 3}, {"source_id": "health services", "target_id": "electronic health records", "strength": 3}, {"source_id": "United States", "target_id": "health disparities", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "therapeutic target", "strength": 3}, {"source_id": "lung disease", "target_id": "acute phase", "strength": 3}, {"source_id": "COVID-19 pneumonia", "target_id": "high risk", "strength": 3}, {"source_id": "hospital stay", "target_id": "risk factors", "strength": 3}, {"source_id": "hospital stay", "target_id": "University Hospital", "strength": 3}, {"source_id": "hospital stay", "target_id": "admission", "strength": 3}, {"source_id": "respiratory failure", "target_id": "admission", "strength": 3}, {"source_id": "ill patients", "target_id": "University Hospital", "strength": 3}, {"source_id": "hospital admission", "target_id": "ill patients", "strength": 3}, {"source_id": "University Hospital", "target_id": "ill patients", "strength": 3}, {"source_id": "respiratory failure", "target_id": "severe disease", "strength": 3}, {"source_id": "antibody titers", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "antibody titers", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "disease severity", "strength": 3}, {"source_id": "immune response", "target_id": "therapy", "strength": 3}, {"source_id": "therapy", "target_id": "immune response", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "clinical trials", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "clinical trials", "target_id": "distress syndrome", "strength": 3}, {"source_id": "inflammatory diseases", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "humoral response", "target_id": "booster vaccination", "strength": 3}, {"source_id": "epithelial cells", "target_id": "virus infection", "strength": 3}, {"source_id": "virus infection", "target_id": "epithelial cells", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "care professionals", "target_id": "systematic review", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "spike protein", "strength": 3}, {"source_id": "distress syndrome", "target_id": "spike protein", "strength": 3}, {"source_id": "lung disease", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "spike protein", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "booster vaccination", "target_id": "COVID-19", "strength": 3}, {"source_id": "intensive care unit", "target_id": "women", "strength": 3}, {"source_id": "women", "target_id": "intensive care unit", "strength": 3}, {"source_id": "women", "target_id": "mortality rate", "strength": 3}, {"source_id": "mean age", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "first dose", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "first dose", "strength": 3}, {"source_id": "observational study", "target_id": "study population", "strength": 3}, {"source_id": "nervous system", "target_id": "oxidative stress", "strength": 3}, {"source_id": "clinical trials", "target_id": "blood pressure", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "greater risk", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "Delta variant", "strength": 3}, {"source_id": "Delta variant", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "Delta variant", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "vaccination", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "health professionals", "target_id": "care professionals", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "hospital admission", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "clinical practice", "strength": 3}, {"source_id": "hospital admission", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "observational study", "target_id": "physical activity", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "COVID-19 diagnosis", "target_id": "symptoms", "strength": 3}, {"source_id": "climate change", "target_id": "policy", "strength": 3}, {"source_id": "heart failure", "target_id": "complications", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "severe disease", "strength": 3}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "coronavirus 2 infection", "target_id": "severe disease", "strength": 3}, {"source_id": "severe disease", "target_id": "syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "observational study", "target_id": "syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "admission", "target_id": "syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "cohort study", "target_id": "predictive value", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "predictive value", "target_id": "cohort study", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "D-dimer", "strength": 3}, {"source_id": "hospital mortality", "target_id": "pneumonia", "strength": 3}, {"source_id": "hospital mortality", "target_id": "therapy", "strength": 3}, {"source_id": "adverse outcomes", "target_id": "odds ratio", "strength": 3}, {"source_id": "observational cohort study", "target_id": "women", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "logistic regression", "strength": 3}, {"source_id": "odds ratio", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "care", "target_id": "risk factors", "strength": 3}, {"source_id": "cohort", "target_id": "disease", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "health services", "strength": 3}, {"source_id": "adverse effects", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "severe illness", "strength": 3}, {"source_id": "cytokine storm", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "cytokine storm", "strength": 3}, {"source_id": "primary outcome", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "physical activity", "target_id": "systematic review", "strength": 3}, {"source_id": "mental health outcomes", "target_id": "healthcare workers", "strength": 3}, {"source_id": "mental health", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "clinical data", "strength": 3}, {"source_id": "clinical data", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "symptoms", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "high risk", "target_id": "intensive care", "strength": 3}, {"source_id": "crisis", "target_id": "case study", "strength": 3}, {"source_id": "organization", "target_id": "crisis", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "symptoms", "strength": 3}, {"source_id": "physical activity", "target_id": "older adults", "strength": 3}, {"source_id": "oxidative stress", "target_id": "immune response", "strength": 3}, {"source_id": "hospital mortality", "target_id": "medical records", "strength": 3}, {"source_id": "care unit", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "primary outcome", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "primary outcome", "strength": 3}, {"source_id": "predictive value", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "blood samples", "strength": 3}, {"source_id": "severe disease", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "blood samples", "target_id": "antibody levels", "strength": 3}, {"source_id": "symptoms", "target_id": "inflammation", "strength": 3}, {"source_id": "inflammatory diseases", "target_id": "clinical trials", "strength": 3}, {"source_id": "clinical trials", "target_id": "inflammatory diseases", "strength": 3}, {"source_id": "variants of concern", "target_id": "vaccination", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "infection", "strength": 3}, {"source_id": "pediatric patients", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "high risk", "target_id": "pediatric patients", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "pediatric patients", "strength": 3}, {"source_id": "mass index", "target_id": "logistic regression", "strength": 3}, {"source_id": "age groups", "target_id": "second dose", "strength": 3}, {"source_id": "length of stay", "target_id": "patient outcomes", "strength": 3}, {"source_id": "logistic regression models", "target_id": "length of stay", "strength": 3}, {"source_id": "health care workers", "target_id": "primary outcome", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "care workers", "strength": 3}, {"source_id": "vaccine dose", "target_id": "unvaccinated individuals", "strength": 3}, {"source_id": "high risk", "target_id": "health care workers", "strength": 3}, {"source_id": "care workers", "target_id": "high risk", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "risk factors", "strength": 3}, {"source_id": "emergency department", "target_id": "electronic health records", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "primary care", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "electronic health records", "strength": 3}, {"source_id": "admission", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "Omicron variant", "target_id": "case-control study", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "viral load", "strength": 3}, {"source_id": "mouse model", "target_id": "treatment options", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "kidney disease", "strength": 3}, {"source_id": "vaccination", "target_id": "University Hospital", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "women", "strength": 3}, {"source_id": "hospital discharge", "target_id": "unit admission", "strength": 3}, {"source_id": "outcome measures", "target_id": "risk factors", "strength": 3}, {"source_id": "observational study", "target_id": "primary care", "strength": 3}, {"source_id": "median time", "target_id": "mean age", "strength": 3}, {"source_id": "health outcomes", "target_id": "cohort study", "strength": 3}, {"source_id": "central nervous system", "target_id": "case report", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "body mass index", "strength": 3}, {"source_id": "society", "target_id": "institutions", "strength": 3}, {"source_id": "skills", "target_id": "motivation", "strength": 3}, {"source_id": "heart failure", "target_id": "systematic review", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "World Health Organization", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "Health Organization", "strength": 3}, {"source_id": "World Health Organization", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "myocardial infarction", "target_id": "ischemic stroke", "strength": 3}, {"source_id": "disease burden", "target_id": "infection", "strength": 3}, {"source_id": "infection", "target_id": "disease burden", "strength": 3}, {"source_id": "kidney disease", "target_id": "median age", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "cohort study", "strength": 3}, {"source_id": "inflammatory diseases", "target_id": "case report", "strength": 3}, {"source_id": "general population", "target_id": "immune response", "strength": 3}, {"source_id": "vaccination", "target_id": "pregnant women", "strength": 3}, {"source_id": "clinical trials", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "myocardial infarction", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "health problems", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "high prevalence", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "mental health", "target_id": "high prevalence", "strength": 3}, {"source_id": "hospital mortality", "target_id": "myocardial infarction", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "booster vaccination", "strength": 3}, {"source_id": "study participants", "target_id": "odds ratio", "strength": 3}, {"source_id": "vaccine uptake", "target_id": "logistic regression models", "strength": 3}, {"source_id": "booster vaccination", "target_id": "study participants", "strength": 3}, {"source_id": "third dose", "target_id": "electronic health records", "strength": 3}, {"source_id": "clinical trials", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "health records", "strength": 3}, {"source_id": "study participants", "target_id": "booster vaccination", "strength": 3}, {"source_id": "vaccine", "target_id": "study participants", "strength": 3}, {"source_id": "vaccine", "target_id": "health records", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "health services", "strength": 3}, {"source_id": "severe cases", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "beneficial effects", "strength": 3}, {"source_id": "need", "target_id": "COVID-19", "strength": 3}, {"source_id": "odds ratio", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "clinical studies", "target_id": "antiviral activity", "strength": 3}, {"source_id": "thematic analysis", "target_id": "perception", "strength": 3}, {"source_id": "Omicron infection", "target_id": "care facilities", "strength": 3}, {"source_id": "vaccination campaign", "target_id": "healthcare workers", "strength": 3}, {"source_id": "healthcare workers", "target_id": "vaccination campaign", "strength": 3}, {"source_id": "care providers", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "booster doses", "target_id": "vaccine dose", "strength": 3}, {"source_id": "respiratory tract", "target_id": "vaccine", "strength": 3}, {"source_id": "vaccination", "target_id": "immune system", "strength": 3}, {"source_id": "practice", "target_id": "United States", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "systematic review", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "Meta-Analysis", "strength": 3}, {"source_id": "adult patients", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "adult patients", "strength": 3}, {"source_id": "adverse outcomes", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "adverse outcomes", "strength": 3}, {"source_id": "hospital stay", "target_id": "mean age", "strength": 3}, {"source_id": "general population", "target_id": "mortality", "strength": 3}, {"source_id": "patients", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "mortality", "target_id": "transplant recipients", "strength": 3}, {"source_id": "antibody titers", "target_id": "booster doses", "strength": 3}, {"source_id": "booster dose", "target_id": "variants of concern", "strength": 3}, {"source_id": "booster dose", "target_id": "immune response", "strength": 3}, {"source_id": "immune response", "target_id": "booster dose", "strength": 3}, {"source_id": "flow cytometry", "target_id": "infectious diseases", "strength": 3}, {"source_id": "immune system", "target_id": "blood samples", "strength": 3}, {"source_id": "care system", "target_id": "cancer", "strength": 3}, {"source_id": "disease burden", "target_id": "cohort study", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "dose", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "dose", "strength": 3}, {"source_id": "patient characteristics", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "cancer", "target_id": "diagnosis", "strength": 3}, {"source_id": "hospital", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "vaccine", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "age groups", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "infectious diseases", "strength": 3}, {"source_id": "health interventions", "target_id": "vaccine hesitancy", "strength": 3}, {"source_id": "viral infection", "target_id": "clinical trials", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "median age", "strength": 3}, {"source_id": "control group", "target_id": "immune response", "strength": 3}, {"source_id": "study period", "target_id": "years of age", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "care", "strength": 3}, {"source_id": "social media", "target_id": "interviews", "strength": 3}, {"source_id": "interviews", "target_id": "social media", "strength": 3}, {"source_id": "mental health outcomes", "target_id": "health concern", "strength": 3}, {"source_id": "thematic analysis", "target_id": "engagement", "strength": 3}, {"source_id": "article", "target_id": "perspective", "strength": 3}, {"source_id": "actors", "target_id": "pandemic", "strength": 3}, {"source_id": "teaching", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "learners", "target_id": "institutions", "strength": 3}, {"source_id": "pandemic", "target_id": "program", "strength": 3}, {"source_id": "adult patients", "target_id": "prevalence", "strength": 3}, {"source_id": "ill patients", "target_id": "observational study", "strength": 3}, {"source_id": "study period", "target_id": "care unit admission", "strength": 3}, {"source_id": "study period", "target_id": "unit admission", "strength": 3}, {"source_id": "flow cytometry", "target_id": "vaccination", "strength": 3}, {"source_id": "B cells", "target_id": "humoral response", "strength": 3}, {"source_id": "B cells", "target_id": "COVID-19", "strength": 3}, {"source_id": "healthcare workers", "target_id": "spike protein", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "healthcare workers", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "healthcare workers", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "healthcare workers", "strength": 3}, {"source_id": "vaccination campaign", "target_id": "Omicron variant", "strength": 3}, {"source_id": "vaccination campaign", "target_id": "vaccine dose", "strength": 3}, {"source_id": "spike protein", "target_id": "healthcare workers", "strength": 3}, {"source_id": "healthy controls", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "median time", "strength": 3}, {"source_id": "cohort study", "target_id": "disease control", "strength": 3}, {"source_id": "median time", "target_id": "disease control", "strength": 3}, {"source_id": "respiratory disease", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "pandemic", "target_id": "organization", "strength": 3}, {"source_id": "depressive symptoms", "target_id": "cross-sectional survey", "strength": 3}, {"source_id": "health problems", "target_id": "depressive symptoms", "strength": 3}, {"source_id": "clinical studies", "target_id": "immune response", "strength": 3}, {"source_id": "immune response", "target_id": "clinical studies", "strength": 3}, {"source_id": "hospital mortality", "target_id": "older adults", "strength": 3}, {"source_id": "older adults", "target_id": "hospital mortality", "strength": 3}, {"source_id": "protective effect", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "side effects", "target_id": "vaccination status", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "prospective study", "strength": 3}, {"source_id": "adult patients", "target_id": "prospective study", "strength": 3}, {"source_id": "severe disease", "target_id": "adult patients", "strength": 3}, {"source_id": "University Hospital", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "study period", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "COVID-19", "target_id": "chronic diseases", "strength": 3}, {"source_id": "healthy controls", "target_id": "symptoms", "strength": 3}, {"source_id": "symptoms", "target_id": "healthy controls", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "health services", "strength": 3}, {"source_id": "cancer", "target_id": "control group", "strength": 3}, {"source_id": "Omicron variant", "target_id": "health records", "strength": 3}, {"source_id": "vaccination status", "target_id": "hospital admission", "strength": 3}, {"source_id": "vaccination status", "target_id": "electronic health records", "strength": 3}, {"source_id": "clinical practice", "target_id": "systematic review", "strength": 3}, {"source_id": "respiratory failure", "target_id": "adverse events", "strength": 3}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "high risk", "strength": 3}, {"source_id": "high risk", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "immune cells", "strength": 3}, {"source_id": "immune cells", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "healthy controls", "target_id": "third dose", "strength": 3}, {"source_id": "mortality", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "unit admission", "strength": 3}, {"source_id": "distress syndrome", "target_id": "unit admission", "strength": 3}, {"source_id": "middle-income countries", "target_id": "risk factors", "strength": 3}, {"source_id": "high-income countries", "target_id": "COVID-19", "strength": 3}, {"source_id": "viral replication", "target_id": "gene expression", "strength": 3}, {"source_id": "older adults", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "adult patients", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "ill patients", "target_id": "immune response", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "middle-income countries", "strength": 3}, {"source_id": "observational study", "target_id": "immune response", "strength": 3}, {"source_id": "immune response", "target_id": "observational study", "strength": 3}, {"source_id": "vaccination status", "target_id": "Omicron infection", "strength": 3}, {"source_id": "adverse events", "target_id": "hospital admission", "strength": 3}, {"source_id": "hospital admission", "target_id": "second dose", "strength": 3}, {"source_id": "care unit admission", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "older adults", "strength": 3}, {"source_id": "older adults", "target_id": "independent predictors", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "adult patients", "strength": 3}, {"source_id": "high risk", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "hospital", "target_id": "health system", "strength": 3}, {"source_id": "health system", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "vaccine", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "psychological distress", "target_id": "control group", "strength": 3}, {"source_id": "primary outcome", "target_id": "psychological distress", "strength": 3}, {"source_id": "control group", "target_id": "psychological distress", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "intervention group", "strength": 3}, {"source_id": "hospital stay", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "hospital stay", "strength": 3}, {"source_id": "adverse outcomes", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "therapy", "target_id": "older age", "strength": 3}, {"source_id": "healthy controls", "target_id": "variants of concern", "strength": 3}, {"source_id": "epithelial cells", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "spike protein", "target_id": "epithelial cells", "strength": 3}, {"source_id": "health care workers", "target_id": "symptoms", "strength": 3}, {"source_id": "Delta variant", "target_id": "age groups", "strength": 3}, {"source_id": "vaccination rates", "target_id": "high risk", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "primary care", "strength": 3}, {"source_id": "diagnosis", "target_id": "primary outcome", "strength": 3}, {"source_id": "intensive care unit", "target_id": "prevalence", "strength": 3}, {"source_id": "prevalence", "target_id": "intensive care unit", "strength": 3}, {"source_id": "qualitative study", "target_id": "young people", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "length of stay", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "health records", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "health records", "strength": 3}, {"source_id": "diagnosis", "target_id": "logistic regression", "strength": 3}, {"source_id": "COVID-19", "target_id": "justice", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "educators", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "risk factors", "strength": 3}, {"source_id": "severe illness", "target_id": "vaccination", "strength": 3}, {"source_id": "C-reactive protein", "target_id": "mortality", "strength": 3}, {"source_id": "median age", "target_id": "admission", "strength": 3}, {"source_id": "admission", "target_id": "median age", "strength": 3}, {"source_id": "observational study", "target_id": "outcome measures", "strength": 3}, {"source_id": "antibody titers", "target_id": "second dose", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "health care workers", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "humoral response", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "T cells", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "T cells", "strength": 3}, {"source_id": "mortality", "target_id": "incidence rate", "strength": 3}, {"source_id": "chronic diseases", "target_id": "infection", "strength": 3}, {"source_id": "mean age", "target_id": "myocardial infarction", "strength": 3}, {"source_id": "health status", "target_id": "risk factors", "strength": 3}, {"source_id": "health care workers", "target_id": "antibody levels", "strength": 3}, {"source_id": "median age", "target_id": "vaccine dose", "strength": 3}, {"source_id": "lower risk", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "surgery", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "older age", "target_id": "vaccine", "strength": 3}, {"source_id": "logistic regression models", "target_id": "emergency department", "strength": 3}, {"source_id": "case study", "target_id": "governance", "strength": 3}, {"source_id": "thematic analysis", "target_id": "skills", "strength": 3}, {"source_id": "children", "target_id": "skills", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "inflammation", "strength": 3}, {"source_id": "immune system", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "time points", "target_id": "risk factors", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "pregnant women", "strength": 3}, {"source_id": "median age", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "immune response", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "respiratory disease", "strength": 3}, {"source_id": "blood pressure", "target_id": "cohort study", "strength": 3}, {"source_id": "respiratory disease", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "vaccine dose", "target_id": "transplant recipients", "strength": 3}, {"source_id": "vaccine dose", "target_id": "humoral immune response", "strength": 3}, {"source_id": "humoral immune response", "target_id": "vaccine dose", "strength": 3}, {"source_id": "dose", "target_id": "transplant recipients", "strength": 3}, {"source_id": "emergency department", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "oxidative stress", "target_id": "inflammatory response", "strength": 3}, {"source_id": "children", "target_id": "COVID-19", "strength": 3}, {"source_id": "primary endpoint", "target_id": "clinical studies", "strength": 3}, {"source_id": "breast cancer", "target_id": "clinical trials", "strength": 3}, {"source_id": "serious adverse events", "target_id": "adult patients", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "mortality rate", "strength": 3}, {"source_id": "mortality rate", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "high risk", "target_id": "transplant recipients", "strength": 3}, {"source_id": "hospitalization", "target_id": "logistic regression models", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "general population", "strength": 3}, {"source_id": "vaccine", "target_id": "incidence", "strength": 3}, {"source_id": "incidence", "target_id": "vaccine", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "cause mortality", "strength": 3}, {"source_id": "patient population", "target_id": "adult patients", "strength": 3}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "respiratory disease", "strength": 3}, {"source_id": "respiratory disease", "target_id": "syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "clinical care", "strength": 3}, {"source_id": "immune system", "target_id": "World Health Organization", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "adverse effects", "strength": 3}, {"source_id": "clinical trials", "target_id": "type 2 diabetes", "strength": 3}, {"source_id": "mortality rate", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "vaccine doses", "target_id": "T cell responses", "strength": 3}, {"source_id": "healthcare workers", "target_id": "third dose", "strength": 3}, {"source_id": "lung disease", "target_id": "immune response", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "T cells", "strength": 3}, {"source_id": "transplant recipients", "target_id": "infectious diseases", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "infectious diseases", "target_id": "cohort study", "strength": 3}, {"source_id": "disease", "target_id": "transplant recipients", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "vaccine", "strength": 3}, {"source_id": "care unit admission", "target_id": "disease severity", "strength": 3}, {"source_id": "protective effect", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "unit admission", "strength": 3}, {"source_id": "cause mortality", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "incidence rate", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "infection", "target_id": "vaccination campaign", "strength": 3}, {"source_id": "perspective", "target_id": "book", "strength": 3}, {"source_id": "qualitative study", "target_id": "education", "strength": 3}, {"source_id": "higher education", "target_id": "context", "strength": 3}, {"source_id": "use disorders", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "clinical presentation", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "case report", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "case report", "strength": 3}, {"source_id": "case report", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "case report", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "spike protein", "target_id": "blood samples", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "Omicron variant", "strength": 3}, {"source_id": "Omicron variant", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "logistic regression", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "high risk", "target_id": "study design", "strength": 3}, {"source_id": "hazard ratio", "target_id": "illness", "strength": 3}, {"source_id": "admission", "target_id": "logistic regression models", "strength": 3}, {"source_id": "rights", "target_id": "crisis", "strength": 3}, {"source_id": "crisis", "target_id": "rights", "strength": 3}, {"source_id": "young people", "target_id": "children", "strength": 3}, {"source_id": "young adults", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "young adults", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "hospital stay", "target_id": "clinical trials", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "primary outcome", "strength": 3}, {"source_id": "protective effect", "target_id": "immune response", "strength": 3}, {"source_id": "mean age", "target_id": "therapy", "strength": 3}, {"source_id": "immune response", "target_id": "mean age", "strength": 3}, {"source_id": "therapy", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "complications", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "nervous system", "target_id": "inflammation", "strength": 3}, {"source_id": "inflammation", "target_id": "nervous system", "strength": 3}, {"source_id": "hospitalization", "target_id": "electronic health records", "strength": 3}, {"source_id": "health records", "target_id": "hospitalization", "strength": 3}, {"source_id": "vaccine dose", "target_id": "age groups", "strength": 3}, {"source_id": "median age", "target_id": "control group", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "schools", "strength": 3}, {"source_id": "schools", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "experience", "target_id": "need", "strength": 3}, {"source_id": "need", "target_id": "experience", "strength": 3}, {"source_id": "adverse events", "target_id": "care professionals", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "body mass index", "strength": 3}, {"source_id": "mass index", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "ill patients", "target_id": "viral infection", "strength": 3}, {"source_id": "healthy controls", "target_id": "cell responses", "strength": 3}, {"source_id": "cell responses", "target_id": "antibody levels", "strength": 3}, {"source_id": "adverse events", "target_id": "mortality rate", "strength": 3}, {"source_id": "mortality rate", "target_id": "adverse events", "strength": 3}, {"source_id": "weight loss", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "quality of life", "target_id": "adverse events", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "high risk", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "severe disease", "strength": 3}, {"source_id": "protective effect", "target_id": "severe disease", "strength": 3}, {"source_id": "pain", "target_id": "primary outcome", "strength": 3}, {"source_id": "health care workers", "target_id": "Delta variant", "strength": 3}, {"source_id": "Delta variant", "target_id": "care workers", "strength": 3}, {"source_id": "animal models", "target_id": "respiratory tract", "strength": 3}, {"source_id": "animal models", "target_id": "T cells", "strength": 3}, {"source_id": "United States", "target_id": "mental health", "strength": 3}, {"source_id": "intensive care unit", "target_id": "clinical data", "strength": 3}, {"source_id": "care unit", "target_id": "clinical data", "strength": 3}, {"source_id": "COVID-19 severity", "target_id": "disease 2019", "strength": 3}, {"source_id": "adverse events", "target_id": "risk factors", "strength": 3}, {"source_id": "clinical symptoms", "target_id": "clinical trials", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "D-dimer", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "severe illness", "strength": 3}, {"source_id": "ICU admission", "target_id": "high prevalence", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "cancer patients", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "electronic health records", "strength": 3}, {"source_id": "intensive care unit", "target_id": "time points", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "respiratory failure", "strength": 3}, {"source_id": "time points", "target_id": "intensive care unit", "strength": 3}, {"source_id": "pandemic", "target_id": "public health measures", "strength": 3}, {"source_id": "mean age", "target_id": "clinical practice", "strength": 3}, {"source_id": "clinical practice", "target_id": "mean age", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "emergency department", "strength": 3}, {"source_id": "physical activity", "target_id": "pain", "strength": 3}, {"source_id": "COVID-19 pneumonia", "target_id": "intensive care unit", "strength": 3}, {"source_id": "median age", "target_id": "most patients", "strength": 3}, {"source_id": "mortality", "target_id": "pneumonia", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "unit admission", "target_id": "logistic regression", "strength": 3}, {"source_id": "health issues", "target_id": "high risk", "strength": 3}, {"source_id": "technology", "target_id": "teaching", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "injury", "strength": 3}, {"source_id": "distress syndrome", "target_id": "disease", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "pregnancy", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "pneumonia", "strength": 3}, {"source_id": "disease severity", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "viral replication", "target_id": "cell responses", "strength": 3}, {"source_id": "women", "target_id": "mass index", "strength": 3}, {"source_id": "vaccination status", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "cell types", "target_id": "COVID-19", "strength": 3}, {"source_id": "therapy", "target_id": "risk factors", "strength": 3}, {"source_id": "severe disease", "target_id": "booster dose", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "epithelial cells", "strength": 3}, {"source_id": "cause mortality", "target_id": "lower risk", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "receptor-binding domain", "strength": 3}, {"source_id": "second dose", "target_id": "high risk", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "pregnancy", "strength": 3}, {"source_id": "women", "target_id": "vaccination rates", "strength": 3}, {"source_id": "perception", "target_id": "skills", "strength": 3}, {"source_id": "immune cells", "target_id": "central nervous system", "strength": 3}, {"source_id": "immune cells", "target_id": "nervous system", "strength": 3}, {"source_id": "women", "target_id": "study population", "strength": 3}, {"source_id": "clinical trials", "target_id": "pulmonary disease", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "quality of life", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "incidence", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "vaccine", "strength": 3}, {"source_id": "disease severity", "target_id": "Health Organization", "strength": 3}, {"source_id": "chronic diseases", "target_id": "risk factors", "strength": 3}, {"source_id": "clinical trials", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "severe cases", "strength": 3}, {"source_id": "distress syndrome", "target_id": "severe cases", "strength": 3}, {"source_id": "severe cases", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "observational study", "target_id": "most patients", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "most patients", "strength": 3}, {"source_id": "primary outcome", "target_id": "booster dose", "strength": 3}, {"source_id": "primary outcome", "target_id": "first dose", "strength": 3}, {"source_id": "primary outcome", "target_id": "dose", "strength": 3}, {"source_id": "dose", "target_id": "primary outcome", "strength": 3}, {"source_id": "hospital stay", "target_id": "adverse events", "strength": 3}, {"source_id": "adult patients", "target_id": "medical records", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "healthcare workers", "strength": 3}, {"source_id": "infection", "target_id": "emergency department", "strength": 3}, {"source_id": "hospital admission", "target_id": "cause mortality", "strength": 3}, {"source_id": "body mass index", "target_id": "type 2 diabetes", "strength": 3}, {"source_id": "hazard ratio", "target_id": "risk factors", "strength": 3}, {"source_id": "vaccine doses", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "unit admission", "target_id": "hospitalization", "strength": 3}, {"source_id": "adverse events", "target_id": "antibody response", "strength": 3}, {"source_id": "primary outcome", "target_id": "unit admission", "strength": 3}, {"source_id": "mean age", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "mean age", "target_id": "hospitalization", "strength": 3}, {"source_id": "antibody response", "target_id": "adverse events", "strength": 3}, {"source_id": "hospitalization", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "hospitalization", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "hospitalization", "target_id": "mean age", "strength": 3}, {"source_id": "hospitalization", "target_id": "admission", "strength": 3}, {"source_id": "care facilities", "target_id": "patients", "strength": 3}, {"source_id": "observational study", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "general population", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "health care workers", "strength": 3}, {"source_id": "COVID-19 symptoms", "target_id": "disease 2019", "strength": 3}, {"source_id": "vaccination", "target_id": "Meta-Analysis", "strength": 3}, {"source_id": "hospital", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "viral load", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "retrospective study", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "Web of Science", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "adverse events", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "COVID-19 diagnosis", "target_id": "odds ratio", "strength": 3}, {"source_id": "odds ratio", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "general population", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "disease severity", "strength": 3}, {"source_id": "general population", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "B cells", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "B cells", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "B cells", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "vaccination", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "ICU admission", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "intensive care", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "years of age", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "patient characteristics", "strength": 3}, {"source_id": "patient characteristics", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "patient characteristics", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "intensive care", "target_id": "distress syndrome", "strength": 3}, {"source_id": "intensive care", "target_id": "ICU admission", "strength": 3}, {"source_id": "adverse events", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "respiratory disease", "target_id": "cohort study", "strength": 3}, {"source_id": "quality of life", "target_id": "depressive symptoms", "strength": 3}, {"source_id": "cancer patients", "target_id": "risk factors", "strength": 3}, {"source_id": "depressive symptoms", "target_id": "quality of life", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "nervous system", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "disease 2019", "strength": 3}, {"source_id": "case series", "target_id": "SARS-CoV-2 pandemic", "strength": 3}, {"source_id": "antibody levels", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "animal models", "target_id": "mouse model", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "clinical practice", "target_id": "patient outcomes", "strength": 3}, {"source_id": "cross-sectional survey", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "sociodemographic characteristics", "target_id": "health status", "strength": 3}, {"source_id": "course", "target_id": "pandemic", "strength": 3}, {"source_id": "interviews", "target_id": "skills", "strength": 3}, {"source_id": "institutions", "target_id": "case study", "strength": 3}, {"source_id": "book", "target_id": "institutions", "strength": 3}, {"source_id": "institutions", "target_id": "book", "strength": 3}, {"source_id": "economy", "target_id": "rights", "strength": 3}, {"source_id": "article", "target_id": "experience", "strength": 3}, {"source_id": "book", "target_id": "economy", "strength": 3}, {"source_id": "University", "target_id": "economy", "strength": 3}, {"source_id": "future research", "target_id": "learning", "strength": 3}, {"source_id": "World Health Organization", "target_id": "infection", "strength": 3}, {"source_id": "infection", "target_id": "Health Organization", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "symptoms", "strength": 3}, {"source_id": "age groups", "target_id": "retrospective study", "strength": 3}, {"source_id": "antibody response", "target_id": "viral load", "strength": 3}, {"source_id": "viral load", "target_id": "antibody response", "strength": 3}, {"source_id": "median time", "target_id": "hospital discharge", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "trials", "strength": 3}, {"source_id": "disease severity", "target_id": "D-dimer", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "antibody titers", "strength": 3}, {"source_id": "oxidative stress", "target_id": "clinical trials", "strength": 3}, {"source_id": "healthcare workers", "target_id": "humoral immune response", "strength": 3}, {"source_id": "logistic regression", "target_id": "median time", "strength": 3}, {"source_id": "pain", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "COVID-19 symptoms", "target_id": "respiratory symptoms", "strength": 3}, {"source_id": "older adults", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "clinical trials", "target_id": "disease progression", "strength": 3}, {"source_id": "World Health Organization", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "World Health Organization", "target_id": "adverse events", "strength": 3}, {"source_id": "adverse events", "target_id": "Health Organization", "strength": 3}, {"source_id": "Health Organization", "target_id": "systematic review", "strength": 3}, {"source_id": "Health Organization", "target_id": "adverse events", "strength": 3}, {"source_id": "study period", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "public health measures", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "women", "strength": 3}, {"source_id": "primary outcome", "target_id": "hospital admission", "strength": 3}, {"source_id": "higher odds", "target_id": "primary outcome", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "incidence", "strength": 3}, {"source_id": "diagnosis", "target_id": "incidence", "strength": 3}, {"source_id": "high incidence", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "social determinants", "target_id": "health disparities", "strength": 3}, {"source_id": "disease 2019", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "healthcare workers", "strength": 3}, {"source_id": "humoral immune response", "target_id": "antibody response", "strength": 3}, {"source_id": "humoral immune response", "target_id": "booster vaccination", "strength": 3}, {"source_id": "Medical Center", "target_id": "diagnosis", "strength": 3}, {"source_id": "severe disease", "target_id": "second dose", "strength": 3}, {"source_id": "observational cohort study", "target_id": "study period", "strength": 3}, {"source_id": "severe disease", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "severe disease", "strength": 3}, {"source_id": "course", "target_id": "practice", "strength": 3}, {"source_id": "healthy controls", "target_id": "T cells", "strength": 3}, {"source_id": "patient characteristics", "target_id": "myocardial infarction", "strength": 3}, {"source_id": "pregnant women", "target_id": "vaccine uptake", "strength": 3}, {"source_id": "health interventions", "target_id": "vaccine", "strength": 3}, {"source_id": "middle-income countries", "target_id": "health interventions", "strength": 3}, {"source_id": "middle-income countries", "target_id": "adverse events", "strength": 3}, {"source_id": "vaccine", "target_id": "health interventions", "strength": 3}, {"source_id": "spike protein", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "immune response", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "animal models", "strength": 3}, {"source_id": "immune cells", "target_id": "spike protein", "strength": 3}, {"source_id": "flow cytometry", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "IL-6", "target_id": "therapeutic target", "strength": 3}, {"source_id": "COVID-19", "target_id": "receptor-binding domain", "strength": 3}, {"source_id": "learning model", "target_id": "learning", "strength": 3}, {"source_id": "case study", "target_id": "teachers", "strength": 3}, {"source_id": "health conditions", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "students", "target_id": "society", "strength": 3}, {"source_id": "curriculum", "target_id": "practice", "strength": 3}, {"source_id": "program", "target_id": "teachers", "strength": 3}, {"source_id": "participants", "target_id": "need", "strength": 3}, {"source_id": "lower risk", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "weight loss", "target_id": "control group", "strength": 3}, {"source_id": "infection rate", "target_id": "age groups", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "adverse outcomes", "strength": 3}, {"source_id": "adverse outcomes", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "disease", "strength": 3}, {"source_id": "vaccine", "target_id": "viral replication", "strength": 3}, {"source_id": "viral replication", "target_id": "vaccine", "strength": 3}, {"source_id": "humoral immune response", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "mouse model", "target_id": "COVID-19", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "Health Organization", "strength": 3}, {"source_id": "booster doses", "target_id": "severe disease", "strength": 3}, {"source_id": "vaccination status", "target_id": "vaccine dose", "strength": 3}, {"source_id": "social media", "target_id": "policy", "strength": 3}, {"source_id": "clinical setting", "target_id": "clinical trials", "strength": 3}, {"source_id": "clinical setting", "target_id": "health services", "strength": 3}, {"source_id": "COVID-19", "target_id": "vaccination campaign", "strength": 3}, {"source_id": "retrospective study", "target_id": "clinical data", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "high prevalence", "strength": 3}, {"source_id": "incidence", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "study period", "target_id": "disease", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "systematic review", "strength": 3}, {"source_id": "systematic review", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "clinical trials", "target_id": "healthcare workers", "strength": 3}, {"source_id": "viral replication", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "blood samples", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "technology", "target_id": "education", "strength": 3}, {"source_id": "care", "target_id": "health care professionals", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "electronic health records", "target_id": "health services", "strength": 3}, {"source_id": "infection", "target_id": "pediatric patients", "strength": 3}, {"source_id": "high risk", "target_id": "COVID-19 pneumonia", "strength": 3}, {"source_id": "mortality rate", "target_id": "ill patients", "strength": 3}, {"source_id": "C-reactive protein", "target_id": "admission", "strength": 3}, {"source_id": "IL-6", "target_id": "C-reactive protein", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "clinical trials", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "innate immune response", "strength": 3}, {"source_id": "risk factors", "target_id": "innate immune response", "strength": 3}, {"source_id": "antibody levels", "target_id": "time points", "strength": 3}, {"source_id": "cytokine storm", "target_id": "disease 2019", "strength": 3}, {"source_id": "clinical trials", "target_id": "health problems", "strength": 3}, {"source_id": "health problems", "target_id": "clinical trials", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "median age", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "median age", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "Omicron variant", "target_id": "infection rate", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "second dose", "strength": 3}, {"source_id": "lung disease", "target_id": "distress syndrome", "strength": 3}, {"source_id": "spike protein", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "infection", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "infection", "target_id": "study population", "strength": 3}, {"source_id": "health records", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "mean age", "strength": 3}, {"source_id": "pregnancy", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "age groups", "strength": 3}, {"source_id": "first dose", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "multivariable logistic regression", "target_id": "primary outcome", "strength": 3}, {"source_id": "primary outcome", "target_id": "multivariable logistic regression", "strength": 3}, {"source_id": "observational study", "target_id": "multivariable logistic regression", "strength": 3}, {"source_id": "study population", "target_id": "observational study", "strength": 3}, {"source_id": "Alzheimer's disease", "target_id": "oxidative stress", "strength": 3}, {"source_id": "oxidative stress", "target_id": "nervous system", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "blood pressure", "strength": 3}, {"source_id": "heart failure", "target_id": "cohort study", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "Delta variant", "strength": 3}, {"source_id": "Delta variant", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "Delta variant", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "World Health Organization", "strength": 3}, {"source_id": "Health Organization", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "clinical practice", "strength": 3}, {"source_id": "hospital admission", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "hospital admission", "target_id": "medical records", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "inflammatory diseases", "target_id": "risk factors", "strength": 3}, {"source_id": "risk factors", "target_id": "inflammation", "strength": 3}, {"source_id": "health disparities", "target_id": "policy", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "admission", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "admission", "strength": 3}, {"source_id": "coronavirus 2 infection", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "coronavirus 2 infection", "target_id": "admission", "strength": 3}, {"source_id": "risk factors", "target_id": "viral infection", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "observational study", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "viral infection", "target_id": "risk factors", "strength": 3}, {"source_id": "admission", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "vaccination", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "dose", "strength": 3}, {"source_id": "adverse outcomes", "target_id": "cohort study", "strength": 3}, {"source_id": "cohort study", "target_id": "adverse outcomes", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "odds ratio", "strength": 3}, {"source_id": "primary outcome", "target_id": "care facilities", "strength": 3}, {"source_id": "disease", "target_id": "cohort", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "quality of life", "strength": 3}, {"source_id": "quality of life", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "ill patients", "target_id": "illness", "strength": 3}, {"source_id": "cancer patients", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "cytokine storm", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "cytokine storm", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "cytokine storm", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "cytokine storm", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "immune cells", "target_id": "immune system", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "primary outcome", "target_id": "care settings", "strength": 3}, {"source_id": "systematic review", "target_id": "physical activity", "strength": 3}, {"source_id": "healthcare workers", "target_id": "mental health", "strength": 3}, {"source_id": "observational study", "target_id": "healthcare workers", "strength": 3}, {"source_id": "symptoms", "target_id": "clinical data", "strength": 3}, {"source_id": "mouse model", "target_id": "treatment strategies", "strength": 3}, {"source_id": "intensive care", "target_id": "high risk", "strength": 3}, {"source_id": "vaccine dose", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "book", "target_id": "teachers", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "mental health problems", "strength": 3}, {"source_id": "control group", "target_id": "mental health problems", "strength": 3}, {"source_id": "mean age", "target_id": "long COVID", "strength": 3}, {"source_id": "older adults", "target_id": "physical activity", "strength": 3}, {"source_id": "cell types", "target_id": "genes", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "distress syndrome", "strength": 3}, {"source_id": "primary outcome", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "high prevalence", "target_id": "mortality", "strength": 3}, {"source_id": "mortality", "target_id": "trials", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "severe disease", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "blood samples", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "antibody levels", "strength": 3}, {"source_id": "antibody levels", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "antibody levels", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "severe disease", "target_id": "antibody response", "strength": 3}, {"source_id": "blood samples", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "primary endpoint", "target_id": "trials", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "side effects", "strength": 3}, {"source_id": "side effects", "target_id": "cancer patients", "strength": 3}, {"source_id": "logistic regression", "target_id": "mass index", "strength": 3}, {"source_id": "severe disease", "target_id": "severe illness", "strength": 3}, {"source_id": "long COVID", "target_id": "systematic review", "strength": 3}, {"source_id": "high risk", "target_id": "vaccine dose", "strength": 3}, {"source_id": "high risk", "target_id": "study period", "strength": 3}, {"source_id": "care workers", "target_id": "logistic regression", "strength": 3}, {"source_id": "logistic regression", "target_id": "health care workers", "strength": 3}, {"source_id": "logistic regression", "target_id": "care workers", "strength": 3}, {"source_id": "study period", "target_id": "high risk", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "health services", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "dose", "strength": 3}, {"source_id": "disease", "target_id": "high incidence", "strength": 3}, {"source_id": "healthy controls", "target_id": "blood samples", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "surgery", "target_id": "observational study", "strength": 3}, {"source_id": "care unit admission", "target_id": "women", "strength": 3}, {"source_id": "unit admission", "target_id": "hospital discharge", "strength": 3}, {"source_id": "unit admission", "target_id": "pregnancy", "strength": 3}, {"source_id": "women", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "high prevalence", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "study period", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "case series", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "case series", "strength": 3}, {"source_id": "T cells", "target_id": "multiple sclerosis", "strength": 3}, {"source_id": "nervous system", "target_id": "case report", "strength": 3}, {"source_id": "cohort", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "disease severity", "target_id": "mass index", "strength": 3}, {"source_id": "violence", "target_id": "narratives", "strength": 3}, {"source_id": "narratives", "target_id": "social media", "strength": 3}, {"source_id": "curriculum", "target_id": "research", "strength": 3}, {"source_id": "engagement", "target_id": "research", "strength": 3}, {"source_id": "motivation", "target_id": "skills", "strength": 3}, {"source_id": "program", "target_id": "training", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "most patients", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "ischemic stroke", "strength": 3}, {"source_id": "World Health Organization", "target_id": "risk factors", "strength": 3}, {"source_id": "disease burden", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "Health Organization", "target_id": "risk factors", "strength": 3}, {"source_id": "antibody titers", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "disease 2019", "target_id": "antibody titers", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "T cell responses", "strength": 3}, {"source_id": "T cell responses", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "cell responses", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "T cells", "target_id": "antibody levels", "strength": 3}, {"source_id": "antibody levels", "target_id": "T cells", "strength": 3}, {"source_id": "cause mortality", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "cause mortality", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "health problems", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "high prevalence", "target_id": "mental health", "strength": 3}, {"source_id": "Meta-Analysis", "target_id": "mortality rate", "strength": 3}, {"source_id": "third dose", "target_id": "health records", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "dose", "strength": 3}, {"source_id": "health services", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "severe cases", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "hospitalization", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "odds ratio", "strength": 3}, {"source_id": "mass index", "target_id": "disease 2019", "strength": 3}, {"source_id": "disease 2019", "target_id": "body mass index", "strength": 3}, {"source_id": "disease 2019", "target_id": "odds ratio", "strength": 3}, {"source_id": "severe cases", "target_id": "D-dimer", "strength": 3}, {"source_id": "perception", "target_id": "thematic analysis", "strength": 3}, {"source_id": "pregnancy", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "pregnancy", "strength": 3}, {"source_id": "pregnancy", "target_id": "high risk", "strength": 3}, {"source_id": "vaccination rates", "target_id": "vaccination status", "strength": 3}, {"source_id": "quality of life", "target_id": "outcome measures", "strength": 3}, {"source_id": "risk factors", "target_id": "care providers", "strength": 3}, {"source_id": "care providers", "target_id": "risk factors", "strength": 3}, {"source_id": "race/ethnicity", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "policy", "target_id": "thematic analysis", "strength": 3}, {"source_id": "social support", "target_id": "mental health problems", "strength": 3}, {"source_id": "social support", "target_id": "health problems", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "immune response", "strength": 3}, {"source_id": "genes", "target_id": "innate immune response", "strength": 3}, {"source_id": "vaccine", "target_id": "respiratory tract", "strength": 3}, {"source_id": "immune system", "target_id": "vaccination", "strength": 3}, {"source_id": "narratives", "target_id": "institutions", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "pulmonary disease", "target_id": "high risk", "strength": 3}, {"source_id": "long COVID", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "spike protein", "target_id": "third dose", "strength": 3}, {"source_id": "median age", "target_id": "dose", "strength": 3}, {"source_id": "vaccine", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "care unit", "target_id": "adverse events", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "COVID-19", "strength": 3}, {"source_id": "antibody response", "target_id": "general population", "strength": 3}, {"source_id": "COVID-19 severity", "target_id": "Omicron variant", "strength": 3}, {"source_id": "COVID-19 severity", "target_id": "mortality", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "COVID-19", "strength": 3}, {"source_id": "mortality", "target_id": "COVID-19 severity", "strength": 3}, {"source_id": "disease severity", "target_id": "blood samples", "strength": 3}, {"source_id": "cancer", "target_id": "care system", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "independent predictors", "strength": 3}, {"source_id": "dose", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "dose", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "diagnosis", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "ICU admission", "strength": 3}, {"source_id": "high risk", "target_id": "trials", "strength": 3}, {"source_id": "vaccination", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "immune system", "target_id": "mortality rate", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "adult patients", "strength": 3}, {"source_id": "adult patients", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "quality of life", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "intensive care unit", "target_id": "older age", "strength": 3}, {"source_id": "adverse events", "target_id": "age groups", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "outcome measures", "strength": 3}, {"source_id": "outcome measures", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "social media", "target_id": "COVID-19", "strength": 3}, {"source_id": "social media", "target_id": "case study", "strength": 3}, {"source_id": "case study", "target_id": "engagement", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "University", "strength": 3}, {"source_id": "community", "target_id": "practice", "strength": 3}, {"source_id": "book", "target_id": "community", "strength": 3}, {"source_id": "politics", "target_id": "University", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "policy", "strength": 3}, {"source_id": "community", "target_id": "education", "strength": 3}, {"source_id": "engagement", "target_id": "perception", "strength": 3}, {"source_id": "ICU admission", "target_id": "respiratory failure", "strength": 3}, {"source_id": "care unit admission", "target_id": "ill patients", "strength": 3}, {"source_id": "care unit admission", "target_id": "adult patients", "strength": 3}, {"source_id": "length of stay", "target_id": "adult patients", "strength": 3}, {"source_id": "length of stay", "target_id": "study period", "strength": 3}, {"source_id": "unit admission", "target_id": "adult patients", "strength": 3}, {"source_id": "adult patients", "target_id": "length of stay", "strength": 3}, {"source_id": "T cells", "target_id": "COVID-19 pneumonia", "strength": 3}, {"source_id": "flow cytometry", "target_id": "B cells", "strength": 3}, {"source_id": "healthcare workers", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "booster dose", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "primary outcome", "target_id": "time points", "strength": 3}, {"source_id": "median time", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "median time", "target_id": "cohort study", "strength": 3}, {"source_id": "respiratory disease", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "disease 2019", "target_id": "respiratory disease", "strength": 3}, {"source_id": "social support", "target_id": "depressive symptoms", "strength": 3}, {"source_id": "social support", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "women", "strength": 3}, {"source_id": "cohort study", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "kidney disease", "target_id": "mortality rate", "strength": 3}, {"source_id": "high risk", "target_id": "heart failure", "strength": 3}, {"source_id": "mortality rate", "target_id": "kidney disease", "strength": 3}, {"source_id": "mortality rate", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "booster dose", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "adverse events", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "cohort", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "treatment options", "target_id": "disease", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "hospital", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "mortality", "strength": 3}, {"source_id": "electronic health records", "target_id": "Omicron variant", "strength": 3}, {"source_id": "electronic health records", "target_id": "vaccination status", "strength": 3}, {"source_id": "electronic health records", "target_id": "mortality", "strength": 3}, {"source_id": "mortality", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "institutions", "target_id": "course", "strength": 3}, {"source_id": "high risk", "target_id": "syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "immune cells", "target_id": "COVID-19 severity", "strength": 3}, {"source_id": "therapy", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "patients", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "spike protein", "target_id": "adverse events", "strength": 3}, {"source_id": "care unit admission", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "unit admission", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "University Hospital", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "T cells", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "gene expression", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "severe illness", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "clinical trials", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "systematic review", "strength": 3}, {"source_id": "pregnant women", "target_id": "observational study", "strength": 3}, {"source_id": "middle-income countries", "target_id": "disease 2019", "strength": 3}, {"source_id": "Omicron infection", "target_id": "study period", "strength": 3}, {"source_id": "vaccination status", "target_id": "Medical Center", "strength": 3}, {"source_id": "narratives", "target_id": "policy", "strength": 3}, {"source_id": "health system", "target_id": "policy", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "hospital admission", "target_id": "adverse events", "strength": 3}, {"source_id": "hospital admission", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "second dose", "target_id": "hospital admission", "strength": 3}, {"source_id": "Delta variant", "target_id": "admission", "strength": 3}, {"source_id": "older adults", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "medical records", "target_id": "vaccination", "strength": 3}, {"source_id": "vaccination", "target_id": "medical records", "strength": 3}, {"source_id": "complications", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "case report", "target_id": "respiratory symptoms", "strength": 3}, {"source_id": "vaccine", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "symptoms", "target_id": "time points", "strength": 3}, {"source_id": "psychological distress", "target_id": "primary outcome", "strength": 3}, {"source_id": "intervention group", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "psychological distress", "strength": 3}, {"source_id": "teachers", "target_id": "children", "strength": 3}, {"source_id": "program", "target_id": "children", "strength": 3}, {"source_id": "adverse events", "target_id": "clinical data", "strength": 3}, {"source_id": "clinical data", "target_id": "adverse events", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "adverse outcomes", "strength": 3}, {"source_id": "University Hospital", "target_id": "mean age", "strength": 3}, {"source_id": "admission", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "Omicron infection", "target_id": "hospital admission", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "Delta variant", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "care workers", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "symptoms", "target_id": "care workers", "strength": 3}, {"source_id": "years of age", "target_id": "inflammatory syndrome", "strength": 3}, {"source_id": "narratives", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "age groups", "target_id": "incidence rate", "strength": 3}, {"source_id": "incidence", "target_id": "age groups", "strength": 3}, {"source_id": "outcome measures", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "intensive care unit", "target_id": "care settings", "strength": 3}, {"source_id": "care settings", "target_id": "care unit", "strength": 3}, {"source_id": "prevalence", "target_id": "care unit", "strength": 3}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "disease 2019", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "electronic health records", "target_id": "booster dose", "strength": 3}, {"source_id": "health records", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "logistic regression", "target_id": "admission", "strength": 3}, {"source_id": "health system", "target_id": "patient population", "strength": 3}, {"source_id": "engagement", "target_id": "institutions", "strength": 3}, {"source_id": "curriculum", "target_id": "institutions", "strength": 3}, {"source_id": "context", "target_id": "engagement", "strength": 3}, {"source_id": "adult patients", "target_id": "emergency department", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "disease 2019", "strength": 3}, {"source_id": "adverse events", "target_id": "severe illness", "strength": 3}, {"source_id": "severe illness", "target_id": "adverse events", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "adverse events", "strength": 3}, {"source_id": "median age", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "outcome measures", "target_id": "observational study", "strength": 3}, {"source_id": "third dose", "target_id": "T cell responses", "strength": 3}, {"source_id": "humoral response", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "T cells", "strength": 3}, {"source_id": "incidence rate", "target_id": "mortality", "strength": 3}, {"source_id": "mortality rate", "target_id": "older age", "strength": 3}, {"source_id": "systematic review", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "systematic review", "target_id": "pregnant women", "strength": 3}, {"source_id": "trials", "target_id": "disease burden", "strength": 3}, {"source_id": "infection", "target_id": "chronic diseases", "strength": 3}, {"source_id": "myocardial infarction", "target_id": "mean age", "strength": 3}, {"source_id": "vaccination coverage", "target_id": "vaccination program", "strength": 3}, {"source_id": "ICU admission", "target_id": "booster dose", "strength": 3}, {"source_id": "risk factors", "target_id": "health status", "strength": 3}, {"source_id": "median age", "target_id": "immune response", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "surgery", "strength": 3}, {"source_id": "outcome measures", "target_id": "complications", "strength": 3}, {"source_id": "complications", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "health care professionals", "target_id": "health problems", "strength": 3}, {"source_id": "care professionals", "target_id": "health problems", "strength": 3}, {"source_id": "health problems", "target_id": "health care professionals", "strength": 3}, {"source_id": "vaccine", "target_id": "older age", "strength": 3}, {"source_id": "long COVID", "target_id": "outcome measures", "strength": 3}, {"source_id": "outcome measures", "target_id": "long COVID", "strength": 3}, {"source_id": "symptoms", "target_id": "outcome measures", "strength": 3}, {"source_id": "emergency department", "target_id": "logistic regression models", "strength": 3}, {"source_id": "book", "target_id": "governance", "strength": 3}, {"source_id": "skills", "target_id": "perspective", "strength": 3}, {"source_id": "crisis", "target_id": "education", "strength": 3}, {"source_id": "skills", "target_id": "children", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "immune system", "strength": 3}, {"source_id": "mortality rate", "target_id": "clinical trials", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "antibody levels", "strength": 3}, {"source_id": "mice", "target_id": "disease", "strength": 3}, {"source_id": "inflammatory response", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "inflammatory response", "strength": 3}, {"source_id": "T cells", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "median age", "strength": 3}, {"source_id": "study population", "target_id": "study period", "strength": 3}, {"source_id": "study period", "target_id": "study population", "strength": 3}, {"source_id": "Omicron variant", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "disease", "target_id": "control group", "strength": 3}, {"source_id": "Medical Center", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "adverse effects", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "healthcare workers", "target_id": "disease 2019", "strength": 3}, {"source_id": "mental health", "target_id": "health professionals", "strength": 3}, {"source_id": "article", "target_id": "climate change", "strength": 3}, {"source_id": "educators", "target_id": "children", "strength": 3}, {"source_id": "children", "target_id": "educators", "strength": 3}, {"source_id": "vaccine", "target_id": "emergency department", "strength": 3}, {"source_id": "clinical trials", "target_id": "breast cancer", "strength": 3}, {"source_id": "logistic regression", "target_id": "vaccine doses", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "illness", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "chronic diseases", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "respiratory disease", "strength": 3}, {"source_id": "respiratory disease", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "race/ethnicity", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "clinical care", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "adverse effects", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "quality of life", "target_id": "prospective study", "strength": 3}, {"source_id": "prospective study", "target_id": "quality of life", "strength": 3}, {"source_id": "educators", "target_id": "research", "strength": 3}, {"source_id": "type 2 diabetes", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "genes", "target_id": "viral replication", "strength": 3}, {"source_id": "viral replication", "target_id": "genes", "strength": 3}, {"source_id": "ICU admission", "target_id": "severe disease", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "disease progression", "strength": 3}, {"source_id": "disease progression", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "respiratory tract", "target_id": "severe disease", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "vaccine", "target_id": "severe cases", "strength": 3}, {"source_id": "disease severity", "target_id": "protective effect", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "race/ethnicity", "strength": 3}, {"source_id": "distress syndrome", "target_id": "cause mortality", "strength": 3}, {"source_id": "logistic regression", "target_id": "ICU admission", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "vaccination campaign", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "antiviral therapy", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "intensive care unit", "target_id": "outcome measures", "strength": 3}, {"source_id": "care unit", "target_id": "outcome measures", "strength": 3}, {"source_id": "outcome measures", "target_id": "intensive care unit", "strength": 3}, {"source_id": "outcome measures", "target_id": "care unit", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "cytokine storm", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "systematic review", "strength": 3}, {"source_id": "systematic review", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "severe illness", "target_id": "clinical trials", "strength": 3}, {"source_id": "lower risk", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "nasopharyngeal swabs", "strength": 3}, {"source_id": "care unit admission", "target_id": "medical records", "strength": 3}, {"source_id": "unit admission", "target_id": "medical records", "strength": 3}, {"source_id": "pain", "target_id": "symptoms", "strength": 3}, {"source_id": "people", "target_id": "rights", "strength": 3}, {"source_id": "qualitative study", "target_id": "learning", "strength": 3}, {"source_id": "context", "target_id": "higher education", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "use disorders", "strength": 3}, {"source_id": "case report", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "ill patients", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "clinical trials", "target_id": "safety profile", "strength": 3}, {"source_id": "care system", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "complications", "target_id": "systematic review", "strength": 3}, {"source_id": "health issues", "target_id": "risk factors", "strength": 3}, {"source_id": "logistic regression models", "target_id": "admission", "strength": 3}, {"source_id": "health care", "target_id": "care services", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "participants", "strength": 3}, {"source_id": "central nervous system", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "young people", "target_id": "students", "strength": 3}, {"source_id": "people", "target_id": "society", "strength": 3}, {"source_id": "primary outcome", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "older age", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "mean age", "target_id": "immune response", "strength": 3}, {"source_id": "immune response", "target_id": "older age", "strength": 3}, {"source_id": "vaccination", "target_id": "older age", "strength": 3}, {"source_id": "electronic health records", "target_id": "hospitalization", "strength": 3}, {"source_id": "hospitalization", "target_id": "health records", "strength": 3}, {"source_id": "logistic regression", "target_id": "greater risk", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "vaccination rates", "strength": 3}, {"source_id": "vaccination rates", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "control group", "target_id": "median age", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "pregnant women", "strength": 3}, {"source_id": "sector", "target_id": "United States", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "humoral response", "target_id": "spike protein", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "women", "strength": 3}, {"source_id": "adverse events", "target_id": "health care professionals", "strength": 3}, {"source_id": "respiratory symptoms", "target_id": "immune response", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "mass index", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "cell responses", "strength": 3}, {"source_id": "severe cases", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "severe cases", "target_id": "median age", "strength": 3}, {"source_id": "hospitalization", "target_id": "vaccine dose", "strength": 3}, {"source_id": "study design", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "cohort study", "target_id": "clinical practice", "strength": 3}, {"source_id": "adverse events", "target_id": "quality of life", "strength": 3}, {"source_id": "cause mortality", "target_id": "primary outcome", "strength": 3}, {"source_id": "primary outcome", "target_id": "cause mortality", "strength": 3}, {"source_id": "primary outcome", "target_id": "incidence rate", "strength": 3}, {"source_id": "incidence rate", "target_id": "control group", "strength": 3}, {"source_id": "severe disease", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "severe disease", "target_id": "protective effect", "strength": 3}, {"source_id": "severe disease", "target_id": "lower risk", "strength": 3}, {"source_id": "booster dose", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "care workers", "target_id": "Delta variant", "strength": 3}, {"source_id": "teachers", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "kidney disease", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "protein", "target_id": "innate immune response", "strength": 3}, {"source_id": "people", "target_id": "need", "strength": 3}, {"source_id": "need", "target_id": "people", "strength": 3}, {"source_id": "hospitalized patients", "target_id": "mortality", "strength": 3}, {"source_id": "high risk", "target_id": "severe illness", "strength": 3}, {"source_id": "high risk", "target_id": "cancer", "strength": 3}, {"source_id": "high prevalence", "target_id": "ICU admission", "strength": 3}, {"source_id": "care unit", "target_id": "time points", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "time points", "target_id": "care unit", "strength": 3}, {"source_id": "public health measures", "target_id": "pandemic", "strength": 3}, {"source_id": "vaccination status", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "vaccination status", "strength": 3}, {"source_id": "control group", "target_id": "care facilities", "strength": 3}, {"source_id": "severe disease", "target_id": "older adults", "strength": 3}, {"source_id": "coronavirus 2 infection", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "emergency department", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "emergency department", "strength": 3}, {"source_id": "median age", "target_id": "hospital mortality", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "mortality", "strength": 3}, {"source_id": "older age", "target_id": "age groups", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "pneumonia", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "logistic regression", "target_id": "unit admission", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "vaccination rates", "strength": 3}, {"source_id": "vaccination rates", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "mortality rate", "target_id": "care facilities", "strength": 3}, {"source_id": "protein", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "antiviral therapy", "target_id": "infection", "strength": 3}, {"source_id": "disease 2019", "target_id": "cell responses", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "injury", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "injury", "strength": 3}, {"source_id": "Meta-Analysis", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "injury", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "cell responses", "target_id": "viral replication", "strength": 3}, {"source_id": "learning", "target_id": "social media", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "vaccination status", "strength": 3}, {"source_id": "myocardial infarction", "target_id": "cohort study", "strength": 3}, {"source_id": "heart failure", "target_id": "injury", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "median age", "strength": 3}, {"source_id": "years of age", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "years of age", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "distress syndrome", "strength": 3}, {"source_id": "high risk", "target_id": "second dose", "strength": 3}, {"source_id": "pregnancy", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "pulmonary disease", "strength": 3}, {"source_id": "perception", "target_id": "practice", "strength": 3}, {"source_id": "clinical trials", "target_id": "high mortality", "strength": 3}, {"source_id": "immune response", "target_id": "central nervous system", "strength": 3}, {"source_id": "variants of concern", "target_id": "receptor-binding domain", "strength": 3}, {"source_id": "mortality rate", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "mortality rate", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "older age", "strength": 3}, {"source_id": "cohort study", "target_id": "care facilities", "strength": 3}, {"source_id": "median age", "target_id": "clinical trials", "strength": 3}, {"source_id": "immune response", "target_id": "protein", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "prevalence", "strength": 3}, {"source_id": "prevalence", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "median age", "target_id": "logistic regression", "strength": 3}, {"source_id": "high risk", "target_id": "clinical studies", "strength": 3}, {"source_id": "incidence rate", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "inflammatory response", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "inflammatory response", "strength": 3}, {"source_id": "distress syndrome", "target_id": "inflammatory response", "strength": 3}, {"source_id": "severe cases", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "primary outcome", "target_id": "BNT162b2 vaccine", "strength": 3}, {"source_id": "retrospective study", "target_id": "adverse events", "strength": 3}, {"source_id": "electronic medical records", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "observational study", "target_id": "electronic medical records", "strength": 3}, {"source_id": "observational study", "target_id": "symptom onset", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "symptom onset", "strength": 3}, {"source_id": "adverse events", "target_id": "medical records", "strength": 3}, {"source_id": "primary outcome", "target_id": "symptom onset", "strength": 3}, {"source_id": "medical records", "target_id": "adult patients", "strength": 3}, {"source_id": "disease 2019", "target_id": "symptom onset", "strength": 3}, {"source_id": "humoral response", "target_id": "healthcare workers", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "BNT162b2 vaccine", "strength": 3}, {"source_id": "healthcare workers", "target_id": "humoral response", "strength": 3}, {"source_id": "antibody levels", "target_id": "severe disease", "strength": 3}, {"source_id": "body mass index", "target_id": "blood pressure", "strength": 3}, {"source_id": "blood pressure", "target_id": "body mass index", "strength": 3}, {"source_id": "mass index", "target_id": "blood pressure", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "hospitalization", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "case-control study", "strength": 3}, {"source_id": "care unit admission", "target_id": "mean age", "strength": 3}, {"source_id": "care unit admission", "target_id": "hospitalization", "strength": 3}, {"source_id": "case-control study", "target_id": "ICU admission", "strength": 3}, {"source_id": "unit admission", "target_id": "mean age", "strength": 3}, {"source_id": "primary outcome", "target_id": "care unit admission", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "lower risk", "strength": 3}, {"source_id": "health care workers", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "adult patients", "target_id": "logistic regression models", "strength": 3}, {"source_id": "policy", "target_id": "students", "strength": 3}, {"source_id": "systematic review", "target_id": "years of age", "strength": 3}, {"source_id": "years of age", "target_id": "systematic review", "strength": 3}, {"source_id": "study protocol", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "study protocol", "target_id": "vaccine", "strength": 3}, {"source_id": "COVID-19 diagnosis", "target_id": "study participants", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "hospital", "strength": 3}, {"source_id": "blood pressure", "target_id": "clinical practice", "strength": 3}, {"source_id": "Omicron variant", "target_id": "study design", "strength": 3}, {"source_id": "retrospective study", "target_id": "control group", "strength": 3}, {"source_id": "study design", "target_id": "Omicron variant", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "Web of Science", "strength": 3}, {"source_id": "adverse events", "target_id": "beneficial effects", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "odds ratio", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "B cells", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "B cells", "strength": 3}, {"source_id": "B cells", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "disease severity", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "disease severity", "target_id": "booster vaccination", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "intensive care", "strength": 3}, {"source_id": "years of age", "target_id": "observational study", "strength": 3}, {"source_id": "ICU admission", "target_id": "intensive care", "strength": 3}, {"source_id": "adverse events", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "healthy controls", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "disease", "strength": 3}, {"source_id": "cohort study", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "central nervous system", "strength": 3}, {"source_id": "central nervous system", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "antibody levels", "strength": 3}, {"source_id": "infection rate", "target_id": "vaccine", "strength": 3}, {"source_id": "health system", "target_id": "clinical care", "strength": 3}, {"source_id": "patient outcomes", "target_id": "clinical practice", "strength": 3}, {"source_id": "mental health", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "pandemic", "target_id": "course", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "World Health Organization", "strength": 3}, {"source_id": "institutions", "target_id": "interviews", "strength": 3}, {"source_id": "interviews", "target_id": "institutions", "strength": 3}, {"source_id": "community", "target_id": "narratives", "strength": 3}, {"source_id": "rights", "target_id": "economy", "strength": 3}, {"source_id": "article", "target_id": "thematic analysis", "strength": 3}, {"source_id": "practice", "target_id": "government", "strength": 3}, {"source_id": "case study", "target_id": "experience", "strength": 3}, {"source_id": "case study", "target_id": "University", "strength": 3}, {"source_id": "economy", "target_id": "book", "strength": 3}, {"source_id": "Health Organization", "target_id": "infection", "strength": 3}, {"source_id": "risk factors", "target_id": "C-reactive protein", "strength": 3}, {"source_id": "illness", "target_id": "mean age", "strength": 3}, {"source_id": "antibody titers", "target_id": "clinical trials", "strength": 3}, {"source_id": "observational study", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "clinical studies", "target_id": "therapy", "strength": 3}, {"source_id": "therapy", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "observational study", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "disease severity", "strength": 3}, {"source_id": "emergency department", "target_id": "observational study", "strength": 3}, {"source_id": "healthcare workers", "target_id": "T cells", "strength": 3}, {"source_id": "risk factors", "target_id": "T cell responses", "strength": 3}, {"source_id": "humoral immune response", "target_id": "healthcare workers", "strength": 3}, {"source_id": "humoral immune response", "target_id": "antibody titers", "strength": 3}, {"source_id": "cell responses", "target_id": "healthcare workers", "strength": 3}, {"source_id": "median time", "target_id": "logistic regression", "strength": 3}, {"source_id": "pain", "target_id": "vaccine", "strength": 3}, {"source_id": "systematic review", "target_id": "hospital stay", "strength": 3}, {"source_id": "safety profile", "target_id": "first dose", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "older adults", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "older adults", "strength": 3}, {"source_id": "clinical presentation", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "nasopharyngeal swabs", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "nasopharyngeal swabs", "target_id": "symptoms", "strength": 3}, {"source_id": "higher odds", "target_id": "symptoms", "strength": 3}, {"source_id": "systematic review", "target_id": "Health Organization", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "Health Organization", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "study period", "strength": 3}, {"source_id": "study period", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "vaccine doses", "target_id": "incidence rate", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "disease 2019", "strength": 3}, {"source_id": "health measures", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "hospital admission", "target_id": "primary outcome", "strength": 3}, {"source_id": "hospital admission", "target_id": "higher odds", "strength": 3}, {"source_id": "higher odds", "target_id": "hospital admission", "strength": 3}, {"source_id": "mass index", "target_id": "mean age", "strength": 3}, {"source_id": "incidence", "target_id": "diagnosis", "strength": 3}, {"source_id": "health disparities", "target_id": "social determinants", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "study period", "strength": 3}, {"source_id": "study period", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "COVID-19", "target_id": "health concern", "strength": 3}, {"source_id": "antibody response", "target_id": "vaccine doses", "strength": 3}, {"source_id": "healthcare workers", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "diagnosis", "target_id": "Medical Center", "strength": 3}, {"source_id": "long COVID", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "second dose", "target_id": "severe disease", "strength": 3}, {"source_id": "healthcare workers", "target_id": "high prevalence", "strength": 3}, {"source_id": "prospective study", "target_id": "healthcare workers", "strength": 3}, {"source_id": "SARS-CoV-2 replication", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "patient care", "target_id": "cancer patients", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "risk factors", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "chronic diseases", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "care services", "strength": 3}, {"source_id": "care services", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "care providers", "target_id": "most patients", "strength": 3}, {"source_id": "vaccine uptake", "target_id": "pregnant women", "strength": 3}, {"source_id": "health conditions", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "health conditions", "target_id": "health interventions", "strength": 3}, {"source_id": "antibody response", "target_id": "Omicron infection", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "B cells", "strength": 3}, {"source_id": "flow cytometry", "target_id": "spike protein", "strength": 3}, {"source_id": "spike protein", "target_id": "animal models", "strength": 3}, {"source_id": "T cells", "target_id": "inflammatory response", "strength": 3}, {"source_id": "receptor-binding domain", "target_id": "COVID-19", "strength": 3}, {"source_id": "countries", "target_id": "actors", "strength": 3}, {"source_id": "skills", "target_id": "COVID-19", "strength": 3}, {"source_id": "COVID-19", "target_id": "skills", "strength": 3}, {"source_id": "governance", "target_id": "narratives", "strength": 3}, {"source_id": "teachers", "target_id": "need", "strength": 3}, {"source_id": "need", "target_id": "teachers", "strength": 3}, {"source_id": "book", "target_id": "COVID-19", "strength": 3}, {"source_id": "control group", "target_id": "weight loss", "strength": 3}, {"source_id": "disease", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "multiple sclerosis", "strength": 3}, {"source_id": "electronic medical records", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "B cells", "target_id": "mice", "strength": 3}, {"source_id": "inflammatory response", "target_id": "mouse model", "strength": 3}, {"source_id": "Health Organization", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "first dose", "target_id": "healthcare workers", "strength": 3}, {"source_id": "policy", "target_id": "social media", "strength": 3}, {"source_id": "health services", "target_id": "primary outcome", "strength": 3}, {"source_id": "health system", "target_id": "clinical trials", "strength": 3}, {"source_id": "climate change", "target_id": "case study", "strength": 3}, {"source_id": "vaccination campaign", "target_id": "COVID-19", "strength": 3}, {"source_id": "high prevalence", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "Omicron variant", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "incidence", "target_id": "risk factors", "strength": 3}, {"source_id": "disease", "target_id": "study period", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "cohort study", "strength": 3}, {"source_id": "healthcare workers", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "care", "target_id": "emergency department", "strength": 3}, {"source_id": "sociodemographic characteristics", "target_id": "health outcomes", "strength": 3}, {"source_id": "healthcare workers", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "health conditions", "target_id": "systematic review", "strength": 3}, {"source_id": "health records", "target_id": "health services", "strength": 3}, {"source_id": "pediatric patients", "target_id": "infection", "strength": 3}, {"source_id": "University Hospital", "target_id": "hospital stay", "strength": 3}, {"source_id": "mortality", "target_id": "University Hospital", "strength": 3}, {"source_id": "clinical presentation", "target_id": "clinical trials", "strength": 3}, {"source_id": "patient outcomes", "target_id": "treatment options", "strength": 3}, {"source_id": "C-reactive protein", "target_id": "ICU admission", "strength": 3}, {"source_id": "admission", "target_id": "C-reactive protein", "strength": 3}, {"source_id": "distress syndrome", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "distress syndrome", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "antibody levels", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "inflammatory diseases", "strength": 3}, {"source_id": "booster vaccination", "target_id": "humoral response", "strength": 3}, {"source_id": "cytokine storm", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "immune system", "strength": 3}, {"source_id": "mortality rate", "target_id": "infection rate", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "spike protein", "strength": 3}, {"source_id": "spike protein", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "intensive care", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "COVID-19", "target_id": "booster vaccination", "strength": 3}, {"source_id": "mortality rate", "target_id": "women", "strength": 3}, {"source_id": "study population", "target_id": "infection", "strength": 3}, {"source_id": "health system", "target_id": "electronic health records", "strength": 3}, {"source_id": "health interventions", "target_id": "primary outcome", "strength": 3}, {"source_id": "primary outcome", "target_id": "health interventions", "strength": 3}, {"source_id": "young adults", "target_id": "disease", "strength": 3}, {"source_id": "first dose", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "Medical Center", "strength": 3}, {"source_id": "greater risk", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "Delta variant", "strength": 3}, {"source_id": "Delta variant", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "primary endpoint", "target_id": "vaccine", "strength": 3}, {"source_id": "Delta variant", "target_id": "median age", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "healthcare workers", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "treatment options", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "treatment options", "strength": 3}, {"source_id": "treatment options", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "health professionals", "target_id": "care providers", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "Health Organization", "strength": 3}, {"source_id": "World Health Organization", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "Health Organization", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "clinical practice", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "hospital admission", "strength": 3}, {"source_id": "hospital admission", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "clinical practice", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "clinical practice", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "policy", "target_id": "climate change", "strength": 3}, {"source_id": "governance", "target_id": "article", "strength": 3}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "observational study", "strength": 3}, {"source_id": "severe disease", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 3}, {"source_id": "severe disease", "target_id": "coronavirus 2 infection", "strength": 3}, {"source_id": "adverse events", "target_id": "vaccine dose", "strength": 3}, {"source_id": "booster doses", "target_id": "antibody levels", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "C-reactive protein", "strength": 3}, {"source_id": "therapy", "target_id": "hospital mortality", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "women", "strength": 3}, {"source_id": "odds ratio", "target_id": "adverse outcomes", "strength": 3}, {"source_id": "logistic regression", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "care facilities", "target_id": "primary outcome", "strength": 3}, {"source_id": "young adults", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "vaccination campaign", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "illness", "target_id": "ill patients", "strength": 3}, {"source_id": "cancer patients", "target_id": "disease 2019", "strength": 3}, {"source_id": "disease 2019", "target_id": "cancer patients", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "cytokine storm", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "cytokine storm", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "cytokine storm", "strength": 3}, {"source_id": "severe illness", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "immune system", "target_id": "clinical trials", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "healthcare workers", "target_id": "observational study", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "greater risk", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "clinical symptoms", "strength": 3}, {"source_id": "treatment strategies", "target_id": "mouse model", "strength": 3}, {"source_id": "health services", "target_id": "middle-income countries", "strength": 3}, {"source_id": "teachers", "target_id": "book", "strength": 3}, {"source_id": "physical activity", "target_id": "time points", "strength": 3}, {"source_id": "long COVID", "target_id": "mean age", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "treatment strategies", "strength": 3}, {"source_id": "treatment strategies", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "immune response", "target_id": "oxidative stress", "strength": 3}, {"source_id": "therapy", "target_id": "spike protein", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "symptoms", "strength": 3}, {"source_id": "disease severity", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "intensive care unit", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "care unit", "strength": 3}, {"source_id": "hospital stay", "target_id": "disease severity", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "blood samples", "strength": 3}, {"source_id": "antibody levels", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "blood samples", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "blood samples", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "inflammation", "target_id": "mouse model", "strength": 3}, {"source_id": "inflammation", "target_id": "symptoms", "strength": 3}, {"source_id": "trials", "target_id": "primary endpoint", "strength": 3}, {"source_id": "variants of concern", "target_id": "booster vaccination", "strength": 3}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "variants of concern", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "SARS-CoV-2 pandemic", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "second dose", "target_id": "systematic review", "strength": 3}, {"source_id": "cancer patients", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "cancer patients", "target_id": "vaccine", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "Meta-Analysis", "strength": 3}, {"source_id": "side effects", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "Meta-Analysis", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "ill patients", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "therapy", "target_id": "ill patients", "strength": 3}, {"source_id": "second dose", "target_id": "age groups", "strength": 3}, {"source_id": "systematic review", "target_id": "long COVID", "strength": 3}, {"source_id": "patient outcomes", "target_id": "length of stay", "strength": 3}, {"source_id": "primary outcome", "target_id": "care workers", "strength": 3}, {"source_id": "risk factors", "target_id": "health problems", "strength": 3}, {"source_id": "hospital admission", "target_id": "odds ratio", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "electronic health records", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "health records", "strength": 3}, {"source_id": "health services", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "health records", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "healthy controls", "strength": 3}, {"source_id": "healthy controls", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "kidney disease", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "chronic kidney disease", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "surgery", "target_id": "primary outcome", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "risk factors", "target_id": "COVID-19 diagnosis", "strength": 3}, {"source_id": "care unit admission", "target_id": "hospital discharge", "strength": 3}, {"source_id": "care unit admission", "target_id": "pregnancy", "strength": 3}, {"source_id": "women", "target_id": "unit admission", "strength": 3}, {"source_id": "therapeutic target", "target_id": "severe cases", "strength": 3}, {"source_id": "severe cases", "target_id": "therapeutic target", "strength": 3}, {"source_id": "care system", "target_id": "risk factors", "strength": 3}, {"source_id": "case series", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "T cells", "target_id": "respiratory tract", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "mass index", "strength": 3}, {"source_id": "mass index", "target_id": "disease severity", "strength": 3}, {"source_id": "article", "target_id": "United States", "strength": 3}, {"source_id": "rights", "target_id": "government", "strength": 3}, {"source_id": "institutions", "target_id": "society", "strength": 3}, {"source_id": "schools", "target_id": "United States", "strength": 3}, {"source_id": "research", "target_id": "engagement", "strength": 3}, {"source_id": "course", "target_id": "motivation", "strength": 3}, {"source_id": "medical students", "target_id": "University", "strength": 3}, {"source_id": "risk factors", "target_id": "Health Organization", "strength": 3}, {"source_id": "COVID-19", "target_id": "ischemic stroke", "strength": 3}, {"source_id": "chronic kidney disease", "target_id": "risk factors", "strength": 3}, {"source_id": "clinical symptoms", "target_id": "risk factors", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "antibody titers", "strength": 3}, {"source_id": "general population", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "infection rate", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "cause mortality", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "lower risk", "strength": 3}, {"source_id": "countries", "target_id": "high-income countries", "strength": 3}, {"source_id": "health problems", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "health problems", "target_id": "high prevalence", "strength": 3}, {"source_id": "pregnant women", "target_id": "severe illness", "strength": 3}, {"source_id": "primary endpoint", "target_id": "myocardial infarction", "strength": 3}, {"source_id": "myocardial infarction", "target_id": "hospital mortality", "strength": 3}, {"source_id": "mortality rate", "target_id": "Meta-Analysis", "strength": 3}, {"source_id": "multivariable logistic regression", "target_id": "odds ratio", "strength": 3}, {"source_id": "multivariable logistic regression", "target_id": "infection", "strength": 3}, {"source_id": "infection", "target_id": "multivariable logistic regression", "strength": 3}, {"source_id": "vaccine uptake", "target_id": "vaccination program", "strength": 3}, {"source_id": "adverse events", "target_id": "booster vaccination", "strength": 3}, {"source_id": "electronic health records", "target_id": "third dose", "strength": 3}, {"source_id": "electronic health records", "target_id": "vaccine", "strength": 3}, {"source_id": "health records", "target_id": "third dose", "strength": 3}, {"source_id": "health records", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "body mass index", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "D-dimer", "strength": 3}, {"source_id": "disease 2019", "target_id": "mass index", "strength": 3}, {"source_id": "disease 2019", "target_id": "D-dimer", "strength": 3}, {"source_id": "pregnant women", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "observational study", "target_id": "age groups", "strength": 3}, {"source_id": "mental health", "target_id": "qualitative study", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "case report", "strength": 3}, {"source_id": "body mass index", "target_id": "adverse events", "strength": 3}, {"source_id": "health problems", "target_id": "social support", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "institutions", "target_id": "narratives", "strength": 3}, {"source_id": "context", "target_id": "community", "strength": 3}, {"source_id": "COVID-19", "target_id": "unvaccinated individuals", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "vaccine", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "general population", "strength": 3}, {"source_id": "general population", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "patients", "strength": 3}, {"source_id": "mortality", "target_id": "general population", "strength": 3}, {"source_id": "respiratory tract", "target_id": "respiratory disease", "strength": 3}, {"source_id": "booster doses", "target_id": "antibody titers", "strength": 3}, {"source_id": "cohort study", "target_id": "disease burden", "strength": 3}, {"source_id": "dose", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "hospital", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "trials", "target_id": "high risk", "strength": 3}, {"source_id": "age groups", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "intensive care unit", "target_id": "hospitalization", "strength": 3}, {"source_id": "hospitalization", "target_id": "intensive care unit", "strength": 3}, {"source_id": "mortality rate", "target_id": "immune system", "strength": 3}, {"source_id": "vaccine hesitancy", "target_id": "health interventions", "strength": 3}, {"source_id": "study protocol", "target_id": "adult patients", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "quality of life", "strength": 3}, {"source_id": "care unit", "target_id": "older age", "strength": 3}, {"source_id": "health concern", "target_id": "mental health outcomes", "strength": 3}, {"source_id": "pandemic", "target_id": "actors", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "teaching", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "institutions", "strength": 3}, {"source_id": "institutions", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "institutions", "target_id": "learners", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "community", "strength": 3}, {"source_id": "research", "target_id": "people", "strength": 3}, {"source_id": "perception", "target_id": "motivation", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "observational study", "strength": 3}, {"source_id": "unit admission", "target_id": "ill patients", "strength": 3}, {"source_id": "unit admission", "target_id": "observational study", "strength": 3}, {"source_id": "adult patients", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "adult patients", "target_id": "unit admission", "strength": 3}, {"source_id": "observational study", "target_id": "ill patients", "strength": 3}, {"source_id": "observational study", "target_id": "unit admission", "strength": 3}, {"source_id": "IL-6", "target_id": "risk factors", "strength": 3}, {"source_id": "risk factors", "target_id": "IL-6", "strength": 3}, {"source_id": "COVID-19 pneumonia", "target_id": "T cells", "strength": 3}, {"source_id": "vaccination", "target_id": "flow cytometry", "strength": 3}, {"source_id": "B cells", "target_id": "flow cytometry", "strength": 3}, {"source_id": "B cells", "target_id": "therapy", "strength": 3}, {"source_id": "Delta variant", "target_id": "COVID-19", "strength": 3}, {"source_id": "healthcare workers", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "healthcare workers", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "healthcare workers", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "healthcare workers", "strength": 3}, {"source_id": "time points", "target_id": "primary outcome", "strength": 3}, {"source_id": "general population", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "control group", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "intensive care unit", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "respiratory disease", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "respiratory disease", "strength": 3}, {"source_id": "respiratory disease", "target_id": "disease 2019", "strength": 3}, {"source_id": "sector", "target_id": "organization", "strength": 3}, {"source_id": "politics", "target_id": "rights", "strength": 3}, {"source_id": "depressive symptoms", "target_id": "social support", "strength": 3}, {"source_id": "pregnant women", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "high risk", "target_id": "type 2 diabetes", "strength": 3}, {"source_id": "chronic kidney disease", "target_id": "mortality rate", "strength": 3}, {"source_id": "mortality rate", "target_id": "chronic kidney disease", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "mortality rate", "strength": 3}, {"source_id": "adult patients", "target_id": "antibody response", "strength": 3}, {"source_id": "prospective study", "target_id": "adult patients", "strength": 3}, {"source_id": "emergency department", "target_id": "length of stay", "strength": 3}, {"source_id": "study period", "target_id": "University Hospital", "strength": 3}, {"source_id": "logistic regression models", "target_id": "ischemic stroke", "strength": 3}, {"source_id": "blood samples", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "health services", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "medical records", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "medical records", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "vaccination status", "target_id": "health records", "strength": 3}, {"source_id": "health records", "target_id": "mortality", "strength": 3}, {"source_id": "treatment options", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "high risk", "target_id": "coronavirus 2 infection", "strength": 3}, {"source_id": "high risk", "target_id": "pneumonia", "strength": 3}, {"source_id": "COVID-19 severity", "target_id": "immune cells", "strength": 3}, {"source_id": "logistic regression", "target_id": "care unit", "strength": 3}, {"source_id": "inflammatory diseases", "target_id": "third dose", "strength": 3}, {"source_id": "therapy", "target_id": "healthy controls", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "mortality", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "unit admission", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "distress syndrome", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "T cells", "strength": 3}, {"source_id": "Omicron variant", "target_id": "older adults", "strength": 3}, {"source_id": "quality of life", "target_id": "surgery", "strength": 3}, {"source_id": "surgery", "target_id": "quality of life", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "adult patients", "strength": 3}, {"source_id": "severe illness", "target_id": "distress syndrome", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "severe illness", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "clinical trials", "strength": 3}, {"source_id": "systematic review", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "lower risk", "target_id": "Omicron infection", "strength": 3}, {"source_id": "study period", "target_id": "Omicron infection", "strength": 3}, {"source_id": "health system", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "policy", "target_id": "narratives", "strength": 3}, {"source_id": "policy", "target_id": "health system", "strength": 3}, {"source_id": "median age", "target_id": "observational study", "strength": 3}, {"source_id": "observational study", "target_id": "median age", "strength": 3}, {"source_id": "retrospective study", "target_id": "Medical Center", "strength": 3}, {"source_id": "mortality", "target_id": "Medical Center", "strength": 3}, {"source_id": "disease severity", "target_id": "mean age", "strength": 3}, {"source_id": "symptoms", "target_id": "study period", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "complications", "strength": 3}, {"source_id": "COVID-19 severity", "target_id": "cancer patients", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "health system", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "adverse outcomes", "strength": 3}, {"source_id": "adverse outcomes", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "admission", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "vaccine", "target_id": "weight loss", "strength": 3}, {"source_id": "cohort study", "target_id": "variants of concern", "strength": 3}, {"source_id": "T cells", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "epithelial cells", "target_id": "spike protein", "strength": 3}, {"source_id": "health care workers", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "care workers", "target_id": "symptoms", "strength": 3}, {"source_id": "symptoms", "target_id": "health care workers", "strength": 3}, {"source_id": "mortality rate", "target_id": "primary outcome", "strength": 3}, {"source_id": "respiratory disease", "target_id": "incidence rate", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "disease", "strength": 3}, {"source_id": "kidney disease", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "vaccine doses", "target_id": "hospitalization", "strength": 3}, {"source_id": "age groups", "target_id": "Delta variant", "strength": 3}, {"source_id": "Omicron variant", "target_id": "age groups", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "outcome measures", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "unvaccinated individuals", "strength": 3}, {"source_id": "primary endpoint", "target_id": "high risk", "strength": 3}, {"source_id": "care unit", "target_id": "prevalence", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "COVID-19", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "multiple sclerosis", "strength": 3}, {"source_id": "multiple sclerosis", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "young people", "target_id": "qualitative study", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "health care professionals", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "electronic health records", "strength": 3}, {"source_id": "electronic health records", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "health records", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "admission", "target_id": "logistic regression", "strength": 3}, {"source_id": "patient population", "target_id": "health system", "strength": 3}, {"source_id": "anxiety", "target_id": "risk factors", "strength": 3}, {"source_id": "people", "target_id": "countries", "strength": 3}, {"source_id": "narratives", "target_id": "COVID-19", "strength": 3}, {"source_id": "schools", "target_id": "motivation", "strength": 3}, {"source_id": "physical activity", "target_id": "logistic regression", "strength": 3}, {"source_id": "risk factors", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "older age", "target_id": "humoral response", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "adverse events", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "median age", "target_id": "care unit", "strength": 3}, {"source_id": "third dose", "target_id": "T cells", "strength": 3}, {"source_id": "T cell responses", "target_id": "third dose", "strength": 3}, {"source_id": "immune response", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "health care workers", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "health care workers", "target_id": "second dose", "strength": 3}, {"source_id": "severe disease", "target_id": "primary outcome", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "T cells", "strength": 3}, {"source_id": "T cells", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "adverse events", "target_id": "disease severity", "strength": 3}, {"source_id": "older age", "target_id": "hospital admission", "strength": 3}, {"source_id": "cancer", "target_id": "adverse events", "strength": 3}, {"source_id": "disease severity", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "pregnant women", "target_id": "systematic review", "strength": 3}, {"source_id": "inflammation", "target_id": "long COVID", "strength": 3}, {"source_id": "incidence", "target_id": "observational study", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "adult patients", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "outcome measures", "strength": 3}, {"source_id": "outcome measures", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "logistic regression models", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "governance", "target_id": "book", "strength": 3}, {"source_id": "perspective", "target_id": "skills", "strength": 3}, {"source_id": "education", "target_id": "crisis", "strength": 3}, {"source_id": "lung disease", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "inflammation", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "antibody levels", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "autoimmune diseases", "strength": 3}, {"source_id": "pregnant women", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "immune response", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "transplant recipients", "target_id": "vaccine dose", "strength": 3}, {"source_id": "health interventions", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "emergency department", "target_id": "health system", "strength": 3}, {"source_id": "symptoms", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "health system", "target_id": "emergency department", "strength": 3}, {"source_id": "vaccination", "target_id": "health care workers", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "electronic medical records", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "medical records", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "healthcare workers", "strength": 3}, {"source_id": "climate change", "target_id": "article", "strength": 3}, {"source_id": "teachers", "target_id": "future research", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "mortality rate", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "mortality rate", "strength": 3}, {"source_id": "mortality rate", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "virus infection", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "vaccination status", "target_id": "high risk", "strength": 3}, {"source_id": "vaccine doses", "target_id": "high risk", "strength": 3}, {"source_id": "case-control study", "target_id": "clinical trials", "strength": 3}, {"source_id": "weight loss", "target_id": "risk factors", "strength": 3}, {"source_id": "respiratory disease", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 3}, {"source_id": "respiratory disease", "target_id": "coronavirus 2 infection", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "mortality rate", "strength": 3}, {"source_id": "World Health Organization", "target_id": "immune system", "strength": 3}, {"source_id": "long COVID", "target_id": "infection", "strength": 3}, {"source_id": "clinical practice", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "community", "target_id": "need", "strength": 3}, {"source_id": "educators", "target_id": "engagement", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "BNT162b2 vaccine", "strength": 3}, {"source_id": "BNT162b2 vaccine", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "cohort study", "target_id": "infectious diseases", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "mean age", "strength": 3}, {"source_id": "mean age", "target_id": "disease 2019", "strength": 3}, {"source_id": "unit admission", "target_id": "disease severity", "strength": 3}, {"source_id": "cause mortality", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "cause mortality", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "cause mortality", "strength": 3}, {"source_id": "Alzheimer's disease", "target_id": "immune response", "strength": 3}, {"source_id": "body mass index", "target_id": "mortality rate", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "disease severity", "strength": 3}, {"source_id": "case-control study", "target_id": "symptoms", "strength": 3}, {"source_id": "World Health Organization", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "clinical trials", "target_id": "severe illness", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "nasopharyngeal swabs", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "clinical practice", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "lower risk", "strength": 3}, {"source_id": "lower risk", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "hospital mortality", "target_id": "hospital discharge", "strength": 3}, {"source_id": "hospital discharge", "target_id": "hospital mortality", "strength": 3}, {"source_id": "public health measures", "target_id": "mental health", "strength": 3}, {"source_id": "health policy", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "perspective", "target_id": "economy", "strength": 3}, {"source_id": "rights", "target_id": "people", "strength": 3}, {"source_id": "book", "target_id": "perspective", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "clinical presentation", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "case report", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "clinical presentation", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "case report", "strength": 3}, {"source_id": "clinical presentation", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "ill patients", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "viral load", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "viral load", "strength": 3}, {"source_id": "logistic regression", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "disease 2019", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "study design", "target_id": "high risk", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "odds ratio", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "central nervous system", "strength": 3}, {"source_id": "Alzheimer's disease", "target_id": "infection", "strength": 3}, {"source_id": "skills", "target_id": "qualitative study", "strength": 3}, {"source_id": "need", "target_id": "qualitative study", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "young adults", "strength": 3}, {"source_id": "young adults", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "Meta-Analysis", "target_id": "infection", "strength": 3}, {"source_id": "high prevalence", "target_id": "high risk", "strength": 3}, {"source_id": "adverse events", "target_id": "Omicron variant", "strength": 3}, {"source_id": "immune response", "target_id": "protective effect", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "older age", "strength": 3}, {"source_id": "older age", "target_id": "vaccination", "strength": 3}, {"source_id": "disease", "target_id": "clinical data", "strength": 3}, {"source_id": "inflammation", "target_id": "inflammatory response", "strength": 3}, {"source_id": "persistent symptoms", "target_id": "clinical presentation", "strength": 3}, {"source_id": "greater risk", "target_id": "high risk", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "perspective", "strength": 3}, {"source_id": "perspective", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "health care professionals", "target_id": "adverse events", "strength": 3}, {"source_id": "care professionals", "target_id": "adverse events", "strength": 3}, {"source_id": "intensive care unit", "target_id": "treatment strategies", "strength": 3}, {"source_id": "treatment strategies", "target_id": "intensive care unit", "strength": 3}, {"source_id": "body mass index", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "cell responses", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "cell responses", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "antiviral therapy", "target_id": "SARS-CoV-2 replication", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "severe cases", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "severe cases", "strength": 3}, {"source_id": "severe cases", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "Web of Science", "target_id": "control group", "strength": 3}, {"source_id": "control group", "target_id": "Web of Science", "strength": 3}, {"source_id": "control group", "target_id": "incidence rate", "strength": 3}, {"source_id": "primary outcome", "target_id": "pain", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "University Hospital", "strength": 3}, {"source_id": "perception", "target_id": "teaching", "strength": 3}, {"source_id": "disease severity", "target_id": "Web of Science", "strength": 3}, {"source_id": "clinical data", "target_id": "care unit", "strength": 3}, {"source_id": "mortality", "target_id": "D-dimer", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 severity", "strength": 3}, {"source_id": "COVID-19 severity", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "risk factors", "target_id": "adverse events", "strength": 3}, {"source_id": "cancer", "target_id": "high risk", "strength": 3}, {"source_id": "cancer", "target_id": "mortality", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "variants of concern", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "variants of concern", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "vaccine doses", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "hospitalization", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "emergency department", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "pain", "target_id": "physical activity", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "primary outcome", "strength": 3}, {"source_id": "disease 2019", "target_id": "pneumonia", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "disease 2019", "strength": 3}, {"source_id": "observational study", "target_id": "study protocol", "strength": 3}, {"source_id": "study protocol", "target_id": "observational study", "strength": 3}, {"source_id": "central nervous system", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "autoimmune diseases", "target_id": "COVID-19", "strength": 3}, {"source_id": "lower risk", "target_id": "clinical trials", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "protein", "strength": 3}, {"source_id": "schools", "target_id": "technology", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "intervention group", "strength": 3}, {"source_id": "lung disease", "target_id": "disease 2019", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "injury", "strength": 3}, {"source_id": "distress syndrome", "target_id": "injury", "strength": 3}, {"source_id": "injury", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "pregnancy", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "vaccine", "target_id": "SARS-CoV-2 pandemic", "strength": 3}, {"source_id": "mass index", "target_id": "women", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "receptor-binding domain", "strength": 3}, {"source_id": "receptor-binding domain", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "cause mortality", "target_id": "median age", "strength": 3}, {"source_id": "observational study", "target_id": "cancer patients", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "Medical Center", "strength": 3}, {"source_id": "COVID-19", "target_id": "cell types", "strength": 3}, {"source_id": "severe illness", "target_id": "risk factors", "strength": 3}, {"source_id": "COVID-19 pneumonia", "target_id": "clinical trials", "strength": 3}, {"source_id": "blood samples", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "blood samples", "target_id": "vaccine", "strength": 3}, {"source_id": "viral infection", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "median age", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "mass index", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "body mass index", "strength": 3}, {"source_id": "lower risk", "target_id": "cause mortality", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "viral infection", "target_id": "nervous system", "strength": 3}, {"source_id": "nervous system", "target_id": "viral infection", "strength": 3}, {"source_id": "kidney disease", "target_id": "oxidative stress", "strength": 3}, {"source_id": "older age", "target_id": "disease", "strength": 3}, {"source_id": "disease", "target_id": "older age", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "severe disease", "strength": 3}, {"source_id": "nervous system", "target_id": "immune cells", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "vaccination program", "strength": 3}, {"source_id": "governance", "target_id": "justice", "strength": 3}, {"source_id": "justice", "target_id": "governance", "strength": 3}, {"source_id": "qualitative study", "target_id": "United States", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "mortality rate", "strength": 3}, {"source_id": "Delta variant", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "Delta variant", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "vaccination rates", "strength": 3}, {"source_id": "study population", "target_id": "women", "strength": 3}, {"source_id": "health services", "target_id": "logistic regression", "strength": 3}, {"source_id": "antiviral therapy", "target_id": "case series", "strength": 3}, {"source_id": "primary outcome", "target_id": "pregnant women", "strength": 3}, {"source_id": "protein", "target_id": "immune response", "strength": 3}, {"source_id": "logistic regression", "target_id": "median age", "strength": 3}, {"source_id": "symptom onset", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "blood samples", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "blood samples", "strength": 3}, {"source_id": "incidence", "target_id": "clinical trials", "strength": 3}, {"source_id": "primary outcome", "target_id": "side effects", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "severe disease", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "severe disease", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "severe cases", "strength": 3}, {"source_id": "severe cases", "target_id": "severe disease", "strength": 3}, {"source_id": "severe cases", "target_id": "distress syndrome", "strength": 3}, {"source_id": "general population", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "adverse events", "target_id": "retrospective study", "strength": 3}, {"source_id": "BNT162b2 vaccine", "target_id": "side effects", "strength": 3}, {"source_id": "humoral response", "target_id": "side effects", "strength": 3}, {"source_id": "side effects", "target_id": "BNT162b2 vaccine", "strength": 3}, {"source_id": "severe disease", "target_id": "antibody levels", "strength": 3}, {"source_id": "emergency department", "target_id": "infection", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "ICU admission", "target_id": "case-control study", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "primary outcome", "strength": 3}, {"source_id": "care unit admission", "target_id": "adverse events", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "ICU admission", "strength": 3}, {"source_id": "unit admission", "target_id": "primary outcome", "strength": 3}, {"source_id": "primary outcome", "target_id": "antibody response", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "transplant recipients", "strength": 3}, {"source_id": "mean age", "target_id": "care unit admission", "strength": 3}, {"source_id": "antibody response", "target_id": "primary outcome", "strength": 3}, {"source_id": "hospitalization", "target_id": "care unit admission", "strength": 3}, {"source_id": "hospitalization", "target_id": "unit admission", "strength": 3}, {"source_id": "lower risk", "target_id": "admission", "strength": 3}, {"source_id": "admission", "target_id": "hospitalization", "strength": 3}, {"source_id": "mental health", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "mortality", "strength": 3}, {"source_id": "logistic regression models", "target_id": "electronic medical records", "strength": 3}, {"source_id": "medical records", "target_id": "logistic regression models", "strength": 3}, {"source_id": "students", "target_id": "policy", "strength": 3}, {"source_id": "Meta-Analysis", "target_id": "vaccination", "strength": 3}, {"source_id": "clinical practice", "target_id": "blood pressure", "strength": 3}, {"source_id": "transplant recipients", "target_id": "retrospective study", "strength": 3}, {"source_id": "retrospective study", "target_id": "transplant recipients", "strength": 3}, {"source_id": "therapy", "target_id": "viral load", "strength": 3}, {"source_id": "therapy", "target_id": "side effects", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "viral load", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "therapy", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "beneficial effects", "strength": 3}, {"source_id": "beneficial effects", "target_id": "therapy", "strength": 3}, {"source_id": "observational study", "target_id": "clinical data", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "odds ratio", "strength": 3}, {"source_id": "B cells", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "distress syndrome", "target_id": "ICU admission", "strength": 3}, {"source_id": "observational study", "target_id": "years of age", "strength": 3}, {"source_id": "intensive care", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "intensive care", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "years of age", "target_id": "therapy", "strength": 3}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "disease", "strength": 3}, {"source_id": "healthy controls", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "disease", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "disease", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "risk factors", "target_id": "cancer patients", "strength": 3}, {"source_id": "patients", "target_id": "depressive symptoms", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "central nervous system", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "central nervous system", "strength": 3}, {"source_id": "central nervous system", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "central nervous system", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "central nervous system", "target_id": "animal models", "strength": 3}, {"source_id": "mice", "target_id": "immune system", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "cross-sectional survey", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "health status", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "mental health", "strength": 3}, {"source_id": "sociodemographic characteristics", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "Omicron variant", "target_id": "vaccination rates", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "World Health Organization", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "case study", "target_id": "institutions", "strength": 3}, {"source_id": "justice", "target_id": "politics", "strength": 3}, {"source_id": "article", "target_id": "government", "strength": 3}, {"source_id": "University", "target_id": "case study", "strength": 3}, {"source_id": "medical students", "target_id": "training", "strength": 3}, {"source_id": "therapy", "target_id": "clinical practice", "strength": 3}, {"source_id": "primary endpoint", "target_id": "primary outcome", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "D-dimer", "strength": 3}, {"source_id": "age groups", "target_id": "mean age", "strength": 3}, {"source_id": "retrospective study", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "COVID-19 pneumonia", "target_id": "immune response", "strength": 3}, {"source_id": "hospitalized patients", "target_id": "hospital discharge", "strength": 3}, {"source_id": "antibody titers", "target_id": "adverse events", "strength": 3}, {"source_id": "receptor-binding domain", "target_id": "patients", "strength": 3}, {"source_id": "disease severity", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "patients", "target_id": "receptor-binding domain", "strength": 3}, {"source_id": "emergency department", "target_id": "risk factors", "strength": 3}, {"source_id": "humoral immune response", "target_id": "risk factors", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "disease severity", "strength": 3}, {"source_id": "T cells", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "BNT162b2 vaccine", "target_id": "mean age", "strength": 3}, {"source_id": "BNT162b2 vaccine", "target_id": "hospital", "strength": 3}, {"source_id": "systematic review", "target_id": "respiratory symptoms", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "respiratory symptoms", "strength": 3}, {"source_id": "respiratory symptoms", "target_id": "systematic review", "strength": 3}, {"source_id": "safety profile", "target_id": "serious adverse events", "strength": 3}, {"source_id": "safety profile", "target_id": "primary outcome", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "nasopharyngeal swabs", "strength": 3}, {"source_id": "age groups", "target_id": "nasopharyngeal swabs", "strength": 3}, {"source_id": "older adults", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "nasopharyngeal swabs", "strength": 3}, {"source_id": "higher odds", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "higher odds", "target_id": "age groups", "strength": 3}, {"source_id": "symptoms", "target_id": "nasopharyngeal swabs", "strength": 3}, {"source_id": "systematic review", "target_id": "World Health Organization", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "trials", "strength": 3}, {"source_id": "trials", "target_id": "systematic review", "strength": 3}, {"source_id": "trials", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "study period", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "cohort", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "cohort", "strength": 3}, {"source_id": "BNT162b2 vaccine", "target_id": "vaccine dose", "strength": 3}, {"source_id": "incidence rate", "target_id": "booster vaccination", "strength": 3}, {"source_id": "incidence rate", "target_id": "vaccine doses", "strength": 3}, {"source_id": "public health measures", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "disease 2019", "target_id": "public health measures", "strength": 3}, {"source_id": "disease 2019", "target_id": "health measures", "strength": 3}, {"source_id": "health measures", "target_id": "disease 2019", "strength": 3}, {"source_id": "clinical setting", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "higher odds", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "mean age", "target_id": "mass index", "strength": 3}, {"source_id": "infection", "target_id": "diagnosis", "strength": 3}, {"source_id": "study period", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "humoral immune response", "strength": 3}, {"source_id": "vaccine doses", "target_id": "antibody response", "strength": 3}, {"source_id": "acute phase", "target_id": "persistent symptoms", "strength": 3}, {"source_id": "persistent symptoms", "target_id": "acute phase", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "observational cohort study", "strength": 3}, {"source_id": "mean age", "target_id": "care providers", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "prospective study", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "symptoms", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "practice", "target_id": "course", "strength": 3}, {"source_id": "SARS-CoV-2 replication", "target_id": "disease 2019", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "treatment strategies", "strength": 3}, {"source_id": "treatment strategies", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "treatment strategies", "target_id": "disease 2019", "strength": 3}, {"source_id": "risk factors", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "health conditions", "strength": 3}, {"source_id": "middle-income countries", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "health care", "target_id": "risk factors", "strength": 3}, {"source_id": "sociodemographic characteristics", "target_id": "risk factors", "strength": 3}, {"source_id": "Omicron infection", "target_id": "immune response", "strength": 3}, {"source_id": "immune response", "target_id": "Omicron infection", "strength": 3}, {"source_id": "immune response", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "animal models", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "animal models", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "flow cytometry", "target_id": "mouse model", "strength": 3}, {"source_id": "central nervous system", "target_id": "T cells", "strength": 3}, {"source_id": "central nervous system", "target_id": "therapeutic target", "strength": 3}, {"source_id": "T cells", "target_id": "central nervous system", "strength": 3}, {"source_id": "T cells", "target_id": "nervous system", "strength": 3}, {"source_id": "therapeutic target", "target_id": "nervous system", "strength": 3}, {"source_id": "economy", "target_id": "politics", "strength": 3}, {"source_id": "higher education", "target_id": "teachers", "strength": 3}, {"source_id": "teachers", "target_id": "case study", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "health conditions", "strength": 3}, {"source_id": "University", "target_id": "society", "strength": 3}, {"source_id": "need", "target_id": "program", "strength": 3}, {"source_id": "COVID-19", "target_id": "book", "strength": 3}, {"source_id": "inflammatory response", "target_id": "respiratory tract", "strength": 3}, {"source_id": "primary outcome", "target_id": "prospective study", "strength": 3}, {"source_id": "hospitalization", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "ICU admission", "strength": 3}, {"source_id": "surgery", "target_id": "mean age", "strength": 3}, {"source_id": "diagnosis", "target_id": "high risk", "strength": 3}, {"source_id": "prospective study", "target_id": "observational study", "strength": 3}, {"source_id": "electronic medical records", "target_id": "vaccine", "strength": 3}, {"source_id": "vaccine", "target_id": "multiple sclerosis", "strength": 3}, {"source_id": "B cells", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "humoral immune response", "strength": 3}, {"source_id": "multiple sclerosis", "target_id": "B cells", "strength": 3}, {"source_id": "mice", "target_id": "B cells", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "viral replication", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "World Health Organization", "strength": 3}, {"source_id": "variants of concern", "target_id": "booster doses", "strength": 3}, {"source_id": "World Health Organization", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "inflammatory response", "target_id": "disease", "strength": 3}, {"source_id": "disease", "target_id": "viral infection", "strength": 3}, {"source_id": "society", "target_id": "government", "strength": 3}, {"source_id": "retrospective study", "target_id": "health system", "strength": 3}, {"source_id": "T cell responses", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "cohort study", "target_id": "T cell responses", "strength": 3}, {"source_id": "risk factors", "target_id": "incidence", "strength": 3}, {"source_id": "high risk", "target_id": "protective effect", "strength": 3}, {"source_id": "lower risk", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "healthcare workers", "target_id": "clinical trials", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "viral replication", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "healthcare workers", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "blood samples", "strength": 3}, {"source_id": "care professionals", "target_id": "care", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "risk factors", "target_id": "health records", "strength": 3}, {"source_id": "therapeutic target", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "respiratory failure", "target_id": "hospital admission", "strength": 3}, {"source_id": "adult patients", "target_id": "hospital stay", "strength": 3}, {"source_id": "mortality", "target_id": "ill patients", "strength": 3}, {"source_id": "admission", "target_id": "hospital stay", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "ICU admission", "target_id": "C-reactive protein", "strength": 3}, {"source_id": "admission", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "clinical trials", "strength": 3}, {"source_id": "immune system", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "infection rate", "target_id": "mortality rate", "strength": 3}, {"source_id": "second dose", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "lung disease", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "spike protein", "target_id": "distress syndrome", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "intensive care", "strength": 3}, {"source_id": "health records", "target_id": "health system", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "pregnancy", "strength": 3}, {"source_id": "mean age", "target_id": "clinical trials", "strength": 3}, {"source_id": "care settings", "target_id": "care providers", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "first dose", "strength": 3}, {"source_id": "first dose", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "primary outcome", "strength": 3}, {"source_id": "primary outcome", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "oxidative stress", "target_id": "Alzheimer's disease", "strength": 3}, {"source_id": "blood pressure", "target_id": "clinical trials", "strength": 3}, {"source_id": "blood pressure", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "vaccine", "target_id": "primary endpoint", "strength": 3}, {"source_id": "healthcare workers", "target_id": "SARS-CoV-2 antibodies", "strength": 3}, {"source_id": "antibody levels", "target_id": "Omicron variant", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "clinical practice", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "medical records", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "medical records", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "clinical practice", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "infection", "target_id": "ischemic stroke", "strength": 3}, {"source_id": "symptoms", "target_id": "COVID-19 diagnosis", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "severe disease", "strength": 3}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "severe disease", "strength": 3}, {"source_id": "hospitalized patients", "target_id": "infection", "strength": 3}, {"source_id": "severe disease", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "coronavirus 2 infection", "strength": 3}, {"source_id": "admission", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 3}, {"source_id": "admission", "target_id": "coronavirus 2 infection", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "vaccination", "strength": 3}, {"source_id": "dose", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "disease severity", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "risk factors", "target_id": "care", "strength": 3}, {"source_id": "systematic review", "target_id": "study design", "strength": 3}, {"source_id": "study design", "target_id": "systematic review", "strength": 3}, {"source_id": "health services", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "adverse effects", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "young adults", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "cytokine storm", "strength": 3}, {"source_id": "immune system", "target_id": "immune cells", "strength": 3}, {"source_id": "clinical trials", "target_id": "immune system", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "primary outcome", "strength": 3}, {"source_id": "healthcare workers", "target_id": "mental health outcomes", "strength": 3}, {"source_id": "care providers", "target_id": "pregnant women", "strength": 3}, {"source_id": "greater risk", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "clinical symptoms", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "clinical data", "target_id": "symptoms", "strength": 3}, {"source_id": "case study", "target_id": "crisis", "strength": 3}, {"source_id": "symptoms", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "disease severity", "strength": 3}, {"source_id": "persistent symptoms", "target_id": "infection", "strength": 3}, {"source_id": "intensive care unit", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "distress syndrome", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "primary outcome", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "mortality", "target_id": "high prevalence", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "antibody levels", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "antibody levels", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "blood samples", "strength": 3}, {"source_id": "antibody levels", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "antibody levels", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "antibody response", "target_id": "severe disease", "strength": 3}, {"source_id": "blood samples", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "blood samples", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "mouse model", "target_id": "inflammation", "strength": 3}, {"source_id": "variants of concern", "target_id": "SARS-CoV-2 pandemic", "strength": 3}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "booster vaccination", "target_id": "variants of concern", "strength": 3}, {"source_id": "mouse model", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "infection", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "cancer patients", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "Web of Science", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "side effects", "strength": 3}, {"source_id": "pediatric patients", "target_id": "high risk", "strength": 3}, {"source_id": "cohort", "target_id": "high risk", "strength": 3}, {"source_id": "surgery", "target_id": "hospital stay", "strength": 3}, {"source_id": "body mass index", "target_id": "logistic regression", "strength": 3}, {"source_id": "logistic regression", "target_id": "body mass index", "strength": 3}, {"source_id": "severe illness", "target_id": "severe disease", "strength": 3}, {"source_id": "dose", "target_id": "vaccination campaign", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "therapy", "strength": 3}, {"source_id": "length of stay", "target_id": "logistic regression models", "strength": 3}, {"source_id": "health care workers", "target_id": "high risk", "strength": 3}, {"source_id": "high risk", "target_id": "care workers", "strength": 3}, {"source_id": "care workers", "target_id": "primary outcome", "strength": 3}, {"source_id": "emergency department", "target_id": "health records", "strength": 3}, {"source_id": "primary care", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "electronic health records", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "health services", "target_id": "emergency department", "strength": 3}, {"source_id": "health records", "target_id": "emergency department", "strength": 3}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "RT-PCR", "strength": 3}, {"source_id": "booster dose", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "RT-PCR", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "healthy controls", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "blood samples", "target_id": "healthy controls", "strength": 3}, {"source_id": "University Hospital", "target_id": "vaccination", "strength": 3}, {"source_id": "observational study", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "observational study", "target_id": "surgery", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "Medical Center", "target_id": "infection", "strength": 3}, {"source_id": "risk factors", "target_id": "outcome measures", "strength": 3}, {"source_id": "risk factors", "target_id": "diagnosis", "strength": 3}, {"source_id": "unit admission", "target_id": "women", "strength": 3}, {"source_id": "hospital discharge", "target_id": "cohort study", "strength": 3}, {"source_id": "pregnancy", "target_id": "unit admission", "strength": 3}, {"source_id": "women", "target_id": "care unit admission", "strength": 3}, {"source_id": "study period", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "cohort study", "target_id": "health outcomes", "strength": 3}, {"source_id": "case series", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "high risk", "target_id": "T cells", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "cohort", "strength": 3}, {"source_id": "body mass index", "target_id": "disease severity", "strength": 3}, {"source_id": "mass index", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "vaccine uptake", "target_id": "high risk", "strength": 3}, {"source_id": "health system", "target_id": "age groups", "strength": 3}, {"source_id": "social media", "target_id": "narratives", "strength": 3}, {"source_id": "United States", "target_id": "schools", "strength": 3}, {"source_id": "program", "target_id": "COVID-19", "strength": 3}, {"source_id": "discourse", "target_id": "United States", "strength": 3}, {"source_id": "COVID-19", "target_id": "genes", "strength": 3}, {"source_id": "systematic review", "target_id": "heart failure", "strength": 3}, {"source_id": "risk factors", "target_id": "chronic kidney disease", "strength": 3}, {"source_id": "kidney disease", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "cohort study", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "disease progression", "target_id": "cohort study", "strength": 3}, {"source_id": "immune response", "target_id": "general population", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "autoimmune diseases", "strength": 3}, {"source_id": "autoimmune diseases", "target_id": "risk factors", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "clinical trials", "strength": 3}, {"source_id": "Delta variant", "target_id": "epithelial cells", "strength": 3}, {"source_id": "high risk", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "clinical setting", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "cause mortality", "target_id": "mortality rate", "strength": 3}, {"source_id": "high-income countries", "target_id": "countries", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "high prevalence", "strength": 3}, {"source_id": "safety profile", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "safety profile", "target_id": "therapy", "strength": 3}, {"source_id": "therapy", "target_id": "safety profile", "strength": 3}, {"source_id": "myocardial infarction", "target_id": "primary endpoint", "strength": 3}, {"source_id": "mRNA vaccination", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "COVID-19 diagnosis", "strength": 3}, {"source_id": "logistic regression", "target_id": "disease severity", "strength": 3}, {"source_id": "vaccination", "target_id": "control group", "strength": 3}, {"source_id": "control group", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "control group", "target_id": "vaccine", "strength": 3}, {"source_id": "use disorders", "target_id": "study period", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "institutions", "target_id": "government", "strength": 3}, {"source_id": "odds ratio", "target_id": "disease 2019", "strength": 3}, {"source_id": "older age", "target_id": "D-dimer", "strength": 3}, {"source_id": "healthcare professionals", "target_id": "pregnant women", "strength": 3}, {"source_id": "age groups", "target_id": "observational study", "strength": 3}, {"source_id": "outcome measures", "target_id": "quality of life", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "care providers", "strength": 3}, {"source_id": "hospital stay", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "qualitative study", "target_id": "policy", "strength": 3}, {"source_id": "case report", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "adverse events", "target_id": "body mass index", "strength": 3}, {"source_id": "adverse events", "target_id": "mass index", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "Alzheimer's disease", "target_id": "mouse model", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "long COVID", "strength": 3}, {"source_id": "third dose", "target_id": "spike protein", "strength": 3}, {"source_id": "Meta-Analysis", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "mean age", "target_id": "hospital stay", "strength": 3}, {"source_id": "median age", "target_id": "symptoms", "strength": 3}, {"source_id": "booster dose", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "Omicron variant", "target_id": "COVID-19 severity", "strength": 3}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "clinical symptoms", "target_id": "T cells", "strength": 3}, {"source_id": "antibody titers", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "dose", "strength": 3}, {"source_id": "dose", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "adult patients", "target_id": "study protocol", "strength": 3}, {"source_id": "median age", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "older age", "target_id": "care unit", "strength": 3}, {"source_id": "case study", "target_id": "COVID-19", "strength": 3}, {"source_id": "engagement", "target_id": "case study", "strength": 3}, {"source_id": "article", "target_id": "case study", "strength": 3}, {"source_id": "community", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "book", "target_id": "United States", "strength": 3}, {"source_id": "people", "target_id": "research", "strength": 3}, {"source_id": "education", "target_id": "community", "strength": 3}, {"source_id": "perception", "target_id": "engagement", "strength": 3}, {"source_id": "higher education", "target_id": "research", "strength": 3}, {"source_id": "hospital mortality", "target_id": "ill patients", "strength": 3}, {"source_id": "ill patients", "target_id": "hospital mortality", "strength": 3}, {"source_id": "ill patients", "target_id": "unit admission", "strength": 3}, {"source_id": "care unit admission", "target_id": "study period", "strength": 3}, {"source_id": "respiratory failure", "target_id": "ICU admission", "strength": 3}, {"source_id": "adult patients", "target_id": "care unit admission", "strength": 3}, {"source_id": "study period", "target_id": "length of stay", "strength": 3}, {"source_id": "COVID-19 pneumonia", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "COVID-19 pneumonia", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "B cells", "strength": 3}, {"source_id": "humoral response", "target_id": "B cells", "strength": 3}, {"source_id": "B cells", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "COVID-19", "target_id": "Delta variant", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "booster dose", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "healthcare workers", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "booster dose", "strength": 3}, {"source_id": "booster dose", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "booster dose", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "booster dose", "strength": 3}, {"source_id": "spike protein", "target_id": "vaccine dose", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "healthy controls", "strength": 3}, {"source_id": "immune response", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "general population", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "disease control", "strength": 3}, {"source_id": "disease control", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "disease control", "target_id": "median time", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "respiratory disease", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "respiratory disease", "strength": 3}, {"source_id": "respiratory disease", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "respiratory disease", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "organization", "target_id": "pandemic", "strength": 3}, {"source_id": "cross-sectional survey", "target_id": "depressive symptoms", "strength": 3}, {"source_id": "depressive symptoms", "target_id": "health problems", "strength": 3}, {"source_id": "Omicron variant", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "lung disease", "target_id": "disease severity", "strength": 3}, {"source_id": "severe disease", "target_id": "prospective study", "strength": 3}, {"source_id": "University Hospital", "target_id": "study period", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "blood samples", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "disease 2019", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "control group", "target_id": "cancer", "strength": 3}, {"source_id": "median time", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "mean age", "target_id": "odds ratio", "strength": 3}, {"source_id": "odds ratio", "target_id": "mean age", "strength": 3}, {"source_id": "health records", "target_id": "Omicron variant", "strength": 3}, {"source_id": "systematic review", "target_id": "clinical practice", "strength": 3}, {"source_id": "adverse events", "target_id": "respiratory failure", "strength": 3}, {"source_id": "cause mortality", "target_id": "adult patients", "strength": 3}, {"source_id": "cause mortality", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "coronavirus 2 infection", "target_id": "high risk", "strength": 3}, {"source_id": "high risk", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 3}, {"source_id": "care unit", "target_id": "logistic regression", "strength": 3}, {"source_id": "logistic regression", "target_id": "intensive care unit", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "risk factors", "strength": 3}, {"source_id": "risk factors", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "risk factors", "target_id": "high mortality", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "patients", "strength": 3}, {"source_id": "adult patients", "target_id": "most patients", "strength": 3}, {"source_id": "adult patients", "target_id": "inflammatory diseases", "strength": 3}, {"source_id": "third dose", "target_id": "healthy controls", "strength": 3}, {"source_id": "vaccination", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "distress syndrome", "strength": 3}, {"source_id": "care unit admission", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "care unit admission", "target_id": "distress syndrome", "strength": 3}, {"source_id": "unit admission", "target_id": "distress syndrome", "strength": 3}, {"source_id": "distress syndrome", "target_id": "care unit admission", "strength": 3}, {"source_id": "inflammatory response", "target_id": "clinical trials", "strength": 3}, {"source_id": "older adults", "target_id": "Omicron variant", "strength": 3}, {"source_id": "immune response", "target_id": "ill patients", "strength": 3}, {"source_id": "middle-income countries", "target_id": "observational study", "strength": 3}, {"source_id": "observational study", "target_id": "pregnant women", "strength": 3}, {"source_id": "Omicron infection", "target_id": "lower risk", "strength": 3}, {"source_id": "Medical Center", "target_id": "vaccination status", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "health system", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "unit admission", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "unit admission", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "inflammatory syndrome", "target_id": "infection", "strength": 3}, {"source_id": "admission", "target_id": "Delta variant", "strength": 3}, {"source_id": "median age", "target_id": "medical records", "strength": 3}, {"source_id": "medical records", "target_id": "median age", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "high risk", "strength": 3}, {"source_id": "Medical Center", "target_id": "mortality", "strength": 3}, {"source_id": "mean age", "target_id": "disease severity", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "disease", "strength": 3}, {"source_id": "disease", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "respiratory symptoms", "target_id": "case report", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "hospital admission", "target_id": "Omicron infection", "strength": 3}, {"source_id": "older age", "target_id": "therapy", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "animal models", "target_id": "vaccine", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "T cells", "strength": 3}, {"source_id": "Delta variant", "target_id": "SARS-CoV-2 pandemic", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "health care workers", "strength": 3}, {"source_id": "primary outcome", "target_id": "median age", "strength": 3}, {"source_id": "median age", "target_id": "primary outcome", "strength": 3}, {"source_id": "disease", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "health system", "target_id": "cohort study", "strength": 3}, {"source_id": "intensive care", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "cohort study", "target_id": "health system", "strength": 3}, {"source_id": "hospitalization", "target_id": "vaccine doses", "strength": 3}, {"source_id": "primary outcome", "target_id": "diagnosis", "strength": 3}, {"source_id": "high risk", "target_id": "vaccination rates", "strength": 3}, {"source_id": "primary care", "target_id": "infection", "strength": 3}, {"source_id": "young people", "target_id": "thematic analysis", "strength": 3}, {"source_id": "health care professionals", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "disease 2019", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "electronic health records", "strength": 3}, {"source_id": "program", "target_id": "engagement", "strength": 3}, {"source_id": "engagement", "target_id": "context", "strength": 3}, {"source_id": "motivation", "target_id": "pandemic", "strength": 3}, {"source_id": "logistic regression", "target_id": "physical activity", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "risk factors", "strength": 3}, {"source_id": "health professionals", "target_id": "risk factors", "strength": 3}, {"source_id": "emergency department", "target_id": "adult patients", "strength": 3}, {"source_id": "emergency department", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "disease 2019", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "intensive care unit", "target_id": "median age", "strength": 3}, {"source_id": "care unit", "target_id": "median age", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "immune response", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "care workers", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "primary outcome", "strength": 3}, {"source_id": "T cells", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "disease severity", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "cause mortality", "strength": 3}, {"source_id": "vaccination program", "target_id": "COVID-19", "strength": 3}, {"source_id": "booster dose", "target_id": "ICU admission", "strength": 3}, {"source_id": "median age", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "complications", "target_id": "outcome measures", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "logistic regression models", "strength": 3}, {"source_id": "governance", "target_id": "case study", "strength": 3}, {"source_id": "COVID-19", "target_id": "health problems", "strength": 3}, {"source_id": "health problems", "target_id": "COVID-19", "strength": 3}, {"source_id": "clinical trials", "target_id": "mortality rate", "strength": 3}, {"source_id": "disease", "target_id": "mice", "strength": 3}, {"source_id": "T cell responses", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "autoimmune diseases", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "mortality rate", "target_id": "general population", "strength": 3}, {"source_id": "case series", "target_id": "COVID-19", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "case series", "strength": 3}, {"source_id": "symptoms", "target_id": "case series", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "Omicron variant", "strength": 3}, {"source_id": "transplant recipients", "target_id": "dose", "strength": 3}, {"source_id": "vaccine dose", "target_id": "Delta variant", "strength": 3}, {"source_id": "control group", "target_id": "disease", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "Medical Center", "strength": 3}, {"source_id": "health care workers", "target_id": "vaccination", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "emergency department", "strength": 3}, {"source_id": "healthcare workers", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "receptor-binding domain", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "oxidative stress", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "clinical studies", "target_id": "primary endpoint", "strength": 3}, {"source_id": "pediatric patients", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "pediatric patients", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "mortality rate", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "mortality rate", "strength": 3}, {"source_id": "mortality rate", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "mortality rate", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "virus infection", "target_id": "patients", "strength": 3}, {"source_id": "vaccine doses", "target_id": "logistic regression", "strength": 3}, {"source_id": "logistic regression models", "target_id": "hospitalization", "strength": 3}, {"source_id": "clinical trials", "target_id": "case-control study", "strength": 3}, {"source_id": "general population", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "general population", "target_id": "young adults", "strength": 3}, {"source_id": "incidence", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "young adults", "target_id": "general population", "strength": 3}, {"source_id": "chronic diseases", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "respiratory disease", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "risk factors", "target_id": "weight loss", "strength": 3}, {"source_id": "primary outcome", "target_id": "blood samples", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "clinical trials", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "disease", "strength": 3}, {"source_id": "disease", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "infection", "target_id": "long COVID", "strength": 3}, {"source_id": "engagement", "target_id": "educators", "strength": 3}, {"source_id": "severe disease", "target_id": "ICU admission", "strength": 3}, {"source_id": "admission", "target_id": "hospital discharge", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "third dose", "target_id": "healthcare workers", "strength": 3}, {"source_id": "antibody levels", "target_id": "vaccine doses", "strength": 3}, {"source_id": "virus infection", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "treatment strategies", "target_id": "disease", "strength": 3}, {"source_id": "disease 2019", "target_id": "mean age", "strength": 3}, {"source_id": "vaccine", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "cause mortality", "target_id": "disease 2019", "strength": 3}, {"source_id": "body mass index", "target_id": "cause mortality", "strength": 3}, {"source_id": "mass index", "target_id": "cause mortality", "strength": 3}, {"source_id": "mass index", "target_id": "mortality", "strength": 3}, {"source_id": "ICU admission", "target_id": "logistic regression", "strength": 3}, {"source_id": "mortality rate", "target_id": "body mass index", "strength": 3}, {"source_id": "disease severity", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "vaccination campaign", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "World Health Organization", "strength": 3}, {"source_id": "nasopharyngeal swabs", "target_id": "coronavirus disease", "strength": 3}, {"source_id": "vaccination program", "target_id": "patients", "strength": 3}, {"source_id": "patients", "target_id": "vaccination program", "strength": 3}, {"source_id": "thematic analysis", "target_id": "curriculum", "strength": 3}, {"source_id": "curriculum", "target_id": "thematic analysis", "strength": 3}, {"source_id": "learning", "target_id": "participants", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "clinical presentation", "strength": 3}, {"source_id": "clinical presentation", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "case report", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "mean age", "target_id": "older age", "strength": 3}, {"source_id": "older age", "target_id": "mean age", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "hospital admission", "strength": 3}, {"source_id": "case-control study", "target_id": "Delta variant", "strength": 3}, {"source_id": "participants", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "Delta variant", "target_id": "receptor-binding domain", "strength": 3}, {"source_id": "receptor-binding domain", "target_id": "Delta variant", "strength": 3}, {"source_id": "SARS-CoV-2 transmission", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "infection", "target_id": "Alzheimer's disease", "strength": 3}, {"source_id": "students", "target_id": "young people", "strength": 3}, {"source_id": "children", "target_id": "young people", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "young adults", "strength": 3}, {"source_id": "young adults", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "society", "target_id": "people", "strength": 3}, {"source_id": "society", "target_id": "perspective", "strength": 3}, {"source_id": "infection", "target_id": "Meta-Analysis", "strength": 3}, {"source_id": "clinical trials", "target_id": "hospital stay", "strength": 3}, {"source_id": "Omicron variant", "target_id": "adverse events", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "treatment strategies", "strength": 3}, {"source_id": "treatment strategies", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "complications", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "Delta variant", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "general population", "target_id": "disease", "strength": 3}, {"source_id": "disease", "target_id": "general population", "strength": 3}, {"source_id": "age groups", "target_id": "vaccine dose", "strength": 3}, {"source_id": "logistic regression models", "target_id": "race/ethnicity", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "spike protein", "target_id": "humoral response", "strength": 3}, {"source_id": "cell types", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "immune response", "target_id": "respiratory symptoms", "strength": 3}, {"source_id": "symptom onset", "target_id": "vaccination", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "severe cases", "strength": 3}, {"source_id": "middle-income countries", "target_id": "mental health", "strength": 3}, {"source_id": "adverse events", "target_id": "incidence rate", "strength": 3}, {"source_id": "incidence rate", "target_id": "adverse events", "strength": 3}, {"source_id": "control group", "target_id": "mortality", "strength": 3}, {"source_id": "mortality", "target_id": "control group", "strength": 3}, {"source_id": "high risk", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "severe disease", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "respiratory tract", "target_id": "animal models", "strength": 3}, {"source_id": "electronic health records", "target_id": "adult patients", "strength": 3}, {"source_id": "adult patients", "target_id": "health records", "strength": 3}, {"source_id": "mental health", "target_id": "United States", "strength": 3}, {"source_id": "technology", "target_id": "institutions", "strength": 3}, {"source_id": "length of stay", "target_id": "clinical trials", "strength": 3}, {"source_id": "clinical trials", "target_id": "length of stay", "strength": 3}, {"source_id": "Web of Science", "target_id": "disease severity", "strength": 3}, {"source_id": "clinical data", "target_id": "intensive care unit", "strength": 3}, {"source_id": "clinical trials", "target_id": "clinical symptoms", "strength": 3}, {"source_id": "chronic kidney disease", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "viral replication", "target_id": "spike protein", "strength": 3}, {"source_id": "spike protein", "target_id": "viral replication", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "ICU admission", "strength": 3}, {"source_id": "health records", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "health records", "strength": 3}, {"source_id": "cancer patients", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "respiratory failure", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "vaccination status", "strength": 3}, {"source_id": "hospitalization", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "systematic review", "target_id": "control group", "strength": 3}, {"source_id": "older adults", "target_id": "severe disease", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "syndrome coronavirus 2 infection", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "mortality", "target_id": "severe disease", "strength": 3}, {"source_id": "C-reactive protein", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "C-reactive protein", "strength": 3}, {"source_id": "disease 2019", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "logistic regression", "target_id": "care unit admission", "strength": 3}, {"source_id": "health system", "target_id": "race/ethnicity", "strength": 3}, {"source_id": "clinical trials", "target_id": "lower risk", "strength": 3}, {"source_id": "symptom onset", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "technology", "target_id": "schools", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "pulmonary disease", "strength": 3}, {"source_id": "pulmonary disease", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "disease", "target_id": "distress syndrome", "strength": 3}, {"source_id": "mental health", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "risk factors", "target_id": "therapy", "strength": 3}, {"source_id": "clinical trials", "target_id": "COVID-19 pneumonia", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "blood samples", "strength": 3}, {"source_id": "vaccine", "target_id": "innate immune response", "strength": 3}, {"source_id": "body mass index", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "mass index", "strength": 3}, {"source_id": "side effects", "target_id": "vaccination rates", "strength": 3}, {"source_id": "pulmonary disease", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "study period", "target_id": "care system", "strength": 3}, {"source_id": "care system", "target_id": "study period", "strength": 3}, {"source_id": "COVID-19", "target_id": "motivation", "strength": 3}, {"source_id": "schools", "target_id": "book", "strength": 3}, {"source_id": "oxidative stress", "target_id": "kidney disease", "strength": 3}, {"source_id": "severe disease", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "vaccination program", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "community", "target_id": "pandemic", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "mortality rate", "strength": 3}, {"source_id": "care facilities", "target_id": "cohort study", "strength": 3}, {"source_id": "hazard ratio", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "logistic regression", "target_id": "health services", "strength": 3}, {"source_id": "health care workers", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "health care workers", "strength": 3}, {"source_id": "clinical trials", "target_id": "median age", "strength": 3}, {"source_id": "incidence", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "pregnant women", "target_id": "intensive care unit", "strength": 3}, {"source_id": "pregnant women", "target_id": "care unit", "strength": 3}, {"source_id": "intensive care unit", "target_id": "pregnant women", "strength": 3}, {"source_id": "care unit", "target_id": "pregnant women", "strength": 3}, {"source_id": "older adults", "target_id": "hospital", "strength": 3}, {"source_id": "observational cohort study", "target_id": "adult patients", "strength": 3}, {"source_id": "risk factors", "target_id": "chronic diseases", "strength": 3}, {"source_id": "antibody levels", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "clinical trials", "target_id": "incidence", "strength": 3}, {"source_id": "second dose", "target_id": "incidence rate", "strength": 3}, {"source_id": "inflammatory syndrome", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "viral infection", "strength": 3}, {"source_id": "inflammatory response", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "severe disease", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "severe disease", "target_id": "distress syndrome", "strength": 3}, {"source_id": "severe disease", "target_id": "severe cases", "strength": 3}, {"source_id": "distress syndrome", "target_id": "severe disease", "strength": 3}, {"source_id": "third dose", "target_id": "most patients", "strength": 3}, {"source_id": "BNT162b2 vaccine", "target_id": "primary outcome", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "retrospective study", "strength": 3}, {"source_id": "adverse events", "target_id": "hospital stay", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "symptom onset", "strength": 3}, {"source_id": "symptom onset", "target_id": "observational study", "strength": 3}, {"source_id": "symptom onset", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "primary outcome", "target_id": "COVID-19 pneumonia", "strength": 3}, {"source_id": "antiviral therapy", "target_id": "patients", "strength": 3}, {"source_id": "side effects", "target_id": "humoral response", "strength": 3}, {"source_id": "side effects", "target_id": "antibody response", "strength": 3}, {"source_id": "vaccine", "target_id": "clinical practice", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "clinical data", "strength": 3}, {"source_id": "predictive value", "target_id": "emergency department", "strength": 3}, {"source_id": "emergency department", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "emergency department", "strength": 3}, {"source_id": "mass index", "target_id": "type 2 diabetes", "strength": 3}, {"source_id": "ICU admission", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "mean age", "strength": 3}, {"source_id": "care unit admission", "target_id": "primary outcome", "strength": 3}, {"source_id": "adverse events", "target_id": "unit admission", "strength": 3}, {"source_id": "greater risk", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "admission", "target_id": "vaccination", "strength": 3}, {"source_id": "patients", "target_id": "care facilities", "strength": 3}, {"source_id": "mental health outcomes", "target_id": "observational study", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "observational study", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "care workers", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "greater risk", "strength": 3}, {"source_id": "greater risk", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "care", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 symptoms", "strength": 3}, {"source_id": "logistic regression models", "target_id": "medical records", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "study protocol", "strength": 3}, {"source_id": "booster vaccination", "target_id": "systematic review", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "safety profile", "strength": 3}, {"source_id": "viral load", "target_id": "therapy", "strength": 3}, {"source_id": "case series", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "case series", "target_id": "side effects", "strength": 3}, {"source_id": "side effects", "target_id": "therapy", "strength": 3}, {"source_id": "therapy", "target_id": "beneficial effects", "strength": 3}, {"source_id": "beneficial effects", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "odds ratio", "target_id": "COVID-19 diagnosis", "strength": 3}, {"source_id": "odds ratio", "target_id": "inclusion criteria", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "vaccination", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "disease severity", "strength": 3}, {"source_id": "vaccine", "target_id": "immune cells", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "ICU admission", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "patient characteristics", "strength": 3}, {"source_id": "observational study", "target_id": "intensive care", "strength": 3}, {"source_id": "years of age", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "ICU admission", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "intensive care", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "intensive care", "target_id": "observational study", "strength": 3}, {"source_id": "therapy", "target_id": "years of age", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "central nervous system", "strength": 3}, {"source_id": "mouse model", "target_id": "animal models", "strength": 3}, {"source_id": "animal models", "target_id": "central nervous system", "strength": 3}, {"source_id": "immune system", "target_id": "mice", "strength": 3}, {"source_id": "infection rate", "target_id": "dose", "strength": 3}, {"source_id": "health outcomes", "target_id": "clinical practice", "strength": 3}, {"source_id": "vaccine", "target_id": "cross-sectional survey", "strength": 3}, {"source_id": "logistic regression", "target_id": "healthcare workers", "strength": 3}, {"source_id": "discourse", "target_id": "policy", "strength": 3}, {"source_id": "policy", "target_id": "discourse", "strength": 3}, {"source_id": "crisis", "target_id": "context", "strength": 3}, {"source_id": "context", "target_id": "crisis", "strength": 3}, {"source_id": "government", "target_id": "practice", "strength": 3}, {"source_id": "article", "target_id": "people", "strength": 3}, {"source_id": "experience", "target_id": "article", "strength": 3}, {"source_id": "economy", "target_id": "University", "strength": 3}, {"source_id": "pandemic", "target_id": "research", "strength": 3}, {"source_id": "future research", "target_id": "pandemic", "strength": 3}, {"source_id": "future research", "target_id": "teaching", "strength": 3}, {"source_id": "research", "target_id": "pandemic", "strength": 3}, {"source_id": "infection", "target_id": "World Health Organization", "strength": 3}, {"source_id": "infection", "target_id": "health issues", "strength": 3}, {"source_id": "retrospective study", "target_id": "age groups", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "retrospective study", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "viral load", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "therapy", "strength": 3}, {"source_id": "hospitalized patients", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "clinical trials", "target_id": "antibody titers", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "trials", "strength": 3}, {"source_id": "trials", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "trials", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "disease severity", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "disease severity", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "disease severity", "strength": 3}, {"source_id": "disease 2019 pandemic", "target_id": "disease severity", "strength": 3}, {"source_id": "clinical trials", "target_id": "oxidative stress", "strength": 3}, {"source_id": "antibody titers", "target_id": "humoral immune response", "strength": 3}, {"source_id": "disease severity", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "multivariable logistic regression", "target_id": "cancer", "strength": 3}, {"source_id": "mean age", "target_id": "BNT162b2 vaccine", "strength": 3}, {"source_id": "vaccine", "target_id": "pain", "strength": 3}, {"source_id": "hospital", "target_id": "BNT162b2 vaccine", "strength": 3}, {"source_id": "Web of Science", "target_id": "symptoms", "strength": 3}, {"source_id": "hospital stay", "target_id": "systematic review", "strength": 3}, {"source_id": "respiratory symptoms", "target_id": "COVID-19 symptoms", "strength": 3}, {"source_id": "respiratory symptoms", "target_id": "disease 2019", "strength": 3}, {"source_id": "primary outcome", "target_id": "safety profile", "strength": 3}, {"source_id": "vaccine", "target_id": "immune system", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "symptoms", "strength": 3}, {"source_id": "older adults", "target_id": "logistic regression", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "older adults", "strength": 3}, {"source_id": "systematic review", "target_id": "adverse outcomes", "strength": 3}, {"source_id": "World Health Organization", "target_id": "systematic review", "strength": 3}, {"source_id": "adverse outcomes", "target_id": "systematic review", "strength": 3}, {"source_id": "adverse outcomes", "target_id": "vaccine", "strength": 3}, {"source_id": "Health Organization", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "study period", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "study period", "target_id": "disease 2019", "strength": 3}, {"source_id": "vaccine dose", "target_id": "incidence rate", "strength": 3}, {"source_id": "incidence rate", "target_id": "vaccine dose", "strength": 3}, {"source_id": "hospital admission", "target_id": "logistic regression models", "strength": 3}, {"source_id": "diagnosis", "target_id": "COVID-19 diagnosis", "strength": 3}, {"source_id": "diagnosis", "target_id": "infection", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "infection rate", "strength": 3}, {"source_id": "health concern", "target_id": "COVID-19", "strength": 3}, {"source_id": "healthcare workers", "target_id": "vaccine doses", "strength": 3}, {"source_id": "humoral immune response", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "severe disease", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "cohort study", "target_id": "high prevalence", "strength": 3}, {"source_id": "symptoms", "target_id": "prospective cohort study", "strength": 3}, {"source_id": "healthy controls", "target_id": "viral infection", "strength": 3}, {"source_id": "T cells", "target_id": "SARS-CoV-2 replication", "strength": 3}, {"source_id": "T cells", "target_id": "healthy controls", "strength": 3}, {"source_id": "patient care", "target_id": "quality of life", "strength": 3}, {"source_id": "chronic diseases", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "adverse events", "target_id": "middle-income countries", "strength": 3}, {"source_id": "vaccine", "target_id": "outcome measures", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "antibody response", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "flow cytometry", "strength": 3}, {"source_id": "animal models", "target_id": "spike protein", "strength": 3}, {"source_id": "spike protein", "target_id": "immune cells", "strength": 3}, {"source_id": "nervous system", "target_id": "T cells", "strength": 3}, {"source_id": "nervous system", "target_id": "therapeutic target", "strength": 3}, {"source_id": "actors", "target_id": "countries", "strength": 3}, {"source_id": "climate change", "target_id": "politics", "strength": 3}, {"source_id": "politics", "target_id": "climate change", "strength": 3}, {"source_id": "discourse", "target_id": "economy", "strength": 3}, {"source_id": "teachers", "target_id": "higher education", "strength": 3}, {"source_id": "people", "target_id": "engagement", "strength": 3}, {"source_id": "narratives", "target_id": "governance", "strength": 3}, {"source_id": "narratives", "target_id": "interviews", "strength": 3}, {"source_id": "interviews", "target_id": "narratives", "strength": 3}, {"source_id": "case study", "target_id": "skills", "strength": 3}, {"source_id": "teachers", "target_id": "program", "strength": 3}, {"source_id": "course", "target_id": "program", "strength": 3}, {"source_id": "program", "target_id": "course", "strength": 3}, {"source_id": "respiratory tract", "target_id": "inflammatory response", "strength": 3}, {"source_id": "body mass index", "target_id": "lower risk", "strength": 3}, {"source_id": "mass index", "target_id": "lower risk", "strength": 3}, {"source_id": "hospital admission", "target_id": "therapy", "strength": 3}, {"source_id": "mean age", "target_id": "surgery", "strength": 3}, {"source_id": "high risk", "target_id": "diagnosis", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "syndrome", "strength": 3}, {"source_id": "syndrome", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "COVID-19 vaccine", "target_id": "electronic medical records", "strength": 3}, {"source_id": "multiple sclerosis", "target_id": "SARS-CoV-2 vaccines", "strength": 3}, {"source_id": "multiple sclerosis", "target_id": "vaccine", "strength": 3}, {"source_id": "vaccine", "target_id": "electronic medical records", "strength": 3}, {"source_id": "prospective study", "target_id": "immune response", "strength": 3}, {"source_id": "B cells", "target_id": "multiple sclerosis", "strength": 3}, {"source_id": "mice", "target_id": "vaccine", "strength": 3}, {"source_id": "COVID-19", "target_id": "mouse model", "strength": 3}, {"source_id": "mouse model", "target_id": "inflammatory response", "strength": 3}, {"source_id": "viral replication", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "pregnant women", "strength": 3}, {"source_id": "disease", "target_id": "inflammatory response", "strength": 3}, {"source_id": "vaccine dose", "target_id": "vaccination status", "strength": 3}, {"source_id": "health system", "target_id": "retrospective study", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "Omicron variant", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "incidence", "strength": 3}, {"source_id": "protective effect", "target_id": "high risk", "strength": 3}, {"source_id": "cohort study", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "systematic review", "target_id": "disease 2019 pandemic", "strength": 3}, {"source_id": "healthcare workers", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "primary care", "target_id": "emergency department", "strength": 3}, {"source_id": "T cell responses", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "symptoms", "target_id": "vaccine", "strength": 3}, {"source_id": "education", "target_id": "technology", "strength": 3}, {"source_id": "emergency department", "target_id": "care", "strength": 3}, {"source_id": "schools", "target_id": "mental health", "strength": 3}, {"source_id": "health care professionals", "target_id": "care", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "SARS-CoV-2 virus", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "health records", "target_id": "risk factors", "strength": 3}, {"source_id": "hospital stay", "target_id": "adult patients", "strength": 3}, {"source_id": "ill patients", "target_id": "COVID-19 pneumonia", "strength": 3}, {"source_id": "ill patients", "target_id": "hospital admission", "strength": 3}, {"source_id": "ill patients", "target_id": "mortality", "strength": 3}, {"source_id": "hospital admission", "target_id": "respiratory failure", "strength": 3}, {"source_id": "University Hospital", "target_id": "mortality", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "hospital admission", "strength": 3}, {"source_id": "hospital admission", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "severe disease", "target_id": "respiratory failure", "strength": 3}, {"source_id": "years of age", "target_id": "severe disease", "strength": 3}, {"source_id": "healthy controls", "target_id": "booster vaccination", "strength": 3}, {"source_id": "antibody levels", "target_id": "SARS-CoV-2 vaccination", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "humoral response", "strength": 3}, {"source_id": "booster vaccination", "target_id": "healthy controls", "strength": 3}, {"source_id": "systematic review", "target_id": "care professionals", "strength": 3}, {"source_id": "infection rate", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "infection rate", "target_id": "Omicron variant", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "spike protein", "strength": 3}, {"source_id": "lung disease", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "COVID-19 vaccine", "strength": 3}, {"source_id": "care unit", "target_id": "women", "strength": 3}, {"source_id": "electronic health records", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "electronic health records", "target_id": "health system", "strength": 3}, {"source_id": "health system", "target_id": "health records", "strength": 3}, {"source_id": "clinical trials", "target_id": "mean age", "strength": 3}, {"source_id": "disease", "target_id": "young adults", "strength": 3}, {"source_id": "care providers", "target_id": "care settings", "strength": 3}, {"source_id": "health disparities", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "Medical Center", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "oxidative stress", "target_id": "immune system", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "Delta variant", "strength": 3}, {"source_id": "median age", "target_id": "Delta variant", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "vaccination", "strength": 3}, {"source_id": "care providers", "target_id": "health professionals", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "World Health Organization", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "Health Organization", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "clinical practice", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "hospital admission", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "medical records", "target_id": "COVID-19 outcomes", "strength": 3}, {"source_id": "medical records", "target_id": "hospital admission", "strength": 3}, {"source_id": "clinical practice", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "physical activity", "target_id": "observational study", "strength": 3}, {"source_id": "risk factors", "target_id": "inflammatory diseases", "strength": 3}, {"source_id": "inflammation", "target_id": "risk factors", "strength": 3}, {"source_id": "article", "target_id": "governance", "strength": 3}, {"source_id": "policy", "target_id": "health disparities", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "admission", "strength": 3}, {"source_id": "coronavirus 2 infection", "target_id": "observational study", "strength": 3}, {"source_id": "observational study", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 3}, {"source_id": "observational study", "target_id": "coronavirus 2 infection", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "trials", "strength": 3}, {"source_id": "serious adverse events", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "time points", "target_id": "second dose", "strength": 3}, {"source_id": "time points", "target_id": "dose", "strength": 3}, {"source_id": "antibody levels", "target_id": "booster doses", "strength": 3}, {"source_id": "C-reactive protein", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "mortality rate", "target_id": "D-dimer", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "women", "target_id": "observational cohort study", "strength": 3}, {"source_id": "older adults", "target_id": "infection", "strength": 3}, {"source_id": "infection", "target_id": "older adults", "strength": 3}, {"source_id": "health system", "target_id": "vaccine uptake", "strength": 3}, {"source_id": "intervention group", "target_id": "COVID-19", "strength": 3}, {"source_id": "COVID-19", "target_id": "intervention group", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "vaccination campaign", "strength": 3}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "severe illness", "strength": 3}, {"source_id": "cytokine storm", "target_id": "clinical manifestations", "strength": 3}, {"source_id": "clinical manifestations", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "severe illness", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "severe illness", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "care settings", "target_id": "primary outcome", "strength": 3}, {"source_id": "healthcare workers", "target_id": "health outcomes", "strength": 3}, {"source_id": "health outcomes", "target_id": "healthcare workers", "strength": 3}, {"source_id": "pregnant women", "target_id": "health problems", "strength": 3}, {"source_id": "health problems", "target_id": "pregnant women", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "symptoms", "strength": 3}, {"source_id": "crisis", "target_id": "organization", "strength": 3}, {"source_id": "time points", "target_id": "physical activity", "strength": 3}, {"source_id": "spike protein", "target_id": "therapy", "strength": 3}, {"source_id": "symptoms", "target_id": "SARS-CoV-2 virus", "strength": 3}, {"source_id": "infection", "target_id": "persistent symptoms", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "predictive value", "strength": 3}, {"source_id": "disease severity", "target_id": "hospital stay", "strength": 3}, {"source_id": "antibody levels", "target_id": "blood samples", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "antibody levels", "strength": 3}, {"source_id": "clinical trials", "target_id": "cause mortality", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "mouse model", "strength": 3}, {"source_id": "systematic review", "target_id": "second dose", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "vaccination", "strength": 3}, {"source_id": "vaccine", "target_id": "cancer patients", "strength": 3}, {"source_id": "patient characteristics", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "ill patients", "strength": 3}, {"source_id": "hospital stay", "target_id": "surgery", "strength": 3}, {"source_id": "vaccination campaign", "target_id": "dose", "strength": 3}, {"source_id": "long COVID", "target_id": "viral infection", "strength": 3}, {"source_id": "viral infection", "target_id": "long COVID", "strength": 3}, {"source_id": "health care workers", "target_id": "logistic regression", "strength": 3}, {"source_id": "emergency department", "target_id": "health services", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "admission", "strength": 3}, {"source_id": "electronic health records", "target_id": "emergency department", "strength": 3}, {"source_id": "odds ratio", "target_id": "hospital admission", "strength": 3}, {"source_id": "case-control study", "target_id": "Omicron variant", "strength": 3}, {"source_id": "dose", "target_id": "SARS-CoV-2 Omicron variant", "strength": 3}, {"source_id": "high incidence", "target_id": "disease", "strength": 3}, {"source_id": "healthy controls", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "mice", "strength": 3}, {"source_id": "mice", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "antibody levels", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "antibody levels", "strength": 3}, {"source_id": "cohort study", "target_id": "hospital discharge", "strength": 3}, {"source_id": "hospital discharge", "target_id": "care unit admission", "strength": 3}, {"source_id": "pregnancy", "target_id": "care unit admission", "strength": 3}, {"source_id": "mean age", "target_id": "median time", "strength": 3}, {"source_id": "high prevalence", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "case series", "target_id": "disease 2019", "strength": 3}, {"source_id": "disease 2019", "target_id": "case series", "strength": 3}, {"source_id": "multiple sclerosis", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "multiple sclerosis", "target_id": "T cells", "strength": 3}, {"source_id": "case report", "target_id": "central nervous system", "strength": 3}, {"source_id": "respiratory tract", "target_id": "T cells", "strength": 3}, {"source_id": "T cells", "target_id": "high risk", "strength": 3}, {"source_id": "body mass index", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "high risk", "target_id": "vaccine uptake", "strength": 3}, {"source_id": "government", "target_id": "rights", "strength": 3}, {"source_id": "United States", "target_id": "article", "strength": 3}, {"source_id": "people", "target_id": "crisis", "strength": 3}, {"source_id": "crisis", "target_id": "people", "strength": 3}, {"source_id": "genes", "target_id": "COVID-19", "strength": 3}, {"source_id": "primary outcome", "target_id": "heart failure", "strength": 3}, {"source_id": "medical records", "target_id": "mean age", "strength": 3}, {"source_id": "surgery", "target_id": "COVID-19", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "disease burden", "strength": 3}, {"source_id": "risk factors", "target_id": "World Health Organization", "strength": 3}, {"source_id": "chronic kidney disease", "target_id": "cohort study", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "cell responses", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "general population", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "SARS-CoV2", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "autoimmune diseases", "strength": 3}, {"source_id": "autoimmune diseases", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "autoimmune diseases", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "pregnant women", "target_id": "vaccination", "strength": 3}, {"source_id": "epithelial cells", "target_id": "Delta variant", "strength": 3}, {"source_id": "clinical characteristics", "target_id": "high risk", "strength": 3}, {"source_id": "mortality rate", "target_id": "cause mortality", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "cause mortality", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "health problems", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "health problems", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "safety profile", "strength": 3}, {"source_id": "severe illness", "target_id": "pregnant women", "strength": 3}, {"source_id": "therapy", "target_id": "observational cohort study", "strength": 3}, {"source_id": "booster vaccination", "target_id": "mRNA vaccination", "strength": 3}, {"source_id": "odds ratio", "target_id": "multivariable logistic regression", "strength": 3}, {"source_id": "disease severity", "target_id": "logistic regression", "strength": 3}, {"source_id": "booster vaccination", "target_id": "adverse events", "strength": 3}, {"source_id": "electronic health records", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "cohort study", "target_id": "study participants", "strength": 3}, {"source_id": "control group", "target_id": "vaccination", "strength": 3}, {"source_id": "study participants", "target_id": "vaccine", "strength": 3}, {"source_id": "vaccine", "target_id": "electronic health records", "strength": 3}, {"source_id": "dose", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "health records", "target_id": "vaccine", "strength": 3}, {"source_id": "study period", "target_id": "use disorders", "strength": 3}, {"source_id": "sociodemographic characteristics", "target_id": "time points", "strength": 3}, {"source_id": "beneficial effects", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "COVID-19", "target_id": "need", "strength": 3}, {"source_id": "hospitalization", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "body mass index", "target_id": "disease 2019", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "mass index", "strength": 3}, {"source_id": "mass index", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "vaccine dose", "target_id": "Omicron infection", "strength": 3}, {"source_id": "care facilities", "target_id": "Omicron infection", "strength": 3}, {"source_id": "vaccination status", "target_id": "vaccination rates", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "race/ethnicity", "strength": 3}, {"source_id": "thematic analysis", "target_id": "policy", "strength": 3}, {"source_id": "qualitative study", "target_id": "mental health", "strength": 3}, {"source_id": "policy", "target_id": "qualitative study", "strength": 3}, {"source_id": "case report", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "mass index", "target_id": "adverse events", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "COVID-19 severity", "target_id": "respiratory tract", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "respiratory tract", "target_id": "COVID-19 severity", "strength": 3}, {"source_id": "immune response", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "systematic review", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "unvaccinated individuals", "strength": 3}, {"source_id": "dose", "target_id": "median age", "strength": 3}, {"source_id": "symptoms", "target_id": "median age", "strength": 3}, {"source_id": "general population", "target_id": "antibody response", "strength": 3}, {"source_id": "admission", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "respiratory disease", "target_id": "respiratory tract", "strength": 3}, {"source_id": "T cells", "target_id": "clinical symptoms", "strength": 3}, {"source_id": "variants of concern", "target_id": "booster dose", "strength": 3}, {"source_id": "infectious diseases", "target_id": "disease severity", "strength": 3}, {"source_id": "dose", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "diagnosis", "strength": 3}, {"source_id": "diagnosis", "target_id": "cancer", "strength": 3}, {"source_id": "ICU admission", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "vaccine", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "care unit", "target_id": "hospitalization", "strength": 3}, {"source_id": "clinical trials", "target_id": "viral infection", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "older age", "strength": 3}, {"source_id": "older age", "target_id": "intensive care unit", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "care", "strength": 3}, {"source_id": "COVID-19", "target_id": "social media", "strength": 3}, {"source_id": "engagement", "target_id": "thematic analysis", "strength": 3}, {"source_id": "perspective", "target_id": "article", "strength": 3}, {"source_id": "University", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "United States", "target_id": "book", "strength": 3}, {"source_id": "University", "target_id": "politics", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "research", "strength": 3}, {"source_id": "policy", "target_id": "semi-structured interviews", "strength": 3}, {"source_id": "motivation", "target_id": "perception", "strength": 3}, {"source_id": "research", "target_id": "higher education", "strength": 3}, {"source_id": "prevalence", "target_id": "adult patients", "strength": 3}, {"source_id": "patient outcomes", "target_id": "primary outcome", "strength": 3}, {"source_id": "ill patients", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "care unit admission", "target_id": "observational study", "strength": 3}, {"source_id": "unit admission", "target_id": "study period", "strength": 3}, {"source_id": "primary outcome", "target_id": "patient outcomes", "strength": 3}, {"source_id": "observational study", "target_id": "care unit admission", "strength": 3}, {"source_id": "therapy", "target_id": "B cells", "strength": 3}, {"source_id": "COVID-19", "target_id": "B cells", "strength": 3}, {"source_id": "vaccine dose", "target_id": "spike protein", "strength": 3}, {"source_id": "healthcare workers", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "booster dose", "strength": 3}, {"source_id": "booster dose", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "antibody response", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "patients", "target_id": "COVID-19 mRNA vaccines", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "control group", "strength": 3}, {"source_id": "cohort study", "target_id": "median time", "strength": 3}, {"source_id": "disease control", "target_id": "cohort study", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "respiratory disease", "strength": 3}, {"source_id": "respiratory disease", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "respiratory disease", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "sector", "target_id": "crisis", "strength": 3}, {"source_id": "climate change", "target_id": "governance", "strength": 3}, {"source_id": "governance", "target_id": "climate change", "strength": 3}, {"source_id": "older adults", "target_id": "older age", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "pregnant women", "strength": 3}, {"source_id": "women", "target_id": "logistic regression analysis", "strength": 3}, {"source_id": "perception", "target_id": "participants", "strength": 3}, {"source_id": "type 2 diabetes", "target_id": "high risk", "strength": 3}, {"source_id": "coronavirus disease", "target_id": "cohort study", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "older adults", "strength": 3}, {"source_id": "logistic regression analysis", "target_id": "protective effect", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "adverse events", "strength": 3}, {"source_id": "prospective study", "target_id": "severe disease", "strength": 3}, {"source_id": "antibody response", "target_id": "adult patients", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "health status", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "University Hospital", "strength": 3}, {"source_id": "health status", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "disease 2019", "strength": 3}, {"source_id": "SARS-CoV-2", "target_id": "chronic diseases", "strength": 3}, {"source_id": "chronic diseases", "target_id": "COVID-19", "strength": 3}, {"source_id": "chronic diseases", "target_id": "SARS-CoV-2", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "symptoms", "strength": 3}, {"source_id": "acute infection", "target_id": "healthy controls", "strength": 3}, {"source_id": "healthy controls", "target_id": "acute infection", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "medical records", "strength": 3}, {"source_id": "hospital admission", "target_id": "vaccination status", "strength": 3}, {"source_id": "Omicron variant", "target_id": "electronic health records", "strength": 3}, {"source_id": "health records", "target_id": "vaccination status", "strength": 3}, {"source_id": "mortality", "target_id": "electronic health records", "strength": 3}, {"source_id": "adult patients", "target_id": "cause mortality", "strength": 3}, {"source_id": "mechanical ventilation", "target_id": "cause mortality", "strength": 3}, {"source_id": "monoclonal antibodies", "target_id": "treatment options", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "high risk", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "high risk", "strength": 3}, {"source_id": "high risk", "target_id": "observational study", "strength": 3}, {"source_id": "length of stay", "target_id": "COVID-19", "strength": 3}, {"source_id": "COVID-19", "target_id": "length of stay", "strength": 3}, {"source_id": "intensive care unit", "target_id": "logistic regression", "strength": 3}, {"source_id": "University Hospital", "target_id": "primary outcome", "strength": 3}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "vaccination", "strength": 3}, {"source_id": "inflammatory diseases", "target_id": "adult patients", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "unit admission", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "care unit admission", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "older adults", "strength": 3}, {"source_id": "gene expression", "target_id": "viral replication", "strength": 3}, {"source_id": "acute respiratory distress syndrome", "target_id": "severe illness", "strength": 3}, {"source_id": "distress syndrome", "target_id": "severe illness", "strength": 3}, {"source_id": "COVID-19 disease", "target_id": "vaccination", "strength": 3}, {"source_id": "vaccination", "target_id": "COVID-19 disease", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "care unit admission", "strength": 3}, {"source_id": "second dose", "target_id": "study period", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "hospital admission", "strength": 3}, {"source_id": "infection", "target_id": "inflammatory syndrome", "strength": 3}, {"source_id": "older adults", "target_id": "vaccine", "strength": 3}, {"source_id": "Medical Center", "target_id": "retrospective study", "strength": 3}, {"source_id": "cancer patients", "target_id": "COVID-19 severity", "strength": 3}, {"source_id": "healthcare workers", "target_id": "University Hospital", "strength": 3}, {"source_id": "University Hospital", "target_id": "infection", "strength": 3}, {"source_id": "infection", "target_id": "University Hospital", "strength": 3}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "vaccine", "strength": 3}, {"source_id": "children", "target_id": "teachers", "strength": 3}, {"source_id": "children", "target_id": "program", "strength": 3}, {"source_id": "weight loss", "target_id": "vaccine", "strength": 3}, {"source_id": "variants of concern", "target_id": "cohort study", "strength": 3}, {"source_id": "variants of concern", "target_id": "healthy controls", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "Delta variant", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "care workers", "strength": 3}, {"source_id": "inflammatory syndrome", "target_id": "years of age", "strength": 3}, {"source_id": "incidence rate", "target_id": "respiratory disease", "strength": 3}, {"source_id": "COVID-19 pandemic", "target_id": "narratives", "strength": 3}, {"source_id": "COVID-19 outcomes", "target_id": "intensive care", "strength": 3}, {"source_id": "incidence rate", "target_id": "age groups", "strength": 3}, {"source_id": "age groups", "target_id": "Omicron variant", "strength": 3}, {"source_id": "primary care", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "infection", "target_id": "primary care", "strength": 3}, {"source_id": "care unit", "target_id": "care settings", "strength": 3}, {"source_id": "care settings", "target_id": "intensive care unit", "strength": 3}, {"source_id": "length of stay", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "SARS-CoV2", "target_id": "coronavirus disease 2019", "strength": 3}, {"source_id": "health records", "target_id": "booster dose", "strength": 3}, {"source_id": "risk factors", "target_id": "anxiety", "strength": 3}, {"source_id": "logistic regression", "target_id": "diagnosis", "strength": 3}, {"source_id": "institutions", "target_id": "engagement", "strength": 3}, {"source_id": "institutions", "target_id": "curriculum", "strength": 3}, {"source_id": "COVID-19", "target_id": "narratives", "strength": 3}, {"source_id": "justice", "target_id": "COVID-19", "strength": 3}, {"source_id": "pandemic", "target_id": "motivation", "strength": 3}, {"source_id": "risk factors", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 3}, {"source_id": "humoral response", "target_id": "older age", "strength": 3}, {"source_id": "vaccination", "target_id": "severe illness", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "median age", "strength": 3}, {"source_id": "median age", "target_id": "intensive care unit", "strength": 3}, {"source_id": "second dose", "target_id": "T cell responses", "strength": 3}, {"source_id": "second dose", "target_id": "antibody titers", "strength": 3}, {"source_id": "T cell responses", "target_id": "second dose", "strength": 3}, {"source_id": "T cells", "target_id": "third dose", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "healthy controls", "strength": 3}, {"source_id": "healthy controls", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "second dose", "target_id": "care workers", "strength": 3}, {"source_id": "care workers", "target_id": "mRNA vaccines", "strength": 3}, {"source_id": "primary outcome", "target_id": "severe disease", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "T cells", "strength": 3}, {"source_id": "T cells", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "cohort", "target_id": "study period", "strength": 3}, {"source_id": "study period", "target_id": "cohort", "strength": 3}, {"source_id": "hospital admission", "target_id": "older age", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "systematic review", "strength": 3}, {"source_id": "electronic medical records", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "adverse events", "target_id": "cancer", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "disease severity", "strength": 3}, {"source_id": "disease severity", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "symptom onset", "target_id": "COVID-19 cases", "strength": 3}, {"source_id": "COVID-19 cases", "target_id": "symptom onset", "strength": 3}, {"source_id": "hazard ratio", "target_id": "mean age", "strength": 3}, {"source_id": "COVID-19", "target_id": "vaccination program", "strength": 3}, {"source_id": "vaccination program", "target_id": "vaccination coverage", "strength": 3}, {"source_id": "antibody levels", "target_id": "health care workers", "strength": 3}, {"source_id": "immune response", "target_id": "median age", "strength": 3}, {"source_id": "adult patients", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "lower risk", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "complications", "strength": 3}, {"source_id": "health problems", "target_id": "care professionals", "strength": 3}, {"source_id": "COVID-19", "target_id": "healthcare professionals", "strength": 3}, {"source_id": "Secondary outcomes", "target_id": "symptoms", "strength": 3}, {"source_id": "outcome measures", "target_id": "symptoms", "strength": 3}, {"source_id": "symptoms", "target_id": "Secondary outcomes", "strength": 3}, {"source_id": "logistic regression models", "target_id": "symptoms", "strength": 3}, {"source_id": "symptoms", "target_id": "logistic regression models", "strength": 3}, {"source_id": "risk factors", "target_id": "time points", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "T cells", "strength": 3}, {"source_id": "hospitalization", "target_id": "dose", "strength": 3}, {"source_id": "dose", "target_id": "hospitalization", "strength": 3}, {"source_id": "general population", "target_id": "mortality rate", "strength": 3}, {"source_id": "cohort study", "target_id": "blood pressure", "strength": 3}, {"source_id": "cohort study", "target_id": "study population", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "case series", "strength": 3}, {"source_id": "case series", "target_id": "COVID-19 patients", "strength": 3}, {"source_id": "case series", "target_id": "severe COVID-19", "strength": 3}, {"source_id": "case series", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "COVID-19", "target_id": "case series", "strength": 3}, {"source_id": "Delta variant", "target_id": "vaccine dose", "strength": 3}, {"source_id": "COVID-19 infection", "target_id": "health interventions", "strength": 3}, {"source_id": "inclusion criteria", "target_id": "symptoms", "strength": 3}, {"source_id": "COVID-19 vaccination", "target_id": "medical records", "strength": 3}, {"source_id": "electronic medical records", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "health professionals", "target_id": "mental health", "strength": 3}, {"source_id": "SARS-CoV-2 infection", "target_id": "oxidative stress", "strength": 3}, {"source_id": "inflammatory response", "target_id": "oxidative stress", "strength": 3}, {"source_id": "COVID-19", "target_id": "children", "strength": 3}, {"source_id": "breast cancer", "target_id": "cohort study", "strength": 3}, {"source_id": "cohort study", "target_id": "breast cancer", "strength": 3}, {"source_id": "mortality rate", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "COVID-19 patients", "target_id": "virus infection", "strength": 3}, {"source_id": "vaccine effectiveness", "target_id": "logistic regression models", "strength": 3}, {"source_id": "logistic regression models", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "illness", "target_id": "vaccine effectiveness", "strength": 3}, {"source_id": "disease", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "cause mortality", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "coronavirus 2 infection", "target_id": "respiratory disease", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "race/ethnicity", "strength": 3}, {"source_id": "diabetes mellitus", "target_id": "primary outcome", "strength": 3}, {"source_id": "immune system", "target_id": "Health Organization", "strength": 3}, {"source_id": "Health Organization", "target_id": "immune system", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "clinical practice", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "type 2 diabetes", "strength": 3}, {"source_id": "inflammatory response", "target_id": "healthy controls", "strength": 3}, {"source_id": "T cell responses", "target_id": "transplant recipients", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "SARS-CoV-2 spike protein", "strength": 3}, {"source_id": "severe disease", "target_id": "respiratory tract", "strength": 3}, {"source_id": "T cells", "target_id": "clinical outcomes", "strength": 3}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "cardiovascular disease", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "cardiovascular disease", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "cause mortality", "target_id": "distress syndrome", "strength": 3}, {"source_id": "cause mortality", "target_id": "mass index", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "cause mortality", "strength": 3}, {"source_id": "mortality", "target_id": "mass index", "strength": 3}, {"source_id": "middle-income countries", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "vaccination campaign", "target_id": "infection", "strength": 3}, {"source_id": "complications", "target_id": "primary outcome", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "lower risk", "strength": 3}, {"source_id": "disease 2019", "target_id": "lower risk", "strength": 3}, {"source_id": "clinical practice", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "intensive care unit admission", "target_id": "medical records", "strength": 3}, {"source_id": "medical records", "target_id": "intensive care unit admission", "strength": 3}, {"source_id": "medical records", "target_id": "care unit admission", "strength": 3}, {"source_id": "mental health", "target_id": "public health measures", "strength": 3}, {"source_id": "economy", "target_id": "perspective", "strength": 3}, {"source_id": "education", "target_id": "qualitative study", "strength": 3}, {"source_id": "learning", "target_id": "qualitative study", "strength": 3}, {"source_id": "clinical presentation", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "clinical presentation", "target_id": "syndrome coronavirus 2", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "clinical presentation", "strength": 3}, {"source_id": "case report", "target_id": "coronavirus 2", "strength": 3}, {"source_id": "clinical outcomes", "target_id": "D-dimer", "strength": 3}, {"source_id": "blood samples", "target_id": "spike protein", "strength": 3}, {"source_id": "therapeutic strategies", "target_id": "disease 2019", "strength": 3}, {"source_id": "safety profile", "target_id": "clinical trials", "strength": 3}, {"source_id": "hospital stay", "target_id": "median age", "strength": 3}, {"source_id": "risk factors", "target_id": "health issues", "strength": 3}, {"source_id": "logistic regression models", "target_id": "electronic health records", "strength": 3}, {"source_id": "logistic regression models", "target_id": "health records", "strength": 3}, {"source_id": "Delta variant", "target_id": "case-control study", "strength": 3}, {"source_id": "health records", "target_id": "logistic regression models", "strength": 3}, {"source_id": "BNT162b2 vaccine", "target_id": "spike protein", "strength": 3}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "vaccine", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "SARS-CoV-2 transmission", "strength": 3}, {"source_id": "qualitative study", "target_id": "skills", "strength": 3}, {"source_id": "qualitative study", "target_id": "need", "strength": 3}, {"source_id": "coronavirus 2", "target_id": "young adults", "strength": 3}, {"source_id": "young adults", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "perspective", "target_id": "society", "strength": 3}, {"source_id": "high risk", "target_id": "high prevalence", "strength": 3}, {"source_id": "adverse events", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "therapy", "strength": 3}, {"source_id": "older age", "target_id": "immune response", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "disease", "strength": 3}, {"source_id": "clinical data", "target_id": "Delta variant", "strength": 3}, {"source_id": "clinical data", "target_id": "disease", "strength": 3}, {"source_id": "SARS-CoV-2 variants", "target_id": "study period", "strength": 3}, {"source_id": "Delta variant", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "disease", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "study period", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "greater risk", "target_id": "logistic regression", "strength": 3}, {"source_id": "adult patients", "target_id": "lower risk", "strength": 3}, {"source_id": "lower risk", "target_id": "adult patients", "strength": 3}, {"source_id": "immune response", "target_id": "adverse effects", "strength": 3}, {"source_id": "race/ethnicity", "target_id": "logistic regression models", "strength": 3}, {"source_id": "women", "target_id": "COVID-19 vaccination", "strength": 3}, {"source_id": "care unit", "target_id": "treatment strategies", "strength": 3}, {"source_id": "treatment strategies", "target_id": "care unit", "strength": 3}, {"source_id": "vaccination", "target_id": "symptom onset", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "cell responses", "strength": 3}, {"source_id": "antiviral therapy", "target_id": "monoclonal antibodies", "strength": 3}, {"source_id": "severe disease", "target_id": "greater risk", "strength": 3}, {"source_id": "median age", "target_id": "severe cases", "strength": 3}, {"source_id": "severe cases", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "severe cases", "target_id": "respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "study design", "strength": 3}, {"source_id": "time points", "target_id": "clinical practice", "strength": 3}, {"source_id": "health policy", "target_id": "mental health", "strength": 3}, {"source_id": "incidence rate", "target_id": "primary outcome", "strength": 3}, {"source_id": "students", "target_id": "pilot study", "strength": 3}, {"source_id": "pilot study", "target_id": "students", "strength": 3}, {"source_id": "T cells", "target_id": "animal models", "strength": 3}, {"source_id": "health records", "target_id": "adult patients", "strength": 3}, {"source_id": "University Hospital", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "sector", "target_id": "case study", "strength": 3}, {"source_id": "semi-structured interviews", "target_id": "teachers", "strength": 3}, {"source_id": "teaching", "target_id": "perception", "strength": 3}, {"source_id": "length of stay", "target_id": "systematic review", "strength": 3}, {"source_id": "care unit", "target_id": "D-dimer", "strength": 3}, {"source_id": "disease 2019", "target_id": "COVID-19 severity", "strength": 3}, {"source_id": "severe illness", "target_id": "high risk", "strength": 3}, {"source_id": "severe illness", "target_id": "COVID-19 infection", "strength": 3}, {"source_id": "mortality", "target_id": "cancer", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "SARS-CoV-2 variants", "strength": 3}, {"source_id": "retrospective cohort study", "target_id": "older age", "strength": 3}, {"source_id": "older age", "target_id": "retrospective cohort study", "strength": 3}, {"source_id": "study participants", "target_id": "immune response", "strength": 3}, {"source_id": "emergency department", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 3}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "emergency department", "strength": 3}, {"source_id": "syndrome coronavirus 2", "target_id": "emergency department", "strength": 3}, {"source_id": "intensive care unit", "target_id": "COVID-19 pneumonia", "strength": 3}, {"source_id": "mortality", "target_id": "diabetes mellitus", "strength": 3}, {"source_id": "lung disease", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "distress syndrome", "target_id": "primary outcome", "strength": 3}, {"source_id": "severe disease", "target_id": "mortality", "strength": 3}, {"source_id": "primary outcome", "target_id": "acute respiratory distress syndrome", "strength": 3}, {"source_id": "primary outcome", "target_id": "respiratory distress syndrome", "strength": 3}, {"source_id": "primary outcome", "target_id": "distress syndrome", "strength": 3}, {"source_id": "care unit admission", "target_id": "logistic regression", "strength": 3}, {"source_id": "coronavirus disease 2019", "target_id": "clinical characteristics", "strength": 3}, {"source_id": "breakthrough infections", "target_id": "dose", "strength": 3}, {"source_id": "care facilities", "target_id": "mortality rate", "strength": 3}, {"source_id": "race/ethnicity", "target_id": "health system", "strength": 3}, {"source_id": "teaching", "target_id": "technology", "strength": 3}, {"source_id": "respiratory distress syndrome", "target_id": "disease", "strength": 3}, {"source_id": "Meta-Analysis", "target_id": "severe disease", "strength": 3}, {"source_id": "injury", "target_id": "SARS-CoV-2 infection", "strength": 3}, {"source_id": "social media", "target_id": "learning", "strength": 3}, {"source_id": "median age", "target_id": "cause mortality", "strength": 3}, {"source_id": "cancer patients", "target_id": "observational study", "strength": 3}, {"source_id": "MAIN OUTCOME", "target_id": "mental health", "strength": 3}, {"source_id": "severe disease", "target_id": "systematic review", "strength": 3}, {"source_id": "Medical Center", "target_id": "MAIN OUTCOME", "strength": 3}, {"source_id": "injury", "target_id": "heart failure", "strength": 3}, {"source_id": "booster dose", "target_id": "severe disease", "strength": 3}, {"source_id": "epithelial cells", "target_id": "therapeutic strategies", "strength": 3}, {"source_id": "severe COVID-19", "target_id": "viral infection", "strength": 3}, {"source_id": "receptor-binding domain", "target_id": "breakthrough infections", "strength": 3}, {"source_id": "flow cytometry", "target_id": "antibody response", "strength": 3}, {"source_id": "pregnant women", "target_id": "vaccination rates", "strength": 3}, {"source_id": "vaccination rates", "target_id": "pregnant women", "strength": 3}, {"source_id": "vaccination rates", "target_id": "side effects", "strength": 3}, {"source_id": "vaccination rates", "target_id": "women", "strength": 3}, {"source_id": "book", "target_id": "schools", "strength": 3}, {"source_id": "context", "target_id": "curriculum", "strength": 3}, {"source_id": "prospective cohort study", "target_id": "disease severity", "strength": 3}, {"source_id": "central nervous system", "target_id": "immune cells", "strength": 3}, {"source_id": "pandemic", "target_id": "community", "strength": 3}, {"source_id": "years of age", "target_id": "incidence rate", "strength": 3}, {"source_id": "incidence rate", "target_id": "years of age", "strength": 3}, {"source_id": "vaccination rates", "target_id": "COVID-19 pandemic", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "care workers", "strength": 3}, {"source_id": "vaccine", "target_id": "mechanical ventilation", "strength": 3}, {"source_id": "hospital", "target_id": "older adults", "strength": 3}, {"source_id": "adult patients", "target_id": "observational cohort study", "strength": 3}, {"source_id": "clinical studies", "target_id": "high risk", "strength": 3}, {"source_id": "mRNA vaccines", "target_id": "incidence rate", "strength": 3}, {"source_id": "cross-sectional study", "target_id": "respiratory tract", "strength": 3}, {"source_id": "respiratory tract", "target_id": "cross-sectional study", "strength": 3}, {"source_id": "systematic review", "target_id": "pediatric patients", "strength": 4}, {"source_id": "pediatric patients", "target_id": "systematic review", "strength": 4}, {"source_id": "World Health Organization", "target_id": "severe disease", "strength": 4}, {"source_id": "World Health Organization", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "distress syndrome", "target_id": "Health Organization", "strength": 4}, {"source_id": "length of stay", "target_id": "care unit", "strength": 4}, {"source_id": "intensive care unit", "target_id": "length of stay", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "hospital mortality", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "hospital mortality", "strength": 4}, {"source_id": "electronic medical records", "target_id": "disease 2019", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "electronic medical records", "strength": 4}, {"source_id": "adverse events", "target_id": "symptom onset", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "second dose", "strength": 4}, {"source_id": "predictive value", "target_id": "COVID-19", "strength": 4}, {"source_id": "COVID-19", "target_id": "predictive value", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "syndrome", "strength": 4}, {"source_id": "inflammatory syndrome", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "ICU admission", "target_id": "vaccination", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "ICU admission", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "hospitalization", "strength": 4}, {"source_id": "infection", "target_id": "transplant recipients", "strength": 4}, {"source_id": "admission", "target_id": "primary outcome", "strength": 4}, {"source_id": "general population", "target_id": "symptoms", "strength": 4}, {"source_id": "symptoms", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "health care workers", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "inclusion criteria", "strength": 4}, {"source_id": "greater risk", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "mortality", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "mortality", "target_id": "disease", "strength": 4}, {"source_id": "primary care", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "women", "target_id": "violence", "strength": 4}, {"source_id": "transplant recipients", "target_id": "therapy", "strength": 4}, {"source_id": "Omicron variant", "target_id": "transplant recipients", "strength": 4}, {"source_id": "viral load", "target_id": "Omicron variant", "strength": 4}, {"source_id": "retrospective study", "target_id": "care unit", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "inclusion criteria", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "vaccine dose", "strength": 4}, {"source_id": "vaccine dose", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "booster vaccination", "strength": 4}, {"source_id": "adverse events", "target_id": "vaccination campaign", "strength": 4}, {"source_id": "diabetes mellitus", "target_id": "disease", "strength": 4}, {"source_id": "vaccination program", "target_id": "vaccine hesitancy", "strength": 4}, {"source_id": "disease", "target_id": "adverse events", "strength": 4}, {"source_id": "risk factors", "target_id": "depressive symptoms", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "nervous system", "strength": 4}, {"source_id": "nervous system", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "nervous system", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "nervous system", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "Omicron infection", "target_id": "RT-PCR", "strength": 4}, {"source_id": "nervous system", "target_id": "animal models", "strength": 4}, {"source_id": "immune system", "target_id": "nervous system", "strength": 4}, {"source_id": "practice", "target_id": "program", "strength": 4}, {"source_id": "health outcomes", "target_id": "young adults", "strength": 4}, {"source_id": "cross-sectional survey", "target_id": "vaccine hesitancy", "strength": 4}, {"source_id": "logistic regression", "target_id": "general population", "strength": 4}, {"source_id": "education", "target_id": "interviews", "strength": 4}, {"source_id": "motivation", "target_id": "mental health", "strength": 4}, {"source_id": "training", "target_id": "thematic analysis", "strength": 4}, {"source_id": "research", "target_id": "COVID-19", "strength": 4}, {"source_id": "World Health Organization", "target_id": "immune response", "strength": 4}, {"source_id": "C-reactive protein", "target_id": "D-dimer", "strength": 4}, {"source_id": "healthy controls", "target_id": "risk factors", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "study period", "strength": 4}, {"source_id": "disease", "target_id": "mean age", "strength": 4}, {"source_id": "retrospective study", "target_id": "hospital mortality", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "hospital discharge", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "adverse events", "strength": 4}, {"source_id": "hospital discharge", "target_id": "observational study", "strength": 4}, {"source_id": "adverse events", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "observational study", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "therapy", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "receptor-binding domain", "target_id": "antibody response", "strength": 4}, {"source_id": "antibody response", "target_id": "receptor-binding domain", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "mRNA vaccination", "strength": 4}, {"source_id": "risk factors", "target_id": "healthcare workers", "strength": 4}, {"source_id": "T cells", "target_id": "humoral immune response", "strength": 4}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "syndrome coronavirus 2 infection", "strength": 4}, {"source_id": "mortality", "target_id": "study period", "strength": 4}, {"source_id": "vaccine", "target_id": "cohort", "strength": 4}, {"source_id": "high risk", "target_id": "health outcomes", "strength": 4}, {"source_id": "women", "target_id": "high risk", "strength": 4}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "Web of Science", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "Web of Science", "target_id": "prevalence", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "intensive care unit admission", "strength": 4}, {"source_id": "care unit admission", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "care unit admission", "target_id": "disease 2019", "strength": 4}, {"source_id": "disease 2019", "target_id": "care unit admission", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "hospitalization", "target_id": "study period", "strength": 4}, {"source_id": "vaccination", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "Delta variant", "target_id": "humoral immune response", "strength": 4}, {"source_id": "long COVID", "target_id": "syndrome", "strength": 4}, {"source_id": "healthcare workers", "target_id": "symptoms", "strength": 4}, {"source_id": "practice", "target_id": "skills", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "years of age", "strength": 4}, {"source_id": "treatment strategies", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "treatment strategies", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "electronic health records", "target_id": "COVID-19", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "logistic regression", "strength": 4}, {"source_id": "logistic regression", "target_id": "study participants", "strength": 4}, {"source_id": "vaccine hesitancy", "target_id": "pregnant women", "strength": 4}, {"source_id": "outcome measures", "target_id": "adverse events", "strength": 4}, {"source_id": "interviews", "target_id": "United States", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "mice", "strength": 4}, {"source_id": "spike protein", "target_id": "mice", "strength": 4}, {"source_id": "ecosystems", "target_id": "case study", "strength": 4}, {"source_id": "neural network", "target_id": "algorithm", "strength": 4}, {"source_id": "practice", "target_id": "interviews", "strength": 4}, {"source_id": "perspective", "target_id": "experience", "strength": 4}, {"source_id": "intervention group", "target_id": "clinical trials", "strength": 4}, {"source_id": "clinical trials", "target_id": "intervention group", "strength": 4}, {"source_id": "schools", "target_id": "learners", "strength": 4}, {"source_id": "COVID-19", "target_id": "practice", "strength": 4}, {"source_id": "control group", "target_id": "body mass index", "strength": 4}, {"source_id": "therapy", "target_id": "disease severity", "strength": 4}, {"source_id": "mean age", "target_id": "mortality", "strength": 4}, {"source_id": "risk factors", "target_id": "age groups", "strength": 4}, {"source_id": "antibody response", "target_id": "observational study", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "clinical manifestations", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "vaccination campaign", "strength": 4}, {"source_id": "vaccination campaign", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "unvaccinated individuals", "strength": 4}, {"source_id": "pregnant women", "target_id": "risk factors", "strength": 4}, {"source_id": "inflammatory response", "target_id": "viral infection", "strength": 4}, {"source_id": "vaccine dose", "target_id": "first dose", "strength": 4}, {"source_id": "society", "target_id": "economy", "strength": 4}, {"source_id": "clinical setting", "target_id": "patients", "strength": 4}, {"source_id": "risk factors", "target_id": "clinical data", "strength": 4}, {"source_id": "mental health outcomes", "target_id": "COVID-19", "strength": 4}, {"source_id": "health outcomes", "target_id": "health services", "strength": 4}, {"source_id": "lower risk", "target_id": "protective effect", "strength": 4}, {"source_id": "high prevalence", "target_id": "prevalence", "strength": 4}, {"source_id": "side effects", "target_id": "case report", "strength": 4}, {"source_id": "blood samples", "target_id": "T cell responses", "strength": 4}, {"source_id": "infection", "target_id": "IL-6", "strength": 4}, {"source_id": "primary care", "target_id": "care services", "strength": 4}, {"source_id": "emergency department", "target_id": "hospital admission", "strength": 4}, {"source_id": "logistic regression", "target_id": "vaccine", "strength": 4}, {"source_id": "care", "target_id": "intensive care", "strength": 4}, {"source_id": "pain", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "systematic review", "target_id": "health interventions", "strength": 4}, {"source_id": "health interventions", "target_id": "systematic review", "strength": 4}, {"source_id": "risk factors", "target_id": "health services", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "prospective cohort study", "strength": 4}, {"source_id": "social media", "target_id": "politics", "strength": 4}, {"source_id": "mortality rate", "target_id": "adult patients", "strength": 4}, {"source_id": "University Hospital", "target_id": "respiratory failure", "strength": 4}, {"source_id": "severe disease", "target_id": "antibody titers", "strength": 4}, {"source_id": "treatment options", "target_id": "clinical trials", "strength": 4}, {"source_id": "C-reactive protein", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "cytokine storm", "strength": 4}, {"source_id": "vaccination", "target_id": "inflammatory diseases", "strength": 4}, {"source_id": "systematic review", "target_id": "health care professionals", "strength": 4}, {"source_id": "vaccine effectiveness", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "inclusion criteria", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "vaccination rates", "target_id": "vaccination program", "strength": 4}, {"source_id": "observational study", "target_id": "admission", "strength": 4}, {"source_id": "mRNA vaccination", "target_id": "vaccine effectiveness", "strength": 4}, {"source_id": "mortality", "target_id": "study population", "strength": 4}, {"source_id": "primary outcome", "target_id": "retrospective study", "strength": 4}, {"source_id": "therapeutic target", "target_id": "disease", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "therapeutic target", "strength": 4}, {"source_id": "clinical trials", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "antibody titers", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "antibody titers", "strength": 4}, {"source_id": "antibody titers", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "antibody titers", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "antibody titers", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "antiviral activity", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "ICU admission", "target_id": "medical records", "strength": 4}, {"source_id": "inflammatory diseases", "target_id": "inflammation", "strength": 4}, {"source_id": "immune system", "target_id": "inflammation", "strength": 4}, {"source_id": "immune response", "target_id": "inflammatory diseases", "strength": 4}, {"source_id": "immune response", "target_id": "inflammation", "strength": 4}, {"source_id": "inflammation", "target_id": "immune response", "strength": 4}, {"source_id": "hospitalized patients", "target_id": "severe disease", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "severe disease", "strength": 4}, {"source_id": "viral infection", "target_id": "innate immune response", "strength": 4}, {"source_id": "cohort study", "target_id": "SARS-CoV-2 antibodies", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "D-dimer", "strength": 4}, {"source_id": "Omicron variant", "target_id": "study period", "strength": 4}, {"source_id": "age groups", "target_id": "vaccination program", "strength": 4}, {"source_id": "clinical trials", "target_id": "adverse effects", "strength": 4}, {"source_id": "young adults", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "adverse events", "target_id": "SARS-CoV-2 vaccination", "strength": 4}, {"source_id": "severe illness", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "viral load", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "observational study", "target_id": "disease 2019 pandemic", "strength": 4}, {"source_id": "qualitative study", "target_id": "COVID-19", "strength": 4}, {"source_id": "pandemic", "target_id": "governance", "strength": 4}, {"source_id": "physical activity", "target_id": "control group", "strength": 4}, {"source_id": "control group", "target_id": "mental health", "strength": 4}, {"source_id": "control group", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "control group", "target_id": "physical activity", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "SARS-CoV-2 spike protein", "strength": 4}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "mortality", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "severe disease", "strength": 4}, {"source_id": "severe disease", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "inflammation", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "immune system", "strength": 4}, {"source_id": "infection", "target_id": "cardiovascular disease", "strength": 4}, {"source_id": "women", "target_id": "infection", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "mass index", "strength": 4}, {"source_id": "observational cohort study", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "hospital stay", "target_id": "cohort study", "strength": 4}, {"source_id": "hazard ratio", "target_id": "high risk", "strength": 4}, {"source_id": "healthcare workers", "target_id": "primary outcome", "strength": 4}, {"source_id": "care workers", "target_id": "risk factors", "strength": 4}, {"source_id": "study period", "target_id": "risk factors", "strength": 4}, {"source_id": "risk factors", "target_id": "health interventions", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "distress syndrome", "strength": 4}, {"source_id": "distress syndrome", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "distress syndrome", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "spike protein", "target_id": "coronavirus disease", "strength": 4}, {"source_id": "antibody levels", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "health conditions", "target_id": "risk factors", "strength": 4}, {"source_id": "older age", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "mean age", "target_id": "mortality rate", "strength": 4}, {"source_id": "cytokine storm", "target_id": "viral infection", "strength": 4}, {"source_id": "myocardial infarction", "target_id": "heart failure", "strength": 4}, {"source_id": "heart failure", "target_id": "chronic kidney disease", "strength": 4}, {"source_id": "autoimmune diseases", "target_id": "infection", "strength": 4}, {"source_id": "use disorders", "target_id": "health outcomes", "strength": 4}, {"source_id": "protective effect", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "logistic regression models", "target_id": "median age", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "health records", "strength": 4}, {"source_id": "second dose", "target_id": "clinical trials", "strength": 4}, {"source_id": "vaccination coverage", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "government", "target_id": "perspective", "strength": 4}, {"source_id": "adverse events", "target_id": "viral load", "strength": 4}, {"source_id": "observational study", "target_id": "Medical Center", "strength": 4}, {"source_id": "semi-structured interviews", "target_id": "practice", "strength": 4}, {"source_id": "institutions", "target_id": "governance", "strength": 4}, {"source_id": "institutions", "target_id": "context", "strength": 4}, {"source_id": "governance", "target_id": "society", "strength": 4}, {"source_id": "care unit", "target_id": "systematic review", "strength": 4}, {"source_id": "vaccination status", "target_id": "disease severity", "strength": 4}, {"source_id": "disease progression", "target_id": "adult patients", "strength": 4}, {"source_id": "C-reactive protein", "target_id": "retrospective study", "strength": 4}, {"source_id": "control group", "target_id": "serious adverse events", "strength": 4}, {"source_id": "Omicron variant", "target_id": "risk factors", "strength": 4}, {"source_id": "flow cytometry", "target_id": "COVID-19", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "immune system", "strength": 4}, {"source_id": "risk factors", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "infectious diseases", "target_id": "risk factors", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "pregnant women", "strength": 4}, {"source_id": "risk factors", "target_id": "study protocol", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "community", "target_id": "COVID-19", "strength": 4}, {"source_id": "mental health", "target_id": "quality of life", "strength": 4}, {"source_id": "logistic regression", "target_id": "adverse events", "strength": 4}, {"source_id": "perception", "target_id": "course", "strength": 4}, {"source_id": "need", "target_id": "schools", "strength": 4}, {"source_id": "unit admission", "target_id": "hospital mortality", "strength": 4}, {"source_id": "COVID-19", "target_id": "symptom onset", "strength": 4}, {"source_id": "inflammation", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "mental health", "target_id": "pregnant women", "strength": 4}, {"source_id": "mortality", "target_id": "primary endpoint", "strength": 4}, {"source_id": "vaccine effectiveness", "target_id": "Omicron infection", "strength": 4}, {"source_id": "infection", "target_id": "SARS-CoV-2 transmission", "strength": 4}, {"source_id": "adult patients", "target_id": "logistic regression", "strength": 4}, {"source_id": "symptoms", "target_id": "clinical practice", "strength": 4}, {"source_id": "risk factors", "target_id": "blood samples", "strength": 4}, {"source_id": "immune cells", "target_id": "COVID-19", "strength": 4}, {"source_id": "receptor-binding domain", "target_id": "vaccination", "strength": 4}, {"source_id": "vaccination", "target_id": "receptor-binding domain", "strength": 4}, {"source_id": "monoclonal antibodies", "target_id": "Delta variant", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "median age", "strength": 4}, {"source_id": "distress syndrome", "target_id": "cohort study", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "World Health Organization", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "World Health Organization", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "Health Organization", "strength": 4}, {"source_id": "ill patients", "target_id": "distress syndrome", "strength": 4}, {"source_id": "Health Organization", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "case report", "target_id": "COVID-19 disease", "strength": 4}, {"source_id": "pregnant women", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "disease 2019", "target_id": "pregnant women", "strength": 4}, {"source_id": "women", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "RT-PCR", "target_id": "Delta variant", "strength": 4}, {"source_id": "mental health", "target_id": "health services", "strength": 4}, {"source_id": "narratives", "target_id": "experience", "strength": 4}, {"source_id": "experience", "target_id": "narratives", "strength": 4}, {"source_id": "general population", "target_id": "cause mortality", "strength": 4}, {"source_id": "health outcomes", "target_id": "health problems", "strength": 4}, {"source_id": "psychological distress", "target_id": "health outcomes", "strength": 4}, {"source_id": "mortality", "target_id": "older adults", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "high prevalence", "strength": 4}, {"source_id": "high prevalence", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "disease", "target_id": "quality of life", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "cancer patients", "strength": 4}, {"source_id": "disease progression", "target_id": "COVID-19 severity", "strength": 4}, {"source_id": "psychological distress", "target_id": "anxiety", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "case report", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "case report", "strength": 4}, {"source_id": "case report", "target_id": "disease 2019", "strength": 4}, {"source_id": "case report", "target_id": "coronavirus 2 infection", "strength": 4}, {"source_id": "anxiety", "target_id": "participants", "strength": 4}, {"source_id": "control group", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "epithelial cells", "target_id": "viral infection", "strength": 4}, {"source_id": "curriculum", "target_id": "learners", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "clinical characteristics", "strength": 4}, {"source_id": "University Hospital", "target_id": "retrospective study", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "weight loss", "strength": 4}, {"source_id": "weight loss", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "variants of concern", "target_id": "Delta variant", "strength": 4}, {"source_id": "immune response", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 4}, {"source_id": "immune response", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 4}, {"source_id": "clinical presentation", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "risk factors", "target_id": "social determinants", "strength": 4}, {"source_id": "mortality rate", "target_id": "median age", "strength": 4}, {"source_id": "healthcare professionals", "target_id": "care", "strength": 4}, {"source_id": "humoral immune response", "target_id": "antibody levels", "strength": 4}, {"source_id": "antibody levels", "target_id": "humoral immune response", "strength": 4}, {"source_id": "study protocol", "target_id": "pain", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "SARS-CoV2", "strength": 4}, {"source_id": "SARS-CoV2", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "acute phase", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "learning", "target_id": "context", "strength": 4}, {"source_id": "research", "target_id": "context", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "clinical presentation", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "median age", "strength": 4}, {"source_id": "adverse effects", "target_id": "COVID-19", "strength": 4}, {"source_id": "cell responses", "target_id": "Delta variant", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "adult patients", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "most patients", "strength": 4}, {"source_id": "adult patients", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "immune response", "target_id": "care workers", "strength": 4}, {"source_id": "care workers", "target_id": "immune response", "strength": 4}, {"source_id": "T cell responses", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "T cell responses", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "disease control", "strength": 4}, {"source_id": "age groups", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "risk factors", "target_id": "persistent symptoms", "strength": 4}, {"source_id": "trials", "target_id": "symptoms", "strength": 4}, {"source_id": "people", "target_id": "context", "strength": 4}, {"source_id": "sector", "target_id": "market", "strength": 4}, {"source_id": "schools", "target_id": "context", "strength": 4}, {"source_id": "thematic analysis", "target_id": "perspective", "strength": 4}, {"source_id": "logistic regression analysis", "target_id": "independent predictors", "strength": 4}, {"source_id": "independent predictors", "target_id": "logistic regression analysis", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "disease progression", "target_id": "disease 2019", "strength": 4}, {"source_id": "cancer", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "dose", "target_id": "immune response", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "health professionals", "strength": 4}, {"source_id": "climate change", "target_id": "species", "strength": 4}, {"source_id": "species", "target_id": "climate change", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "receptor-binding domain", "strength": 4}, {"source_id": "receptor-binding domain", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "receptor-binding domain", "strength": 4}, {"source_id": "cohort study", "target_id": "transplant recipients", "strength": 4}, {"source_id": "COVID-19", "target_id": "vaccine doses", "strength": 4}, {"source_id": "vaccine doses", "target_id": "COVID-19", "strength": 4}, {"source_id": "hospitalization", "target_id": "clinical trials", "strength": 4}, {"source_id": "vaccination", "target_id": "young adults", "strength": 4}, {"source_id": "incidence", "target_id": "vaccination", "strength": 4}, {"source_id": "vaccination status", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "adverse effects", "strength": 4}, {"source_id": "mean age", "target_id": "control group", "strength": 4}, {"source_id": "second dose", "target_id": "case series", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "lower risk", "strength": 4}, {"source_id": "lower risk", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "body mass index", "target_id": "mortality", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "Health Organization", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "nasopharyngeal swabs", "strength": 4}, {"source_id": "nasopharyngeal swabs", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "health measures", "target_id": "health interventions", "strength": 4}, {"source_id": "perspective", "target_id": "qualitative study", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "median age", "strength": 4}, {"source_id": "median age", "target_id": "older age", "strength": 4}, {"source_id": "risk factors", "target_id": "Web of Science", "strength": 4}, {"source_id": "high risk", "target_id": "mental health", "strength": 4}, {"source_id": "disease severity", "target_id": "severe cases", "strength": 4}, {"source_id": "health status", "target_id": "COVID-19", "strength": 4}, {"source_id": "adult patients", "target_id": "disease", "strength": 4}, {"source_id": "body mass index", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "cancer patients", "target_id": "therapy", "strength": 4}, {"source_id": "logistic regression analysis", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "cell responses", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "T cell responses", "strength": 4}, {"source_id": "care unit admission", "target_id": "vaccine", "strength": 4}, {"source_id": "Web of Science", "target_id": "mortality", "strength": 4}, {"source_id": "mortality", "target_id": "Web of Science", "strength": 4}, {"source_id": "COVID-19", "target_id": "United States", "strength": 4}, {"source_id": "COVID-19", "target_id": "study protocol", "strength": 4}, {"source_id": "diabetes mellitus", "target_id": "mortality rate", "strength": 4}, {"source_id": "high risk", "target_id": "ICU admission", "strength": 4}, {"source_id": "ICU admission", "target_id": "high risk", "strength": 4}, {"source_id": "government", "target_id": "organization", "strength": 4}, {"source_id": "crisis", "target_id": "climate change", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "pulmonary disease", "strength": 4}, {"source_id": "cohort study", "target_id": "pneumonia", "strength": 4}, {"source_id": "lower risk", "target_id": "median age", "strength": 4}, {"source_id": "second dose", "target_id": "years of age", "strength": 4}, {"source_id": "immune response", "target_id": "nervous system", "strength": 4}, {"source_id": "disease 2019 pandemic", "target_id": "University Hospital", "strength": 4}, {"source_id": "University Hospital", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "disease 2019", "strength": 4}, {"source_id": "mortality rate", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "syndrome", "target_id": "risk factors", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "World Health Organization", "strength": 4}, {"source_id": "World Health Organization", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "severe disease", "target_id": "Health Organization", "strength": 4}, {"source_id": "booster dose", "target_id": "observational study", "strength": 4}, {"source_id": "second dose", "target_id": "observational study", "strength": 4}, {"source_id": "observational study", "target_id": "booster dose", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "first dose", "strength": 4}, {"source_id": "first dose", "target_id": "patients", "strength": 4}, {"source_id": "therapy", "target_id": "observational study", "strength": 4}, {"source_id": "hospital mortality", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "hospital discharge", "target_id": "hospital stay", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "disease 2019", "strength": 4}, {"source_id": "electronic medical records", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "symptom onset", "target_id": "adverse events", "strength": 4}, {"source_id": "primary outcome", "target_id": "medical records", "strength": 4}, {"source_id": "disease 2019", "target_id": "electronic medical records", "strength": 4}, {"source_id": "side effects", "target_id": "antibody levels", "strength": 4}, {"source_id": "T cell responses", "target_id": "severe disease", "strength": 4}, {"source_id": "inflammatory syndrome", "target_id": "syndrome", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "inflammatory syndrome", "strength": 4}, {"source_id": "syndrome", "target_id": "inflammatory syndrome", "strength": 4}, {"source_id": "primary outcome", "target_id": "transplant recipients", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "case-control study", "strength": 4}, {"source_id": "vaccination", "target_id": "primary outcome", "strength": 4}, {"source_id": "infection", "target_id": "intensive care unit admission", "strength": 4}, {"source_id": "greater risk", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "observational study", "target_id": "health outcomes", "strength": 4}, {"source_id": "disease 2019", "target_id": "greater risk", "strength": 4}, {"source_id": "mortality", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "mortality", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "mortality", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "electronic medical records", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "logistic regression models", "target_id": "care", "strength": 4}, {"source_id": "immune response", "target_id": "safety profile", "strength": 4}, {"source_id": "transplant recipients", "target_id": "control group", "strength": 4}, {"source_id": "Web of Science", "target_id": "adverse events", "strength": 4}, {"source_id": "adverse events", "target_id": "Web of Science", "strength": 4}, {"source_id": "therapy", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "clinical data", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "booster vaccination", "strength": 4}, {"source_id": "observational study", "target_id": "patient characteristics", "strength": 4}, {"source_id": "patient characteristics", "target_id": "observational study", "strength": 4}, {"source_id": "cohort study", "target_id": "vaccination program", "strength": 4}, {"source_id": "cohort study", "target_id": "healthy controls", "strength": 4}, {"source_id": "vaccination campaign", "target_id": "adverse events", "strength": 4}, {"source_id": "disease", "target_id": "diabetes mellitus", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "nervous system", "strength": 4}, {"source_id": "animal models", "target_id": "nervous system", "strength": 4}, {"source_id": "nervous system", "target_id": "immune system", "strength": 4}, {"source_id": "educators", "target_id": "institutions", "strength": 4}, {"source_id": "institutions", "target_id": "program", "strength": 4}, {"source_id": "motivation", "target_id": "teaching", "strength": 4}, {"source_id": "clinical practice", "target_id": "health system", "strength": 4}, {"source_id": "vaccine hesitancy", "target_id": "cross-sectional survey", "strength": 4}, {"source_id": "use disorders", "target_id": "COVID-19", "strength": 4}, {"source_id": "interviews", "target_id": "education", "strength": 4}, {"source_id": "COVID-19", "target_id": "psychological distress", "strength": 4}, {"source_id": "mental health", "target_id": "motivation", "strength": 4}, {"source_id": "research", "target_id": "employees", "strength": 4}, {"source_id": "actors", "target_id": "book", "strength": 4}, {"source_id": "COVID-19", "target_id": "research", "strength": 4}, {"source_id": "risk factors", "target_id": "T cells", "strength": 4}, {"source_id": "Omicron variant", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "hospitalized patients", "target_id": "cohort study", "strength": 4}, {"source_id": "young adults", "target_id": "adverse events", "strength": 4}, {"source_id": "cohort study", "target_id": "multivariable logistic regression", "strength": 4}, {"source_id": "logistic regression analysis", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "cohort", "target_id": "vaccine", "strength": 4}, {"source_id": "high risk", "target_id": "women", "strength": 4}, {"source_id": "infection rate", "target_id": "infection", "strength": 4}, {"source_id": "viral infection", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "care unit admission", "strength": 4}, {"source_id": "disease 2019", "target_id": "unit admission", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "study period", "target_id": "vaccine effectiveness", "strength": 4}, {"source_id": "risk factors", "target_id": "long COVID", "strength": 4}, {"source_id": "antibody response", "target_id": "prospective cohort study", "strength": 4}, {"source_id": "prospective cohort study", "target_id": "antibody response", "strength": 4}, {"source_id": "side effects", "target_id": "adverse events", "strength": 4}, {"source_id": "symptoms", "target_id": "healthcare workers", "strength": 4}, {"source_id": "skills", "target_id": "practice", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "treatment strategies", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "treatment strategies", "strength": 4}, {"source_id": "treatment strategies", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "SARS-CoV-2 replication", "target_id": "viral load", "strength": 4}, {"source_id": "COVID-19", "target_id": "health records", "strength": 4}, {"source_id": "health records", "target_id": "COVID-19", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "study participants", "strength": 4}, {"source_id": "pregnant women", "target_id": "vaccine hesitancy", "strength": 4}, {"source_id": "adverse events", "target_id": "outcome measures", "strength": 4}, {"source_id": "middle-income countries", "target_id": "vaccine", "strength": 4}, {"source_id": "viral infection", "target_id": "SARS-CoV-2 virus", "strength": 4}, {"source_id": "spike protein", "target_id": "mouse model", "strength": 4}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "viral infection", "strength": 4}, {"source_id": "viral infection", "target_id": "virus infection", "strength": 4}, {"source_id": "narratives", "target_id": "politics", "strength": 4}, {"source_id": "higher education", "target_id": "skills", "strength": 4}, {"source_id": "skills", "target_id": "higher education", "strength": 4}, {"source_id": "University", "target_id": "pandemic", "strength": 4}, {"source_id": "education", "target_id": "case study", "strength": 4}, {"source_id": "experience", "target_id": "perspective", "strength": 4}, {"source_id": "experience", "target_id": "engagement", "strength": 4}, {"source_id": "University", "target_id": "learners", "strength": 4}, {"source_id": "schools", "target_id": "course", "strength": 4}, {"source_id": "training", "target_id": "schools", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "hospital stay", "strength": 4}, {"source_id": "case report", "target_id": "adverse effects", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "disease severity", "strength": 4}, {"source_id": "disease severity", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "disease severity", "target_id": "therapy", "strength": 4}, {"source_id": "patients", "target_id": "infection rate", "strength": 4}, {"source_id": "T cells", "target_id": "mouse model", "strength": 4}, {"source_id": "variants of concern", "target_id": "severe disease", "strength": 4}, {"source_id": "spike protein", "target_id": "World Health Organization", "strength": 4}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 pandemic", "strength": 4}, {"source_id": "risk factors", "target_id": "pregnant women", "strength": 4}, {"source_id": "health services", "target_id": "clinical trials", "strength": 4}, {"source_id": "COVID-19", "target_id": "young adults", "strength": 4}, {"source_id": "COVID-19", "target_id": "health issues", "strength": 4}, {"source_id": "health issues", "target_id": "COVID-19", "strength": 4}, {"source_id": "care system", "target_id": "COVID-19", "strength": 4}, {"source_id": "systematic review", "target_id": "prevalence", "strength": 4}, {"source_id": "vaccination", "target_id": "blood samples", "strength": 4}, {"source_id": "students", "target_id": "technology", "strength": 4}, {"source_id": "care settings", "target_id": "care", "strength": 4}, {"source_id": "health outcomes", "target_id": "patients", "strength": 4}, {"source_id": "primary care", "target_id": "health conditions", "strength": 4}, {"source_id": "health disparities", "target_id": "health outcomes", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "pain", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "disease 2019 pandemic", "strength": 4}, {"source_id": "therapeutic target", "target_id": "immune response", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "risk factors", "strength": 4}, {"source_id": "hospital stay", "target_id": "mortality rate", "strength": 4}, {"source_id": "high risk", "target_id": "adult patients", "strength": 4}, {"source_id": "mortality", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "respiratory failure", "target_id": "disease severity", "strength": 4}, {"source_id": "antibody titers", "target_id": "severe disease", "strength": 4}, {"source_id": "disease severity", "target_id": "respiratory failure", "strength": 4}, {"source_id": "clinical trials", "target_id": "treatment options", "strength": 4}, {"source_id": "cytokine storm", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "vaccination", "target_id": "time points", "strength": 4}, {"source_id": "disease control", "target_id": "mortality rate", "strength": 4}, {"source_id": "second dose", "target_id": "spike protein", "strength": 4}, {"source_id": "admission", "target_id": "observational study", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "study population", "strength": 4}, {"source_id": "dose", "target_id": "mRNA vaccination", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "multivariable logistic regression", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "mortality", "strength": 4}, {"source_id": "mortality", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "antibody titers", "strength": 4}, {"source_id": "inflammation", "target_id": "inflammatory diseases", "strength": 4}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "immune response", "strength": 4}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 RNA", "strength": 4}, {"source_id": "economy", "target_id": "COVID-19", "strength": 4}, {"source_id": "COVID-19", "target_id": "economy", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "pulmonary disease", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "viral infection", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "high prevalence", "strength": 4}, {"source_id": "prospective cohort study", "target_id": "antibody levels", "strength": 4}, {"source_id": "time points", "target_id": "SARS-CoV-2 antibodies", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "C-reactive protein", "strength": 4}, {"source_id": "quality of life", "target_id": "older adults", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "older adults", "strength": 4}, {"source_id": "vaccination program", "target_id": "age groups", "strength": 4}, {"source_id": "health system", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "adverse effects", "target_id": "clinical trials", "strength": 4}, {"source_id": "cancer patients", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "severe illness", "strength": 4}, {"source_id": "viral load", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "viral load", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "viral load", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "viral load", "strength": 4}, {"source_id": "inclusion criteria", "target_id": "control group", "strength": 4}, {"source_id": "mental health outcomes", "target_id": "systematic review", "strength": 4}, {"source_id": "COVID-19", "target_id": "qualitative study", "strength": 4}, {"source_id": "high risk", "target_id": "health conditions", "strength": 4}, {"source_id": "health conditions", "target_id": "high risk", "strength": 4}, {"source_id": "mental health", "target_id": "control group", "strength": 4}, {"source_id": "physical activity", "target_id": "symptoms", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "hospital mortality", "strength": 4}, {"source_id": "mortality rate", "target_id": "disease", "strength": 4}, {"source_id": "COVID-19", "target_id": "most patients", "strength": 4}, {"source_id": "mean age", "target_id": "most patients", "strength": 4}, {"source_id": "mortality", "target_id": "disease 2019 pandemic", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "distress syndrome", "strength": 4}, {"source_id": "disease severity", "target_id": "case-control study", "strength": 4}, {"source_id": "cause mortality", "target_id": "primary endpoint", "strength": 4}, {"source_id": "booster vaccination", "target_id": "T cell responses", "strength": 4}, {"source_id": "immune system", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "Web of Science", "strength": 4}, {"source_id": "Meta-Analysis", "target_id": "inclusion criteria", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "body mass index", "strength": 4}, {"source_id": "patient characteristics", "target_id": "cohort study", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "use disorders", "strength": 4}, {"source_id": "use disorders", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "length of stay", "target_id": "cohort study", "strength": 4}, {"source_id": "care unit", "target_id": "patient outcomes", "strength": 4}, {"source_id": "patient outcomes", "target_id": "intensive care unit", "strength": 4}, {"source_id": "patient outcomes", "target_id": "care unit", "strength": 4}, {"source_id": "health care workers", "target_id": "risk factors", "strength": 4}, {"source_id": "risk factors", "target_id": "study period", "strength": 4}, {"source_id": "care workers", "target_id": "infection", "strength": 4}, {"source_id": "emergency department", "target_id": "odds ratio", "strength": 4}, {"source_id": "hospital admission", "target_id": "electronic health records", "strength": 4}, {"source_id": "hospital admission", "target_id": "health records", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "hospital admission", "strength": 4}, {"source_id": "health services", "target_id": "study period", "strength": 4}, {"source_id": "health records", "target_id": "hospital admission", "strength": 4}, {"source_id": "viral load", "target_id": "SARS-CoV-2 virus", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "acute phase", "strength": 4}, {"source_id": "acute phase", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "University Hospital", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "distress syndrome", "strength": 4}, {"source_id": "coronavirus disease", "target_id": "distress syndrome", "strength": 4}, {"source_id": "viral infection", "target_id": "cytokine storm", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "cohort", "strength": 4}, {"source_id": "age groups", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "artificial intelligence", "target_id": "neural network", "strength": 4}, {"source_id": "learning", "target_id": "artificial intelligence", "strength": 4}, {"source_id": "people", "target_id": "social media", "strength": 4}, {"source_id": "heart failure", "target_id": "myocardial infarction", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "chronic kidney disease", "strength": 4}, {"source_id": "chronic kidney disease", "target_id": "infection", "strength": 4}, {"source_id": "prospective cohort study", "target_id": "disease", "strength": 4}, {"source_id": "disease progression", "target_id": "median age", "strength": 4}, {"source_id": "ill patients", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "myocardial infarction", "target_id": "mortality rate", "strength": 4}, {"source_id": "mortality rate", "target_id": "myocardial infarction", "strength": 4}, {"source_id": "cardiovascular disease", "target_id": "mortality", "strength": 4}, {"source_id": "mortality", "target_id": "cardiovascular disease", "strength": 4}, {"source_id": "young adults", "target_id": "cohort study", "strength": 4}, {"source_id": "mortality", "target_id": "diagnosis", "strength": 4}, {"source_id": "risk factors", "target_id": "hospitalization", "strength": 4}, {"source_id": "electronic health records", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "mRNA vaccination", "target_id": "vaccine dose", "strength": 4}, {"source_id": "clinical trials", "target_id": "second dose", "strength": 4}, {"source_id": "clinical characteristics", "target_id": "symptoms", "strength": 4}, {"source_id": "severe cases", "target_id": "risk factors", "strength": 4}, {"source_id": "qualitative study", "target_id": "healthcare professionals", "strength": 4}, {"source_id": "healthcare professionals", "target_id": "qualitative study", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "dose", "strength": 4}, {"source_id": "dose", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "study population", "strength": 4}, {"source_id": "disease severity", "target_id": "adult patients", "strength": 4}, {"source_id": "serious adverse events", "target_id": "control group", "strength": 4}, {"source_id": "hospital admission", "target_id": "clinical characteristics", "strength": 4}, {"source_id": "Omicron variant", "target_id": "observational study", "strength": 4}, {"source_id": "observational study", "target_id": "Omicron variant", "strength": 4}, {"source_id": "admission", "target_id": "Omicron variant", "strength": 4}, {"source_id": "cell responses", "target_id": "disease severity", "strength": 4}, {"source_id": "COVID-19 disease", "target_id": "immune system", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "disease 2019", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "vaccination campaign", "strength": 4}, {"source_id": "risk factors", "target_id": "infectious diseases", "strength": 4}, {"source_id": "incidence", "target_id": "mortality rate", "strength": 4}, {"source_id": "pain", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "pregnant women", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "quality of life", "target_id": "mental health", "strength": 4}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "pandemic", "target_id": "social media", "strength": 4}, {"source_id": "adverse events", "target_id": "logistic regression", "strength": 4}, {"source_id": "policy", "target_id": "need", "strength": 4}, {"source_id": "control group", "target_id": "risk factors", "strength": 4}, {"source_id": "therapeutic strategies", "target_id": "therapy", "strength": 4}, {"source_id": "therapy", "target_id": "therapeutic strategies", "strength": 4}, {"source_id": "spike protein", "target_id": "dose", "strength": 4}, {"source_id": "prospective cohort study", "target_id": "care unit", "strength": 4}, {"source_id": "book", "target_id": "crisis", "strength": 4}, {"source_id": "organization", "target_id": "interviews", "strength": 4}, {"source_id": "clinical studies", "target_id": "systematic review", "strength": 4}, {"source_id": "primary endpoint", "target_id": "mortality", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "health conditions", "strength": 4}, {"source_id": "logistic regression", "target_id": "mortality rate", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "vaccine uptake", "target_id": "vaccination status", "strength": 4}, {"source_id": "Omicron infection", "target_id": "vaccine effectiveness", "strength": 4}, {"source_id": "lung disease", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "young adults", "strength": 4}, {"source_id": "young adults", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "observational study", "target_id": "healthy controls", "strength": 4}, {"source_id": "antibody response", "target_id": "SARS-CoV-2 spike protein", "strength": 4}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "antibody response", "strength": 4}, {"source_id": "clinical practice", "target_id": "risk factors", "strength": 4}, {"source_id": "clinical practice", "target_id": "symptoms", "strength": 4}, {"source_id": "severe disease", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "patients", "target_id": "high-income countries", "strength": 4}, {"source_id": "Delta variant", "target_id": "monoclonal antibodies", "strength": 4}, {"source_id": "cohort study", "target_id": "distress syndrome", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "cohort study", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "Health Organization", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "ill patients", "strength": 4}, {"source_id": "World Health Organization", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "distress syndrome", "target_id": "ill patients", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "World Health Organization", "strength": 4}, {"source_id": "Health Organization", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "COVID-19 disease", "target_id": "case report", "strength": 4}, {"source_id": "case report", "target_id": "adverse events", "strength": 4}, {"source_id": "Omicron variant", "target_id": "lower risk", "strength": 4}, {"source_id": "Delta variant", "target_id": "RT-PCR", "strength": 4}, {"source_id": "Delta variant", "target_id": "study period", "strength": 4}, {"source_id": "care unit admission", "target_id": "hospital admission", "strength": 4}, {"source_id": "unit admission", "target_id": "hospital admission", "strength": 4}, {"source_id": "mortality", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "health problems", "target_id": "health outcomes", "strength": 4}, {"source_id": "median age", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "Medical Center", "strength": 4}, {"source_id": "quality of life", "target_id": "disease", "strength": 4}, {"source_id": "anxiety", "target_id": "students", "strength": 4}, {"source_id": "disease", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "case report", "strength": 4}, {"source_id": "case report", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "case report", "target_id": "syndrome coronavirus 2 infection", "strength": 4}, {"source_id": "control group", "target_id": "outcome measures", "strength": 4}, {"source_id": "outcome measures", "target_id": "control group", "strength": 4}, {"source_id": "politics", "target_id": "article", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "patient population", "strength": 4}, {"source_id": "retrospective study", "target_id": "admission", "strength": 4}, {"source_id": "patient population", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "observational cohort study", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "observational cohort study", "strength": 4}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "infection", "strength": 4}, {"source_id": "infection", "target_id": "SARS-CoV-2 pandemic", "strength": 4}, {"source_id": "Delta variant", "target_id": "variants of concern", "strength": 4}, {"source_id": "pediatric patients", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "immune response", "target_id": "coronavirus 2 infection", "strength": 4}, {"source_id": "hospitalization", "target_id": "vaccination status", "strength": 4}, {"source_id": "health outcomes", "target_id": "high-income countries", "strength": 4}, {"source_id": "humoral response", "target_id": "cohort study", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "pregnant women", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "intervention group", "strength": 4}, {"source_id": "acute phase", "target_id": "disease 2019", "strength": 4}, {"source_id": "justice", "target_id": "education", "strength": 4}, {"source_id": "COVID-19", "target_id": "discourse", "strength": 4}, {"source_id": "semi-structured interviews", "target_id": "skills", "strength": 4}, {"source_id": "context", "target_id": "teaching", "strength": 4}, {"source_id": "injury", "target_id": "disease 2019", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "viral load", "strength": 4}, {"source_id": "viral load", "target_id": "vaccine", "strength": 4}, {"source_id": "vaccine", "target_id": "viral load", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "study population", "strength": 4}, {"source_id": "mRNA vaccination", "target_id": "cell responses", "strength": 4}, {"source_id": "dose", "target_id": "T cells", "strength": 4}, {"source_id": "vaccine", "target_id": "health care workers", "strength": 4}, {"source_id": "T cell responses", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "T cell responses", "strength": 4}, {"source_id": "heart failure", "target_id": "mortality", "strength": 4}, {"source_id": "booster dose", "target_id": "hospitalization", "strength": 4}, {"source_id": "study population", "target_id": "vaccine", "strength": 4}, {"source_id": "hospitalization", "target_id": "booster doses", "strength": 4}, {"source_id": "myocardial infarction", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "persistent symptoms", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "antibody levels", "target_id": "vaccine dose", "strength": 4}, {"source_id": "Health Organization", "target_id": "clinical trials", "strength": 4}, {"source_id": "control group", "target_id": "beneficial effects", "strength": 4}, {"source_id": "vaccination rates", "target_id": "age groups", "strength": 4}, {"source_id": "perspective", "target_id": "thematic analysis", "strength": 4}, {"source_id": "disease progression", "target_id": "mortality", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "time points", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "disease 2019", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "disease progression", "strength": 4}, {"source_id": "immune response", "target_id": "dose", "strength": 4}, {"source_id": "vaccination", "target_id": "adverse effects", "strength": 4}, {"source_id": "receptor-binding domain", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "children", "target_id": "students", "strength": 4}, {"source_id": "logistic regression models", "target_id": "case-control study", "strength": 4}, {"source_id": "vaccination", "target_id": "incidence", "strength": 4}, {"source_id": "risk factors", "target_id": "respiratory disease", "strength": 4}, {"source_id": "control group", "target_id": "mean age", "strength": 4}, {"source_id": "disease progression", "target_id": "risk factors", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "epithelial cells", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "epithelial cells", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "nasopharyngeal swabs", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "nasopharyngeal swabs", "strength": 4}, {"source_id": "nasopharyngeal swabs", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "disease 2019", "target_id": "clinical practice", "strength": 4}, {"source_id": "qualitative study", "target_id": "perspective", "strength": 4}, {"source_id": "curriculum", "target_id": "training", "strength": 4}, {"source_id": "inflammatory diseases", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "risk factors", "target_id": "complications", "strength": 4}, {"source_id": "health care", "target_id": "health services", "strength": 4}, {"source_id": "nervous system", "target_id": "symptoms", "strength": 4}, {"source_id": "Omicron variant", "target_id": "receptor-binding domain", "strength": 4}, {"source_id": "society", "target_id": "countries", "strength": 4}, {"source_id": "severe cases", "target_id": "disease severity", "strength": 4}, {"source_id": "COVID-19", "target_id": "health status", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "high risk", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "retrospective study", "target_id": "COVID-19 severity", "strength": 4}, {"source_id": "health professionals", "target_id": "health services", "strength": 4}, {"source_id": "case series", "target_id": "vaccination", "strength": 4}, {"source_id": "vaccine", "target_id": "care unit admission", "strength": 4}, {"source_id": "vaccine", "target_id": "unit admission", "strength": 4}, {"source_id": "infectious diseases", "target_id": "clinical trials", "strength": 4}, {"source_id": "disease severity", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "retrospective study", "strength": 4}, {"source_id": "disease 2019", "target_id": "retrospective study", "strength": 4}, {"source_id": "cancer patients", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "nervous system", "strength": 4}, {"source_id": "viral infection", "target_id": "autoimmune diseases", "strength": 4}, {"source_id": "climate change", "target_id": "crisis", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "genes", "strength": 4}, {"source_id": "hospital mortality", "target_id": "high risk", "strength": 4}, {"source_id": "years of age", "target_id": "second dose", "strength": 4}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "booster vaccination", "strength": 4}, {"source_id": "Delta variant", "target_id": "vaccination status", "strength": 4}, {"source_id": "viral replication", "target_id": "SARS-CoV2", "strength": 4}, {"source_id": "severe disease", "target_id": "World Health Organization", "strength": 4}, {"source_id": "Health Organization", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "second dose", "target_id": "booster dose", "strength": 4}, {"source_id": "observational study", "target_id": "dose", "strength": 4}, {"source_id": "hospital mortality", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "care unit", "target_id": "length of stay", "strength": 4}, {"source_id": "care unit", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "disease 2019", "target_id": "hospital mortality", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "hospital discharge", "strength": 4}, {"source_id": "hospital stay", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "hospital stay", "target_id": "hospital discharge", "strength": 4}, {"source_id": "retrospective study", "target_id": "hospital stay", "strength": 4}, {"source_id": "retrospective study", "target_id": "pneumonia", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "medical records", "strength": 4}, {"source_id": "medical records", "target_id": "primary outcome", "strength": 4}, {"source_id": "healthcare workers", "target_id": "BNT162b2 vaccine", "strength": 4}, {"source_id": "mouse model", "target_id": "immune system", "strength": 4}, {"source_id": "vaccination", "target_id": "safety profile", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "patient outcomes", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 mRNA vaccines", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "greater risk", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "mean age", "strength": 4}, {"source_id": "transplant recipients", "target_id": "infection", "strength": 4}, {"source_id": "ICU admission", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "intensive care unit admission", "target_id": "infection", "strength": 4}, {"source_id": "case-control study", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "primary outcome", "target_id": "admission", "strength": 4}, {"source_id": "lower risk", "target_id": "ICU admission", "strength": 4}, {"source_id": "lower risk", "target_id": "vaccination", "strength": 4}, {"source_id": "mental health outcomes", "target_id": "symptoms", "strength": 4}, {"source_id": "health outcomes", "target_id": "observational study", "strength": 4}, {"source_id": "symptoms", "target_id": "mental health outcomes", "strength": 4}, {"source_id": "inclusion criteria", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "mortality", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "greater risk", "strength": 4}, {"source_id": "disease", "target_id": "mortality", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "medical records", "strength": 4}, {"source_id": "medical records", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "booster vaccination", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "Omicron variant", "target_id": "viral load", "strength": 4}, {"source_id": "intensive care unit", "target_id": "retrospective study", "strength": 4}, {"source_id": "control group", "target_id": "transplant recipients", "strength": 4}, {"source_id": "therapy", "target_id": "retrospective study", "strength": 4}, {"source_id": "monoclonal antibodies", "target_id": "transplant recipients", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "therapy", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "vaccine dose", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "vaccine dose", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "intensive care", "strength": 4}, {"source_id": "years of age", "target_id": "general population", "strength": 4}, {"source_id": "retrospective study", "target_id": "disease", "strength": 4}, {"source_id": "vaccine hesitancy", "target_id": "vaccination program", "strength": 4}, {"source_id": "disease", "target_id": "retrospective study", "strength": 4}, {"source_id": "quality of life", "target_id": "cancer patients", "strength": 4}, {"source_id": "vaccine hesitancy", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "health system", "target_id": "clinical practice", "strength": 4}, {"source_id": "general population", "target_id": "logistic regression", "strength": 4}, {"source_id": "psychological distress", "target_id": "COVID-19", "strength": 4}, {"source_id": "antibody titers", "target_id": "cohort study", "strength": 4}, {"source_id": "crisis", "target_id": "practice", "strength": 4}, {"source_id": "future research", "target_id": "COVID-19", "strength": 4}, {"source_id": "COVID-19", "target_id": "future research", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "primary endpoint", "strength": 4}, {"source_id": "primary endpoint", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "infection", "target_id": "D-dimer", "strength": 4}, {"source_id": "illness", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "study period", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "age groups", "target_id": "symptoms", "strength": 4}, {"source_id": "mean age", "target_id": "disease", "strength": 4}, {"source_id": "symptoms", "target_id": "age groups", "strength": 4}, {"source_id": "hospital mortality", "target_id": "retrospective study", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "observational study", "strength": 4}, {"source_id": "hospital discharge", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "hospitalized patients", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "observational study", "target_id": "hospital discharge", "strength": 4}, {"source_id": "clinical studies", "target_id": "adverse events", "strength": 4}, {"source_id": "humoral response", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "mRNA vaccination", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "healthcare workers", "target_id": "risk factors", "strength": 4}, {"source_id": "healthcare workers", "target_id": "antibody titers", "strength": 4}, {"source_id": "humoral immune response", "target_id": "T cells", "strength": 4}, {"source_id": "antibody titers", "target_id": "healthcare workers", "strength": 4}, {"source_id": "clinical trials", "target_id": "patient characteristics", "strength": 4}, {"source_id": "symptoms", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "second dose", "target_id": "safety profile", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "age groups", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "higher odds", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "logistic regression", "strength": 4}, {"source_id": "nasopharyngeal swabs", "target_id": "cohort study", "strength": 4}, {"source_id": "higher odds", "target_id": "older adults", "strength": 4}, {"source_id": "higher odds", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "trials", "target_id": "vaccine", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "high mortality", "strength": 4}, {"source_id": "infection", "target_id": "cohort", "strength": 4}, {"source_id": "study design", "target_id": "vaccine", "strength": 4}, {"source_id": "logistic regression models", "target_id": "higher odds", "strength": 4}, {"source_id": "diagnosis", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "Web of Science", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "viral infection", "strength": 4}, {"source_id": "prevalence", "target_id": "Web of Science", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "study period", "target_id": "hospitalization", "strength": 4}, {"source_id": "humoral immune response", "target_id": "cohort study", "strength": 4}, {"source_id": "booster vaccination", "target_id": "cohort study", "strength": 4}, {"source_id": "cohort study", "target_id": "humoral immune response", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "persistent symptoms", "strength": 4}, {"source_id": "syndrome", "target_id": "COVID-19", "strength": 4}, {"source_id": "adverse events", "target_id": "side effects", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "disease 2019", "strength": 4}, {"source_id": "cohort study", "target_id": "prospective study", "strength": 4}, {"source_id": "cohort study", "target_id": "care", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "training", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "treatment strategies", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "treatment strategies", "strength": 4}, {"source_id": "viral infection", "target_id": "SARS-CoV-2 replication", "strength": 4}, {"source_id": "study participants", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "logistic regression", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "vaccine", "target_id": "middle-income countries", "strength": 4}, {"source_id": "disease 2019 pandemic", "target_id": "viral infection", "strength": 4}, {"source_id": "algorithm", "target_id": "learning", "strength": 4}, {"source_id": "economy", "target_id": "government", "strength": 4}, {"source_id": "politics", "target_id": "narratives", "strength": 4}, {"source_id": "University", "target_id": "course", "strength": 4}, {"source_id": "skills", "target_id": "institutions", "strength": 4}, {"source_id": "engagement", "target_id": "experience", "strength": 4}, {"source_id": "learning", "target_id": "case study", "strength": 4}, {"source_id": "education", "target_id": "society", "strength": 4}, {"source_id": "society", "target_id": "education", "strength": 4}, {"source_id": "higher education", "target_id": "engagement", "strength": 4}, {"source_id": "learners", "target_id": "engagement", "strength": 4}, {"source_id": "policy", "target_id": "engagement", "strength": 4}, {"source_id": "mass index", "target_id": "control group", "strength": 4}, {"source_id": "weight loss", "target_id": "mass index", "strength": 4}, {"source_id": "adverse effects", "target_id": "case report", "strength": 4}, {"source_id": "infection rate", "target_id": "risk factors", "strength": 4}, {"source_id": "infection rate", "target_id": "patients", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "years of age", "strength": 4}, {"source_id": "risk factors", "target_id": "coronavirus disease", "strength": 4}, {"source_id": "women", "target_id": "breast cancer", "strength": 4}, {"source_id": "dose", "target_id": "SARS-CoV-2 vaccination", "strength": 4}, {"source_id": "years of age", "target_id": "humoral response", "strength": 4}, {"source_id": "humoral response", "target_id": "years of age", "strength": 4}, {"source_id": "mouse model", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "immune response", "target_id": "clinical manifestations", "strength": 4}, {"source_id": "patients", "target_id": "unvaccinated individuals", "strength": 4}, {"source_id": "viral infection", "target_id": "infectious diseases", "strength": 4}, {"source_id": "violence", "target_id": "COVID-19", "strength": 4}, {"source_id": "case report", "target_id": "clinical presentation", "strength": 4}, {"source_id": "case report", "target_id": "side effects", "strength": 4}, {"source_id": "clinical presentation", "target_id": "vaccine", "strength": 4}, {"source_id": "T cell responses", "target_id": "blood samples", "strength": 4}, {"source_id": "care services", "target_id": "primary care", "strength": 4}, {"source_id": "serious adverse events", "target_id": "pilot study", "strength": 4}, {"source_id": "adverse events", "target_id": "pilot study", "strength": 4}, {"source_id": "pilot study", "target_id": "serious adverse events", "strength": 4}, {"source_id": "pilot study", "target_id": "adverse events", "strength": 4}, {"source_id": "intensive care", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "intensive care", "target_id": "health system", "strength": 4}, {"source_id": "health system", "target_id": "intensive care", "strength": 4}, {"source_id": "disease control", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "health outcomes", "target_id": "health disparities", "strength": 4}, {"source_id": "health services", "target_id": "risk factors", "strength": 4}, {"source_id": "health records", "target_id": "primary care", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 4}, {"source_id": "prospective cohort study", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "high risk", "target_id": "admission", "strength": 4}, {"source_id": "mortality rate", "target_id": "hospital stay", "strength": 4}, {"source_id": "adult patients", "target_id": "high risk", "strength": 4}, {"source_id": "time points", "target_id": "vaccination", "strength": 4}, {"source_id": "mortality rate", "target_id": "disease control", "strength": 4}, {"source_id": "inclusion criteria", "target_id": "vaccine", "strength": 4}, {"source_id": "vaccine", "target_id": "inclusion criteria", "strength": 4}, {"source_id": "clinical data", "target_id": "health records", "strength": 4}, {"source_id": "health system", "target_id": "infection", "strength": 4}, {"source_id": "physical activity", "target_id": "mean age", "strength": 4}, {"source_id": "vaccine effectiveness", "target_id": "mRNA vaccination", "strength": 4}, {"source_id": "mRNA vaccination", "target_id": "dose", "strength": 4}, {"source_id": "retrospective study", "target_id": "primary outcome", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "clinical trials", "strength": 4}, {"source_id": "cohort study", "target_id": "greater risk", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "antibody titers", "strength": 4}, {"source_id": "antibody titers", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "inflammation", "target_id": "immune system", "strength": 4}, {"source_id": "immune response", "target_id": "SARS-CoV-2 pandemic", "strength": 4}, {"source_id": "first dose", "target_id": "COVID-19 mRNA vaccines", "strength": 4}, {"source_id": "teaching", "target_id": "article", "strength": 4}, {"source_id": "inflammatory diseases", "target_id": "immune response", "strength": 4}, {"source_id": "genes", "target_id": "cells", "strength": 4}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "viral infection", "strength": 4}, {"source_id": "vaccine dose", "target_id": "primary outcome", "strength": 4}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "antibody levels", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "study period", "strength": 4}, {"source_id": "study period", "target_id": "Omicron variant", "strength": 4}, {"source_id": "primary outcome", "target_id": "pneumonia", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "clinical symptoms", "strength": 4}, {"source_id": "observational cohort study", "target_id": "risk factors", "strength": 4}, {"source_id": "viral infection", "target_id": "immune system", "strength": 4}, {"source_id": "immune system", "target_id": "viral infection", "strength": 4}, {"source_id": "adverse events", "target_id": "adverse effects", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "viral load", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "respiratory disease", "strength": 4}, {"source_id": "mental health outcomes", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "years of age", "target_id": "cancer", "strength": 4}, {"source_id": "cancer", "target_id": "years of age", "strength": 4}, {"source_id": "governance", "target_id": "pandemic", "strength": 4}, {"source_id": "education", "target_id": "young people", "strength": 4}, {"source_id": "inclusion criteria", "target_id": "health problems", "strength": 4}, {"source_id": "health problems", "target_id": "inclusion criteria", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "intensive care unit", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "mortality", "strength": 4}, {"source_id": "mortality", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "disease 2019 pandemic", "target_id": "mortality", "strength": 4}, {"source_id": "therapy", "target_id": "mortality", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "distress syndrome", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "severe disease", "target_id": "blood samples", "strength": 4}, {"source_id": "primary endpoint", "target_id": "cause mortality", "strength": 4}, {"source_id": "T cell responses", "target_id": "variants of concern", "strength": 4}, {"source_id": "T cell responses", "target_id": "booster vaccination", "strength": 4}, {"source_id": "cardiovascular disease", "target_id": "infection", "strength": 4}, {"source_id": "inclusion criteria", "target_id": "Meta-Analysis", "strength": 4}, {"source_id": "mass index", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "observational cohort study", "strength": 4}, {"source_id": "cohort study", "target_id": "hospital stay", "strength": 4}, {"source_id": "retrospective study", "target_id": "logistic regression", "strength": 4}, {"source_id": "intensive care unit", "target_id": "patient outcomes", "strength": 4}, {"source_id": "health care workers", "target_id": "study period", "strength": 4}, {"source_id": "primary outcome", "target_id": "healthcare workers", "strength": 4}, {"source_id": "infection", "target_id": "health care workers", "strength": 4}, {"source_id": "logistic regression", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "study period", "target_id": "health care workers", "strength": 4}, {"source_id": "hospital admission", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "hospital admission", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "coronavirus disease", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "distress syndrome", "strength": 4}, {"source_id": "distress syndrome", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "antibody levels", "strength": 4}, {"source_id": "respiratory symptoms", "target_id": "risk factors", "strength": 4}, {"source_id": "mortality rate", "target_id": "high prevalence", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "multiple sclerosis", "strength": 4}, {"source_id": "pregnant women", "target_id": "high risk", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "age groups", "strength": 4}, {"source_id": "rights", "target_id": "article", "strength": 4}, {"source_id": "medical students", "target_id": "program", "strength": 4}, {"source_id": "skills", "target_id": "research", "strength": 4}, {"source_id": "social media", "target_id": "people", "strength": 4}, {"source_id": "chronic kidney disease", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "disease", "target_id": "median age", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "ill patients", "strength": 4}, {"source_id": "odds ratio", "target_id": "mortality rate", "strength": 4}, {"source_id": "myocardial infarction", "target_id": "mortality", "strength": 4}, {"source_id": "odds ratio", "target_id": "infection", "strength": 4}, {"source_id": "hazard ratio", "target_id": "disease severity", "strength": 4}, {"source_id": "adverse events", "target_id": "dose", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "electronic health records", "strength": 4}, {"source_id": "vaccine dose", "target_id": "mRNA vaccination", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "health records", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "vaccination coverage", "strength": 4}, {"source_id": "interviews", "target_id": "perspective", "strength": 4}, {"source_id": "perspective", "target_id": "government", "strength": 4}, {"source_id": "risk factors", "target_id": "severe cases", "strength": 4}, {"source_id": "viral load", "target_id": "adverse events", "strength": 4}, {"source_id": "COVID-19 severity", "target_id": "observational study", "strength": 4}, {"source_id": "vaccination campaign", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "respiratory tract", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "respiratory tract", "strength": 4}, {"source_id": "governance", "target_id": "institutions", "strength": 4}, {"source_id": "systematic review", "target_id": "intensive care unit", "strength": 4}, {"source_id": "disease severity", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "disease severity", "target_id": "vaccination status", "strength": 4}, {"source_id": "retrospective study", "target_id": "C-reactive protein", "strength": 4}, {"source_id": "adverse events", "target_id": "intervention group", "strength": 4}, {"source_id": "disease severity", "target_id": "cell responses", "strength": 4}, {"source_id": "immune system", "target_id": "COVID-19 disease", "strength": 4}, {"source_id": "animal models", "target_id": "disease 2019", "strength": 4}, {"source_id": "care system", "target_id": "cohort study", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "risk factors", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "immune response", "target_id": "serious adverse events", "strength": 4}, {"source_id": "serious adverse events", "target_id": "immune response", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "women", "strength": 4}, {"source_id": "women", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "study protocol", "target_id": "risk factors", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "disease 2019 pandemic", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "need", "target_id": "semi-structured interviews", "strength": 4}, {"source_id": "schools", "target_id": "need", "strength": 4}, {"source_id": "educators", "target_id": "need", "strength": 4}, {"source_id": "need", "target_id": "educators", "strength": 4}, {"source_id": "respiratory failure", "target_id": "cohort study", "strength": 4}, {"source_id": "mental health", "target_id": "women", "strength": 4}, {"source_id": "hospitalized patients", "target_id": "primary outcome", "strength": 4}, {"source_id": "age groups", "target_id": "hospitalization", "strength": 4}, {"source_id": "logistic regression", "target_id": "kidney disease", "strength": 4}, {"source_id": "vaccine dose", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "vaccine hesitancy", "target_id": "vaccination status", "strength": 4}, {"source_id": "adult patients", "target_id": "cohort", "strength": 4}, {"source_id": "prospective study", "target_id": "antibody response", "strength": 4}, {"source_id": "antibody response", "target_id": "prospective study", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "emergency department", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "young adults", "strength": 4}, {"source_id": "healthy controls", "target_id": "observational study", "strength": 4}, {"source_id": "SARS-CoV-2 transmission", "target_id": "infection", "strength": 4}, {"source_id": "mental health", "target_id": "primary care", "strength": 4}, {"source_id": "care services", "target_id": "health professionals", "strength": 4}, {"source_id": "logistic regression", "target_id": "adult patients", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "severe illness", "strength": 4}, {"source_id": "severe illness", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "prospective study", "target_id": "risk factors", "strength": 4}, {"source_id": "inflammatory syndrome", "target_id": "clinical characteristics", "strength": 4}, {"source_id": "high-income countries", "target_id": "patients", "strength": 4}, {"source_id": "gene expression", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "epithelial cells", "target_id": "SARS-CoV-2 replication", "strength": 4}, {"source_id": "ill patients", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "Health Organization", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "Health Organization", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "observational study", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "clinical studies", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "women", "strength": 4}, {"source_id": "clinical studies", "target_id": "disease 2019", "strength": 4}, {"source_id": "health outcomes", "target_id": "psychological distress", "strength": 4}, {"source_id": "Medical Center", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "clinical trials", "target_id": "healthcare professionals", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "case report", "strength": 4}, {"source_id": "participants", "target_id": "anxiety", "strength": 4}, {"source_id": "disease progression", "target_id": "adverse events", "strength": 4}, {"source_id": "variants of concern", "target_id": "antibody response", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "pediatric patients", "strength": 4}, {"source_id": "immune response", "target_id": "syndrome coronavirus 2 infection", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "epithelial cells", "strength": 4}, {"source_id": "social determinants", "target_id": "risk factors", "strength": 4}, {"source_id": "median age", "target_id": "mortality rate", "strength": 4}, {"source_id": "health system", "target_id": "logistic regression models", "strength": 4}, {"source_id": "vaccine doses", "target_id": "vaccination status", "strength": 4}, {"source_id": "vaccination status", "target_id": "hospitalization", "strength": 4}, {"source_id": "care", "target_id": "healthcare professionals", "strength": 4}, {"source_id": "cohort study", "target_id": "quality of life", "strength": 4}, {"source_id": "pregnant women", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "pregnant women", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "SARS-CoV2", "strength": 4}, {"source_id": "SARS-CoV2", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "intervention group", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "disease 2019", "target_id": "acute phase", "strength": 4}, {"source_id": "context", "target_id": "learning", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "injury", "strength": 4}, {"source_id": "disease 2019", "target_id": "injury", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "severe illness", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "clinical presentation", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "median age", "target_id": "disease severity", "strength": 4}, {"source_id": "retrospective study", "target_id": "study period", "strength": 4}, {"source_id": "cell responses", "target_id": "mRNA vaccination", "strength": 4}, {"source_id": "dose", "target_id": "Delta variant", "strength": 4}, {"source_id": "severe disease", "target_id": "dose", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "T cell responses", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "cell responses", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "persistent symptoms", "strength": 4}, {"source_id": "vaccine dose", "target_id": "antibody levels", "strength": 4}, {"source_id": "primary outcome", "target_id": "symptoms", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "disease", "strength": 4}, {"source_id": "cohort study", "target_id": "autoimmune diseases", "strength": 4}, {"source_id": "diabetes mellitus", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "pediatric patients", "strength": 4}, {"source_id": "health professionals", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "receptor-binding domain", "strength": 4}, {"source_id": "infection", "target_id": "severe cases", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "case-control study", "target_id": "logistic regression models", "strength": 4}, {"source_id": "adverse effects", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "control group", "strength": 4}, {"source_id": "risk factors", "target_id": "disease progression", "strength": 4}, {"source_id": "adult patients", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "epithelial cells", "strength": 4}, {"source_id": "epithelial cells", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "epithelial cells", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "epithelial cells", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "case series", "target_id": "second dose", "strength": 4}, {"source_id": "care unit", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "intensive care unit", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "care unit", "strength": 4}, {"source_id": "cohort study", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "prevalence", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "pregnant women", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "clinical practice", "strength": 4}, {"source_id": "nasopharyngeal swabs", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "qualitative study", "target_id": "students", "strength": 4}, {"source_id": "research", "target_id": "qualitative study", "strength": 4}, {"source_id": "older age", "target_id": "median age", "strength": 4}, {"source_id": "blood samples", "target_id": "T cells", "strength": 4}, {"source_id": "care", "target_id": "quality of life", "strength": 4}, {"source_id": "genes", "target_id": "protein", "strength": 4}, {"source_id": "countries", "target_id": "society", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "hospitalization", "strength": 4}, {"source_id": "high risk", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "hospital", "target_id": "cohort study", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "hospital admission", "target_id": "retrospective study", "strength": 4}, {"source_id": "health services", "target_id": "health professionals", "strength": 4}, {"source_id": "mortality", "target_id": "Meta-Analysis", "strength": 4}, {"source_id": "retrospective study", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "diabetes mellitus", "target_id": "intensive care unit", "strength": 4}, {"source_id": "diabetes mellitus", "target_id": "care unit", "strength": 4}, {"source_id": "cardiovascular disease", "target_id": "heart failure", "strength": 4}, {"source_id": "heart failure", "target_id": "cardiovascular disease", "strength": 4}, {"source_id": "older age", "target_id": "cardiovascular disease", "strength": 4}, {"source_id": "cardiovascular disease", "target_id": "older age", "strength": 4}, {"source_id": "University Hospital", "target_id": "disease 2019 pandemic", "strength": 4}, {"source_id": "Health Organization", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "Health Organization", "target_id": "severe disease", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "World Health Organization", "strength": 4}, {"source_id": "distress syndrome", "target_id": "World Health Organization", "strength": 4}, {"source_id": "booster dose", "target_id": "second dose", "strength": 4}, {"source_id": "observational study", "target_id": "therapy", "strength": 4}, {"source_id": "length of stay", "target_id": "hospital mortality", "strength": 4}, {"source_id": "intensive care unit", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "care unit", "strength": 4}, {"source_id": "hospital discharge", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "medical records", "target_id": "disease 2019", "strength": 4}, {"source_id": "disease 2019", "target_id": "medical records", "strength": 4}, {"source_id": "immune system", "target_id": "mouse model", "strength": 4}, {"source_id": "safety profile", "target_id": "vaccination", "strength": 4}, {"source_id": "clinical data", "target_id": "vaccination", "strength": 4}, {"source_id": "vaccination", "target_id": "clinical data", "strength": 4}, {"source_id": "median age", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "syndrome", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "antibody response", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "vaccination", "target_id": "ICU admission", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "care workers", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "mortality", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "mortality", "strength": 4}, {"source_id": "greater risk", "target_id": "disease 2019", "strength": 4}, {"source_id": "greater risk", "target_id": "disease", "strength": 4}, {"source_id": "mortality", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "violence", "target_id": "women", "strength": 4}, {"source_id": "health outcomes", "target_id": "women", "strength": 4}, {"source_id": "women", "target_id": "health outcomes", "strength": 4}, {"source_id": "transplant recipients", "target_id": "monoclonal antibodies", "strength": 4}, {"source_id": "retrospective study", "target_id": "intensive care unit", "strength": 4}, {"source_id": "retrospective study", "target_id": "therapy", "strength": 4}, {"source_id": "inclusion criteria", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "therapy", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "disease severity", "strength": 4}, {"source_id": "vaccine dose", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "vaccine dose", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "booster vaccination", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "vaccine dose", "strength": 4}, {"source_id": "general population", "target_id": "years of age", "strength": 4}, {"source_id": "adverse events", "target_id": "disease", "strength": 4}, {"source_id": "vaccination", "target_id": "retrospective study", "strength": 4}, {"source_id": "cancer patients", "target_id": "quality of life", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "nervous system", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "nervous system", "strength": 4}, {"source_id": "nervous system", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "RT-PCR", "target_id": "Omicron infection", "strength": 4}, {"source_id": "program", "target_id": "institutions", "strength": 4}, {"source_id": "program", "target_id": "teaching", "strength": 4}, {"source_id": "institutions", "target_id": "educators", "strength": 4}, {"source_id": "education", "target_id": "motivation", "strength": 4}, {"source_id": "motivation", "target_id": "education", "strength": 4}, {"source_id": "young adults", "target_id": "health outcomes", "strength": 4}, {"source_id": "COVID-19", "target_id": "use disorders", "strength": 4}, {"source_id": "cohort study", "target_id": "antibody titers", "strength": 4}, {"source_id": "antibody titers", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "Omicron variant", "target_id": "clinical characteristics", "strength": 4}, {"source_id": "discourse", "target_id": "interviews", "strength": 4}, {"source_id": "employees", "target_id": "research", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "book", "strength": 4}, {"source_id": "practice", "target_id": "crisis", "strength": 4}, {"source_id": "physical activity", "target_id": "quality of life", "strength": 4}, {"source_id": "Health Organization", "target_id": "immune response", "strength": 4}, {"source_id": "C-reactive protein", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "risk factors", "target_id": "healthy controls", "strength": 4}, {"source_id": "retrospective study", "target_id": "mean age", "strength": 4}, {"source_id": "hospital discharge", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "hospital discharge", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "hospital discharge", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "humoral response", "strength": 4}, {"source_id": "clinical trials", "target_id": "injury", "strength": 4}, {"source_id": "injury", "target_id": "clinical trials", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "Omicron variant", "strength": 4}, {"source_id": "Web of Science", "target_id": "disease 2019", "strength": 4}, {"source_id": "adverse events", "target_id": "young adults", "strength": 4}, {"source_id": "multivariable logistic regression", "target_id": "cohort study", "strength": 4}, {"source_id": "cohort study", "target_id": "nasopharyngeal swabs", "strength": 4}, {"source_id": "higher odds", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "logistic regression", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "vaccine", "target_id": "trials", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "logistic regression analysis", "strength": 4}, {"source_id": "vaccine", "target_id": "study design", "strength": 4}, {"source_id": "incidence", "target_id": "infection", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "SARS-CoV-2 antibodies", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "unit admission", "strength": 4}, {"source_id": "care unit admission", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "vaccine effectiveness", "strength": 4}, {"source_id": "persistent symptoms", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "acute infection", "target_id": "symptoms", "strength": 4}, {"source_id": "study participants", "target_id": "logistic regression", "strength": 4}, {"source_id": "United States", "target_id": "interviews", "strength": 4}, {"source_id": "mouse model", "target_id": "spike protein", "strength": 4}, {"source_id": "immune cells", "target_id": "therapeutic strategies", "strength": 4}, {"source_id": "therapeutic strategies", "target_id": "immune cells", "strength": 4}, {"source_id": "mice", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "mice", "target_id": "spike protein", "strength": 4}, {"source_id": "virus infection", "target_id": "viral infection", "strength": 4}, {"source_id": "learning", "target_id": "algorithm", "strength": 4}, {"source_id": "interviews", "target_id": "community", "strength": 4}, {"source_id": "pandemic", "target_id": "University", "strength": 4}, {"source_id": "case study", "target_id": "learning", "strength": 4}, {"source_id": "engagement", "target_id": "higher education", "strength": 4}, {"source_id": "engagement", "target_id": "learners", "strength": 4}, {"source_id": "course", "target_id": "learners", "strength": 4}, {"source_id": "participants", "target_id": "skills", "strength": 4}, {"source_id": "mass index", "target_id": "weight loss", "strength": 4}, {"source_id": "adverse effects", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "infection rate", "strength": 4}, {"source_id": "breast cancer", "target_id": "women", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "viral replication", "strength": 4}, {"source_id": "mouse model", "target_id": "vaccine", "strength": 4}, {"source_id": "viral replication", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "COVID-19", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "humoral immune response", "strength": 4}, {"source_id": "years of age", "target_id": "humoral immune response", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "vaccine", "strength": 4}, {"source_id": "hospital admission", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "vaccine dose", "target_id": "study period", "strength": 4}, {"source_id": "first dose", "target_id": "vaccine dose", "strength": 4}, {"source_id": "Omicron variant", "target_id": "unvaccinated individuals", "strength": 4}, {"source_id": "vaccination coverage", "target_id": "vaccination rates", "strength": 4}, {"source_id": "COVID-19", "target_id": "care system", "strength": 4}, {"source_id": "blood samples", "target_id": "vaccination", "strength": 4}, {"source_id": "technology", "target_id": "students", "strength": 4}, {"source_id": "patients", "target_id": "health outcomes", "strength": 4}, {"source_id": "risk factors", "target_id": "high incidence", "strength": 4}, {"source_id": "primary care", "target_id": "clinical care", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "disease control", "strength": 4}, {"source_id": "primary care", "target_id": "health records", "strength": 4}, {"source_id": "disease 2019 pandemic", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "immune response", "target_id": "therapeutic target", "strength": 4}, {"source_id": "adult patients", "target_id": "mortality rate", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "respiratory failure", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "vaccine effectiveness", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "inclusion criteria", "strength": 4}, {"source_id": "observational study", "target_id": "inclusion criteria", "strength": 4}, {"source_id": "observational study", "target_id": "intensive care unit", "strength": 4}, {"source_id": "electronic health records", "target_id": "clinical data", "strength": 4}, {"source_id": "study population", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "mean age", "target_id": "physical activity", "strength": 4}, {"source_id": "primary outcome", "target_id": "study population", "strength": 4}, {"source_id": "study population", "target_id": "primary outcome", "strength": 4}, {"source_id": "study population", "target_id": "mortality", "strength": 4}, {"source_id": "therapeutic target", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "disease", "target_id": "therapeutic target", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "antibody titers", "strength": 4}, {"source_id": "antibody titers", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "Delta variant", "target_id": "unvaccinated individuals", "strength": 4}, {"source_id": "pulmonary disease", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "hospitalized patients", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "severe disease", "target_id": "observational study", "strength": 4}, {"source_id": "viral infection", "target_id": "coronavirus 2 infection", "strength": 4}, {"source_id": "severe disease", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "autoimmune diseases", "strength": 4}, {"source_id": "clinical symptoms", "target_id": "disease severity", "strength": 4}, {"source_id": "older adults", "target_id": "quality of life", "strength": 4}, {"source_id": "adverse effects", "target_id": "adverse events", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "young adults", "strength": 4}, {"source_id": "viral load", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "viral load", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "mental health outcomes", "strength": 4}, {"source_id": "mean age", "target_id": "observational study", "strength": 4}, {"source_id": "COVID-19", "target_id": "social support", "strength": 4}, {"source_id": "COVID-19", "target_id": "multiple sclerosis", "strength": 4}, {"source_id": "young people", "target_id": "education", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "control group", "strength": 4}, {"source_id": "genes", "target_id": "species", "strength": 4}, {"source_id": "species", "target_id": "genes", "strength": 4}, {"source_id": "intensive care unit", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "hospital mortality", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "medical records", "strength": 4}, {"source_id": "medical records", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "distress syndrome", "target_id": "mortality", "strength": 4}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "mortality", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "severe disease", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "severe disease", "strength": 4}, {"source_id": "severe disease", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "severe disease", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "blood samples", "target_id": "severe disease", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "inflammation", "strength": 4}, {"source_id": "adverse events", "target_id": "cause mortality", "strength": 4}, {"source_id": "variants of concern", "target_id": "T cell responses", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "women", "strength": 4}, {"source_id": "diabetes mellitus", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "women", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "Web of Science", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "Meta-Analysis", "target_id": "Web of Science", "strength": 4}, {"source_id": "body mass index", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "cohort study", "target_id": "patient characteristics", "strength": 4}, {"source_id": "cohort study", "target_id": "length of stay", "strength": 4}, {"source_id": "health care workers", "target_id": "infection", "strength": 4}, {"source_id": "care workers", "target_id": "study period", "strength": 4}, {"source_id": "infection", "target_id": "care workers", "strength": 4}, {"source_id": "health interventions", "target_id": "mental health", "strength": 4}, {"source_id": "study period", "target_id": "health services", "strength": 4}, {"source_id": "hospital admission", "target_id": "SARS-CoV-2 Omicron variant", "strength": 4}, {"source_id": "SARS-CoV-2 virus", "target_id": "viral load", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "distress syndrome", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "distress syndrome", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "coronavirus disease", "target_id": "spike protein", "strength": 4}, {"source_id": "Omicron variant", "target_id": "ICU admission", "strength": 4}, {"source_id": "women", "target_id": "care", "strength": 4}, {"source_id": "risk factors", "target_id": "hospital discharge", "strength": 4}, {"source_id": "risk factors", "target_id": "health conditions", "strength": 4}, {"source_id": "mortality rate", "target_id": "mean age", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "cohort", "strength": 4}, {"source_id": "cohort", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "health system", "strength": 4}, {"source_id": "artificial intelligence", "target_id": "learning", "strength": 4}, {"source_id": "article", "target_id": "rights", "strength": 4}, {"source_id": "teaching", "target_id": "engagement", "strength": 4}, {"source_id": "engagement", "target_id": "teaching", "strength": 4}, {"source_id": "genes", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "observational study", "target_id": "myocardial infarction", "strength": 4}, {"source_id": "median age", "target_id": "disease progression", "strength": 4}, {"source_id": "disease", "target_id": "prospective cohort study", "strength": 4}, {"source_id": "infection", "target_id": "autoimmune diseases", "strength": 4}, {"source_id": "SARS-CoV-2 transmission", "target_id": "COVID-19", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "mental health", "strength": 4}, {"source_id": "Meta-Analysis", "target_id": "observational study", "strength": 4}, {"source_id": "hospitalization", "target_id": "risk factors", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "vaccine doses", "target_id": "dose", "strength": 4}, {"source_id": "health records", "target_id": "vaccination", "strength": 4}, {"source_id": "pandemic", "target_id": "need", "strength": 4}, {"source_id": "need", "target_id": "pandemic", "strength": 4}, {"source_id": "odds ratio", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "Omicron infection", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "Omicron infection", "strength": 4}, {"source_id": "vaccination status", "target_id": "observational cohort study", "strength": 4}, {"source_id": "observational cohort study", "target_id": "vaccination status", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "odds ratio", "strength": 4}, {"source_id": "severe disease", "target_id": "viral load", "strength": 4}, {"source_id": "disease severity", "target_id": "viral load", "strength": 4}, {"source_id": "genes", "target_id": "immune response", "strength": 4}, {"source_id": "practice", "target_id": "semi-structured interviews", "strength": 4}, {"source_id": "society", "target_id": "governance", "strength": 4}, {"source_id": "context", "target_id": "pandemic", "strength": 4}, {"source_id": "pandemic", "target_id": "context", "strength": 4}, {"source_id": "adult patients", "target_id": "disease progression", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "disease severity", "strength": 4}, {"source_id": "disease 2019", "target_id": "animal models", "strength": 4}, {"source_id": "cohort study", "target_id": "care system", "strength": 4}, {"source_id": "mortality rate", "target_id": "incidence", "strength": 4}, {"source_id": "immune system", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "pain", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "COVID-19", "target_id": "community", "strength": 4}, {"source_id": "perspective", "target_id": "crisis", "strength": 4}, {"source_id": "crisis", "target_id": "perspective", "strength": 4}, {"source_id": "institutions", "target_id": "schools", "strength": 4}, {"source_id": "semi-structured interviews", "target_id": "need", "strength": 4}, {"source_id": "learning", "target_id": "perception", "strength": 4}, {"source_id": "hospital mortality", "target_id": "unit admission", "strength": 4}, {"source_id": "patient outcomes", "target_id": "study period", "strength": 4}, {"source_id": "ICU admission", "target_id": "ill patients", "strength": 4}, {"source_id": "cohort study", "target_id": "respiratory failure", "strength": 4}, {"source_id": "mortality", "target_id": "patient outcomes", "strength": 4}, {"source_id": "IL-6", "target_id": "COVID-19 severity", "strength": 4}, {"source_id": "COVID-19 severity", "target_id": "IL-6", "strength": 4}, {"source_id": "risk factors", "target_id": "control group", "strength": 4}, {"source_id": "care unit", "target_id": "prospective cohort study", "strength": 4}, {"source_id": "crisis", "target_id": "book", "strength": 4}, {"source_id": "health conditions", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "emergency department", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "young adults", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "emergency department", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "logistic regression models", "target_id": "years of age", "strength": 4}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "infection", "strength": 4}, {"source_id": "COVID-19", "target_id": "clinical care", "strength": 4}, {"source_id": "thematic analysis", "target_id": "teachers", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "severe disease", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "cohort study", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "Health Organization", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "World Health Organization", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "ill patients", "strength": 4}, {"source_id": "World Health Organization", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "Health Organization", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "adverse events", "target_id": "case report", "strength": 4}, {"source_id": "pregnant women", "target_id": "disease 2019", "strength": 4}, {"source_id": "clinical studies", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "health services", "target_id": "mental health", "strength": 4}, {"source_id": "hospital admission", "target_id": "care unit admission", "strength": 4}, {"source_id": "cause mortality", "target_id": "general population", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "mortality", "strength": 4}, {"source_id": "healthcare professionals", "target_id": "clinical trials", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "disease", "strength": 4}, {"source_id": "case report", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "control group", "strength": 4}, {"source_id": "clinical characteristics", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "admission", "target_id": "hospital", "strength": 4}, {"source_id": "hospital", "target_id": "admission", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "immune response", "strength": 4}, {"source_id": "coronavirus 2 infection", "target_id": "immune response", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "clinical presentation", "strength": 4}, {"source_id": "vaccine doses", "target_id": "age groups", "strength": 4}, {"source_id": "high-income countries", "target_id": "health outcomes", "strength": 4}, {"source_id": "high risk", "target_id": "adverse outcomes", "strength": 4}, {"source_id": "adult patients", "target_id": "coronavirus disease", "strength": 4}, {"source_id": "cohort study", "target_id": "humoral response", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "pregnant women", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "pregnant women", "strength": 4}, {"source_id": "pregnant women", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "people", "target_id": "thematic analysis", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV2", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV2", "strength": 4}, {"source_id": "discourse", "target_id": "COVID-19", "strength": 4}, {"source_id": "viral load", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "median age", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "hospital admission", "target_id": "median age", "strength": 4}, {"source_id": "COVID-19", "target_id": "adverse effects", "strength": 4}, {"source_id": "T cell responses", "target_id": "mRNA vaccination", "strength": 4}, {"source_id": "Delta variant", "target_id": "cell responses", "strength": 4}, {"source_id": "health care workers", "target_id": "immune response", "strength": 4}, {"source_id": "health care workers", "target_id": "vaccine", "strength": 4}, {"source_id": "T cell responses", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "Medical Center", "target_id": "cohort study", "strength": 4}, {"source_id": "cell responses", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "myocardial infarction", "strength": 4}, {"source_id": "persistent symptoms", "target_id": "risk factors", "strength": 4}, {"source_id": "symptoms", "target_id": "trials", "strength": 4}, {"source_id": "context", "target_id": "people", "strength": 4}, {"source_id": "context", "target_id": "schools", "strength": 4}, {"source_id": "mortality", "target_id": "disease progression", "strength": 4}, {"source_id": "disease", "target_id": "mouse model", "strength": 4}, {"source_id": "autoimmune diseases", "target_id": "cohort study", "strength": 4}, {"source_id": "adverse effects", "target_id": "vaccination", "strength": 4}, {"source_id": "symptoms", "target_id": "emergency department", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "receptor-binding domain", "strength": 4}, {"source_id": "receptor-binding domain", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "receptor-binding domain", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "severe cases", "target_id": "infection", "strength": 4}, {"source_id": "algorithm", "target_id": "artificial intelligence", "strength": 4}, {"source_id": "pandemic", "target_id": "children", "strength": 4}, {"source_id": "students", "target_id": "children", "strength": 4}, {"source_id": "mean age", "target_id": "hospital admission", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "vaccination status", "strength": 4}, {"source_id": "clinical data", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "immune response", "target_id": "epithelial cells", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "epithelial cells", "strength": 4}, {"source_id": "epithelial cells", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "immune response", "target_id": "cardiovascular disease", "strength": 4}, {"source_id": "intensive care unit", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "ICU admission", "target_id": "mortality rate", "strength": 4}, {"source_id": "body mass index", "target_id": "women", "strength": 4}, {"source_id": "women", "target_id": "body mass index", "strength": 4}, {"source_id": "antiviral therapy", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "nasopharyngeal swabs", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "students", "target_id": "qualitative study", "strength": 4}, {"source_id": "median age", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "median age", "target_id": "ICU admission", "strength": 4}, {"source_id": "Web of Science", "target_id": "risk factors", "strength": 4}, {"source_id": "receptor-binding domain", "target_id": "Omicron variant", "strength": 4}, {"source_id": "hospitalization", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "adult patients", "target_id": "hospital discharge", "strength": 4}, {"source_id": "hospital discharge", "target_id": "adult patients", "strength": 4}, {"source_id": "retrospective study", "target_id": "hospital admission", "strength": 4}, {"source_id": "mass index", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "logistic regression analysis", "strength": 4}, {"source_id": "T cell responses", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "viral infection", "target_id": "disease severity", "strength": 4}, {"source_id": "intensive care unit admission", "target_id": "vaccine", "strength": 4}, {"source_id": "unit admission", "target_id": "vaccine", "strength": 4}, {"source_id": "vaccine", "target_id": "vaccination rates", "strength": 4}, {"source_id": "vaccine", "target_id": "infectious diseases", "strength": 4}, {"source_id": "infectious diseases", "target_id": "vaccine", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "disease severity", "strength": 4}, {"source_id": "study protocol", "target_id": "COVID-19", "strength": 4}, {"source_id": "retrospective study", "target_id": "disease 2019", "strength": 4}, {"source_id": "intensive care unit", "target_id": "diabetes mellitus", "strength": 4}, {"source_id": "care unit", "target_id": "diabetes mellitus", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "cancer patients", "strength": 4}, {"source_id": "median age", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "second dose", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "second dose", "strength": 4}, {"source_id": "systematic review", "target_id": "SARS-CoV-2 pandemic", "strength": 4}, {"source_id": "high risk", "target_id": "hospital mortality", "strength": 4}, {"source_id": "years of age", "target_id": "hospital admission", "strength": 4}, {"source_id": "nervous system", "target_id": "immune response", "strength": 4}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "University Hospital", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "disease 2019", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "mortality rate", "strength": 4}, {"source_id": "vaccination status", "target_id": "Delta variant", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "Health Organization", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "Health Organization", "strength": 4}, {"source_id": "first dose", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "patients", "target_id": "first dose", "strength": 4}, {"source_id": "length of stay", "target_id": "intensive care unit", "strength": 4}, {"source_id": "hospital mortality", "target_id": "length of stay", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "hospital stay", "strength": 4}, {"source_id": "medical records", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "severe disease", "target_id": "T cell responses", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "median age", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 mRNA vaccines", "strength": 4}, {"source_id": "transplant recipients", "target_id": "primary outcome", "strength": 4}, {"source_id": "ICU admission", "target_id": "lower risk", "strength": 4}, {"source_id": "intensive care unit admission", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "hospitalization", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "vaccination", "target_id": "lower risk", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "health care workers", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "mortality", "strength": 4}, {"source_id": "disease", "target_id": "greater risk", "strength": 4}, {"source_id": "safety profile", "target_id": "immune response", "strength": 4}, {"source_id": "transplant recipients", "target_id": "Omicron variant", "strength": 4}, {"source_id": "care unit", "target_id": "retrospective study", "strength": 4}, {"source_id": "therapy", "target_id": "transplant recipients", "strength": 4}, {"source_id": "study design", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "therapy", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "disease severity", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "observational study", "target_id": "clinical characteristics", "strength": 4}, {"source_id": "intensive care", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "therapy", "target_id": "trials", "strength": 4}, {"source_id": "vaccination program", "target_id": "cohort study", "strength": 4}, {"source_id": "healthy controls", "target_id": "cohort study", "strength": 4}, {"source_id": "vaccination campaign", "target_id": "vaccine hesitancy", "strength": 4}, {"source_id": "vaccine hesitancy", "target_id": "vaccination campaign", "strength": 4}, {"source_id": "nervous system", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "disease 2019", "target_id": "side effects", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "vaccine hesitancy", "strength": 4}, {"source_id": "program", "target_id": "practice", "strength": 4}, {"source_id": "teaching", "target_id": "program", "strength": 4}, {"source_id": "teaching", "target_id": "motivation", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "antibody titers", "strength": 4}, {"source_id": "clinical characteristics", "target_id": "Omicron variant", "strength": 4}, {"source_id": "book", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "context", "target_id": "countries", "strength": 4}, {"source_id": "article", "target_id": "practice", "strength": 4}, {"source_id": "practice", "target_id": "article", "strength": 4}, {"source_id": "thematic analysis", "target_id": "training", "strength": 4}, {"source_id": "schools", "target_id": "article", "strength": 4}, {"source_id": "quality of life", "target_id": "physical activity", "strength": 4}, {"source_id": "immune response", "target_id": "Health Organization", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "primary endpoint", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "C-reactive protein", "strength": 4}, {"source_id": "mean age", "target_id": "retrospective study", "strength": 4}, {"source_id": "disease", "target_id": "age groups", "strength": 4}, {"source_id": "hospital discharge", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "hospitalized patients", "target_id": "observational study", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "therapy", "strength": 4}, {"source_id": "patient characteristics", "target_id": "clinical trials", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "coronavirus 2 infection", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "Web of Science", "strength": 4}, {"source_id": "safety profile", "target_id": "second dose", "strength": 4}, {"source_id": "older adults", "target_id": "higher odds", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "age groups", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "higher odds", "strength": 4}, {"source_id": "study period", "target_id": "mortality", "strength": 4}, {"source_id": "hospital admission", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "infection", "target_id": "incidence", "strength": 4}, {"source_id": "intensive care unit admission", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "unit admission", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "unit admission", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "vaccine effectiveness", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "prospective cohort study", "strength": 4}, {"source_id": "COVID-19", "target_id": "syndrome", "strength": 4}, {"source_id": "symptoms", "target_id": "acute infection", "strength": 4}, {"source_id": "syndrome", "target_id": "long COVID", "strength": 4}, {"source_id": "disease 2019", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "prospective study", "target_id": "cohort study", "strength": 4}, {"source_id": "care", "target_id": "cohort study", "strength": 4}, {"source_id": "training", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "years of age", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "treatment strategies", "strength": 4}, {"source_id": "treatment strategies", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "treatment strategies", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "SARS-CoV-2 replication", "target_id": "viral infection", "strength": 4}, {"source_id": "viral load", "target_id": "SARS-CoV-2 replication", "strength": 4}, {"source_id": "COVID-19", "target_id": "electronic health records", "strength": 4}, {"source_id": "health outcomes", "target_id": "healthcare professionals", "strength": 4}, {"source_id": "healthcare professionals", "target_id": "health outcomes", "strength": 4}, {"source_id": "mouse model", "target_id": "immune cells", "strength": 4}, {"source_id": "SARS-CoV-2 virus", "target_id": "viral infection", "strength": 4}, {"source_id": "immune cells", "target_id": "mouse model", "strength": 4}, {"source_id": "case study", "target_id": "ecosystems", "strength": 4}, {"source_id": "government", "target_id": "economy", "strength": 4}, {"source_id": "community", "target_id": "interviews", "strength": 4}, {"source_id": "course", "target_id": "University", "strength": 4}, {"source_id": "case study", "target_id": "education", "strength": 4}, {"source_id": "learners", "target_id": "University", "strength": 4}, {"source_id": "learners", "target_id": "course", "strength": 4}, {"source_id": "learners", "target_id": "schools", "strength": 4}, {"source_id": "course", "target_id": "schools", "strength": 4}, {"source_id": "practice", "target_id": "COVID-19", "strength": 4}, {"source_id": "program", "target_id": "participants", "strength": 4}, {"source_id": "participants", "target_id": "program", "strength": 4}, {"source_id": "students", "target_id": "book", "strength": 4}, {"source_id": "control group", "target_id": "mass index", "strength": 4}, {"source_id": "weight loss", "target_id": "body mass index", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "adverse effects", "strength": 4}, {"source_id": "adult patients", "target_id": "therapy", "strength": 4}, {"source_id": "mouse model", "target_id": "T cells", "strength": 4}, {"source_id": "vaccine", "target_id": "mouse model", "strength": 4}, {"source_id": "third dose", "target_id": "SARS-CoV-2 vaccination", "strength": 4}, {"source_id": "humoral immune response", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "mouse model", "strength": 4}, {"source_id": "clinical manifestations", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "clinical manifestations", "target_id": "immune response", "strength": 4}, {"source_id": "vaccine", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "viral infection", "target_id": "inflammatory response", "strength": 4}, {"source_id": "study period", "target_id": "vaccine dose", "strength": 4}, {"source_id": "economy", "target_id": "society", "strength": 4}, {"source_id": "clinical data", "target_id": "risk factors", "strength": 4}, {"source_id": "protective effect", "target_id": "lower risk", "strength": 4}, {"source_id": "vaccine", "target_id": "clinical presentation", "strength": 4}, {"source_id": "booster doses", "target_id": "vaccination", "strength": 4}, {"source_id": "vaccination", "target_id": "booster doses", "strength": 4}, {"source_id": "IL-6", "target_id": "infection", "strength": 4}, {"source_id": "high incidence", "target_id": "risk factors", "strength": 4}, {"source_id": "intensive care", "target_id": "care", "strength": 4}, {"source_id": "health conditions", "target_id": "primary care", "strength": 4}, {"source_id": "politics", "target_id": "social media", "strength": 4}, {"source_id": "respiratory failure", "target_id": "University Hospital", "strength": 4}, {"source_id": "admission", "target_id": "high risk", "strength": 4}, {"source_id": "inflammatory diseases", "target_id": "vaccination", "strength": 4}, {"source_id": "diabetes mellitus", "target_id": "kidney disease", "strength": 4}, {"source_id": "spike protein", "target_id": "second dose", "strength": 4}, {"source_id": "intensive care unit", "target_id": "observational study", "strength": 4}, {"source_id": "health records", "target_id": "clinical data", "strength": 4}, {"source_id": "clinical trials", "target_id": "pregnancy", "strength": 4}, {"source_id": "pregnancy", "target_id": "clinical trials", "strength": 4}, {"source_id": "time points", "target_id": "young adults", "strength": 4}, {"source_id": "hospital mortality", "target_id": "logistic regression", "strength": 4}, {"source_id": "multivariable logistic regression", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "oxidative stress", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "oxidative stress", "strength": 4}, {"source_id": "antibody response", "target_id": "median age", "strength": 4}, {"source_id": "medical records", "target_id": "ICU admission", "strength": 4}, {"source_id": "learners", "target_id": "pandemic", "strength": 4}, {"source_id": "T cells", "target_id": "inflammation", "strength": 4}, {"source_id": "inflammation", "target_id": "T cells", "strength": 4}, {"source_id": "cells", "target_id": "genes", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "viral infection", "strength": 4}, {"source_id": "coronavirus 2 infection", "target_id": "viral infection", "strength": 4}, {"source_id": "observational study", "target_id": "severe disease", "strength": 4}, {"source_id": "high prevalence", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "viral infection", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 4}, {"source_id": "primary outcome", "target_id": "vaccine dose", "strength": 4}, {"source_id": "viral replication", "target_id": "SARS-CoV-2 replication", "strength": 4}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "cohort study", "strength": 4}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "time points", "strength": 4}, {"source_id": "booster doses", "target_id": "dose", "strength": 4}, {"source_id": "antibody levels", "target_id": "SARS-CoV-2 antibodies", "strength": 4}, {"source_id": "antibody levels", "target_id": "prospective cohort study", "strength": 4}, {"source_id": "dose", "target_id": "booster doses", "strength": 4}, {"source_id": "C-reactive protein", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "autoimmune diseases", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "risk factors", "target_id": "observational cohort study", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "quality of life", "strength": 4}, {"source_id": "quality of life", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "quality of life", "target_id": "systematic review", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "cancer patients", "strength": 4}, {"source_id": "viral load", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "respiratory disease", "target_id": "immune response", "strength": 4}, {"source_id": "control group", "target_id": "inclusion criteria", "strength": 4}, {"source_id": "systematic review", "target_id": "mental health outcomes", "strength": 4}, {"source_id": "disease 2019 pandemic", "target_id": "observational study", "strength": 4}, {"source_id": "symptoms", "target_id": "physical activity", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "logistic regression analysis", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "logistic regression analysis", "strength": 4}, {"source_id": "mortality", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "primary outcome", "target_id": "outcome measures", "strength": 4}, {"source_id": "mortality", "target_id": "therapy", "strength": 4}, {"source_id": "case-control study", "target_id": "disease severity", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "severe disease", "strength": 4}, {"source_id": "severe disease", "target_id": "syndrome coronavirus 2", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "observational cohort study", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "logistic regression", "strength": 4}, {"source_id": "risk factors", "target_id": "care workers", "strength": 4}, {"source_id": "health interventions", "target_id": "risk factors", "strength": 4}, {"source_id": "mental health", "target_id": "health interventions", "strength": 4}, {"source_id": "systematic review", "target_id": "mental health problems", "strength": 4}, {"source_id": "hospital admission", "target_id": "study period", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "retrospective cohort study", "strength": 4}, {"source_id": "study period", "target_id": "hospital admission", "strength": 4}, {"source_id": "electronic health records", "target_id": "hospital admission", "strength": 4}, {"source_id": "case-control study", "target_id": "cohort study", "strength": 4}, {"source_id": "cohort study", "target_id": "case-control study", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "mean age", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "University Hospital", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "distress syndrome", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "distress syndrome", "target_id": "coronavirus disease", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "coronavirus disease", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "high prevalence", "strength": 4}, {"source_id": "high prevalence", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "cohort", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "medical students", "target_id": "course", "strength": 4}, {"source_id": "research", "target_id": "skills", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "genes", "strength": 4}, {"source_id": "chronic kidney disease", "target_id": "heart failure", "strength": 4}, {"source_id": "infection", "target_id": "chronic kidney disease", "strength": 4}, {"source_id": "primary outcome", "target_id": "ill patients", "strength": 4}, {"source_id": "cohort study", "target_id": "kidney disease", "strength": 4}, {"source_id": "median age", "target_id": "disease", "strength": 4}, {"source_id": "mortality rate", "target_id": "odds ratio", "strength": 4}, {"source_id": "mortality", "target_id": "myocardial infarction", "strength": 4}, {"source_id": "cohort study", "target_id": "young adults", "strength": 4}, {"source_id": "diagnosis", "target_id": "mortality", "strength": 4}, {"source_id": "infection", "target_id": "odds ratio", "strength": 4}, {"source_id": "median age", "target_id": "logistic regression models", "strength": 4}, {"source_id": "electronic health records", "target_id": "vaccination", "strength": 4}, {"source_id": "third dose", "target_id": "mRNA vaccination", "strength": 4}, {"source_id": "vaccination", "target_id": "electronic health records", "strength": 4}, {"source_id": "dose", "target_id": "adverse events", "strength": 4}, {"source_id": "perspective", "target_id": "interviews", "strength": 4}, {"source_id": "symptoms", "target_id": "clinical characteristics", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "odds ratio", "strength": 4}, {"source_id": "COVID-19 disease", "target_id": "adverse events", "strength": 4}, {"source_id": "adverse events", "target_id": "COVID-19 disease", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "Omicron infection", "strength": 4}, {"source_id": "Omicron infection", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "healthcare workers", "target_id": "age groups", "strength": 4}, {"source_id": "viral load", "target_id": "severe disease", "strength": 4}, {"source_id": "study population", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "policy", "target_id": "mental health", "strength": 4}, {"source_id": "mental health", "target_id": "policy", "strength": 4}, {"source_id": "immune response", "target_id": "genes", "strength": 4}, {"source_id": "COVID-19 disease", "target_id": "high risk", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "third dose", "strength": 4}, {"source_id": "third dose", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "intensive care unit", "target_id": "systematic review", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "vaccination status", "strength": 4}, {"source_id": "clinical characteristics", "target_id": "hospital admission", "strength": 4}, {"source_id": "risk factors", "target_id": "Omicron variant", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "animal models", "strength": 4}, {"source_id": "ICU admission", "target_id": "vaccine", "strength": 4}, {"source_id": "vaccine", "target_id": "ICU admission", "strength": 4}, {"source_id": "vaccination campaign", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "immune response", "target_id": "study period", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "health outcomes", "target_id": "health concern", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 4}, {"source_id": "mental health", "target_id": "clinical practice", "strength": 4}, {"source_id": "need", "target_id": "learners", "strength": 4}, {"source_id": "COVID-19", "target_id": "independent predictors", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "course", "target_id": "perception", "strength": 4}, {"source_id": "perception", "target_id": "learning", "strength": 4}, {"source_id": "hospital mortality", "target_id": "intensive care unit admission", "strength": 4}, {"source_id": "ill patients", "target_id": "ICU admission", "strength": 4}, {"source_id": "study period", "target_id": "patient outcomes", "strength": 4}, {"source_id": "symptom onset", "target_id": "COVID-19", "strength": 4}, {"source_id": "dose", "target_id": "spike protein", "strength": 4}, {"source_id": "pregnant women", "target_id": "mental health", "strength": 4}, {"source_id": "women", "target_id": "mental health", "strength": 4}, {"source_id": "hospitalization", "target_id": "age groups", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "vaccine dose", "strength": 4}, {"source_id": "vaccination status", "target_id": "vaccine hesitancy", "strength": 4}, {"source_id": "Delta variant", "target_id": "booster doses", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "emergency department", "strength": 4}, {"source_id": "infection", "target_id": "SARS-CoV-2 vaccination", "strength": 4}, {"source_id": "clinical care", "target_id": "COVID-19", "strength": 4}, {"source_id": "health professionals", "target_id": "care services", "strength": 4}, {"source_id": "risk factors", "target_id": "clinical practice", "strength": 4}, {"source_id": "cause mortality", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "blood samples", "target_id": "risk factors", "strength": 4}, {"source_id": "healthy controls", "target_id": "adult patients", "strength": 4}, {"source_id": "adult patients", "target_id": "healthy controls", "strength": 4}, {"source_id": "clinical characteristics", "target_id": "inflammatory syndrome", "strength": 4}, {"source_id": "SARS-CoV-2 replication", "target_id": "epithelial cells", "strength": 4}, {"source_id": "cohort study", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "World Health Organization", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "World Health Organization", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "ill patients", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "Health Organization", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "pregnant women", "strength": 4}, {"source_id": "middle-income countries", "target_id": "clinical trials", "strength": 4}, {"source_id": "study period", "target_id": "Delta variant", "strength": 4}, {"source_id": "hospital admission", "target_id": "unit admission", "strength": 4}, {"source_id": "cancer patients", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "students", "target_id": "anxiety", "strength": 4}, {"source_id": "anxiety", "target_id": "psychological distress", "strength": 4}, {"source_id": "disease 2019", "target_id": "case report", "strength": 4}, {"source_id": "coronavirus 2 infection", "target_id": "case report", "strength": 4}, {"source_id": "article", "target_id": "politics", "strength": 4}, {"source_id": "disease progression", "target_id": "therapeutic strategies", "strength": 4}, {"source_id": "therapeutic strategies", "target_id": "disease progression", "strength": 4}, {"source_id": "retrospective study", "target_id": "University Hospital", "strength": 4}, {"source_id": "retrospective study", "target_id": "disease severity", "strength": 4}, {"source_id": "disease severity", "target_id": "retrospective study", "strength": 4}, {"source_id": "admission", "target_id": "retrospective study", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "immune response", "strength": 4}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "immune response", "strength": 4}, {"source_id": "epithelial cells", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "patients", "target_id": "psychological distress", "strength": 4}, {"source_id": "psychological distress", "target_id": "patients", "strength": 4}, {"source_id": "logistic regression models", "target_id": "health system", "strength": 4}, {"source_id": "adverse outcomes", "target_id": "high risk", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "pregnant women", "strength": 4}, {"source_id": "pregnant women", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "thematic analysis", "target_id": "people", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "SARS-CoV2", "strength": 4}, {"source_id": "SARS-CoV2", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "lung disease", "target_id": "infection", "strength": 4}, {"source_id": "education", "target_id": "justice", "strength": 4}, {"source_id": "teaching", "target_id": "context", "strength": 4}, {"source_id": "viral load", "target_id": "antibody titers", "strength": 4}, {"source_id": "Delta variant", "target_id": "dose", "strength": 4}, {"source_id": "immune response", "target_id": "health care workers", "strength": 4}, {"source_id": "dose", "target_id": "severe disease", "strength": 4}, {"source_id": "T cell responses", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "T cell responses", "strength": 4}, {"source_id": "mortality", "target_id": "heart failure", "strength": 4}, {"source_id": "cohort study", "target_id": "electronic medical records", "strength": 4}, {"source_id": "cohort study", "target_id": "Medical Center", "strength": 4}, {"source_id": "disease control", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "age groups", "strength": 4}, {"source_id": "vaccine", "target_id": "study population", "strength": 4}, {"source_id": "hospitalization", "target_id": "booster dose", "strength": 4}, {"source_id": "beneficial effects", "target_id": "control group", "strength": 4}, {"source_id": "autoimmune diseases", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "disease", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "SARS-CoV-2 Omicron variant", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "cancer", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "diabetes mellitus", "strength": 4}, {"source_id": "emergency department", "target_id": "symptoms", "strength": 4}, {"source_id": "COVID-19", "target_id": "health professionals", "strength": 4}, {"source_id": "health professionals", "target_id": "COVID-19", "strength": 4}, {"source_id": "hospital admission", "target_id": "mean age", "strength": 4}, {"source_id": "transplant recipients", "target_id": "cohort study", "strength": 4}, {"source_id": "respiratory disease", "target_id": "risk factors", "strength": 4}, {"source_id": "control group", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "respiratory tract", "target_id": "viral infection", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "adult patients", "strength": 4}, {"source_id": "epithelial cells", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "cardiovascular disease", "target_id": "immune response", "strength": 4}, {"source_id": "mortality rate", "target_id": "ICU admission", "strength": 4}, {"source_id": "ICU admission", "target_id": "systematic review", "strength": 4}, {"source_id": "systematic review", "target_id": "ICU admission", "strength": 4}, {"source_id": "mortality", "target_id": "body mass index", "strength": 4}, {"source_id": "clinical trials", "target_id": "animal models", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "prevalence", "strength": 4}, {"source_id": "Health Organization", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "pregnant women", "strength": 4}, {"source_id": "clinical practice", "target_id": "disease 2019", "strength": 4}, {"source_id": "health care", "target_id": "patients", "strength": 4}, {"source_id": "health interventions", "target_id": "public health measures", "strength": 4}, {"source_id": "qualitative study", "target_id": "research", "strength": 4}, {"source_id": "median age", "target_id": "disease 2019", "strength": 4}, {"source_id": "mental health", "target_id": "high risk", "strength": 4}, {"source_id": "protein", "target_id": "genes", "strength": 4}, {"source_id": "disease", "target_id": "adult patients", "strength": 4}, {"source_id": "hospitalization", "target_id": "mortality", "strength": 4}, {"source_id": "cohort study", "target_id": "hospital", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "disease", "strength": 4}, {"source_id": "disease", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "body mass index", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "mass index", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "prospective cohort study", "strength": 4}, {"source_id": "cell responses", "target_id": "SARS-CoV-2 vaccination", "strength": 4}, {"source_id": "vaccination rates", "target_id": "vaccine", "strength": 4}, {"source_id": "symptoms", "target_id": "health services", "strength": 4}, {"source_id": "clinical outcomes", "target_id": "median age", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "care unit", "strength": 4}, {"source_id": "autoimmune diseases", "target_id": "viral infection", "strength": 4}, {"source_id": "actors", "target_id": "government", "strength": 4}, {"source_id": "government", "target_id": "actors", "strength": 4}, {"source_id": "organization", "target_id": "government", "strength": 4}, {"source_id": "genes", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "pulmonary disease", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "hospital admission", "target_id": "years of age", "strength": 4}, {"source_id": "median age", "target_id": "lower risk", "strength": 4}, {"source_id": "booster vaccination", "target_id": "SARS-CoV-2 Omicron variant", "strength": 4}, {"source_id": "SARS-CoV2", "target_id": "viral replication", "strength": 4}, {"source_id": "risk factors", "target_id": "syndrome", "strength": 4}, {"source_id": "World Health Organization", "target_id": "distress syndrome", "strength": 4}, {"source_id": "Health Organization", "target_id": "distress syndrome", "strength": 4}, {"source_id": "observational study", "target_id": "second dose", "strength": 4}, {"source_id": "dose", "target_id": "observational study", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "intensive care unit", "strength": 4}, {"source_id": "hospital mortality", "target_id": "disease 2019", "strength": 4}, {"source_id": "hospital stay", "target_id": "retrospective study", "strength": 4}, {"source_id": "disease 2019", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "BNT162b2 vaccine", "target_id": "healthcare workers", "strength": 4}, {"source_id": "antibody levels", "target_id": "side effects", "strength": 4}, {"source_id": "second dose", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "patient outcomes", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "intensive care unit admission", "strength": 4}, {"source_id": "primary outcome", "target_id": "vaccination", "strength": 4}, {"source_id": "mean age", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "clinical outcomes", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "antibody response", "strength": 4}, {"source_id": "MAIN OUTCOME", "target_id": "symptoms", "strength": 4}, {"source_id": "symptoms", "target_id": "general population", "strength": 4}, {"source_id": "care workers", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "mortality", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "primary care", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "electronic medical records", "strength": 4}, {"source_id": "care", "target_id": "logistic regression models", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "booster vaccination", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "study design", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "case series", "strength": 4}, {"source_id": "case series", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "clinical data", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "vaccine dose", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "vaccine dose", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "vaccine dose", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "booster vaccination", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "clinical characteristics", "target_id": "observational study", "strength": 4}, {"source_id": "trials", "target_id": "therapy", "strength": 4}, {"source_id": "retrospective study", "target_id": "vaccination", "strength": 4}, {"source_id": "depressive symptoms", "target_id": "risk factors", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "nervous system", "strength": 4}, {"source_id": "side effects", "target_id": "disease 2019", "strength": 4}, {"source_id": "interviews", "target_id": "discourse", "strength": 4}, {"source_id": "countries", "target_id": "context", "strength": 4}, {"source_id": "qualitative study", "target_id": "people", "strength": 4}, {"source_id": "people", "target_id": "qualitative study", "strength": 4}, {"source_id": "United States", "target_id": "experience", "strength": 4}, {"source_id": "experience", "target_id": "United States", "strength": 4}, {"source_id": "book", "target_id": "actors", "strength": 4}, {"source_id": "article", "target_id": "schools", "strength": 4}, {"source_id": "immune response", "target_id": "World Health Organization", "strength": 4}, {"source_id": "primary endpoint", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "C-reactive protein", "target_id": "infection", "strength": 4}, {"source_id": "infection", "target_id": "C-reactive protein", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "illness", "strength": 4}, {"source_id": "age groups", "target_id": "disease", "strength": 4}, {"source_id": "adverse events", "target_id": "clinical studies", "strength": 4}, {"source_id": "T cells", "target_id": "risk factors", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "coronavirus 2 infection", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "clinical presentation", "strength": 4}, {"source_id": "Web of Science", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "clinical presentation", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "symptoms", "strength": 4}, {"source_id": "disease 2019", "target_id": "Web of Science", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "mortality", "target_id": "high mortality", "strength": 4}, {"source_id": "cohort", "target_id": "infection", "strength": 4}, {"source_id": "health outcomes", "target_id": "high risk", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "hospital admission", "strength": 4}, {"source_id": "higher odds", "target_id": "logistic regression models", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "diagnosis", "strength": 4}, {"source_id": "infection", "target_id": "infection rate", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "care unit admission", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "unit admission", "strength": 4}, {"source_id": "unit admission", "target_id": "disease 2019", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "vaccination", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "COVID-19 outcomes", "target_id": "vaccination", "strength": 4}, {"source_id": "vaccine effectiveness", "target_id": "study period", "strength": 4}, {"source_id": "vaccination", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "long COVID", "target_id": "risk factors", "strength": 4}, {"source_id": "prospective cohort study", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "humoral immune response", "target_id": "Delta variant", "strength": 4}, {"source_id": "cohort study", "target_id": "booster vaccination", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "treatment strategies", "strength": 4}, {"source_id": "treatment strategies", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "viral infection", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 4}, {"source_id": "viral infection", "target_id": "disease 2019 pandemic", "strength": 4}, {"source_id": "algorithm", "target_id": "neural network", "strength": 4}, {"source_id": "interviews", "target_id": "practice", "strength": 4}, {"source_id": "institutions", "target_id": "skills", "strength": 4}, {"source_id": "engagement", "target_id": "policy", "strength": 4}, {"source_id": "schools", "target_id": "training", "strength": 4}, {"source_id": "skills", "target_id": "participants", "strength": 4}, {"source_id": "book", "target_id": "students", "strength": 4}, {"source_id": "body mass index", "target_id": "control group", "strength": 4}, {"source_id": "body mass index", "target_id": "weight loss", "strength": 4}, {"source_id": "hospital stay", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "therapy", "target_id": "adult patients", "strength": 4}, {"source_id": "infection rate", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "years of age", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "risk factors", "target_id": "infection rate", "strength": 4}, {"source_id": "age groups", "target_id": "risk factors", "strength": 4}, {"source_id": "coronavirus disease", "target_id": "risk factors", "strength": 4}, {"source_id": "mortality", "target_id": "mean age", "strength": 4}, {"source_id": "observational study", "target_id": "antibody response", "strength": 4}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 vaccines", "strength": 4}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "third dose", "strength": 4}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "dose", "strength": 4}, {"source_id": "humoral immune response", "target_id": "years of age", "strength": 4}, {"source_id": "COVID-19", "target_id": "viral replication", "strength": 4}, {"source_id": "viral replication", "target_id": "COVID-19", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "severe COVID-19", "strength": 4}, {"source_id": "World Health Organization", "target_id": "spike protein", "strength": 4}, {"source_id": "severe disease", "target_id": "variants of concern", "strength": 4}, {"source_id": "Health Organization", "target_id": "spike protein", "strength": 4}, {"source_id": "spike protein", "target_id": "Health Organization", "strength": 4}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "COVID-19", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "hospital admission", "strength": 4}, {"source_id": "infectious diseases", "target_id": "viral infection", "strength": 4}, {"source_id": "COVID-19", "target_id": "violence", "strength": 4}, {"source_id": "clinical trials", "target_id": "health services", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "climate change", "strength": 4}, {"source_id": "climate change", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "young adults", "target_id": "COVID-19", "strength": 4}, {"source_id": "health services", "target_id": "health outcomes", "strength": 4}, {"source_id": "COVID-19", "target_id": "mental health outcomes", "strength": 4}, {"source_id": "cohort study", "target_id": "protective effect", "strength": 4}, {"source_id": "protective effect", "target_id": "cohort study", "strength": 4}, {"source_id": "vaccination rates", "target_id": "vaccination coverage", "strength": 4}, {"source_id": "prevalence", "target_id": "high prevalence", "strength": 4}, {"source_id": "prevalence", "target_id": "systematic review", "strength": 4}, {"source_id": "clinical presentation", "target_id": "case report", "strength": 4}, {"source_id": "hospital admission", "target_id": "emergency department", "strength": 4}, {"source_id": "hospital admission", "target_id": "hospital", "strength": 4}, {"source_id": "hospital", "target_id": "hospital admission", "strength": 4}, {"source_id": "care", "target_id": "care settings", "strength": 4}, {"source_id": "vaccine", "target_id": "logistic regression", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "intensive care", "strength": 4}, {"source_id": "clinical care", "target_id": "primary care", "strength": 4}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "injury", "strength": 4}, {"source_id": "injury", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "COVID-19 pneumonia", "target_id": "mortality", "strength": 4}, {"source_id": "risk factors", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "severe COVID-19", "target_id": "respiratory failure", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "C-reactive protein", "strength": 4}, {"source_id": "health care professionals", "target_id": "systematic review", "strength": 4}, {"source_id": "kidney disease", "target_id": "diabetes mellitus", "strength": 4}, {"source_id": "mortality rate", "target_id": "Omicron variant", "strength": 4}, {"source_id": "Omicron variant", "target_id": "mortality rate", "strength": 4}, {"source_id": "inclusion criteria", "target_id": "observational study", "strength": 4}, {"source_id": "vaccination program", "target_id": "vaccination rates", "strength": 4}, {"source_id": "clinical data", "target_id": "electronic health records", "strength": 4}, {"source_id": "infection", "target_id": "health system", "strength": 4}, {"source_id": "young adults", "target_id": "time points", "strength": 4}, {"source_id": "logistic regression", "target_id": "hospital mortality", "strength": 4}, {"source_id": "greater risk", "target_id": "cohort study", "strength": 4}, {"source_id": "median age", "target_id": "antibody response", "strength": 4}, {"source_id": "antiviral activity", "target_id": "SARS-CoV-2 variants", "strength": 4}, {"source_id": "mechanical ventilation", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "pandemic", "target_id": "learners", "strength": 4}, {"source_id": "article", "target_id": "teaching", "strength": 4}, {"source_id": "viral infection", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 4}, {"source_id": "viral infection", "target_id": "syndrome coronavirus 2 infection", "strength": 4}, {"source_id": "SARS-CoV-2 replication", "target_id": "viral replication", "strength": 4}, {"source_id": "study period", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "clinical symptoms", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "disease severity", "target_id": "clinical symptoms", "strength": 4}, {"source_id": "older adults", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "systematic review", "target_id": "quality of life", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "health system", "strength": 4}, {"source_id": "hospitalized patients", "target_id": "systematic review", "strength": 4}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "adverse events", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "viral load", "strength": 4}, {"source_id": "respiratory disease", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "immune response", "target_id": "respiratory disease", "strength": 4}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "observational study", "strength": 4}, {"source_id": "observational study", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 4}, {"source_id": "observational study", "target_id": "mean age", "strength": 4}, {"source_id": "social support", "target_id": "COVID-19", "strength": 4}, {"source_id": "multiple sclerosis", "target_id": "COVID-19", "strength": 4}, {"source_id": "disease", "target_id": "mortality rate", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "mortality", "strength": 4}, {"source_id": "mortality", "target_id": "distress syndrome", "strength": 4}, {"source_id": "outcome measures", "target_id": "primary outcome", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "case-control study", "target_id": "hospital admission", "strength": 4}, {"source_id": "hospital admission", "target_id": "case-control study", "strength": 4}, {"source_id": "cause mortality", "target_id": "adverse events", "strength": 4}, {"source_id": "clinical trials", "target_id": "disease", "strength": 4}, {"source_id": "disease", "target_id": "clinical trials", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "diabetes mellitus", "strength": 4}, {"source_id": "infection", "target_id": "women", "strength": 4}, {"source_id": "Web of Science", "target_id": "Meta-Analysis", "strength": 4}, {"source_id": "observational cohort study", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "logistic regression", "target_id": "retrospective study", "strength": 4}, {"source_id": "use disorders", "target_id": "MAIN OUTCOME", "strength": 4}, {"source_id": "retrospective cohort study", "target_id": "use disorders", "strength": 4}, {"source_id": "risk factors", "target_id": "health care workers", "strength": 4}, {"source_id": "study period", "target_id": "care workers", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "odds ratio", "strength": 4}, {"source_id": "odds ratio", "target_id": "emergency department", "strength": 4}, {"source_id": "odds ratio", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "mean age", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "distress syndrome", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "respiratory distress syndrome", "target_id": "coronavirus disease", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "coronavirus 2", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "coronavirus disease", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "ICU admission", "target_id": "Omicron variant", "strength": 4}, {"source_id": "care", "target_id": "women", "strength": 4}, {"source_id": "risk factors", "target_id": "respiratory symptoms", "strength": 4}, {"source_id": "hospital discharge", "target_id": "risk factors", "strength": 4}, {"source_id": "cross-sectional study", "target_id": "older age", "strength": 4}, {"source_id": "high prevalence", "target_id": "mortality rate", "strength": 4}, {"source_id": "multiple sclerosis", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "high risk", "target_id": "pregnant women", "strength": 4}, {"source_id": "health system", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "neural network", "target_id": "artificial intelligence", "strength": 4}, {"source_id": "myocardial infarction", "target_id": "observational study", "strength": 4}, {"source_id": "infection", "target_id": "most patients", "strength": 4}, {"source_id": "ill patients", "target_id": "primary outcome", "strength": 4}, {"source_id": "kidney disease", "target_id": "cohort study", "strength": 4}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 transmission", "strength": 4}, {"source_id": "health outcomes", "target_id": "use disorders", "strength": 4}, {"source_id": "mental health", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "protective effect", "strength": 4}, {"source_id": "observational study", "target_id": "Meta-Analysis", "strength": 4}, {"source_id": "mRNA vaccination", "target_id": "third dose", "strength": 4}, {"source_id": "vaccination", "target_id": "health records", "strength": 4}, {"source_id": "dose", "target_id": "vaccine doses", "strength": 4}, {"source_id": "Medical Center", "target_id": "observational study", "strength": 4}, {"source_id": "age groups", "target_id": "healthcare workers", "strength": 4}, {"source_id": "odds ratio", "target_id": "SARS-CoV-2", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "Omicron variant", "strength": 4}, {"source_id": "Omicron variant", "target_id": "COVID-19 vaccination", "strength": 4}, {"source_id": "viral load", "target_id": "disease severity", "strength": 4}, {"source_id": "observational study", "target_id": "COVID-19 severity", "strength": 4}, {"source_id": "lower risk", "target_id": "symptoms", "strength": 4}, {"source_id": "symptoms", "target_id": "lower risk", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "vaccination campaign", "strength": 4}, {"source_id": "context", "target_id": "institutions", "strength": 4}, {"source_id": "high risk", "target_id": "COVID-19 disease", "strength": 4}, {"source_id": "systematic review", "target_id": "care unit", "strength": 4}, {"source_id": "adult patients", "target_id": "disease severity", "strength": 4}, {"source_id": "vaccination status", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "intervention group", "target_id": "adverse events", "strength": 4}, {"source_id": "clinical characteristics", "target_id": "risk factors", "strength": 4}, {"source_id": "Omicron variant", "target_id": "admission", "strength": 4}, {"source_id": "risk factors", "target_id": "clinical characteristics", "strength": 4}, {"source_id": "COVID-19", "target_id": "flow cytometry", "strength": 4}, {"source_id": "observational cohort study", "target_id": "lower risk", "strength": 4}, {"source_id": "lower risk", "target_id": "observational cohort study", "strength": 4}, {"source_id": "animal models", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 cases", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "disease 2019", "strength": 4}, {"source_id": "study period", "target_id": "immune response", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "cross-sectional study", "strength": 4}, {"source_id": "health concern", "target_id": "health outcomes", "strength": 4}, {"source_id": "SARS-CoV-2 variants", "target_id": "disease 2019 pandemic", "strength": 4}, {"source_id": "clinical practice", "target_id": "mental health", "strength": 4}, {"source_id": "social media", "target_id": "pandemic", "strength": 4}, {"source_id": "schools", "target_id": "institutions", "strength": 4}, {"source_id": "learners", "target_id": "need", "strength": 4}, {"source_id": "independent predictors", "target_id": "COVID-19", "strength": 4}, {"source_id": "COVID-19 vaccine", "target_id": "COVID-19 pandemic", "strength": 4}, {"source_id": "need", "target_id": "policy", "strength": 4}, {"source_id": "hospital mortality", "target_id": "care unit admission", "strength": 4}, {"source_id": "patient outcomes", "target_id": "mortality", "strength": 4}, {"source_id": "intensive care unit admission", "target_id": "hospital mortality", "strength": 4}, {"source_id": "care unit admission", "target_id": "hospital mortality", "strength": 4}, {"source_id": "length of stay", "target_id": "mortality", "strength": 4}, {"source_id": "mortality", "target_id": "length of stay", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "inflammation", "strength": 4}, {"source_id": "interviews", "target_id": "organization", "strength": 4}, {"source_id": "systematic review", "target_id": "clinical studies", "strength": 4}, {"source_id": "kidney disease", "target_id": "logistic regression", "strength": 4}, {"source_id": "mortality rate", "target_id": "logistic regression", "strength": 4}, {"source_id": "vaccination status", "target_id": "vaccine uptake", "strength": 4}, {"source_id": "booster doses", "target_id": "Delta variant", "strength": 4}, {"source_id": "cohort", "target_id": "adult patients", "strength": 4}, {"source_id": "years of age", "target_id": "logistic regression models", "strength": 4}, {"source_id": "primary care", "target_id": "mental health", "strength": 4}, {"source_id": "teachers", "target_id": "thematic analysis", "strength": 4}, {"source_id": "COVID-19 patients", "target_id": "cause mortality", "strength": 4}, {"source_id": "COVID-19", "target_id": "immune cells", "strength": 4}, {"source_id": "acute respiratory distress syndrome", "target_id": "risk factors", "strength": 4}, {"source_id": "risk factors", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "risk factors", "target_id": "prospective study", "strength": 4}, {"source_id": "hazard ratio", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "gene expression", "strength": 4}, {"source_id": "cohort study", "target_id": "respiratory distress syndrome", "strength": 4}, {"source_id": "median age", "target_id": "mechanical ventilation", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "ill patients", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "Health Organization", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "World Health Organization", "strength": 4}, {"source_id": "World Health Organization", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "ill patients", "target_id": "acute respiratory distress syndrome", "strength": 4}, {"source_id": "clinical trials", "target_id": "middle-income countries", "strength": 4}, {"source_id": "observational study", "target_id": "COVID-19 outcomes", "strength": 4}, {"source_id": "disease 2019", "target_id": "clinical studies", "strength": 4}, {"source_id": "lower risk", "target_id": "Omicron variant", "strength": 4}, {"source_id": "older adults", "target_id": "mortality", "strength": 4}, {"source_id": "mRNA vaccines", "target_id": "median age", "strength": 4}, {"source_id": "COVID-19 severity", "target_id": "disease progression", "strength": 4}, {"source_id": "case report", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 4}, {"source_id": "viral infection", "target_id": "epithelial cells", "strength": 4}, {"source_id": "learners", "target_id": "curriculum", "strength": 4}, {"source_id": "adverse events", "target_id": "disease progression", "strength": 4}, {"source_id": "antibody response", "target_id": "variants of concern", "strength": 4}, {"source_id": "age groups", "target_id": "vaccine doses", "strength": 4}, {"source_id": "vaccination status", "target_id": "vaccine doses", "strength": 4}, {"source_id": "coronavirus disease", "target_id": "adult patients", "strength": 4}, {"source_id": "quality of life", "target_id": "cohort study", "strength": 4}, {"source_id": "syndrome coronavirus 2", "target_id": "pregnant women", "strength": 4}, {"source_id": "pregnant women", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "pain", "target_id": "study protocol", "strength": 4}, {"source_id": "SARS-CoV2", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "SARS-CoV2", "target_id": "coronavirus 2", "strength": 4}, {"source_id": "coronavirus disease 2019", "target_id": "acute phase", "strength": 4}, {"source_id": "skills", "target_id": "semi-structured interviews", "strength": 4}, {"source_id": "context", "target_id": "research", "strength": 4}, {"source_id": "antibody titers", "target_id": "viral load", "strength": 4}, {"source_id": "injury", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "severe illness", "target_id": "COVID-19 vaccine", "strength": 4}, {"source_id": "study population", "target_id": "COVID-19 patients", "strength": 4}, {"source_id": "median age", "target_id": "hospital admission", "strength": 4}, {"source_id": "disease severity", "target_id": "median age", "strength": 4}, {"source_id": "study period", "target_id": "retrospective study", "strength": 4}, {"source_id": "mRNA vaccination", "target_id": "T cell responses", "strength": 4}, {"source_id": "T cells", "target_id": "dose", "strength": 4}, {"source_id": "vaccine", "target_id": "most patients", "strength": 4}, {"source_id": "T cell responses", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "T cell responses", "strength": 4}, {"source_id": "electronic medical records", "target_id": "cohort study", "strength": 4}, {"source_id": "booster doses", "target_id": "hospitalization", "strength": 4}, {"source_id": "clinical trials", "target_id": "Health Organization", "strength": 4}, {"source_id": "age groups", "target_id": "vaccination rates", "strength": 4}, {"source_id": "Secondary outcomes", "target_id": "women", "strength": 4}, {"source_id": "women", "target_id": "Secondary outcomes", "strength": 4}, {"source_id": "symptoms", "target_id": "primary outcome", "strength": 4}, {"source_id": "COVID-19 vaccination", "target_id": "autoimmune diseases", "strength": 4}, {"source_id": "mouse model", "target_id": "disease", "strength": 4}, {"source_id": "time points", "target_id": "SARS-CoV-2 infection", "strength": 4}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "disease 2019", "strength": 4}, {"source_id": "disease progression", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "disease 2019", "target_id": "disease progression", "strength": 4}, {"source_id": "pediatric patients", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "receptor-binding domain", "strength": 4}, {"source_id": "receptor-binding domain", "target_id": "respiratory syndrome coronavirus 2", "strength": 4}, {"source_id": "artificial intelligence", "target_id": "algorithm", "strength": 4}, {"source_id": "children", "target_id": "pandemic", "strength": 4}, {"source_id": "clinical trials", "target_id": "hospitalization", "strength": 4}, {"source_id": "young adults", "target_id": "vaccination", "strength": 4}, {"source_id": "COVID-19 infection", "target_id": "acute infection", "strength": 4}, {"source_id": "acute infection", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "race/ethnicity", "target_id": "cohort study", "strength": 4}, {"source_id": "cohort study", "target_id": "race/ethnicity", "strength": 4}, {"source_id": "SARS-CoV-2", "target_id": "clinical data", "strength": 4}, {"source_id": "viral infection", "target_id": "respiratory tract", "strength": 4}, {"source_id": "epithelial cells", "target_id": "immune response", "strength": 4}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "epithelial cells", "strength": 4}, {"source_id": "animal models", "target_id": "clinical trials", "strength": 4}, {"source_id": "COVID-19 cases", "target_id": "cohort study", "strength": 4}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "nasopharyngeal swabs", "strength": 4}, {"source_id": "clinical practice", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "vaccine", "target_id": "health system", "strength": 4}, {"source_id": "health system", "target_id": "vaccine", "strength": 4}, {"source_id": "public health measures", "target_id": "health interventions", "strength": 4}, {"source_id": "health interventions", "target_id": "health measures", "strength": 4}, {"source_id": "narratives", "target_id": "book", "strength": 4}, {"source_id": "book", "target_id": "narratives", "strength": 4}, {"source_id": "training", "target_id": "curriculum", "strength": 4}, {"source_id": "ICU admission", "target_id": "median age", "strength": 4}, {"source_id": "disease 2019", "target_id": "median age", "strength": 4}, {"source_id": "T cells", "target_id": "blood samples", "strength": 4}, {"source_id": "SARS-CoV-2 infection", "target_id": "inflammatory diseases", "strength": 4}, {"source_id": "complications", "target_id": "risk factors", "strength": 4}, {"source_id": "Omicron variant", "target_id": "BNT162b2 vaccine", "strength": 4}, {"source_id": "BNT162b2 vaccine", "target_id": "Omicron variant", "strength": 4}, {"source_id": "SARS-CoV-2 replication", "target_id": "therapeutic target", "strength": 4}, {"source_id": "therapeutic target", "target_id": "SARS-CoV-2 replication", "strength": 4}, {"source_id": "quality of life", "target_id": "care", "strength": 4}, {"source_id": "symptoms", "target_id": "nervous system", "strength": 4}, {"source_id": "mortality", "target_id": "hospitalization", "strength": 4}, {"source_id": "COVID-19 severity", "target_id": "retrospective study", "strength": 4}, {"source_id": "prospective cohort study", "target_id": "mRNA vaccines", "strength": 4}, {"source_id": "vaccination", "target_id": "case series", "strength": 4}, {"source_id": "pandemic", "target_id": "discourse", "strength": 4}, {"source_id": "discourse", "target_id": "pandemic", "strength": 4}, {"source_id": "therapy", "target_id": "cancer patients", "strength": 4}, {"source_id": "breakthrough infections", "target_id": "antibody levels", "strength": 4}, {"source_id": "antibody levels", "target_id": "breakthrough infections", "strength": 4}, {"source_id": "disease severity", "target_id": "viral infection", "strength": 4}, {"source_id": "vaccine", "target_id": "intensive care unit admission", "strength": 4}, {"source_id": "clinical trials", "target_id": "infectious diseases", "strength": 4}, {"source_id": "health services", "target_id": "symptoms", "strength": 4}, {"source_id": "United States", "target_id": "COVID-19", "strength": 4}, {"source_id": "Meta-Analysis", "target_id": "mortality", "strength": 4}, {"source_id": "mortality rate", "target_id": "diabetes mellitus", "strength": 4}, {"source_id": "care unit", "target_id": "COVID-19 pneumonia", "strength": 4}, {"source_id": "nervous system", "target_id": "COVID-19 infection", "strength": 4}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "systematic review", "strength": 4}, {"source_id": "COVID-19 pandemic", "target_id": "coronavirus disease 2019", "strength": 4}, {"source_id": "Delta variant", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "BNT162b2 vaccine", "target_id": "third dose", "strength": 5}, {"source_id": "primary outcome", "target_id": "second dose", "strength": 5}, {"source_id": "COVID-19 pneumonia", "target_id": "adverse events", "strength": 5}, {"source_id": "COVID-19 pneumonia", "target_id": "adult patients", "strength": 5}, {"source_id": "adverse events", "target_id": "adult patients", "strength": 5}, {"source_id": "medical records", "target_id": "observational study", "strength": 5}, {"source_id": "second dose", "target_id": "side effects", "strength": 5}, {"source_id": "type 2 diabetes", "target_id": "blood pressure", "strength": 5}, {"source_id": "blood pressure", "target_id": "risk factors", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "transplant recipients", "strength": 5}, {"source_id": "transplant recipients", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "care unit admission", "strength": 5}, {"source_id": "primary outcome", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "mean age", "strength": 5}, {"source_id": "mean age", "target_id": "adverse events", "strength": 5}, {"source_id": "hospitalization", "target_id": "ICU admission", "strength": 5}, {"source_id": "infection", "target_id": "case-control study", "strength": 5}, {"source_id": "observational study", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "disease 2019", "target_id": "COVID-19 outcomes", "strength": 5}, {"source_id": "greater risk", "target_id": "COVID-19", "strength": 5}, {"source_id": "mortality", "target_id": "severe COVID-19", "strength": 5}, {"source_id": "disease", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "disease", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "systematic review", "target_id": "study protocol", "strength": 5}, {"source_id": "years of age", "target_id": "vaccination", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "years of age", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "study participants", "strength": 5}, {"source_id": "COVID-19 diagnosis", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "intensive care unit", "target_id": "therapy", "strength": 5}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "COVID-19", "strength": 5}, {"source_id": "kidney disease", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "disease severity", "target_id": "vaccine", "strength": 5}, {"source_id": "vaccination", "target_id": "vaccination program", "strength": 5}, {"source_id": "vaccination", "target_id": "disease", "strength": 5}, {"source_id": "disease", "target_id": "chronic diseases", "strength": 5}, {"source_id": "central nervous system", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "side effects", "strength": 5}, {"source_id": "educators", "target_id": "teaching", "strength": 5}, {"source_id": "experience", "target_id": "program", "strength": 5}, {"source_id": "sociodemographic characteristics", "target_id": "mental health", "strength": 5}, {"source_id": "central nervous system", "target_id": "Alzheimer's disease", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "vaccination rates", "strength": 5}, {"source_id": "vaccination rates", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 RNA", "strength": 5}, {"source_id": "clinical trials", "target_id": "World Health Organization", "strength": 5}, {"source_id": "pandemic", "target_id": "article", "strength": 5}, {"source_id": "research", "target_id": "experience", "strength": 5}, {"source_id": "higher education", "target_id": "practice", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "study period", "strength": 5}, {"source_id": "flow cytometry", "target_id": "infection", "strength": 5}, {"source_id": "mean age", "target_id": "study period", "strength": 5}, {"source_id": "viral load", "target_id": "COVID-19", "strength": 5}, {"source_id": "clinical studies", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "cancer", "target_id": "logistic regression", "strength": 5}, {"source_id": "logistic regression", "target_id": "cancer", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "Web of Science", "strength": 5}, {"source_id": "clinical presentation", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "clinical presentation", "target_id": "disease 2019", "strength": 5}, {"source_id": "disease 2019", "target_id": "clinical presentation", "strength": 5}, {"source_id": "older adults", "target_id": "cohort study", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "older adults", "strength": 5}, {"source_id": "cohort study", "target_id": "older adults", "strength": 5}, {"source_id": "COVID-19 diagnosis", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "retrospective cohort study", "target_id": "hospital mortality", "strength": 5}, {"source_id": "incidence rate", "target_id": "vaccine", "strength": 5}, {"source_id": "infection", "target_id": "study design", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "body mass index", "strength": 5}, {"source_id": "mass index", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "incidence rate", "strength": 5}, {"source_id": "acute phase", "target_id": "long COVID", "strength": 5}, {"source_id": "oxidative stress", "target_id": "inflammation", "strength": 5}, {"source_id": "COVID-19 outcomes", "target_id": "severe disease", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "high risk", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "risk factors", "strength": 5}, {"source_id": "logistic regression", "target_id": "years of age", "strength": 5}, {"source_id": "SARS-CoV-2 replication", "target_id": "antiviral activity", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "therapeutic strategies", "strength": 5}, {"source_id": "health concern", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "logistic regression models", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "antibody response", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "antibody response", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "antibody response", "strength": 5}, {"source_id": "antibody response", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "mouse model", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "infection", "target_id": "disease 2019 pandemic", "strength": 5}, {"source_id": "inflammatory response", "target_id": "central nervous system", "strength": 5}, {"source_id": "nervous system", "target_id": "inflammatory response", "strength": 5}, {"source_id": "practice", "target_id": "people", "strength": 5}, {"source_id": "teaching", "target_id": "course", "strength": 5}, {"source_id": "case study", "target_id": "pandemic", "strength": 5}, {"source_id": "booster dose", "target_id": "antibody response", "strength": 5}, {"source_id": "University", "target_id": "engagement", "strength": 5}, {"source_id": "COVID-19", "target_id": "society", "strength": 5}, {"source_id": "primary outcome", "target_id": "mass index", "strength": 5}, {"source_id": "severe COVID-19", "target_id": "hospital admission", "strength": 5}, {"source_id": "mean age", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "autoimmune diseases", "strength": 5}, {"source_id": "vaccine", "target_id": "autoimmune diseases", "strength": 5}, {"source_id": "vaccine", "target_id": "medical records", "strength": 5}, {"source_id": "antibody titers", "target_id": "dose", "strength": 5}, {"source_id": "inflammatory response", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "severe disease", "target_id": "spike protein", "strength": 5}, {"source_id": "United States", "target_id": "politics", "strength": 5}, {"source_id": "crisis", "target_id": "society", "strength": 5}, {"source_id": "clinical data", "target_id": "COVID-19", "strength": 5}, {"source_id": "health services", "target_id": "primary care", "strength": 5}, {"source_id": "Omicron variant", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "COVID-19 symptoms", "target_id": "risk factors", "strength": 5}, {"source_id": "infection", "target_id": "protective effect", "strength": 5}, {"source_id": "healthcare workers", "target_id": "infection rate", "strength": 5}, {"source_id": "booster doses", "target_id": "SARS-CoV-2 variants", "strength": 5}, {"source_id": "mental health", "target_id": "experience", "strength": 5}, {"source_id": "experience", "target_id": "mental health", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "care facilities", "strength": 5}, {"source_id": "participants", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "respiratory failure", "target_id": "mortality", "strength": 5}, {"source_id": "risk factors", "target_id": "respiratory failure", "strength": 5}, {"source_id": "University Hospital", "target_id": "high risk", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "cytokine storm", "strength": 5}, {"source_id": "healthy controls", "target_id": "antibody levels", "strength": 5}, {"source_id": "healthy controls", "target_id": "inflammatory diseases", "strength": 5}, {"source_id": "healthy controls", "target_id": "humoral response", "strength": 5}, {"source_id": "second dose", "target_id": "median age", "strength": 5}, {"source_id": "COVID-19 cases", "target_id": "mortality rate", "strength": 5}, {"source_id": "mental health", "target_id": "health issues", "strength": 5}, {"source_id": "infection", "target_id": "observational study", "strength": 5}, {"source_id": "observational study", "target_id": "care unit", "strength": 5}, {"source_id": "admission", "target_id": "care unit", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "high mortality", "strength": 5}, {"source_id": "observational study", "target_id": "hospital mortality", "strength": 5}, {"source_id": "COVID-19", "target_id": "oxidative stress", "strength": 5}, {"source_id": "COVID-19 severity", "target_id": "cohort study", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "symptoms", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "cohort study", "target_id": "observational study", "strength": 5}, {"source_id": "disease", "target_id": "COVID-19 severity", "strength": 5}, {"source_id": "inflammatory diseases", "target_id": "infection", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "SARS-CoV-2 virus", "strength": 5}, {"source_id": "politics", "target_id": "government", "strength": 5}, {"source_id": "governance", "target_id": "actors", "strength": 5}, {"source_id": "article", "target_id": "students", "strength": 5}, {"source_id": "heart failure", "target_id": "COVID-19", "strength": 5}, {"source_id": "COVID-19", "target_id": "heart failure", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "risk factors", "strength": 5}, {"source_id": "risk factors", "target_id": "high prevalence", "strength": 5}, {"source_id": "infection", "target_id": "high prevalence", "strength": 5}, {"source_id": "serious adverse events", "target_id": "COVID-19", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "D-dimer", "strength": 5}, {"source_id": "intensive care", "target_id": "cohort study", "strength": 5}, {"source_id": "care facilities", "target_id": "infection", "strength": 5}, {"source_id": "intervention group", "target_id": "quality of life", "strength": 5}, {"source_id": "quality of life", "target_id": "intervention group", "strength": 5}, {"source_id": "intensive care unit", "target_id": "coronavirus disease", "strength": 5}, {"source_id": "respiratory disease", "target_id": "disease severity", "strength": 5}, {"source_id": "physical activity", "target_id": "health outcomes", "strength": 5}, {"source_id": "health outcomes", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "mental health", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "disease 2019", "target_id": "mental health", "strength": 5}, {"source_id": "care providers", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "mean age", "target_id": "older adults", "strength": 5}, {"source_id": "intensive care unit", "target_id": "symptoms", "strength": 5}, {"source_id": "young people", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "young people", "strength": 5}, {"source_id": "time points", "target_id": "mental health", "strength": 5}, {"source_id": "severe disease", "target_id": "age groups", "strength": 5}, {"source_id": "independent predictors", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "independent predictors", "target_id": "mortality", "strength": 5}, {"source_id": "serious adverse events", "target_id": "primary endpoint", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "disease 2019", "strength": 5}, {"source_id": "disease 2019", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "body mass index", "strength": 5}, {"source_id": "logistic regression", "target_id": "study period", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "infectious diseases", "strength": 5}, {"source_id": "cohort study", "target_id": "outcome measures", "strength": 5}, {"source_id": "race/ethnicity", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "systematic review", "target_id": "health issues", "strength": 5}, {"source_id": "nervous system", "target_id": "multiple sclerosis", "strength": 5}, {"source_id": "immune response", "target_id": "pregnant women", "strength": 5}, {"source_id": "health system", "target_id": "high risk", "strength": 5}, {"source_id": "crisis", "target_id": "institutions", "strength": 5}, {"source_id": "United States", "target_id": "people", "strength": 5}, {"source_id": "crisis", "target_id": "narratives", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "hospital admission", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "disease 2019", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "women", "target_id": "vaccination", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "clinical characteristics", "strength": 5}, {"source_id": "mRNA vaccination", "target_id": "infection", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "disease severity", "strength": 5}, {"source_id": "vaccine", "target_id": "logistic regression models", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "clinical trials", "strength": 5}, {"source_id": "vaccination", "target_id": "COVID-19 mRNA vaccines", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "clinical studies", "strength": 5}, {"source_id": "COVID-19", "target_id": "study participants", "strength": 5}, {"source_id": "perception", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "disease progression", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "antibody titers", "target_id": "booster dose", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "adverse events", "strength": 5}, {"source_id": "breakthrough infections", "target_id": "severe disease", "strength": 5}, {"source_id": "incidence rate", "target_id": "mortality rate", "strength": 5}, {"source_id": "adult patients", "target_id": "vaccine", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "prospective study", "strength": 5}, {"source_id": "adverse events", "target_id": "immune response", "strength": 5}, {"source_id": "age groups", "target_id": "study period", "strength": 5}, {"source_id": "hospital mortality", "target_id": "ICU admission", "strength": 5}, {"source_id": "adult patients", "target_id": "ICU admission", "strength": 5}, {"source_id": "observational study", "target_id": "respiratory failure", "strength": 5}, {"source_id": "control group", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "crisis", "target_id": "social media", "strength": 5}, {"source_id": "cohort", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "logistic regression", "target_id": "disease", "strength": 5}, {"source_id": "intensive care unit admission", "target_id": "severe COVID-19", "strength": 5}, {"source_id": "severe COVID-19", "target_id": "care unit admission", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "COVID-19 severity", "strength": 5}, {"source_id": "older age", "target_id": "high risk", "strength": 5}, {"source_id": "University Hospital", "target_id": "intensive care unit", "strength": 5}, {"source_id": "risk factors", "target_id": "distress syndrome", "strength": 5}, {"source_id": "vaccine", "target_id": "COVID-19 outcomes", "strength": 5}, {"source_id": "median age", "target_id": "adult patients", "strength": 5}, {"source_id": "women", "target_id": "clinical trials", "strength": 5}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "Omicron infection", "strength": 5}, {"source_id": "violence", "target_id": "policy", "strength": 5}, {"source_id": "schools", "target_id": "children", "strength": 5}, {"source_id": "COVID-19 severity", "target_id": "infection", "strength": 5}, {"source_id": "complications", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "infection", "target_id": "disease control", "strength": 5}, {"source_id": "COVID-19", "target_id": "incidence", "strength": 5}, {"source_id": "adult patients", "target_id": "immune response", "strength": 5}, {"source_id": "cell responses", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "older age", "target_id": "logistic regression analysis", "strength": 5}, {"source_id": "age groups", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "older adults", "strength": 5}, {"source_id": "primary outcome", "target_id": "women", "strength": 5}, {"source_id": "perspective", "target_id": "teachers", "strength": 5}, {"source_id": "high risk", "target_id": "clinical trials", "strength": 5}, {"source_id": "time points", "target_id": "COVID-19", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "disease progression", "strength": 5}, {"source_id": "median age", "target_id": "severe disease", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "immune system", "strength": 5}, {"source_id": "vaccine dose", "target_id": "SARS-CoV-2 variants", "strength": 5}, {"source_id": "antibody response", "target_id": "dose", "strength": 5}, {"source_id": "clinical trials", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "health interventions", "strength": 5}, {"source_id": "health interventions", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "young people", "target_id": "mental health", "strength": 5}, {"source_id": "mental health", "target_id": "young people", "strength": 5}, {"source_id": "people", "target_id": "mental health", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "young adults", "strength": 5}, {"source_id": "logistic regression models", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "mRNA vaccination", "strength": 5}, {"source_id": "teachers", "target_id": "research", "strength": 5}, {"source_id": "infection", "target_id": "years of age", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "nasopharyngeal swabs", "strength": 5}, {"source_id": "general population", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "COVID-19", "target_id": "antibody levels", "strength": 5}, {"source_id": "nervous system", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "cancer patients", "target_id": "breast cancer", "strength": 5}, {"source_id": "case series", "target_id": "vaccine", "strength": 5}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "T cell responses", "strength": 5}, {"source_id": "distress syndrome", "target_id": "cytokine storm", "strength": 5}, {"source_id": "incidence rate", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "Delta variant", "strength": 5}, {"source_id": "SARS-CoV2", "target_id": "infection", "strength": 5}, {"source_id": "intensive care unit", "target_id": "high risk", "strength": 5}, {"source_id": "severe disease", "target_id": "general population", "strength": 5}, {"source_id": "high risk", "target_id": "intensive care unit", "strength": 5}, {"source_id": "patients", "target_id": "Health Organization", "strength": 5}, {"source_id": "BNT162b2 vaccine", "target_id": "dose", "strength": 5}, {"source_id": "intensive care unit", "target_id": "disease 2019", "strength": 5}, {"source_id": "hospital mortality", "target_id": "respiratory failure", "strength": 5}, {"source_id": "respiratory failure", "target_id": "hospital mortality", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "primary outcome", "strength": 5}, {"source_id": "adult patients", "target_id": "COVID-19 pneumonia", "strength": 5}, {"source_id": "primary outcome", "target_id": "disease 2019", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "healthcare workers", "strength": 5}, {"source_id": "healthcare workers", "target_id": "vaccine", "strength": 5}, {"source_id": "syndrome", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "MAIN OUTCOME", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "admission", "strength": 5}, {"source_id": "adverse events", "target_id": "mean age", "strength": 5}, {"source_id": "primary outcome", "target_id": "ICU admission", "strength": 5}, {"source_id": "infection", "target_id": "greater risk", "strength": 5}, {"source_id": "COVID-19", "target_id": "social determinants", "strength": 5}, {"source_id": "severe COVID-19", "target_id": "mortality", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "mortality", "strength": 5}, {"source_id": "social determinants", "target_id": "COVID-19", "strength": 5}, {"source_id": "mortality", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "disease", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "vaccination", "target_id": "years of age", "strength": 5}, {"source_id": "care", "target_id": "health system", "strength": 5}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 antibodies", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "kidney disease", "strength": 5}, {"source_id": "infection", "target_id": "kidney disease", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 vaccines", "strength": 5}, {"source_id": "B cells", "target_id": "vaccine", "strength": 5}, {"source_id": "mechanical ventilation", "target_id": "clinical characteristics", "strength": 5}, {"source_id": "ICU admission", "target_id": "observational study", "strength": 5}, {"source_id": "cohort study", "target_id": "diabetes mellitus", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 spike protein", "strength": 5}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "Alzheimer's disease", "target_id": "nervous system", "strength": 5}, {"source_id": "anxiety", "target_id": "symptoms", "strength": 5}, {"source_id": "breakthrough infections", "target_id": "spike protein", "strength": 5}, {"source_id": "qualitative study", "target_id": "pandemic", "strength": 5}, {"source_id": "experience", "target_id": "violence", "strength": 5}, {"source_id": "United States", "target_id": "pandemic", "strength": 5}, {"source_id": "experience", "target_id": "research", "strength": 5}, {"source_id": "education", "target_id": "article", "strength": 5}, {"source_id": "infection", "target_id": "flow cytometry", "strength": 5}, {"source_id": "retrospective cohort study", "target_id": "MAIN OUTCOME", "strength": 5}, {"source_id": "illness", "target_id": "cohort study", "strength": 5}, {"source_id": "illness", "target_id": "infection", "strength": 5}, {"source_id": "infection", "target_id": "illness", "strength": 5}, {"source_id": "hospital discharge", "target_id": "clinical trials", "strength": 5}, {"source_id": "antibody titers", "target_id": "COVID-19", "strength": 5}, {"source_id": "adverse events", "target_id": "monoclonal antibodies", "strength": 5}, {"source_id": "humoral response", "target_id": "T cells", "strength": 5}, {"source_id": "mean age", "target_id": "hospital", "strength": 5}, {"source_id": "hospital", "target_id": "mean age", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "symptoms", "strength": 5}, {"source_id": "coronavirus 2 infection", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "coronavirus 2 infection", "target_id": "symptoms", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "Web of Science", "strength": 5}, {"source_id": "Web of Science", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "older adults", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "infection", "target_id": "COVID-19 diagnosis", "strength": 5}, {"source_id": "logistic regression analysis", "target_id": "hospital mortality", "strength": 5}, {"source_id": "vaccine", "target_id": "incidence rate", "strength": 5}, {"source_id": "high risk", "target_id": "coronavirus disease", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "mass index", "strength": 5}, {"source_id": "COVID-19 diagnosis", "target_id": "cohort study", "strength": 5}, {"source_id": "incidence rate", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "study period", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "breakthrough infections", "target_id": "booster vaccination", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "healthcare workers", "strength": 5}, {"source_id": "clinical characteristics", "target_id": "mean age", "strength": 5}, {"source_id": "clinical characteristics", "target_id": "study period", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "vaccination", "strength": 5}, {"source_id": "high prevalence", "target_id": "symptoms", "strength": 5}, {"source_id": "cross-sectional survey", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "therapeutic strategies", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "middle-income countries", "strength": 5}, {"source_id": "antibody response", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "antibody response", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "heart failure", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "flow cytometry", "strength": 5}, {"source_id": "immune response", "target_id": "mice", "strength": 5}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "infection", "strength": 5}, {"source_id": "disease 2019 pandemic", "target_id": "infection", "strength": 5}, {"source_id": "immune response", "target_id": "receptor-binding domain", "strength": 5}, {"source_id": "medical students", "target_id": "teaching", "strength": 5}, {"source_id": "medical students", "target_id": "curriculum", "strength": 5}, {"source_id": "perspective", "target_id": "pandemic", "strength": 5}, {"source_id": "University", "target_id": "training", "strength": 5}, {"source_id": "need", "target_id": "skills", "strength": 5}, {"source_id": "primary outcome", "target_id": "body mass index", "strength": 5}, {"source_id": "therapy", "target_id": "disease 2019", "strength": 5}, {"source_id": "risk factors", "target_id": "years of age", "strength": 5}, {"source_id": "prospective study", "target_id": "high risk", "strength": 5}, {"source_id": "high risk", "target_id": "prospective study", "strength": 5}, {"source_id": "observational study", "target_id": "women", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "medical records", "strength": 5}, {"source_id": "SARS-CoV-2 variants", "target_id": "mouse model", "strength": 5}, {"source_id": "vaccine", "target_id": "humoral immune response", "strength": 5}, {"source_id": "vaccine", "target_id": "unvaccinated individuals", "strength": 5}, {"source_id": "pregnancy", "target_id": "risk factors", "strength": 5}, {"source_id": "vaccination status", "target_id": "study period", "strength": 5}, {"source_id": "primary care", "target_id": "COVID-19", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "Omicron variant", "strength": 5}, {"source_id": "risk factors", "target_id": "protective effect", "strength": 5}, {"source_id": "care system", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "healthcare workers", "strength": 5}, {"source_id": "COVID-19", "target_id": "infection rate", "strength": 5}, {"source_id": "SARS-CoV-2 variants", "target_id": "booster doses", "strength": 5}, {"source_id": "cross-sectional survey", "target_id": "COVID-19", "strength": 5}, {"source_id": "logistic regression", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "risk factors", "target_id": "clinical trials", "strength": 5}, {"source_id": "clinical trials", "target_id": "risk factors", "strength": 5}, {"source_id": "risk factors", "target_id": "electronic health records", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "participants", "strength": 5}, {"source_id": "therapeutic target", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "respiratory failure", "target_id": "risk factors", "strength": 5}, {"source_id": "respiratory failure", "target_id": "ill patients", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "disease 2019 pandemic", "strength": 5}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "control group", "target_id": "health problems", "strength": 5}, {"source_id": "health problems", "target_id": "control group", "strength": 5}, {"source_id": "median age", "target_id": "second dose", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "health care professionals", "strength": 5}, {"source_id": "observational study", "target_id": "infection", "strength": 5}, {"source_id": "health system", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "infection", "target_id": "electronic health records", "strength": 5}, {"source_id": "infection", "target_id": "health records", "strength": 5}, {"source_id": "young adults", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 5}, {"source_id": "young adults", "target_id": "disease 2019 pandemic", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "primary outcome", "strength": 5}, {"source_id": "primary outcome", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "symptoms", "strength": 5}, {"source_id": "symptoms", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "healthcare workers", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "COVID-19 outcomes", "target_id": "ICU admission", "strength": 5}, {"source_id": "medical records", "target_id": "mechanical ventilation", "strength": 5}, {"source_id": "COVID-19 severity", "target_id": "disease", "strength": 5}, {"source_id": "thematic analysis", "target_id": "teaching", "strength": 5}, {"source_id": "risk factors", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 5}, {"source_id": "COVID-19", "target_id": "patient population", "strength": 5}, {"source_id": "cohort study", "target_id": "time points", "strength": 5}, {"source_id": "time points", "target_id": "cohort study", "strength": 5}, {"source_id": "study period", "target_id": "mortality rate", "strength": 5}, {"source_id": "odds ratio", "target_id": "cohort study", "strength": 5}, {"source_id": "infection", "target_id": "care facilities", "strength": 5}, {"source_id": "age groups", "target_id": "vaccine effectiveness", "strength": 5}, {"source_id": "MAIN OUTCOME", "target_id": "mortality", "strength": 5}, {"source_id": "mean age", "target_id": "emergency department", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "T cells", "strength": 5}, {"source_id": "booster doses", "target_id": "Omicron variant", "strength": 5}, {"source_id": "mean age", "target_id": "mental health", "strength": 5}, {"source_id": "mental health", "target_id": "disease 2019", "strength": 5}, {"source_id": "middle-income countries", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "COVID-19 outcomes", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "respiratory failure", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "care unit", "strength": 5}, {"source_id": "care unit", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "hospital mortality", "target_id": "hospital admission", "strength": 5}, {"source_id": "surgery", "target_id": "complications", "strength": 5}, {"source_id": "kidney disease", "target_id": "high risk", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "mass index", "strength": 5}, {"source_id": "age groups", "target_id": "vaccination campaign", "strength": 5}, {"source_id": "vaccination coverage", "target_id": "vaccination campaign", "strength": 5}, {"source_id": "MAIN OUTCOME", "target_id": "high risk", "strength": 5}, {"source_id": "use disorders", "target_id": "cohort study", "strength": 5}, {"source_id": "retrospective cohort study", "target_id": "therapy", "strength": 5}, {"source_id": "high risk", "target_id": "MAIN OUTCOME", "strength": 5}, {"source_id": "patient outcomes", "target_id": "hospital mortality", "strength": 5}, {"source_id": "risk factors", "target_id": "Secondary outcomes", "strength": 5}, {"source_id": "cohort study", "target_id": "health records", "strength": 5}, {"source_id": "health services", "target_id": "cohort study", "strength": 5}, {"source_id": "admission", "target_id": "study period", "strength": 5}, {"source_id": "health records", "target_id": "cohort study", "strength": 5}, {"source_id": "SARS-CoV-2 variants", "target_id": "SARS-CoV-2 virus", "strength": 5}, {"source_id": "SARS-CoV-2 variants", "target_id": "adult patients", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "infectious diseases", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "infectious diseases", "strength": 5}, {"source_id": "pregnancy", "target_id": "infection", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "mortality rate", "strength": 5}, {"source_id": "mortality rate", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "central nervous system", "target_id": "multiple sclerosis", "strength": 5}, {"source_id": "pregnant women", "target_id": "immune response", "strength": 5}, {"source_id": "infection", "target_id": "pregnant women", "strength": 5}, {"source_id": "high risk", "target_id": "health system", "strength": 5}, {"source_id": "students", "target_id": "participants", "strength": 5}, {"source_id": "practice", "target_id": "research", "strength": 5}, {"source_id": "engagement", "target_id": "curriculum", "strength": 5}, {"source_id": "research", "target_id": "practice", "strength": 5}, {"source_id": "medical students", "target_id": "learning", "strength": 5}, {"source_id": "narratives", "target_id": "crisis", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "myocardial infarction", "strength": 5}, {"source_id": "kidney disease", "target_id": "heart failure", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "antibody titers", "strength": 5}, {"source_id": "observational study", "target_id": "odds ratio", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "severe cases", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "odds ratio", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "multivariable logistic regression", "strength": 5}, {"source_id": "multivariable logistic regression", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "electronic health records", "strength": 5}, {"source_id": "clinical trials", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "health records", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "body mass index", "target_id": "older age", "strength": 5}, {"source_id": "older age", "target_id": "body mass index", "strength": 5}, {"source_id": "clinical studies", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "perception", "target_id": "experience", "strength": 5}, {"source_id": "COVID-19", "target_id": "perception", "strength": 5}, {"source_id": "transplant recipients", "target_id": "risk factors", "strength": 5}, {"source_id": "risk factors", "target_id": "transplant recipients", "strength": 5}, {"source_id": "booster doses", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "pandemic", "target_id": "mental health", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "Meta-Analysis", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "disease progression", "strength": 5}, {"source_id": "mRNA vaccination", "target_id": "transplant recipients", "strength": 5}, {"source_id": "immune response", "target_id": "variants of concern", "strength": 5}, {"source_id": "adverse events", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "adverse events", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "adverse events", "strength": 5}, {"source_id": "cohort study", "target_id": "cancer", "strength": 5}, {"source_id": "immune response", "target_id": "adverse events", "strength": 5}, {"source_id": "health concern", "target_id": "mental health", "strength": 5}, {"source_id": "teaching", "target_id": "need", "strength": 5}, {"source_id": "need", "target_id": "teaching", "strength": 5}, {"source_id": "young people", "target_id": "policy", "strength": 5}, {"source_id": "respiratory failure", "target_id": "observational study", "strength": 5}, {"source_id": "Omicron infection", "target_id": "Delta variant", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "healthy controls", "strength": 5}, {"source_id": "logistic regression analysis", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "disease", "target_id": "logistic regression", "strength": 5}, {"source_id": "severe COVID-19", "target_id": "intensive care unit admission", "strength": 5}, {"source_id": "booster doses", "target_id": "booster vaccination", "strength": 5}, {"source_id": "booster vaccination", "target_id": "booster doses", "strength": 5}, {"source_id": "third dose", "target_id": "COVID-19", "strength": 5}, {"source_id": "thematic analysis", "target_id": "educators", "strength": 5}, {"source_id": "vaccine effectiveness", "target_id": "observational study", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "logistic regression", "strength": 5}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "receptor-binding domain", "strength": 5}, {"source_id": "risk factors", "target_id": "respiratory distress syndrome", "strength": 5}, {"source_id": "inflammatory syndrome", "target_id": "pediatric patients", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "epithelial cells", "strength": 5}, {"source_id": "cancer", "target_id": "clinical trials", "strength": 5}, {"source_id": "clinical trials", "target_id": "women", "strength": 5}, {"source_id": "Omicron infection", "target_id": "SARS-CoV-2 Omicron variant", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "older adults", "strength": 5}, {"source_id": "observational study", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "observational study", "target_id": "older adults", "strength": 5}, {"source_id": "children", "target_id": "schools", "strength": 5}, {"source_id": "Omicron infection", "target_id": "patients", "strength": 5}, {"source_id": "high risk", "target_id": "median age", "strength": 5}, {"source_id": "COVID-19", "target_id": "prevalence", "strength": 5}, {"source_id": "prevalence", "target_id": "COVID-19", "strength": 5}, {"source_id": "logistic regression", "target_id": "vaccination", "strength": 5}, {"source_id": "disease control", "target_id": "infection", "strength": 5}, {"source_id": "cohort study", "target_id": "older age", "strength": 5}, {"source_id": "T cell responses", "target_id": "Delta variant", "strength": 5}, {"source_id": "case series", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "cell responses", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "cell responses", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "cell responses", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "cell responses", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "age groups", "strength": 5}, {"source_id": "symptoms", "target_id": "young adults", "strength": 5}, {"source_id": "young adults", "target_id": "symptoms", "strength": 5}, {"source_id": "women", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "COVID-19", "target_id": "time points", "strength": 5}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "transplant recipients", "strength": 5}, {"source_id": "transplant recipients", "target_id": "SARS-CoV-2 vaccines", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "immune system", "strength": 5}, {"source_id": "immune system", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "clinical trials", "strength": 5}, {"source_id": "mental health", "target_id": "people", "strength": 5}, {"source_id": "young adults", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "health conditions", "target_id": "mental health", "strength": 5}, {"source_id": "retrospective cohort study", "target_id": "adult patients", "strength": 5}, {"source_id": "adult patients", "target_id": "retrospective cohort study", "strength": 5}, {"source_id": "clinical trials", "target_id": "COVID-19 cases", "strength": 5}, {"source_id": "disease 2019", "target_id": "general population", "strength": 5}, {"source_id": "COVID-19", "target_id": "antiviral activity", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "logistic regression analysis", "strength": 5}, {"source_id": "middle-income countries", "target_id": "health system", "strength": 5}, {"source_id": "acute respiratory distress syndrome", "target_id": "cytokine storm", "strength": 5}, {"source_id": "Health Organization", "target_id": "patients", "strength": 5}, {"source_id": "general population", "target_id": "severe disease", "strength": 5}, {"source_id": "patients", "target_id": "World Health Organization", "strength": 5}, {"source_id": "antibody levels", "target_id": "BNT162b2 vaccine", "strength": 5}, {"source_id": "mechanical ventilation", "target_id": "adverse events", "strength": 5}, {"source_id": "mechanical ventilation", "target_id": "pneumonia", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "clinical data", "strength": 5}, {"source_id": "antibody levels", "target_id": "T cell responses", "strength": 5}, {"source_id": "blood pressure", "target_id": "type 2 diabetes", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "syndrome", "strength": 5}, {"source_id": "ICU admission", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "care unit admission", "target_id": "infection", "strength": 5}, {"source_id": "case-control study", "target_id": "infection", "strength": 5}, {"source_id": "unit admission", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "unit admission", "target_id": "infection", "strength": 5}, {"source_id": "infection", "target_id": "unit admission", "strength": 5}, {"source_id": "risk factors", "target_id": "mental health outcomes", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "observational study", "strength": 5}, {"source_id": "mental health outcomes", "target_id": "risk factors", "strength": 5}, {"source_id": "COVID-19", "target_id": "greater risk", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "disease", "strength": 5}, {"source_id": "severe COVID-19", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "severe COVID-19", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "disease", "strength": 5}, {"source_id": "disease", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "years of age", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 diagnosis", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "beneficial effects", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "observational study", "strength": 5}, {"source_id": "general population", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "SARS-CoV-2 vaccines", "strength": 5}, {"source_id": "cohort study", "target_id": "SARS-CoV-2 vaccines", "strength": 5}, {"source_id": "vaccination", "target_id": "serious adverse events", "strength": 5}, {"source_id": "disease", "target_id": "vaccination", "strength": 5}, {"source_id": "quality of life", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "nervous system", "strength": 5}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "SARS-CoV-2 spike protein", "strength": 5}, {"source_id": "nervous system", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "symptom onset", "target_id": "infection", "strength": 5}, {"source_id": "infection", "target_id": "symptom onset", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "vaccine", "strength": 5}, {"source_id": "experience", "target_id": "educators", "strength": 5}, {"source_id": "experience", "target_id": "motivation", "strength": 5}, {"source_id": "program", "target_id": "educators", "strength": 5}, {"source_id": "practice", "target_id": "teaching", "strength": 5}, {"source_id": "clinical practice", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "teaching", "target_id": "practice", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "Alzheimer's disease", "target_id": "central nervous system", "strength": 5}, {"source_id": "spike protein", "target_id": "breakthrough infections", "strength": 5}, {"source_id": "book", "target_id": "pandemic", "strength": 5}, {"source_id": "educators", "target_id": "higher education", "strength": 5}, {"source_id": "study period", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "hazard ratio", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "trials", "strength": 5}, {"source_id": "clinical studies", "target_id": "clinical trials", "strength": 5}, {"source_id": "monoclonal antibodies", "target_id": "adverse events", "strength": 5}, {"source_id": "antibody titers", "target_id": "mRNA vaccination", "strength": 5}, {"source_id": "healthcare workers", "target_id": "T cell responses", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "clinical presentation", "strength": 5}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "symptoms", "strength": 5}, {"source_id": "clinical presentation", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "symptoms", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 5}, {"source_id": "primary outcome", "target_id": "vaccine", "strength": 5}, {"source_id": "vaccine", "target_id": "primary outcome", "strength": 5}, {"source_id": "logistic regression", "target_id": "mechanical ventilation", "strength": 5}, {"source_id": "hospital mortality", "target_id": "logistic regression analysis", "strength": 5}, {"source_id": "retrospective cohort study", "target_id": "disease 2019", "strength": 5}, {"source_id": "diabetes mellitus", "target_id": "cardiovascular disease", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "study period", "strength": 5}, {"source_id": "study period", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "infectious diseases", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "healthcare workers", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "healthcare workers", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "course", "target_id": "experience", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "health concern", "strength": 5}, {"source_id": "COVID-19", "target_id": "disease burden", "strength": 5}, {"source_id": "antibody response", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "antibody response", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "mouse model", "strength": 5}, {"source_id": "immune cells", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "immune cells", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "viral infection", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "virus infection", "strength": 5}, {"source_id": "inflammatory response", "target_id": "nervous system", "strength": 5}, {"source_id": "countries", "target_id": "economy", "strength": 5}, {"source_id": "economy", "target_id": "countries", "strength": 5}, {"source_id": "countries", "target_id": "book", "strength": 5}, {"source_id": "course", "target_id": "COVID-19", "strength": 5}, {"source_id": "body mass index", "target_id": "primary outcome", "strength": 5}, {"source_id": "mortality", "target_id": "hospital stay", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "therapy", "strength": 5}, {"source_id": "years of age", "target_id": "risk factors", "strength": 5}, {"source_id": "autoimmune diseases", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "medical records", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "risk factors", "target_id": "pregnancy", "strength": 5}, {"source_id": "interviews", "target_id": "government", "strength": 5}, {"source_id": "COVID-19", "target_id": "clinical data", "strength": 5}, {"source_id": "breakthrough infections", "target_id": "risk factors", "strength": 5}, {"source_id": "risk factors", "target_id": "breakthrough infections", "strength": 5}, {"source_id": "high risk", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "lower risk", "target_id": "high risk", "strength": 5}, {"source_id": "vaccination coverage", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "disease 2019 pandemic", "target_id": "healthcare workers", "strength": 5}, {"source_id": "cohort study", "target_id": "viral load", "strength": 5}, {"source_id": "COVID-19", "target_id": "care services", "strength": 5}, {"source_id": "COVID-19", "target_id": "cross-sectional survey", "strength": 5}, {"source_id": "risk factors", "target_id": "primary care", "strength": 5}, {"source_id": "primary care", "target_id": "risk factors", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "therapeutic target", "strength": 5}, {"source_id": "respiratory failure", "target_id": "COVID-19 pneumonia", "strength": 5}, {"source_id": "high risk", "target_id": "respiratory failure", "strength": 5}, {"source_id": "high risk", "target_id": "University Hospital", "strength": 5}, {"source_id": "risk factors", "target_id": "kidney disease", "strength": 5}, {"source_id": "care unit", "target_id": "admission", "strength": 5}, {"source_id": "admission", "target_id": "intensive care unit", "strength": 5}, {"source_id": "electronic health records", "target_id": "infection", "strength": 5}, {"source_id": "disease 2019 pandemic", "target_id": "young adults", "strength": 5}, {"source_id": "hospital mortality", "target_id": "observational study", "strength": 5}, {"source_id": "logistic regression", "target_id": "observational study", "strength": 5}, {"source_id": "cohort study", "target_id": "COVID-19 severity", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "symptoms", "strength": 5}, {"source_id": "symptoms", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "vaccine", "strength": 5}, {"source_id": "practice", "target_id": "case study", "strength": 5}, {"source_id": "government", "target_id": "politics", "strength": 5}, {"source_id": "students", "target_id": "article", "strength": 5}, {"source_id": "disease", "target_id": "pulmonary disease", "strength": 5}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "risk factors", "strength": 5}, {"source_id": "patient population", "target_id": "COVID-19", "strength": 5}, {"source_id": "Omicron variant", "target_id": "variants of concern", "strength": 5}, {"source_id": "coronavirus disease", "target_id": "care unit", "strength": 5}, {"source_id": "T cells", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "clinical manifestations", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "disease 2019", "target_id": "severe illness", "strength": 5}, {"source_id": "health outcomes", "target_id": "physical activity", "strength": 5}, {"source_id": "older adults", "target_id": "mean age", "strength": 5}, {"source_id": "crisis", "target_id": "actors", "strength": 5}, {"source_id": "actors", "target_id": "crisis", "strength": 5}, {"source_id": "COVID-19", "target_id": "organization", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 outcomes", "strength": 5}, {"source_id": "age groups", "target_id": "severe disease", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "symptom onset", "strength": 5}, {"source_id": "clinical trials", "target_id": "mortality", "strength": 5}, {"source_id": "outcome measures", "target_id": "therapy", "strength": 5}, {"source_id": "mortality", "target_id": "clinical trials", "strength": 5}, {"source_id": "ICU admission", "target_id": "disease severity", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "RT-PCR", "strength": 5}, {"source_id": "RT-PCR", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "primary endpoint", "target_id": "serious adverse events", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "cancer patients", "strength": 5}, {"source_id": "high risk", "target_id": "kidney disease", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "ill patients", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "ill patients", "target_id": "disease 2019", "strength": 5}, {"source_id": "vaccination campaign", "target_id": "vaccination coverage", "strength": 5}, {"source_id": "symptoms", "target_id": "viral infection", "strength": 5}, {"source_id": "cohort study", "target_id": "primary care", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "infectious diseases", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "infectious diseases", "strength": 5}, {"source_id": "side effects", "target_id": "vaccine uptake", "strength": 5}, {"source_id": "infection", "target_id": "pregnancy", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "clinical characteristics", "strength": 5}, {"source_id": "health issues", "target_id": "systematic review", "strength": 5}, {"source_id": "multiple sclerosis", "target_id": "central nervous system", "strength": 5}, {"source_id": "mental health outcomes", "target_id": "anxiety", "strength": 5}, {"source_id": "severe disease", "target_id": "Omicron infection", "strength": 5}, {"source_id": "participants", "target_id": "students", "strength": 5}, {"source_id": "curriculum", "target_id": "engagement", "strength": 5}, {"source_id": "people", "target_id": "United States", "strength": 5}, {"source_id": "chronic kidney disease", "target_id": "COVID-19", "strength": 5}, {"source_id": "heart failure", "target_id": "kidney disease", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "antibody titers", "target_id": "SARS-CoV-2 vaccines", "strength": 5}, {"source_id": "clinical characteristics", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "cohort study", "target_id": "mRNA vaccination", "strength": 5}, {"source_id": "study participants", "target_id": "vaccination", "strength": 5}, {"source_id": "experience", "target_id": "perception", "strength": 5}, {"source_id": "qualitative study", "target_id": "health services", "strength": 5}, {"source_id": "health services", "target_id": "qualitative study", "strength": 5}, {"source_id": "COVID-19 severity", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "high-income countries", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "incidence rate", "target_id": "patients", "strength": 5}, {"source_id": "case report", "target_id": "symptoms", "strength": 5}, {"source_id": "transplant recipients", "target_id": "mRNA vaccination", "strength": 5}, {"source_id": "booster dose", "target_id": "antibody titers", "strength": 5}, {"source_id": "MAIN OUTCOME", "target_id": "cancer", "strength": 5}, {"source_id": "primary outcome", "target_id": "care", "strength": 5}, {"source_id": "ICU admission", "target_id": "hospital mortality", "strength": 5}, {"source_id": "ICU admission", "target_id": "adult patients", "strength": 5}, {"source_id": "interviews", "target_id": "crisis", "strength": 5}, {"source_id": "COVID-19", "target_id": "primary endpoint", "strength": 5}, {"source_id": "care unit admission", "target_id": "severe COVID-19", "strength": 5}, {"source_id": "severe COVID-19", "target_id": "unit admission", "strength": 5}, {"source_id": "COVID-19 severity", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "logistic regression", "target_id": "emergency department", "strength": 5}, {"source_id": "educators", "target_id": "thematic analysis", "strength": 5}, {"source_id": "high risk", "target_id": "older age", "strength": 5}, {"source_id": "intensive care unit", "target_id": "University Hospital", "strength": 5}, {"source_id": "COVID-19", "target_id": "University Hospital", "strength": 5}, {"source_id": "care unit", "target_id": "University Hospital", "strength": 5}, {"source_id": "observational study", "target_id": "vaccination", "strength": 5}, {"source_id": "vaccination", "target_id": "adult patients", "strength": 5}, {"source_id": "respiratory distress syndrome", "target_id": "risk factors", "strength": 5}, {"source_id": "clinical trials", "target_id": "cancer", "strength": 5}, {"source_id": "older adults", "target_id": "observational study", "strength": 5}, {"source_id": "logistic regression models", "target_id": "vaccination", "strength": 5}, {"source_id": "independent predictors", "target_id": "median age", "strength": 5}, {"source_id": "vaccination", "target_id": "logistic regression models", "strength": 5}, {"source_id": "children", "target_id": "learning", "strength": 5}, {"source_id": "learning", "target_id": "children", "strength": 5}, {"source_id": "variants of concern", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 pandemic", "strength": 5}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "cohort study", "target_id": "infection rate", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "emergency department", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "T cell responses", "strength": 5}, {"source_id": "T cell responses", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "cell responses", "strength": 5}, {"source_id": "cell responses", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "logistic regression analysis", "target_id": "older age", "strength": 5}, {"source_id": "COVID-19", "target_id": "health interventions", "strength": 5}, {"source_id": "health interventions", "target_id": "COVID-19", "strength": 5}, {"source_id": "vaccine effectiveness", "target_id": "SARS-CoV-2 vaccines", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "incidence", "strength": 5}, {"source_id": "women", "target_id": "primary outcome", "strength": 5}, {"source_id": "teachers", "target_id": "perspective", "strength": 5}, {"source_id": "infectious diseases", "target_id": "T cells", "strength": 5}, {"source_id": "vaccination", "target_id": "autoimmune diseases", "strength": 5}, {"source_id": "injury", "target_id": "risk factors", "strength": 5}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "SARS-CoV-2 vaccination", "strength": 5}, {"source_id": "vaccine doses", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "mental health", "target_id": "health conditions", "strength": 5}, {"source_id": "diabetes mellitus", "target_id": "type 2 diabetes", "strength": 5}, {"source_id": "pandemic", "target_id": "rights", "strength": 5}, {"source_id": "COVID-19 outcomes", "target_id": "vaccine doses", "strength": 5}, {"source_id": "vaccine doses", "target_id": "COVID-19 outcomes", "strength": 5}, {"source_id": "immune cells", "target_id": "cytokine storm", "strength": 5}, {"source_id": "mean age", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "general population", "target_id": "disease 2019", "strength": 5}, {"source_id": "Secondary outcomes", "target_id": "incidence rate", "strength": 5}, {"source_id": "health system", "target_id": "middle-income countries", "strength": 5}, {"source_id": "breast cancer", "target_id": "cancer patients", "strength": 5}, {"source_id": "COVID-19", "target_id": "pulmonary disease", "strength": 5}, {"source_id": "pulmonary disease", "target_id": "COVID-19", "strength": 5}, {"source_id": "cytokine storm", "target_id": "respiratory distress syndrome", "strength": 5}, {"source_id": "antibody levels", "target_id": "observational study", "strength": 5}, {"source_id": "disease 2019", "target_id": "care unit", "strength": 5}, {"source_id": "oxidative stress", "target_id": "patients", "strength": 5}, {"source_id": "adverse events", "target_id": "COVID-19 pneumonia", "strength": 5}, {"source_id": "adverse events", "target_id": "pneumonia", "strength": 5}, {"source_id": "observational study", "target_id": "medical records", "strength": 5}, {"source_id": "primary outcome", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "BNT162b2 vaccine", "target_id": "humoral response", "strength": 5}, {"source_id": "humoral response", "target_id": "BNT162b2 vaccine", "strength": 5}, {"source_id": "vaccine", "target_id": "healthcare workers", "strength": 5}, {"source_id": "side effects", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "patient outcomes", "target_id": "infection", "strength": 5}, {"source_id": "infection", "target_id": "care unit admission", "strength": 5}, {"source_id": "greater risk", "target_id": "infection", "strength": 5}, {"source_id": "care workers", "target_id": "COVID-19", "strength": 5}, {"source_id": "COVID-19", "target_id": "health care workers", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "disease", "strength": 5}, {"source_id": "COVID-19 outcomes", "target_id": "disease 2019", "strength": 5}, {"source_id": "disease", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "years of age", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "hospital", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "vaccine", "target_id": "disease severity", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "intensive care", "strength": 5}, {"source_id": "chronic diseases", "target_id": "disease", "strength": 5}, {"source_id": "vaccination program", "target_id": "vaccination", "strength": 5}, {"source_id": "vaccination campaign", "target_id": "vaccination", "strength": 5}, {"source_id": "disease", "target_id": "healthy controls", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "quality of life", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "central nervous system", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 spike protein", "strength": 5}, {"source_id": "social determinants", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "World Health Organization", "target_id": "clinical trials", "strength": 5}, {"source_id": "case study", "target_id": "interviews", "strength": 5}, {"source_id": "interviews", "target_id": "case study", "strength": 5}, {"source_id": "market", "target_id": "crisis", "strength": 5}, {"source_id": "economy", "target_id": "actors", "strength": 5}, {"source_id": "education", "target_id": "future research", "strength": 5}, {"source_id": "higher education", "target_id": "educators", "strength": 5}, {"source_id": "practice", "target_id": "higher education", "strength": 5}, {"source_id": "curriculum", "target_id": "educators", "strength": 5}, {"source_id": "retrospective cohort study", "target_id": "Secondary outcomes", "strength": 5}, {"source_id": "COVID-19", "target_id": "viral load", "strength": 5}, {"source_id": "clinical trials", "target_id": "hospital discharge", "strength": 5}, {"source_id": "clinical trials", "target_id": "clinical studies", "strength": 5}, {"source_id": "adverse events", "target_id": "years of age", "strength": 5}, {"source_id": "observational study", "target_id": "Secondary outcomes", "strength": 5}, {"source_id": "COVID-19", "target_id": "antibody titers", "strength": 5}, {"source_id": "antibody titers", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "mRNA vaccination", "target_id": "antibody titers", "strength": 5}, {"source_id": "T cells", "target_id": "humoral response", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "symptoms", "strength": 5}, {"source_id": "Web of Science", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 5}, {"source_id": "symptoms", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 5}, {"source_id": "adverse events", "target_id": "first dose", "strength": 5}, {"source_id": "first dose", "target_id": "adverse events", "strength": 5}, {"source_id": "higher odds", "target_id": "cohort study", "strength": 5}, {"source_id": "retrospective cohort study", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "incidence rate", "strength": 5}, {"source_id": "infection", "target_id": "BNT162b2 vaccine", "strength": 5}, {"source_id": "study design", "target_id": "infection", "strength": 5}, {"source_id": "body mass index", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 antibodies", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "study period", "strength": 5}, {"source_id": "breakthrough infections", "target_id": "antibody response", "strength": 5}, {"source_id": "antibody response", "target_id": "booster vaccination", "strength": 5}, {"source_id": "humoral immune response", "target_id": "infection", "strength": 5}, {"source_id": "booster vaccination", "target_id": "breakthrough infections", "strength": 5}, {"source_id": "vaccine doses", "target_id": "Delta variant", "strength": 5}, {"source_id": "immune response", "target_id": "vaccine doses", "strength": 5}, {"source_id": "infection", "target_id": "humoral immune response", "strength": 5}, {"source_id": "inflammation", "target_id": "oxidative stress", "strength": 5}, {"source_id": "severe disease", "target_id": "COVID-19 outcomes", "strength": 5}, {"source_id": "mean age", "target_id": "clinical characteristics", "strength": 5}, {"source_id": "study period", "target_id": "clinical characteristics", "strength": 5}, {"source_id": "high risk", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "symptoms", "target_id": "high prevalence", "strength": 5}, {"source_id": "antiviral activity", "target_id": "SARS-CoV-2 replication", "strength": 5}, {"source_id": "patient care", "target_id": "patients", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "logistic regression models", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "antibody response", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "immune cells", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "heart failure", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "immune cells", "strength": 5}, {"source_id": "heart failure", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "flow cytometry", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "spike protein", "target_id": "viral infection", "strength": 5}, {"source_id": "virus infection", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "receptor-binding domain", "target_id": "immune response", "strength": 5}, {"source_id": "actors", "target_id": "politics", "strength": 5}, {"source_id": "book", "target_id": "countries", "strength": 5}, {"source_id": "course", "target_id": "teaching", "strength": 5}, {"source_id": "pandemic", "target_id": "perspective", "strength": 5}, {"source_id": "antibody response", "target_id": "booster dose", "strength": 5}, {"source_id": "training", "target_id": "University", "strength": 5}, {"source_id": "mass index", "target_id": "primary outcome", "strength": 5}, {"source_id": "disease 2019", "target_id": "therapy", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "mean age", "strength": 5}, {"source_id": "high risk", "target_id": "therapy", "strength": 5}, {"source_id": "infection", "target_id": "clinical manifestations", "strength": 5}, {"source_id": "therapy", "target_id": "high risk", "strength": 5}, {"source_id": "case report", "target_id": "autoimmune diseases", "strength": 5}, {"source_id": "mouse model", "target_id": "SARS-CoV-2 variants", "strength": 5}, {"source_id": "BNT162b2 vaccine", "target_id": "immune response", "strength": 5}, {"source_id": "immune response", "target_id": "BNT162b2 vaccine", "strength": 5}, {"source_id": "variants of concern", "target_id": "Health Organization", "strength": 5}, {"source_id": "government", "target_id": "interviews", "strength": 5}, {"source_id": "interviews", "target_id": "violence", "strength": 5}, {"source_id": "study period", "target_id": "vaccination status", "strength": 5}, {"source_id": "society", "target_id": "crisis", "strength": 5}, {"source_id": "risk factors", "target_id": "retrospective study", "strength": 5}, {"source_id": "retrospective study", "target_id": "risk factors", "strength": 5}, {"source_id": "primary care", "target_id": "health services", "strength": 5}, {"source_id": "high risk", "target_id": "lower risk", "strength": 5}, {"source_id": "healthcare workers", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 5}, {"source_id": "viral load", "target_id": "cohort study", "strength": 5}, {"source_id": "respiratory failure", "target_id": "high risk", "strength": 5}, {"source_id": "humoral immune response", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "disease 2019 pandemic", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "cytokine storm", "target_id": "IL-6", "strength": 5}, {"source_id": "humoral response", "target_id": "healthy controls", "strength": 5}, {"source_id": "mortality rate", "target_id": "COVID-19 cases", "strength": 5}, {"source_id": "observational study", "target_id": "logistic regression", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "symptoms", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "mechanical ventilation", "target_id": "medical records", "strength": 5}, {"source_id": "risk factors", "target_id": "ischemic stroke", "strength": 5}, {"source_id": "protein", "target_id": "spike protein", "strength": 5}, {"source_id": "actors", "target_id": "governance", "strength": 5}, {"source_id": "article", "target_id": "learning", "strength": 5}, {"source_id": "learning", "target_id": "article", "strength": 5}, {"source_id": "sector", "target_id": "economy", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "risk factors", "strength": 5}, {"source_id": "hospitalized patients", "target_id": "risk factors", "strength": 5}, {"source_id": "high prevalence", "target_id": "risk factors", "strength": 5}, {"source_id": "mortality rate", "target_id": "study period", "strength": 5}, {"source_id": "cohort study", "target_id": "intensive care", "strength": 5}, {"source_id": "cohort study", "target_id": "odds ratio", "strength": 5}, {"source_id": "vaccine effectiveness", "target_id": "age groups", "strength": 5}, {"source_id": "case study", "target_id": "people", "strength": 5}, {"source_id": "variants of concern", "target_id": "Omicron variant", "strength": 5}, {"source_id": "Omicron variant", "target_id": "booster doses", "strength": 5}, {"source_id": "immune response", "target_id": "severe illness", "strength": 5}, {"source_id": "infection", "target_id": "respiratory disease", "strength": 5}, {"source_id": "Secondary outcomes", "target_id": "intervention group", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "care providers", "strength": 5}, {"source_id": "symptoms", "target_id": "intensive care unit", "strength": 5}, {"source_id": "organization", "target_id": "COVID-19", "strength": 5}, {"source_id": "context", "target_id": "article", "strength": 5}, {"source_id": "mental health", "target_id": "time points", "strength": 5}, {"source_id": "treatment strategies", "target_id": "immune response", "strength": 5}, {"source_id": "immune response", "target_id": "treatment strategies", "strength": 5}, {"source_id": "respiratory failure", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "persistent symptoms", "target_id": "disease severity", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "independent predictors", "strength": 5}, {"source_id": "symptom onset", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "complications", "target_id": "surgery", "strength": 5}, {"source_id": "disease severity", "target_id": "ICU admission", "strength": 5}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "antibody titers", "strength": 5}, {"source_id": "second dose", "target_id": "MAIN OUTCOME", "strength": 5}, {"source_id": "MAIN OUTCOME", "target_id": "systematic review", "strength": 5}, {"source_id": "ill patients", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "body mass index", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "cohort study", "target_id": "use disorders", "strength": 5}, {"source_id": "study period", "target_id": "logistic regression", "strength": 5}, {"source_id": "infectious diseases", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "pregnancy", "strength": 5}, {"source_id": "vaccine uptake", "target_id": "side effects", "strength": 5}, {"source_id": "older age", "target_id": "observational study", "strength": 5}, {"source_id": "clinical characteristics", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "multiple sclerosis", "target_id": "nervous system", "strength": 5}, {"source_id": "adverse effects", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "pregnant women", "target_id": "infection", "strength": 5}, {"source_id": "anxiety", "target_id": "mental health outcomes", "strength": 5}, {"source_id": "risk factors", "target_id": "myocardial infarction", "strength": 5}, {"source_id": "risk factors", "target_id": "disease burden", "strength": 5}, {"source_id": "disease burden", "target_id": "risk factors", "strength": 5}, {"source_id": "hospital admission", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "immune response", "target_id": "SARS-CoV2", "strength": 5}, {"source_id": "SARS-CoV2", "target_id": "immune response", "strength": 5}, {"source_id": "odds ratio", "target_id": "observational study", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "treatment options", "strength": 5}, {"source_id": "severe cases", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "infection", "target_id": "mRNA vaccination", "strength": 5}, {"source_id": "hazard ratio", "target_id": "infection", "strength": 5}, {"source_id": "disease severity", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "logistic regression models", "target_id": "vaccine", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "need", "strength": 5}, {"source_id": "older age", "target_id": "mass index", "strength": 5}, {"source_id": "perception", "target_id": "COVID-19", "strength": 5}, {"source_id": "vaccine", "target_id": "Omicron infection", "strength": 5}, {"source_id": "general population", "target_id": "age groups", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "booster dose", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "booster doses", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 severity", "strength": 5}, {"source_id": "thematic analysis", "target_id": "mental health", "strength": 5}, {"source_id": "mental health", "target_id": "pandemic", "strength": 5}, {"source_id": "disease severity", "target_id": "immune system", "strength": 5}, {"source_id": "cancer", "target_id": "MAIN OUTCOME", "strength": 5}, {"source_id": "adverse events", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "SARS-CoV-2 RNA", "strength": 5}, {"source_id": "severe disease", "target_id": "breakthrough infections", "strength": 5}, {"source_id": "mortality rate", "target_id": "incidence rate", "strength": 5}, {"source_id": "lower risk", "target_id": "mortality", "strength": 5}, {"source_id": "vaccine", "target_id": "adult patients", "strength": 5}, {"source_id": "study period", "target_id": "age groups", "strength": 5}, {"source_id": "Secondary outcomes", "target_id": "study protocol", "strength": 5}, {"source_id": "study protocol", "target_id": "Secondary outcomes", "strength": 5}, {"source_id": "policy", "target_id": "young people", "strength": 5}, {"source_id": "perception", "target_id": "teachers", "strength": 5}, {"source_id": "admission", "target_id": "hospital mortality", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "control group", "strength": 5}, {"source_id": "spike protein", "target_id": "disease severity", "strength": 5}, {"source_id": "COVID-19 cases", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "logistic regression analysis", "strength": 5}, {"source_id": "immune response", "target_id": "SARS-CoV-2 spike protein", "strength": 5}, {"source_id": "cardiovascular disease", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "risk factors", "target_id": "pneumonia", "strength": 5}, {"source_id": "cohort study", "target_id": "University Hospital", "strength": 5}, {"source_id": "University Hospital", "target_id": "cohort study", "strength": 5}, {"source_id": "logistic regression", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "receptor-binding domain", "target_id": "SARS-CoV-2 spike protein", "strength": 5}, {"source_id": "vaccination", "target_id": "observational study", "strength": 5}, {"source_id": "transplant recipients", "target_id": "vaccine doses", "strength": 5}, {"source_id": "vaccine doses", "target_id": "transplant recipients", "strength": 5}, {"source_id": "vaccine doses", "target_id": "patients", "strength": 5}, {"source_id": "distress syndrome", "target_id": "risk factors", "strength": 5}, {"source_id": "pediatric patients", "target_id": "inflammatory syndrome", "strength": 5}, {"source_id": "middle-income countries", "target_id": "patients", "strength": 5}, {"source_id": "pregnant women", "target_id": "clinical trials", "strength": 5}, {"source_id": "clinical trials", "target_id": "pregnant women", "strength": 5}, {"source_id": "vaccination status", "target_id": "vaccine", "strength": 5}, {"source_id": "older adults", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "observational study", "strength": 5}, {"source_id": "patients", "target_id": "Omicron infection", "strength": 5}, {"source_id": "infection rate", "target_id": "cohort study", "strength": 5}, {"source_id": "patients", "target_id": "vaccination rates", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "complications", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "health professionals", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "acute infection", "strength": 5}, {"source_id": "older age", "target_id": "cohort study", "strength": 5}, {"source_id": "Delta variant", "target_id": "T cell responses", "strength": 5}, {"source_id": "healthy controls", "target_id": "T cell responses", "strength": 5}, {"source_id": "care workers", "target_id": "vaccine", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "case series", "strength": 5}, {"source_id": "cell responses", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19", "target_id": "electronic medical records", "strength": 5}, {"source_id": "medical records", "target_id": "cohort study", "strength": 5}, {"source_id": "central nervous system", "target_id": "infection", "strength": 5}, {"source_id": "transplant recipients", "target_id": "vaccine", "strength": 5}, {"source_id": "disease progression", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "immune system", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "immune system", "strength": 5}, {"source_id": "immune system", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "SARS-CoV-2 variants", "target_id": "vaccine dose", "strength": 5}, {"source_id": "dose", "target_id": "antibody response", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "logistic regression models", "strength": 5}, {"source_id": "research", "target_id": "teachers", "strength": 5}, {"source_id": "vaccine", "target_id": "viral infection", "strength": 5}, {"source_id": "nasopharyngeal swabs", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "rights", "target_id": "pandemic", "strength": 5}, {"source_id": "cytokine storm", "target_id": "immune cells", "strength": 5}, {"source_id": "vaccine", "target_id": "women", "strength": 5}, {"source_id": "antiviral activity", "target_id": "COVID-19", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "nervous system", "strength": 5}, {"source_id": "symptoms", "target_id": "high risk", "strength": 5}, {"source_id": "hospitalized patients", "target_id": "mechanical ventilation", "strength": 5}, {"source_id": "cytokine storm", "target_id": "acute respiratory distress syndrome", "strength": 5}, {"source_id": "cytokine storm", "target_id": "distress syndrome", "strength": 5}, {"source_id": "cell types", "target_id": "cells", "strength": 5}, {"source_id": "infection", "target_id": "SARS-CoV2", "strength": 5}, {"source_id": "World Health Organization", "target_id": "patients", "strength": 5}, {"source_id": "adverse events", "target_id": "mechanical ventilation", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "medical records", "strength": 5}, {"source_id": "adult patients", "target_id": "adverse events", "strength": 5}, {"source_id": "disease 2019", "target_id": "primary outcome", "strength": 5}, {"source_id": "healthcare workers", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "healthcare workers", "target_id": "patients", "strength": 5}, {"source_id": "patients", "target_id": "healthcare workers", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "side effects", "strength": 5}, {"source_id": "T cell responses", "target_id": "antibody levels", "strength": 5}, {"source_id": "infection", "target_id": "patient outcomes", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "primary outcome", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "ICU admission", "strength": 5}, {"source_id": "ICU admission", "target_id": "primary outcome", "strength": 5}, {"source_id": "ICU admission", "target_id": "hospitalization", "strength": 5}, {"source_id": "mean age", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "MAIN OUTCOME", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "disease", "strength": 5}, {"source_id": "COVID-19 outcomes", "target_id": "severe COVID-19", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 outcomes", "strength": 5}, {"source_id": "cohort study", "target_id": "unvaccinated individuals", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "logistic regression models", "strength": 5}, {"source_id": "logistic regression models", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "study protocol", "target_id": "systematic review", "strength": 5}, {"source_id": "study participants", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "therapy", "target_id": "intensive care unit", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "inclusion criteria", "strength": 5}, {"source_id": "inclusion criteria", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "kidney disease", "target_id": "infection", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "SARS-CoV-2 vaccines", "strength": 5}, {"source_id": "B cells", "target_id": "vaccination", "strength": 5}, {"source_id": "vaccination", "target_id": "B cells", "strength": 5}, {"source_id": "serious adverse events", "target_id": "vaccination", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 spike protein", "strength": 5}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "vaccine", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "program", "target_id": "experience", "strength": 5}, {"source_id": "teaching", "target_id": "educators", "strength": 5}, {"source_id": "logistic regression analysis", "target_id": "cross-sectional survey", "strength": 5}, {"source_id": "symptoms", "target_id": "anxiety", "strength": 5}, {"source_id": "pandemic", "target_id": "book", "strength": 5}, {"source_id": "article", "target_id": "pandemic", "strength": 5}, {"source_id": "pandemic", "target_id": "United States", "strength": 5}, {"source_id": "actors", "target_id": "economy", "strength": 5}, {"source_id": "future research", "target_id": "education", "strength": 5}, {"source_id": "teaching", "target_id": "research", "strength": 5}, {"source_id": "article", "target_id": "education", "strength": 5}, {"source_id": "virus infection", "target_id": "immune response", "strength": 5}, {"source_id": "cohort study", "target_id": "illness", "strength": 5}, {"source_id": "Secondary outcomes", "target_id": "retrospective cohort study", "strength": 5}, {"source_id": "MAIN OUTCOME", "target_id": "retrospective cohort study", "strength": 5}, {"source_id": "hospitalized patients", "target_id": "Secondary outcomes", "strength": 5}, {"source_id": "Secondary outcomes", "target_id": "observational study", "strength": 5}, {"source_id": "trials", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "T cell responses", "target_id": "healthcare workers", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "systematic review", "target_id": "mechanical ventilation", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "syndrome coronavirus 2 infection", "strength": 5}, {"source_id": "mechanical ventilation", "target_id": "systematic review", "strength": 5}, {"source_id": "symptoms", "target_id": "syndrome coronavirus 2 infection", "strength": 5}, {"source_id": "multivariable logistic regression", "target_id": "COVID-19", "strength": 5}, {"source_id": "cohort study", "target_id": "higher odds", "strength": 5}, {"source_id": "mechanical ventilation", "target_id": "logistic regression", "strength": 5}, {"source_id": "hospital mortality", "target_id": "retrospective cohort study", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "retrospective cohort study", "strength": 5}, {"source_id": "vaccine effectiveness", "target_id": "study design", "strength": 5}, {"source_id": "incidence rate", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "study design", "target_id": "vaccine effectiveness", "strength": 5}, {"source_id": "coronavirus disease", "target_id": "high risk", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "vaccine effectiveness", "strength": 5}, {"source_id": "vaccine effectiveness", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "infectious diseases", "strength": 5}, {"source_id": "antibody response", "target_id": "breakthrough infections", "strength": 5}, {"source_id": "healthcare workers", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "vaccine doses", "target_id": "immune response", "strength": 5}, {"source_id": "immune response", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "cross-sectional survey", "strength": 5}, {"source_id": "years of age", "target_id": "logistic regression", "strength": 5}, {"source_id": "patients", "target_id": "patient care", "strength": 5}, {"source_id": "risk factors", "target_id": "cancer", "strength": 5}, {"source_id": "disease burden", "target_id": "COVID-19", "strength": 5}, {"source_id": "coronavirus 2", "target_id": "antibody response", "strength": 5}, {"source_id": "mice", "target_id": "immune response", "strength": 5}, {"source_id": "mice", "target_id": "infection", "strength": 5}, {"source_id": "central nervous system", "target_id": "inflammatory response", "strength": 5}, {"source_id": "politics", "target_id": "actors", "strength": 5}, {"source_id": "University", "target_id": "practice", "strength": 5}, {"source_id": "practice", "target_id": "University", "strength": 5}, {"source_id": "COVID-19", "target_id": "course", "strength": 5}, {"source_id": "skills", "target_id": "need", "strength": 5}, {"source_id": "hospital stay", "target_id": "mortality", "strength": 5}, {"source_id": "therapy", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "medical records", "target_id": "vaccine", "strength": 5}, {"source_id": "Health Organization", "target_id": "variants of concern", "strength": 5}, {"source_id": "violence", "target_id": "interviews", "strength": 5}, {"source_id": "protective effect", "target_id": "risk factors", "strength": 5}, {"source_id": "protective effect", "target_id": "infection", "strength": 5}, {"source_id": "cohort study", "target_id": "surgery", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "vaccination coverage", "strength": 5}, {"source_id": "COVID-19", "target_id": "vaccination coverage", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "care system", "strength": 5}, {"source_id": "healthcare workers", "target_id": "disease 2019 pandemic", "strength": 5}, {"source_id": "infection rate", "target_id": "healthcare workers", "strength": 5}, {"source_id": "care services", "target_id": "COVID-19", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "logistic regression", "strength": 5}, {"source_id": "care facilities", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "electronic health records", "target_id": "risk factors", "strength": 5}, {"source_id": "young adults", "target_id": "years of age", "strength": 5}, {"source_id": "COVID-19 pneumonia", "target_id": "respiratory failure", "strength": 5}, {"source_id": "cytokine storm", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "inflammatory diseases", "target_id": "healthy controls", "strength": 5}, {"source_id": "health care professionals", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "health issues", "target_id": "symptoms", "strength": 5}, {"source_id": "mortality rate", "target_id": "observational study", "strength": 5}, {"source_id": "health records", "target_id": "infection", "strength": 5}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "young adults", "strength": 5}, {"source_id": "oxidative stress", "target_id": "COVID-19", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "symptoms", "strength": 5}, {"source_id": "Delta variant", "target_id": "booster dose", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "healthcare workers", "strength": 5}, {"source_id": "antibody levels", "target_id": "spike protein", "strength": 5}, {"source_id": "ICU admission", "target_id": "COVID-19 outcomes", "strength": 5}, {"source_id": "infection", "target_id": "inflammatory diseases", "strength": 5}, {"source_id": "SARS-CoV-2 virus", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "mice", "target_id": "SARS-CoV-2 variants", "strength": 5}, {"source_id": "coronavirus 2 infection", "target_id": "risk factors", "strength": 5}, {"source_id": "risk factors", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "serious adverse events", "strength": 5}, {"source_id": "COVID-19", "target_id": "serious adverse events", "strength": 5}, {"source_id": "serious adverse events", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "clinical trials", "target_id": "disease severity", "strength": 5}, {"source_id": "primary outcome", "target_id": "disease progression", "strength": 5}, {"source_id": "disease progression", "target_id": "primary outcome", "strength": 5}, {"source_id": "people", "target_id": "case study", "strength": 5}, {"source_id": "care unit", "target_id": "coronavirus disease", "strength": 5}, {"source_id": "coronavirus disease", "target_id": "intensive care unit", "strength": 5}, {"source_id": "emergency department", "target_id": "mean age", "strength": 5}, {"source_id": "severe illness", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "severe illness", "target_id": "immune response", "strength": 5}, {"source_id": "disease 2019", "target_id": "clinical manifestations", "strength": 5}, {"source_id": "respiratory disease", "target_id": "infection", "strength": 5}, {"source_id": "mental health", "target_id": "mean age", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "health outcomes", "strength": 5}, {"source_id": "medical students", "target_id": "COVID-19", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "mental health", "strength": 5}, {"source_id": "clinical symptoms", "target_id": "symptoms", "strength": 5}, {"source_id": "symptoms", "target_id": "clinical symptoms", "strength": 5}, {"source_id": "article", "target_id": "context", "strength": 5}, {"source_id": "mortality rate", "target_id": "age groups", "strength": 5}, {"source_id": "hospital admission", "target_id": "hospital mortality", "strength": 5}, {"source_id": "mortality", "target_id": "independent predictors", "strength": 5}, {"source_id": "outcome measures", "target_id": "trials", "strength": 5}, {"source_id": "trials", "target_id": "outcome measures", "strength": 5}, {"source_id": "therapy", "target_id": "outcome measures", "strength": 5}, {"source_id": "antibody titers", "target_id": "SARS-CoV-2 antibodies", "strength": 5}, {"source_id": "systematic review", "target_id": "MAIN OUTCOME", "strength": 5}, {"source_id": "cancer patients", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "severe illness", "target_id": "infection", "strength": 5}, {"source_id": "therapy", "target_id": "retrospective cohort study", "strength": 5}, {"source_id": "high risk", "target_id": "healthcare workers", "strength": 5}, {"source_id": "SARS-CoV-2 virus", "target_id": "SARS-CoV-2 variants", "strength": 5}, {"source_id": "infectious diseases", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "infectious diseases", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "pregnancy", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "risk factors", "target_id": "intensive care unit admission", "strength": 5}, {"source_id": "intensive care unit admission", "target_id": "risk factors", "strength": 5}, {"source_id": "outcome measures", "target_id": "cohort study", "strength": 5}, {"source_id": "institutions", "target_id": "crisis", "strength": 5}, {"source_id": "medical students", "target_id": "schools", "strength": 5}, {"source_id": "myocardial infarction", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "COVID-19", "target_id": "chronic kidney disease", "strength": 5}, {"source_id": "myocardial infarction", "target_id": "risk factors", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "vaccination", "target_id": "women", "strength": 5}, {"source_id": "cause mortality", "target_id": "myocardial infarction", "strength": 5}, {"source_id": "treatment options", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "hospitalization", "target_id": "logistic regression", "strength": 5}, {"source_id": "logistic regression", "target_id": "hospitalization", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "health records", "strength": 5}, {"source_id": "electronic health records", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "mRNA vaccination", "target_id": "COVID-19 mRNA vaccines", "strength": 5}, {"source_id": "mass index", "target_id": "older age", "strength": 5}, {"source_id": "booster dose", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "study participants", "target_id": "COVID-19", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "high-income countries", "strength": 5}, {"source_id": "Meta-Analysis", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "variants of concern", "target_id": "immune response", "strength": 5}, {"source_id": "immune system", "target_id": "disease severity", "strength": 5}, {"source_id": "adverse events", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "adverse events", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "adverse events", "strength": 5}, {"source_id": "cancer", "target_id": "cohort study", "strength": 5}, {"source_id": "mortality", "target_id": "lower risk", "strength": 5}, {"source_id": "patient outcomes", "target_id": "adult patients", "strength": 5}, {"source_id": "mental health", "target_id": "health concern", "strength": 5}, {"source_id": "Delta variant", "target_id": "Omicron infection", "strength": 5}, {"source_id": "crisis", "target_id": "interviews", "strength": 5}, {"source_id": "primary endpoint", "target_id": "COVID-19", "strength": 5}, {"source_id": "vaccination coverage", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "high risk", "target_id": "disease", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "vaccine", "strength": 5}, {"source_id": "emergency department", "target_id": "logistic regression", "strength": 5}, {"source_id": "COVID-19", "target_id": "third dose", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "higher odds", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "cardiovascular disease", "strength": 5}, {"source_id": "University Hospital", "target_id": "COVID-19", "strength": 5}, {"source_id": "University Hospital", "target_id": "care unit", "strength": 5}, {"source_id": "vaccination", "target_id": "therapy", "strength": 5}, {"source_id": "therapy", "target_id": "vaccination", "strength": 5}, {"source_id": "patients", "target_id": "middle-income countries", "strength": 5}, {"source_id": "adult patients", "target_id": "median age", "strength": 5}, {"source_id": "World Health Organization", "target_id": "disease 2019", "strength": 5}, {"source_id": "disease 2019", "target_id": "World Health Organization", "strength": 5}, {"source_id": "disease 2019", "target_id": "Health Organization", "strength": 5}, {"source_id": "clinical characteristics", "target_id": "disease severity", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "variants of concern", "strength": 5}, {"source_id": "infection", "target_id": "COVID-19 severity", "strength": 5}, {"source_id": "median age", "target_id": "high risk", "strength": 5}, {"source_id": "hospitalization", "target_id": "SARS-CoV-2 variants", "strength": 5}, {"source_id": "incidence", "target_id": "COVID-19", "strength": 5}, {"source_id": "health professionals", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "acute infection", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "emergency department", "target_id": "disease 2019", "strength": 5}, {"source_id": "T cells", "target_id": "second dose", "strength": 5}, {"source_id": "T cell responses", "target_id": "healthy controls", "strength": 5}, {"source_id": "mRNA vaccination", "target_id": "immune response", "strength": 5}, {"source_id": "vaccine", "target_id": "care workers", "strength": 5}, {"source_id": "electronic medical records", "target_id": "COVID-19", "strength": 5}, {"source_id": "cohort study", "target_id": "medical records", "strength": 5}, {"source_id": "high risk", "target_id": "hospitalization", "strength": 5}, {"source_id": "hospitalization", "target_id": "high risk", "strength": 5}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "vaccine effectiveness", "strength": 5}, {"source_id": "breakthrough infections", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "breakthrough infections", "strength": 5}, {"source_id": "incidence", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "nervous system", "target_id": "infection", "strength": 5}, {"source_id": "infection", "target_id": "central nervous system", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "women", "strength": 5}, {"source_id": "immune system", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "immune system", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "clinical practice", "target_id": "disease", "strength": 5}, {"source_id": "disease severity", "target_id": "Omicron infection", "strength": 5}, {"source_id": "COVID-19 cases", "target_id": "clinical trials", "strength": 5}, {"source_id": "years of age", "target_id": "infection", "strength": 5}, {"source_id": "cohort study", "target_id": "COVID-19 disease", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "general population", "strength": 5}, {"source_id": "women", "target_id": "vaccine", "strength": 5}, {"source_id": "logistic regression analysis", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "incidence rate", "target_id": "Secondary outcomes", "strength": 5}, {"source_id": "vaccine", "target_id": "case series", "strength": 5}, {"source_id": "T cell responses", "target_id": "SARS-CoV-2 vaccination", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "incidence rate", "strength": 5}, {"source_id": "cells", "target_id": "cell types", "strength": 5}, {"source_id": "second dose", "target_id": "primary outcome", "strength": 5}, {"source_id": "third dose", "target_id": "BNT162b2 vaccine", "strength": 5}, {"source_id": "observational study", "target_id": "antibody levels", "strength": 5}, {"source_id": "BNT162b2 vaccine", "target_id": "antibody levels", "strength": 5}, {"source_id": "dose", "target_id": "BNT162b2 vaccine", "strength": 5}, {"source_id": "care unit", "target_id": "disease 2019", "strength": 5}, {"source_id": "disease 2019", "target_id": "intensive care unit", "strength": 5}, {"source_id": "patients", "target_id": "oxidative stress", "strength": 5}, {"source_id": "medical records", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "side effects", "target_id": "second dose", "strength": 5}, {"source_id": "clinical data", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "risk factors", "target_id": "blood pressure", "strength": 5}, {"source_id": "care unit admission", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "unit admission", "strength": 5}, {"source_id": "admission", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "health care workers", "target_id": "COVID-19", "strength": 5}, {"source_id": "COVID-19", "target_id": "care workers", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "disease", "strength": 5}, {"source_id": "severe COVID-19", "target_id": "COVID-19 outcomes", "strength": 5}, {"source_id": "COVID-19 outcomes", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "years of age", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "health system", "target_id": "care", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "hospital", "strength": 5}, {"source_id": "therapy", "target_id": "monoclonal antibodies", "strength": 5}, {"source_id": "monoclonal antibodies", "target_id": "therapy", "strength": 5}, {"source_id": "COVID-19", "target_id": "beneficial effects", "strength": 5}, {"source_id": "beneficial effects", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "beneficial effects", "target_id": "COVID-19", "strength": 5}, {"source_id": "observational study", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "general population", "strength": 5}, {"source_id": "vaccine", "target_id": "B cells", "strength": 5}, {"source_id": "observational study", "target_id": "ICU admission", "strength": 5}, {"source_id": "clinical characteristics", "target_id": "mechanical ventilation", "strength": 5}, {"source_id": "intensive care", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "diabetes mellitus", "target_id": "cohort study", "strength": 5}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "cohort study", "strength": 5}, {"source_id": "healthy controls", "target_id": "disease", "strength": 5}, {"source_id": "vaccination", "target_id": "vaccination campaign", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "SARS-CoV-2 spike protein", "strength": 5}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "side effects", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "clinical practice", "strength": 5}, {"source_id": "educators", "target_id": "experience", "strength": 5}, {"source_id": "educators", "target_id": "program", "strength": 5}, {"source_id": "motivation", "target_id": "experience", "strength": 5}, {"source_id": "cross-sectional survey", "target_id": "logistic regression analysis", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "social determinants", "strength": 5}, {"source_id": "nervous system", "target_id": "Alzheimer's disease", "strength": 5}, {"source_id": "crisis", "target_id": "market", "strength": 5}, {"source_id": "pandemic", "target_id": "qualitative study", "strength": 5}, {"source_id": "violence", "target_id": "experience", "strength": 5}, {"source_id": "research", "target_id": "teaching", "strength": 5}, {"source_id": "educators", "target_id": "curriculum", "strength": 5}, {"source_id": "immune response", "target_id": "virus infection", "strength": 5}, {"source_id": "animal models", "target_id": "infection", "strength": 5}, {"source_id": "infection", "target_id": "animal models", "strength": 5}, {"source_id": "MAIN OUTCOME", "target_id": "study period", "strength": 5}, {"source_id": "study period", "target_id": "mean age", "strength": 5}, {"source_id": "study period", "target_id": "MAIN OUTCOME", "strength": 5}, {"source_id": "hazard ratio", "target_id": "COVID-19", "strength": 5}, {"source_id": "years of age", "target_id": "adverse events", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "antibody titers", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "clinical studies", "strength": 5}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "clinical presentation", "strength": 5}, {"source_id": "respiratory symptoms", "target_id": "coronavirus 2 infection", "strength": 5}, {"source_id": "symptoms", "target_id": "coronavirus 2 infection", "strength": 5}, {"source_id": "COVID-19", "target_id": "multivariable logistic regression", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 diagnosis", "strength": 5}, {"source_id": "COVID-19 diagnosis", "target_id": "infection", "strength": 5}, {"source_id": "disease 2019", "target_id": "retrospective cohort study", "strength": 5}, {"source_id": "cardiovascular disease", "target_id": "diabetes mellitus", "strength": 5}, {"source_id": "BNT162b2 vaccine", "target_id": "infection", "strength": 5}, {"source_id": "cohort study", "target_id": "COVID-19 diagnosis", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "immune response", "strength": 5}, {"source_id": "booster vaccination", "target_id": "antibody response", "strength": 5}, {"source_id": "Delta variant", "target_id": "vaccine doses", "strength": 5}, {"source_id": "acute phase", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "acute phase", "strength": 5}, {"source_id": "long COVID", "target_id": "acute phase", "strength": 5}, {"source_id": "risk factors", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "vaccination", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "experience", "target_id": "course", "strength": 5}, {"source_id": "cancer", "target_id": "risk factors", "strength": 5}, {"source_id": "middle-income countries", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "health care", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "viral infection", "strength": 5}, {"source_id": "heart failure", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "viral infection", "target_id": "spike protein", "strength": 5}, {"source_id": "infection", "target_id": "mice", "strength": 5}, {"source_id": "infection", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 5}, {"source_id": "people", "target_id": "practice", "strength": 5}, {"source_id": "pandemic", "target_id": "case study", "strength": 5}, {"source_id": "practice", "target_id": "engagement", "strength": 5}, {"source_id": "engagement", "target_id": "practice", "strength": 5}, {"source_id": "engagement", "target_id": "University", "strength": 5}, {"source_id": "society", "target_id": "COVID-19", "strength": 5}, {"source_id": "care settings", "target_id": "infection", "strength": 5}, {"source_id": "infection", "target_id": "care settings", "strength": 5}, {"source_id": "hospital admission", "target_id": "severe COVID-19", "strength": 5}, {"source_id": "clinical manifestations", "target_id": "infection", "strength": 5}, {"source_id": "women", "target_id": "observational study", "strength": 5}, {"source_id": "autoimmune diseases", "target_id": "case report", "strength": 5}, {"source_id": "autoimmune diseases", "target_id": "vaccine", "strength": 5}, {"source_id": "dose", "target_id": "antibody titers", "strength": 5}, {"source_id": "humoral immune response", "target_id": "vaccine", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "inflammatory response", "strength": 5}, {"source_id": "spike protein", "target_id": "severe disease", "strength": 5}, {"source_id": "politics", "target_id": "United States", "strength": 5}, {"source_id": "COVID-19", "target_id": "primary care", "strength": 5}, {"source_id": "risk factors", "target_id": "COVID-19 symptoms", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "high risk", "strength": 5}, {"source_id": "surgery", "target_id": "cohort study", "strength": 5}, {"source_id": "vaccination coverage", "target_id": "COVID-19", "strength": 5}, {"source_id": "infection rate", "target_id": "COVID-19", "strength": 5}, {"source_id": "years of age", "target_id": "young adults", "strength": 5}, {"source_id": "ill patients", "target_id": "respiratory failure", "strength": 5}, {"source_id": "mortality", "target_id": "respiratory failure", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "humoral immune response", "strength": 5}, {"source_id": "IL-6", "target_id": "cytokine storm", "strength": 5}, {"source_id": "antibody levels", "target_id": "healthy controls", "strength": 5}, {"source_id": "kidney disease", "target_id": "risk factors", "strength": 5}, {"source_id": "health issues", "target_id": "mental health", "strength": 5}, {"source_id": "symptoms", "target_id": "health issues", "strength": 5}, {"source_id": "clinical trials", "target_id": "inclusion criteria", "strength": 5}, {"source_id": "inclusion criteria", "target_id": "clinical trials", "strength": 5}, {"source_id": "intensive care unit", "target_id": "admission", "strength": 5}, {"source_id": "care unit", "target_id": "observational study", "strength": 5}, {"source_id": "observational study", "target_id": "mortality rate", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "health system", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "retrospective study", "strength": 5}, {"source_id": "retrospective study", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "oxidative stress", "target_id": "disease", "strength": 5}, {"source_id": "disease", "target_id": "oxidative stress", "strength": 5}, {"source_id": "SARS-CoV-2 variants", "target_id": "COVID-19 infection", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "SARS-CoV-2 variants", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "respiratory symptoms", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "symptoms", "strength": 5}, {"source_id": "symptoms", "target_id": "respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "symptoms", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "booster dose", "target_id": "Delta variant", "strength": 5}, {"source_id": "vaccine", "target_id": "prospective cohort study", "strength": 5}, {"source_id": "spike protein", "target_id": "antibody levels", "strength": 5}, {"source_id": "case study", "target_id": "practice", "strength": 5}, {"source_id": "ICU admission", "target_id": "hospital admission", "strength": 5}, {"source_id": "hospital admission", "target_id": "ICU admission", "strength": 5}, {"source_id": "observational study", "target_id": "cohort study", "strength": 5}, {"source_id": "spike protein", "target_id": "protein", "strength": 5}, {"source_id": "discourse", "target_id": "context", "strength": 5}, {"source_id": "context", "target_id": "discourse", "strength": 5}, {"source_id": "teaching", "target_id": "thematic analysis", "strength": 5}, {"source_id": "SARS-CoV-2 variants", "target_id": "mice", "strength": 5}, {"source_id": "pulmonary disease", "target_id": "disease", "strength": 5}, {"source_id": "risk factors", "target_id": "syndrome coronavirus 2 infection", "strength": 5}, {"source_id": "risk factors", "target_id": "coronavirus 2 infection", "strength": 5}, {"source_id": "high prevalence", "target_id": "infection", "strength": 5}, {"source_id": "disease severity", "target_id": "clinical trials", "strength": 5}, {"source_id": "mortality", "target_id": "MAIN OUTCOME", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "young adults", "strength": 5}, {"source_id": "young adults", "target_id": "COVID-19 vaccine", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "clinical manifestations", "strength": 5}, {"source_id": "coronavirus disease 2019", "target_id": "severe illness", "strength": 5}, {"source_id": "clinical manifestations", "target_id": "disease 2019", "strength": 5}, {"source_id": "severe illness", "target_id": "disease 2019", "strength": 5}, {"source_id": "disease severity", "target_id": "respiratory disease", "strength": 5}, {"source_id": "intervention group", "target_id": "Secondary outcomes", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "middle-income countries", "strength": 5}, {"source_id": "BNT162b2 vaccine", "target_id": "cohort study", "strength": 5}, {"source_id": "cohort study", "target_id": "BNT162b2 vaccine", "strength": 5}, {"source_id": "COVID-19 infection", "target_id": "respiratory failure", "strength": 5}, {"source_id": "clinical outcomes", "target_id": "respiratory failure", "strength": 5}, {"source_id": "disease severity", "target_id": "persistent symptoms", "strength": 5}, {"source_id": "age groups", "target_id": "mortality rate", "strength": 5}, {"source_id": "MAIN OUTCOME", "target_id": "second dose", "strength": 5}, {"source_id": "disease 2019", "target_id": "ill patients", "strength": 5}, {"source_id": "mass index", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "infection", "target_id": "severe illness", "strength": 5}, {"source_id": "vaccination campaign", "target_id": "age groups", "strength": 5}, {"source_id": "viral infection", "target_id": "symptoms", "strength": 5}, {"source_id": "hospital mortality", "target_id": "patient outcomes", "strength": 5}, {"source_id": "Secondary outcomes", "target_id": "risk factors", "strength": 5}, {"source_id": "healthcare workers", "target_id": "high risk", "strength": 5}, {"source_id": "health problems", "target_id": "systematic review", "strength": 5}, {"source_id": "systematic review", "target_id": "health problems", "strength": 5}, {"source_id": "primary care", "target_id": "cohort study", "strength": 5}, {"source_id": "study period", "target_id": "admission", "strength": 5}, {"source_id": "cohort study", "target_id": "health services", "strength": 5}, {"source_id": "adult patients", "target_id": "SARS-CoV-2 variants", "strength": 5}, {"source_id": "infectious diseases", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "infectious diseases", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "observational study", "target_id": "older age", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "race/ethnicity", "strength": 5}, {"source_id": "SARS-CoV-2", "target_id": "adverse effects", "strength": 5}, {"source_id": "SARS-CoV-2 infection", "target_id": "pregnant women", "strength": 5}, {"source_id": "cytokine storm", "target_id": "infection", "strength": 5}, {"source_id": "pregnant women", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "infection", "target_id": "cytokine storm", "strength": 5}, {"source_id": "Omicron infection", "target_id": "severe disease", "strength": 5}, {"source_id": "systematic review", "target_id": "myocardial infarction", "strength": 5}, {"source_id": "myocardial infarction", "target_id": "systematic review", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "disease 2019", "strength": 5}, {"source_id": "myocardial infarction", "target_id": "cause mortality", "strength": 5}, {"source_id": "odds ratio", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "logistic regression models", "target_id": "vaccine hesitancy", "strength": 5}, {"source_id": "vaccine hesitancy", "target_id": "logistic regression models", "strength": 5}, {"source_id": "mRNA vaccination", "target_id": "cohort study", "strength": 5}, {"source_id": "vaccination", "target_id": "study participants", "strength": 5}, {"source_id": "need", "target_id": "COVID-19 pandemic", "strength": 5}, {"source_id": "Omicron infection", "target_id": "vaccine", "strength": 5}, {"source_id": "age groups", "target_id": "general population", "strength": 5}, {"source_id": "mental health", "target_id": "thematic analysis", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "perception", "strength": 5}, {"source_id": "patients", "target_id": "incidence rate", "strength": 5}, {"source_id": "COVID-19 patients", "target_id": "Meta-Analysis", "strength": 5}, {"source_id": "Meta-Analysis", "target_id": "clinical outcomes", "strength": 5}, {"source_id": "symptoms", "target_id": "case report", "strength": 5}, {"source_id": "adverse events", "target_id": "syndrome coronavirus 2", "strength": 5}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "adverse events", "strength": 5}, {"source_id": "prospective study", "target_id": "SARS-CoV-2", "strength": 5}, {"source_id": "adult patients", "target_id": "patient outcomes", "strength": 5}, {"source_id": "care", "target_id": "primary outcome", "strength": 5}, {"source_id": "teachers", "target_id": "perception", "strength": 5}, {"source_id": "hospital mortality", "target_id": "admission", "strength": 5}, {"source_id": "disease severity", "target_id": "spike protein", "strength": 5}, {"source_id": "healthy controls", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "social media", "target_id": "crisis", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "COVID-19 cases", "strength": 5}, {"source_id": "COVID-19 pandemic", "target_id": "cohort", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "vaccination coverage", "strength": 5}, {"source_id": "disease", "target_id": "high risk", "strength": 5}, {"source_id": "unit admission", "target_id": "severe COVID-19", "strength": 5}, {"source_id": "vaccine", "target_id": "COVID-19 patients", "strength": 5}, {"source_id": "lung disease", "target_id": "COVID-19", "strength": 5}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "immune response", "strength": 5}, {"source_id": "higher odds", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "observational study", "target_id": "vaccine effectiveness", "strength": 5}, {"source_id": "adult patients", "target_id": "vaccination", "strength": 5}, {"source_id": "patients", "target_id": "vaccine doses", "strength": 5}, {"source_id": "COVID-19 outcomes", "target_id": "vaccine", "strength": 5}, {"source_id": "epithelial cells", "target_id": "SARS-CoV-2 infection", "strength": 5}, {"source_id": "Health Organization", "target_id": "disease 2019", "strength": 5}, {"source_id": "vaccine", "target_id": "vaccination status", "strength": 5}, {"source_id": "policy", "target_id": "violence", "strength": 5}, {"source_id": "median age", "target_id": "independent predictors", "strength": 5}, {"source_id": "case report", "target_id": "disease", "strength": 5}, {"source_id": "disease", "target_id": "case report", "strength": 5}, {"source_id": "disease severity", "target_id": "clinical characteristics", "strength": 5}, {"source_id": "SARS-CoV-2 variants", "target_id": "hospitalization", "strength": 5}, {"source_id": "vaccination rates", "target_id": "patients", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "third dose", "strength": 5}, {"source_id": "third dose", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "vaccination", "target_id": "logistic regression", "strength": 5}, {"source_id": "emergency department", "target_id": "coronavirus disease 2019", "strength": 5}, {"source_id": "disease 2019", "target_id": "emergency department", "strength": 5}, {"source_id": "second dose", "target_id": "T cells", "strength": 5}, {"source_id": "COVID-19 vaccine", "target_id": "most patients", "strength": 5}, {"source_id": "immune response", "target_id": "adult patients", "strength": 5}, {"source_id": "immune response", "target_id": "mRNA vaccination", "strength": 5}, {"source_id": "cell responses", "target_id": "coronavirus 2", "strength": 5}, {"source_id": "syndrome coronavirus 2", "target_id": "cell responses", "strength": 5}, {"source_id": "older age", "target_id": "mortality", "strength": 5}, {"source_id": "mortality", "target_id": "older age", "strength": 5}, {"source_id": "mRNA vaccines", "target_id": "hospitalization", "strength": 5}, {"source_id": "hospitalization", "target_id": "mRNA vaccines", "strength": 5}, {"source_id": "cross-sectional study", "target_id": "COVID-19 symptoms", "strength": 5}, {"source_id": "COVID-19 symptoms", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "older adults", "target_id": "cross-sectional study", "strength": 5}, {"source_id": "infection", "target_id": "nervous system", "strength": 5}, {"source_id": "T cells", "target_id": "infectious diseases", "strength": 5}, {"source_id": "clinical trials", "target_id": "high risk", "strength": 5}, {"source_id": "autoimmune diseases", "target_id": "vaccination", "strength": 5}, {"source_id": "vaccine", "target_id": "transplant recipients", "strength": 5}, {"source_id": "risk factors", "target_id": "injury", "strength": 5}, {"source_id": "severe disease", "target_id": "median age", "strength": 5}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "immune system", "strength": 5}, {"source_id": "immune system", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 5}, {"source_id": "COVID-19 vaccination", "target_id": "vaccine doses", "strength": 5}, {"source_id": "mRNA vaccination", "target_id": "COVID-19 vaccination", "strength": 5}, {"source_id": "type 2 diabetes", "target_id": "diabetes mellitus", "strength": 5}, {"source_id": "disease", "target_id": "clinical practice", "strength": 5}, {"source_id": "Omicron infection", "target_id": "disease severity", "strength": 5}, {"source_id": "viral infection", "target_id": "vaccine", "strength": 5}, {"source_id": "COVID-19 disease", "target_id": "cohort study", "strength": 5}, {"source_id": "prospective cohort study", "target_id": "mean age", "strength": 5}, {"source_id": "antibody levels", "target_id": "COVID-19", "strength": 5}, {"source_id": "high risk", "target_id": "symptoms", "strength": 5}, {"source_id": "respiratory distress syndrome", "target_id": "cytokine storm", "strength": 5}, {"source_id": "protein", "target_id": "cells", "strength": 6}, {"source_id": "cells", "target_id": "protein", "strength": 6}, {"source_id": "COVID-19", "target_id": "SARS-CoV2", "strength": 6}, {"source_id": "care unit", "target_id": "acute respiratory distress syndrome", "strength": 6}, {"source_id": "patients", "target_id": "booster dose", "strength": 6}, {"source_id": "adult patients", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "disease 2019", "target_id": "adverse events", "strength": 6}, {"source_id": "BNT162b2 vaccine", "target_id": "antibody response", "strength": 6}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "antibody levels", "strength": 6}, {"source_id": "second dose", "target_id": "healthcare workers", "strength": 6}, {"source_id": "antibody response", "target_id": "BNT162b2 vaccine", "strength": 6}, {"source_id": "side effects", "target_id": "mRNA vaccines", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "intensive care unit admission", "strength": 6}, {"source_id": "COVID-19 vaccination", "target_id": "MAIN OUTCOME", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "intensive care unit admission", "strength": 6}, {"source_id": "care unit admission", "target_id": "clinical outcomes", "strength": 6}, {"source_id": "hospitalization", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "general population", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "safety profile", "strength": 6}, {"source_id": "control group", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "adverse events", "target_id": "inclusion criteria", "strength": 6}, {"source_id": "vaccination", "target_id": "syndrome coronavirus 2", "strength": 6}, {"source_id": "disease severity", "target_id": "vaccination", "strength": 6}, {"source_id": "chronic diseases", "target_id": "patients", "strength": 6}, {"source_id": "intensive care unit", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "institutions", "target_id": "practice", "strength": 6}, {"source_id": "spike protein", "target_id": "cohort study", "strength": 6}, {"source_id": "Omicron infection", "target_id": "cohort study", "strength": 6}, {"source_id": "World Health Organization", "target_id": "variants of concern", "strength": 6}, {"source_id": "variants of concern", "target_id": "World Health Organization", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "future research", "strength": 6}, {"source_id": "immune response", "target_id": "animal models", "strength": 6}, {"source_id": "heart failure", "target_id": "mortality rate", "strength": 6}, {"source_id": "clinical outcomes", "target_id": "Secondary outcomes", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "Secondary outcomes", "strength": 6}, {"source_id": "Secondary outcomes", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "monoclonal antibodies", "target_id": "COVID-19", "strength": 6}, {"source_id": "cell responses", "target_id": "antibody titers", "strength": 6}, {"source_id": "race/ethnicity", "target_id": "patients", "strength": 6}, {"source_id": "retrospective cohort study", "target_id": "clinical outcomes", "strength": 6}, {"source_id": "vaccine doses", "target_id": "booster vaccination", "strength": 6}, {"source_id": "blood samples", "target_id": "antibody response", "strength": 6}, {"source_id": "COVID-19", "target_id": "second dose", "strength": 6}, {"source_id": "logistic regression", "target_id": "mean age", "strength": 6}, {"source_id": "antiviral activity", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "therapeutic strategies", "target_id": "T cells", "strength": 6}, {"source_id": "COVID-19", "target_id": "patient characteristics", "strength": 6}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "monoclonal antibodies", "strength": 6}, {"source_id": "monoclonal antibodies", "target_id": "respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "monoclonal antibodies", "target_id": "syndrome coronavirus 2", "strength": 6}, {"source_id": "monoclonal antibodies", "target_id": "coronavirus 2", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "mouse model", "strength": 6}, {"source_id": "immune cells", "target_id": "viral infection", "strength": 6}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "respiratory tract", "strength": 6}, {"source_id": "respiratory tract", "target_id": "syndrome coronavirus 2", "strength": 6}, {"source_id": "higher education", "target_id": "experience", "strength": 6}, {"source_id": "learning", "target_id": "training", "strength": 6}, {"source_id": "society", "target_id": "book", "strength": 6}, {"source_id": "book", "target_id": "education", "strength": 6}, {"source_id": "mortality", "target_id": "adverse events", "strength": 6}, {"source_id": "prospective study", "target_id": "infection", "strength": 6}, {"source_id": "humoral response", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "antibody response", "target_id": "therapy", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "pregnancy", "strength": 6}, {"source_id": "healthcare workers", "target_id": "study period", "strength": 6}, {"source_id": "health issues", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "experience", "target_id": "participants", "strength": 6}, {"source_id": "high risk", "target_id": "breakthrough infections", "strength": 6}, {"source_id": "vaccination rates", "target_id": "COVID-19 vaccination", "strength": 6}, {"source_id": "general population", "target_id": "systematic review", "strength": 6}, {"source_id": "clinical trials", "target_id": "beneficial effects", "strength": 6}, {"source_id": "emergency department", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "cross-sectional study", "target_id": "study population", "strength": 6}, {"source_id": "study population", "target_id": "cross-sectional study", "strength": 6}, {"source_id": "vaccine", "target_id": "risk factors", "strength": 6}, {"source_id": "risk factors", "target_id": "adult patients", "strength": 6}, {"source_id": "mortality rate", "target_id": "admission", "strength": 6}, {"source_id": "ill patients", "target_id": "adult patients", "strength": 6}, {"source_id": "admission", "target_id": "mortality rate", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "IL-6", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "care professionals", "strength": 6}, {"source_id": "mortality", "target_id": "logistic regression", "strength": 6}, {"source_id": "disease", "target_id": "immune system", "strength": 6}, {"source_id": "care workers", "target_id": "vaccination", "strength": 6}, {"source_id": "pandemic", "target_id": "educators", "strength": 6}, {"source_id": "young adults", "target_id": "mental health", "strength": 6}, {"source_id": "pregnancy", "target_id": "cohort study", "strength": 6}, {"source_id": "clinical care", "target_id": "patients", "strength": 6}, {"source_id": "patients", "target_id": "clinical care", "strength": 6}, {"source_id": "primary outcome", "target_id": "emergency department", "strength": 6}, {"source_id": "employees", "target_id": "organization", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "semi-structured interviews", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "SARS-CoV-2 variants", "strength": 6}, {"source_id": "disease severity", "target_id": "hospital mortality", "strength": 6}, {"source_id": "intensive care unit", "target_id": "mortality", "strength": 6}, {"source_id": "mortality", "target_id": "care unit", "strength": 6}, {"source_id": "RT-PCR", "target_id": "patients", "strength": 6}, {"source_id": "primary endpoint", "target_id": "clinical trials", "strength": 6}, {"source_id": "inflammatory diseases", "target_id": "disease", "strength": 6}, {"source_id": "COVID-19", "target_id": "cohort", "strength": 6}, {"source_id": "cohort", "target_id": "COVID-19", "strength": 6}, {"source_id": "infectious diseases", "target_id": "disease 2019", "strength": 6}, {"source_id": "logistic regression", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "emergency department", "target_id": "retrospective cohort study", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "case report", "strength": 6}, {"source_id": "high risk", "target_id": "immune response", "strength": 6}, {"source_id": "health policy", "target_id": "policy", "strength": 6}, {"source_id": "participants", "target_id": "education", "strength": 6}, {"source_id": "clinical symptoms", "target_id": "COVID-19", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "protective effect", "strength": 6}, {"source_id": "protective effect", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "Omicron infection", "target_id": "booster vaccination", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "logistic regression models", "strength": 6}, {"source_id": "logistic regression models", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "adverse events", "target_id": "third dose", "strength": 6}, {"source_id": "third dose", "target_id": "adverse events", "strength": 6}, {"source_id": "mRNA vaccination", "target_id": "vaccine doses", "strength": 6}, {"source_id": "severe cases", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "severe cases", "target_id": "disease 2019", "strength": 6}, {"source_id": "acute respiratory distress syndrome", "target_id": "immune response", "strength": 6}, {"source_id": "high risk", "target_id": "health services", "strength": 6}, {"source_id": "vaccination status", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "patients", "target_id": "infectious diseases", "strength": 6}, {"source_id": "context", "target_id": "COVID-19", "strength": 6}, {"source_id": "disease severity", "target_id": "lower risk", "strength": 6}, {"source_id": "syndrome coronavirus 2", "target_id": "animal models", "strength": 6}, {"source_id": "mortality", "target_id": "Secondary outcomes", "strength": 6}, {"source_id": "care unit", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "primary outcome", "target_id": "hospital discharge", "strength": 6}, {"source_id": "perception", "target_id": "education", "strength": 6}, {"source_id": "primary outcome", "target_id": "length of stay", "strength": 6}, {"source_id": "T cells", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "respiratory failure", "target_id": "Secondary outcomes", "strength": 6}, {"source_id": "respiratory distress syndrome", "target_id": "respiratory failure", "strength": 6}, {"source_id": "depressive symptoms", "target_id": "COVID-19", "strength": 6}, {"source_id": "vaccine uptake", "target_id": "vaccination", "strength": 6}, {"source_id": "COVID-19 disease", "target_id": "clinical trials", "strength": 6}, {"source_id": "observational cohort study", "target_id": "infection", "strength": 6}, {"source_id": "ICU admission", "target_id": "care unit", "strength": 6}, {"source_id": "community", "target_id": "policy", "strength": 6}, {"source_id": "context", "target_id": "teachers", "strength": 6}, {"source_id": "hospitalization", "target_id": "vaccine", "strength": 6}, {"source_id": "vaccination", "target_id": "prospective cohort study", "strength": 6}, {"source_id": "pulmonary disease", "target_id": "risk factors", "strength": 6}, {"source_id": "disease severity", "target_id": "high risk", "strength": 6}, {"source_id": "cardiovascular disease", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "IL-6", "target_id": "immune response", "strength": 6}, {"source_id": "disease", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "disease", "strength": 6}, {"source_id": "disease", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "intensive care unit", "target_id": "acute respiratory distress syndrome", "strength": 6}, {"source_id": "severe disease", "target_id": "hospital admission", "strength": 6}, {"source_id": "second dose", "target_id": "BNT162b2 vaccine", "strength": 6}, {"source_id": "mechanical ventilation", "target_id": "COVID-19 pneumonia", "strength": 6}, {"source_id": "adverse events", "target_id": "hospital discharge", "strength": 6}, {"source_id": "adverse events", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "mRNA vaccines", "target_id": "side effects", "strength": 6}, {"source_id": "care unit admission", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "care unit admission", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "intensive care unit admission", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "care unit admission", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "hospitalization", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "greater risk", "strength": 6}, {"source_id": "clinical outcomes", "target_id": "unit admission", "strength": 6}, {"source_id": "mean age", "target_id": "vaccination", "strength": 6}, {"source_id": "MAIN OUTCOME", "target_id": "COVID-19 vaccination", "strength": 6}, {"source_id": "vaccination", "target_id": "mean age", "strength": 6}, {"source_id": "general population", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "median age", "target_id": "prospective cohort study", "strength": 6}, {"source_id": "care unit", "target_id": "control group", "strength": 6}, {"source_id": "care unit", "target_id": "therapy", "strength": 6}, {"source_id": "therapy", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "health concern", "target_id": "patients", "strength": 6}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "vaccination", "strength": 6}, {"source_id": "coronavirus disease", "target_id": "vaccine", "strength": 6}, {"source_id": "vaccination", "target_id": "vaccine hesitancy", "strength": 6}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "practice", "target_id": "institutions", "strength": 6}, {"source_id": "study period", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "cohort study", "target_id": "spike protein", "strength": 6}, {"source_id": "patients", "target_id": "variants of concern", "strength": 6}, {"source_id": "justice", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "thematic analysis", "target_id": "pandemic", "strength": 6}, {"source_id": "case study", "target_id": "book", "strength": 6}, {"source_id": "policy", "target_id": "experience", "strength": 6}, {"source_id": "schools", "target_id": "educators", "strength": 6}, {"source_id": "animal models", "target_id": "immune response", "strength": 6}, {"source_id": "injury", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "antibody response", "strength": 6}, {"source_id": "COVID-19", "target_id": "median time", "strength": 6}, {"source_id": "clinical studies", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "second dose", "target_id": "young adults", "strength": 6}, {"source_id": "logistic regression analysis", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "COVID-19", "target_id": "high mortality", "strength": 6}, {"source_id": "booster vaccination", "target_id": "vaccine doses", "strength": 6}, {"source_id": "incidence rate", "target_id": "vaccination", "strength": 6}, {"source_id": "infection", "target_id": "therapeutic strategies", "strength": 6}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "monoclonal antibodies", "strength": 6}, {"source_id": "syndrome coronavirus 2", "target_id": "monoclonal antibodies", "strength": 6}, {"source_id": "antibody response", "target_id": "B cells", "strength": 6}, {"source_id": "monoclonal antibodies", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "mouse model", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "coronavirus 2", "target_id": "respiratory tract", "strength": 6}, {"source_id": "respiratory tract", "target_id": "coronavirus 2", "strength": 6}, {"source_id": "species", "target_id": "ecosystems", "strength": 6}, {"source_id": "University", "target_id": "institutions", "strength": 6}, {"source_id": "engagement", "target_id": "skills", "strength": 6}, {"source_id": "curriculum", "target_id": "program", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "second dose", "strength": 6}, {"source_id": "second dose", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "hospital admission", "strength": 6}, {"source_id": "disease 2019", "target_id": "hospital admission", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "age groups", "strength": 6}, {"source_id": "surgery", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "T cells", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "clinical trials", "target_id": "quality of life", "strength": 6}, {"source_id": "Omicron variant", "target_id": "T cell responses", "strength": 6}, {"source_id": "breakthrough infections", "target_id": "high risk", "strength": 6}, {"source_id": "COVID-19 vaccination", "target_id": "vaccination rates", "strength": 6}, {"source_id": "beneficial effects", "target_id": "clinical trials", "strength": 6}, {"source_id": "booster doses", "target_id": "COVID-19 vaccination", "strength": 6}, {"source_id": "immune response", "target_id": "symptoms", "strength": 6}, {"source_id": "health care professionals", "target_id": "patients", "strength": 6}, {"source_id": "health professionals", "target_id": "healthcare professionals", "strength": 6}, {"source_id": "risk factors", "target_id": "vaccine", "strength": 6}, {"source_id": "electronic health records", "target_id": "primary care", "strength": 6}, {"source_id": "young adults", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "mortality rate", "target_id": "hospital admission", "strength": 6}, {"source_id": "University Hospital", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "intensive care", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "healthy controls", "strength": 6}, {"source_id": "IL-6", "target_id": "disease 2019", "strength": 6}, {"source_id": "logistic regression", "target_id": "mortality", "strength": 6}, {"source_id": "mortality", "target_id": "clinical outcomes", "strength": 6}, {"source_id": "thematic analysis", "target_id": "interviews", "strength": 6}, {"source_id": "healthcare workers", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "healthcare workers", "strength": 6}, {"source_id": "second dose", "target_id": "COVID-19 mRNA vaccines", "strength": 6}, {"source_id": "health measures", "target_id": "mental health", "strength": 6}, {"source_id": "COVID-19", "target_id": "vaccine dose", "strength": 6}, {"source_id": "case-control study", "target_id": "vaccine effectiveness", "strength": 6}, {"source_id": "symptoms", "target_id": "care unit", "strength": 6}, {"source_id": "blood samples", "target_id": "antibody titers", "strength": 6}, {"source_id": "patients", "target_id": "RT-PCR", "strength": 6}, {"source_id": "disease", "target_id": "inflammatory diseases", "strength": 6}, {"source_id": "risk factors", "target_id": "cohort", "strength": 6}, {"source_id": "study design", "target_id": "COVID-19", "strength": 6}, {"source_id": "severe illness", "target_id": "vaccine", "strength": 6}, {"source_id": "vaccination coverage", "target_id": "age groups", "strength": 6}, {"source_id": "cohort study", "target_id": "patient outcomes", "strength": 6}, {"source_id": "patient outcomes", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "patient outcomes", "target_id": "cohort study", "strength": 6}, {"source_id": "study period", "target_id": "emergency department", "strength": 6}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "cohort study", "strength": 6}, {"source_id": "COVID-19 disease", "target_id": "vaccine", "strength": 6}, {"source_id": "care unit admission", "target_id": "risk factors", "strength": 6}, {"source_id": "policy", "target_id": "context", "strength": 6}, {"source_id": "University", "target_id": "program", "strength": 6}, {"source_id": "disease", "target_id": "chronic kidney disease", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "cytokine storm", "strength": 6}, {"source_id": "COVID-19", "target_id": "cause mortality", "strength": 6}, {"source_id": "observational study", "target_id": "hospital admission", "strength": 6}, {"source_id": "cohort study", "target_id": "COVID-19 outcomes", "strength": 6}, {"source_id": "Omicron infection", "target_id": "vaccination", "strength": 6}, {"source_id": "vaccine doses", "target_id": "mRNA vaccination", "strength": 6}, {"source_id": "age groups", "target_id": "COVID-19 vaccination", "strength": 6}, {"source_id": "perspective", "target_id": "policy", "strength": 6}, {"source_id": "immune response", "target_id": "distress syndrome", "strength": 6}, {"source_id": "respiratory distress syndrome", "target_id": "immune response", "strength": 6}, {"source_id": "health services", "target_id": "high risk", "strength": 6}, {"source_id": "COVID-19", "target_id": "context", "strength": 6}, {"source_id": "countries", "target_id": "pandemic", "strength": 6}, {"source_id": "booster dose", "target_id": "adverse events", "strength": 6}, {"source_id": "mortality", "target_id": "clinical characteristics", "strength": 6}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "animal models", "strength": 6}, {"source_id": "cohort study", "target_id": "complications", "strength": 6}, {"source_id": "patients", "target_id": "SARS-CoV-2 RNA", "strength": 6}, {"source_id": "hospital discharge", "target_id": "primary outcome", "strength": 6}, {"source_id": "community", "target_id": "United States", "strength": 6}, {"source_id": "hospital mortality", "target_id": "adult patients", "strength": 6}, {"source_id": "care unit admission", "target_id": "mortality", "strength": 6}, {"source_id": "mortality", "target_id": "intensive care unit admission", "strength": 6}, {"source_id": "distress syndrome", "target_id": "respiratory failure", "strength": 6}, {"source_id": "COVID-19", "target_id": "depressive symptoms", "strength": 6}, {"source_id": "side effects", "target_id": "vaccine hesitancy", "strength": 6}, {"source_id": "severe disease", "target_id": "mRNA vaccines", "strength": 6}, {"source_id": "third dose", "target_id": "vaccine effectiveness", "strength": 6}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 replication", "strength": 6}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "risk factors", "strength": 6}, {"source_id": "risk factors", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "risk factors", "target_id": "coronavirus 2", "strength": 6}, {"source_id": "adult patients", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "logistic regression", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "vaccination", "target_id": "most patients", "strength": 6}, {"source_id": "cell responses", "target_id": "SARS-CoV-2 vaccines", "strength": 6}, {"source_id": "Health Organization", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "complications", "strength": 6}, {"source_id": "intensive care unit", "target_id": "ICU admission", "strength": 6}, {"source_id": "SARS-CoV-2 variants", "target_id": "vaccine doses", "strength": 6}, {"source_id": "Omicron variant", "target_id": "hospitalization", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "intensive care unit admission", "strength": 6}, {"source_id": "disease", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "clinical symptoms", "target_id": "patients", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "cardiovascular disease", "strength": 6}, {"source_id": "case series", "target_id": "COVID-19 vaccination", "strength": 6}, {"source_id": "systematic review", "target_id": "lower risk", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "rights", "strength": 6}, {"source_id": "COVID-19", "target_id": "inflammation", "strength": 6}, {"source_id": "inflammation", "target_id": "COVID-19", "strength": 6}, {"source_id": "cancer patients", "target_id": "cancer", "strength": 6}, {"source_id": "cancer", "target_id": "cancer patients", "strength": 6}, {"source_id": "patients", "target_id": "cell responses", "strength": 6}, {"source_id": "care services", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "protein", "strength": 6}, {"source_id": "intensive care unit", "target_id": "respiratory distress syndrome", "strength": 6}, {"source_id": "care unit", "target_id": "respiratory distress syndrome", "strength": 6}, {"source_id": "high risk", "target_id": "care unit", "strength": 6}, {"source_id": "booster dose", "target_id": "patients", "strength": 6}, {"source_id": "third dose", "target_id": "booster dose", "strength": 6}, {"source_id": "healthcare workers", "target_id": "second dose", "strength": 6}, {"source_id": "risk factors", "target_id": "body mass index", "strength": 6}, {"source_id": "body mass index", "target_id": "risk factors", "strength": 6}, {"source_id": "intensive care unit admission", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "unit admission", "strength": 6}, {"source_id": "primary outcome", "target_id": "lower risk", "strength": 6}, {"source_id": "lower risk", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "lower risk", "target_id": "primary outcome", "strength": 6}, {"source_id": "symptoms", "target_id": "health outcomes", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "logistic regression models", "strength": 6}, {"source_id": "immune response", "target_id": "systematic review", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "therapy", "strength": 6}, {"source_id": "therapy", "target_id": "care unit", "strength": 6}, {"source_id": "general population", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "vaccination", "strength": 6}, {"source_id": "vaccine dose", "target_id": "SARS-CoV-2 vaccines", "strength": 6}, {"source_id": "vaccine", "target_id": "general population", "strength": 6}, {"source_id": "clinical characteristics", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "vaccine", "target_id": "disease", "strength": 6}, {"source_id": "spike protein", "target_id": "disease 2019", "strength": 6}, {"source_id": "pandemic", "target_id": "society", "strength": 6}, {"source_id": "Omicron infection", "target_id": "breakthrough infections", "strength": 6}, {"source_id": "variants of concern", "target_id": "patients", "strength": 6}, {"source_id": "experience", "target_id": "young people", "strength": 6}, {"source_id": "University", "target_id": "policy", "strength": 6}, {"source_id": "future research", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "mortality rate", "target_id": "heart failure", "strength": 6}, {"source_id": "COVID-19", "target_id": "pneumonia", "strength": 6}, {"source_id": "antibody response", "target_id": "COVID-19", "strength": 6}, {"source_id": "COVID-19", "target_id": "monoclonal antibodies", "strength": 6}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "SARS-CoV-2 variants", "strength": 6}, {"source_id": "clinical outcomes", "target_id": "retrospective cohort study", "strength": 6}, {"source_id": "BNT162b2 vaccine", "target_id": "vaccine effectiveness", "strength": 6}, {"source_id": "second dose", "target_id": "COVID-19", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "high prevalence", "strength": 6}, {"source_id": "high prevalence", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "antiviral activity", "strength": 6}, {"source_id": "respiratory tract", "target_id": "respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "respiratory tract", "target_id": "patients", "strength": 6}, {"source_id": "interviews", "target_id": "people", "strength": 6}, {"source_id": "COVID-19", "target_id": "institutions", "strength": 6}, {"source_id": "teaching", "target_id": "case study", "strength": 6}, {"source_id": "University", "target_id": "curriculum", "strength": 6}, {"source_id": "learners", "target_id": "COVID-19", "strength": 6}, {"source_id": "patients", "target_id": "weight loss", "strength": 6}, {"source_id": "primary outcome", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "age groups", "target_id": "mortality", "strength": 6}, {"source_id": "mortality", "target_id": "age groups", "strength": 6}, {"source_id": "T cell responses", "target_id": "Omicron variant", "strength": 6}, {"source_id": "risk factors", "target_id": "lower risk", "strength": 6}, {"source_id": "systematic review", "target_id": "middle-income countries", "strength": 6}, {"source_id": "systematic review", "target_id": "general population", "strength": 6}, {"source_id": "retrospective cohort study", "target_id": "hospitalization", "strength": 6}, {"source_id": "COVID-19 vaccination", "target_id": "healthcare workers", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "IL-6", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "young adults", "strength": 6}, {"source_id": "hospital stay", "target_id": "hospital admission", "strength": 6}, {"source_id": "adult patients", "target_id": "risk factors", "strength": 6}, {"source_id": "hospital admission", "target_id": "mortality rate", "strength": 6}, {"source_id": "patients", "target_id": "humoral immune response", "strength": 6}, {"source_id": "C-reactive protein", "target_id": "COVID-19", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "innate immune response", "strength": 6}, {"source_id": "care professionals", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "study period", "target_id": "observational study", "strength": 6}, {"source_id": "interviews", "target_id": "thematic analysis", "strength": 6}, {"source_id": "governance", "target_id": "COVID-19", "strength": 6}, {"source_id": "learning", "target_id": "thematic analysis", "strength": 6}, {"source_id": "qualitative study", "target_id": "interviews", "strength": 6}, {"source_id": "T cells", "target_id": "disease 2019", "strength": 6}, {"source_id": "Omicron variant", "target_id": "vaccine doses", "strength": 6}, {"source_id": "mental health", "target_id": "observational study", "strength": 6}, {"source_id": "social support", "target_id": "mental health", "strength": 6}, {"source_id": "general population", "target_id": "mental health", "strength": 6}, {"source_id": "need", "target_id": "students", "strength": 6}, {"source_id": "disease severity", "target_id": "healthy controls", "strength": 6}, {"source_id": "care unit", "target_id": "mortality", "strength": 6}, {"source_id": "mortality", "target_id": "intensive care unit", "strength": 6}, {"source_id": "inflammation", "target_id": "patients", "strength": 6}, {"source_id": "mRNA vaccines", "target_id": "variants of concern", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "patient outcomes", "strength": 6}, {"source_id": "cohort study", "target_id": "electronic health records", "strength": 6}, {"source_id": "risk factors", "target_id": "care unit admission", "strength": 6}, {"source_id": "case report", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "context", "target_id": "policy", "strength": 6}, {"source_id": "education", "target_id": "participants", "strength": 6}, {"source_id": "clinical trials", "target_id": "vaccination", "strength": 6}, {"source_id": "COVID-19 outcomes", "target_id": "cohort study", "strength": 6}, {"source_id": "booster vaccination", "target_id": "Omicron infection", "strength": 6}, {"source_id": "second dose", "target_id": "vaccine doses", "strength": 6}, {"source_id": "vaccination", "target_id": "vaccination coverage", "strength": 6}, {"source_id": "older age", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "severe cases", "strength": 6}, {"source_id": "immune response", "target_id": "respiratory distress syndrome", "strength": 6}, {"source_id": "odds ratio", "target_id": "logistic regression models", "strength": 6}, {"source_id": "COVID-19 severity", "target_id": "severe disease", "strength": 6}, {"source_id": "control group", "target_id": "infection", "strength": 6}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "animal models", "strength": 6}, {"source_id": "coronavirus 2", "target_id": "animal models", "strength": 6}, {"source_id": "complications", "target_id": "cohort study", "strength": 6}, {"source_id": "cohort study", "target_id": "vaccine effectiveness", "strength": 6}, {"source_id": "viral infection", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "viral infection", "strength": 6}, {"source_id": "syndrome coronavirus 2", "target_id": "viral infection", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "intensive care unit", "strength": 6}, {"source_id": "intensive care unit", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "adult patients", "target_id": "hospital mortality", "strength": 6}, {"source_id": "inflammation", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "respiratory failure", "target_id": "respiratory distress syndrome", "strength": 6}, {"source_id": "respiratory failure", "target_id": "distress syndrome", "strength": 6}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "COVID-19", "strength": 6}, {"source_id": "patients", "target_id": "immune cells", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "adult patients", "strength": 6}, {"source_id": "logistic regression", "target_id": "disease 2019", "strength": 6}, {"source_id": "middle-income countries", "target_id": "COVID-19", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "World Health Organization", "strength": 6}, {"source_id": "clinical trials", "target_id": "COVID-19 disease", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "observational cohort study", "strength": 6}, {"source_id": "infection", "target_id": "observational cohort study", "strength": 6}, {"source_id": "second dose", "target_id": "infection", "strength": 6}, {"source_id": "care unit", "target_id": "ICU admission", "strength": 6}, {"source_id": "hospitalization", "target_id": "Delta variant", "strength": 6}, {"source_id": "vaccine effectiveness", "target_id": "unvaccinated individuals", "strength": 6}, {"source_id": "teachers", "target_id": "context", "strength": 6}, {"source_id": "vaccine", "target_id": "hospitalization", "strength": 6}, {"source_id": "retrospective cohort study", "target_id": "vaccination", "strength": 6}, {"source_id": "vaccination", "target_id": "retrospective cohort study", "strength": 6}, {"source_id": "risk factors", "target_id": "pulmonary disease", "strength": 6}, {"source_id": "syndrome coronavirus 2", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "COVID-19 vaccination", "target_id": "case series", "strength": 6}, {"source_id": "intensive care unit", "target_id": "distress syndrome", "strength": 6}, {"source_id": "SARS-CoV2", "target_id": "COVID-19", "strength": 6}, {"source_id": "distress syndrome", "target_id": "intensive care unit", "strength": 6}, {"source_id": "distress syndrome", "target_id": "care unit", "strength": 6}, {"source_id": "hospital admission", "target_id": "severe disease", "strength": 6}, {"source_id": "booster dose", "target_id": "antibody levels", "strength": 6}, {"source_id": "antibody levels", "target_id": "booster dose", "strength": 6}, {"source_id": "BNT162b2 vaccine", "target_id": "second dose", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "respiratory failure", "strength": 6}, {"source_id": "respiratory failure", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "COVID-19 pneumonia", "target_id": "mechanical ventilation", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "adult patients", "strength": 6}, {"source_id": "adult patients", "target_id": "observational study", "strength": 6}, {"source_id": "antibody levels", "target_id": "SARS-CoV-2 vaccines", "strength": 6}, {"source_id": "humoral response", "target_id": "SARS-CoV-2 vaccines", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "care unit admission", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "antibody response", "strength": 6}, {"source_id": "intensive care unit admission", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "unit admission", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "unit admission", "target_id": "clinical outcomes", "strength": 6}, {"source_id": "greater risk", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "admission", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "symptoms", "target_id": "observational study", "strength": 6}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "syndrome coronavirus 2", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "disease 2019", "target_id": "mortality", "strength": 6}, {"source_id": "vaccination status", "target_id": "unvaccinated individuals", "strength": 6}, {"source_id": "logistic regression models", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "case-control study", "target_id": "risk factors", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "humoral response", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "study design", "strength": 6}, {"source_id": "control group", "target_id": "intensive care unit", "strength": 6}, {"source_id": "study design", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "SARS-CoV-2 antibodies", "strength": 6}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "inclusion criteria", "target_id": "adverse events", "strength": 6}, {"source_id": "patients", "target_id": "health concern", "strength": 6}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "vaccine dose", "strength": 6}, {"source_id": "vaccination", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "vaccination", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "vaccination", "target_id": "disease severity", "strength": 6}, {"source_id": "vaccine hesitancy", "target_id": "vaccination", "strength": 6}, {"source_id": "Omicron infection", "target_id": "spike protein", "strength": 6}, {"source_id": "spike protein", "target_id": "Omicron infection", "strength": 6}, {"source_id": "cross-sectional study", "target_id": "observational study", "strength": 6}, {"source_id": "care unit", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "society", "target_id": "pandemic", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "study period", "strength": 6}, {"source_id": "cohort study", "target_id": "Omicron infection", "strength": 6}, {"source_id": "pandemic", "target_id": "thematic analysis", "strength": 6}, {"source_id": "young people", "target_id": "experience", "strength": 6}, {"source_id": "book", "target_id": "case study", "strength": 6}, {"source_id": "policy", "target_id": "University", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "research", "strength": 6}, {"source_id": "curriculum", "target_id": "schools", "strength": 6}, {"source_id": "Secondary outcomes", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "retrospective cohort study", "target_id": "primary outcome", "strength": 6}, {"source_id": "primary outcome", "target_id": "retrospective cohort study", "strength": 6}, {"source_id": "symptoms", "target_id": "disease", "strength": 6}, {"source_id": "antibody response", "target_id": "SARS-CoV-2 antibodies", "strength": 6}, {"source_id": "COVID-19", "target_id": "COVID-19 pneumonia", "strength": 6}, {"source_id": "COVID-19 pneumonia", "target_id": "COVID-19", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "clinical studies", "strength": 6}, {"source_id": "Secondary outcomes", "target_id": "clinical outcomes", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "antibody response", "strength": 6}, {"source_id": "antibody response", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "mRNA vaccination", "target_id": "patients", "strength": 6}, {"source_id": "vaccination", "target_id": "humoral immune response", "strength": 6}, {"source_id": "SARS-CoV-2 variants", "target_id": "SARS-CoV-2 vaccines", "strength": 6}, {"source_id": "patients", "target_id": "race/ethnicity", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "hospital stay", "strength": 6}, {"source_id": "hospital stay", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "infection", "target_id": "COVID-19 symptoms", "strength": 6}, {"source_id": "disease control", "target_id": "COVID-19", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "logistic regression analysis", "strength": 6}, {"source_id": "vaccination", "target_id": "incidence rate", "strength": 6}, {"source_id": "incidence", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "booster vaccination", "target_id": "Delta variant", "strength": 6}, {"source_id": "Delta variant", "target_id": "booster vaccination", "strength": 6}, {"source_id": "vaccination", "target_id": "severe disease", "strength": 6}, {"source_id": "mean age", "target_id": "logistic regression", "strength": 6}, {"source_id": "care", "target_id": "care services", "strength": 6}, {"source_id": "patient characteristics", "target_id": "COVID-19", "strength": 6}, {"source_id": "antibody response", "target_id": "Omicron variant", "strength": 6}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "monoclonal antibodies", "strength": 6}, {"source_id": "monoclonal antibodies", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "respiratory tract", "strength": 6}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "respiratory tract", "strength": 6}, {"source_id": "respiratory tract", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "ecosystems", "target_id": "species", "strength": 6}, {"source_id": "case study", "target_id": "government", "strength": 6}, {"source_id": "government", "target_id": "case study", "strength": 6}, {"source_id": "people", "target_id": "interviews", "strength": 6}, {"source_id": "institutions", "target_id": "COVID-19", "strength": 6}, {"source_id": "case study", "target_id": "teaching", "strength": 6}, {"source_id": "skills", "target_id": "engagement", "strength": 6}, {"source_id": "COVID-19", "target_id": "learners", "strength": 6}, {"source_id": "training", "target_id": "learning", "strength": 6}, {"source_id": "adverse events", "target_id": "mortality", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "surgery", "strength": 6}, {"source_id": "age groups", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "mortality", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "humoral response", "strength": 6}, {"source_id": "study period", "target_id": "healthcare workers", "strength": 6}, {"source_id": "governance", "target_id": "crisis", "strength": 6}, {"source_id": "high prevalence", "target_id": "systematic review", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "emergency department", "strength": 6}, {"source_id": "healthcare workers", "target_id": "COVID-19 vaccination", "strength": 6}, {"source_id": "IL-6", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "symptoms", "target_id": "immune response", "strength": 6}, {"source_id": "patients", "target_id": "health care professionals", "strength": 6}, {"source_id": "primary care", "target_id": "electronic health records", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "University Hospital", "strength": 6}, {"source_id": "adult patients", "target_id": "ill patients", "strength": 6}, {"source_id": "severe disease", "target_id": "admission", "strength": 6}, {"source_id": "patients", "target_id": "booster vaccination", "strength": 6}, {"source_id": "vaccine effectiveness", "target_id": "severe disease", "strength": 6}, {"source_id": "severe disease", "target_id": "vaccine effectiveness", "strength": 6}, {"source_id": "clinical outcomes", "target_id": "mortality", "strength": 6}, {"source_id": "immune system", "target_id": "disease", "strength": 6}, {"source_id": "treatment strategies", "target_id": "risk factors", "strength": 6}, {"source_id": "infection", "target_id": "treatment strategies", "strength": 6}, {"source_id": "article", "target_id": "COVID-19", "strength": 6}, {"source_id": "thematic analysis", "target_id": "learning", "strength": 6}, {"source_id": "mental health", "target_id": "young adults", "strength": 6}, {"source_id": "vaccine effectiveness", "target_id": "case-control study", "strength": 6}, {"source_id": "vaccine doses", "target_id": "Omicron variant", "strength": 6}, {"source_id": "observational study", "target_id": "mental health", "strength": 6}, {"source_id": "mental health", "target_id": "social support", "strength": 6}, {"source_id": "disease progression", "target_id": "immune cells", "strength": 6}, {"source_id": "mental health", "target_id": "general population", "strength": 6}, {"source_id": "organization", "target_id": "employees", "strength": 6}, {"source_id": "medical students", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "SARS-CoV-2 variants", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "antibody titers", "target_id": "blood samples", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "protective effect", "strength": 6}, {"source_id": "protective effect", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "cardiovascular disease", "strength": 6}, {"source_id": "pediatric patients", "target_id": "risk factors", "strength": 6}, {"source_id": "cohort", "target_id": "risk factors", "strength": 6}, {"source_id": "disease 2019", "target_id": "infectious diseases", "strength": 6}, {"source_id": "age groups", "target_id": "vaccination coverage", "strength": 6}, {"source_id": "cohort study", "target_id": "SARS-CoV-2 Omicron variant", "strength": 6}, {"source_id": "sector", "target_id": "policy", "strength": 6}, {"source_id": "program", "target_id": "University", "strength": 6}, {"source_id": "cause mortality", "target_id": "COVID-19", "strength": 6}, {"source_id": "COVID-19 vaccination", "target_id": "age groups", "strength": 6}, {"source_id": "disease 2019", "target_id": "severe cases", "strength": 6}, {"source_id": "immune response", "target_id": "acute respiratory distress syndrome", "strength": 6}, {"source_id": "distress syndrome", "target_id": "immune response", "strength": 6}, {"source_id": "COVID-19", "target_id": "booster doses", "strength": 6}, {"source_id": "booster doses", "target_id": "COVID-19", "strength": 6}, {"source_id": "severe disease", "target_id": "COVID-19 severity", "strength": 6}, {"source_id": "adverse events", "target_id": "booster dose", "strength": 6}, {"source_id": "third dose", "target_id": "Delta variant", "strength": 6}, {"source_id": "infection", "target_id": "control group", "strength": 6}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "animal models", "strength": 6}, {"source_id": "animal models", "target_id": "respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "risk factors", "target_id": "older adults", "strength": 6}, {"source_id": "vaccine", "target_id": "study period", "strength": 6}, {"source_id": "study period", "target_id": "vaccine", "strength": 6}, {"source_id": "politics", "target_id": "COVID-19", "strength": 6}, {"source_id": "COVID-19", "target_id": "politics", "strength": 6}, {"source_id": "intensive care unit admission", "target_id": "mortality", "strength": 6}, {"source_id": "length of stay", "target_id": "primary outcome", "strength": 6}, {"source_id": "therapeutic strategies", "target_id": "patients", "strength": 6}, {"source_id": "patients", "target_id": "therapeutic strategies", "strength": 6}, {"source_id": "Secondary outcomes", "target_id": "respiratory failure", "strength": 6}, {"source_id": "vaccine hesitancy", "target_id": "side effects", "strength": 6}, {"source_id": "mRNA vaccines", "target_id": "severe disease", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "health status", "strength": 6}, {"source_id": "vaccine effectiveness", "target_id": "third dose", "strength": 6}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 spike protein", "strength": 6}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "risk factors", "strength": 6}, {"source_id": "syndrome coronavirus 2", "target_id": "risk factors", "strength": 6}, {"source_id": "risk factors", "target_id": "syndrome coronavirus 2", "strength": 6}, {"source_id": "COVID-19", "target_id": "middle-income countries", "strength": 6}, {"source_id": "patients", "target_id": "inflammatory syndrome", "strength": 6}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "cell responses", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "Health Organization", "strength": 6}, {"source_id": "World Health Organization", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "discourse", "strength": 6}, {"source_id": "vaccine doses", "target_id": "SARS-CoV-2 variants", "strength": 6}, {"source_id": "Delta variant", "target_id": "hospitalization", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "time points", "strength": 6}, {"source_id": "intensive care unit admission", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "cohort study", "target_id": "cardiovascular disease", "strength": 6}, {"source_id": "high risk", "target_id": "disease severity", "strength": 6}, {"source_id": "mortality rate", "target_id": "retrospective cohort study", "strength": 6}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "Delta variant", "target_id": "patients", "strength": 6}, {"source_id": "COVID-19", "target_id": "perspective", "strength": 6}, {"source_id": "risk factors", "target_id": "ICU admission", "strength": 6}, {"source_id": "acute respiratory distress syndrome", "target_id": "care unit", "strength": 6}, {"source_id": "respiratory distress syndrome", "target_id": "care unit", "strength": 6}, {"source_id": "care unit", "target_id": "high risk", "strength": 6}, {"source_id": "hospital discharge", "target_id": "adverse events", "strength": 6}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "humoral response", "strength": 6}, {"source_id": "mass index", "target_id": "risk factors", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "admission", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "lower risk", "strength": 6}, {"source_id": "transplant recipients", "target_id": "vaccination", "strength": 6}, {"source_id": "intensive care unit admission", "target_id": "clinical outcomes", "strength": 6}, {"source_id": "clinical outcomes", "target_id": "intensive care unit admission", "strength": 6}, {"source_id": "clinical outcomes", "target_id": "care unit admission", "strength": 6}, {"source_id": "antibody response", "target_id": "COVID-19 vaccination", "strength": 6}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "systematic review", "target_id": "immune response", "strength": 6}, {"source_id": "risk factors", "target_id": "case-control study", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "clinical studies", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "control group", "strength": 6}, {"source_id": "control group", "target_id": "care unit", "strength": 6}, {"source_id": "general population", "target_id": "vaccine", "strength": 6}, {"source_id": "syndrome coronavirus 2", "target_id": "vaccination", "strength": 6}, {"source_id": "coronavirus 2", "target_id": "vaccination", "strength": 6}, {"source_id": "vaccination", "target_id": "respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "vaccine", "target_id": "coronavirus disease", "strength": 6}, {"source_id": "vaccination campaign", "target_id": "vaccine", "strength": 6}, {"source_id": "observational study", "target_id": "cross-sectional study", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "intensive care unit", "strength": 6}, {"source_id": "clinical characteristics", "target_id": "infection", "strength": 6}, {"source_id": "climate change", "target_id": "conservation", "strength": 6}, {"source_id": "conservation", "target_id": "climate change", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "justice", "strength": 6}, {"source_id": "pandemic", "target_id": "practice", "strength": 6}, {"source_id": "research", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "educators", "target_id": "schools", "strength": 6}, {"source_id": "schools", "target_id": "curriculum", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "Secondary outcomes", "strength": 6}, {"source_id": "injury", "target_id": "COVID-19", "strength": 6}, {"source_id": "disease", "target_id": "symptoms", "strength": 6}, {"source_id": "median time", "target_id": "COVID-19", "strength": 6}, {"source_id": "patients", "target_id": "mRNA vaccination", "strength": 6}, {"source_id": "antibody titers", "target_id": "cell responses", "strength": 6}, {"source_id": "disease severity", "target_id": "Omicron variant", "strength": 6}, {"source_id": "COVID-19 symptoms", "target_id": "infection", "strength": 6}, {"source_id": "young adults", "target_id": "second dose", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "cohort study", "strength": 6}, {"source_id": "cohort study", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "COVID-19", "target_id": "disease control", "strength": 6}, {"source_id": "vaccine effectiveness", "target_id": "BNT162b2 vaccine", "strength": 6}, {"source_id": "antibody response", "target_id": "blood samples", "strength": 6}, {"source_id": "severe disease", "target_id": "vaccination", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "treatment strategies", "strength": 6}, {"source_id": "T cells", "target_id": "therapeutic strategies", "strength": 6}, {"source_id": "T cells", "target_id": "viral infection", "strength": 6}, {"source_id": "therapeutic strategies", "target_id": "infection", "strength": 6}, {"source_id": "viral infection", "target_id": "T cells", "strength": 6}, {"source_id": "care services", "target_id": "care", "strength": 6}, {"source_id": "COVID-19", "target_id": "vaccine uptake", "strength": 6}, {"source_id": "vaccine uptake", "target_id": "COVID-19", "strength": 6}, {"source_id": "Omicron variant", "target_id": "antibody response", "strength": 6}, {"source_id": "B cells", "target_id": "antibody response", "strength": 6}, {"source_id": "SARS-CoV-2 virus", "target_id": "spike protein", "strength": 6}, {"source_id": "viral infection", "target_id": "immune cells", "strength": 6}, {"source_id": "spike protein", "target_id": "SARS-CoV-2 virus", "strength": 6}, {"source_id": "patients", "target_id": "respiratory tract", "strength": 6}, {"source_id": "algorithm", "target_id": "learning model", "strength": 6}, {"source_id": "case study", "target_id": "countries", "strength": 6}, {"source_id": "countries", "target_id": "case study", "strength": 6}, {"source_id": "higher education", "target_id": "pandemic", "strength": 6}, {"source_id": "pandemic", "target_id": "higher education", "strength": 6}, {"source_id": "experience", "target_id": "higher education", "strength": 6}, {"source_id": "health conditions", "target_id": "COVID-19", "strength": 6}, {"source_id": "curriculum", "target_id": "University", "strength": 6}, {"source_id": "course", "target_id": "curriculum", "strength": 6}, {"source_id": "program", "target_id": "curriculum", "strength": 6}, {"source_id": "lung disease", "target_id": "pulmonary disease", "strength": 6}, {"source_id": "weight loss", "target_id": "patients", "strength": 6}, {"source_id": "hospital admission", "target_id": "disease 2019", "strength": 6}, {"source_id": "primary outcome", "target_id": "disease severity", "strength": 6}, {"source_id": "disease severity", "target_id": "primary outcome", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "mortality", "strength": 6}, {"source_id": "infection", "target_id": "prospective study", "strength": 6}, {"source_id": "infectious diseases", "target_id": "infection", "strength": 6}, {"source_id": "quality of life", "target_id": "clinical trials", "strength": 6}, {"source_id": "crisis", "target_id": "governance", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "health issues", "strength": 6}, {"source_id": "lower risk", "target_id": "risk factors", "strength": 6}, {"source_id": "middle-income countries", "target_id": "systematic review", "strength": 6}, {"source_id": "COVID-19 vaccination", "target_id": "booster doses", "strength": 6}, {"source_id": "healthcare professionals", "target_id": "health professionals", "strength": 6}, {"source_id": "hospital admission", "target_id": "hospital stay", "strength": 6}, {"source_id": "humoral immune response", "target_id": "patients", "strength": 6}, {"source_id": "admission", "target_id": "severe disease", "strength": 6}, {"source_id": "COVID-19", "target_id": "C-reactive protein", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "intensive care", "strength": 6}, {"source_id": "healthy controls", "target_id": "SARS-CoV-2 vaccination", "strength": 6}, {"source_id": "COVID-19 cases", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "risk factors", "target_id": "treatment strategies", "strength": 6}, {"source_id": "treatment strategies", "target_id": "infection", "strength": 6}, {"source_id": "COVID-19", "target_id": "governance", "strength": 6}, {"source_id": "COVID-19", "target_id": "article", "strength": 6}, {"source_id": "mental health", "target_id": "health measures", "strength": 6}, {"source_id": "lung disease", "target_id": "disease", "strength": 6}, {"source_id": "third dose", "target_id": "SARS-CoV-2 variants", "strength": 6}, {"source_id": "SARS-CoV-2 variants", "target_id": "third dose", "strength": 6}, {"source_id": "cohort study", "target_id": "pregnancy", "strength": 6}, {"source_id": "disease 2019", "target_id": "T cells", "strength": 6}, {"source_id": "immune cells", "target_id": "disease progression", "strength": 6}, {"source_id": "governance", "target_id": "government", "strength": 6}, {"source_id": "students", "target_id": "need", "strength": 6}, {"source_id": "healthy controls", "target_id": "disease severity", "strength": 6}, {"source_id": "mortality rate", "target_id": "hospital mortality", "strength": 6}, {"source_id": "clinical trials", "target_id": "primary endpoint", "strength": 6}, {"source_id": "side effects", "target_id": "clinical trials", "strength": 6}, {"source_id": "risk factors", "target_id": "pediatric patients", "strength": 6}, {"source_id": "COVID-19", "target_id": "study design", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "infectious diseases", "strength": 6}, {"source_id": "infectious diseases", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "age groups", "target_id": "high risk", "strength": 6}, {"source_id": "emergency department", "target_id": "study period", "strength": 6}, {"source_id": "retrospective cohort study", "target_id": "emergency department", "strength": 6}, {"source_id": "electronic health records", "target_id": "cohort study", "strength": 6}, {"source_id": "admission", "target_id": "cohort study", "strength": 6}, {"source_id": "vaccine", "target_id": "COVID-19 disease", "strength": 6}, {"source_id": "risk factors", "target_id": "unit admission", "strength": 6}, {"source_id": "medical records", "target_id": "COVID-19", "strength": 6}, {"source_id": "chronic kidney disease", "target_id": "disease", "strength": 6}, {"source_id": "risk factors", "target_id": "case report", "strength": 6}, {"source_id": "cytokine storm", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "vaccination", "target_id": "clinical trials", "strength": 6}, {"source_id": "hospital admission", "target_id": "observational study", "strength": 6}, {"source_id": "COVID-19 outcomes", "target_id": "infection", "strength": 6}, {"source_id": "infection", "target_id": "COVID-19 outcomes", "strength": 6}, {"source_id": "vaccination", "target_id": "Omicron infection", "strength": 6}, {"source_id": "vaccine doses", "target_id": "third dose", "strength": 6}, {"source_id": "vaccination coverage", "target_id": "vaccination", "strength": 6}, {"source_id": "policy", "target_id": "perspective", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "older age", "strength": 6}, {"source_id": "logistic regression models", "target_id": "odds ratio", "strength": 6}, {"source_id": "pandemic", "target_id": "countries", "strength": 6}, {"source_id": "Delta variant", "target_id": "third dose", "strength": 6}, {"source_id": "clinical characteristics", "target_id": "mortality", "strength": 6}, {"source_id": "lower risk", "target_id": "disease severity", "strength": 6}, {"source_id": "animal models", "target_id": "coronavirus 2", "strength": 6}, {"source_id": "vaccine effectiveness", "target_id": "cohort study", "strength": 6}, {"source_id": "viral infection", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "viral infection", "target_id": "respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "viral infection", "strength": 6}, {"source_id": "older adults", "target_id": "risk factors", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "care unit", "strength": 6}, {"source_id": "intensive care unit admission", "target_id": "mechanical ventilation", "strength": 6}, {"source_id": "unit admission", "target_id": "mortality", "strength": 6}, {"source_id": "mortality", "target_id": "unit admission", "strength": 6}, {"source_id": "T cells", "target_id": "SARS-CoV-2 vaccination", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "T cells", "strength": 6}, {"source_id": "respiratory failure", "target_id": "acute respiratory distress syndrome", "strength": 6}, {"source_id": "vaccination", "target_id": "vaccine uptake", "strength": 6}, {"source_id": "vaccination status", "target_id": "SARS-CoV-2 variants", "strength": 6}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "risk factors", "strength": 6}, {"source_id": "risk factors", "target_id": "respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "logistic regression", "strength": 6}, {"source_id": "inflammatory syndrome", "target_id": "patients", "strength": 6}, {"source_id": "observational cohort study", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "complications", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "policy", "target_id": "community", "strength": 6}, {"source_id": "third dose", "target_id": "transplant recipients", "strength": 6}, {"source_id": "vaccine effectiveness", "target_id": "vaccination status", "strength": 6}, {"source_id": "vaccination status", "target_id": "vaccine effectiveness", "strength": 6}, {"source_id": "COVID-19 vaccine", "target_id": "disease", "strength": 6}, {"source_id": "cardiovascular disease", "target_id": "cohort study", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "severe cases", "strength": 6}, {"source_id": "severe cases", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "illness", "strength": 6}, {"source_id": "retrospective cohort study", "target_id": "mortality rate", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "syndrome coronavirus 2", "strength": 6}, {"source_id": "disease severity", "target_id": "systematic review", "strength": 6}, {"source_id": "systematic review", "target_id": "disease severity", "strength": 6}, {"source_id": "nasopharyngeal swabs", "target_id": "infection", "strength": 6}, {"source_id": "rights", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "perspective", "target_id": "COVID-19", "strength": 6}, {"source_id": "cell responses", "target_id": "patients", "strength": 6}, {"source_id": "adverse events", "target_id": "median age", "strength": 6}, {"source_id": "median age", "target_id": "adverse events", "strength": 6}, {"source_id": "ICU admission", "target_id": "risk factors", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "care services", "strength": 6}, {"source_id": "protein", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "acute respiratory distress syndrome", "target_id": "intensive care unit", "strength": 6}, {"source_id": "respiratory distress syndrome", "target_id": "intensive care unit", "strength": 6}, {"source_id": "care unit", "target_id": "distress syndrome", "strength": 6}, {"source_id": "booster dose", "target_id": "third dose", "strength": 6}, {"source_id": "observational study", "target_id": "adult patients", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "adverse events", "strength": 6}, {"source_id": "adverse events", "target_id": "disease 2019", "strength": 6}, {"source_id": "risk factors", "target_id": "mass index", "strength": 6}, {"source_id": "COVID-19 vaccination", "target_id": "antibody response", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "unit admission", "strength": 6}, {"source_id": "intensive care unit admission", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "unit admission", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "antibody response", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "vaccination", "target_id": "transplant recipients", "strength": 6}, {"source_id": "observational study", "target_id": "symptoms", "strength": 6}, {"source_id": "health outcomes", "target_id": "symptoms", "strength": 6}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "severe COVID-19", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "syndrome coronavirus 2", "strength": 6}, {"source_id": "mortality", "target_id": "disease 2019", "strength": 6}, {"source_id": "prospective cohort study", "target_id": "median age", "strength": 6}, {"source_id": "safety profile", "target_id": "COVID-19 vaccine", "strength": 6}, {"source_id": "clinical studies", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "intensive care unit", "target_id": "control group", "strength": 6}, {"source_id": "humoral response", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "humoral response", "target_id": "therapy", "strength": 6}, {"source_id": "therapy", "target_id": "humoral response", "strength": 6}, {"source_id": "SARS-CoV-2", "target_id": "general population", "strength": 6}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "vaccination", "strength": 6}, {"source_id": "vaccination", "target_id": "coronavirus 2", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "clinical characteristics", "strength": 6}, {"source_id": "vaccine", "target_id": "vaccination campaign", "strength": 6}, {"source_id": "disease", "target_id": "vaccine", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 spike protein", "strength": 6}, {"source_id": "coronavirus disease 2019", "target_id": "spike protein", "strength": 6}, {"source_id": "disease 2019", "target_id": "spike protein", "strength": 6}, {"source_id": "spike protein", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "patients", "target_id": "chronic diseases", "strength": 6}, {"source_id": "COVID-19 pandemic", "target_id": "care unit", "strength": 6}, {"source_id": "sociodemographic characteristics", "target_id": "cross-sectional study", "strength": 6}, {"source_id": "breakthrough infections", "target_id": "Omicron infection", "strength": 6}, {"source_id": "infection", "target_id": "clinical characteristics", "strength": 6}, {"source_id": "practice", "target_id": "pandemic", "strength": 6}, {"source_id": "experience", "target_id": "policy", "strength": 6}, {"source_id": "COVID-19", "target_id": "injury", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "injury", "strength": 6}, {"source_id": "COVID-19", "target_id": "antibody response", "strength": 6}, {"source_id": "disease severity", "target_id": "disease progression", "strength": 6}, {"source_id": "disease progression", "target_id": "disease severity", "strength": 6}, {"source_id": "humoral immune response", "target_id": "vaccination", "strength": 6}, {"source_id": "Omicron variant", "target_id": "disease severity", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "incidence", "strength": 6}, {"source_id": "breakthrough infections", "target_id": "COVID-19 infection", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "breakthrough infections", "strength": 6}, {"source_id": "treatment strategies", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "coronavirus 2", "target_id": "monoclonal antibodies", "strength": 6}, {"source_id": "SARS-CoV-2 virus", "target_id": "immune response", "strength": 6}, {"source_id": "immune response", "target_id": "SARS-CoV-2 virus", "strength": 6}, {"source_id": "syndrome coronavirus 2", "target_id": "respiratory tract", "strength": 6}, {"source_id": "respiratory tract", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "learning model", "target_id": "algorithm", "strength": 6}, {"source_id": "institutions", "target_id": "University", "strength": 6}, {"source_id": "COVID-19", "target_id": "health conditions", "strength": 6}, {"source_id": "curriculum", "target_id": "course", "strength": 6}, {"source_id": "education", "target_id": "book", "strength": 6}, {"source_id": "book", "target_id": "society", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "primary outcome", "strength": 6}, {"source_id": "hospital admission", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "therapy", "target_id": "antibody response", "strength": 6}, {"source_id": "severe COVID-19", "target_id": "T cells", "strength": 6}, {"source_id": "T cells", "target_id": "severe disease", "strength": 6}, {"source_id": "severe disease", "target_id": "T cells", "strength": 6}, {"source_id": "pregnancy", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "infection", "target_id": "infectious diseases", "strength": 6}, {"source_id": "vaccine dose", "target_id": "healthcare workers", "strength": 6}, {"source_id": "healthcare workers", "target_id": "vaccine dose", "strength": 6}, {"source_id": "participants", "target_id": "experience", "strength": 6}, {"source_id": "systematic review", "target_id": "high prevalence", "strength": 6}, {"source_id": "hospitalization", "target_id": "retrospective cohort study", "strength": 6}, {"source_id": "T cell responses", "target_id": "SARS-CoV-2 variants", "strength": 6}, {"source_id": "SARS-CoV-2 variants", "target_id": "T cell responses", "strength": 6}, {"source_id": "risk factors", "target_id": "median age", "strength": 6}, {"source_id": "median age", "target_id": "risk factors", "strength": 6}, {"source_id": "respiratory failure", "target_id": "adult patients", "strength": 6}, {"source_id": "adult patients", "target_id": "respiratory failure", "strength": 6}, {"source_id": "booster vaccination", "target_id": "patients", "strength": 6}, {"source_id": "IL-6", "target_id": "coronavirus disease 2019", "strength": 6}, {"source_id": "disease 2019", "target_id": "IL-6", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 cases", "strength": 6}, {"source_id": "health status", "target_id": "patients", "strength": 6}, {"source_id": "patients", "target_id": "health status", "strength": 6}, {"source_id": "observational study", "target_id": "study period", "strength": 6}, {"source_id": "vaccination", "target_id": "care workers", "strength": 6}, {"source_id": "educators", "target_id": "pandemic", "strength": 6}, {"source_id": "interviews", "target_id": "qualitative study", "strength": 6}, {"source_id": "vaccine dose", "target_id": "COVID-19", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "Omicron variant", "strength": 6}, {"source_id": "Omicron variant", "target_id": "COVID-19 patients", "strength": 6}, {"source_id": "care unit", "target_id": "symptoms", "strength": 6}, {"source_id": "emergency department", "target_id": "primary outcome", "strength": 6}, {"source_id": "government", "target_id": "governance", "strength": 6}, {"source_id": "semi-structured interviews", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "hospital mortality", "target_id": "mortality rate", "strength": 6}, {"source_id": "hospital mortality", "target_id": "disease severity", "strength": 6}, {"source_id": "patients", "target_id": "inflammation", "strength": 6}, {"source_id": "clinical trials", "target_id": "side effects", "strength": 6}, {"source_id": "variants of concern", "target_id": "mRNA vaccines", "strength": 6}, {"source_id": "cardiovascular disease", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "logistic regression", "strength": 6}, {"source_id": "vaccine", "target_id": "severe illness", "strength": 6}, {"source_id": "high risk", "target_id": "age groups", "strength": 6}, {"source_id": "cohort study", "target_id": "admission", "strength": 6}, {"source_id": "unit admission", "target_id": "risk factors", "strength": 6}, {"source_id": "immune response", "target_id": "high risk", "strength": 6}, {"source_id": "COVID-19", "target_id": "medical records", "strength": 6}, {"source_id": "COVID-19", "target_id": "clinical symptoms", "strength": 6}, {"source_id": "case report", "target_id": "risk factors", "strength": 6}, {"source_id": "vaccine doses", "target_id": "second dose", "strength": 6}, {"source_id": "third dose", "target_id": "vaccine doses", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "vaccination status", "strength": 6}, {"source_id": "infectious diseases", "target_id": "patients", "strength": 6}, {"source_id": "animal models", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "animal models", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "animal models", "target_id": "syndrome coronavirus 2", "strength": 6}, {"source_id": "Secondary outcomes", "target_id": "mortality", "strength": 6}, {"source_id": "viral infection", "target_id": "syndrome coronavirus 2", "strength": 6}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "viral infection", "strength": 6}, {"source_id": "United States", "target_id": "community", "strength": 6}, {"source_id": "education", "target_id": "perception", "strength": 6}, {"source_id": "mechanical ventilation", "target_id": "intensive care unit admission", "strength": 6}, {"source_id": "mortality", "target_id": "care unit admission", "strength": 6}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "T cells", "strength": 6}, {"source_id": "SARS-CoV-2 infection", "target_id": "inflammation", "strength": 6}, {"source_id": "acute respiratory distress syndrome", "target_id": "respiratory failure", "strength": 6}, {"source_id": "health status", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "third dose", "target_id": "infection", "strength": 6}, {"source_id": "infection", "target_id": "third dose", "strength": 6}, {"source_id": "SARS-CoV-2 replication", "target_id": "COVID-19", "strength": 6}, {"source_id": "SARS-CoV-2 variants", "target_id": "vaccination status", "strength": 6}, {"source_id": "coronavirus 2", "target_id": "risk factors", "strength": 6}, {"source_id": "risk factors", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "immune cells", "target_id": "patients", "strength": 6}, {"source_id": "disease 2019", "target_id": "logistic regression", "strength": 6}, {"source_id": "infection", "target_id": "second dose", "strength": 6}, {"source_id": "ICU admission", "target_id": "intensive care unit", "strength": 6}, {"source_id": "discourse", "target_id": "COVID-19 pandemic", "strength": 6}, {"source_id": "transplant recipients", "target_id": "third dose", "strength": 6}, {"source_id": "hospitalization", "target_id": "Omicron variant", "strength": 6}, {"source_id": "complications", "target_id": "infection", "strength": 6}, {"source_id": "infection", "target_id": "complications", "strength": 6}, {"source_id": "time points", "target_id": "SARS-CoV-2", "strength": 6}, {"source_id": "prospective cohort study", "target_id": "vaccination", "strength": 6}, {"source_id": "patients", "target_id": "clinical symptoms", "strength": 6}, {"source_id": "illness", "target_id": "SARS-CoV-2 infection", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "COVID-19 infection", "target_id": "respiratory syndrome coronavirus 2", "strength": 6}, {"source_id": "immune response", "target_id": "IL-6", "strength": 6}, {"source_id": "patients", "target_id": "Delta variant", "strength": 6}, {"source_id": "lower risk", "target_id": "systematic review", "strength": 6}, {"source_id": "infection", "target_id": "nasopharyngeal swabs", "strength": 6}, {"source_id": "COVID-19 patients", "target_id": "disease", "strength": 6}, {"source_id": "antibody levels", "target_id": "third dose", "strength": 7}, {"source_id": "COVID-19 pneumonia", "target_id": "pneumonia", "strength": 7}, {"source_id": "observational study", "target_id": "coronavirus disease 2019", "strength": 7}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "SARS-CoV-2 vaccination", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "care unit admission", "strength": 7}, {"source_id": "case-control study", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "primary outcome", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "clinical outcomes", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "MAIN OUTCOME", "strength": 7}, {"source_id": "MAIN OUTCOME", "target_id": "mean age", "strength": 7}, {"source_id": "infection", "target_id": "admission", "strength": 7}, {"source_id": "COVID-19 symptoms", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "intensive care unit", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "care unit", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "program", "strength": 7}, {"source_id": "program", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "spike protein", "target_id": "SARS-CoV-2 Omicron variant", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "clinical characteristics", "strength": 7}, {"source_id": "clinical trials", "target_id": "monoclonal antibodies", "strength": 7}, {"source_id": "policy", "target_id": "actors", "strength": 7}, {"source_id": "students", "target_id": "future research", "strength": 7}, {"source_id": "research", "target_id": "learning", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "D-dimer", "strength": 7}, {"source_id": "intensive care unit", "target_id": "intensive care", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "illness", "strength": 7}, {"source_id": "adverse events", "target_id": "trials", "strength": 7}, {"source_id": "Omicron variant", "target_id": "T cells", "strength": 7}, {"source_id": "mean age", "target_id": "vaccine", "strength": 7}, {"source_id": "vaccine", "target_id": "young adults", "strength": 7}, {"source_id": "retrospective cohort study", "target_id": "mechanical ventilation", "strength": 7}, {"source_id": "mechanical ventilation", "target_id": "retrospective cohort study", "strength": 7}, {"source_id": "vaccine", "target_id": "World Health Organization", "strength": 7}, {"source_id": "BNT162b2 vaccine", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "higher odds", "target_id": "risk factors", "strength": 7}, {"source_id": "cohort study", "target_id": "diagnosis", "strength": 7}, {"source_id": "diagnosis", "target_id": "cohort study", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "incidence rate", "strength": 7}, {"source_id": "risk factors", "target_id": "COVID-19 vaccination", "strength": 7}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 replication", "strength": 7}, {"source_id": "antiviral activity", "target_id": "syndrome coronavirus 2", "strength": 7}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 replication", "strength": 7}, {"source_id": "SARS-CoV-2 replication", "target_id": "respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "therapeutic strategies", "strength": 7}, {"source_id": "therapeutic strategies", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "Omicron variant", "strength": 7}, {"source_id": "Omicron variant", "target_id": "syndrome coronavirus 2", "strength": 7}, {"source_id": "Omicron variant", "target_id": "coronavirus 2", "strength": 7}, {"source_id": "government", "target_id": "countries", "strength": 7}, {"source_id": "teachers", "target_id": "practice", "strength": 7}, {"source_id": "adverse effects", "target_id": "vaccine", "strength": 7}, {"source_id": "adverse outcomes", "target_id": "patients", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "economy", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "booster doses", "strength": 7}, {"source_id": "booster doses", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "long COVID", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "students", "target_id": "mental health", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "health care workers", "strength": 7}, {"source_id": "adult patients", "target_id": "hospital admission", "strength": 7}, {"source_id": "mechanical ventilation", "target_id": "hospital admission", "strength": 7}, {"source_id": "disease", "target_id": "kidney disease", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "COVID-19 cases", "strength": 7}, {"source_id": "intensive care unit", "target_id": "mortality rate", "strength": 7}, {"source_id": "care unit", "target_id": "mortality rate", "strength": 7}, {"source_id": "mortality rate", "target_id": "care unit", "strength": 7}, {"source_id": "healthcare workers", "target_id": "dose", "strength": 7}, {"source_id": "hospital mortality", "target_id": "primary outcome", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "clinical trials", "strength": 7}, {"source_id": "patients", "target_id": "health professionals", "strength": 7}, {"source_id": "learners", "target_id": "educators", "strength": 7}, {"source_id": "cohort study", "target_id": "third dose", "strength": 7}, {"source_id": "clinical symptoms", "target_id": "infection", "strength": 7}, {"source_id": "COVID-19", "target_id": "care providers", "strength": 7}, {"source_id": "patients", "target_id": "central nervous system", "strength": 7}, {"source_id": "cytokine storm", "target_id": "immune response", "strength": 7}, {"source_id": "immune response", "target_id": "cytokine storm", "strength": 7}, {"source_id": "respiratory disease", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "cohort study", "target_id": "pregnant women", "strength": 7}, {"source_id": "risk factors", "target_id": "physical activity", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "employees", "strength": 7}, {"source_id": "governance", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "cross-sectional study", "target_id": "physical activity", "strength": 7}, {"source_id": "acute respiratory distress syndrome", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "adult patients", "target_id": "distress syndrome", "strength": 7}, {"source_id": "respiratory distress syndrome", "target_id": "adult patients", "strength": 7}, {"source_id": "symptom onset", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "clinical trials", "target_id": "serious adverse events", "strength": 7}, {"source_id": "serious adverse events", "target_id": "clinical trials", "strength": 7}, {"source_id": "body mass index", "target_id": "COVID-19", "strength": 7}, {"source_id": "COVID-19", "target_id": "mass index", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "length of stay", "strength": 7}, {"source_id": "cohort study", "target_id": "intensive care unit", "strength": 7}, {"source_id": "mortality", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "cohort study", "target_id": "RT-PCR", "strength": 7}, {"source_id": "cohort study", "target_id": "care unit admission", "strength": 7}, {"source_id": "unit admission", "target_id": "cohort study", "strength": 7}, {"source_id": "case report", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "immune response", "target_id": "SARS-CoV-2 vaccination", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "vaccination program", "strength": 7}, {"source_id": "cohort study", "target_id": "clinical trials", "strength": 7}, {"source_id": "control group", "target_id": "adverse events", "strength": 7}, {"source_id": "immune response", "target_id": "transplant recipients", "strength": 7}, {"source_id": "health problems", "target_id": "patients", "strength": 7}, {"source_id": "patients", "target_id": "immune system", "strength": 7}, {"source_id": "patients", "target_id": "health problems", "strength": 7}, {"source_id": "COVID-19", "target_id": "dose", "strength": 7}, {"source_id": "infectious diseases", "target_id": "immune system", "strength": 7}, {"source_id": "systematic review", "target_id": "clinical outcomes", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "prospective study", "strength": 7}, {"source_id": "B cells", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "SARS-CoV-2 variants", "strength": 7}, {"source_id": "general population", "target_id": "cohort study", "strength": 7}, {"source_id": "cohort study", "target_id": "cohort", "strength": 7}, {"source_id": "syndrome coronavirus 2", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "coronavirus 2", "strength": 7}, {"source_id": "severe illness", "target_id": "patients", "strength": 7}, {"source_id": "COVID-19 outcomes", "target_id": "COVID-19 severity", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "acute respiratory distress syndrome", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "retrospective study", "strength": 7}, {"source_id": "second dose", "target_id": "Delta variant", "strength": 7}, {"source_id": "adult patients", "target_id": "retrospective study", "strength": 7}, {"source_id": "immune response", "target_id": "third dose", "strength": 7}, {"source_id": "SARS-CoV-2 variants", "target_id": "vaccine effectiveness", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "care unit admission", "strength": 7}, {"source_id": "unit admission", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "clinical trials", "target_id": "mechanical ventilation", "strength": 7}, {"source_id": "autoimmune diseases", "target_id": "disease", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "logistic regression", "strength": 7}, {"source_id": "inflammatory syndrome", "target_id": "cohort study", "strength": 7}, {"source_id": "third dose", "target_id": "antibody levels", "strength": 7}, {"source_id": "third dose", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "third dose", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "BNT162b2 vaccine", "strength": 7}, {"source_id": "coronavirus disease 2019", "target_id": "observational study", "strength": 7}, {"source_id": "adult patients", "target_id": "disease 2019", "strength": 7}, {"source_id": "adverse events", "target_id": "observational study", "strength": 7}, {"source_id": "disease 2019", "target_id": "adult patients", "strength": 7}, {"source_id": "humoral response", "target_id": "second dose", "strength": 7}, {"source_id": "antibody response", "target_id": "second dose", "strength": 7}, {"source_id": "case-control study", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "admission", "strength": 7}, {"source_id": "mean age", "target_id": "MAIN OUTCOME", "strength": 7}, {"source_id": "years of age", "target_id": "vaccine", "strength": 7}, {"source_id": "retrospective study", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "therapy", "target_id": "control group", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "Web of Science", "strength": 7}, {"source_id": "general population", "target_id": "vaccination", "strength": 7}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "disease severity", "strength": 7}, {"source_id": "acute respiratory distress syndrome", "target_id": "observational study", "strength": 7}, {"source_id": "respiratory distress syndrome", "target_id": "observational study", "strength": 7}, {"source_id": "distress syndrome", "target_id": "observational study", "strength": 7}, {"source_id": "observational study", "target_id": "distress syndrome", "strength": 7}, {"source_id": "vaccine", "target_id": "serious adverse events", "strength": 7}, {"source_id": "Omicron variant", "target_id": "RT-PCR", "strength": 7}, {"source_id": "educators", "target_id": "practice", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "society", "strength": 7}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "spike protein", "strength": 7}, {"source_id": "crisis", "target_id": "countries", "strength": 7}, {"source_id": "future research", "target_id": "students", "strength": 7}, {"source_id": "healthy controls", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "intensive care", "target_id": "care unit", "strength": 7}, {"source_id": "mean age", "target_id": "symptoms", "strength": 7}, {"source_id": "antibody titers", "target_id": "humoral response", "strength": 7}, {"source_id": "disease 2019 pandemic", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "BNT162b2 vaccine", "target_id": "vaccination", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "BNT162b2 vaccine", "strength": 7}, {"source_id": "vaccination", "target_id": "BNT162b2 vaccine", "strength": 7}, {"source_id": "coronavirus disease 2019", "target_id": "systematic review", "strength": 7}, {"source_id": "logistic regression", "target_id": "higher odds", "strength": 7}, {"source_id": "Health Organization", "target_id": "vaccine", "strength": 7}, {"source_id": "logistic regression analysis", "target_id": "mortality", "strength": 7}, {"source_id": "patients", "target_id": "acute phase", "strength": 7}, {"source_id": "severe disease", "target_id": "disease 2019", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "cross-sectional study", "strength": 7}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 replication", "strength": 7}, {"source_id": "therapeutic strategies", "target_id": "viral infection", "strength": 7}, {"source_id": "coronavirus 2", "target_id": "Omicron variant", "strength": 7}, {"source_id": "Omicron variant", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "antibody response", "target_id": "mRNA vaccination", "strength": 7}, {"source_id": "higher education", "target_id": "University", "strength": 7}, {"source_id": "students", "target_id": "case study", "strength": 7}, {"source_id": "case study", "target_id": "students", "strength": 7}, {"source_id": "physical activity", "target_id": "COVID-19", "strength": 7}, {"source_id": "University", "target_id": "schools", "strength": 7}, {"source_id": "COVID-19", "target_id": "engagement", "strength": 7}, {"source_id": "age groups", "target_id": "years of age", "strength": 7}, {"source_id": "COVID-19", "target_id": "diagnosis", "strength": 7}, {"source_id": "mRNA vaccines", "target_id": "case report", "strength": 7}, {"source_id": "case report", "target_id": "mRNA vaccines", "strength": 7}, {"source_id": "antibody titers", "target_id": "third dose", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "inflammatory response", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "symptom onset", "strength": 7}, {"source_id": "symptom onset", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "COVID-19 disease", "target_id": "risk factors", "strength": 7}, {"source_id": "disease", "target_id": "infectious diseases", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "social media", "strength": 7}, {"source_id": "middle-income countries", "target_id": "cohort study", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "retrospective cohort study", "strength": 7}, {"source_id": "coronavirus disease", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "booster doses", "target_id": "infection", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "long COVID", "strength": 7}, {"source_id": "persistent symptoms", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "primary care", "target_id": "care settings", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "cancer", "strength": 7}, {"source_id": "care workers", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "autoimmune diseases", "target_id": "immune response", "strength": 7}, {"source_id": "mortality rate", "target_id": "intensive care unit", "strength": 7}, {"source_id": "vaccine effectiveness", "target_id": "dose", "strength": 7}, {"source_id": "primary outcome", "target_id": "hospital mortality", "strength": 7}, {"source_id": "cohort study", "target_id": "physical activity", "strength": 7}, {"source_id": "complications", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "SARS-CoV-2 variants", "target_id": "cohort study", "strength": 7}, {"source_id": "antibody levels", "target_id": "SARS-CoV-2 variants", "strength": 7}, {"source_id": "patients", "target_id": "breast cancer", "strength": 7}, {"source_id": "primary outcome", "target_id": "older adults", "strength": 7}, {"source_id": "older adults", "target_id": "high risk", "strength": 7}, {"source_id": "physical activity", "target_id": "risk factors", "strength": 7}, {"source_id": "time points", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "treatment strategies", "target_id": "COVID-19", "strength": 7}, {"source_id": "acute respiratory distress syndrome", "target_id": "adult patients", "strength": 7}, {"source_id": "adult patients", "target_id": "respiratory distress syndrome", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "symptom onset", "strength": 7}, {"source_id": "risk factors", "target_id": "multivariable logistic regression", "strength": 7}, {"source_id": "use disorders", "target_id": "patients", "strength": 7}, {"source_id": "intensive care unit", "target_id": "cohort study", "strength": 7}, {"source_id": "hospital admission", "target_id": "Omicron variant", "strength": 7}, {"source_id": "viral load", "target_id": "SARS-CoV-2 variants", "strength": 7}, {"source_id": "systematic review", "target_id": "primary outcome", "strength": 7}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "vaccine", "strength": 7}, {"source_id": "cohort study", "target_id": "intensive care unit admission", "strength": 7}, {"source_id": "clinical characteristics", "target_id": "mortality rate", "strength": 7}, {"source_id": "mortality rate", "target_id": "clinical characteristics", "strength": 7}, {"source_id": "students", "target_id": "motivation", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 transmission", "strength": 7}, {"source_id": "protective effect", "target_id": "COVID-19", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "severe cases", "strength": 7}, {"source_id": "COVID-19", "target_id": "older age", "strength": 7}, {"source_id": "COVID-19 vaccination", "target_id": "vaccination status", "strength": 7}, {"source_id": "immune response", "target_id": "COVID-19 severity", "strength": 7}, {"source_id": "T cells", "target_id": "immune system", "strength": 7}, {"source_id": "immune system", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "ICU admission", "target_id": "retrospective cohort study", "strength": 7}, {"source_id": "older age", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "curriculum", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "mechanical ventilation", "target_id": "care unit admission", "strength": 7}, {"source_id": "mental health", "target_id": "cross-sectional survey", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "social support", "strength": 7}, {"source_id": "patients", "target_id": "type 2 diabetes", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "cancer", "target_id": "COVID-19", "strength": 7}, {"source_id": "patients", "target_id": "health conditions", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "respiratory distress syndrome", "strength": 7}, {"source_id": "respiratory distress syndrome", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "retrospective study", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "COVID-19", "target_id": "T cell responses", "strength": 7}, {"source_id": "COVID-19", "target_id": "cell responses", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "unit admission", "strength": 7}, {"source_id": "health measures", "target_id": "COVID-19", "strength": 7}, {"source_id": "disease", "target_id": "autoimmune diseases", "strength": 7}, {"source_id": "SARS-CoV-2 variants", "target_id": "antibody response", "strength": 7}, {"source_id": "case series", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "antiviral therapy", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "viral infection", "target_id": "viral replication", "strength": 7}, {"source_id": "BNT162b2 vaccine", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "second dose", "target_id": "humoral response", "strength": 7}, {"source_id": "intensive care unit admission", "target_id": "admission", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "case-control study", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "retrospective study", "strength": 7}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "patients", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 diagnosis", "strength": 7}, {"source_id": "booster vaccination", "target_id": "vaccine dose", "strength": 7}, {"source_id": "vaccination", "target_id": "general population", "strength": 7}, {"source_id": "disease severity", "target_id": "coronavirus 2", "strength": 7}, {"source_id": "mechanical ventilation", "target_id": "observational study", "strength": 7}, {"source_id": "observational study", "target_id": "mechanical ventilation", "strength": 7}, {"source_id": "breakthrough infections", "target_id": "Omicron variant", "strength": 7}, {"source_id": "antibody titers", "target_id": "Omicron variant", "strength": 7}, {"source_id": "Omicron variant", "target_id": "breakthrough infections", "strength": 7}, {"source_id": "policy", "target_id": "case study", "strength": 7}, {"source_id": "crisis", "target_id": "article", "strength": 7}, {"source_id": "people", "target_id": "experience", "strength": 7}, {"source_id": "actors", "target_id": "case study", "strength": 7}, {"source_id": "physical activity", "target_id": "patients", "strength": 7}, {"source_id": "intensive care", "target_id": "intensive care unit", "strength": 7}, {"source_id": "symptoms", "target_id": "mean age", "strength": 7}, {"source_id": "immune response", "target_id": "viral load", "strength": 7}, {"source_id": "trials", "target_id": "adverse events", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "disease 2019 pandemic", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "disease progression", "strength": 7}, {"source_id": "humoral response", "target_id": "antibody titers", "strength": 7}, {"source_id": "therapy", "target_id": "infection", "strength": 7}, {"source_id": "T cells", "target_id": "Omicron variant", "strength": 7}, {"source_id": "systematic review", "target_id": "disease 2019", "strength": 7}, {"source_id": "Web of Science", "target_id": "infection", "strength": 7}, {"source_id": "clinical presentation", "target_id": "symptoms", "strength": 7}, {"source_id": "disease 2019", "target_id": "systematic review", "strength": 7}, {"source_id": "infection", "target_id": "Web of Science", "strength": 7}, {"source_id": "risk factors", "target_id": "higher odds", "strength": 7}, {"source_id": "incidence rate", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "acute phase", "target_id": "patients", "strength": 7}, {"source_id": "COVID-19 vaccination", "target_id": "risk factors", "strength": 7}, {"source_id": "cross-sectional study", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "disease 2019", "target_id": "severe disease", "strength": 7}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "antiviral activity", "strength": 7}, {"source_id": "antiviral activity", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "syndrome coronavirus 2", "target_id": "antiviral activity", "strength": 7}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "Omicron variant", "strength": 7}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "Omicron variant", "strength": 7}, {"source_id": "syndrome coronavirus 2", "target_id": "Omicron variant", "strength": 7}, {"source_id": "therapeutic strategies", "target_id": "immune response", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "politics", "strength": 7}, {"source_id": "skills", "target_id": "learners", "strength": 7}, {"source_id": "engagement", "target_id": "schools", "strength": 7}, {"source_id": "engagement", "target_id": "COVID-19", "strength": 7}, {"source_id": "schools", "target_id": "University", "strength": 7}, {"source_id": "schools", "target_id": "engagement", "strength": 7}, {"source_id": "patients", "target_id": "adverse outcomes", "strength": 7}, {"source_id": "diagnosis", "target_id": "COVID-19", "strength": 7}, {"source_id": "variants of concern", "target_id": "vaccine", "strength": 7}, {"source_id": "infectious diseases", "target_id": "disease", "strength": 7}, {"source_id": "infection", "target_id": "booster doses", "strength": 7}, {"source_id": "hospital admission", "target_id": "hospital discharge", "strength": 7}, {"source_id": "risk factors", "target_id": "heart failure", "strength": 7}, {"source_id": "care professionals", "target_id": "patients", "strength": 7}, {"source_id": "COVID-19 pneumonia", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "COVID-19 pneumonia", "strength": 7}, {"source_id": "hospital admission", "target_id": "adult patients", "strength": 7}, {"source_id": "hospital admission", "target_id": "mechanical ventilation", "strength": 7}, {"source_id": "admission", "target_id": "adult patients", "strength": 7}, {"source_id": "admission", "target_id": "mechanical ventilation", "strength": 7}, {"source_id": "disease severity", "target_id": "admission", "strength": 7}, {"source_id": "immune response", "target_id": "autoimmune diseases", "strength": 7}, {"source_id": "COVID-19 cases", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "clinical trials", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "antibody titers", "target_id": "Delta variant", "strength": 7}, {"source_id": "cohort study", "target_id": "booster dose", "strength": 7}, {"source_id": "vaccination rates", "target_id": "vaccination", "strength": 7}, {"source_id": "physical activity", "target_id": "cohort study", "strength": 7}, {"source_id": "immune system", "target_id": "risk factors", "strength": 7}, {"source_id": "COVID-19 severity", "target_id": "risk factors", "strength": 7}, {"source_id": "infection", "target_id": "innate immune response", "strength": 7}, {"source_id": "breast cancer", "target_id": "patients", "strength": 7}, {"source_id": "infection", "target_id": "clinical symptoms", "strength": 7}, {"source_id": "COVID-19", "target_id": "observational cohort study", "strength": 7}, {"source_id": "disease progression", "target_id": "disease", "strength": 7}, {"source_id": "disease", "target_id": "disease progression", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "respiratory disease", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "long COVID", "strength": 7}, {"source_id": "physical activity", "target_id": "cross-sectional study", "strength": 7}, {"source_id": "disease severity", "target_id": "mortality rate", "strength": 7}, {"source_id": "symptoms", "target_id": "disease severity", "strength": 7}, {"source_id": "infection", "target_id": "age groups", "strength": 7}, {"source_id": "COVID-19", "target_id": "body mass index", "strength": 7}, {"source_id": "length of stay", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "high risk", "target_id": "Secondary outcomes", "strength": 7}, {"source_id": "Omicron variant", "target_id": "hospital admission", "strength": 7}, {"source_id": "vaccine", "target_id": "SARS-CoV-2 spike protein", "strength": 7}, {"source_id": "care unit admission", "target_id": "cohort study", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "case report", "strength": 7}, {"source_id": "vaccination program", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "second dose", "target_id": "vaccine dose", "strength": 7}, {"source_id": "transplant recipients", "target_id": "immune response", "strength": 7}, {"source_id": "vaccination rates", "target_id": "vaccine uptake", "strength": 7}, {"source_id": "vaccination status", "target_id": "COVID-19 vaccination", "strength": 7}, {"source_id": "booster dose", "target_id": "vaccination", "strength": 7}, {"source_id": "context", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "clinical outcomes", "target_id": "systematic review", "strength": 7}, {"source_id": "SARS-CoV-2 variants", "target_id": "booster dose", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "immune system", "strength": 7}, {"source_id": "patients", "target_id": "care system", "strength": 7}, {"source_id": "primary outcome", "target_id": "study protocol", "strength": 7}, {"source_id": "viral infection", "target_id": "coronavirus 2", "strength": 7}, {"source_id": "risk factors", "target_id": "intensive care unit", "strength": 7}, {"source_id": "intensive care unit", "target_id": "risk factors", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "older age", "strength": 7}, {"source_id": "governance", "target_id": "countries", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "curriculum", "strength": 7}, {"source_id": "mechanical ventilation", "target_id": "unit admission", "strength": 7}, {"source_id": "study period", "target_id": "adult patients", "strength": 7}, {"source_id": "T cells", "target_id": "mRNA vaccination", "strength": 7}, {"source_id": "type 2 diabetes", "target_id": "patients", "strength": 7}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "distress syndrome", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "inflammatory diseases", "strength": 7}, {"source_id": "T cell responses", "target_id": "SARS-CoV-2 vaccines", "strength": 7}, {"source_id": "clinical outcomes", "target_id": "vaccine", "strength": 7}, {"source_id": "vaccine", "target_id": "clinical outcomes", "strength": 7}, {"source_id": "students", "target_id": "context", "strength": 7}, {"source_id": "learning", "target_id": "semi-structured interviews", "strength": 7}, {"source_id": "high risk", "target_id": "general population", "strength": 7}, {"source_id": "general population", "target_id": "high risk", "strength": 7}, {"source_id": "dose", "target_id": "first dose", "strength": 7}, {"source_id": "antibody levels", "target_id": "humoral response", "strength": 7}, {"source_id": "disease severity", "target_id": "T cell responses", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "vaccine doses", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "mean age", "strength": 7}, {"source_id": "primary outcome", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "mean age", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "hospitalization", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "admission", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "severe COVID-19", "target_id": "disease", "strength": 7}, {"source_id": "disease", "target_id": "severe COVID-19", "strength": 7}, {"source_id": "policy", "target_id": "schools", "strength": 7}, {"source_id": "immune response", "target_id": "booster vaccination", "strength": 7}, {"source_id": "vaccine", "target_id": "years of age", "strength": 7}, {"source_id": "Web of Science", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "COVID-19 diagnosis", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "coronavirus 2", "target_id": "disease severity", "strength": 7}, {"source_id": "disease severity", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "care workers", "strength": 7}, {"source_id": "healthcare workers", "target_id": "general population", "strength": 7}, {"source_id": "society", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "article", "strength": 7}, {"source_id": "article", "target_id": "crisis", "strength": 7}, {"source_id": "experience", "target_id": "people", "strength": 7}, {"source_id": "learning", "target_id": "research", "strength": 7}, {"source_id": "retrospective cohort study", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "hazard ratio", "target_id": "patients", "strength": 7}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "humoral response", "target_id": "vaccination", "strength": 7}, {"source_id": "vaccination", "target_id": "humoral response", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 Omicron variant", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 symptoms", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "respiratory symptoms", "strength": 7}, {"source_id": "systematic review", "target_id": "coronavirus disease 2019", "strength": 7}, {"source_id": "respiratory symptoms", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "young adults", "target_id": "vaccine", "strength": 7}, {"source_id": "World Health Organization", "target_id": "vaccine", "strength": 7}, {"source_id": "infection", "target_id": "incidence rate", "strength": 7}, {"source_id": "cohort study", "target_id": "incidence", "strength": 7}, {"source_id": "mass index", "target_id": "cohort study", "strength": 7}, {"source_id": "cohort study", "target_id": "antibody response", "strength": 7}, {"source_id": "severe disease", "target_id": "coronavirus disease 2019", "strength": 7}, {"source_id": "coronavirus disease 2019", "target_id": "severe disease", "strength": 7}, {"source_id": "viral infection", "target_id": "therapeutic strategies", "strength": 7}, {"source_id": "vaccine hesitancy", "target_id": "COVID-19", "strength": 7}, {"source_id": "sociodemographic characteristics", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "Omicron variant", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "learning model", "target_id": "neural network", "strength": 7}, {"source_id": "COVID-19", "target_id": "physical activity", "strength": 7}, {"source_id": "practice", "target_id": "teachers", "strength": 7}, {"source_id": "mortality", "target_id": "infection", "strength": 7}, {"source_id": "infection", "target_id": "mortality", "strength": 7}, {"source_id": "years of age", "target_id": "age groups", "strength": 7}, {"source_id": "adverse outcomes", "target_id": "risk factors", "strength": 7}, {"source_id": "inflammatory response", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "therapeutic strategies", "target_id": "COVID-19", "strength": 7}, {"source_id": "vaccine", "target_id": "variants of concern", "strength": 7}, {"source_id": "risk factors", "target_id": "COVID-19 disease", "strength": 7}, {"source_id": "cohort study", "target_id": "middle-income countries", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "emergency department", "strength": 7}, {"source_id": "emergency department", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "coronavirus disease", "strength": 7}, {"source_id": "care settings", "target_id": "primary care", "strength": 7}, {"source_id": "cancer", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "health care workers", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "care workers", "strength": 7}, {"source_id": "health services", "target_id": "health conditions", "strength": 7}, {"source_id": "health conditions", "target_id": "health services", "strength": 7}, {"source_id": "admission", "target_id": "disease severity", "strength": 7}, {"source_id": "patients", "target_id": "inflammatory diseases", "strength": 7}, {"source_id": "median age", "target_id": "vaccination", "strength": 7}, {"source_id": "sector", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "third dose", "target_id": "cohort study", "strength": 7}, {"source_id": "cohort study", "target_id": "SARS-CoV-2 variants", "strength": 7}, {"source_id": "older adults", "target_id": "primary outcome", "strength": 7}, {"source_id": "anxiety", "target_id": "health outcomes", "strength": 7}, {"source_id": "care providers", "target_id": "COVID-19", "strength": 7}, {"source_id": "quality of life", "target_id": "symptoms", "strength": 7}, {"source_id": "respiratory disease", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "intervention group", "target_id": "primary outcome", "strength": 7}, {"source_id": "high risk", "target_id": "older adults", "strength": 7}, {"source_id": "intensive care unit", "target_id": "infection", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "time points", "strength": 7}, {"source_id": "adult patients", "target_id": "acute respiratory distress syndrome", "strength": 7}, {"source_id": "respiratory distress syndrome", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "acute respiratory distress syndrome", "strength": 7}, {"source_id": "distress syndrome", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "COVID-19", "target_id": "outcome measures", "strength": 7}, {"source_id": "SARS-CoV-2 variants", "target_id": "viral load", "strength": 7}, {"source_id": "intensive care unit admission", "target_id": "cohort study", "strength": 7}, {"source_id": "COVID-19", "target_id": "protective effect", "strength": 7}, {"source_id": "treatment options", "target_id": "COVID-19", "strength": 7}, {"source_id": "vaccination", "target_id": "booster dose", "strength": 7}, {"source_id": "COVID-19", "target_id": "case report", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "context", "strength": 7}, {"source_id": "booster dose", "target_id": "SARS-CoV-2 variants", "strength": 7}, {"source_id": "care system", "target_id": "patients", "strength": 7}, {"source_id": "retrospective cohort study", "target_id": "ICU admission", "strength": 7}, {"source_id": "mechanical ventilation", "target_id": "patient outcomes", "strength": 7}, {"source_id": "patient outcomes", "target_id": "mechanical ventilation", "strength": 7}, {"source_id": "care unit", "target_id": "risk factors", "strength": 7}, {"source_id": "motivation", "target_id": "teachers", "strength": 7}, {"source_id": "care unit admission", "target_id": "mechanical ventilation", "strength": 7}, {"source_id": "unit admission", "target_id": "mechanical ventilation", "strength": 7}, {"source_id": "cohort study", "target_id": "ill patients", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "syndrome coronavirus 2", "strength": 7}, {"source_id": "coronavirus 2", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "health conditions", "target_id": "patients", "strength": 7}, {"source_id": "educators", "target_id": "COVID-19", "strength": 7}, {"source_id": "acute respiratory distress syndrome", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "patients", "target_id": "vaccine dose", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "mRNA vaccination", "strength": 7}, {"source_id": "third dose", "target_id": "immune response", "strength": 7}, {"source_id": "skills", "target_id": "educators", "strength": 7}, {"source_id": "T cell responses", "target_id": "COVID-19", "strength": 7}, {"source_id": "cell responses", "target_id": "COVID-19", "strength": 7}, {"source_id": "third dose", "target_id": "antibody response", "strength": 7}, {"source_id": "immune response", "target_id": "B cells", "strength": 7}, {"source_id": "semi-structured interviews", "target_id": "learning", "strength": 7}, {"source_id": "third dose", "target_id": "patients", "strength": 7}, {"source_id": "observational study", "target_id": "adverse events", "strength": 7}, {"source_id": "disease 2019", "target_id": "observational study", "strength": 7}, {"source_id": "second dose", "target_id": "antibody response", "strength": 7}, {"source_id": "vaccine doses", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "unit admission", "strength": 7}, {"source_id": "care unit admission", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "primary outcome", "target_id": "hospitalization", "strength": 7}, {"source_id": "clinical outcomes", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "mean age", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "hospitalization", "target_id": "primary outcome", "strength": 7}, {"source_id": "years of age", "target_id": "immune response", "strength": 7}, {"source_id": "control group", "target_id": "therapy", "strength": 7}, {"source_id": "adverse events", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "patients", "target_id": "SARS-CoV-2 antibodies", "strength": 7}, {"source_id": "observational study", "target_id": "acute respiratory distress syndrome", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "health care workers", "strength": 7}, {"source_id": "Omicron variant", "target_id": "antibody titers", "strength": 7}, {"source_id": "ecosystems", "target_id": "climate change", "strength": 7}, {"source_id": "monoclonal antibodies", "target_id": "clinical trials", "strength": 7}, {"source_id": "countries", "target_id": "crisis", "strength": 7}, {"source_id": "case study", "target_id": "actors", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "healthy controls", "strength": 7}, {"source_id": "risk factors", "target_id": "D-dimer", "strength": 7}, {"source_id": "care unit", "target_id": "intensive care", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "retrospective cohort study", "strength": 7}, {"source_id": "illness", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "mortality", "target_id": "retrospective study", "strength": 7}, {"source_id": "infection", "target_id": "therapy", "strength": 7}, {"source_id": "vaccine", "target_id": "mean age", "strength": 7}, {"source_id": "older adults", "target_id": "COVID-19", "strength": 7}, {"source_id": "vaccine", "target_id": "Health Organization", "strength": 7}, {"source_id": "mortality", "target_id": "logistic regression analysis", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "BNT162b2 vaccine", "strength": 7}, {"source_id": "vaccine dose", "target_id": "vaccine effectiveness", "strength": 7}, {"source_id": "cohort study", "target_id": "mass index", "strength": 7}, {"source_id": "breakthrough infections", "target_id": "vaccine doses", "strength": 7}, {"source_id": "antibody response", "target_id": "cohort study", "strength": 7}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "antiviral activity", "strength": 7}, {"source_id": "antiviral activity", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "antiviral activity", "target_id": "respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "antiviral activity", "strength": 7}, {"source_id": "SARS-CoV-2 replication", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "pregnant women", "strength": 7}, {"source_id": "COVID-19", "target_id": "vaccine hesitancy", "strength": 7}, {"source_id": "vaccine", "target_id": "pregnant women", "strength": 7}, {"source_id": "immune response", "target_id": "Omicron variant", "strength": 7}, {"source_id": "immune cells", "target_id": "infection", "strength": 7}, {"source_id": "immune response", "target_id": "therapeutic strategies", "strength": 7}, {"source_id": "neural network", "target_id": "learning model", "strength": 7}, {"source_id": "countries", "target_id": "government", "strength": 7}, {"source_id": "University", "target_id": "higher education", "strength": 7}, {"source_id": "politics", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "learners", "target_id": "skills", "strength": 7}, {"source_id": "case report", "target_id": "second dose", "strength": 7}, {"source_id": "vaccine", "target_id": "adverse effects", "strength": 7}, {"source_id": "risk factors", "target_id": "adverse outcomes", "strength": 7}, {"source_id": "third dose", "target_id": "vaccination", "strength": 7}, {"source_id": "vaccination", "target_id": "third dose", "strength": 7}, {"source_id": "economy", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "social media", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "retrospective cohort study", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "hospital discharge", "target_id": "hospital admission", "strength": 7}, {"source_id": "inflammatory diseases", "target_id": "patients", "strength": 7}, {"source_id": "vaccination", "target_id": "median age", "strength": 7}, {"source_id": "kidney disease", "target_id": "disease", "strength": 7}, {"source_id": "booster dose", "target_id": "cohort study", "strength": 7}, {"source_id": "health professionals", "target_id": "patients", "strength": 7}, {"source_id": "vaccination", "target_id": "vaccination rates", "strength": 7}, {"source_id": "risk factors", "target_id": "immune system", "strength": 7}, {"source_id": "health outcomes", "target_id": "anxiety", "strength": 7}, {"source_id": "central nervous system", "target_id": "patients", "strength": 7}, {"source_id": "symptoms", "target_id": "quality of life", "strength": 7}, {"source_id": "primary outcome", "target_id": "intervention group", "strength": 7}, {"source_id": "pregnant women", "target_id": "cohort study", "strength": 7}, {"source_id": "mortality rate", "target_id": "disease severity", "strength": 7}, {"source_id": "disease severity", "target_id": "symptoms", "strength": 7}, {"source_id": "age groups", "target_id": "infection", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "distress syndrome", "strength": 7}, {"source_id": "distress syndrome", "target_id": "adult patients", "strength": 7}, {"source_id": "outcome measures", "target_id": "COVID-19", "strength": 7}, {"source_id": "hospital mortality", "target_id": "risk factors", "strength": 7}, {"source_id": "mass index", "target_id": "COVID-19", "strength": 7}, {"source_id": "multivariable logistic regression", "target_id": "risk factors", "strength": 7}, {"source_id": "risk factors", "target_id": "hospital mortality", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "mortality", "strength": 7}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "infection", "strength": 7}, {"source_id": "booster dose", "target_id": "vaccine dose", "strength": 7}, {"source_id": "infection", "target_id": "SARS-CoV-2 Omicron variant", "strength": 7}, {"source_id": "RT-PCR", "target_id": "cohort study", "strength": 7}, {"source_id": "primary outcome", "target_id": "systematic review", "strength": 7}, {"source_id": "general population", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "cell responses", "target_id": "infection", "strength": 7}, {"source_id": "infection", "target_id": "cell responses", "strength": 7}, {"source_id": "SARS-CoV-2 transmission", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "transplant recipients", "target_id": "COVID-19", "strength": 7}, {"source_id": "COVID-19", "target_id": "transplant recipients", "strength": 7}, {"source_id": "vaccine dose", "target_id": "third dose", "strength": 7}, {"source_id": "vaccine dose", "target_id": "second dose", "strength": 7}, {"source_id": "third dose", "target_id": "vaccine dose", "strength": 7}, {"source_id": "clinical trials", "target_id": "cohort study", "strength": 7}, {"source_id": "older age", "target_id": "COVID-19", "strength": 7}, {"source_id": "immune system", "target_id": "patients", "strength": 7}, {"source_id": "antibody response", "target_id": "vaccine dose", "strength": 7}, {"source_id": "dose", "target_id": "COVID-19", "strength": 7}, {"source_id": "COVID-19 severity", "target_id": "immune response", "strength": 7}, {"source_id": "immune system", "target_id": "infectious diseases", "strength": 7}, {"source_id": "COVID-19", "target_id": "breakthrough infections", "strength": 7}, {"source_id": "breakthrough infections", "target_id": "COVID-19", "strength": 7}, {"source_id": "study protocol", "target_id": "primary outcome", "strength": 7}, {"source_id": "prospective study", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "coronavirus 2", "target_id": "viral infection", "strength": 7}, {"source_id": "risk factors", "target_id": "care unit", "strength": 7}, {"source_id": "countries", "target_id": "governance", "strength": 7}, {"source_id": "teachers", "target_id": "motivation", "strength": 7}, {"source_id": "ill patients", "target_id": "cohort study", "strength": 7}, {"source_id": "adult patients", "target_id": "study period", "strength": 7}, {"source_id": "mRNA vaccination", "target_id": "T cells", "strength": 7}, {"source_id": "cohort study", "target_id": "general population", "strength": 7}, {"source_id": "social support", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "years of age", "target_id": "cohort study", "strength": 7}, {"source_id": "cohort study", "target_id": "years of age", "strength": 7}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "COVID-19", "target_id": "cancer", "strength": 7}, {"source_id": "COVID-19", "target_id": "educators", "strength": 7}, {"source_id": "vaccine dose", "target_id": "patients", "strength": 7}, {"source_id": "mRNA vaccination", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "T cell responses", "strength": 7}, {"source_id": "Delta variant", "target_id": "second dose", "strength": 7}, {"source_id": "retrospective study", "target_id": "adult patients", "strength": 7}, {"source_id": "vaccine effectiveness", "target_id": "SARS-CoV-2 variants", "strength": 7}, {"source_id": "educators", "target_id": "skills", "strength": 7}, {"source_id": "COVID-19", "target_id": "health measures", "strength": 7}, {"source_id": "immune response", "target_id": "disease progression", "strength": 7}, {"source_id": "breakthrough infections", "target_id": "vaccine dose", "strength": 7}, {"source_id": "vaccine dose", "target_id": "breakthrough infections", "strength": 7}, {"source_id": "cohort study", "target_id": "inflammatory syndrome", "strength": 7}, {"source_id": "viral replication", "target_id": "viral infection", "strength": 7}, {"source_id": "first dose", "target_id": "dose", "strength": 7}, {"source_id": "patients", "target_id": "third dose", "strength": 7}, {"source_id": "observational study", "target_id": "disease 2019", "strength": 7}, {"source_id": "humoral response", "target_id": "antibody levels", "strength": 7}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "SARS-CoV-2 vaccines", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 vaccination", "strength": 7}, {"source_id": "T cell responses", "target_id": "disease severity", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "hospitalization", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "mean age", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "case-control study", "strength": 7}, {"source_id": "unit admission", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "MAIN OUTCOME", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "admission", "target_id": "intensive care unit admission", "strength": 7}, {"source_id": "admission", "target_id": "infection", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "COVID-19 symptoms", "strength": 7}, {"source_id": "schools", "target_id": "policy", "strength": 7}, {"source_id": "immune response", "target_id": "years of age", "strength": 7}, {"source_id": "booster vaccination", "target_id": "immune response", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "intensive care unit", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "care unit", "strength": 7}, {"source_id": "COVID-19 patients", "target_id": "adverse events", "strength": 7}, {"source_id": "Web of Science", "target_id": "inclusion criteria", "strength": 7}, {"source_id": "inclusion criteria", "target_id": "Web of Science", "strength": 7}, {"source_id": "vaccine dose", "target_id": "booster vaccination", "strength": 7}, {"source_id": "observational study", "target_id": "respiratory distress syndrome", "strength": 7}, {"source_id": "serious adverse events", "target_id": "vaccine", "strength": 7}, {"source_id": "RT-PCR", "target_id": "Omicron variant", "strength": 7}, {"source_id": "practice", "target_id": "educators", "strength": 7}, {"source_id": "health care workers", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "care workers", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "general population", "target_id": "healthcare workers", "strength": 7}, {"source_id": "clinical characteristics", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "climate change", "target_id": "ecosystems", "strength": 7}, {"source_id": "case study", "target_id": "policy", "strength": 7}, {"source_id": "article", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "actors", "target_id": "policy", "strength": 7}, {"source_id": "patients", "target_id": "physical activity", "strength": 7}, {"source_id": "retrospective study", "target_id": "mortality", "strength": 7}, {"source_id": "viral load", "target_id": "immune response", "strength": 7}, {"source_id": "disease progression", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "BNT162b2 vaccine", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "COVID-19 symptoms", "target_id": "SARS-CoV-2 infection", "strength": 7}, {"source_id": "symptoms", "target_id": "clinical presentation", "strength": 7}, {"source_id": "COVID-19", "target_id": "older adults", "strength": 7}, {"source_id": "higher odds", "target_id": "logistic regression", "strength": 7}, {"source_id": "booster vaccination", "target_id": "vaccine effectiveness", "strength": 7}, {"source_id": "vaccine effectiveness", "target_id": "booster vaccination", "strength": 7}, {"source_id": "vaccine effectiveness", "target_id": "vaccine dose", "strength": 7}, {"source_id": "incidence rate", "target_id": "infection", "strength": 7}, {"source_id": "incidence", "target_id": "cohort study", "strength": 7}, {"source_id": "vaccine doses", "target_id": "breakthrough infections", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "high risk", "strength": 7}, {"source_id": "high risk", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "SARS-CoV-2 replication", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "SARS-CoV-2 replication", "target_id": "syndrome coronavirus 2", "strength": 7}, {"source_id": "syndrome coronavirus 2", "target_id": "SARS-CoV-2 replication", "strength": 7}, {"source_id": "pregnant women", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "pregnant women", "target_id": "vaccine", "strength": 7}, {"source_id": "Omicron variant", "target_id": "respiratory syndrome coronavirus 2", "strength": 7}, {"source_id": "Omicron variant", "target_id": "immune response", "strength": 7}, {"source_id": "mRNA vaccination", "target_id": "antibody response", "strength": 7}, {"source_id": "infection", "target_id": "immune cells", "strength": 7}, {"source_id": "education", "target_id": "perspective", "strength": 7}, {"source_id": "perspective", "target_id": "education", "strength": 7}, {"source_id": "second dose", "target_id": "case report", "strength": 7}, {"source_id": "third dose", "target_id": "antibody titers", "strength": 7}, {"source_id": "COVID-19", "target_id": "therapeutic strategies", "strength": 7}, {"source_id": "case report", "target_id": "first dose", "strength": 7}, {"source_id": "first dose", "target_id": "case report", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "persistent symptoms", "strength": 7}, {"source_id": "mental health", "target_id": "students", "strength": 7}, {"source_id": "heart failure", "target_id": "risk factors", "strength": 7}, {"source_id": "patients", "target_id": "care professionals", "strength": 7}, {"source_id": "therapeutic target", "target_id": "patients", "strength": 7}, {"source_id": "patients", "target_id": "therapeutic target", "strength": 7}, {"source_id": "adult patients", "target_id": "admission", "strength": 7}, {"source_id": "mechanical ventilation", "target_id": "admission", "strength": 7}, {"source_id": "dose", "target_id": "vaccine effectiveness", "strength": 7}, {"source_id": "dose", "target_id": "healthcare workers", "strength": 7}, {"source_id": "Delta variant", "target_id": "antibody titers", "strength": 7}, {"source_id": "risk factors", "target_id": "COVID-19 severity", "strength": 7}, {"source_id": "educators", "target_id": "learners", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "complications", "strength": 7}, {"source_id": "SARS-CoV-2 variants", "target_id": "antibody levels", "strength": 7}, {"source_id": "observational cohort study", "target_id": "COVID-19", "strength": 7}, {"source_id": "SARS-CoV-2", "target_id": "respiratory disease", "strength": 7}, {"source_id": "infection", "target_id": "intensive care unit", "strength": 7}, {"source_id": "long COVID", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "employees", "target_id": "COVID-19 pandemic", "strength": 7}, {"source_id": "COVID-19 pandemic", "target_id": "governance", "strength": 7}, {"source_id": "COVID-19", "target_id": "treatment strategies", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "respiratory distress syndrome", "strength": 7}, {"source_id": "patients", "target_id": "use disorders", "strength": 7}, {"source_id": "Secondary outcomes", "target_id": "high risk", "strength": 7}, {"source_id": "vaccine dose", "target_id": "booster dose", "strength": 7}, {"source_id": "cohort study", "target_id": "unit admission", "strength": 7}, {"source_id": "motivation", "target_id": "students", "strength": 7}, {"source_id": "COVID-19 infection", "target_id": "general population", "strength": 7}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "immune response", "strength": 7}, {"source_id": "COVID-19", "target_id": "treatment options", "strength": 7}, {"source_id": "severe cases", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "adverse events", "target_id": "control group", "strength": 7}, {"source_id": "vaccine dose", "target_id": "antibody response", "strength": 7}, {"source_id": "vaccine uptake", "target_id": "vaccination rates", "strength": 7}, {"source_id": "case report", "target_id": "COVID-19", "strength": 7}, {"source_id": "immune system", "target_id": "T cells", "strength": 7}, {"source_id": "incidence rate", "target_id": "incidence", "strength": 7}, {"source_id": "incidence", "target_id": "incidence rate", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "B cells", "strength": 7}, {"source_id": "SARS-CoV-2 variants", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "cross-sectional survey", "target_id": "mental health", "strength": 7}, {"source_id": "cohort", "target_id": "cohort study", "strength": 7}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "COVID-19 vaccine", "strength": 7}, {"source_id": "patients", "target_id": "severe illness", "strength": 7}, {"source_id": "COVID-19 severity", "target_id": "COVID-19 outcomes", "strength": 7}, {"source_id": "SARS-CoV-2 infection", "target_id": "distress syndrome", "strength": 7}, {"source_id": "inflammatory diseases", "target_id": "SARS-CoV-2", "strength": 7}, {"source_id": "context", "target_id": "students", "strength": 7}, {"source_id": "care unit admission", "target_id": "COVID-19 patients", "strength": 7}, {"source_id": "mechanical ventilation", "target_id": "clinical trials", "strength": 7}, {"source_id": "antibody response", "target_id": "third dose", "strength": 7}, {"source_id": "B cells", "target_id": "immune response", "strength": 7}, {"source_id": "disease progression", "target_id": "immune response", "strength": 7}, {"source_id": "antibody response", "target_id": "SARS-CoV-2 variants", "strength": 7}, {"source_id": "logistic regression", "target_id": "COVID-19 infection", "strength": 7}, {"source_id": "COVID-19 vaccine", "target_id": "case series", "strength": 7}, {"source_id": "BNT162b2 vaccine", "target_id": "patients", "strength": 8}, {"source_id": "hospital mortality", "target_id": "intensive care unit", "strength": 8}, {"source_id": "hospital discharge", "target_id": "mechanical ventilation", "strength": 8}, {"source_id": "observational study", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "antibody response", "target_id": "healthcare workers", "strength": 8}, {"source_id": "patient outcomes", "target_id": "COVID-19", "strength": 8}, {"source_id": "spike protein", "target_id": "COVID-19 vaccine", "strength": 8}, {"source_id": "ICU admission", "target_id": "intensive care unit admission", "strength": 8}, {"source_id": "mean age", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "antibody response", "target_id": "transplant recipients", "strength": 8}, {"source_id": "patients", "target_id": "greater risk", "strength": 8}, {"source_id": "Web of Science", "target_id": "COVID-19", "strength": 8}, {"source_id": "case report", "target_id": "systematic review", "strength": 8}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "disease severity", "strength": 8}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "coronavirus disease", "strength": 8}, {"source_id": "syndrome coronavirus 2", "target_id": "disease severity", "strength": 8}, {"source_id": "patients", "target_id": "disease burden", "strength": 8}, {"source_id": "motivation", "target_id": "learning", "strength": 8}, {"source_id": "course", "target_id": "skills", "strength": 8}, {"source_id": "clinical characteristics", "target_id": "cohort study", "strength": 8}, {"source_id": "antibody titers", "target_id": "spike protein", "strength": 8}, {"source_id": "market", "target_id": "policy", "strength": 8}, {"source_id": "pandemic", "target_id": "people", "strength": 8}, {"source_id": "research", "target_id": "students", "strength": 8}, {"source_id": "flow cytometry", "target_id": "immune response", "strength": 8}, {"source_id": "antibody titers", "target_id": "T cell responses", "strength": 8}, {"source_id": "mechanical ventilation", "target_id": "coronavirus disease 2019", "strength": 8}, {"source_id": "older adults", "target_id": "age groups", "strength": 8}, {"source_id": "logistic regression", "target_id": "retrospective cohort study", "strength": 8}, {"source_id": "logistic regression", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "vaccine hesitancy", "target_id": "vaccination rates", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "vaccine doses", "strength": 8}, {"source_id": "acute phase", "target_id": "symptoms", "strength": 8}, {"source_id": "persistent symptoms", "target_id": "long COVID", "strength": 8}, {"source_id": "long COVID", "target_id": "persistent symptoms", "strength": 8}, {"source_id": "long COVID", "target_id": "patients", "strength": 8}, {"source_id": "symptoms", "target_id": "acute phase", "strength": 8}, {"source_id": "disease 2019", "target_id": "COVID-19 vaccination", "strength": 8}, {"source_id": "vaccination", "target_id": "disease 2019", "strength": 8}, {"source_id": "antiviral activity", "target_id": "coronavirus 2", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "T cells", "strength": 8}, {"source_id": "infection", "target_id": "viral load", "strength": 8}, {"source_id": "myocardial infarction", "target_id": "COVID-19", "strength": 8}, {"source_id": "respiratory tract", "target_id": "infection", "strength": 8}, {"source_id": "SARS-CoV-2 virus", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "mice", "strength": 8}, {"source_id": "older adults", "target_id": "young adults", "strength": 8}, {"source_id": "young adults", "target_id": "older adults", "strength": 8}, {"source_id": "teachers", "target_id": "experience", "strength": 8}, {"source_id": "University", "target_id": "COVID-19", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 8}, {"source_id": "perspective", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "practice", "target_id": "policy", "strength": 8}, {"source_id": "adult patients", "target_id": "infection", "strength": 8}, {"source_id": "policy", "target_id": "society", "strength": 8}, {"source_id": "economy", "target_id": "crisis", "strength": 8}, {"source_id": "society", "target_id": "policy", "strength": 8}, {"source_id": "quality of life", "target_id": "control group", "strength": 8}, {"source_id": "health services", "target_id": "health system", "strength": 8}, {"source_id": "health system", "target_id": "health services", "strength": 8}, {"source_id": "systematic review", "target_id": "high-income countries", "strength": 8}, {"source_id": "patients", "target_id": "SARS-CoV-2 pandemic", "strength": 8}, {"source_id": "mortality rate", "target_id": "high risk", "strength": 8}, {"source_id": "cross-sectional study", "target_id": "infection", "strength": 8}, {"source_id": "infection", "target_id": "cross-sectional study", "strength": 8}, {"source_id": "healthy controls", "target_id": "antibody response", "strength": 8}, {"source_id": "high risk", "target_id": "vaccine", "strength": 8}, {"source_id": "mortality rate", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "physical activity", "target_id": "Secondary outcomes", "strength": 8}, {"source_id": "physical activity", "target_id": "primary outcome", "strength": 8}, {"source_id": "justice", "target_id": "policy", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "hospital discharge", "strength": 8}, {"source_id": "risk factors", "target_id": "odds ratio", "strength": 8}, {"source_id": "odds ratio", "target_id": "COVID-19", "strength": 8}, {"source_id": "case-control study", "target_id": "vaccine", "strength": 8}, {"source_id": "hospitalized patients", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "COVID-19", "target_id": "illness", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "care unit", "strength": 8}, {"source_id": "qualitative study", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "qualitative study", "strength": 8}, {"source_id": "mortality", "target_id": "disease severity", "strength": 8}, {"source_id": "mechanical ventilation", "target_id": "disease severity", "strength": 8}, {"source_id": "healthcare workers", "target_id": "care workers", "strength": 8}, {"source_id": "infection", "target_id": "unvaccinated individuals", "strength": 8}, {"source_id": "booster dose", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "epithelial cells", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "observational cohort study", "strength": 8}, {"source_id": "booster dose", "target_id": "vaccine effectiveness", "strength": 8}, {"source_id": "vaccine effectiveness", "target_id": "booster dose", "strength": 8}, {"source_id": "COVID-19", "target_id": "blood samples", "strength": 8}, {"source_id": "primary outcome", "target_id": "prospective cohort study", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "cross-sectional study", "strength": 8}, {"source_id": "transplant recipients", "target_id": "mRNA vaccines", "strength": 8}, {"source_id": "booster vaccination", "target_id": "SARS-CoV-2 variants", "strength": 8}, {"source_id": "cause mortality", "target_id": "cohort study", "strength": 8}, {"source_id": "conservation", "target_id": "species", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "mortality", "strength": 8}, {"source_id": "inflammatory response", "target_id": "patients", "strength": 8}, {"source_id": "antibody levels", "target_id": "dose", "strength": 8}, {"source_id": "care unit", "target_id": "hospital mortality", "strength": 8}, {"source_id": "mechanical ventilation", "target_id": "hospital discharge", "strength": 8}, {"source_id": "COVID-19 vaccine", "target_id": "spike protein", "strength": 8}, {"source_id": "vaccination", "target_id": "hospitalization", "strength": 8}, {"source_id": "greater risk", "target_id": "patients", "strength": 8}, {"source_id": "COVID-19", "target_id": "health outcomes", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "median age", "strength": 8}, {"source_id": "disease severity", "target_id": "syndrome coronavirus 2", "strength": 8}, {"source_id": "coronavirus disease", "target_id": "syndrome coronavirus 2", "strength": 8}, {"source_id": "healthy controls", "target_id": "vaccine", "strength": 8}, {"source_id": "mouse model", "target_id": "mice", "strength": 8}, {"source_id": "disease", "target_id": "central nervous system", "strength": 8}, {"source_id": "spike protein", "target_id": "antibody titers", "strength": 8}, {"source_id": "conservation", "target_id": "ecosystems", "strength": 8}, {"source_id": "policy", "target_id": "institutions", "strength": 8}, {"source_id": "students", "target_id": "research", "strength": 8}, {"source_id": "clinical studies", "target_id": "patients", "strength": 8}, {"source_id": "trials", "target_id": "Secondary outcomes", "strength": 8}, {"source_id": "SARS-CoV-2 variants", "target_id": "disease severity", "strength": 8}, {"source_id": "mechanical ventilation", "target_id": "disease 2019", "strength": 8}, {"source_id": "age groups", "target_id": "older adults", "strength": 8}, {"source_id": "age groups", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "booster vaccination", "strength": 8}, {"source_id": "booster vaccination", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "women", "strength": 8}, {"source_id": "women", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "vaccination rates", "target_id": "vaccine hesitancy", "strength": 8}, {"source_id": "infection rate", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "antibody response", "target_id": "Delta variant", "strength": 8}, {"source_id": "blood samples", "target_id": "infection", "strength": 8}, {"source_id": "Delta variant", "target_id": "antibody response", "strength": 8}, {"source_id": "severe disease", "target_id": "COVID-19 vaccine", "strength": 8}, {"source_id": "COVID-19", "target_id": "prospective cohort study", "strength": 8}, {"source_id": "coronavirus 2", "target_id": "SARS-CoV-2 replication", "strength": 8}, {"source_id": "viral load", "target_id": "infection", "strength": 8}, {"source_id": "care providers", "target_id": "care", "strength": 8}, {"source_id": "care", "target_id": "care providers", "strength": 8}, {"source_id": "immune response", "target_id": "respiratory tract", "strength": 8}, {"source_id": "SARS-CoV-2 virus", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "flow cytometry", "strength": 8}, {"source_id": "receptor-binding domain", "target_id": "vaccine", "strength": 8}, {"source_id": "vaccine", "target_id": "receptor-binding domain", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "disease 2019 pandemic", "strength": 8}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "engagement", "target_id": "course", "strength": 8}, {"source_id": "clinical manifestations", "target_id": "patients", "strength": 8}, {"source_id": "patients", "target_id": "B cells", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "hospital admission", "strength": 8}, {"source_id": "control group", "target_id": "quality of life", "strength": 8}, {"source_id": "primary care", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "middle-income countries", "target_id": "high-income countries", "strength": 8}, {"source_id": "vaccination rates", "target_id": "COVID-19", "strength": 8}, {"source_id": "coronavirus disease", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "COVID-19", "target_id": "intensive care", "strength": 8}, {"source_id": "mental health", "target_id": "cohort study", "strength": 8}, {"source_id": "mortality rate", "target_id": "mechanical ventilation", "strength": 8}, {"source_id": "hospital admission", "target_id": "infection", "strength": 8}, {"source_id": "infection", "target_id": "hospital admission", "strength": 8}, {"source_id": "antibody response", "target_id": "SARS-CoV-2 vaccination", "strength": 8}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "antibody response", "strength": 8}, {"source_id": "clinical trials", "target_id": "T cells", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "health measures", "strength": 8}, {"source_id": "health measures", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "mortality rate", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "booster vaccination", "target_id": "severe disease", "strength": 8}, {"source_id": "patients", "target_id": "study population", "strength": 8}, {"source_id": "COVID-19", "target_id": "central nervous system", "strength": 8}, {"source_id": "central nervous system", "target_id": "COVID-19", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "children", "strength": 8}, {"source_id": "artificial intelligence", "target_id": "technology", "strength": 8}, {"source_id": "policy", "target_id": "article", "strength": 8}, {"source_id": "hospital discharge", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "cohort study", "target_id": "second dose", "strength": 8}, {"source_id": "dose", "target_id": "cohort study", "strength": 8}, {"source_id": "patients", "target_id": "nervous system", "strength": 8}, {"source_id": "intensive care unit", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "disease severity", "target_id": "mortality", "strength": 8}, {"source_id": "adult patients", "target_id": "intensive care unit", "strength": 8}, {"source_id": "protective effect", "target_id": "patients", "strength": 8}, {"source_id": "pediatric patients", "target_id": "COVID-19", "strength": 8}, {"source_id": "primary outcome", "target_id": "high risk", "strength": 8}, {"source_id": "cohort study", "target_id": "care unit", "strength": 8}, {"source_id": "COVID-19 vaccination", "target_id": "vaccine uptake", "strength": 8}, {"source_id": "general population", "target_id": "infection", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "epithelial cells", "strength": 8}, {"source_id": "observational cohort study", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "third dose", "strength": 8}, {"source_id": "COVID-19", "target_id": "Omicron variant", "strength": 8}, {"source_id": "race/ethnicity", "target_id": "COVID-19", "strength": 8}, {"source_id": "COVID-19", "target_id": "race/ethnicity", "strength": 8}, {"source_id": "disease severity", "target_id": "COVID-19 severity", "strength": 8}, {"source_id": "countries", "target_id": "COVID-19", "strength": 8}, {"source_id": "clinical practice", "target_id": "COVID-19", "strength": 8}, {"source_id": "politics", "target_id": "pandemic", "strength": 8}, {"source_id": "pandemic", "target_id": "politics", "strength": 8}, {"source_id": "education", "target_id": "semi-structured interviews", "strength": 8}, {"source_id": "patients", "target_id": "blood pressure", "strength": 8}, {"source_id": "median age", "target_id": "mortality", "strength": 8}, {"source_id": "mortality", "target_id": "median age", "strength": 8}, {"source_id": "MAIN OUTCOME", "target_id": "cross-sectional study", "strength": 8}, {"source_id": "high risk", "target_id": "hospital admission", "strength": 8}, {"source_id": "high incidence", "target_id": "COVID-19", "strength": 8}, {"source_id": "patients", "target_id": "BNT162b2 vaccine", "strength": 8}, {"source_id": "patients", "target_id": "dose", "strength": 8}, {"source_id": "intensive care unit", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "care unit", "strength": 8}, {"source_id": "hospital mortality", "target_id": "care unit", "strength": 8}, {"source_id": "patients", "target_id": "flow cytometry", "strength": 8}, {"source_id": "flow cytometry", "target_id": "patients", "strength": 8}, {"source_id": "clinical trials", "target_id": "severe COVID-19", "strength": 8}, {"source_id": "mRNA vaccines", "target_id": "BNT162b2 vaccine", "strength": 8}, {"source_id": "transplant recipients", "target_id": "COVID-19 vaccine", "strength": 8}, {"source_id": "primary outcome", "target_id": "mean age", "strength": 8}, {"source_id": "clinical outcomes", "target_id": "infection", "strength": 8}, {"source_id": "lower risk", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "logistic regression models", "target_id": "patients", "strength": 8}, {"source_id": "patients", "target_id": "logistic regression models", "strength": 8}, {"source_id": "care", "target_id": "primary care", "strength": 8}, {"source_id": "patients", "target_id": "COVID-19 diagnosis", "strength": 8}, {"source_id": "coronavirus disease", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 8}, {"source_id": "coronavirus disease", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "educators", "strength": 8}, {"source_id": "experience", "target_id": "practice", "strength": 8}, {"source_id": "practice", "target_id": "experience", "strength": 8}, {"source_id": "pandemic", "target_id": "skills", "strength": 8}, {"source_id": "central nervous system", "target_id": "disease", "strength": 8}, {"source_id": "book", "target_id": "policy", "strength": 8}, {"source_id": "semi-structured interviews", "target_id": "students", "strength": 8}, {"source_id": "students", "target_id": "semi-structured interviews", "strength": 8}, {"source_id": "Secondary outcomes", "target_id": "care unit", "strength": 8}, {"source_id": "injury", "target_id": "patients", "strength": 8}, {"source_id": "antibody titers", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "Secondary outcomes", "target_id": "trials", "strength": 8}, {"source_id": "patients", "target_id": "clinical studies", "strength": 8}, {"source_id": "antibody titers", "target_id": "disease severity", "strength": 8}, {"source_id": "patients", "target_id": "multivariable logistic regression", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "respiratory symptoms", "strength": 8}, {"source_id": "respiratory symptoms", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "severe COVID-19", "target_id": "mechanical ventilation", "strength": 8}, {"source_id": "higher odds", "target_id": "patients", "strength": 8}, {"source_id": "vaccination", "target_id": "study period", "strength": 8}, {"source_id": "vaccine doses", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "patients", "target_id": "long COVID", "strength": 8}, {"source_id": "COVID-19 vaccination", "target_id": "disease 2019", "strength": 8}, {"source_id": "vaccination", "target_id": "coronavirus disease 2019", "strength": 8}, {"source_id": "coronavirus 2", "target_id": "antiviral activity", "strength": 8}, {"source_id": "T cells", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "COVID-19", "target_id": "myocardial infarction", "strength": 8}, {"source_id": "teaching", "target_id": "learners", "strength": 8}, {"source_id": "teachers", "target_id": "institutions", "strength": 8}, {"source_id": "COVID-19", "target_id": "University", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "perspective", "strength": 8}, {"source_id": "COVID-19 severity", "target_id": "severe COVID-19", "strength": 8}, {"source_id": "SARS-CoV-2 variants", "target_id": "mRNA vaccines", "strength": 8}, {"source_id": "mRNA vaccines", "target_id": "SARS-CoV-2 variants", "strength": 8}, {"source_id": "immune response", "target_id": "severe disease", "strength": 8}, {"source_id": "hospital admission", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "pregnancy", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "market", "strength": 8}, {"source_id": "quality of life", "target_id": "Secondary outcomes", "strength": 8}, {"source_id": "cohort study", "target_id": "mental health", "strength": 8}, {"source_id": "T cells", "target_id": "clinical trials", "strength": 8}, {"source_id": "systematic review", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "risk factors", "target_id": "diabetes mellitus", "strength": 8}, {"source_id": "severe disease", "target_id": "booster vaccination", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "severe illness", "strength": 8}, {"source_id": "severe illness", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "systematic review", "target_id": "mental health", "strength": 8}, {"source_id": "mental health", "target_id": "systematic review", "strength": 8}, {"source_id": "mean age", "target_id": "high risk", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "intensive care unit", "strength": 8}, {"source_id": "adult patients", "target_id": "care unit", "strength": 8}, {"source_id": "disease severity", "target_id": "mechanical ventilation", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "systematic review", "strength": 8}, {"source_id": "COVID-19", "target_id": "pediatric patients", "strength": 8}, {"source_id": "retrospective study", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "logistic regression models", "target_id": "cohort study", "strength": 8}, {"source_id": "healthcare workers", "target_id": "health care workers", "strength": 8}, {"source_id": "COVID-19", "target_id": "respiratory tract", "strength": 8}, {"source_id": "age groups", "target_id": "vaccination", "strength": 8}, {"source_id": "students", "target_id": "perception", "strength": 8}, {"source_id": "perception", "target_id": "students", "strength": 8}, {"source_id": "COVID-19 vaccine", "target_id": "severe COVID-19", "strength": 8}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "spike protein", "strength": 8}, {"source_id": "COVID-19", "target_id": "clinical practice", "strength": 8}, {"source_id": "vaccine", "target_id": "breakthrough infections", "strength": 8}, {"source_id": "prospective cohort study", "target_id": "primary outcome", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "higher odds", "strength": 8}, {"source_id": "COVID-19 vaccine", "target_id": "age groups", "strength": 8}, {"source_id": "cross-sectional study", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "COVID-19", "target_id": "Meta-Analysis", "strength": 8}, {"source_id": "epithelial cells", "target_id": "infection", "strength": 8}, {"source_id": "genes", "target_id": "gene expression", "strength": 8}, {"source_id": "cell responses", "target_id": "mRNA vaccines", "strength": 8}, {"source_id": "children", "target_id": "education", "strength": 8}, {"source_id": "species", "target_id": "conservation", "strength": 8}, {"source_id": "coronavirus 2", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "cross-sectional study", "target_id": "MAIN OUTCOME", "strength": 8}, {"source_id": "cell responses", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "care unit", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "BNT162b2 vaccine", "target_id": "mRNA vaccines", "strength": 8}, {"source_id": "infection", "target_id": "median age", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "clinical outcomes", "strength": 8}, {"source_id": "clinical outcomes", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "mean age", "target_id": "primary outcome", "strength": 8}, {"source_id": "infection", "target_id": "adverse events", "strength": 8}, {"source_id": "infection", "target_id": "clinical outcomes", "strength": 8}, {"source_id": "health outcomes", "target_id": "COVID-19", "strength": 8}, {"source_id": "disease severity", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 8}, {"source_id": "disease burden", "target_id": "patients", "strength": 8}, {"source_id": "learning", "target_id": "motivation", "strength": 8}, {"source_id": "skills", "target_id": "course", "strength": 8}, {"source_id": "institutions", "target_id": "policy", "strength": 8}, {"source_id": "policy", "target_id": "market", "strength": 8}, {"source_id": "book", "target_id": "University", "strength": 8}, {"source_id": "Secondary outcomes", "target_id": "intensive care unit", "strength": 8}, {"source_id": "care unit", "target_id": "Secondary outcomes", "strength": 8}, {"source_id": "T cell responses", "target_id": "antibody titers", "strength": 8}, {"source_id": "vaccination", "target_id": "cell responses", "strength": 8}, {"source_id": "retrospective cohort study", "target_id": "logistic regression", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "age groups", "strength": 8}, {"source_id": "cohort study", "target_id": "logistic regression analysis", "strength": 8}, {"source_id": "logistic regression analysis", "target_id": "cohort study", "strength": 8}, {"source_id": "symptoms", "target_id": "syndrome", "strength": 8}, {"source_id": "severe disease", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "severe disease", "strength": 8}, {"source_id": "coronavirus disease 2019", "target_id": "vaccination", "strength": 8}, {"source_id": "viral load", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 virus", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "respiratory tract", "strength": 8}, {"source_id": "respiratory tract", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "institutions", "target_id": "teachers", "strength": 8}, {"source_id": "course", "target_id": "engagement", "strength": 8}, {"source_id": "policy", "target_id": "practice", "strength": 8}, {"source_id": "care unit", "target_id": "infection", "strength": 8}, {"source_id": "patients", "target_id": "clinical manifestations", "strength": 8}, {"source_id": "COVID-19 vaccine", "target_id": "antibody levels", "strength": 8}, {"source_id": "severe disease", "target_id": "immune response", "strength": 8}, {"source_id": "vaccination campaign", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "pregnancy", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "primary care", "strength": 8}, {"source_id": "high-income countries", "target_id": "systematic review", "strength": 8}, {"source_id": "systematic review", "target_id": "cohort study", "strength": 8}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "patients", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "cytokine storm", "strength": 8}, {"source_id": "antibody response", "target_id": "healthy controls", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "systematic review", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "mortality rate", "strength": 8}, {"source_id": "health system", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "COVID-19 pandemic", "target_id": "health system", "strength": 8}, {"source_id": "Secondary outcomes", "target_id": "physical activity", "strength": 8}, {"source_id": "children", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "cohort study", "target_id": "dose", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "cytokine storm", "strength": 8}, {"source_id": "care unit", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "outcome measures", "target_id": "clinical trials", "strength": 8}, {"source_id": "patients", "target_id": "protective effect", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "booster dose", "strength": 8}, {"source_id": "program", "target_id": "schools", "strength": 8}, {"source_id": "infection", "target_id": "general population", "strength": 8}, {"source_id": "third dose", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "logistic regression models", "strength": 8}, {"source_id": "logistic regression models", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "COVID-19", "target_id": "mRNA vaccines", "strength": 8}, {"source_id": "severe COVID-19", "target_id": "COVID-19 vaccine", "strength": 8}, {"source_id": "spike protein", "target_id": "SARS-CoV-2 vaccines", "strength": 8}, {"source_id": "control group", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "patients", "target_id": "prevalence", "strength": 8}, {"source_id": "education", "target_id": "thematic analysis", "strength": 8}, {"source_id": "intensive care unit", "target_id": "ill patients", "strength": 8}, {"source_id": "Meta-Analysis", "target_id": "COVID-19", "strength": 8}, {"source_id": "clinical trials", "target_id": "clinical practice", "strength": 8}, {"source_id": "third dose", "target_id": "Omicron variant", "strength": 8}, {"source_id": "gene expression", "target_id": "genes", "strength": 8}, {"source_id": "cohort study", "target_id": "cause mortality", "strength": 8}, {"source_id": "mortality", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "patients", "target_id": "inflammatory response", "strength": 8}, {"source_id": "dose", "target_id": "antibody levels", "strength": 8}, {"source_id": "severe COVID-19", "target_id": "clinical trials", "strength": 8}, {"source_id": "spike protein", "target_id": "mRNA vaccines", "strength": 8}, {"source_id": "transplant recipients", "target_id": "antibody response", "strength": 8}, {"source_id": "COVID-19 vaccine", "target_id": "transplant recipients", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "ICU admission", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "mean age", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "lower risk", "strength": 8}, {"source_id": "adverse events", "target_id": "infection", "strength": 8}, {"source_id": "median age", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "monoclonal antibodies", "strength": 8}, {"source_id": "monoclonal antibodies", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "COVID-19", "target_id": "Web of Science", "strength": 8}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "disease severity", "strength": 8}, {"source_id": "syndrome coronavirus 2", "target_id": "coronavirus disease", "strength": 8}, {"source_id": "disease severity", "target_id": "respiratory syndrome coronavirus 2", "strength": 8}, {"source_id": "coronavirus disease", "target_id": "respiratory syndrome coronavirus 2", "strength": 8}, {"source_id": "antibody response", "target_id": "coronavirus disease 2019", "strength": 8}, {"source_id": "antibody response", "target_id": "disease 2019", "strength": 8}, {"source_id": "mice", "target_id": "mouse model", "strength": 8}, {"source_id": "people", "target_id": "pandemic", "strength": 8}, {"source_id": "immune response", "target_id": "flow cytometry", "strength": 8}, {"source_id": "intensive care unit", "target_id": "Secondary outcomes", "strength": 8}, {"source_id": "patients", "target_id": "injury", "strength": 8}, {"source_id": "disease severity", "target_id": "antibody response", "strength": 8}, {"source_id": "antibody response", "target_id": "disease severity", "strength": 8}, {"source_id": "disease severity", "target_id": "SARS-CoV-2 variants", "strength": 8}, {"source_id": "coronavirus disease 2019", "target_id": "mechanical ventilation", "strength": 8}, {"source_id": "mechanical ventilation", "target_id": "severe COVID-19", "strength": 8}, {"source_id": "COVID-19", "target_id": "adverse outcomes", "strength": 8}, {"source_id": "risk factors", "target_id": "logistic regression models", "strength": 8}, {"source_id": "cohort study", "target_id": "body mass index", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "infection rate", "strength": 8}, {"source_id": "study period", "target_id": "vaccination", "strength": 8}, {"source_id": "syndrome", "target_id": "symptoms", "strength": 8}, {"source_id": "COVID-19 vaccination", "target_id": "coronavirus disease 2019", "strength": 8}, {"source_id": "disease 2019", "target_id": "vaccination", "strength": 8}, {"source_id": "SARS-CoV-2 replication", "target_id": "coronavirus 2", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "viral load", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "SARS-CoV-2 virus", "strength": 8}, {"source_id": "book", "target_id": "politics", "strength": 8}, {"source_id": "politics", "target_id": "book", "strength": 8}, {"source_id": "experience", "target_id": "teachers", "strength": 8}, {"source_id": "severe COVID-19", "target_id": "COVID-19 severity", "strength": 8}, {"source_id": "ICU admission", "target_id": "mortality", "strength": 8}, {"source_id": "infection", "target_id": "adult patients", "strength": 8}, {"source_id": "B cells", "target_id": "patients", "strength": 8}, {"source_id": "spike protein", "target_id": "variants of concern", "strength": 8}, {"source_id": "market", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "crisis", "target_id": "economy", "strength": 8}, {"source_id": "crisis", "target_id": "politics", "strength": 8}, {"source_id": "COVID-19", "target_id": "vaccination rates", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "coronavirus disease", "strength": 8}, {"source_id": "high risk", "target_id": "mortality rate", "strength": 8}, {"source_id": "mechanical ventilation", "target_id": "mortality rate", "strength": 8}, {"source_id": "diabetes mellitus", "target_id": "risk factors", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "mortality rate", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 vaccination", "strength": 8}, {"source_id": "study population", "target_id": "patients", "strength": 8}, {"source_id": "primary outcome", "target_id": "physical activity", "strength": 8}, {"source_id": "technology", "target_id": "artificial intelligence", "strength": 8}, {"source_id": "policy", "target_id": "justice", "strength": 8}, {"source_id": "second dose", "target_id": "cohort study", "strength": 8}, {"source_id": "nervous system", "target_id": "patients", "strength": 8}, {"source_id": "illness", "target_id": "COVID-19", "strength": 8}, {"source_id": "high risk", "target_id": "mean age", "strength": 8}, {"source_id": "semi-structured interviews", "target_id": "qualitative study", "strength": 8}, {"source_id": "systematic review", "target_id": "COVID-19 infection", "strength": 8}, {"source_id": "high risk", "target_id": "primary outcome", "strength": 8}, {"source_id": "care workers", "target_id": "healthcare workers", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "Omicron infection", "strength": 8}, {"source_id": "Omicron infection", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "age groups", "target_id": "SARS-CoV-2 infection", "strength": 8}, {"source_id": "schools", "target_id": "program", "strength": 8}, {"source_id": "respiratory tract", "target_id": "COVID-19", "strength": 8}, {"source_id": "vaccination", "target_id": "age groups", "strength": 8}, {"source_id": "COVID-19 severity", "target_id": "disease severity", "strength": 8}, {"source_id": "blood samples", "target_id": "COVID-19", "strength": 8}, {"source_id": "patients", "target_id": "spike protein", "strength": 8}, {"source_id": "spike protein", "target_id": "patients", "strength": 8}, {"source_id": "multiple sclerosis", "target_id": "patients", "strength": 8}, {"source_id": "patients", "target_id": "multiple sclerosis", "strength": 8}, {"source_id": "thematic analysis", "target_id": "education", "strength": 8}, {"source_id": "ill patients", "target_id": "intensive care unit", "strength": 8}, {"source_id": "blood pressure", "target_id": "patients", "strength": 8}, {"source_id": "SARS-CoV-2 variants", "target_id": "booster vaccination", "strength": 8}, {"source_id": "education", "target_id": "children", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "coronavirus 2", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "cell responses", "strength": 8}, {"source_id": "COVID-19", "target_id": "high incidence", "strength": 8}, {"source_id": "hospital admission", "target_id": "high risk", "strength": 8}, {"source_id": "dose", "target_id": "patients", "strength": 8}, {"source_id": "intensive care unit", "target_id": "hospital mortality", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "intensive care unit", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "observational study", "strength": 8}, {"source_id": "mRNA vaccines", "target_id": "humoral response", "strength": 8}, {"source_id": "humoral response", "target_id": "mRNA vaccines", "strength": 8}, {"source_id": "healthcare workers", "target_id": "antibody response", "strength": 8}, {"source_id": "COVID-19", "target_id": "patient outcomes", "strength": 8}, {"source_id": "median age", "target_id": "infection", "strength": 8}, {"source_id": "mRNA vaccines", "target_id": "spike protein", "strength": 8}, {"source_id": "ICU admission", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "intensive care unit admission", "target_id": "ICU admission", "strength": 8}, {"source_id": "hospitalization", "target_id": "vaccination", "strength": 8}, {"source_id": "primary care", "target_id": "care", "strength": 8}, {"source_id": "systematic review", "target_id": "case report", "strength": 8}, {"source_id": "COVID-19 diagnosis", "target_id": "patients", "strength": 8}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "coronavirus disease", "strength": 8}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "coronavirus disease", "strength": 8}, {"source_id": "vaccine", "target_id": "healthy controls", "strength": 8}, {"source_id": "coronavirus disease 2019", "target_id": "antibody response", "strength": 8}, {"source_id": "disease 2019", "target_id": "antibody response", "strength": 8}, {"source_id": "educators", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "mental health", "target_id": "health status", "strength": 8}, {"source_id": "cross-sectional study", "target_id": "logistic regression analysis", "strength": 8}, {"source_id": "logistic regression analysis", "target_id": "cross-sectional study", "strength": 8}, {"source_id": "health status", "target_id": "mental health", "strength": 8}, {"source_id": "skills", "target_id": "pandemic", "strength": 8}, {"source_id": "cohort study", "target_id": "clinical characteristics", "strength": 8}, {"source_id": "ecosystems", "target_id": "conservation", "strength": 8}, {"source_id": "University", "target_id": "book", "strength": 8}, {"source_id": "policy", "target_id": "book", "strength": 8}, {"source_id": "medical students", "target_id": "skills", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "antibody titers", "strength": 8}, {"source_id": "disease severity", "target_id": "antibody titers", "strength": 8}, {"source_id": "cell responses", "target_id": "vaccination", "strength": 8}, {"source_id": "multivariable logistic regression", "target_id": "patients", "strength": 8}, {"source_id": "disease 2019", "target_id": "mechanical ventilation", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "logistic regression", "strength": 8}, {"source_id": "patients", "target_id": "higher odds", "strength": 8}, {"source_id": "adverse outcomes", "target_id": "COVID-19", "strength": 8}, {"source_id": "logistic regression models", "target_id": "risk factors", "strength": 8}, {"source_id": "body mass index", "target_id": "cohort study", "strength": 8}, {"source_id": "infection", "target_id": "blood samples", "strength": 8}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 vaccination", "strength": 8}, {"source_id": "COVID-19 vaccine", "target_id": "severe disease", "strength": 8}, {"source_id": "prospective cohort study", "target_id": "COVID-19", "strength": 8}, {"source_id": "respiratory tract", "target_id": "immune response", "strength": 8}, {"source_id": "infection", "target_id": "respiratory tract", "strength": 8}, {"source_id": "flow cytometry", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "mice", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "learners", "target_id": "teaching", "strength": 8}, {"source_id": "disease 2019 pandemic", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "mortality", "target_id": "ICU admission", "strength": 8}, {"source_id": "infection", "target_id": "care unit", "strength": 8}, {"source_id": "antibody levels", "target_id": "COVID-19 vaccine", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "vaccination campaign", "strength": 8}, {"source_id": "variants of concern", "target_id": "spike protein", "strength": 8}, {"source_id": "Secondary outcomes", "target_id": "quality of life", "strength": 8}, {"source_id": "politics", "target_id": "crisis", "strength": 8}, {"source_id": "high-income countries", "target_id": "middle-income countries", "strength": 8}, {"source_id": "cohort study", "target_id": "systematic review", "strength": 8}, {"source_id": "intensive care", "target_id": "COVID-19", "strength": 8}, {"source_id": "cytokine storm", "target_id": "COVID-19 patients", "strength": 8}, {"source_id": "vaccine", "target_id": "high risk", "strength": 8}, {"source_id": "SARS-CoV-2", "target_id": "women", "strength": 8}, {"source_id": "women", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "article", "target_id": "policy", "strength": 8}, {"source_id": "COVID-19", "target_id": "odds ratio", "strength": 8}, {"source_id": "odds ratio", "target_id": "risk factors", "strength": 8}, {"source_id": "vaccine", "target_id": "case-control study", "strength": 8}, {"source_id": "cytokine storm", "target_id": "SARS-CoV-2", "strength": 8}, {"source_id": "people", "target_id": "COVID-19", "strength": 8}, {"source_id": "COVID-19", "target_id": "people", "strength": 8}, {"source_id": "qualitative study", "target_id": "semi-structured interviews", "strength": 8}, {"source_id": "intensive care unit", "target_id": "adult patients", "strength": 8}, {"source_id": "care unit", "target_id": "adult patients", "strength": 8}, {"source_id": "clinical trials", "target_id": "outcome measures", "strength": 8}, {"source_id": "COVID-19 patients", "target_id": "retrospective study", "strength": 8}, {"source_id": "cohort study", "target_id": "logistic regression models", "strength": 8}, {"source_id": "care unit", "target_id": "cohort study", "strength": 8}, {"source_id": "health care workers", "target_id": "healthcare workers", "strength": 8}, {"source_id": "vaccine uptake", "target_id": "COVID-19 vaccination", "strength": 8}, {"source_id": "SARS-CoV-2 infection", "target_id": "age groups", "strength": 8}, {"source_id": "respiratory failure", "target_id": "primary outcome", "strength": 8}, {"source_id": "primary outcome", "target_id": "respiratory failure", "strength": 8}, {"source_id": "COVID-19", "target_id": "D-dimer", "strength": 8}, {"source_id": "mRNA vaccines", "target_id": "COVID-19", "strength": 8}, {"source_id": "Omicron variant", "target_id": "COVID-19", "strength": 8}, {"source_id": "COVID-19", "target_id": "countries", "strength": 8}, {"source_id": "breakthrough infections", "target_id": "vaccine", "strength": 8}, {"source_id": "COVID-19 infection", "target_id": "control group", "strength": 8}, {"source_id": "semi-structured interviews", "target_id": "education", "strength": 8}, {"source_id": "prevalence", "target_id": "patients", "strength": 8}, {"source_id": "higher odds", "target_id": "COVID-19 pandemic", "strength": 8}, {"source_id": "age groups", "target_id": "COVID-19 vaccine", "strength": 8}, {"source_id": "Omicron variant", "target_id": "vaccination status", "strength": 8}, {"source_id": "vaccination status", "target_id": "Omicron variant", "strength": 8}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "vaccine", "strength": 8}, {"source_id": "vaccine", "target_id": "SARS-CoV-2 vaccination", "strength": 8}, {"source_id": "infection", "target_id": "epithelial cells", "strength": 8}, {"source_id": "clinical practice", "target_id": "clinical trials", "strength": 8}, {"source_id": "COVID-19 vaccination", "target_id": "vaccine hesitancy", "strength": 8}, {"source_id": "vaccine hesitancy", "target_id": "COVID-19 vaccination", "strength": 8}, {"source_id": "mRNA vaccines", "target_id": "transplant recipients", "strength": 8}, {"source_id": "Omicron variant", "target_id": "third dose", "strength": 8}, {"source_id": "mRNA vaccines", "target_id": "cell responses", "strength": 8}, {"source_id": "infectious diseases", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "viral replication", "target_id": "infection", "strength": 9}, {"source_id": "severe disease", "target_id": "high risk", "strength": 9}, {"source_id": "high risk", "target_id": "severe disease", "strength": 9}, {"source_id": "intensive care unit", "target_id": "respiratory failure", "strength": 9}, {"source_id": "symptom onset", "target_id": "patients", "strength": 9}, {"source_id": "COVID-19", "target_id": "emergency department", "strength": 9}, {"source_id": "MAIN OUTCOME", "target_id": "adverse events", "strength": 9}, {"source_id": "infection", "target_id": "ICU admission", "strength": 9}, {"source_id": "COVID-19 symptoms", "target_id": "COVID-19 infection", "strength": 9}, {"source_id": "mRNA vaccines", "target_id": "booster vaccination", "strength": 9}, {"source_id": "B cells", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "adverse events", "target_id": "cohort study", "strength": 9}, {"source_id": "experience", "target_id": "University", "strength": 9}, {"source_id": "University", "target_id": "experience", "strength": 9}, {"source_id": "patients", "target_id": "age groups", "strength": 9}, {"source_id": "COVID-19", "target_id": "years of age", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "years of age", "strength": 9}, {"source_id": "years of age", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "antibody response", "target_id": "antibody titers", "strength": 9}, {"source_id": "infection", "target_id": "monoclonal antibodies", "strength": 9}, {"source_id": "healthcare workers", "target_id": "vaccination", "strength": 9}, {"source_id": "symptoms", "target_id": "disease 2019", "strength": 9}, {"source_id": "age groups", "target_id": "cohort study", "strength": 9}, {"source_id": "patients", "target_id": "incidence", "strength": 9}, {"source_id": "viral infection", "target_id": "coronavirus disease 2019", "strength": 9}, {"source_id": "COVID-19 outcomes", "target_id": "COVID-19 vaccine", "strength": 9}, {"source_id": "COVID-19 vaccine", "target_id": "COVID-19 outcomes", "strength": 9}, {"source_id": "vaccine doses", "target_id": "cohort study", "strength": 9}, {"source_id": "persistent symptoms", "target_id": "patients", "strength": 9}, {"source_id": "care", "target_id": "COVID-19", "strength": 9}, {"source_id": "healthy controls", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "mouse model", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "mouse model", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "animal models", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "University", "strength": 9}, {"source_id": "University", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "viral replication", "strength": 9}, {"source_id": "severe COVID-19", "target_id": "severe disease", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "Health Organization", "strength": 9}, {"source_id": "immune response", "target_id": "inflammatory response", "strength": 9}, {"source_id": "cohort study", "target_id": "hospitalization", "strength": 9}, {"source_id": "older adults", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "COVID-19", "target_id": "therapeutic target", "strength": 9}, {"source_id": "ill patients", "target_id": "mechanical ventilation", "strength": 9}, {"source_id": "mortality", "target_id": "adult patients", "strength": 9}, {"source_id": "mRNA vaccination", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "second dose", "target_id": "vaccine effectiveness", "strength": 9}, {"source_id": "COVID-19", "target_id": "Medical Center", "strength": 9}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "Delta variant", "strength": 9}, {"source_id": "immune system", "target_id": "infection", "strength": 9}, {"source_id": "infection", "target_id": "immune system", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "organization", "strength": 9}, {"source_id": "primary outcome", "target_id": "mechanical ventilation", "strength": 9}, {"source_id": "mechanical ventilation", "target_id": "primary outcome", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "care", "strength": 9}, {"source_id": "COVID-19 vaccine", "target_id": "vaccine dose", "strength": 9}, {"source_id": "hazard ratio", "target_id": "cohort study", "strength": 9}, {"source_id": "syndrome coronavirus 2", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "Secondary outcomes", "target_id": "outcome measures", "strength": 9}, {"source_id": "T cells", "target_id": "B cells", "strength": 9}, {"source_id": "T cells", "target_id": "Delta variant", "strength": 9}, {"source_id": "Delta variant", "target_id": "T cells", "strength": 9}, {"source_id": "COVID-19", "target_id": "spike protein", "strength": 9}, {"source_id": "cell responses", "target_id": "vaccine", "strength": 9}, {"source_id": "T cells", "target_id": "antibody response", "strength": 9}, {"source_id": "spike protein", "target_id": "cell responses", "strength": 9}, {"source_id": "SARS-CoV2", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "patients", "target_id": "SARS-CoV2", "strength": 9}, {"source_id": "respiratory failure", "target_id": "coronavirus disease 2019", "strength": 9}, {"source_id": "respiratory failure", "target_id": "disease 2019", "strength": 9}, {"source_id": "emergency department", "target_id": "COVID-19", "strength": 9}, {"source_id": "COVID-19 vaccine", "target_id": "COVID-19 mRNA vaccines", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "MAIN OUTCOME", "strength": 9}, {"source_id": "coronavirus disease 2019", "target_id": "disease", "strength": 9}, {"source_id": "disease 2019", "target_id": "severe COVID-19", "strength": 9}, {"source_id": "disease 2019", "target_id": "disease", "strength": 9}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 symptoms", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "booster vaccination", "strength": 9}, {"source_id": "coronavirus disease", "target_id": "coronavirus 2", "strength": 9}, {"source_id": "COVID-19 patients", "target_id": "complications", "strength": 9}, {"source_id": "respiratory disease", "target_id": "disease", "strength": 9}, {"source_id": "observational study", "target_id": "vaccine", "strength": 9}, {"source_id": "experience", "target_id": "institutions", "strength": 9}, {"source_id": "institutions", "target_id": "experience", "strength": 9}, {"source_id": "nervous system", "target_id": "disease", "strength": 9}, {"source_id": "patients", "target_id": "monoclonal antibodies", "strength": 9}, {"source_id": "institutions", "target_id": "pandemic", "strength": 9}, {"source_id": "United States", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "humoral response", "target_id": "humoral immune response", "strength": 9}, {"source_id": "antibody titers", "target_id": "T cells", "strength": 9}, {"source_id": "T cells", "target_id": "antibody titers", "strength": 9}, {"source_id": "infection", "target_id": "respiratory symptoms", "strength": 9}, {"source_id": "primary outcome", "target_id": "serious adverse events", "strength": 9}, {"source_id": "cohort study", "target_id": "age groups", "strength": 9}, {"source_id": "vaccine effectiveness", "target_id": "vaccine doses", "strength": 9}, {"source_id": "vaccine effectiveness", "target_id": "COVID-19", "strength": 9}, {"source_id": "cohort study", "target_id": "vaccine doses", "strength": 9}, {"source_id": "immune response", "target_id": "Delta variant", "strength": 9}, {"source_id": "severe COVID-19", "target_id": "high risk", "strength": 9}, {"source_id": "coronavirus disease 2019", "target_id": "risk factors", "strength": 9}, {"source_id": "disease 2019", "target_id": "risk factors", "strength": 9}, {"source_id": "high risk", "target_id": "COVID-19 vaccination", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "healthy controls", "strength": 9}, {"source_id": "patients", "target_id": "care services", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "infection", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "curriculum", "target_id": "teaching", "strength": 9}, {"source_id": "higher education", "target_id": "COVID-19", "strength": 9}, {"source_id": "perspective", "target_id": "students", "strength": 9}, {"source_id": "engagement", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "training", "target_id": "teachers", "strength": 9}, {"source_id": "COVID-19", "target_id": "interviews", "strength": 9}, {"source_id": "hospitalization", "target_id": "cohort study", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "COVID-19 vaccination", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "IL-6", "strength": 9}, {"source_id": "therapeutic target", "target_id": "COVID-19", "strength": 9}, {"source_id": "COVID-19 patients", "target_id": "severe disease", "strength": 9}, {"source_id": "patients", "target_id": "cytokine storm", "strength": 9}, {"source_id": "mortality rate", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "vaccine effectiveness", "target_id": "second dose", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "mRNA vaccination", "strength": 9}, {"source_id": "interviews", "target_id": "experience", "strength": 9}, {"source_id": "experience", "target_id": "interviews", "strength": 9}, {"source_id": "COVID-19", "target_id": "complications", "strength": 9}, {"source_id": "severe disease", "target_id": "disease", "strength": 9}, {"source_id": "disease", "target_id": "severe disease", "strength": 9}, {"source_id": "diabetes mellitus", "target_id": "COVID-19", "strength": 9}, {"source_id": "odds ratio", "target_id": "logistic regression", "strength": 9}, {"source_id": "women", "target_id": "cohort study", "strength": 9}, {"source_id": "care", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "intervention group", "target_id": "patients", "strength": 9}, {"source_id": "patients", "target_id": "intervention group", "strength": 9}, {"source_id": "clinical outcomes", "target_id": "high risk", "strength": 9}, {"source_id": "vaccine dose", "target_id": "cohort study", "strength": 9}, {"source_id": "infection", "target_id": "dose", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "coronavirus 2", "strength": 9}, {"source_id": "COVID-19 vaccine", "target_id": "antibody titers", "strength": 9}, {"source_id": "cohort study", "target_id": "control group", "strength": 9}, {"source_id": "control group", "target_id": "cohort study", "strength": 9}, {"source_id": "COVID-19", "target_id": "study population", "strength": 9}, {"source_id": "COVID-19", "target_id": "public health measures", "strength": 9}, {"source_id": "antibody response", "target_id": "T cells", "strength": 9}, {"source_id": "cell responses", "target_id": "antibody response", "strength": 9}, {"source_id": "cell responses", "target_id": "spike protein", "strength": 9}, {"source_id": "second dose", "target_id": "antibody levels", "strength": 9}, {"source_id": "respiratory failure", "target_id": "intensive care unit", "strength": 9}, {"source_id": "mechanical ventilation", "target_id": "hospital stay", "strength": 9}, {"source_id": "antibody levels", "target_id": "healthcare workers", "strength": 9}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "vaccination", "strength": 9}, {"source_id": "COVID-19", "target_id": "MAIN OUTCOME", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "inflammatory syndrome", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "inflammatory syndrome", "strength": 9}, {"source_id": "mRNA vaccines", "target_id": "vaccine doses", "strength": 9}, {"source_id": "inflammatory syndrome", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "vaccine doses", "target_id": "mRNA vaccines", "strength": 9}, {"source_id": "transplant recipients", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "unit admission", "target_id": "admission", "strength": 9}, {"source_id": "admission", "target_id": "unit admission", "strength": 9}, {"source_id": "severe COVID-19", "target_id": "coronavirus disease 2019", "strength": 9}, {"source_id": "schools", "target_id": "COVID-19", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "B cells", "strength": 9}, {"source_id": "COVID-19 vaccination", "target_id": "vaccine dose", "strength": 9}, {"source_id": "ICU admission", "target_id": "mechanical ventilation", "strength": 9}, {"source_id": "experience", "target_id": "teaching", "strength": 9}, {"source_id": "policy", "target_id": "interviews", "strength": 9}, {"source_id": "government", "target_id": "crisis", "strength": 9}, {"source_id": "education", "target_id": "training", "strength": 9}, {"source_id": "training", "target_id": "education", "strength": 9}, {"source_id": "infection", "target_id": "Secondary outcomes", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "patients", "strength": 9}, {"source_id": "antibody titers", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "humoral immune response", "target_id": "humoral response", "strength": 9}, {"source_id": "coronavirus disease 2019", "target_id": "symptoms", "strength": 9}, {"source_id": "disease 2019", "target_id": "symptoms", "strength": 9}, {"source_id": "COVID-19", "target_id": "vaccine effectiveness", "strength": 9}, {"source_id": "hospital admission", "target_id": "mortality", "strength": 9}, {"source_id": "mortality", "target_id": "hospital admission", "strength": 9}, {"source_id": "high risk", "target_id": "severe COVID-19", "strength": 9}, {"source_id": "risk factors", "target_id": "coronavirus disease 2019", "strength": 9}, {"source_id": "COVID-19 infection", "target_id": "cross-sectional study", "strength": 9}, {"source_id": "vaccination", "target_id": "high risk", "strength": 9}, {"source_id": "vaccine uptake", "target_id": "vaccine", "strength": 9}, {"source_id": "animal models", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "spike protein", "target_id": "COVID-19 patients", "strength": 9}, {"source_id": "higher education", "target_id": "teaching", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "engagement", "strength": 9}, {"source_id": "teachers", "target_id": "training", "strength": 9}, {"source_id": "control group", "target_id": "Secondary outcomes", "strength": 9}, {"source_id": "viral replication", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "booster doses", "strength": 9}, {"source_id": "COVID-19 vaccination", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "IL-6", "target_id": "COVID-19 patients", "strength": 9}, {"source_id": "IL-6", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "older adults", "strength": 9}, {"source_id": "severe disease", "target_id": "COVID-19 patients", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "public health measures", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "mortality rate", "strength": 9}, {"source_id": "age groups", "target_id": "young adults", "strength": 9}, {"source_id": "mental health", "target_id": "physical activity", "strength": 9}, {"source_id": "young adults", "target_id": "age groups", "strength": 9}, {"source_id": "severe COVID-19", "target_id": "COVID-19 infection", "strength": 9}, {"source_id": "mRNA vaccines", "target_id": "antibody titers", "strength": 9}, {"source_id": "cohort study", "target_id": "severe disease", "strength": 9}, {"source_id": "COVID-19", "target_id": "diabetes mellitus", "strength": 9}, {"source_id": "COVID-19", "target_id": "women", "strength": 9}, {"source_id": "cohort study", "target_id": "women", "strength": 9}, {"source_id": "logistic regression", "target_id": "odds ratio", "strength": 9}, {"source_id": "COVID-19 patients", "target_id": "blood samples", "strength": 9}, {"source_id": "patients", "target_id": "ischemic stroke", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "respiratory syndrome coronavirus 2", "strength": 9}, {"source_id": "Omicron variant", "target_id": "patients", "strength": 9}, {"source_id": "study protocol", "target_id": "patients", "strength": 9}, {"source_id": "patients", "target_id": "study protocol", "strength": 9}, {"source_id": "vaccine", "target_id": "cell responses", "strength": 9}, {"source_id": "infection", "target_id": "COVID-19 cases", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "infectious diseases", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV2", "strength": 9}, {"source_id": "infection", "target_id": "viral replication", "strength": 9}, {"source_id": "SARS-CoV2", "target_id": "patients", "strength": 9}, {"source_id": "hospital stay", "target_id": "mechanical ventilation", "strength": 9}, {"source_id": "healthcare workers", "target_id": "antibody levels", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 vaccines", "strength": 9}, {"source_id": "MAIN OUTCOME", "target_id": "COVID-19", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "case-control study", "strength": 9}, {"source_id": "care unit admission", "target_id": "admission", "strength": 9}, {"source_id": "case-control study", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "transplant recipients", "strength": 9}, {"source_id": "clinical outcomes", "target_id": "primary outcome", "strength": 9}, {"source_id": "disease", "target_id": "disease 2019", "strength": 9}, {"source_id": "policy", "target_id": "education", "strength": 9}, {"source_id": "education", "target_id": "policy", "strength": 9}, {"source_id": "vaccine", "target_id": "safety profile", "strength": 9}, {"source_id": "adverse events", "target_id": "therapy", "strength": 9}, {"source_id": "patients", "target_id": "odds ratio", "strength": 9}, {"source_id": "vaccine dose", "target_id": "COVID-19 vaccination", "strength": 9}, {"source_id": "disease", "target_id": "respiratory disease", "strength": 9}, {"source_id": "disease", "target_id": "nervous system", "strength": 9}, {"source_id": "infection", "target_id": "antibody titers", "strength": 9}, {"source_id": "interviews", "target_id": "policy", "strength": 9}, {"source_id": "crisis", "target_id": "government", "strength": 9}, {"source_id": "thematic analysis", "target_id": "students", "strength": 9}, {"source_id": "age groups", "target_id": "patients", "strength": 9}, {"source_id": "severe COVID-19", "target_id": "clinical outcomes", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "years of age", "strength": 9}, {"source_id": "COVID-19 symptoms", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 symptoms", "strength": 9}, {"source_id": "respiratory symptoms", "target_id": "infection", "strength": 9}, {"source_id": "patients", "target_id": "disease control", "strength": 9}, {"source_id": "disease control", "target_id": "patients", "strength": 9}, {"source_id": "vaccine doses", "target_id": "vaccine effectiveness", "strength": 9}, {"source_id": "viral infection", "target_id": "disease 2019", "strength": 9}, {"source_id": "risk factors", "target_id": "disease 2019", "strength": 9}, {"source_id": "COVID-19", "target_id": "care", "strength": 9}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "infection", "strength": 9}, {"source_id": "teachers", "target_id": "course", "strength": 9}, {"source_id": "infection", "target_id": "inflammatory response", "strength": 9}, {"source_id": "inflammatory response", "target_id": "immune response", "strength": 9}, {"source_id": "COVID-19", "target_id": "government", "strength": 9}, {"source_id": "interviews", "target_id": "COVID-19", "strength": 9}, {"source_id": "coronavirus disease", "target_id": "infection", "strength": 9}, {"source_id": "infection", "target_id": "coronavirus disease", "strength": 9}, {"source_id": "respiratory failure", "target_id": "mechanical ventilation", "strength": 9}, {"source_id": "public health measures", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "primary outcome", "target_id": "logistic regression", "strength": 9}, {"source_id": "antibody titers", "target_id": "mRNA vaccines", "strength": 9}, {"source_id": "severe disease", "target_id": "cohort study", "strength": 9}, {"source_id": "women", "target_id": "COVID-19", "strength": 9}, {"source_id": "vaccine dose", "target_id": "COVID-19 vaccine", "strength": 9}, {"source_id": "high risk", "target_id": "clinical outcomes", "strength": 9}, {"source_id": "dose", "target_id": "infection", "strength": 9}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "study population", "target_id": "COVID-19", "strength": 9}, {"source_id": "case-control study", "target_id": "COVID-19", "strength": 9}, {"source_id": "outcome measures", "target_id": "Secondary outcomes", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "cross-sectional survey", "strength": 9}, {"source_id": "care unit", "target_id": "ill patients", "strength": 9}, {"source_id": "vaccination status", "target_id": "infection", "strength": 9}, {"source_id": "infection", "target_id": "vaccination status", "strength": 9}, {"source_id": "Omicron variant", "target_id": "COVID-19 vaccine", "strength": 9}, {"source_id": "COVID-19 cases", "target_id": "infection", "strength": 9}, {"source_id": "receptor-binding domain", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "antibody response", "target_id": "cell responses", "strength": 9}, {"source_id": "antibody levels", "target_id": "second dose", "strength": 9}, {"source_id": "coronavirus disease 2019", "target_id": "respiratory failure", "strength": 9}, {"source_id": "safety profile", "target_id": "patients", "strength": 9}, {"source_id": "patients", "target_id": "safety profile", "strength": 9}, {"source_id": "care unit admission", "target_id": "ICU admission", "strength": 9}, {"source_id": "unit admission", "target_id": "ICU admission", "strength": 9}, {"source_id": "adverse events", "target_id": "MAIN OUTCOME", "strength": 9}, {"source_id": "MAIN OUTCOME", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "severe COVID-19", "target_id": "disease 2019", "strength": 9}, {"source_id": "coronavirus disease 2019", "target_id": "severe COVID-19", "strength": 9}, {"source_id": "disease", "target_id": "coronavirus disease 2019", "strength": 9}, {"source_id": "safety profile", "target_id": "vaccine", "strength": 9}, {"source_id": "COVID-19", "target_id": "kidney disease", "strength": 9}, {"source_id": "mortality rate", "target_id": "systematic review", "strength": 9}, {"source_id": "booster vaccination", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "mechanical ventilation", "target_id": "ICU admission", "strength": 9}, {"source_id": "learning", "target_id": "institutions", "strength": 9}, {"source_id": "pandemic", "target_id": "institutions", "strength": 9}, {"source_id": "COVID-19 pandemic", "target_id": "United States", "strength": 9}, {"source_id": "training", "target_id": "skills", "strength": 9}, {"source_id": "schools", "target_id": "practice", "strength": 9}, {"source_id": "curriculum", "target_id": "teachers", "strength": 9}, {"source_id": "teachers", "target_id": "curriculum", "strength": 9}, {"source_id": "COVID-19 infection", "target_id": "Secondary outcomes", "strength": 9}, {"source_id": "Secondary outcomes", "target_id": "COVID-19 infection", "strength": 9}, {"source_id": "Secondary outcomes", "target_id": "infection", "strength": 9}, {"source_id": "disease", "target_id": "COVID-19 disease", "strength": 9}, {"source_id": "years of age", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "years of age", "target_id": "COVID-19", "strength": 9}, {"source_id": "patients", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "symptoms", "target_id": "coronavirus disease 2019", "strength": 9}, {"source_id": "serious adverse events", "target_id": "primary outcome", "strength": 9}, {"source_id": "COVID-19", "target_id": "higher odds", "strength": 9}, {"source_id": "breakthrough infections", "target_id": "Delta variant", "strength": 9}, {"source_id": "Delta variant", "target_id": "immune response", "strength": 9}, {"source_id": "patients", "target_id": "persistent symptoms", "strength": 9}, {"source_id": "cross-sectional study", "target_id": "COVID-19 infection", "strength": 9}, {"source_id": "SARS-CoV-2 replication", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "care services", "target_id": "patients", "strength": 9}, {"source_id": "COVID-19 patients", "target_id": "spike protein", "strength": 9}, {"source_id": "COVID-19", "target_id": "higher education", "strength": 9}, {"source_id": "Secondary outcomes", "target_id": "control group", "strength": 9}, {"source_id": "severe disease", "target_id": "severe COVID-19", "strength": 9}, {"source_id": "booster doses", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "Health Organization", "target_id": "SARS-CoV-2", "strength": 9}, {"source_id": "government", "target_id": "COVID-19", "strength": 9}, {"source_id": "adult patients", "target_id": "mortality", "strength": 9}, {"source_id": "mechanical ventilation", "target_id": "ill patients", "strength": 9}, {"source_id": "cytokine storm", "target_id": "patients", "strength": 9}, {"source_id": "first dose", "target_id": "vaccination", "strength": 9}, {"source_id": "logistic regression", "target_id": "primary outcome", "strength": 9}, {"source_id": "mortality", "target_id": "observational study", "strength": 9}, {"source_id": "Delta variant", "target_id": "SARS-CoV-2 Omicron variant", "strength": 9}, {"source_id": "complications", "target_id": "COVID-19", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "high prevalence", "strength": 9}, {"source_id": "COVID-19 infection", "target_id": "severe COVID-19", "strength": 9}, {"source_id": "blood samples", "target_id": "COVID-19 patients", "strength": 9}, {"source_id": "cohort study", "target_id": "vaccine dose", "strength": 9}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "syndrome coronavirus 2", "strength": 9}, {"source_id": "coronavirus 2", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "COVID-19 patients", "target_id": "COVID-19 outcomes", "strength": 9}, {"source_id": "antibody titers", "target_id": "COVID-19 vaccine", "strength": 9}, {"source_id": "systematic review", "target_id": "mortality", "strength": 9}, {"source_id": "mortality", "target_id": "systematic review", "strength": 9}, {"source_id": "immune response", "target_id": "vaccine dose", "strength": 9}, {"source_id": "experience", "target_id": "qualitative study", "strength": 9}, {"source_id": "patients", "target_id": "Omicron variant", "strength": 9}, {"source_id": "B cells", "target_id": "T cells", "strength": 9}, {"source_id": "immune response", "target_id": "second dose", "strength": 9}, {"source_id": "ill patients", "target_id": "care unit", "strength": 9}, {"source_id": "COVID-19 vaccine", "target_id": "Omicron variant", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "nasopharyngeal swabs", "strength": 9}, {"source_id": "nasopharyngeal swabs", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "disease 2019", "target_id": "respiratory failure", "strength": 9}, {"source_id": "patients", "target_id": "symptom onset", "strength": 9}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "vaccination", "target_id": "SARS-CoV-2 vaccines", "strength": 9}, {"source_id": "inflammatory syndrome", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "transplant recipients", "strength": 9}, {"source_id": "transplant recipients", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "ICU admission", "target_id": "care unit admission", "strength": 9}, {"source_id": "ICU admission", "target_id": "unit admission", "strength": 9}, {"source_id": "ICU admission", "target_id": "infection", "strength": 9}, {"source_id": "primary outcome", "target_id": "clinical outcomes", "strength": 9}, {"source_id": "admission", "target_id": "care unit admission", "strength": 9}, {"source_id": "COVID-19", "target_id": "schools", "strength": 9}, {"source_id": "booster vaccination", "target_id": "mRNA vaccines", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "control group", "strength": 9}, {"source_id": "control group", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "therapy", "target_id": "adverse events", "strength": 9}, {"source_id": "kidney disease", "target_id": "COVID-19", "strength": 9}, {"source_id": "systematic review", "target_id": "mortality rate", "strength": 9}, {"source_id": "odds ratio", "target_id": "patients", "strength": 9}, {"source_id": "coronavirus 2", "target_id": "coronavirus disease", "strength": 9}, {"source_id": "complications", "target_id": "COVID-19 patients", "strength": 9}, {"source_id": "cohort study", "target_id": "adverse events", "strength": 9}, {"source_id": "vaccine", "target_id": "observational study", "strength": 9}, {"source_id": "institutions", "target_id": "learning", "strength": 9}, {"source_id": "teaching", "target_id": "experience", "strength": 9}, {"source_id": "antibody titers", "target_id": "infection", "strength": 9}, {"source_id": "monoclonal antibodies", "target_id": "patients", "strength": 9}, {"source_id": "students", "target_id": "thematic analysis", "strength": 9}, {"source_id": "skills", "target_id": "training", "strength": 9}, {"source_id": "practice", "target_id": "schools", "strength": 9}, {"source_id": "COVID-19 disease", "target_id": "disease", "strength": 9}, {"source_id": "clinical outcomes", "target_id": "severe COVID-19", "strength": 9}, {"source_id": "antibody titers", "target_id": "antibody response", "strength": 9}, {"source_id": "monoclonal antibodies", "target_id": "infection", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "antibody titers", "strength": 9}, {"source_id": "vaccination", "target_id": "healthcare workers", "strength": 9}, {"source_id": "higher odds", "target_id": "COVID-19", "strength": 9}, {"source_id": "incidence", "target_id": "patients", "strength": 9}, {"source_id": "coronavirus disease 2019", "target_id": "viral infection", "strength": 9}, {"source_id": "disease 2019", "target_id": "viral infection", "strength": 9}, {"source_id": "Delta variant", "target_id": "breakthrough infections", "strength": 9}, {"source_id": "COVID-19 vaccination", "target_id": "high risk", "strength": 9}, {"source_id": "high risk", "target_id": "vaccination", "strength": 9}, {"source_id": "SARS-CoV-2 infection", "target_id": "SARS-CoV-2 replication", "strength": 9}, {"source_id": "vaccine", "target_id": "vaccine uptake", "strength": 9}, {"source_id": "course", "target_id": "teachers", "strength": 9}, {"source_id": "teaching", "target_id": "curriculum", "strength": 9}, {"source_id": "teaching", "target_id": "higher education", "strength": 9}, {"source_id": "students", "target_id": "perspective", "strength": 9}, {"source_id": "inflammatory response", "target_id": "infection", "strength": 9}, {"source_id": "COVID-19 patients", "target_id": "IL-6", "strength": 9}, {"source_id": "mechanical ventilation", "target_id": "respiratory failure", "strength": 9}, {"source_id": "vaccination", "target_id": "first dose", "strength": 9}, {"source_id": "observational study", "target_id": "mortality", "strength": 9}, {"source_id": "Medical Center", "target_id": "COVID-19", "strength": 9}, {"source_id": "physical activity", "target_id": "mental health", "strength": 9}, {"source_id": "organization", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "high prevalence", "target_id": "SARS-CoV-2 infection", "strength": 9}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "SARS-CoV-2 variants", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 9}, {"source_id": "COVID-19 outcomes", "target_id": "COVID-19 patients", "strength": 9}, {"source_id": "vaccine dose", "target_id": "immune response", "strength": 9}, {"source_id": "qualitative study", "target_id": "experience", "strength": 9}, {"source_id": "COVID-19", "target_id": "case-control study", "strength": 9}, {"source_id": "second dose", "target_id": "immune response", "strength": 9}, {"source_id": "cross-sectional survey", "target_id": "COVID-19 pandemic", "strength": 9}, {"source_id": "spike protein", "target_id": "COVID-19", "strength": 9}, {"source_id": "public health measures", "target_id": "COVID-19", "strength": 9}, {"source_id": "SARS-CoV-2 variants", "target_id": "receptor-binding domain", "strength": 9}, {"source_id": "cohort study", "target_id": "Delta variant", "strength": 10}, {"source_id": "COVID-19", "target_id": "inflammatory response", "strength": 10}, {"source_id": "severe cases", "target_id": "COVID-19", "strength": 10}, {"source_id": "therapy", "target_id": "primary outcome", "strength": 10}, {"source_id": "dose", "target_id": "booster dose", "strength": 10}, {"source_id": "respiratory failure", "target_id": "care unit", "strength": 10}, {"source_id": "electronic medical records", "target_id": "patients", "strength": 10}, {"source_id": "patients", "target_id": "electronic medical records", "strength": 10}, {"source_id": "antibody response", "target_id": "humoral response", "strength": 10}, {"source_id": "patients", "target_id": "SARS-CoV-2 vaccines", "strength": 10}, {"source_id": "COVID-19 vaccination", "target_id": "COVID-19 infection", "strength": 10}, {"source_id": "adverse events", "target_id": "SARS-CoV-2 infection", "strength": 10}, {"source_id": "mean age", "target_id": "infection", "strength": 10}, {"source_id": "infection", "target_id": "mean age", "strength": 10}, {"source_id": "inclusion criteria", "target_id": "COVID-19", "strength": 10}, {"source_id": "prospective cohort study", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "Secondary outcomes", "strength": 10}, {"source_id": "safety profile", "target_id": "adverse events", "strength": 10}, {"source_id": "vaccine", "target_id": "MAIN OUTCOME", "strength": 10}, {"source_id": "healthy controls", "target_id": "vaccination", "strength": 10}, {"source_id": "mental health", "target_id": "cross-sectional study", "strength": 10}, {"source_id": "nasopharyngeal swabs", "target_id": "COVID-19", "strength": 10}, {"source_id": "risk factors", "target_id": "vaccination", "strength": 10}, {"source_id": "vaccination", "target_id": "risk factors", "strength": 10}, {"source_id": "COVID-19", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "clinical presentation", "strength": 10}, {"source_id": "clinical presentation", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "patients", "target_id": "clinical presentation", "strength": 10}, {"source_id": "vaccination", "target_id": "vaccine doses", "strength": 10}, {"source_id": "immune response", "target_id": "cohort study", "strength": 10}, {"source_id": "acute infection", "target_id": "patients", "strength": 10}, {"source_id": "patients", "target_id": "syndrome", "strength": 10}, {"source_id": "disease 2019", "target_id": "high risk", "strength": 10}, {"source_id": "COVID-19 pandemic", "target_id": "COVID-19 infection", "strength": 10}, {"source_id": "higher education", "target_id": "learning", "strength": 10}, {"source_id": "clinical trials", "target_id": "control group", "strength": 10}, {"source_id": "vaccine", "target_id": "COVID-19 infection", "strength": 10}, {"source_id": "dose", "target_id": "vaccination", "strength": 10}, {"source_id": "severe disease", "target_id": "SARS-CoV-2 variants", "strength": 10}, {"source_id": "pregnant women", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "risk factors", "target_id": "admission", "strength": 10}, {"source_id": "patients", "target_id": "healthcare professionals", "strength": 10}, {"source_id": "adverse effects", "target_id": "patients", "strength": 10}, {"source_id": "dose", "target_id": "SARS-CoV-2 infection", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "mortality rate", "strength": 10}, {"source_id": "clinical symptoms", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "mRNA vaccines", "target_id": "vaccine dose", "strength": 10}, {"source_id": "patients", "target_id": "treatment strategies", "strength": 10}, {"source_id": "COVID-19 infection", "target_id": "mechanical ventilation", "strength": 10}, {"source_id": "high risk", "target_id": "retrospective cohort study", "strength": 10}, {"source_id": "policy", "target_id": "rights", "strength": 10}, {"source_id": "autoimmune diseases", "target_id": "patients", "strength": 10}, {"source_id": "patients", "target_id": "autoimmune diseases", "strength": 10}, {"source_id": "mRNA vaccination", "target_id": "vaccine", "strength": 10}, {"source_id": "COVID-19", "target_id": "booster dose", "strength": 10}, {"source_id": "retrospective cohort study", "target_id": "risk factors", "strength": 10}, {"source_id": "general population", "target_id": "SARS-CoV-2 infection", "strength": 10}, {"source_id": "cardiovascular disease", "target_id": "risk factors", "strength": 10}, {"source_id": "inflammatory response", "target_id": "COVID-19", "strength": 10}, {"source_id": "primary outcome", "target_id": "therapy", "strength": 10}, {"source_id": "length of stay", "target_id": "patients", "strength": 10}, {"source_id": "humoral response", "target_id": "antibody response", "strength": 10}, {"source_id": "COVID-19 infection", "target_id": "mean age", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "unvaccinated individuals", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "median age", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "prospective cohort study", "strength": 10}, {"source_id": "learning", "target_id": "practice", "strength": 10}, {"source_id": "World Health Organization", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "pandemic", "target_id": "violence", "strength": 10}, {"source_id": "teaching", "target_id": "pandemic", "strength": 10}, {"source_id": "COVID-19 patients", "target_id": "primary outcome", "strength": 10}, {"source_id": "study period", "target_id": "primary outcome", "strength": 10}, {"source_id": "healthcare workers", "target_id": "immune response", "strength": 10}, {"source_id": "immune response", "target_id": "healthcare workers", "strength": 10}, {"source_id": "coronavirus 2 infection", "target_id": "COVID-19", "strength": 10}, {"source_id": "adverse events", "target_id": "second dose", "strength": 10}, {"source_id": "clinical outcomes", "target_id": "mechanical ventilation", "strength": 10}, {"source_id": "hospital mortality", "target_id": "cohort study", "strength": 10}, {"source_id": "retrospective cohort study", "target_id": "COVID-19 patients", "strength": 10}, {"source_id": "retrospective cohort study", "target_id": "mortality", "strength": 10}, {"source_id": "healthcare workers", "target_id": "cohort study", "strength": 10}, {"source_id": "coronavirus disease 2019", "target_id": "high risk", "strength": 10}, {"source_id": "health outcomes", "target_id": "systematic review", "strength": 10}, {"source_id": "mental health", "target_id": "patients", "strength": 10}, {"source_id": "higher education", "target_id": "COVID-19 pandemic", "strength": 10}, {"source_id": "hospital admission", "target_id": "disease severity", "strength": 10}, {"source_id": "T cells", "target_id": "flow cytometry", "strength": 10}, {"source_id": "serious adverse events", "target_id": "patients", "strength": 10}, {"source_id": "health system", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "cross-sectional study", "target_id": "SARS-CoV-2 infection", "strength": 10}, {"source_id": "antibody levels", "target_id": "vaccination", "strength": 10}, {"source_id": "mental health", "target_id": "health problems", "strength": 10}, {"source_id": "hospital mortality", "target_id": "clinical outcomes", "strength": 10}, {"source_id": "central nervous system", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "cohort study", "target_id": "antibody levels", "strength": 10}, {"source_id": "disease severity", "target_id": "disease", "strength": 10}, {"source_id": "COVID-19", "target_id": "severe illness", "strength": 10}, {"source_id": "thematic analysis", "target_id": "COVID-19", "strength": 10}, {"source_id": "governance", "target_id": "policy", "strength": 10}, {"source_id": "mortality rate", "target_id": "infection", "strength": 10}, {"source_id": "T cell responses", "target_id": "mRNA vaccines", "strength": 10}, {"source_id": "cohort study", "target_id": "ICU admission", "strength": 10}, {"source_id": "vaccine dose", "target_id": "Omicron variant", "strength": 10}, {"source_id": "disease severity", "target_id": "COVID-19 infection", "strength": 10}, {"source_id": "booster dose", "target_id": "COVID-19", "strength": 10}, {"source_id": "vaccination status", "target_id": "patients", "strength": 10}, {"source_id": "patients", "target_id": "vaccination status", "strength": 10}, {"source_id": "coronavirus disease 2019", "target_id": "acute respiratory distress syndrome", "strength": 10}, {"source_id": "distress syndrome", "target_id": "coronavirus disease 2019", "strength": 10}, {"source_id": "education", "target_id": "context", "strength": 10}, {"source_id": "risk factors", "target_id": "cardiovascular disease", "strength": 10}, {"source_id": "care unit", "target_id": "respiratory failure", "strength": 10}, {"source_id": "patients", "target_id": "length of stay", "strength": 10}, {"source_id": "vaccine doses", "target_id": "vaccine", "strength": 10}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 vaccination", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "MAIN OUTCOME", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "vaccination status", "strength": 10}, {"source_id": "vaccination status", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "median age", "target_id": "SARS-CoV-2 infection", "strength": 10}, {"source_id": "Omicron variant", "target_id": "monoclonal antibodies", "strength": 10}, {"source_id": "monoclonal antibodies", "target_id": "Omicron variant", "strength": 10}, {"source_id": "beneficial effects", "target_id": "patients", "strength": 10}, {"source_id": "adverse events", "target_id": "safety profile", "strength": 10}, {"source_id": "vaccination program", "target_id": "vaccine", "strength": 10}, {"source_id": "vaccination", "target_id": "healthy controls", "strength": 10}, {"source_id": "vaccine", "target_id": "vaccination program", "strength": 10}, {"source_id": "COVID-19 pandemic", "target_id": "motivation", "strength": 10}, {"source_id": "practice", "target_id": "learning", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "World Health Organization", "strength": 10}, {"source_id": "COVID-19", "target_id": "teaching", "strength": 10}, {"source_id": "COVID-19", "target_id": "nasopharyngeal swabs", "strength": 10}, {"source_id": "COVID-19", "target_id": "inflammatory syndrome", "strength": 10}, {"source_id": "COVID-19", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 10}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "COVID-19", "strength": 10}, {"source_id": "second dose", "target_id": "adverse events", "strength": 10}, {"source_id": "older adults", "target_id": "patients", "strength": 10}, {"source_id": "mechanical ventilation", "target_id": "clinical outcomes", "strength": 10}, {"source_id": "symptoms", "target_id": "clinical trials", "strength": 10}, {"source_id": "booster vaccination", "target_id": "infection", "strength": 10}, {"source_id": "cohort study", "target_id": "immune response", "strength": 10}, {"source_id": "COVID-19", "target_id": "prospective study", "strength": 10}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 pandemic", "strength": 10}, {"source_id": "control group", "target_id": "clinical trials", "strength": 10}, {"source_id": "learning", "target_id": "engagement", "strength": 10}, {"source_id": "coronavirus disease 2019", "target_id": "disease severity", "strength": 10}, {"source_id": "disease severity", "target_id": "hospital admission", "strength": 10}, {"source_id": "T cells", "target_id": "mRNA vaccines", "strength": 10}, {"source_id": "flow cytometry", "target_id": "T cells", "strength": 10}, {"source_id": "vaccination", "target_id": "dose", "strength": 10}, {"source_id": "COVID-19", "target_id": "pregnancy", "strength": 10}, {"source_id": "pregnancy", "target_id": "COVID-19", "strength": 10}, {"source_id": "coronavirus disease", "target_id": "COVID-19 infection", "strength": 10}, {"source_id": "patients", "target_id": "serious adverse events", "strength": 10}, {"source_id": "COVID-19 patients", "target_id": "mortality rate", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "cross-sectional study", "strength": 10}, {"source_id": "COVID-19", "target_id": "IL-6", "strength": 10}, {"source_id": "healthy controls", "target_id": "COVID-19", "strength": 10}, {"source_id": "nervous system", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "Delta variant", "target_id": "COVID-19 vaccine", "strength": 10}, {"source_id": "vaccination", "target_id": "case report", "strength": 10}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "antibody levels", "target_id": "cohort study", "strength": 10}, {"source_id": "mortality rate", "target_id": "SARS-CoV-2 infection", "strength": 10}, {"source_id": "severe illness", "target_id": "COVID-19", "strength": 10}, {"source_id": "symptoms", "target_id": "cross-sectional study", "strength": 10}, {"source_id": "mental health", "target_id": "mental health problems", "strength": 10}, {"source_id": "treatment strategies", "target_id": "patients", "strength": 10}, {"source_id": "ICU admission", "target_id": "cohort study", "strength": 10}, {"source_id": "infection", "target_id": "antibody levels", "strength": 10}, {"source_id": "patients", "target_id": "treatment options", "strength": 10}, {"source_id": "vaccine effectiveness", "target_id": "booster doses", "strength": 10}, {"source_id": "COVID-19 vaccine", "target_id": "booster doses", "strength": 10}, {"source_id": "COVID-19 pandemic", "target_id": "community", "strength": 10}, {"source_id": "community", "target_id": "COVID-19 pandemic", "strength": 10}, {"source_id": "cohort study", "target_id": "mortality rate", "strength": 10}, {"source_id": "Delta variant", "target_id": "vaccination", "strength": 10}, {"source_id": "vaccination", "target_id": "Delta variant", "strength": 10}, {"source_id": "acute infection", "target_id": "infection", "strength": 10}, {"source_id": "Delta variant", "target_id": "cohort study", "strength": 10}, {"source_id": "systematic review", "target_id": "Secondary outcomes", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "dose", "strength": 10}, {"source_id": "mRNA vaccines", "target_id": "antibody levels", "strength": 10}, {"source_id": "mRNA vaccines", "target_id": "SARS-CoV-2 vaccines", "strength": 10}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "patients", "strength": 10}, {"source_id": "women", "target_id": "pregnancy", "strength": 10}, {"source_id": "vaccine", "target_id": "vaccine doses", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "ICU admission", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "adverse events", "strength": 10}, {"source_id": "ICU admission", "target_id": "SARS-CoV-2 infection", "strength": 10}, {"source_id": "risk factors", "target_id": "observational study", "strength": 10}, {"source_id": "observational study", "target_id": "risk factors", "strength": 10}, {"source_id": "COVID-19", "target_id": "inclusion criteria", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "immune cells", "strength": 10}, {"source_id": "motivation", "target_id": "COVID-19 pandemic", "strength": 10}, {"source_id": "violence", "target_id": "pandemic", "strength": 10}, {"source_id": "COVID-19 patients", "target_id": "C-reactive protein", "strength": 10}, {"source_id": "C-reactive protein", "target_id": "COVID-19 patients", "strength": 10}, {"source_id": "clinical trials", "target_id": "observational study", "strength": 10}, {"source_id": "observational study", "target_id": "clinical trials", "strength": 10}, {"source_id": "humoral immune response", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "disease severity", "target_id": "T cells", "strength": 10}, {"source_id": "clinical presentation", "target_id": "patients", "strength": 10}, {"source_id": "patients", "target_id": "older adults", "strength": 10}, {"source_id": "cohort study", "target_id": "hospital mortality", "strength": 10}, {"source_id": "COVID-19 patients", "target_id": "retrospective cohort study", "strength": 10}, {"source_id": "mortality", "target_id": "retrospective cohort study", "strength": 10}, {"source_id": "vaccine doses", "target_id": "vaccination", "strength": 10}, {"source_id": "immune response", "target_id": "blood samples", "strength": 10}, {"source_id": "side effects", "target_id": "COVID-19 vaccination", "strength": 10}, {"source_id": "skills", "target_id": "experience", "strength": 10}, {"source_id": "systematic review", "target_id": "health outcomes", "strength": 10}, {"source_id": "infection", "target_id": "mouse model", "strength": 10}, {"source_id": "University", "target_id": "teaching", "strength": 10}, {"source_id": "COVID-19 pandemic", "target_id": "higher education", "strength": 10}, {"source_id": "skills", "target_id": "curriculum", "strength": 10}, {"source_id": "program", "target_id": "skills", "strength": 10}, {"source_id": "skills", "target_id": "program", "strength": 10}, {"source_id": "lung disease", "target_id": "patients", "strength": 10}, {"source_id": "disease severity", "target_id": "disease 2019", "strength": 10}, {"source_id": "COVID-19 vaccine", "target_id": "observational study", "strength": 10}, {"source_id": "SARS-CoV-2 variants", "target_id": "severe disease", "strength": 10}, {"source_id": "policy", "target_id": "politics", "strength": 10}, {"source_id": "politics", "target_id": "policy", "strength": 10}, {"source_id": "infection", "target_id": "T cell responses", "strength": 10}, {"source_id": "experience", "target_id": "schools", "strength": 10}, {"source_id": "COVID-19 patients", "target_id": "hospital admission", "strength": 10}, {"source_id": "COVID-19", "target_id": "healthy controls", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "dose", "strength": 10}, {"source_id": "clinical outcomes", "target_id": "hospital mortality", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "nervous system", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 Omicron variant", "strength": 10}, {"source_id": "Delta variant", "target_id": "spike protein", "strength": 10}, {"source_id": "spike protein", "target_id": "Delta variant", "strength": 10}, {"source_id": "immune response", "target_id": "viral replication", "strength": 10}, {"source_id": "viral replication", "target_id": "immune response", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "clinical symptoms", "strength": 10}, {"source_id": "COVID-19", "target_id": "thematic analysis", "strength": 10}, {"source_id": "mechanical ventilation", "target_id": "COVID-19 infection", "strength": 10}, {"source_id": "Omicron variant", "target_id": "vaccine dose", "strength": 10}, {"source_id": "antibody levels", "target_id": "infection", "strength": 10}, {"source_id": "COVID-19 infection", "target_id": "disease severity", "strength": 10}, {"source_id": "rights", "target_id": "policy", "strength": 10}, {"source_id": "booster doses", "target_id": "vaccine effectiveness", "strength": 10}, {"source_id": "booster doses", "target_id": "COVID-19 vaccine", "strength": 10}, {"source_id": "T cells", "target_id": "spike protein", "strength": 10}, {"source_id": "spike protein", "target_id": "T cells", "strength": 10}, {"source_id": "booster dose", "target_id": "booster vaccination", "strength": 10}, {"source_id": "Medical Center", "target_id": "patients", "strength": 10}, {"source_id": "context", "target_id": "education", "strength": 10}, {"source_id": "infection", "target_id": "acute infection", "strength": 10}, {"source_id": "Secondary outcomes", "target_id": "systematic review", "strength": 10}, {"source_id": "dose", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "antibody levels", "target_id": "mRNA vaccines", "strength": 10}, {"source_id": "MAIN OUTCOME", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "unvaccinated individuals", "strength": 10}, {"source_id": "viral load", "target_id": "SARS-CoV-2 infection", "strength": 10}, {"source_id": "immune cells", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "MAIN OUTCOME", "target_id": "vaccine", "strength": 10}, {"source_id": "pandemic", "target_id": "teaching", "strength": 10}, {"source_id": "Secondary outcomes", "target_id": "MAIN OUTCOME", "strength": 10}, {"source_id": "primary outcome", "target_id": "study period", "strength": 10}, {"source_id": "patients", "target_id": "viral load", "strength": 10}, {"source_id": "clinical trials", "target_id": "therapy", "strength": 10}, {"source_id": "therapy", "target_id": "clinical trials", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "humoral immune response", "strength": 10}, {"source_id": "T cells", "target_id": "disease severity", "strength": 10}, {"source_id": "inflammatory syndrome", "target_id": "COVID-19", "strength": 10}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "COVID-19", "strength": 10}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "COVID-19", "strength": 10}, {"source_id": "COVID-19", "target_id": "syndrome coronavirus 2 infection", "strength": 10}, {"source_id": "COVID-19", "target_id": "coronavirus 2 infection", "strength": 10}, {"source_id": "mechanical ventilation", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "clinical trials", "target_id": "symptoms", "strength": 10}, {"source_id": "vaccine dose", "target_id": "vaccine doses", "strength": 10}, {"source_id": "infection", "target_id": "booster vaccination", "strength": 10}, {"source_id": "blood samples", "target_id": "immune response", "strength": 10}, {"source_id": "COVID-19", "target_id": "acute infection", "strength": 10}, {"source_id": "acute infection", "target_id": "COVID-19", "strength": 10}, {"source_id": "syndrome", "target_id": "patients", "strength": 10}, {"source_id": "COVID-19 vaccination", "target_id": "side effects", "strength": 10}, {"source_id": "high risk", "target_id": "coronavirus disease 2019", "strength": 10}, {"source_id": "prospective study", "target_id": "COVID-19", "strength": 10}, {"source_id": "experience", "target_id": "skills", "strength": 10}, {"source_id": "risk factors", "target_id": "mental health", "strength": 10}, {"source_id": "teaching", "target_id": "University", "strength": 10}, {"source_id": "learning", "target_id": "higher education", "strength": 10}, {"source_id": "engagement", "target_id": "learning", "strength": 10}, {"source_id": "disease severity", "target_id": "coronavirus disease 2019", "strength": 10}, {"source_id": "observational study", "target_id": "COVID-19 vaccine", "strength": 10}, {"source_id": "mRNA vaccines", "target_id": "T cells", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "pregnant women", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "health system", "strength": 10}, {"source_id": "vaccination", "target_id": "antibody levels", "strength": 10}, {"source_id": "median age", "target_id": "COVID-19 vaccine", "strength": 10}, {"source_id": "health problems", "target_id": "mental health", "strength": 10}, {"source_id": "COVID-19 vaccine", "target_id": "Delta variant", "strength": 10}, {"source_id": "case report", "target_id": "vaccination", "strength": 10}, {"source_id": "disease", "target_id": "disease severity", "strength": 10}, {"source_id": "age groups", "target_id": "vaccine", "strength": 10}, {"source_id": "vaccine", "target_id": "age groups", "strength": 10}, {"source_id": "cross-sectional study", "target_id": "symptoms", "strength": 10}, {"source_id": "vaccine dose", "target_id": "mRNA vaccines", "strength": 10}, {"source_id": "policy", "target_id": "governance", "strength": 10}, {"source_id": "infection", "target_id": "mortality rate", "strength": 10}, {"source_id": "mRNA vaccines", "target_id": "T cell responses", "strength": 10}, {"source_id": "Omicron variant", "target_id": "dose", "strength": 10}, {"source_id": "dose", "target_id": "Omicron variant", "strength": 10}, {"source_id": "incidence rate", "target_id": "cohort study", "strength": 10}, {"source_id": "vaccination status", "target_id": "vaccination", "strength": 10}, {"source_id": "respiratory distress syndrome", "target_id": "coronavirus disease 2019", "strength": 10}, {"source_id": "quality of life", "target_id": "COVID-19", "strength": 10}, {"source_id": "COVID-19", "target_id": "severe cases", "strength": 10}, {"source_id": "booster dose", "target_id": "dose", "strength": 10}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "mRNA vaccines", "strength": 10}, {"source_id": "pregnancy", "target_id": "women", "strength": 10}, {"source_id": "mean age", "target_id": "COVID-19 infection", "strength": 10}, {"source_id": "Secondary outcomes", "target_id": "SARS-CoV-2", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "viral load", "strength": 10}, {"source_id": "patients", "target_id": "beneficial effects", "strength": 10}, {"source_id": "cross-sectional study", "target_id": "mental health", "strength": 10}, {"source_id": "teaching", "target_id": "COVID-19", "strength": 10}, {"source_id": "primary outcome", "target_id": "COVID-19 patients", "strength": 10}, {"source_id": "retrospective cohort study", "target_id": "infection", "strength": 10}, {"source_id": "MAIN OUTCOME", "target_id": "Secondary outcomes", "strength": 10}, {"source_id": "infection", "target_id": "retrospective cohort study", "strength": 10}, {"source_id": "viral load", "target_id": "patients", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "mechanical ventilation", "strength": 10}, {"source_id": "vaccine doses", "target_id": "vaccine dose", "strength": 10}, {"source_id": "cohort study", "target_id": "healthcare workers", "strength": 10}, {"source_id": "patients", "target_id": "acute infection", "strength": 10}, {"source_id": "high risk", "target_id": "disease 2019", "strength": 10}, {"source_id": "patients", "target_id": "mental health", "strength": 10}, {"source_id": "mental health", "target_id": "risk factors", "strength": 10}, {"source_id": "mouse model", "target_id": "infection", "strength": 10}, {"source_id": "curriculum", "target_id": "skills", "strength": 10}, {"source_id": "COVID-19 infection", "target_id": "vaccine", "strength": 10}, {"source_id": "disease 2019", "target_id": "disease severity", "strength": 10}, {"source_id": "COVID-19 infection", "target_id": "coronavirus disease", "strength": 10}, {"source_id": "T cell responses", "target_id": "infection", "strength": 10}, {"source_id": "schools", "target_id": "experience", "strength": 10}, {"source_id": "mortality rate", "target_id": "COVID-19 patients", "strength": 10}, {"source_id": "hospital admission", "target_id": "COVID-19 patients", "strength": 10}, {"source_id": "admission", "target_id": "risk factors", "strength": 10}, {"source_id": "IL-6", "target_id": "COVID-19", "strength": 10}, {"source_id": "healthcare professionals", "target_id": "patients", "strength": 10}, {"source_id": "COVID-19 vaccine", "target_id": "median age", "strength": 10}, {"source_id": "patients", "target_id": "adverse effects", "strength": 10}, {"source_id": "SARS-CoV-2", "target_id": "central nervous system", "strength": 10}, {"source_id": "COVID-19 pandemic", "target_id": "mental health problems", "strength": 10}, {"source_id": "retrospective cohort study", "target_id": "high risk", "strength": 10}, {"source_id": "treatment options", "target_id": "patients", "strength": 10}, {"source_id": "vaccine", "target_id": "mRNA vaccination", "strength": 10}, {"source_id": "COVID-19 vaccine", "target_id": "vaccination rates", "strength": 10}, {"source_id": "vaccination rates", "target_id": "COVID-19 vaccine", "strength": 10}, {"source_id": "COVID-19", "target_id": "lower risk", "strength": 10}, {"source_id": "lower risk", "target_id": "COVID-19", "strength": 10}, {"source_id": "mortality rate", "target_id": "cohort study", "strength": 10}, {"source_id": "risk factors", "target_id": "retrospective cohort study", "strength": 10}, {"source_id": "booster vaccination", "target_id": "booster dose", "strength": 10}, {"source_id": "cohort study", "target_id": "incidence rate", "strength": 10}, {"source_id": "vaccination", "target_id": "vaccination status", "strength": 10}, {"source_id": "SARS-CoV-2 infection", "target_id": "general population", "strength": 10}, {"source_id": "acute respiratory distress syndrome", "target_id": "coronavirus disease 2019", "strength": 10}, {"source_id": "coronavirus disease 2019", "target_id": "respiratory distress syndrome", "strength": 10}, {"source_id": "coronavirus disease 2019", "target_id": "distress syndrome", "strength": 10}, {"source_id": "patients", "target_id": "Medical Center", "strength": 10}, {"source_id": "COVID-19", "target_id": "quality of life", "strength": 10}, {"source_id": "patients", "target_id": "severe cases", "strength": 11}, {"source_id": "second dose", "target_id": "first dose", "strength": 11}, {"source_id": "vaccination", "target_id": "side effects", "strength": 11}, {"source_id": "hospitalization", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "course", "target_id": "learning", "strength": 11}, {"source_id": "mRNA vaccination", "target_id": "second dose", "strength": 11}, {"source_id": "cohort study", "target_id": "mean age", "strength": 11}, {"source_id": "study period", "target_id": "retrospective cohort study", "strength": 11}, {"source_id": "monoclonal antibodies", "target_id": "SARS-CoV-2 variants", "strength": 11}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "coronavirus disease 2019", "strength": 11}, {"source_id": "COVID-19 patients", "target_id": "hospital stay", "strength": 11}, {"source_id": "coronavirus disease 2019", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 11}, {"source_id": "coronavirus disease 2019", "target_id": "syndrome coronavirus 2 infection", "strength": 11}, {"source_id": "hospital stay", "target_id": "COVID-19", "strength": 11}, {"source_id": "coronavirus disease 2019", "target_id": "COVID-19 vaccine", "strength": 11}, {"source_id": "COVID-19 vaccine", "target_id": "disease 2019", "strength": 11}, {"source_id": "COVID-19 infection", "target_id": "immune response", "strength": 11}, {"source_id": "SARS-CoV-2 virus", "target_id": "infection", "strength": 11}, {"source_id": "infection", "target_id": "SARS-CoV-2 virus", "strength": 11}, {"source_id": "higher education", "target_id": "institutions", "strength": 11}, {"source_id": "teachers", "target_id": "skills", "strength": 11}, {"source_id": "skills", "target_id": "schools", "strength": 11}, {"source_id": "immune response", "target_id": "immune system", "strength": 11}, {"source_id": "immune response", "target_id": "disease", "strength": 11}, {"source_id": "infectious diseases", "target_id": "immune response", "strength": 11}, {"source_id": "policy", "target_id": "United States", "strength": 11}, {"source_id": "risk factors", "target_id": "mechanical ventilation", "strength": 11}, {"source_id": "high risk", "target_id": "mechanical ventilation", "strength": 11}, {"source_id": "risk factors", "target_id": "severe COVID-19", "strength": 11}, {"source_id": "respiratory distress syndrome", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "acute respiratory distress syndrome", "strength": 11}, {"source_id": "COVID-19 vaccination", "target_id": "case report", "strength": 11}, {"source_id": "SARS-CoV-2 infection", "target_id": "acute infection", "strength": 11}, {"source_id": "acute infection", "target_id": "SARS-CoV-2 infection", "strength": 11}, {"source_id": "cohort study", "target_id": "emergency department", "strength": 11}, {"source_id": "clinical trials", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 11}, {"source_id": "clinical trials", "target_id": "syndrome coronavirus 2", "strength": 11}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "clinical trials", "strength": 11}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "clinical trials", "strength": 11}, {"source_id": "syndrome coronavirus 2", "target_id": "clinical trials", "strength": 11}, {"source_id": "SARS-CoV-2 virus", "target_id": "patients", "strength": 11}, {"source_id": "disease 2019", "target_id": "acute respiratory distress syndrome", "strength": 11}, {"source_id": "Omicron variant", "target_id": "severe disease", "strength": 11}, {"source_id": "anxiety", "target_id": "mental health", "strength": 11}, {"source_id": "COVID-19 patients", "target_id": "COVID-19 cases", "strength": 11}, {"source_id": "breakthrough infections", "target_id": "vaccination", "strength": 11}, {"source_id": "Omicron variant", "target_id": "vaccine effectiveness", "strength": 11}, {"source_id": "adult patients", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "policy", "target_id": "people", "strength": 11}, {"source_id": "COVID-19 cases", "target_id": "patients", "strength": 11}, {"source_id": "mRNA vaccines", "target_id": "Delta variant", "strength": 11}, {"source_id": "MAIN OUTCOME", "target_id": "infection", "strength": 11}, {"source_id": "vaccine doses", "target_id": "COVID-19 vaccine", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "hospitalization", "strength": 11}, {"source_id": "lower risk", "target_id": "SARS-CoV-2 infection", "strength": 11}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "risk factors", "target_id": "cross-sectional study", "strength": 11}, {"source_id": "infection", "target_id": "spike protein", "strength": 11}, {"source_id": "institutions", "target_id": "teaching", "strength": 11}, {"source_id": "teaching", "target_id": "institutions", "strength": 11}, {"source_id": "mental health", "target_id": "psychological distress", "strength": 11}, {"source_id": "psychological distress", "target_id": "mental health", "strength": 11}, {"source_id": "SARS-CoV-2 transmission", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "COVID-19 pandemic", "target_id": "violence", "strength": 11}, {"source_id": "young people", "target_id": "people", "strength": 11}, {"source_id": "educators", "target_id": "teachers", "strength": 11}, {"source_id": "COVID-19 patients", "target_id": "healthy controls", "strength": 11}, {"source_id": "study period", "target_id": "infection", "strength": 11}, {"source_id": "COVID-19", "target_id": "trials", "strength": 11}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "patients", "strength": 11}, {"source_id": "patients", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 11}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "disease 2019", "strength": 11}, {"source_id": "coronavirus disease 2019", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 11}, {"source_id": "hospital stay", "target_id": "COVID-19 patients", "strength": 11}, {"source_id": "adverse events", "target_id": "systematic review", "strength": 11}, {"source_id": "COVID-19", "target_id": "respiratory disease", "strength": 11}, {"source_id": "mean age", "target_id": "cross-sectional study", "strength": 11}, {"source_id": "infection", "target_id": "case report", "strength": 11}, {"source_id": "learners", "target_id": "teachers", "strength": 11}, {"source_id": "University", "target_id": "skills", "strength": 11}, {"source_id": "respiratory disease", "target_id": "patients", "strength": 11}, {"source_id": "patients", "target_id": "respiratory disease", "strength": 11}, {"source_id": "mean age", "target_id": "risk factors", "strength": 11}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 variants", "strength": 11}, {"source_id": "SARS-CoV-2 variants", "target_id": "COVID-19", "strength": 11}, {"source_id": "immune response", "target_id": "infectious diseases", "strength": 11}, {"source_id": "quality of life", "target_id": "primary outcome", "strength": 11}, {"source_id": "immune response", "target_id": "COVID-19 vaccination", "strength": 11}, {"source_id": "mechanical ventilation", "target_id": "high risk", "strength": 11}, {"source_id": "hospital admission", "target_id": "SARS-CoV-2 infection", "strength": 11}, {"source_id": "severe COVID-19", "target_id": "risk factors", "strength": 11}, {"source_id": "acute respiratory distress syndrome", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "systematic review", "target_id": "high risk", "strength": 11}, {"source_id": "high risk", "target_id": "systematic review", "strength": 11}, {"source_id": "cardiovascular disease", "target_id": "COVID-19", "strength": 11}, {"source_id": "emergency department", "target_id": "cohort study", "strength": 11}, {"source_id": "COVID-19", "target_id": "crisis", "strength": 11}, {"source_id": "disease 2019", "target_id": "respiratory distress syndrome", "strength": 11}, {"source_id": "disease 2019", "target_id": "distress syndrome", "strength": 11}, {"source_id": "blood samples", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "systematic review", "target_id": "COVID-19 vaccination", "strength": 11}, {"source_id": "high risk", "target_id": "logistic regression", "strength": 11}, {"source_id": "booster dose", "target_id": "booster doses", "strength": 11}, {"source_id": "COVID-19 vaccine", "target_id": "dose", "strength": 11}, {"source_id": "people", "target_id": "policy", "strength": 11}, {"source_id": "patients", "target_id": "COVID-19 cases", "strength": 11}, {"source_id": "Delta variant", "target_id": "vaccine effectiveness", "strength": 11}, {"source_id": "Delta variant", "target_id": "mRNA vaccines", "strength": 11}, {"source_id": "SARS-CoV-2 infection", "target_id": "lower risk", "strength": 11}, {"source_id": "lower risk", "target_id": "infection", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "disease 2019 pandemic", "strength": 11}, {"source_id": "disease 2019 pandemic", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "illness", "target_id": "patients", "strength": 11}, {"source_id": "acute respiratory distress syndrome", "target_id": "COVID-19 patients", "strength": 11}, {"source_id": "cross-sectional study", "target_id": "risk factors", "strength": 11}, {"source_id": "spike protein", "target_id": "infection", "strength": 11}, {"source_id": "people", "target_id": "young people", "strength": 11}, {"source_id": "teaching", "target_id": "schools", "strength": 11}, {"source_id": "clinical outcomes", "target_id": "clinical trials", "strength": 11}, {"source_id": "patients", "target_id": "disease 2019 pandemic", "strength": 11}, {"source_id": "T cells", "target_id": "vaccination", "strength": 11}, {"source_id": "vaccination", "target_id": "T cells", "strength": 11}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "coronavirus disease 2019", "strength": 11}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "coronavirus disease 2019", "strength": 11}, {"source_id": "coronavirus 2 infection", "target_id": "disease 2019", "strength": 11}, {"source_id": "coronavirus disease 2019", "target_id": "coronavirus 2 infection", "strength": 11}, {"source_id": "disease 2019", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 11}, {"source_id": "disease 2019", "target_id": "coronavirus 2 infection", "strength": 11}, {"source_id": "systematic review", "target_id": "adverse events", "strength": 11}, {"source_id": "cross-sectional study", "target_id": "mean age", "strength": 11}, {"source_id": "COVID-19 infection", "target_id": "case report", "strength": 11}, {"source_id": "case report", "target_id": "COVID-19 infection", "strength": 11}, {"source_id": "immune response", "target_id": "mouse model", "strength": 11}, {"source_id": "teachers", "target_id": "University", "strength": 11}, {"source_id": "COVID-19 pandemic", "target_id": "learners", "strength": 11}, {"source_id": "learners", "target_id": "COVID-19 pandemic", "strength": 11}, {"source_id": "skills", "target_id": "teaching", "strength": 11}, {"source_id": "skills", "target_id": "University", "strength": 11}, {"source_id": "teachers", "target_id": "engagement", "strength": 11}, {"source_id": "disease", "target_id": "immune response", "strength": 11}, {"source_id": "economy", "target_id": "market", "strength": 11}, {"source_id": "COVID-19 vaccination", "target_id": "immune response", "strength": 11}, {"source_id": "SARS-CoV-2 infection", "target_id": "hospital admission", "strength": 11}, {"source_id": "time points", "target_id": "patients", "strength": 11}, {"source_id": "semi-structured interviews", "target_id": "interviews", "strength": 11}, {"source_id": "experience", "target_id": "semi-structured interviews", "strength": 11}, {"source_id": "COVID-19", "target_id": "cardiovascular disease", "strength": 11}, {"source_id": "COVID-19 diagnosis", "target_id": "COVID-19", "strength": 11}, {"source_id": "variants of concern", "target_id": "SARS-CoV-2 variants", "strength": 11}, {"source_id": "adverse events", "target_id": "primary endpoint", "strength": 11}, {"source_id": "cancer patients", "target_id": "COVID-19", "strength": 11}, {"source_id": "clinical trials", "target_id": "respiratory syndrome coronavirus 2", "strength": 11}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "clinical trials", "strength": 11}, {"source_id": "patients", "target_id": "independent predictors", "strength": 11}, {"source_id": "acute respiratory distress syndrome", "target_id": "disease 2019", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "blood samples", "strength": 11}, {"source_id": "logistic regression", "target_id": "infection", "strength": 11}, {"source_id": "risk factors", "target_id": "disease severity", "strength": 11}, {"source_id": "diabetes mellitus", "target_id": "patients", "strength": 11}, {"source_id": "vaccine effectiveness", "target_id": "Omicron variant", "strength": 11}, {"source_id": "severe cases", "target_id": "patients", "strength": 11}, {"source_id": "COVID-19 infection", "target_id": "adult patients", "strength": 11}, {"source_id": "side effects", "target_id": "vaccination", "strength": 11}, {"source_id": "COVID-19 symptoms", "target_id": "patients", "strength": 11}, {"source_id": "patients", "target_id": "COVID-19 symptoms", "strength": 11}, {"source_id": "patients", "target_id": "illness", "strength": 11}, {"source_id": "COVID-19 patients", "target_id": "respiratory distress syndrome", "strength": 11}, {"source_id": "second dose", "target_id": "mRNA vaccination", "strength": 11}, {"source_id": "violence", "target_id": "COVID-19 pandemic", "strength": 11}, {"source_id": "schools", "target_id": "teaching", "strength": 11}, {"source_id": "healthy controls", "target_id": "COVID-19 patients", "strength": 11}, {"source_id": "healthy controls", "target_id": "infection", "strength": 11}, {"source_id": "infection", "target_id": "healthy controls", "strength": 11}, {"source_id": "retrospective cohort study", "target_id": "study period", "strength": 11}, {"source_id": "mean age", "target_id": "cohort study", "strength": 11}, {"source_id": "SARS-CoV-2 infection", "target_id": "systematic review", "strength": 11}, {"source_id": "COVID-19", "target_id": "hospital stay", "strength": 11}, {"source_id": "disease 2019", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 11}, {"source_id": "high risk", "target_id": "COVID-19 pandemic", "strength": 11}, {"source_id": "disease 2019", "target_id": "COVID-19 vaccine", "strength": 11}, {"source_id": "vaccine effectiveness", "target_id": "hospitalization", "strength": 11}, {"source_id": "immune response", "target_id": "COVID-19 infection", "strength": 11}, {"source_id": "COVID-19", "target_id": "side effects", "strength": 11}, {"source_id": "COVID-19 patients", "target_id": "viral infection", "strength": 11}, {"source_id": "therapeutic strategies", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "teaching", "target_id": "skills", "strength": 11}, {"source_id": "risk factors", "target_id": "mean age", "strength": 11}, {"source_id": "immune system", "target_id": "SARS-CoV-2 infection", "strength": 11}, {"source_id": "prospective cohort study", "target_id": "risk factors", "strength": 11}, {"source_id": "mechanical ventilation", "target_id": "risk factors", "strength": 11}, {"source_id": "case report", "target_id": "COVID-19 vaccination", "strength": 11}, {"source_id": "antibody levels", "target_id": "antibody titers", "strength": 11}, {"source_id": "antibody titers", "target_id": "antibody levels", "strength": 11}, {"source_id": "semi-structured interviews", "target_id": "experience", "strength": 11}, {"source_id": "interviews", "target_id": "semi-structured interviews", "strength": 11}, {"source_id": "COVID-19", "target_id": "COVID-19 diagnosis", "strength": 11}, {"source_id": "clinical trials", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 11}, {"source_id": "qualitative study", "target_id": "thematic analysis", "strength": 11}, {"source_id": "health problems", "target_id": "COVID-19 pandemic", "strength": 11}, {"source_id": "crisis", "target_id": "COVID-19", "strength": 11}, {"source_id": "patients", "target_id": "SARS-CoV-2 virus", "strength": 11}, {"source_id": "severe disease", "target_id": "Omicron variant", "strength": 11}, {"source_id": "older age", "target_id": "risk factors", "strength": 11}, {"source_id": "COVID-19 cases", "target_id": "COVID-19 patients", "strength": 11}, {"source_id": "antibody response", "target_id": "T cell responses", "strength": 11}, {"source_id": "T cell responses", "target_id": "antibody response", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "therapy", "strength": 11}, {"source_id": "infection", "target_id": "MAIN OUTCOME", "strength": 11}, {"source_id": "infection", "target_id": "lower risk", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 11}, {"source_id": "respiratory distress syndrome", "target_id": "COVID-19 patients", "strength": 11}, {"source_id": "distress syndrome", "target_id": "COVID-19 patients", "strength": 11}, {"source_id": "COVID-19 patients", "target_id": "acute respiratory distress syndrome", "strength": 11}, {"source_id": "learning", "target_id": "course", "strength": 11}, {"source_id": "COVID-19 pandemic", "target_id": "thematic analysis", "strength": 11}, {"source_id": "teachers", "target_id": "educators", "strength": 11}, {"source_id": "infection", "target_id": "study period", "strength": 11}, {"source_id": "clinical trials", "target_id": "clinical outcomes", "strength": 11}, {"source_id": "observational study", "target_id": "SARS-CoV-2 infection", "strength": 11}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "disease 2019", "strength": 11}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "disease 2019", "strength": 11}, {"source_id": "coronavirus 2 infection", "target_id": "coronavirus disease 2019", "strength": 11}, {"source_id": "respiratory disease", "target_id": "COVID-19", "strength": 11}, {"source_id": "hospitalization", "target_id": "vaccine effectiveness", "strength": 11}, {"source_id": "case report", "target_id": "infection", "strength": 11}, {"source_id": "viral infection", "target_id": "COVID-19 patients", "strength": 11}, {"source_id": "mouse model", "target_id": "immune response", "strength": 11}, {"source_id": "University", "target_id": "teachers", "strength": 11}, {"source_id": "engagement", "target_id": "teachers", "strength": 11}, {"source_id": "immune system", "target_id": "immune response", "strength": 11}, {"source_id": "United States", "target_id": "policy", "strength": 11}, {"source_id": "primary outcome", "target_id": "quality of life", "strength": 11}, {"source_id": "COVID-19 patients", "target_id": "admission", "strength": 11}, {"source_id": "distress syndrome", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "distress syndrome", "strength": 11}, {"source_id": "SARS-CoV-2 variants", "target_id": "variants of concern", "strength": 11}, {"source_id": "adverse events", "target_id": "mRNA vaccines", "strength": 11}, {"source_id": "mRNA vaccines", "target_id": "adverse events", "strength": 11}, {"source_id": "primary endpoint", "target_id": "adverse events", "strength": 11}, {"source_id": "thematic analysis", "target_id": "qualitative study", "strength": 11}, {"source_id": "COVID-19 pandemic", "target_id": "health problems", "strength": 11}, {"source_id": "independent predictors", "target_id": "patients", "strength": 11}, {"source_id": "SARS-CoV-2 infection", "target_id": "respiratory tract", "strength": 11}, {"source_id": "SARS-CoV-2 variants", "target_id": "Omicron infection", "strength": 11}, {"source_id": "Omicron infection", "target_id": "SARS-CoV-2 variants", "strength": 11}, {"source_id": "disease severity", "target_id": "risk factors", "strength": 11}, {"source_id": "booster doses", "target_id": "booster dose", "strength": 11}, {"source_id": "pulmonary disease", "target_id": "patients", "strength": 11}, {"source_id": "patients", "target_id": "pulmonary disease", "strength": 11}, {"source_id": "dose", "target_id": "COVID-19 vaccine", "strength": 11}, {"source_id": "vaccine effectiveness", "target_id": "Delta variant", "strength": 11}, {"source_id": "first dose", "target_id": "second dose", "strength": 11}, {"source_id": "therapy", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "adult patients", "target_id": "COVID-19 infection", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "acute infection", "strength": 11}, {"source_id": "acute infection", "target_id": "SARS-CoV-2", "strength": 11}, {"source_id": "COVID-19 vaccine", "target_id": "vaccine doses", "strength": 11}, {"source_id": "COVID-19 patients", "target_id": "distress syndrome", "strength": 11}, {"source_id": "education", "target_id": "course", "strength": 11}, {"source_id": "course", "target_id": "education", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 transmission", "strength": 11}, {"source_id": "thematic analysis", "target_id": "COVID-19 pandemic", "strength": 11}, {"source_id": "SARS-CoV-2 infection", "target_id": "observational study", "strength": 11}, {"source_id": "trials", "target_id": "COVID-19", "strength": 11}, {"source_id": "disease 2019 pandemic", "target_id": "patients", "strength": 11}, {"source_id": "SARS-CoV-2 variants", "target_id": "monoclonal antibodies", "strength": 11}, {"source_id": "systematic review", "target_id": "SARS-CoV-2 infection", "strength": 11}, {"source_id": "disease 2019", "target_id": "syndrome coronavirus 2 infection", "strength": 11}, {"source_id": "COVID-19 pandemic", "target_id": "high risk", "strength": 11}, {"source_id": "COVID-19 vaccine", "target_id": "coronavirus disease 2019", "strength": 11}, {"source_id": "side effects", "target_id": "COVID-19", "strength": 11}, {"source_id": "cross-sectional study", "target_id": "logistic regression", "strength": 11}, {"source_id": "logistic regression", "target_id": "cross-sectional study", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "therapeutic strategies", "strength": 11}, {"source_id": "teachers", "target_id": "learners", "strength": 11}, {"source_id": "skills", "target_id": "teachers", "strength": 11}, {"source_id": "institutions", "target_id": "higher education", "strength": 11}, {"source_id": "schools", "target_id": "skills", "strength": 11}, {"source_id": "SARS-CoV-2 infection", "target_id": "immune system", "strength": 11}, {"source_id": "market", "target_id": "economy", "strength": 11}, {"source_id": "risk factors", "target_id": "prospective cohort study", "strength": 11}, {"source_id": "admission", "target_id": "COVID-19 patients", "strength": 11}, {"source_id": "patients", "target_id": "time points", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "respiratory distress syndrome", "strength": 11}, {"source_id": "COVID-19", "target_id": "SARS-CoV-2 virus", "strength": 11}, {"source_id": "SARS-CoV-2 virus", "target_id": "COVID-19", "strength": 11}, {"source_id": "COVID-19", "target_id": "cancer patients", "strength": 11}, {"source_id": "respiratory distress syndrome", "target_id": "disease 2019", "strength": 11}, {"source_id": "distress syndrome", "target_id": "disease 2019", "strength": 11}, {"source_id": "COVID-19 vaccination", "target_id": "systematic review", "strength": 11}, {"source_id": "infection", "target_id": "logistic regression", "strength": 11}, {"source_id": "logistic regression", "target_id": "high risk", "strength": 11}, {"source_id": "risk factors", "target_id": "older age", "strength": 11}, {"source_id": "respiratory tract", "target_id": "SARS-CoV-2 infection", "strength": 11}, {"source_id": "mental health", "target_id": "anxiety", "strength": 11}, {"source_id": "vaccination", "target_id": "breakthrough infections", "strength": 11}, {"source_id": "patients", "target_id": "diabetes mellitus", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "adult patients", "strength": 11}, {"source_id": "pandemic", "target_id": "schools", "strength": 11}, {"source_id": "schools", "target_id": "pandemic", "strength": 11}, {"source_id": "SARS-CoV-2", "target_id": "second dose", "strength": 12}, {"source_id": "adverse events", "target_id": "COVID-19 infection", "strength": 12}, {"source_id": "viral infection", "target_id": "patients", "strength": 12}, {"source_id": "MAIN OUTCOME", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "risk factors", "target_id": "health outcomes", "strength": 12}, {"source_id": "vaccine", "target_id": "vaccine dose", "strength": 12}, {"source_id": "acute respiratory distress syndrome", "target_id": "mechanical ventilation", "strength": 12}, {"source_id": "mechanical ventilation", "target_id": "acute respiratory distress syndrome", "strength": 12}, {"source_id": "study period", "target_id": "COVID-19", "strength": 12}, {"source_id": "research", "target_id": "education", "strength": 12}, {"source_id": "retrospective cohort study", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "surgery", "target_id": "patients", "strength": 12}, {"source_id": "adverse events", "target_id": "Secondary outcomes", "strength": 12}, {"source_id": "Secondary outcomes", "target_id": "clinical trials", "strength": 12}, {"source_id": "T cell responses", "target_id": "vaccination", "strength": 12}, {"source_id": "systematic review", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "respiratory symptoms", "target_id": "symptoms", "strength": 12}, {"source_id": "symptoms", "target_id": "COVID-19 symptoms", "strength": 12}, {"source_id": "cohort study", "target_id": "symptoms", "strength": 12}, {"source_id": "clinical outcomes", "target_id": "cohort study", "strength": 12}, {"source_id": "nasopharyngeal swabs", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "COVID-19", "target_id": "logistic regression analysis", "strength": 12}, {"source_id": "immune response", "target_id": "breakthrough infections", "strength": 12}, {"source_id": "persistent symptoms", "target_id": "COVID-19", "strength": 12}, {"source_id": "education", "target_id": "engagement", "strength": 12}, {"source_id": "COVID-19", "target_id": "clinical manifestations", "strength": 12}, {"source_id": "patients", "target_id": "health services", "strength": 12}, {"source_id": "COVID-19", "target_id": "health services", "strength": 12}, {"source_id": "blood samples", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "mortality rate", "target_id": "risk factors", "strength": 12}, {"source_id": "vaccination", "target_id": "spike protein", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "second dose", "strength": 12}, {"source_id": "trials", "target_id": "primary outcome", "strength": 12}, {"source_id": "mental health outcomes", "target_id": "mental health", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "antibody levels", "strength": 12}, {"source_id": "vaccine", "target_id": "Omicron variant", "strength": 12}, {"source_id": "program", "target_id": "students", "strength": 12}, {"source_id": "T cell responses", "target_id": "vaccine", "strength": 12}, {"source_id": "T cell responses", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "high incidence", "target_id": "patients", "strength": 12}, {"source_id": "patients", "target_id": "SARS-CoV-2 vaccination", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "hospitalization", "strength": 12}, {"source_id": "general population", "target_id": "risk factors", "strength": 12}, {"source_id": "vaccination", "target_id": "systematic review", "strength": 12}, {"source_id": "respiratory distress syndrome", "target_id": "mechanical ventilation", "strength": 12}, {"source_id": "RT-PCR", "target_id": "infection", "strength": 12}, {"source_id": "program", "target_id": "learning", "strength": 12}, {"source_id": "learning", "target_id": "program", "strength": 12}, {"source_id": "disease", "target_id": "Alzheimer's disease", "strength": 12}, {"source_id": "medical students", "target_id": "education", "strength": 12}, {"source_id": "cohort study", "target_id": "Secondary outcomes", "strength": 12}, {"source_id": "SARS-CoV-2", "target_id": "retrospective cohort study", "strength": 12}, {"source_id": "Secondary outcomes", "target_id": "cohort study", "strength": 12}, {"source_id": "patients", "target_id": "surgery", "strength": 12}, {"source_id": "clinical trials", "target_id": "Secondary outcomes", "strength": 12}, {"source_id": "symptoms", "target_id": "respiratory symptoms", "strength": 12}, {"source_id": "cohort study", "target_id": "clinical outcomes", "strength": 12}, {"source_id": "logistic regression analysis", "target_id": "COVID-19", "strength": 12}, {"source_id": "SARS-CoV-2 antibodies", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "health services", "target_id": "patients", "strength": 12}, {"source_id": "health services", "target_id": "COVID-19", "strength": 12}, {"source_id": "mechanical ventilation", "target_id": "adult patients", "strength": 12}, {"source_id": "mortality", "target_id": "admission", "strength": 12}, {"source_id": "COVID-19", "target_id": "cytokine storm", "strength": 12}, {"source_id": "spike protein", "target_id": "vaccination", "strength": 12}, {"source_id": "cardiovascular disease", "target_id": "patients", "strength": 12}, {"source_id": "patients", "target_id": "cardiovascular disease", "strength": 12}, {"source_id": "mRNA vaccination", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "first dose", "target_id": "COVID-19 vaccination", "strength": 12}, {"source_id": "clinical trials", "target_id": "coronavirus 2", "strength": 12}, {"source_id": "need", "target_id": "education", "strength": 12}, {"source_id": "vaccine", "target_id": "third dose", "strength": 12}, {"source_id": "COVID-19 patients", "target_id": "COVID-19 disease", "strength": 12}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 disease", "strength": 12}, {"source_id": "control group", "target_id": "COVID-19", "strength": 12}, {"source_id": "SARS-CoV-2", "target_id": "infectious diseases", "strength": 12}, {"source_id": "second dose", "target_id": "third dose", "strength": 12}, {"source_id": "COVID-19 infection", "target_id": "adverse events", "strength": 12}, {"source_id": "humoral response", "target_id": "vaccine", "strength": 12}, {"source_id": "patients", "target_id": "viral infection", "strength": 12}, {"source_id": "patients", "target_id": "predictive value", "strength": 12}, {"source_id": "ICU admission", "target_id": "admission", "strength": 12}, {"source_id": "clinical outcomes", "target_id": "adverse events", "strength": 12}, {"source_id": "distress syndrome", "target_id": "mechanical ventilation", "strength": 12}, {"source_id": "mechanical ventilation", "target_id": "distress syndrome", "strength": 12}, {"source_id": "SARS-CoV-2 variants", "target_id": "T cells", "strength": 12}, {"source_id": "T cells", "target_id": "SARS-CoV-2 variants", "strength": 12}, {"source_id": "COVID-19 symptoms", "target_id": "symptoms", "strength": 12}, {"source_id": "symptoms", "target_id": "cohort study", "strength": 12}, {"source_id": "coronavirus disease 2019", "target_id": "cohort study", "strength": 12}, {"source_id": "acute phase", "target_id": "COVID-19", "strength": 12}, {"source_id": "risk factors", "target_id": "mortality rate", "strength": 12}, {"source_id": "adult patients", "target_id": "mechanical ventilation", "strength": 12}, {"source_id": "breakthrough infections", "target_id": "SARS-CoV-2 variants", "strength": 12}, {"source_id": "coronavirus 2", "target_id": "clinical trials", "strength": 12}, {"source_id": "mental health", "target_id": "mental health outcomes", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 disease", "strength": 12}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 spike protein", "strength": 12}, {"source_id": "Meta-Analysis", "target_id": "patients", "strength": 12}, {"source_id": "infection", "target_id": "COVID-19 disease", "strength": 12}, {"source_id": "COVID-19 severity", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "infectious diseases", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "predictive value", "target_id": "patients", "strength": 12}, {"source_id": "hospitalization", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "health outcomes", "target_id": "risk factors", "strength": 12}, {"source_id": "infection", "target_id": "RT-PCR", "strength": 12}, {"source_id": "COVID-19 pandemic", "target_id": "institutions", "strength": 12}, {"source_id": "interviews", "target_id": "pandemic", "strength": 12}, {"source_id": "pandemic", "target_id": "interviews", "strength": 12}, {"source_id": "Alzheimer's disease", "target_id": "disease", "strength": 12}, {"source_id": "Secondary outcomes", "target_id": "adverse events", "strength": 12}, {"source_id": "vaccination", "target_id": "T cell responses", "strength": 12}, {"source_id": "side effects", "target_id": "COVID-19 vaccine", "strength": 12}, {"source_id": "cohort study", "target_id": "coronavirus disease 2019", "strength": 12}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 antibodies", "strength": 12}, {"source_id": "COVID-19", "target_id": "persistent symptoms", "strength": 12}, {"source_id": "care providers", "target_id": "patients", "strength": 12}, {"source_id": "pregnant women", "target_id": "COVID-19", "strength": 12}, {"source_id": "SARS-CoV-2 virus", "target_id": "COVID-19 infection", "strength": 12}, {"source_id": "teachers", "target_id": "COVID-19", "strength": 12}, {"source_id": "COVID-19", "target_id": "teachers", "strength": 12}, {"source_id": "engagement", "target_id": "education", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "blood samples", "strength": 12}, {"source_id": "SARS-CoV-2 variants", "target_id": "breakthrough infections", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "mRNA vaccination", "strength": 12}, {"source_id": "SARS-CoV-2", "target_id": "severe illness", "strength": 12}, {"source_id": "severe illness", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "COVID-19 infection", "target_id": "symptoms", "strength": 12}, {"source_id": "SARS-CoV-2 spike protein", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "cohort study", "target_id": "therapy", "strength": 12}, {"source_id": "COVID-19", "target_id": "vaccination status", "strength": 12}, {"source_id": "Omicron variant", "target_id": "mRNA vaccines", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 severity", "strength": 12}, {"source_id": "patients", "target_id": "T cell responses", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "T cell responses", "strength": 12}, {"source_id": "second dose", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "vaccine", "target_id": "humoral response", "strength": 12}, {"source_id": "vaccine", "target_id": "COVID-19 mRNA vaccines", "strength": 12}, {"source_id": "adverse events", "target_id": "clinical outcomes", "strength": 12}, {"source_id": "prospective cohort study", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "systematic review", "target_id": "vaccination", "strength": 12}, {"source_id": "vaccine dose", "target_id": "vaccine", "strength": 12}, {"source_id": "educators", "target_id": "learning", "strength": 12}, {"source_id": "institutions", "target_id": "COVID-19 pandemic", "strength": 12}, {"source_id": "learning", "target_id": "educators", "strength": 12}, {"source_id": "breakthrough infections", "target_id": "cohort study", "strength": 12}, {"source_id": "education", "target_id": "research", "strength": 12}, {"source_id": "COVID-19", "target_id": "clinical studies", "strength": 12}, {"source_id": "clinical studies", "target_id": "COVID-19", "strength": 12}, {"source_id": "SARS-CoV-2", "target_id": "nasopharyngeal swabs", "strength": 12}, {"source_id": "cohort study", "target_id": "disease 2019", "strength": 12}, {"source_id": "disease 2019", "target_id": "cohort study", "strength": 12}, {"source_id": "risk factors", "target_id": "hospital admission", "strength": 12}, {"source_id": "hospital admission", "target_id": "risk factors", "strength": 12}, {"source_id": "breakthrough infections", "target_id": "immune response", "strength": 12}, {"source_id": "COVID-19 infection", "target_id": "SARS-CoV-2 virus", "strength": 12}, {"source_id": "learners", "target_id": "learning", "strength": 12}, {"source_id": "cohort study", "target_id": "lower risk", "strength": 12}, {"source_id": "admission", "target_id": "mortality", "strength": 12}, {"source_id": "disease severity", "target_id": "immune response", "strength": 12}, {"source_id": "immune response", "target_id": "disease severity", "strength": 12}, {"source_id": "COVID-19 vaccination", "target_id": "first dose", "strength": 12}, {"source_id": "primary outcome", "target_id": "trials", "strength": 12}, {"source_id": "hospital mortality", "target_id": "mechanical ventilation", "strength": 12}, {"source_id": "disease severity", "target_id": "cohort study", "strength": 12}, {"source_id": "patients", "target_id": "Meta-Analysis", "strength": 12}, {"source_id": "Omicron variant", "target_id": "vaccine", "strength": 12}, {"source_id": "therapy", "target_id": "cohort study", "strength": 12}, {"source_id": "COVID-19 disease", "target_id": "infection", "strength": 12}, {"source_id": "third dose", "target_id": "vaccine", "strength": 12}, {"source_id": "COVID-19", "target_id": "control group", "strength": 12}, {"source_id": "T cell responses", "target_id": "patients", "strength": 12}, {"source_id": "spike protein", "target_id": "T cell responses", "strength": 12}, {"source_id": "T cell responses", "target_id": "spike protein", "strength": 12}, {"source_id": "patients", "target_id": "high incidence", "strength": 12}, {"source_id": "third dose", "target_id": "second dose", "strength": 12}, {"source_id": "SARS-CoV-2 vaccination", "target_id": "patients", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "MAIN OUTCOME", "strength": 12}, {"source_id": "admission", "target_id": "ICU admission", "strength": 12}, {"source_id": "risk factors", "target_id": "general population", "strength": 12}, {"source_id": "SARS-CoV-2 infection", "target_id": "prospective cohort study", "strength": 12}, {"source_id": "mechanical ventilation", "target_id": "respiratory distress syndrome", "strength": 12}, {"source_id": "program", "target_id": "education", "strength": 12}, {"source_id": "education", "target_id": "program", "strength": 12}, {"source_id": "COVID-19 pandemic", "target_id": "interviews", "strength": 12}, {"source_id": "interviews", "target_id": "COVID-19 pandemic", "strength": 12}, {"source_id": "COVID-19", "target_id": "study period", "strength": 12}, {"source_id": "cohort study", "target_id": "breakthrough infections", "strength": 12}, {"source_id": "COVID-19 vaccine", "target_id": "side effects", "strength": 12}, {"source_id": "SARS-CoV-2", "target_id": "systematic review", "strength": 12}, {"source_id": "infection rate", "target_id": "SARS-CoV-2", "strength": 12}, {"source_id": "SARS-CoV-2", "target_id": "infection rate", "strength": 12}, {"source_id": "COVID-19", "target_id": "acute phase", "strength": 12}, {"source_id": "patients", "target_id": "care providers", "strength": 12}, {"source_id": "COVID-19", "target_id": "pregnant women", "strength": 12}, {"source_id": "learning", "target_id": "learners", "strength": 12}, {"source_id": "clinical manifestations", "target_id": "COVID-19", "strength": 12}, {"source_id": "lower risk", "target_id": "cohort study", "strength": 12}, {"source_id": "cytokine storm", "target_id": "COVID-19", "strength": 12}, {"source_id": "second dose", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "mechanical ventilation", "target_id": "hospital mortality", "strength": 12}, {"source_id": "cohort study", "target_id": "disease severity", "strength": 12}, {"source_id": "symptoms", "target_id": "COVID-19 infection", "strength": 12}, {"source_id": "COVID-19 disease", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "education", "target_id": "need", "strength": 12}, {"source_id": "antibody levels", "target_id": "SARS-CoV-2 infection", "strength": 12}, {"source_id": "students", "target_id": "program", "strength": 12}, {"source_id": "COVID-19 disease", "target_id": "COVID-19 patients", "strength": 12}, {"source_id": "COVID-19 disease", "target_id": "COVID-19 infection", "strength": 12}, {"source_id": "vaccination status", "target_id": "COVID-19", "strength": 12}, {"source_id": "mRNA vaccines", "target_id": "Omicron variant", "strength": 12}, {"source_id": "vaccine", "target_id": "T cell responses", "strength": 12}, {"source_id": "vaccination status", "target_id": "cohort study", "strength": 13}, {"source_id": "patients", "target_id": "second dose", "strength": 13}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "antibody response", "strength": 13}, {"source_id": "side effects", "target_id": "patients", "strength": 13}, {"source_id": "clinical outcomes", "target_id": "SARS-CoV-2 infection", "strength": 13}, {"source_id": "infection", "target_id": "hospitalization", "strength": 13}, {"source_id": "patients", "target_id": "electronic health records", "strength": 13}, {"source_id": "patients", "target_id": "health records", "strength": 13}, {"source_id": "vaccine", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 13}, {"source_id": "intensive care", "target_id": "patients", "strength": 13}, {"source_id": "patients", "target_id": "intensive care", "strength": 13}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "spike protein", "strength": 13}, {"source_id": "Omicron infection", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "disease progression", "target_id": "patients", "strength": 13}, {"source_id": "pain", "target_id": "patients", "strength": 13}, {"source_id": "patients", "target_id": "pain", "strength": 13}, {"source_id": "infection", "target_id": "mechanical ventilation", "strength": 13}, {"source_id": "infection", "target_id": "clinical trials", "strength": 13}, {"source_id": "SARS-CoV-2 replication", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "antiviral activity", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 replication", "strength": 13}, {"source_id": "first dose", "target_id": "mRNA vaccines", "strength": 13}, {"source_id": "admission", "target_id": "COVID-19", "strength": 13}, {"source_id": "vaccine", "target_id": "Delta variant", "strength": 13}, {"source_id": "SARS-CoV-2 infection", "target_id": "disease", "strength": 13}, {"source_id": "disease", "target_id": "SARS-CoV-2 infection", "strength": 13}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 cases", "strength": 13}, {"source_id": "COVID-19 cases", "target_id": "SARS-CoV-2 infection", "strength": 13}, {"source_id": "SARS-CoV-2 infection", "target_id": "RT-PCR", "strength": 13}, {"source_id": "clinical characteristics", "target_id": "COVID-19", "strength": 13}, {"source_id": "outcome measures", "target_id": "patients", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "observational study", "strength": 13}, {"source_id": "hospitalization", "target_id": "infection", "strength": 13}, {"source_id": "health records", "target_id": "patients", "strength": 13}, {"source_id": "therapy", "target_id": "COVID-19 patients", "strength": 13}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "vaccine", "strength": 13}, {"source_id": "vaccine", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 13}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "spike protein", "strength": 13}, {"source_id": "spike protein", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 13}, {"source_id": "spike protein", "target_id": "respiratory syndrome coronavirus 2", "strength": 13}, {"source_id": "psychological distress", "target_id": "COVID-19 pandemic", "strength": 13}, {"source_id": "virus infection", "target_id": "infection", "strength": 13}, {"source_id": "nasopharyngeal swabs", "target_id": "patients", "strength": 13}, {"source_id": "patients", "target_id": "median time", "strength": 13}, {"source_id": "respiratory symptoms", "target_id": "patients", "strength": 13}, {"source_id": "mechanical ventilation", "target_id": "infection", "strength": 13}, {"source_id": "COVID-19 patients", "target_id": "hospital mortality", "strength": 13}, {"source_id": "vaccine doses", "target_id": "infection", "strength": 13}, {"source_id": "vaccination", "target_id": "vaccine effectiveness", "strength": 13}, {"source_id": "curriculum", "target_id": "learning", "strength": 13}, {"source_id": "learning", "target_id": "curriculum", "strength": 13}, {"source_id": "COVID-19 vaccine", "target_id": "SARS-CoV-2 vaccines", "strength": 13}, {"source_id": "severe disease", "target_id": "vaccine", "strength": 13}, {"source_id": "pregnant women", "target_id": "COVID-19 pandemic", "strength": 13}, {"source_id": "patients", "target_id": "IL-6", "strength": 13}, {"source_id": "MAIN OUTCOME", "target_id": "clinical trials", "strength": 13}, {"source_id": "COVID-19", "target_id": "nervous system", "strength": 13}, {"source_id": "nervous system", "target_id": "COVID-19", "strength": 13}, {"source_id": "logistic regression", "target_id": "SARS-CoV-2 infection", "strength": 13}, {"source_id": "booster vaccination", "target_id": "Omicron variant", "strength": 13}, {"source_id": "healthy controls", "target_id": "immune response", "strength": 13}, {"source_id": "immune response", "target_id": "healthy controls", "strength": 13}, {"source_id": "case series", "target_id": "patients", "strength": 13}, {"source_id": "cohort study", "target_id": "vaccination status", "strength": 13}, {"source_id": "antibody levels", "target_id": "patients", "strength": 13}, {"source_id": "case-control study", "target_id": "patients", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "adverse events", "strength": 13}, {"source_id": "COVID-19", "target_id": "therapy", "strength": 13}, {"source_id": "therapy", "target_id": "COVID-19", "strength": 13}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "spike protein", "strength": 13}, {"source_id": "COVID-19 pandemic", "target_id": "practice", "strength": 13}, {"source_id": "course", "target_id": "COVID-19 pandemic", "strength": 13}, {"source_id": "cohort study", "target_id": "Omicron variant", "strength": 13}, {"source_id": "infection", "target_id": "virus infection", "strength": 13}, {"source_id": "heart failure", "target_id": "patients", "strength": 13}, {"source_id": "hospital discharge", "target_id": "COVID-19", "strength": 13}, {"source_id": "median time", "target_id": "patients", "strength": 13}, {"source_id": "hospitalized patients", "target_id": "COVID-19", "strength": 13}, {"source_id": "systematic review", "target_id": "symptoms", "strength": 13}, {"source_id": "infection", "target_id": "vaccine doses", "strength": 13}, {"source_id": "infection", "target_id": "prospective cohort study", "strength": 13}, {"source_id": "patients", "target_id": "care settings", "strength": 13}, {"source_id": "booster doses", "target_id": "vaccine", "strength": 13}, {"source_id": "SARS-CoV-2 pandemic", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "SARS-CoV-2 infection", "target_id": "study period", "strength": 13}, {"source_id": "booster dose", "target_id": "infection", "strength": 13}, {"source_id": "infection", "target_id": "booster dose", "strength": 13}, {"source_id": "mRNA vaccines", "target_id": "third dose", "strength": 13}, {"source_id": "third dose", "target_id": "mRNA vaccines", "strength": 13}, {"source_id": "COVID-19 severity", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "Health Organization", "target_id": "COVID-19", "strength": 13}, {"source_id": "second dose", "target_id": "patients", "strength": 13}, {"source_id": "patients", "target_id": "antibody levels", "strength": 13}, {"source_id": "patients", "target_id": "pneumonia", "strength": 13}, {"source_id": "SARS-CoV-2 infection", "target_id": "clinical outcomes", "strength": 13}, {"source_id": "adverse events", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "booster vaccination", "target_id": "vaccine", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "monoclonal antibodies", "strength": 13}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "vaccine", "strength": 13}, {"source_id": "immune response", "target_id": "antibody levels", "strength": 13}, {"source_id": "COVID-19 pandemic", "target_id": "course", "strength": 13}, {"source_id": "COVID-19 patients", "target_id": "clinical trials", "strength": 13}, {"source_id": "clinical trials", "target_id": "COVID-19 patients", "strength": 13}, {"source_id": "patients", "target_id": "C-reactive protein", "strength": 13}, {"source_id": "patients", "target_id": "nasopharyngeal swabs", "strength": 13}, {"source_id": "patients", "target_id": "disease progression", "strength": 13}, {"source_id": "COVID-19", "target_id": "COVID-19 symptoms", "strength": 13}, {"source_id": "symptoms", "target_id": "systematic review", "strength": 13}, {"source_id": "vaccine effectiveness", "target_id": "vaccination", "strength": 13}, {"source_id": "risk factors", "target_id": "primary outcome", "strength": 13}, {"source_id": "prospective cohort study", "target_id": "infection", "strength": 13}, {"source_id": "booster dose", "target_id": "mRNA vaccines", "strength": 13}, {"source_id": "mRNA vaccines", "target_id": "booster dose", "strength": 13}, {"source_id": "vaccine", "target_id": "severe disease", "strength": 13}, {"source_id": "vaccine", "target_id": "booster doses", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 pandemic", "strength": 13}, {"source_id": "study period", "target_id": "SARS-CoV-2 infection", "strength": 13}, {"source_id": "mRNA vaccines", "target_id": "first dose", "strength": 13}, {"source_id": "breast cancer", "target_id": "cancer", "strength": 13}, {"source_id": "clinical trials", "target_id": "immune response", "strength": 13}, {"source_id": "median age", "target_id": "vaccine", "strength": 13}, {"source_id": "vaccine", "target_id": "median age", "strength": 13}, {"source_id": "clinical trials", "target_id": "MAIN OUTCOME", "strength": 13}, {"source_id": "risk factors", "target_id": "clinical outcomes", "strength": 13}, {"source_id": "patients", "target_id": "chronic kidney disease", "strength": 13}, {"source_id": "mRNA vaccines", "target_id": "cohort study", "strength": 13}, {"source_id": "cohort study", "target_id": "mRNA vaccines", "strength": 13}, {"source_id": "vaccination", "target_id": "Omicron variant", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 severity", "strength": 13}, {"source_id": "Omicron variant", "target_id": "booster vaccination", "strength": 13}, {"source_id": "patients", "target_id": "outcome measures", "strength": 13}, {"source_id": "patients", "target_id": "case series", "strength": 13}, {"source_id": "COVID-19", "target_id": "Health Organization", "strength": 13}, {"source_id": "observational study", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "patients", "target_id": "side effects", "strength": 13}, {"source_id": "risk factors", "target_id": "symptoms", "strength": 13}, {"source_id": "electronic health records", "target_id": "patients", "strength": 13}, {"source_id": "coronavirus disease", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "coronavirus 2", "target_id": "spike protein", "strength": 13}, {"source_id": "spike protein", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 13}, {"source_id": "spike protein", "target_id": "syndrome coronavirus 2", "strength": 13}, {"source_id": "spike protein", "target_id": "coronavirus 2", "strength": 13}, {"source_id": "antibody levels", "target_id": "immune response", "strength": 13}, {"source_id": "COVID-19 pandemic", "target_id": "psychological distress", "strength": 13}, {"source_id": "Omicron variant", "target_id": "cohort study", "strength": 13}, {"source_id": "government", "target_id": "pandemic", "strength": 13}, {"source_id": "pandemic", "target_id": "government", "strength": 13}, {"source_id": "patients", "target_id": "heart failure", "strength": 13}, {"source_id": "COVID-19", "target_id": "hospital discharge", "strength": 13}, {"source_id": "patients", "target_id": "respiratory symptoms", "strength": 13}, {"source_id": "vaccine uptake", "target_id": "COVID-19 vaccine", "strength": 13}, {"source_id": "students", "target_id": "learners", "strength": 13}, {"source_id": "care settings", "target_id": "patients", "strength": 13}, {"source_id": "COVID-19 pandemic", "target_id": "pregnant women", "strength": 13}, {"source_id": "IL-6", "target_id": "patients", "strength": 13}, {"source_id": "patients", "target_id": "pilot study", "strength": 13}, {"source_id": "COVID-19", "target_id": "admission", "strength": 13}, {"source_id": "immune response", "target_id": "clinical trials", "strength": 13}, {"source_id": "Delta variant", "target_id": "vaccine", "strength": 13}, {"source_id": "RT-PCR", "target_id": "SARS-CoV-2 infection", "strength": 13}, {"source_id": "clinical outcomes", "target_id": "risk factors", "strength": 13}, {"source_id": "antibody response", "target_id": "SARS-CoV-2 vaccines", "strength": 13}, {"source_id": "patients", "target_id": "case-control study", "strength": 13}, {"source_id": "symptoms", "target_id": "risk factors", "strength": 13}, {"source_id": "vaccine", "target_id": "booster vaccination", "strength": 13}, {"source_id": "monoclonal antibodies", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "COVID-19 patients", "target_id": "therapy", "strength": 13}, {"source_id": "Web of Science", "target_id": "patients", "strength": 13}, {"source_id": "patients", "target_id": "Web of Science", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "coronavirus disease", "strength": 13}, {"source_id": "COVID-19 patients", "target_id": "ICU admission", "strength": 13}, {"source_id": "ICU admission", "target_id": "COVID-19 patients", "strength": 13}, {"source_id": "syndrome coronavirus 2", "target_id": "spike protein", "strength": 13}, {"source_id": "practice", "target_id": "COVID-19 pandemic", "strength": 13}, {"source_id": "SARS-CoV-2", "target_id": "Omicron infection", "strength": 13}, {"source_id": "C-reactive protein", "target_id": "patients", "strength": 13}, {"source_id": "COVID-19 symptoms", "target_id": "COVID-19", "strength": 13}, {"source_id": "clinical trials", "target_id": "infection", "strength": 13}, {"source_id": "hospital mortality", "target_id": "COVID-19 patients", "strength": 13}, {"source_id": "primary outcome", "target_id": "risk factors", "strength": 13}, {"source_id": "antiviral activity", "target_id": "SARS-CoV-2", "strength": 13}, {"source_id": "COVID-19 vaccine", "target_id": "vaccine uptake", "strength": 13}, {"source_id": "COVID-19 pandemic", "target_id": "anxiety", "strength": 13}, {"source_id": "anxiety", "target_id": "COVID-19 pandemic", "strength": 13}, {"source_id": "learners", "target_id": "students", "strength": 13}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "COVID-19 vaccine", "strength": 13}, {"source_id": "cancer", "target_id": "breast cancer", "strength": 13}, {"source_id": "pilot study", "target_id": "patients", "strength": 13}, {"source_id": "SARS-CoV-2 infection", "target_id": "logistic regression", "strength": 13}, {"source_id": "chronic kidney disease", "target_id": "patients", "strength": 13}, {"source_id": "COVID-19", "target_id": "clinical characteristics", "strength": 13}, {"source_id": "Omicron variant", "target_id": "vaccination", "strength": 13}, {"source_id": "adult patients", "target_id": "primary outcome", "strength": 14}, {"source_id": "patients", "target_id": "patient population", "strength": 14}, {"source_id": "MAIN OUTCOME", "target_id": "primary outcome", "strength": 14}, {"source_id": "complications", "target_id": "patients", "strength": 14}, {"source_id": "primary outcome", "target_id": "intensive care unit", "strength": 14}, {"source_id": "COVID-19 disease", "target_id": "patients", "strength": 14}, {"source_id": "SARS-CoV-2 infection", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 14}, {"source_id": "symptoms", "target_id": "infection", "strength": 14}, {"source_id": "infection", "target_id": "systematic review", "strength": 14}, {"source_id": "clinical trials", "target_id": "COVID-19 vaccine", "strength": 14}, {"source_id": "vaccine uptake", "target_id": "vaccine hesitancy", "strength": 14}, {"source_id": "pandemic", "target_id": "teachers", "strength": 14}, {"source_id": "COVID-19", "target_id": "immune system", "strength": 14}, {"source_id": "immune system", "target_id": "SARS-CoV-2", "strength": 14}, {"source_id": "patients", "target_id": "health system", "strength": 14}, {"source_id": "health system", "target_id": "patients", "strength": 14}, {"source_id": "thematic analysis", "target_id": "experience", "strength": 14}, {"source_id": "high prevalence", "target_id": "patients", "strength": 14}, {"source_id": "patients", "target_id": "high prevalence", "strength": 14}, {"source_id": "mRNA vaccines", "target_id": "dose", "strength": 14}, {"source_id": "dose", "target_id": "mRNA vaccines", "strength": 14}, {"source_id": "breakthrough infections", "target_id": "patients", "strength": 14}, {"source_id": "spike protein", "target_id": "receptor-binding domain", "strength": 14}, {"source_id": "patient population", "target_id": "patients", "strength": 14}, {"source_id": "COVID-19 vaccine", "target_id": "COVID-19 infection", "strength": 14}, {"source_id": "MAIN OUTCOME", "target_id": "vaccination", "strength": 14}, {"source_id": "symptoms", "target_id": "COVID-19 pandemic", "strength": 14}, {"source_id": "SARS-CoV-2 infection", "target_id": "vaccination status", "strength": 14}, {"source_id": "vaccine", "target_id": "respiratory syndrome coronavirus 2", "strength": 14}, {"source_id": "patients", "target_id": "complications", "strength": 14}, {"source_id": "intensive care unit", "target_id": "primary outcome", "strength": 14}, {"source_id": "patients", "target_id": "COVID-19 disease", "strength": 14}, {"source_id": "infection", "target_id": "symptoms", "strength": 14}, {"source_id": "COVID-19 vaccine", "target_id": "clinical trials", "strength": 14}, {"source_id": "logistic regression models", "target_id": "COVID-19", "strength": 14}, {"source_id": "severe COVID-19", "target_id": "immune response", "strength": 14}, {"source_id": "patients", "target_id": "blood samples", "strength": 14}, {"source_id": "patients", "target_id": "breakthrough infections", "strength": 14}, {"source_id": "cohort study", "target_id": "adult patients", "strength": 14}, {"source_id": "COVID-19 patients", "target_id": "COVID-19 severity", "strength": 14}, {"source_id": "vaccine", "target_id": "BNT162b2 vaccine", "strength": 14}, {"source_id": "primary outcome", "target_id": "SARS-CoV-2 infection", "strength": 14}, {"source_id": "patients", "target_id": "lower risk", "strength": 14}, {"source_id": "infection", "target_id": "COVID-19 vaccination", "strength": 14}, {"source_id": "COVID-19 pandemic", "target_id": "symptoms", "strength": 14}, {"source_id": "SARS-CoV-2", "target_id": "humoral response", "strength": 14}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "vaccine", "strength": 14}, {"source_id": "syndrome coronavirus 2", "target_id": "vaccine", "strength": 14}, {"source_id": "vaccine dose", "target_id": "vaccination", "strength": 14}, {"source_id": "vaccine hesitancy", "target_id": "vaccine", "strength": 14}, {"source_id": "vaccine", "target_id": "vaccine hesitancy", "strength": 14}, {"source_id": "learning", "target_id": "pandemic", "strength": 14}, {"source_id": "economy", "target_id": "policy", "strength": 14}, {"source_id": "semi-structured interviews", "target_id": "thematic analysis", "strength": 14}, {"source_id": "training", "target_id": "students", "strength": 14}, {"source_id": "thematic analysis", "target_id": "semi-structured interviews", "strength": 14}, {"source_id": "COVID-19", "target_id": "age groups", "strength": 14}, {"source_id": "risk factors", "target_id": "immune response", "strength": 14}, {"source_id": "COVID-19", "target_id": "clinical presentation", "strength": 14}, {"source_id": "systematic review", "target_id": "infection", "strength": 14}, {"source_id": "COVID-19", "target_id": "logistic regression models", "strength": 14}, {"source_id": "COVID-19 outcomes", "target_id": "patients", "strength": 14}, {"source_id": "teachers", "target_id": "pandemic", "strength": 14}, {"source_id": "vaccine", "target_id": "case report", "strength": 14}, {"source_id": "immune system", "target_id": "COVID-19", "strength": 14}, {"source_id": "COVID-19 patients", "target_id": "respiratory failure", "strength": 14}, {"source_id": "cause mortality", "target_id": "mortality", "strength": 14}, {"source_id": "mortality", "target_id": "cause mortality", "strength": 14}, {"source_id": "dose", "target_id": "vaccine dose", "strength": 14}, {"source_id": "COVID-19 pandemic", "target_id": "depressive symptoms", "strength": 14}, {"source_id": "breakthrough infections", "target_id": "SARS-CoV-2 infection", "strength": 14}, {"source_id": "antibody response", "target_id": "SARS-CoV-2 infection", "strength": 14}, {"source_id": "primary outcome", "target_id": "MAIN OUTCOME", "strength": 14}, {"source_id": "vaccination", "target_id": "MAIN OUTCOME", "strength": 14}, {"source_id": "humoral response", "target_id": "SARS-CoV-2", "strength": 14}, {"source_id": "vaccine", "target_id": "syndrome coronavirus 2", "strength": 14}, {"source_id": "patients", "target_id": "patient characteristics", "strength": 14}, {"source_id": "pandemic", "target_id": "learning", "strength": 14}, {"source_id": "students", "target_id": "training", "strength": 14}, {"source_id": "age groups", "target_id": "COVID-19", "strength": 14}, {"source_id": "antibody titers", "target_id": "vaccination", "strength": 14}, {"source_id": "vaccination", "target_id": "antibody titers", "strength": 14}, {"source_id": "clinical presentation", "target_id": "COVID-19", "strength": 14}, {"source_id": "patients", "target_id": "COVID-19 outcomes", "strength": 14}, {"source_id": "severe disease", "target_id": "risk factors", "strength": 14}, {"source_id": "vaccine hesitancy", "target_id": "vaccine uptake", "strength": 14}, {"source_id": "patients", "target_id": "prospective study", "strength": 14}, {"source_id": "case report", "target_id": "vaccine", "strength": 14}, {"source_id": "immune response", "target_id": "severe COVID-19", "strength": 14}, {"source_id": "health system", "target_id": "COVID-19", "strength": 14}, {"source_id": "Omicron variant", "target_id": "booster dose", "strength": 14}, {"source_id": "booster dose", "target_id": "Omicron variant", "strength": 14}, {"source_id": "infection", "target_id": "mRNA vaccines", "strength": 14}, {"source_id": "COVID-19 vaccine", "target_id": "third dose", "strength": 14}, {"source_id": "adult patients", "target_id": "cohort study", "strength": 14}, {"source_id": "risk factors", "target_id": "logistic regression analysis", "strength": 14}, {"source_id": "antibody response", "target_id": "spike protein", "strength": 14}, {"source_id": "spike protein", "target_id": "antibody response", "strength": 14}, {"source_id": "primary outcome", "target_id": "adult patients", "strength": 14}, {"source_id": "pregnancy", "target_id": "pregnant women", "strength": 14}, {"source_id": "COVID-19 infection", "target_id": "COVID-19 vaccine", "strength": 14}, {"source_id": "COVID-19 infection", "target_id": "vaccination", "strength": 14}, {"source_id": "vaccination", "target_id": "COVID-19 infection", "strength": 14}, {"source_id": "hospital", "target_id": "patients", "strength": 14}, {"source_id": "patients", "target_id": "hospital", "strength": 14}, {"source_id": "vaccination status", "target_id": "SARS-CoV-2 infection", "strength": 14}, {"source_id": "vaccination", "target_id": "vaccine dose", "strength": 14}, {"source_id": "SARS-CoV-2 Omicron variant", "target_id": "SARS-CoV-2 variants", "strength": 14}, {"source_id": "patients", "target_id": "trials", "strength": 14}, {"source_id": "trials", "target_id": "patients", "strength": 14}, {"source_id": "SARS-CoV-2 infection", "target_id": "mechanical ventilation", "strength": 14}, {"source_id": "infection", "target_id": "healthcare workers", "strength": 14}, {"source_id": "COVID-19", "target_id": "health system", "strength": 14}, {"source_id": "experience", "target_id": "thematic analysis", "strength": 14}, {"source_id": "mRNA vaccines", "target_id": "infection", "strength": 14}, {"source_id": "COVID-19 pandemic", "target_id": "countries", "strength": 14}, {"source_id": "third dose", "target_id": "COVID-19 vaccine", "strength": 14}, {"source_id": "COVID-19 severity", "target_id": "COVID-19 patients", "strength": 14}, {"source_id": "depressive symptoms", "target_id": "COVID-19 pandemic", "strength": 14}, {"source_id": "SARS-CoV-2 infection", "target_id": "breakthrough infections", "strength": 14}, {"source_id": "SARS-CoV-2 infection", "target_id": "antibody response", "strength": 14}, {"source_id": "World Health Organization", "target_id": "COVID-19", "strength": 14}, {"source_id": "COVID-19", "target_id": "World Health Organization", "strength": 14}, {"source_id": "BNT162b2 vaccine", "target_id": "vaccine", "strength": 14}, {"source_id": "pregnant women", "target_id": "pregnancy", "strength": 14}, {"source_id": "SARS-CoV-2 infection", "target_id": "primary outcome", "strength": 14}, {"source_id": "COVID-19 vaccination", "target_id": "infection", "strength": 14}, {"source_id": "lower risk", "target_id": "patients", "strength": 14}, {"source_id": "patient characteristics", "target_id": "patients", "strength": 14}, {"source_id": "SARS-CoV-2 variants", "target_id": "SARS-CoV-2 Omicron variant", "strength": 14}, {"source_id": "policy", "target_id": "economy", "strength": 14}, {"source_id": "experience", "target_id": "COVID-19", "strength": 14}, {"source_id": "COVID-19", "target_id": "experience", "strength": 14}, {"source_id": "primary outcome", "target_id": "care unit", "strength": 14}, {"source_id": "care unit", "target_id": "primary outcome", "strength": 14}, {"source_id": "immune response", "target_id": "risk factors", "strength": 14}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "SARS-CoV-2 infection", "strength": 14}, {"source_id": "mechanical ventilation", "target_id": "SARS-CoV-2 infection", "strength": 14}, {"source_id": "patients", "target_id": "high mortality", "strength": 14}, {"source_id": "healthcare workers", "target_id": "infection", "strength": 14}, {"source_id": "risk factors", "target_id": "severe disease", "strength": 14}, {"source_id": "prospective study", "target_id": "patients", "strength": 14}, {"source_id": "SARS-CoV-2", "target_id": "immune system", "strength": 14}, {"source_id": "respiratory failure", "target_id": "COVID-19 patients", "strength": 14}, {"source_id": "blood samples", "target_id": "patients", "strength": 14}, {"source_id": "vaccine dose", "target_id": "dose", "strength": 14}, {"source_id": "countries", "target_id": "COVID-19 pandemic", "strength": 14}, {"source_id": "logistic regression analysis", "target_id": "risk factors", "strength": 14}, {"source_id": "receptor-binding domain", "target_id": "spike protein", "strength": 14}, {"source_id": "COVID-19", "target_id": "median age", "strength": 15}, {"source_id": "median age", "target_id": "COVID-19", "strength": 15}, {"source_id": "antibody response", "target_id": "infection", "strength": 15}, {"source_id": "patients", "target_id": "diagnosis", "strength": 15}, {"source_id": "primary care", "target_id": "patients", "strength": 15}, {"source_id": "patients", "target_id": "primary care", "strength": 15}, {"source_id": "vaccine", "target_id": "systematic review", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "vaccine dose", "strength": 15}, {"source_id": "patients", "target_id": "years of age", "strength": 15}, {"source_id": "government", "target_id": "COVID-19 pandemic", "strength": 15}, {"source_id": "students", "target_id": "educators", "strength": 15}, {"source_id": "COVID-19 patients", "target_id": "ill patients", "strength": 15}, {"source_id": "antibody titers", "target_id": "immune response", "strength": 15}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "SARS-CoV-2 infection", "strength": 15}, {"source_id": "disease progression", "target_id": "COVID-19", "strength": 15}, {"source_id": "vaccine dose", "target_id": "infection", "strength": 15}, {"source_id": "infection", "target_id": "vaccine dose", "strength": 15}, {"source_id": "patients", "target_id": "body mass index", "strength": 15}, {"source_id": "patients", "target_id": "mass index", "strength": 15}, {"source_id": "vaccine", "target_id": "T cells", "strength": 15}, {"source_id": "COVID-19 vaccine", "target_id": "first dose", "strength": 15}, {"source_id": "antibody titers", "target_id": "vaccine", "strength": 15}, {"source_id": "vaccination", "target_id": "adverse events", "strength": 15}, {"source_id": "COVID-19 pandemic", "target_id": "mental health outcomes", "strength": 15}, {"source_id": "coronavirus 2", "target_id": "vaccine", "strength": 15}, {"source_id": "study period", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "patients", "target_id": "D-dimer", "strength": 15}, {"source_id": "retrospective study", "target_id": "COVID-19", "strength": 15}, {"source_id": "SARS-CoV-2 infection", "target_id": "coronavirus 2 infection", "strength": 15}, {"source_id": "coronavirus 2 infection", "target_id": "SARS-CoV-2 infection", "strength": 15}, {"source_id": "students", "target_id": "institutions", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 cases", "strength": 15}, {"source_id": "Delta variant", "target_id": "SARS-CoV-2 infection", "strength": 15}, {"source_id": "SARS-CoV-2 infection", "target_id": "COVID-19 outcomes", "strength": 15}, {"source_id": "mRNA vaccines", "target_id": "vaccine effectiveness", "strength": 15}, {"source_id": "clinical trials", "target_id": "coronavirus disease 2019", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "booster dose", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "clinical outcomes", "strength": 15}, {"source_id": "patients", "target_id": "hospitalization", "strength": 15}, {"source_id": "mental health outcomes", "target_id": "COVID-19 pandemic", "strength": 15}, {"source_id": "cohort study", "target_id": "disease", "strength": 15}, {"source_id": "education", "target_id": "practice", "strength": 15}, {"source_id": "COVID-19 pandemic", "target_id": "government", "strength": 15}, {"source_id": "infection", "target_id": "coronavirus disease 2019", "strength": 15}, {"source_id": "SARS-CoV-2 infection", "target_id": "vaccine dose", "strength": 15}, {"source_id": "body mass index", "target_id": "patients", "strength": 15}, {"source_id": "COVID-19", "target_id": "infectious diseases", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "receptor-binding domain", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "COVID-19 disease", "strength": 15}, {"source_id": "clinical trials", "target_id": "primary outcome", "strength": 15}, {"source_id": "SARS-CoV-2 infection", "target_id": "Delta variant", "strength": 15}, {"source_id": "cohort study", "target_id": "COVID-19 vaccine", "strength": 15}, {"source_id": "COVID-19 outcomes", "target_id": "SARS-CoV-2 infection", "strength": 15}, {"source_id": "COVID-19 infection", "target_id": "mortality", "strength": 15}, {"source_id": "vaccine effectiveness", "target_id": "mRNA vaccines", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "cell responses", "strength": 15}, {"source_id": "observational study", "target_id": "primary outcome", "strength": 15}, {"source_id": "antibody levels", "target_id": "antibody response", "strength": 15}, {"source_id": "antibody response", "target_id": "antibody levels", "strength": 15}, {"source_id": "clinical outcomes", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "observational study", "target_id": "COVID-19 patients", "strength": 15}, {"source_id": "vaccine dose", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "vaccine", "target_id": "coronavirus 2", "strength": 15}, {"source_id": "years of age", "target_id": "patients", "strength": 15}, {"source_id": "disease", "target_id": "cohort study", "strength": 15}, {"source_id": "practice", "target_id": "education", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "study period", "strength": 15}, {"source_id": "ill patients", "target_id": "COVID-19 patients", "strength": 15}, {"source_id": "SARS-CoV-2 infection", "target_id": "syndrome coronavirus 2 infection", "strength": 15}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "SARS-CoV-2 infection", "strength": 15}, {"source_id": "COVID-19", "target_id": "disease progression", "strength": 15}, {"source_id": "vaccine dose", "target_id": "SARS-CoV-2 infection", "strength": 15}, {"source_id": "infectious diseases", "target_id": "COVID-19", "strength": 15}, {"source_id": "mortality", "target_id": "high risk", "strength": 15}, {"source_id": "COVID-19 patients", "target_id": "high risk", "strength": 15}, {"source_id": "primary outcome", "target_id": "clinical trials", "strength": 15}, {"source_id": "health outcomes", "target_id": "mental health", "strength": 15}, {"source_id": "mortality", "target_id": "COVID-19 infection", "strength": 15}, {"source_id": "clinical trials", "target_id": "disease 2019", "strength": 15}, {"source_id": "booster dose", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "diagnosis", "target_id": "patients", "strength": 15}, {"source_id": "systematic review", "target_id": "vaccine", "strength": 15}, {"source_id": "COVID-19 patients", "target_id": "observational study", "strength": 15}, {"source_id": "disease 2019", "target_id": "infection", "strength": 15}, {"source_id": "infection", "target_id": "disease 2019", "strength": 15}, {"source_id": "mass index", "target_id": "patients", "strength": 15}, {"source_id": "high risk", "target_id": "COVID-19 patients", "strength": 15}, {"source_id": "SARS-CoV-2", "target_id": "respiratory tract", "strength": 15}, {"source_id": "receptor-binding domain", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "institutions", "target_id": "students", "strength": 15}, {"source_id": "COVID-19 cases", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "COVID-19", "target_id": "intensive care unit admission", "strength": 15}, {"source_id": "vaccine", "target_id": "antibody titers", "strength": 15}, {"source_id": "cell responses", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "primary outcome", "target_id": "observational study", "strength": 15}, {"source_id": "adverse events", "target_id": "vaccination", "strength": 15}, {"source_id": "hospitalization", "target_id": "patients", "strength": 15}, {"source_id": "infection", "target_id": "antibody response", "strength": 15}, {"source_id": "educators", "target_id": "students", "strength": 15}, {"source_id": "COVID-19", "target_id": "retrospective study", "strength": 15}, {"source_id": "immune response", "target_id": "antibody titers", "strength": 15}, {"source_id": "SARS-CoV-2 infection", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 15}, {"source_id": "coronavirus disease 2019", "target_id": "infection", "strength": 15}, {"source_id": "high risk", "target_id": "mortality", "strength": 15}, {"source_id": "respiratory tract", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "T cells", "target_id": "vaccine", "strength": 15}, {"source_id": "COVID-19 disease", "target_id": "SARS-CoV-2", "strength": 15}, {"source_id": "first dose", "target_id": "COVID-19 vaccine", "strength": 15}, {"source_id": "COVID-19 vaccine", "target_id": "cohort study", "strength": 15}, {"source_id": "mental health", "target_id": "health outcomes", "strength": 15}, {"source_id": "intensive care unit admission", "target_id": "COVID-19", "strength": 15}, {"source_id": "coronavirus disease 2019", "target_id": "clinical trials", "strength": 15}, {"source_id": "disease 2019", "target_id": "clinical trials", "strength": 15}, {"source_id": "dose", "target_id": "second dose", "strength": 16}, {"source_id": "antibody levels", "target_id": "vaccine", "strength": 16}, {"source_id": "SARS-CoV-2 infection", "target_id": "vaccine doses", "strength": 16}, {"source_id": "COVID-19", "target_id": "respiratory symptoms", "strength": 16}, {"source_id": "systematic review", "target_id": "COVID-19 patients", "strength": 16}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "patients", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 16}, {"source_id": "University", "target_id": "learning", "strength": 16}, {"source_id": "control group", "target_id": "primary outcome", "strength": 16}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "immune response", "strength": 16}, {"source_id": "cause mortality", "target_id": "patients", "strength": 16}, {"source_id": "COVID-19 vaccine", "target_id": "booster dose", "strength": 16}, {"source_id": "depressive symptoms", "target_id": "symptoms", "strength": 16}, {"source_id": "cohort study", "target_id": "COVID-19 vaccination", "strength": 16}, {"source_id": "vaccine", "target_id": "coronavirus disease 2019", "strength": 16}, {"source_id": "antibody levels", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "mRNA vaccines", "target_id": "patients", "strength": 16}, {"source_id": "disease severity", "target_id": "severe disease", "strength": 16}, {"source_id": "viral infection", "target_id": "COVID-19", "strength": 16}, {"source_id": "COVID-19", "target_id": "viral infection", "strength": 16}, {"source_id": "intensive care unit admission", "target_id": "patients", "strength": 16}, {"source_id": "COVID-19 pandemic", "target_id": "skills", "strength": 16}, {"source_id": "learning", "target_id": "COVID-19", "strength": 16}, {"source_id": "students", "target_id": "practice", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "strength": 16}, {"source_id": "patients", "target_id": "coronavirus 2 infection", "strength": 16}, {"source_id": "patients", "target_id": "observational cohort study", "strength": 16}, {"source_id": "inclusion criteria", "target_id": "systematic review", "strength": 16}, {"source_id": "people", "target_id": "COVID-19 pandemic", "strength": 16}, {"source_id": "engagement", "target_id": "students", "strength": 16}, {"source_id": "primary outcome", "target_id": "control group", "strength": 16}, {"source_id": "SARS-CoV-2 variants", "target_id": "immune response", "strength": 16}, {"source_id": "T cells", "target_id": "COVID-19", "strength": 16}, {"source_id": "COVID-19", "target_id": "care unit admission", "strength": 16}, {"source_id": "prospective cohort study", "target_id": "patients", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "viral replication", "strength": 16}, {"source_id": "patients", "target_id": "general population", "strength": 16}, {"source_id": "mRNA vaccines", "target_id": "antibody response", "strength": 16}, {"source_id": "humoral response", "target_id": "patients", "strength": 16}, {"source_id": "patients", "target_id": "humoral response", "strength": 16}, {"source_id": "vaccine", "target_id": "antibody levels", "strength": 16}, {"source_id": "severe disease", "target_id": "disease severity", "strength": 16}, {"source_id": "COVID-19", "target_id": "policy", "strength": 16}, {"source_id": "COVID-19 vaccine", "target_id": "systematic review", "strength": 16}, {"source_id": "COVID-19", "target_id": "learning", "strength": 16}, {"source_id": "ill patients", "target_id": "COVID-19", "strength": 16}, {"source_id": "coronavirus 2 infection", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "coronavirus 2 infection", "strength": 16}, {"source_id": "respiratory symptoms", "target_id": "COVID-19", "strength": 16}, {"source_id": "cohort study", "target_id": "hospital admission", "strength": 16}, {"source_id": "hospital admission", "target_id": "cohort study", "strength": 16}, {"source_id": "observational cohort study", "target_id": "patients", "strength": 16}, {"source_id": "systematic review", "target_id": "inclusion criteria", "strength": 16}, {"source_id": "COVID-19 pandemic", "target_id": "people", "strength": 16}, {"source_id": "COVID-19 pandemic", "target_id": "case study", "strength": 16}, {"source_id": "mortality", "target_id": "mechanical ventilation", "strength": 16}, {"source_id": "patients", "target_id": "cause mortality", "strength": 16}, {"source_id": "booster dose", "target_id": "COVID-19 vaccine", "strength": 16}, {"source_id": "symptoms", "target_id": "depressive symptoms", "strength": 16}, {"source_id": "unit admission", "target_id": "COVID-19", "strength": 16}, {"source_id": "second dose", "target_id": "dose", "strength": 16}, {"source_id": "antibody response", "target_id": "mRNA vaccines", "strength": 16}, {"source_id": "COVID-19 patients", "target_id": "adult patients", "strength": 16}, {"source_id": "patients", "target_id": "case report", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 vaccines", "strength": 16}, {"source_id": "learning", "target_id": "experience", "strength": 16}, {"source_id": "skills", "target_id": "COVID-19 pandemic", "strength": 16}, {"source_id": "practice", "target_id": "students", "strength": 16}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "patients", "strength": 16}, {"source_id": "coronavirus 2 infection", "target_id": "patients", "strength": 16}, {"source_id": "COVID-19 patients", "target_id": "systematic review", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "syndrome coronavirus 2 infection", "strength": 16}, {"source_id": "mechanical ventilation", "target_id": "cohort study", "strength": 16}, {"source_id": "physical activity", "target_id": "COVID-19 pandemic", "strength": 16}, {"source_id": "students", "target_id": "engagement", "strength": 16}, {"source_id": "immune response", "target_id": "SARS-CoV-2 vaccines", "strength": 16}, {"source_id": "immune response", "target_id": "SARS-CoV-2 variants", "strength": 16}, {"source_id": "COVID-19", "target_id": "T cells", "strength": 16}, {"source_id": "government", "target_id": "policy", "strength": 16}, {"source_id": "cardiovascular disease", "target_id": "disease", "strength": 16}, {"source_id": "COVID-19 vaccination", "target_id": "cohort study", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "RT-PCR", "strength": 16}, {"source_id": "RT-PCR", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "viral replication", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "general population", "target_id": "patients", "strength": 16}, {"source_id": "patients", "target_id": "mRNA vaccines", "strength": 16}, {"source_id": "vaccine doses", "target_id": "SARS-CoV-2 infection", "strength": 16}, {"source_id": "patients", "target_id": "transplant recipients", "strength": 16}, {"source_id": "patients", "target_id": "intensive care unit admission", "strength": 16}, {"source_id": "adult patients", "target_id": "COVID-19 patients", "strength": 16}, {"source_id": "policy", "target_id": "COVID-19", "strength": 16}, {"source_id": "case report", "target_id": "patients", "strength": 16}, {"source_id": "schools", "target_id": "learning", "strength": 16}, {"source_id": "COVID-19", "target_id": "ill patients", "strength": 16}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "patients", "strength": 16}, {"source_id": "acute respiratory syndrome coronavirus 2 infection", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "syndrome coronavirus 2 infection", "target_id": "patients", "strength": 16}, {"source_id": "patients", "target_id": "syndrome coronavirus 2 infection", "strength": 16}, {"source_id": "cohort study", "target_id": "mechanical ventilation", "strength": 16}, {"source_id": "learning", "target_id": "University", "strength": 16}, {"source_id": "COVID-19 pandemic", "target_id": "physical activity", "strength": 16}, {"source_id": "case report", "target_id": "COVID-19 vaccine", "strength": 16}, {"source_id": "policy", "target_id": "government", "strength": 16}, {"source_id": "primary outcome", "target_id": "mortality", "strength": 16}, {"source_id": "vaccine", "target_id": "disease 2019", "strength": 16}, {"source_id": "patients", "target_id": "prospective cohort study", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "antibody levels", "strength": 16}, {"source_id": "transplant recipients", "target_id": "patients", "strength": 16}, {"source_id": "systematic review", "target_id": "COVID-19 vaccine", "strength": 16}, {"source_id": "SARS-CoV-2 vaccines", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "experience", "target_id": "learning", "strength": 16}, {"source_id": "learning", "target_id": "schools", "strength": 16}, {"source_id": "immune response", "target_id": "humoral response", "strength": 16}, {"source_id": "humoral response", "target_id": "immune response", "strength": 16}, {"source_id": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "patients", "target_id": "acute respiratory syndrome coronavirus 2 infection", "strength": 16}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 virus", "strength": 16}, {"source_id": "SARS-CoV-2 virus", "target_id": "SARS-CoV-2", "strength": 16}, {"source_id": "case study", "target_id": "COVID-19 pandemic", "strength": 16}, {"source_id": "mechanical ventilation", "target_id": "mortality", "strength": 16}, {"source_id": "COVID-19 vaccine", "target_id": "case report", "strength": 16}, {"source_id": "mortality", "target_id": "primary outcome", "strength": 16}, {"source_id": "disease", "target_id": "cardiovascular disease", "strength": 16}, {"source_id": "COVID-19", "target_id": "unit admission", "strength": 16}, {"source_id": "care unit admission", "target_id": "COVID-19", "strength": 16}, {"source_id": "coronavirus disease 2019", "target_id": "vaccine", "strength": 16}, {"source_id": "disease 2019", "target_id": "vaccine", "strength": 16}, {"source_id": "spike protein", "target_id": "vaccine", "strength": 17}, {"source_id": "infection", "target_id": "primary outcome", "strength": 17}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 17}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 17}, {"source_id": "disease 2019 pandemic", "target_id": "coronavirus 2", "strength": 17}, {"source_id": "coronavirus 2", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 17}, {"source_id": "median age", "target_id": "cohort study", "strength": 17}, {"source_id": "vaccine", "target_id": "dose", "strength": 17}, {"source_id": "healthcare workers", "target_id": "SARS-CoV-2 infection", "strength": 17}, {"source_id": "hospital mortality", "target_id": "mortality", "strength": 17}, {"source_id": "clinical trials", "target_id": "SARS-CoV-2 infection", "strength": 17}, {"source_id": "antibody titers", "target_id": "patients", "strength": 17}, {"source_id": "SARS-CoV-2 variants", "target_id": "vaccination", "strength": 17}, {"source_id": "first dose", "target_id": "vaccine", "strength": 17}, {"source_id": "COVID-19", "target_id": "high prevalence", "strength": 17}, {"source_id": "COVID-19 patients", "target_id": "syndrome coronavirus 2", "strength": 17}, {"source_id": "infection", "target_id": "severe COVID-19", "strength": 17}, {"source_id": "disease", "target_id": "risk factors", "strength": 17}, {"source_id": "systematic review", "target_id": "observational study", "strength": 17}, {"source_id": "SARS-CoV-2", "target_id": "vaccine effectiveness", "strength": 17}, {"source_id": "primary outcome", "target_id": "infection", "strength": 17}, {"source_id": "patients", "target_id": "unit admission", "strength": 17}, {"source_id": "syndrome coronavirus 2", "target_id": "disease 2019 pandemic", "strength": 17}, {"source_id": "disease 2019 pandemic", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "disease 2019 pandemic", "target_id": "respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "inclusion criteria", "target_id": "patients", "strength": 17}, {"source_id": "Omicron variant", "target_id": "spike protein", "strength": 17}, {"source_id": "dose", "target_id": "vaccine", "strength": 17}, {"source_id": "SARS-CoV-2 infection", "target_id": "healthcare workers", "strength": 17}, {"source_id": "experience", "target_id": "pandemic", "strength": 17}, {"source_id": "vaccination", "target_id": "SARS-CoV-2 variants", "strength": 17}, {"source_id": "Delta variant", "target_id": "infection", "strength": 17}, {"source_id": "healthy controls", "target_id": "SARS-CoV-2 infection", "strength": 17}, {"source_id": "risk factors", "target_id": "systematic review", "strength": 17}, {"source_id": "coronavirus 2", "target_id": "COVID-19 patients", "strength": 17}, {"source_id": "SARS-CoV-2 variants", "target_id": "vaccine", "strength": 17}, {"source_id": "observational study", "target_id": "systematic review", "strength": 17}, {"source_id": "vaccine effectiveness", "target_id": "SARS-CoV-2", "strength": 17}, {"source_id": "vaccine", "target_id": "side effects", "strength": 17}, {"source_id": "patient outcomes", "target_id": "patients", "strength": 17}, {"source_id": "vaccine", "target_id": "spike protein", "strength": 17}, {"source_id": "unit admission", "target_id": "patients", "strength": 17}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 17}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "disease 2019 pandemic", "strength": 17}, {"source_id": "disease 2019 pandemic", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "disease 2019 pandemic", "target_id": "syndrome coronavirus 2", "strength": 17}, {"source_id": "mRNA vaccination", "target_id": "mRNA vaccines", "strength": 17}, {"source_id": "SARS-CoV-2 infection", "target_id": "clinical trials", "strength": 17}, {"source_id": "cell responses", "target_id": "immune response", "strength": 17}, {"source_id": "SARS-CoV-2 infection", "target_id": "healthy controls", "strength": 17}, {"source_id": "systematic review", "target_id": "risk factors", "strength": 17}, {"source_id": "COVID-19 patients", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "COVID-19 patients", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "COVID-19 patients", "target_id": "coronavirus 2", "strength": 17}, {"source_id": "respiratory failure", "target_id": "COVID-19", "strength": 17}, {"source_id": "side effects", "target_id": "vaccine", "strength": 17}, {"source_id": "patients", "target_id": "patient outcomes", "strength": 17}, {"source_id": "care unit admission", "target_id": "patients", "strength": 17}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "disease 2019 pandemic", "strength": 17}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "syndrome coronavirus 2", "strength": 17}, {"source_id": "risk factors", "target_id": "COVID-19 pandemic", "strength": 17}, {"source_id": "spike protein", "target_id": "Omicron variant", "strength": 17}, {"source_id": "patients", "target_id": "antibody titers", "strength": 17}, {"source_id": "COVID-19 patients", "target_id": "symptoms", "strength": 17}, {"source_id": "vaccine", "target_id": "first dose", "strength": 17}, {"source_id": "infection", "target_id": "Delta variant", "strength": 17}, {"source_id": "high prevalence", "target_id": "COVID-19", "strength": 17}, {"source_id": "University Hospital", "target_id": "patients", "strength": 17}, {"source_id": "mechanical ventilation", "target_id": "intensive care unit", "strength": 17}, {"source_id": "syndrome coronavirus 2", "target_id": "coronavirus disease 2019 (COVID-19) pandemic", "strength": 17}, {"source_id": "coronavirus 2", "target_id": "disease 2019 pandemic", "strength": 17}, {"source_id": "COVID-19 pandemic", "target_id": "risk factors", "strength": 17}, {"source_id": "cohort study", "target_id": "median age", "strength": 17}, {"source_id": "pandemic", "target_id": "experience", "strength": 17}, {"source_id": "medical students", "target_id": "students", "strength": 17}, {"source_id": "immune response", "target_id": "cell responses", "strength": 17}, {"source_id": "vaccine effectiveness", "target_id": "infection", "strength": 17}, {"source_id": "infection", "target_id": "vaccine effectiveness", "strength": 17}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "COVID-19 patients", "strength": 17}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "COVID-19 patients", "strength": 17}, {"source_id": "patients", "target_id": "University Hospital", "strength": 17}, {"source_id": "vaccine", "target_id": "SARS-CoV-2 variants", "strength": 17}, {"source_id": "COVID-19", "target_id": "respiratory failure", "strength": 17}, {"source_id": "patients", "target_id": "care unit admission", "strength": 17}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "disease 2019 pandemic", "strength": 17}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "coronavirus disease 2019 (COVID-19) pandemic", "target_id": "coronavirus 2", "strength": 17}, {"source_id": "patients", "target_id": "inclusion criteria", "strength": 17}, {"source_id": "Omicron infection", "target_id": "Omicron variant", "strength": 17}, {"source_id": "Omicron variant", "target_id": "Omicron infection", "strength": 17}, {"source_id": "mRNA vaccines", "target_id": "mRNA vaccination", "strength": 17}, {"source_id": "mortality", "target_id": "hospital mortality", "strength": 17}, {"source_id": "symptoms", "target_id": "COVID-19 patients", "strength": 17}, {"source_id": "SARS-CoV-2", "target_id": "SARS-CoV-2 RNA", "strength": 17}, {"source_id": "COVID-19 patients", "target_id": "respiratory syndrome coronavirus 2", "strength": 17}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "COVID-19 patients", "strength": 17}, {"source_id": "syndrome coronavirus 2", "target_id": "COVID-19 patients", "strength": 17}, {"source_id": "intervention group", "target_id": "control group", "strength": 17}, {"source_id": "control group", "target_id": "intervention group", "strength": 17}, {"source_id": "severe COVID-19", "target_id": "infection", "strength": 17}, {"source_id": "risk factors", "target_id": "disease", "strength": 17}, {"source_id": "intensive care unit", "target_id": "mechanical ventilation", "strength": 17}, {"source_id": "patients", "target_id": "medical records", "strength": 18}, {"source_id": "vaccine", "target_id": "cohort study", "strength": 18}, {"source_id": "vaccine hesitancy", "target_id": "COVID-19 vaccine", "strength": 18}, {"source_id": "breakthrough infections", "target_id": "SARS-CoV-2", "strength": 18}, {"source_id": "SARS-CoV-2", "target_id": "healthcare workers", "strength": 18}, {"source_id": "symptoms", "target_id": "long COVID", "strength": 18}, {"source_id": "high risk", "target_id": "COVID-19 infection", "strength": 18}, {"source_id": "infection", "target_id": "T cells", "strength": 18}, {"source_id": "immune cells", "target_id": "immune response", "strength": 18}, {"source_id": "education", "target_id": "learners", "strength": 18}, {"source_id": "COVID-19", "target_id": "ICU admission", "strength": 18}, {"source_id": "immune response", "target_id": "syndrome coronavirus 2", "strength": 18}, {"source_id": "mortality", "target_id": "mortality rate", "strength": 18}, {"source_id": "SARS-CoV-2", "target_id": "high risk", "strength": 18}, {"source_id": "high risk", "target_id": "SARS-CoV-2", "strength": 18}, {"source_id": "primary outcome", "target_id": "COVID-19 infection", "strength": 18}, {"source_id": "cohort study", "target_id": "vaccine", "strength": 18}, {"source_id": "COVID-19 vaccine", "target_id": "vaccine hesitancy", "strength": 18}, {"source_id": "immune response", "target_id": "spike protein", "strength": 18}, {"source_id": "immune response", "target_id": "immune cells", "strength": 18}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "immune response", "strength": 18}, {"source_id": "immune response", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 18}, {"source_id": "immune response", "target_id": "respiratory syndrome coronavirus 2", "strength": 18}, {"source_id": "hospital admission", "target_id": "admission", "strength": 18}, {"source_id": "symptoms", "target_id": "mental health", "strength": 18}, {"source_id": "risk factors", "target_id": "logistic regression", "strength": 18}, {"source_id": "myocardial infarction", "target_id": "patients", "strength": 18}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "infection", "strength": 18}, {"source_id": "coronavirus 2", "target_id": "infection", "strength": 18}, {"source_id": "infection", "target_id": "coronavirus 2", "strength": 18}, {"source_id": "third dose", "target_id": "dose", "strength": 18}, {"source_id": "COVID-19 vaccination", "target_id": "adverse events", "strength": 18}, {"source_id": "adverse events", "target_id": "COVID-19 vaccination", "strength": 18}, {"source_id": "schools", "target_id": "COVID-19 pandemic", "strength": 18}, {"source_id": "infection", "target_id": "Omicron infection", "strength": 18}, {"source_id": "students", "target_id": "course", "strength": 18}, {"source_id": "SARS-CoV-2", "target_id": "breakthrough infections", "strength": 18}, {"source_id": "COVID-19 patients", "target_id": "intensive care unit", "strength": 18}, {"source_id": "long COVID", "target_id": "symptoms", "strength": 18}, {"source_id": "COVID-19 infection", "target_id": "high risk", "strength": 18}, {"source_id": "learners", "target_id": "education", "strength": 18}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "immune response", "strength": 18}, {"source_id": "respiratory syndrome coronavirus 2", "target_id": "immune response", "strength": 18}, {"source_id": "syndrome coronavirus 2", "target_id": "immune response", "strength": 18}, {"source_id": "mental health", "target_id": "symptoms", "strength": 18}, {"source_id": "policy", "target_id": "pandemic", "strength": 18}, {"source_id": "acute respiratory syndrome coronavirus 2", "target_id": "infection", "strength": 18}, {"source_id": "syndrome coronavirus 2", "target_id": "infection", "strength": 18}, {"source_id": "COVID-19 pandemic", "target_id": "schools", "strength": 18}, {"source_id": "vaccination", "target_id": "booster vaccination", "strength": 18}, {"source_id": "hospitalized patients", "target_id": "patients", "strength": 18}, {"source_id": "Secondary outcomes", "target_id": "COVID-19", "strength": 18}, {"source_id": "cohort study", "target_id": "logistic regression", "strength": 18}, {"source_id": "COVID-19", "target_id": "hospitalization", "strength": 18}, {"source_id": "mortality rate", "target_id": "mortality", "strength": 18}, {"source_id": "logistic regression", "target_id": "risk factors", "strength": 18}, {"source_id": "pandemic", "target_id": "policy", "strength": 18}, {"source_id": "infection", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 18}, {"source_id": "medical records", "target_id": "patients", "strength": 18}, {"source_id": "course", "target_id": "students", "strength": 18}, {"source_id": "COVID-19", "target_id": "Secondary outcomes", "strength": 18}, {"source_id": "healthcare workers", "target_id": "SARS-CoV-2", "strength": 18}, {"source_id": "logistic regression", "target_id": "cohort study", "strength": 18}, {"source_id": "COVID-19 vaccine", "target_id": "vaccine effectiveness", "strength": 18}, {"source_id": "hospitalization", "target_id": "COVID-19", "strength": 18}, {"source_id": "COVID-19", "target_id": "long COVID", "strength": 18}, {"source_id": "long COVID", "target_id": "COVID-19", "strength": 18}, {"source_id": "T cells", "target_id": "infection", "strength": 18}, {"source_id": "spike protein", "target_id": "immune response", "strength": 18}, {"source_id": "ICU admission", "target_id": "COVID-19", "strength": 18}, {"source_id": "COVID-19 vaccination", "target_id": "mRNA vaccines", "strength": 18}, {"source_id": "immune response", "target_id": "severe acute respiratory syndrome coronavirus 2", "strength": 18}, {"source_id": "care unit", "target_id": "mechanical ventilation", "strength": 18}, {"source_id": "patients", "target_id": "myocardial infarction", "strength": 18}, {"source_id": "infection", "target_id": "syndrome coronavirus 2", "strength": 18}, {"source_id": "dose", "target_id": "third dose", "strength": 18}, {"source_id": "COVID-19 infection", "target_id": "primary outcome", "strength": 18}, {"source_id": "booster vaccination", "target_id": "vaccination", "strength": 18}, {"source_id": "Omicron infection", "target_id": "infection", "strength": 18}, {"source_id": "intensive care unit", "target_id": "COVID-19 patients", "strength": 18}, {"source_id": "vaccine effectiveness", "target_id": "COVID-19 vaccine", "strength": 18}, {"source_id": "mRNA vaccines", "target_id": "COVID-19 vaccination", "strength": 18}, {"source_id": "admission", "target_id": "hospital admission", "strength": 18}, {"source_id": "mechanical ventilation", "target_id": "care unit", "strength": 18}, {"source_id": "severe acute respiratory syndrome coronavirus 2", "target_id": "infection", "strength": 18}, {"source_id": "infection", "target_id": "acute respiratory syndrome coronavirus 2", "strength": 18}, {"source_id": "infection", "target_id": "respiratory syndrome coronavirus 2", "strength": 18}]}}